data_2rs8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rs8 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -95.32 124.89 39.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.588 1.555 . . . . 0.0 111.253 -171.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.5 mt -109.03 134.82 51.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.241 1.817 . . . . 0.0 110.328 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -89.56 137.85 31.97 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 127.092 2.157 . . . . 0.0 107.717 169.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.41 111.07 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.841 0.856 . . . . 0.0 109.153 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.8 172.26 15.72 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.626 1.584 . . . . 0.0 113.097 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.6 m120 61.74 30.63 18.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.005 1.322 . . . . 0.0 111.807 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.54 140.66 96.63 Favored Pre-proline 0 CA--C 1.546 0.82 0 O-C-N 121.459 -0.776 . . . . 0.0 111.21 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.2 161.59 39.64 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.225 2.617 . . . . 0.0 111.165 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.87 -7.2 18.2 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.396 2.731 . . . . 0.0 112.676 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -102.87 11.47 37.43 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.797 2.039 . . . . 0.0 112.701 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.04 147.23 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 120.863 -1.148 . . . . 0.0 110.894 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.5 p -133.19 167.16 20.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.045 1.738 . . . . 0.0 109.671 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.55 -32.74 67.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.106 0.562 . . . . 0.0 111.488 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.52 -38.05 59.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.146 0.978 . . . . 0.0 112.473 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -63.95 -42.85 97.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.872 0.76 . . . . 0.0 110.659 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.8 ttt -68.99 -37.32 78.68 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.321 0.649 . . . . 0.0 112.127 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -62.68 -42.83 99.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.721 0.808 . . . . 0.0 111.225 171.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.92 -42.55 85.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.116 0.967 . . . . 0.0 113.212 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.6 mt -56.74 -25.02 53.79 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.74 1.216 . . . . 0.0 113.315 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -110.44 5.7 21.59 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.229 1.412 . . . . 0.0 113.464 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -67.33 -21.5 65.65 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.127 -0.983 . . . . 0.0 113.371 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -22.9 67.11 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.11 1.364 . . . . 0.0 112.388 172.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -105.67 7.26 32.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.568 1.947 . . . . 0.0 112.465 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.31 177.26 51.78 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.207 1.384 . . . . 0.0 113.069 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -71.37 130.08 40.44 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.805 -0.821 . . . . 0.0 111.347 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.21 153.4 42.49 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.351 1.06 . . . . 0.0 112.211 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.24 -17.29 67.18 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.816 1.198 . . . . 0.0 113.537 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -154.48 146.03 23.18 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.736 1.214 . . . . 0.0 110.809 170.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.2 t -145.22 126.47 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 126.456 1.902 . . . . 0.0 109.247 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -141.8 144.1 33.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.05 1.34 . . . . 0.0 112.316 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.3 mt -140.67 133.83 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 126.142 1.777 . . . . 0.0 108.483 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -124.88 107.49 10.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.954 0.902 . . . . 0.0 112.043 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -72.14 -27.24 62.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -171.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.67 -11.68 60.49 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.897 0.879 . . . . 0.0 113.27 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -114.8 -31.34 6.16 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.942 1.297 . . . . 0.0 113.204 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.5 29.34 19.42 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.744 1.164 . . . . 0.0 113.985 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -138.74 155.38 48.26 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.317 1.447 . . . . 0.0 112.022 -173.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.06 170.82 25.19 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.198 1.38 . . . . 0.0 113.49 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -144.78 144.03 30.96 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.197 1.799 . . . . 0.0 109.412 -173.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.1 tt -153.83 134.99 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.522 0.729 . . . . 0.0 110.6 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -125.79 117.99 24.58 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.898 0.879 . . . . 0.0 110.04 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.92 178.65 5.59 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.765 0.826 . . . . 0.0 111.965 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -80.85 -27.32 36.49 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.1 p -144.19 158.07 43.94 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.366 1.066 . . . . 0.0 111.792 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -57.44 -37.82 73.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.935 0.894 . . . . 0.0 112.404 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.0 m -62.06 -47.42 84.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.189 1.396 . . . . 0.0 110.794 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.03 -42.98 99.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.11 0.564 . . . . 0.0 111.305 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.53 -35.94 80.05 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.59 -47.74 71.77 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.2 1.0 . . . . 0.0 111.347 173.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.47 -47.63 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.715 -0.615 . . . . 0.0 110.14 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.06 -45.52 86.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.71 0.804 . . . . 0.0 112.249 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -55.58 -50.6 69.65 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.206 -0.934 . . . . 0.0 111.697 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.1 t -65.47 -34.01 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.762 0.71 . . . . 0.0 112.29 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -82.75 -32.69 27.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 61.0 mt -105.48 -20.42 13.48 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.275 1.584 . . . . 0.0 115.275 -168.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -70.5 128.61 36.73 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.514 1.052 . . . . 0.0 111.421 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 58.0 t30 69.02 13.73 8.79 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.394 2.278 . . . . 0.0 114.186 -171.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.5 ttp -72.48 138.65 80.85 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 120.569 -1.332 . . . . 0.0 110.894 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -74.37 134.31 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.448 2.766 . . . . 0.0 111.153 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 45.1 tp -143.22 115.99 8.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.49 1.516 . . . . 0.0 110.172 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 57.57 21.74 7.45 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.241 1.416 . . . . 0.0 113.471 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.28 -3.02 68.94 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.925 1.726 . . . . 0.0 115.083 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -97.08 156.15 16.5 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.723 1.609 . . . . 0.0 110.959 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -105.58 117.09 33.14 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.265 -0.897 . . . . 0.0 109.366 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.3 mt -72.71 136.01 45.48 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.96 0.904 . . . . 0.0 112.226 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.0 tpp180 -99.77 124.29 44.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.619 1.168 . . . . 0.0 108.767 169.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.74 128.06 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.985 0.914 . . . . 0.0 109.75 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -150.7 160.16 44.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.863 1.265 . . . . 0.0 111.192 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -68.69 132.61 47.14 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.721 -0.612 . . . . 0.0 110.356 170.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.183 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -83.27 129.01 34.98 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.335 1.454 . . . . 0.0 110.468 -176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.4 mt -113.98 134.38 54.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.146 1.778 . . . . 0.0 110.056 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -89.26 137.4 32.36 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.141 2.176 . . . . 0.0 108.529 170.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -130.06 109.93 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.126 0.97 . . . . 0.0 109.415 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.1 173.8 20.11 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.21 1.862 . . . . 0.0 113.328 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.1 m120 64.0 19.59 11.82 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.951 1.701 . . . . 0.0 113.276 -173.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.67 140.63 92.78 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.067 -1.021 . . . . 0.0 112.778 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -69.44 157.35 61.34 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.856 3.037 . . . . 0.0 110.991 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.66 -5.47 17.12 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.26 2.64 . . . . 0.0 113.164 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -104.38 9.74 35.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.338 1.855 . . . . 0.0 113.321 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.2 tp -82.04 144.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.091 -1.006 . . . . 0.0 111.016 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.9 p -135.12 166.57 22.76 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.492 1.917 . . . . 0.0 109.303 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -60.73 -27.34 67.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.859 0.464 . . . . 0.0 112.012 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -72.9 -40.0 65.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.983 0.913 . . . . 0.0 111.773 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -65.42 -42.3 92.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.409 0.55 . . . . 0.0 111.004 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.3 ttt -69.12 -36.76 77.86 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.621 0.768 . . . . 0.0 112.221 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -61.62 -46.61 89.07 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.742 0.817 . . . . 0.0 110.79 169.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -66.38 -39.8 89.31 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.0 mt -59.62 -22.85 62.42 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.074 1.35 . . . . 0.0 113.694 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -116.09 7.83 14.33 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.437 1.495 . . . . 0.0 112.569 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -68.72 -22.0 64.37 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -169.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -67.13 -22.28 65.8 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.286 -0.883 . . . . 0.0 112.207 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -93.92 10.8 31.88 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.414 1.886 . . . . 0.0 112.589 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.48 -175.94 53.55 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.334 1.445 . . . . 0.0 113.189 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -72.1 128.92 37.2 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.992 -0.71 . . . . 0.0 111.186 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.35 147.08 48.37 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.959 0.904 . . . . 0.0 111.673 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.05 -1.28 82.25 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.831 1.205 . . . . 0.0 113.819 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -162.76 128.63 3.34 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.496 1.918 . . . . 0.0 108.18 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.71 123.32 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.745 1.218 . . . . 0.0 108.917 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -141.22 137.79 32.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.976 1.311 . . . . 0.0 110.927 176.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.7 mt -137.76 126.77 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.42 1.488 . . . . 0.0 108.359 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -118.32 108.42 15.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.281 1.033 . . . . 0.0 112.02 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -71.62 -30.6 65.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.019 0.928 . . . . 0.0 113.285 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.78 -20.22 61.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.049 0.94 . . . . 0.0 113.454 -176.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -112.83 -24.47 9.55 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.54 38.15 7.76 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 124.76 1.172 . . . . 0.0 114.154 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -140.62 152.99 45.87 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.16 1.384 . . . . 0.0 112.122 -173.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.37 161.48 24.97 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.029 1.3 . . . . 0.0 113.553 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.45 138.11 34.43 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.486 1.914 . . . . 0.0 109.476 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.4 tt -147.81 135.13 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 110.713 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -118.71 123.52 45.08 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.543 0.737 . . . . 0.0 110.749 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.64 170.33 9.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.711 0.804 . . . . 0.0 110.887 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.43 -22.27 51.74 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.8 p -146.26 144.05 29.6 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.747 1.219 . . . . 0.0 111.951 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -32.53 71.45 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 m -63.92 -48.15 77.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.578 1.151 . . . . 0.0 110.756 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.18 -35.77 82.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.844 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.17 86.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.033 0.833 . . . . 0.0 112.736 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.09 -47.39 71.36 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.176 0.898 . . . . 0.0 111.812 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.9 mt -60.08 -50.12 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.778 -0.576 . . . . 0.0 110.044 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.02 -43.55 91.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.626 0.77 . . . . 0.0 111.87 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -57.24 -47.91 80.16 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.076 0.853 . . . . 0.0 111.586 174.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 78.6 t -71.09 -34.94 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 118.802 0.728 . . . . 0.0 112.176 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -82.79 -28.86 30.0 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 55.5 mt -99.31 -16.25 18.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.165 0.986 . . . . 0.0 113.374 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.96 116.6 2.84 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.022 1.729 . . . . 0.0 111.885 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.0 m120 64.32 19.47 11.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.138 2.175 . . . . 0.0 114.286 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.9 ttp -70.5 137.12 86.04 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 120.703 -1.248 . . . . 0.0 110.858 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.27 139.28 23.42 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.356 2.704 . . . . 0.0 111.437 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.9 tp -142.08 115.2 8.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.684 1.594 . . . . 0.0 109.801 173.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 57.18 25.22 10.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.931 1.292 . . . . 0.0 113.768 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.54 -3.67 83.64 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.542 1.544 . . . . 0.0 114.706 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -95.66 161.39 14.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.551 1.54 . . . . 0.0 111.047 172.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -88.24 176.05 7.41 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.79 169.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.0 mt -134.51 115.07 13.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.525 1.13 . . . . 0.0 109.704 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -91.97 115.91 28.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.629 0.771 . . . . 0.0 109.064 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.4 t -119.6 123.31 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.904 0.882 . . . . 0.0 110.503 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -139.94 164.61 29.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.029 1.732 . . . . 0.0 111.387 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -79.04 126.84 31.23 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.532 -0.73 . . . . 0.0 111.051 169.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 125.74 1.616 . . . . 0.0 110.603 176.068 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.7 p . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -95.11 128.27 41.81 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.829 1.652 . . . . 0.0 111.257 -169.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -111.18 137.98 48.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.381 1.872 . . . . 0.0 110.474 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -92.47 136.3 33.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.371 2.268 . . . . 0.0 108.596 169.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.8 t -128.71 116.06 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.469 1.108 . . . . 0.0 109.024 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.88 165.51 14.03 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 125.013 1.292 . . . . 0.0 114.561 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 64.76 33.1 10.59 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.691 1.596 . . . . 0.0 111.658 -174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 mt -66.19 143.29 98.28 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 121.143 -0.973 . . . . 0.0 112.144 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.27 163.81 37.34 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.167 3.245 . . . . 0.0 111.506 174.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.0 -7.68 19.39 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.243 2.629 . . . . 0.0 113.195 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -94.87 7.75 44.96 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.725 1.61 . . . . 0.0 113.528 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 tp -97.43 135.95 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.644 1.178 . . . . 0.0 111.398 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.8 p -131.23 179.6 5.92 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.594 1.558 . . . . 0.0 109.235 169.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -57.31 -25.37 59.21 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.712 0.805 . . . . 0.0 112.549 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.45 -47.79 38.77 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.979 -1.076 . . . . 0.0 111.808 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -63.72 -41.54 98.05 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.078 0.551 . . . . 0.0 111.115 174.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.9 ttt -67.78 -33.14 74.24 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -67.56 -40.05 84.92 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.877 0.762 . . . . 0.0 111.447 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.8 -42.42 81.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.9 0.88 . . . . 0.0 112.683 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.7 mt -57.4 -28.18 63.01 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.404 1.482 . . . . 0.0 113.526 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -110.49 9.18 23.27 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.339 1.456 . . . . 0.0 112.677 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.29 -25.12 67.91 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -62.57 -22.82 66.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.955 1.302 . . . . 0.0 112.987 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -102.88 9.88 38.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.324 1.85 . . . . 0.0 112.644 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.78 -179.05 53.52 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.233 0.921 . . . . 0.0 112.612 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.52 141.28 50.13 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.79 -0.829 . . . . 0.0 112.175 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.41 150.42 27.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.483 1.113 . . . . 0.0 112.133 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.06 -9.42 73.69 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.205 1.384 . . . . 0.0 113.886 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -155.91 137.41 14.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.577 1.951 . . . . 0.0 108.409 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.2 t -143.87 127.24 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.448 1.499 . . . . 0.0 109.174 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -144.9 142.56 29.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.312 1.445 . . . . 0.0 112.201 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 57.4 mt -141.02 131.84 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.455 1.902 . . . . 0.0 108.838 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -125.28 113.17 17.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.094 0.957 . . . . 0.0 111.86 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -72.79 -36.19 67.56 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -170.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.39 -24.6 62.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.741 0.817 . . . . 0.0 113.043 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -100.19 -27.87 13.3 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.237 1.015 . . . . 0.0 113.346 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.81 29.78 19.91 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.798 1.19 . . . . 0.0 114.304 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -137.8 156.59 47.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.245 1.418 . . . . 0.0 112.267 -172.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.28 168.79 26.54 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.215 1.388 . . . . 0.0 113.417 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -142.52 149.68 39.45 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.034 1.733 . . . . 0.0 110.402 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.6 tt -155.31 141.92 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.233 1.013 . . . . 0.0 110.492 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -123.7 123.93 41.61 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.944 0.793 . . . . 0.0 111.308 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.4 mt -95.44 167.43 11.32 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.998 0.919 . . . . 0.0 110.639 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.29 -13.25 61.09 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.2 p -147.32 157.72 43.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.288 1.435 . . . . 0.0 111.684 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -60.12 -32.27 70.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.758 0.823 . . . . 0.0 113.1 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 m -63.97 -48.49 76.25 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.394 1.478 . . . . 0.0 110.506 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.66 -41.45 99.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.136 0.574 . . . . 0.0 111.202 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.63 87.26 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.48 -50.29 70.23 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.306 0.957 . . . . 0.0 111.969 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 83.4 mt -61.31 -47.92 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.752 -0.593 . . . . 0.0 110.289 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.14 95.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.703 0.801 . . . . 0.0 111.998 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.26 -44.57 92.41 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.213 -0.929 . . . . 0.0 112.042 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.2 t -66.72 -36.89 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.268 0.627 . . . . 0.0 111.918 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -85.23 -28.55 25.32 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.5 mt -103.69 -18.84 14.54 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.64 140.83 58.91 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.4 1.0 . . . . 0.0 111.127 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . 0.298 12.0 p30 55.15 18.99 2.62 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.327 2.251 . . . . 0.0 114.966 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.2 ttp -76.29 139.5 68.32 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.092 1.357 . . . . 0.0 111.109 173.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.83 138.88 19.19 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.546 2.831 . . . . 0.0 111.371 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -149.11 122.63 9.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.698 1.599 . . . . 0.0 109.726 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 56.51 32.19 20.33 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.758 1.223 . . . . 0.0 113.235 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.36 4.46 89.96 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.122 1.344 . . . . 0.0 114.637 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.45 156.92 20.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.492 1.917 . . . . 0.0 110.633 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -90.08 167.83 12.45 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.764 -0.585 . . . . 0.0 109.893 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.9 mt -129.77 140.32 51.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.69 1.196 . . . . 0.0 110.857 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -102.93 130.59 50.04 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.868 1.267 . . . . 0.0 108.312 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.39 120.42 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.136 0.88 . . . . 0.0 110.347 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -140.02 167.76 21.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.427 1.891 . . . . 0.0 110.554 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -75.94 134.44 40.22 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.575 -0.703 . . . . 0.0 111.127 169.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.886 0 C-N-CA 124.552 1.141 . . . . 0.0 113.054 172.765 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.64 134.73 34.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.705 1.202 . . . . 0.0 110.483 172.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.1 mt -111.54 133.98 53.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.147 1.379 . . . . 0.0 110.056 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -85.57 144.76 27.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.225 2.21 . . . . 0.0 108.004 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.53 110.02 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.192 0.997 . . . . 0.0 109.185 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.65 169.94 13.69 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.501 1.524 . . . . 0.0 113.249 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 65.47 29.04 11.43 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.381 1.473 . . . . 0.0 111.819 -173.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.8 mt -65.6 144.08 98.81 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.848 -1.157 . . . . 0.0 111.928 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.4 159.39 50.55 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.224 2.616 . . . . 0.0 111.292 174.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.08 -0.47 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.484 2.789 . . . . 0.0 113.299 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -114.38 7.35 16.31 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.732 1.613 . . . . 0.0 113.083 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.9 tp -73.28 145.54 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.789 0.836 . . . . 0.0 111.126 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.8 p -127.7 163.03 25.18 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.654 1.582 . . . . 0.0 110.079 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.98 -28.09 67.39 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.323 0.649 . . . . 0.0 111.687 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.24 -41.94 69.49 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.122 0.969 . . . . 0.0 111.507 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -66.07 -37.56 86.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.84 -0.537 . . . . 0.0 111.494 172.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.9 ttt -68.07 -38.98 83.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.536 0.734 . . . . 0.0 112.064 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -62.39 -37.55 86.17 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.107 0.963 . . . . 0.0 111.939 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -71.52 -42.74 67.59 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.412 -0.805 . . . . 0.0 112.453 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.6 mt -57.94 -27.86 63.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.862 1.265 . . . . 0.0 113.082 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -108.82 11.94 25.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.371 1.469 . . . . 0.0 112.769 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.73 -22.31 66.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.093 -1.004 . . . . 0.0 113.684 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -61.1 -22.79 64.98 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.895 1.278 . . . . 0.0 112.616 171.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -108.39 12.14 26.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.784 2.033 . . . . 0.0 112.375 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.18 -172.36 55.18 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.465 1.031 . . . . 0.0 112.94 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -71.47 133.73 46.06 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.989 0.916 . . . . 0.0 111.026 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.11 150.68 31.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.592 1.157 . . . . 0.0 112.02 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.45 -11.84 74.14 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.614 1.102 . . . . 0.0 114.138 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -159.87 138.77 10.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.065 1.746 . . . . 0.0 109.28 174.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.0 t -139.09 130.92 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.934 1.693 . . . . 0.0 109.222 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -141.59 141.03 33.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.21 1.404 . . . . 0.0 111.443 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.3 mt -140.6 129.34 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.011 1.724 . . . . 0.0 107.929 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -118.15 108.7 15.5 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.721 0.772 . . . . 0.0 112.324 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -72.26 -19.65 61.66 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -81.2 -13.75 58.25 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.192 0.997 . . . . 0.0 112.992 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -117.07 -25.66 7.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.916 1.286 . . . . 0.0 113.987 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.43 27.73 35.18 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 124.482 1.039 . . . . 0.0 114.257 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -134.5 149.96 50.75 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.419 1.488 . . . . 0.0 111.616 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.67 166.87 25.23 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.38 1.467 . . . . 0.0 113.134 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -146.19 143.28 29.17 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.342 1.857 . . . . 0.0 109.745 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.1 tt -150.95 133.39 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.078 0.951 . . . . 0.0 110.974 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -112.88 122.12 46.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.172 0.989 . . . . 0.0 110.541 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.27 163.48 12.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.688 0.795 . . . . 0.0 111.063 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.6 -23.77 53.45 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -171.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.5 p -148.71 143.6 26.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.402 1.481 . . . . 0.0 111.642 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -58.95 -32.92 70.06 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.7 m -59.43 -48.59 81.06 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.987 1.315 . . . . 0.0 111.032 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.07 -37.9 89.11 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.388 0.675 . . . . 0.0 111.817 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.51 -33.62 73.1 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.2 -46.78 72.88 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.831 0.852 . . . . 0.0 111.545 171.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.75 -47.46 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.72 -0.613 . . . . 0.0 110.061 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.96 -45.18 91.15 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.899 0.88 . . . . 0.0 112.218 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -55.47 -50.55 69.58 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.076 -1.015 . . . . 0.0 111.66 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.62 -34.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.695 0.68 . . . . 0.0 112.287 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -82.37 -32.89 29.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.8 mt -105.91 -19.57 13.7 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -168.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -71.97 127.46 32.63 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.696 1.135 . . . . 0.0 111.235 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 71.49 12.37 6.53 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.843 2.457 . . . . 0.0 113.736 -169.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.6 ttp -72.63 134.35 81.91 Favored Pre-proline 0 N--CA 1.473 0.691 0 O-C-N 120.574 -1.329 . . . . 0.0 110.767 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.61 132.29 15.8 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.065 2.51 . . . . 0.0 110.801 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 tp -137.29 104.76 5.49 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.514 1.126 . . . . 0.0 110.235 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.5 mtp-105 58.93 26.42 14.93 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.043 1.337 . . . . 0.0 113.691 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.94 -12.53 60.74 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.112 1.815 . . . . 0.0 114.576 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -82.09 163.86 21.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.578 1.189 . . . . 0.0 111.512 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -128.98 105.52 8.26 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.816 1.247 . . . . 0.0 108.878 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.81 125.13 25.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.008 1.323 . . . . 0.0 112.749 -168.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -93.06 118.02 30.72 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.264 1.025 . . . . 0.0 109.313 173.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.32 126.23 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.068 0.947 . . . . 0.0 109.943 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -143.33 159.73 41.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.753 1.621 . . . . 0.0 110.475 -173.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -81.31 124.62 29.5 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.504 -0.747 . . . . 0.0 110.792 170.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.823 0 C-N-CA 124.149 0.98 . . . . 0.0 111.231 174.899 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -76.91 128.82 35.26 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.092 1.357 . . . . 0.0 111.848 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.5 mt -105.26 141.58 36.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.574 1.95 . . . . 0.0 110.437 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -96.94 143.68 27.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.526 2.33 . . . . 0.0 108.474 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.2 t -132.56 115.89 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.184 0.994 . . . . 0.0 109.782 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.98 173.26 16.5 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 125.912 1.72 . . . . 0.0 113.226 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m120 64.95 20.47 12.12 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.956 1.702 . . . . 0.0 113.093 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.9 mt -61.6 140.75 95.05 Favored Pre-proline 0 CA--C 1.549 0.936 0 O-C-N 121.198 -0.939 . . . . 0.0 112.319 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.41 164.4 35.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.369 3.38 . . . . 0.0 111.898 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.88 5.8 4.19 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.837 3.024 . . . . 0.0 113.691 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.3 p30 -128.15 13.9 6.71 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.969 1.708 . . . . 0.0 114.042 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.8 tp -80.12 143.63 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.123 0.969 . . . . 0.0 110.423 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.3 p -132.8 167.25 20.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.126 1.77 . . . . 0.0 109.677 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.67 -28.47 68.63 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.641 0.376 . . . . 0.0 111.82 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -70.43 -45.56 65.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.346 1.058 . . . . 0.0 110.975 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -65.2 -38.66 91.16 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.719 -0.613 . . . . 0.0 111.695 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.6 ttt -69.44 -38.2 77.73 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.646 0.657 . . . . 0.0 111.98 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -63.66 -37.22 86.5 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.435 -0.791 . . . . 0.0 111.992 170.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.3 -43.1 64.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.087 0.955 . . . . 0.0 111.872 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.6 mt -57.02 -28.85 62.86 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.058 1.343 . . . . 0.0 113.343 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -105.45 8.17 33.4 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.311 1.444 . . . . 0.0 112.693 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.09 -25.74 67.92 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -169.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -64.41 -21.54 66.67 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.696 0.798 . . . . 0.0 112.724 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -102.96 6.33 38.85 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.096 1.758 . . . . 0.0 112.097 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.13 173.7 46.26 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.174 1.369 . . . . 0.0 112.587 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -67.18 136.04 54.43 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.497 -1.001 . . . . 0.0 111.317 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.08 157.24 37.22 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.927 0.891 . . . . 0.0 112.071 173.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.06 -12.07 62.37 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.048 1.308 . . . . 0.0 113.753 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -152.77 137.09 16.61 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.901 1.68 . . . . 0.0 109.28 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.0 127.81 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.06 1.744 . . . . 0.0 108.853 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -143.96 140.48 29.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.836 1.254 . . . . 0.0 111.454 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.7 mt -139.85 129.4 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.859 1.664 . . . . 0.0 108.276 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -122.23 112.95 18.79 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.841 0.857 . . . . 0.0 112.56 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -70.5 -35.19 73.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 113.613 -173.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.23 -23.66 61.27 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.805 0.842 . . . . 0.0 113.044 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -103.3 -26.48 12.93 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.23 35.68 14.34 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 124.876 1.227 . . . . 0.0 114.115 175.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -140.64 153.16 45.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.21 1.404 . . . . 0.0 112.366 -172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.06 158.14 22.99 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.359 1.456 . . . . 0.0 113.092 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -138.67 137.84 37.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.83 2.052 . . . . 0.0 109.012 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.3 tt -151.81 130.39 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.535 0.734 . . . . 0.0 110.971 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -119.15 113.56 21.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.948 0.899 . . . . 0.0 110.409 -170.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.0 mt -90.73 166.07 13.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.641 0.777 . . . . 0.0 111.124 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -78.56 -17.95 55.36 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.0 p -144.04 157.32 44.4 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.773 1.229 . . . . 0.0 111.616 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -59.6 -40.33 87.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.789 0.835 . . . . 0.0 111.429 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.7 m -58.88 -47.53 84.62 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.011 1.325 . . . . 0.0 111.212 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.3 -42.9 99.08 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.265 0.626 . . . . 0.0 111.179 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.03 -36.27 83.84 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.03 -46.5 71.03 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.888 0.875 . . . . 0.0 111.697 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.95 -47.96 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.633 -0.667 . . . . 0.0 110.102 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.76 -44.35 93.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.423 0.689 . . . . 0.0 112.104 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -54.57 -52.58 61.66 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.258 0.935 . . . . 0.0 111.507 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.29 -34.3 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.382 0.537 . . . . 0.0 111.961 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -81.03 -36.05 31.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.5 -21.78 17.5 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -170.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.31 127.24 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.02 0.827 . . . . 0.0 111.276 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 71.2 11.75 6.82 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.28 2.232 . . . . 0.0 113.786 -173.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.9 ttp -74.33 137.34 75.02 Favored Pre-proline 0 N--CA 1.475 0.796 0 O-C-N 120.549 -1.344 . . . . 0.0 110.893 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.67 141.07 24.37 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.256 2.637 . . . . 0.0 111.191 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.6 tp -137.04 104.25 5.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.512 1.525 . . . . 0.0 110.059 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 59.03 22.56 10.6 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.594 1.558 . . . . 0.0 114.256 172.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.37 -9.97 49.9 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.994 1.759 . . . . 0.0 114.788 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -94.27 166.44 12.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.796 1.298 . . . . 0.0 111.254 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -96.62 176.18 6.11 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.089 0.956 . . . . 0.0 110.401 169.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.8 mt -135.7 116.66 14.22 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.608 1.163 . . . . 0.0 109.723 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -95.77 111.09 23.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.734 0.814 . . . . 0.0 108.955 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.81 130.51 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.127 0.971 . . . . 0.0 109.54 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -150.99 163.76 37.98 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.401 1.48 . . . . 0.0 111.077 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -72.67 137.76 46.23 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.535 -0.728 . . . . 0.0 110.83 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.829 0 C-N-CA 124.979 1.312 . . . . 0.0 113.084 177.001 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -80.97 123.33 28.24 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.367 1.467 . . . . 0.0 111.015 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -115.07 140.78 48.78 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.829 1.652 . . . . 0.0 110.795 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -95.92 140.17 31.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.257 2.223 . . . . 0.0 108.669 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.52 108.38 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.301 1.04 . . . . 0.0 109.31 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.06 171.63 19.93 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.337 1.446 . . . . 0.0 112.873 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.0 m120 62.09 31.15 17.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.007 1.323 . . . . 0.0 111.923 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.9 mt -66.67 143.32 98.06 Favored Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 121.457 -0.777 . . . . 0.0 111.395 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.35 162.06 40.44 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.193 2.595 . . . . 0.0 111.158 170.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.99 -7.61 18.37 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.249 2.633 . . . . 0.0 112.413 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -96.14 6.95 47.68 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.559 1.944 . . . . 0.0 113.332 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -81.97 146.56 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.211 -0.931 . . . . 0.0 111.029 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.7 p -134.0 166.34 22.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.073 1.749 . . . . 0.0 109.351 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -61.58 -25.54 67.39 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.13 -40.8 59.47 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.164 0.986 . . . . 0.0 111.67 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -64.38 -41.97 96.41 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.494 0.588 . . . . 0.0 110.637 171.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.3 ttt -68.43 -36.55 79.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.534 0.734 . . . . 0.0 112.394 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -62.51 -41.55 98.92 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.716 0.689 . . . . 0.0 111.567 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -71.43 -39.75 70.85 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.976 0.807 . . . . 0.0 112.919 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -57.65 -22.59 46.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.148 1.379 . . . . 0.0 113.581 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -114.57 11.45 17.04 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.752 1.621 . . . . 0.0 112.616 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.4 -23.38 67.27 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -63.33 -23.33 67.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.177 1.391 . . . . 0.0 112.989 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -106.56 9.83 31.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.048 1.739 . . . . 0.0 112.598 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.44 -175.45 50.99 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.026 1.298 . . . . 0.0 113.121 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -73.77 128.48 35.63 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.094 -0.651 . . . . 0.0 110.944 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.05 143.34 47.52 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.239 1.015 . . . . 0.0 111.562 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.22 -11.9 82.94 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.973 0.797 . . . . 0.0 113.936 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -158.71 138.03 11.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.095 1.758 . . . . 0.0 109.389 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.56 127.39 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.873 1.669 . . . . 0.0 108.534 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -144.79 143.84 30.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.843 1.257 . . . . 0.0 112.018 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.1 mt -140.77 132.79 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.144 1.777 . . . . 0.0 108.687 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -125.59 104.95 8.67 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.936 0.895 . . . . 0.0 112.066 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.08 -23.97 60.6 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -172.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -72.92 -14.22 61.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.24 1.016 . . . . 0.0 113.339 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -117.22 -19.87 9.46 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.958 1.303 . . . . 0.0 114.005 173.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.2 26.45 40.3 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 124.826 1.203 . . . . 0.0 114.213 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -130.87 145.98 52.16 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.013 1.325 . . . . 0.0 112.196 -172.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.05 162.38 24.24 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.691 1.615 . . . . 0.0 112.576 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -143.19 136.47 28.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.485 1.914 . . . . 0.0 108.632 -170.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.2 tt -149.23 143.36 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.455 0.702 . . . . 0.0 111.099 -175.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.2 112.68 17.97 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.976 1.31 . . . . 0.0 110.135 -172.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.0 mt -89.67 175.76 7.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.389 0.54 . . . . 0.0 111.726 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.23 -26.43 58.91 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.3 p -144.54 159.27 43.06 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.684 1.193 . . . . 0.0 111.95 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -60.59 -33.64 73.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.804 0.842 . . . . 0.0 112.357 170.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.8 m -67.2 -45.88 75.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.461 1.504 . . . . 0.0 111.024 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.7 mt -61.19 -39.88 91.83 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.182 0.593 . . . . 0.0 111.131 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.84 -35.69 77.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -60.93 -51.56 68.75 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.398 0.999 . . . . 0.0 110.882 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.33 -49.09 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.3 0.64 . . . . 0.0 110.565 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.46 86.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.517 0.727 . . . . 0.0 111.819 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.44 -45.29 91.98 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.272 -0.892 . . . . 0.0 111.748 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.12 -33.27 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.837 0.855 . . . . 0.0 112.31 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -86.12 -24.66 26.14 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.9 mt -107.03 -16.95 14.31 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -170.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.81 134.2 52.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.204 1.365 . . . . 0.0 112.074 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.2 t30 65.57 14.31 9.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.901 2.08 . . . . 0.0 113.845 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.1 ttp -72.77 135.84 80.63 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 120.56 -1.337 . . . . 0.0 110.559 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.71 131.8 13.86 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.488 2.792 . . . . 0.0 110.869 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.9 tp -143.47 115.44 8.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.151 1.38 . . . . 0.0 109.55 174.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 53.55 35.51 21.06 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.789 1.236 . . . . 0.0 112.951 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.7 1.84 89.94 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.556 1.55 . . . . 0.0 115.204 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -105.91 149.5 26.51 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.762 1.625 . . . . 0.0 110.854 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -104.44 110.85 23.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.029 0.932 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 82.1 mt -72.23 125.69 27.94 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.874 0.87 . . . . 0.0 112.513 -169.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.17 105.97 18.2 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.979 0.912 . . . . 0.0 109.04 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.7 t -114.66 131.39 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.023 0.929 . . . . 0.0 110.123 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -153.37 169.27 23.52 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.569 1.548 . . . . 0.0 111.218 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -70.62 138.88 51.15 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.519 -0.738 . . . . 0.0 111.572 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.542 0 C-N-CA 123.96 0.904 . . . . 0.0 108.835 171.424 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -89.78 125.65 35.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.867 1.267 . . . . 0.0 112.057 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.31 146.45 35.7 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.859 2.063 . . . . 0.0 110.988 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -97.62 143.12 28.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.985 2.514 . . . . 0.0 108.658 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.1 t -135.38 112.99 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.148 0.979 . . . . 0.0 109.861 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -111.29 174.41 16.75 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 125.748 1.642 . . . . 0.0 113.498 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 m120 64.93 20.92 12.24 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.988 1.715 . . . . 0.0 113.161 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.17 142.7 95.6 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 121.206 -0.934 . . . . 0.0 112.21 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.77 163.71 38.04 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.207 3.271 . . . . 0.0 111.9 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.39 5.84 2.57 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 123.715 2.943 . . . . 0.0 113.557 171.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -124.15 12.13 8.89 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.168 1.787 . . . . 0.0 113.486 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.1 tp -82.06 145.28 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 120.911 -1.118 . . . . 0.0 110.828 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 31.5 p -133.2 168.27 18.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.198 1.799 . . . . 0.0 109.623 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.11 -31.61 70.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.818 0.447 . . . . 0.0 111.824 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.08 -40.41 65.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.092 0.957 . . . . 0.0 111.709 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -66.2 -38.43 87.94 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.568 0.622 . . . . 0.0 111.31 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 6.0 ttt -68.74 -36.1 77.95 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.612 -0.68 . . . . 0.0 112.201 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -64.52 -40.23 95.23 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.692 0.797 . . . . 0.0 111.688 169.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -68.81 -41.85 78.06 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.305 1.042 . . . . 0.0 112.699 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.13 -24.36 62.93 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.435 1.494 . . . . 0.0 113.596 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -112.42 11.47 19.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.503 1.521 . . . . 0.0 112.654 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.44 -21.66 66.68 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -171.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -62.69 -24.57 67.72 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.253 1.021 . . . . 0.0 112.517 172.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -104.11 14.02 31.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.528 1.931 . . . . 0.0 112.307 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.53 -173.64 54.83 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.386 0.993 . . . . 0.0 112.176 -173.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -71.54 147.25 47.88 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.66 -0.906 . . . . 0.0 111.88 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.95 147.13 37.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.495 0.718 . . . . 0.0 111.577 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.27 -17.39 66.92 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.062 1.315 . . . . 0.0 113.553 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -157.94 147.76 20.09 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.318 1.447 . . . . 0.0 110.645 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -142.31 129.07 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 126.992 2.117 . . . . 0.0 109.643 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -140.99 138.64 33.88 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.03 1.332 . . . . 0.0 111.387 171.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 61.6 mt -138.84 124.58 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.59 1.556 . . . . 0.0 108.211 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -121.36 102.19 8.12 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.075 0.94 . . . . 0.0 112.379 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.33 -18.77 61.74 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -77.53 -14.54 59.64 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.282 1.033 . . . . 0.0 112.96 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -116.78 -27.14 6.72 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.83 1.252 . . . . 0.0 113.498 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.4 27.19 23.39 Favored Glycine 0 N--CA 1.476 1.342 0 C-N-CA 124.896 1.236 . . . . 0.0 114.078 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -137.04 154.37 50.39 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.354 1.462 . . . . 0.0 111.822 -173.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.79 170.13 25.34 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.501 1.524 . . . . 0.0 113.038 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -143.83 148.72 35.93 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.312 1.845 . . . . 0.0 109.874 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 tt -153.87 137.75 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.786 0.834 . . . . 0.0 110.317 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -115.59 125.37 52.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.791 0.836 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -96.01 170.03 9.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.998 0.519 . . . . 0.0 111.438 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -72.74 -26.6 61.62 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.4 p -142.64 155.9 45.0 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.137 1.375 . . . . 0.0 110.931 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -69.38 -27.46 65.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.911 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.8 m -62.32 -47.49 84.04 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.955 1.302 . . . . 0.0 110.54 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.55 -39.01 93.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.946 -0.55 . . . . 0.0 111.427 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.99 89.43 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -64.59 -50.38 67.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.315 0.961 . . . . 0.0 111.226 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.06 -49.42 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 122.891 0.476 . . . . 0.0 110.25 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.28 -46.1 89.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.497 0.719 . . . . 0.0 111.979 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.53 -43.4 93.47 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.182 -0.949 . . . . 0.0 111.802 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.35 -32.93 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.932 0.893 . . . . 0.0 112.388 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -88.8 -24.5 22.58 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.1 mt -102.92 -18.12 15.19 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.43 131.21 45.85 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.944 1.247 . . . . 0.0 111.739 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.0 t30 65.07 17.26 10.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.517 1.927 . . . . 0.0 113.834 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.5 ttp -72.83 134.76 81.14 Favored Pre-proline 0 CA--C 1.544 0.718 0 O-C-N 120.609 -1.307 . . . . 0.0 110.223 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.52 138.79 19.85 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.159 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.0 tp -138.07 105.85 5.63 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.504 1.522 . . . . 0.0 109.821 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 55.57 27.53 10.54 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.491 1.516 . . . . 0.0 113.798 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.49 -8.46 69.0 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.729 1.633 . . . . 0.0 114.812 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -89.08 155.92 19.16 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.868 1.334 . . . . 0.0 110.653 170.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.53 172.16 9.97 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.643 0.777 . . . . 0.0 109.814 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.0 mt -132.57 117.41 17.92 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 110.364 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -92.87 113.68 26.02 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.833 0.853 . . . . 0.0 109.188 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.9 t -123.55 126.02 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.882 0.873 . . . . 0.0 110.141 -174.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -149.44 168.74 22.59 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.52 1.528 . . . . 0.0 111.661 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -78.54 136.98 37.68 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.352 0.661 . . . . 0.0 111.671 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 125.351 1.46 . . . . 0.0 112.553 172.736 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 m . . . . . 0 CA--C 1.548 0.882 0 CA-C-O 121.728 0.775 . . . . 0.0 112.315 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -99.13 132.36 44.49 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.315 1.846 . . . . 0.0 111.739 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -117.78 143.94 45.79 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.67 1.588 . . . . 0.0 111.352 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -102.6 139.41 38.23 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.178 2.591 . . . . 0.0 108.441 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.76 116.71 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.306 1.043 . . . . 0.0 108.978 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.89 167.81 13.19 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.31 1.433 . . . . 0.0 114.053 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.66 31.51 9.77 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.504 1.522 . . . . 0.0 111.836 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.5 mt -66.21 143.64 98.42 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.969 0.908 . . . . 0.0 112.432 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -69.6 159.44 53.51 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.166 2.578 . . . . 0.0 111.271 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.44 -9.12 23.74 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.414 2.742 . . . . 0.0 113.275 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -94.41 5.33 52.12 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.709 1.604 . . . . 0.0 113.461 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.3 tp -86.78 137.59 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 121.051 -1.03 . . . . 0.0 111.65 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.0 p -133.74 176.98 8.07 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.593 1.557 . . . . 0.0 108.786 168.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.31 -21.74 62.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.44 0.696 . . . . 0.0 112.548 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -73.68 -47.82 36.89 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.125 0.875 . . . . 0.0 111.249 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -63.04 -42.56 99.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.144 0.578 . . . . 0.0 110.874 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.5 ttt -66.12 -33.86 76.75 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -69.35 -36.27 76.71 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.14 0.882 . . . . 0.0 112.336 170.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -44.14 67.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.117 0.967 . . . . 0.0 111.344 178.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.4 mt -56.33 -28.14 57.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.68 1.592 . . . . 0.0 113.343 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.84 10.54 26.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.406 1.483 . . . . 0.0 112.93 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.81 -23.03 66.61 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -170.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -62.88 -23.3 67.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.445 1.098 . . . . 0.0 112.375 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.64 12.97 30.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.589 1.956 . . . . 0.0 112.2 -175.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.08 -171.06 54.98 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.76 1.171 . . . . 0.0 112.488 -176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -71.45 142.07 50.24 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.746 -0.855 . . . . 0.0 111.723 172.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.14 148.23 32.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.779 0.831 . . . . 0.0 111.302 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.51 -11.39 71.71 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.918 1.247 . . . . 0.0 113.962 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -158.83 137.94 11.37 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.454 1.902 . . . . 0.0 108.607 173.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.7 t -140.05 128.65 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.311 1.444 . . . . 0.0 109.055 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -143.03 139.42 30.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.92 1.288 . . . . 0.0 111.796 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.2 mt -140.45 128.23 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.375 1.87 . . . . 0.0 107.702 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -125.46 112.54 16.38 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.659 0.742 . . . . 0.0 112.864 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -75.92 -20.13 58.25 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -171.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.86 -21.21 51.74 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.87 0.868 . . . . 0.0 112.515 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -104.31 -32.58 9.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.816 1.247 . . . . 0.0 113.143 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.28 29.01 26.19 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 124.641 1.115 . . . . 0.0 113.857 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -140.92 156.47 46.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.671 1.588 . . . . 0.0 111.767 -171.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.95 166.52 27.03 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.085 1.326 . . . . 0.0 113.507 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -142.48 147.6 36.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.475 1.91 . . . . 0.0 109.806 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.9 tt -154.3 132.21 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.912 0.885 . . . . 0.0 110.738 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 -107.81 125.66 51.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.765 0.826 . . . . 0.0 110.074 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.6 mt -97.87 164.56 12.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.465 0.706 . . . . 0.0 109.684 173.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -82.58 -11.58 58.32 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 65.9 p -148.47 146.72 28.51 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.172 1.389 . . . . 0.0 111.741 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.57 -33.09 69.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.466 1.106 . . . . 0.0 113.592 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 m -68.24 -46.86 69.34 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.756 1.222 . . . . 0.0 110.573 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.38 -37.02 85.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.76 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.21 93.46 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.046 0.839 . . . . 0.0 112.718 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.3 -50.88 68.35 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.169 0.988 . . . . 0.0 111.381 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.28 -46.91 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.855 -0.528 . . . . 0.0 110.379 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.68 90.83 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.63 0.772 . . . . 0.0 112.015 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -48.86 78.17 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.258 0.936 . . . . 0.0 111.219 174.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.76 -36.6 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.593 0.757 . . . . 0.0 112.225 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.31 -29.47 34.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.6 mt -106.26 -22.89 12.71 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -169.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.06 130.41 43.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.417 1.008 . . . . 0.0 110.781 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.0 t30 73.86 8.93 4.83 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.38 2.272 . . . . 0.0 114.074 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.3 ttp -76.15 137.35 68.73 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.462 -1.399 . . . . 0.0 111.528 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.67 135.29 15.96 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.449 2.766 . . . . 0.0 111.319 175.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.6 tp -145.89 120.21 9.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.442 1.497 . . . . 0.0 109.848 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 58.3 23.59 10.59 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.813 1.245 . . . . 0.0 113.619 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.42 -2.85 85.22 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.583 1.563 . . . . 0.0 114.593 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -93.61 148.4 22.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.491 1.517 . . . . 0.0 110.936 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -98.56 109.38 22.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.552 1.541 . . . . 0.0 107.182 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.75 147.46 47.3 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.664 0.786 . . . . 0.0 111.693 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 130.88 53.62 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.246 1.418 . . . . 0.0 109.054 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.7 t -134.02 129.23 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.857 0.863 . . . . 0.0 110.855 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -140.18 170.22 16.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.112 1.765 . . . . 0.0 110.387 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -77.61 134.54 38.19 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.502 -0.749 . . . . 0.0 110.373 168.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.584 0 C-N-CA 124.294 1.037 . . . . 0.0 109.432 172.471 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 -86.97 129.44 34.88 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.372 1.469 . . . . 0.0 111.513 -176.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.9 mt -116.54 135.46 53.8 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.25 1.82 . . . . 0.0 110.544 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -89.4 142.48 27.62 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.347 2.259 . . . . 0.0 108.608 171.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.1 103.29 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.06 168.53 15.79 Favored Glycine 0 N--CA 1.464 0.565 0 C-N-CA 125.315 1.436 . . . . 0.0 112.986 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 60.09 32.45 20.99 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.897 1.279 . . . . 0.0 111.969 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.4 mt -63.25 143.37 97.72 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 121.269 -0.894 . . . . 0.0 111.347 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -66.93 158.0 58.81 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.801 2.334 . . . . 0.0 110.655 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.13 -7.32 20.4 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.699 2.933 . . . . 0.0 113.163 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -104.15 5.55 35.09 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.986 1.714 . . . . 0.0 113.264 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -75.18 146.67 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.274 -0.891 . . . . 0.0 111.247 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.5 p -131.73 165.55 23.5 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.961 1.704 . . . . 0.0 109.875 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.16 -32.85 66.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.245 0.618 . . . . 0.0 111.419 172.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -70.09 -36.79 75.15 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.242 1.017 . . . . 0.0 112.294 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -72.1 -36.7 69.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.78 0.718 . . . . 0.0 111.91 173.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.6 ttm -66.52 -38.62 87.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.24 0.927 . . . . 0.0 111.989 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -61.68 -40.44 94.98 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.09 0.956 . . . . 0.0 111.45 170.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -73.35 -41.19 63.76 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.1 mt -56.48 -24.98 49.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.118 1.367 . . . . 0.0 113.389 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -112.38 11.04 19.92 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.536 1.534 . . . . 0.0 112.802 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.97 -22.42 65.92 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -171.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.13 -25.36 67.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.978 0.911 . . . . 0.0 112.343 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.01 11.27 37.53 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.49 1.916 . . . . 0.0 112.672 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.87 -171.03 55.04 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.633 1.111 . . . . 0.0 112.974 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -71.76 134.61 46.31 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.989 -0.712 . . . . 0.0 111.561 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.14 148.86 35.75 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.438 1.095 . . . . 0.0 111.37 174.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.99 -15.34 75.19 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.166 0.888 . . . . 0.0 113.393 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -155.39 145.25 21.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.433 1.093 . . . . 0.0 111.547 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.0 127.9 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.651 1.98 . . . . 0.0 110.057 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -142.3 142.5 32.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.735 1.614 . . . . 0.0 112.006 171.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 68.9 mt -138.15 125.91 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.909 1.683 . . . . 0.0 107.995 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -119.59 102.62 8.76 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.36 1.064 . . . . 0.0 111.776 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -74.11 -24.22 59.43 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.96 -23.11 63.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.307 1.043 . . . . 0.0 113.053 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -109.45 -26.47 9.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.416 1.086 . . . . 0.0 113.488 174.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.69 29.23 13.95 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 124.957 1.265 . . . . 0.0 114.274 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.68 148.47 45.74 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.229 1.412 . . . . 0.0 111.788 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.71 168.9 23.74 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.696 1.617 . . . . 0.0 112.939 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -146.1 140.71 26.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.131 1.772 . . . . 0.0 109.449 -170.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.9 tt -148.7 146.75 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.115 0.966 . . . . 0.0 110.559 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.66 117.3 22.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.487 1.115 . . . . 0.0 109.407 -178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.72 163.56 13.71 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.104 0.562 . . . . 0.0 110.516 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.65 -21.55 59.37 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.5 p -141.69 151.97 43.47 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.383 1.073 . . . . 0.0 112.354 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -57.22 -38.63 74.04 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.733 1.213 . . . . 0.0 112.869 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -63.29 -50.44 70.07 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.814 1.246 . . . . 0.0 110.85 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.85 -38.77 92.08 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.64 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.17 -39.88 94.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.65 -47.87 76.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.206 0.912 . . . . 0.0 111.759 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.5 mt -59.31 -48.49 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.092 0.557 . . . . 0.0 110.262 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.3 94.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.146 0.579 . . . . 0.0 112.322 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -46.29 88.54 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.961 -1.087 . . . . 0.0 111.131 174.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.19 -38.82 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.211 0.605 . . . . 0.0 112.002 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -82.33 -23.58 35.02 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.2 mt -108.63 -22.16 12.38 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.53 133.0 48.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.924 1.238 . . . . 0.0 111.142 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.5 t30 68.64 11.28 8.29 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.565 1.946 . . . . 0.0 113.732 -175.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.1 ttp -75.72 137.61 70.23 Favored Pre-proline 0 CA--C 1.544 0.719 0 O-C-N 120.611 -1.305 . . . . 0.0 110.933 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.46 134.23 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.365 2.71 . . . . 0.0 111.038 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.2 tp -140.14 113.61 8.56 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.28 1.432 . . . . 0.0 109.96 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.88 24.18 7.26 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.163 1.385 . . . . 0.0 113.344 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.27 -5.55 74.94 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.887 1.708 . . . . 0.0 114.771 -176.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -88.66 146.75 24.9 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.242 1.417 . . . . 0.0 110.451 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -92.56 119.56 32.14 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 69.2 mt -78.15 134.64 37.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.398 0.544 . . . . 0.0 111.669 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -99.17 125.25 44.7 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.823 1.249 . . . . 0.0 108.465 169.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.4 t -135.2 126.25 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.3 0.955 . . . . 0.0 110.362 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -146.13 168.98 19.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.159 1.783 . . . . 0.0 110.848 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -77.12 140.07 40.14 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.607 -0.683 . . . . 0.0 111.053 169.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.497 0 C-N-CA 124.877 1.271 . . . . 0.0 111.347 178.168 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.2 p . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -77.45 122.37 25.11 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.746 1.618 . . . . 0.0 110.321 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -103.45 135.47 45.0 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.771 1.628 . . . . 0.0 110.027 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -90.57 137.63 32.2 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.103 2.161 . . . . 0.0 108.549 169.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.1 110.07 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.513 1.125 . . . . 0.0 109.388 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.75 170.8 14.13 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.58 1.562 . . . . 0.0 114.151 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 69.74 20.05 7.0 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.415 1.886 . . . . 0.0 113.006 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -61.72 143.48 93.93 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.823 0.849 . . . . 0.0 112.321 -171.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.03 165.08 33.53 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.405 3.403 . . . . 0.0 111.535 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.18 -3.61 14.09 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.111 2.541 . . . . 0.0 113.162 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -106.92 5.52 28.37 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.231 1.813 . . . . 0.0 113.739 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 tp -82.25 144.97 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.057 -1.027 . . . . 0.0 110.862 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.4 p -132.81 168.82 17.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.225 1.81 . . . . 0.0 109.037 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.56 -26.92 67.28 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -76.21 -40.06 53.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.948 0.899 . . . . 0.0 111.658 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -64.62 -37.17 86.66 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.963 -0.46 . . . . 0.0 111.193 171.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.3 tpt -66.11 -44.56 83.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.648 0.779 . . . . 0.0 111.416 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -59.58 -33.57 71.62 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.97 0.908 . . . . 0.0 112.097 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -74.62 -45.53 44.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.75 0.82 . . . . 0.0 112.579 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.95 -31.08 64.62 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.981 1.312 . . . . 0.0 113.097 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -106.92 10.85 30.43 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.211 1.404 . . . . 0.0 113.12 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -63.47 -28.81 70.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -16.26 63.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.582 0.753 . . . . 0.0 112.618 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -100.83 9.82 41.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.545 1.938 . . . . 0.0 112.458 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.73 -177.46 54.36 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.749 1.166 . . . . 0.0 112.962 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -71.32 134.91 47.09 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.708 -0.878 . . . . 0.0 111.111 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.63 148.82 34.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.609 1.164 . . . . 0.0 112.194 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.89 -10.23 79.26 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.865 1.221 . . . . 0.0 113.923 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -158.92 137.64 11.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.379 1.872 . . . . 0.0 108.983 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.14 130.05 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.602 1.561 . . . . 0.0 108.808 174.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -144.29 139.24 28.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.592 1.157 . . . . 0.0 111.295 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 86.9 mt -138.8 126.66 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.455 1.502 . . . . 0.0 108.518 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -120.11 104.43 10.11 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.522 1.129 . . . . 0.0 111.846 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -73.76 -26.4 60.64 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -171.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.86 -22.03 62.35 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.957 0.903 . . . . 0.0 113.086 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -107.42 -29.12 9.43 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.475 1.11 . . . . 0.0 113.465 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.05 28.44 17.96 Favored Glycine 0 N--CA 1.477 1.374 0 C-N-CA 124.891 1.234 . . . . 0.0 114.152 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -137.6 155.79 48.8 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.339 1.455 . . . . 0.0 111.788 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.16 176.74 30.32 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.111 1.339 . . . . 0.0 113.576 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -144.37 153.71 42.24 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.306 1.842 . . . . 0.0 110.779 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 tt -155.23 132.36 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.54 1.136 . . . . 0.0 110.607 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -113.52 121.93 45.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.904 0.881 . . . . 0.0 110.961 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.39 165.64 12.46 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.236 0.614 . . . . 0.0 111.305 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.61 -23.72 60.98 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -172.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.6 p -145.11 146.47 31.83 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.118 1.367 . . . . 0.0 111.513 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -55.88 -43.42 77.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.059 1.344 . . . . 0.0 112.246 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.4 m -59.2 -45.87 89.93 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.924 1.289 . . . . 0.0 112.081 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.76 -35.89 82.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 119.158 -0.448 . . . . 0.0 112.088 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.06 -33.44 74.57 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -64.55 -49.55 70.76 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.21 0.914 . . . . 0.0 110.22 172.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.8 mt -60.94 -48.47 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.604 0.762 . . . . 0.0 110.399 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.22 91.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.238 0.615 . . . . 0.0 111.819 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -57.19 -49.61 75.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.29 0.95 . . . . 0.0 111.332 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.71 -36.17 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.438 0.695 . . . . 0.0 112.095 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -81.65 -25.14 35.84 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.5 mt -109.61 -23.99 11.18 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -170.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.42 121.98 16.95 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.843 1.202 . . . . 0.0 110.839 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 74.59 15.52 3.32 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 128.142 2.577 . . . . 0.0 114.01 -173.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.0 ttp -76.44 137.12 67.74 Favored Pre-proline 0 N--CA 1.475 0.782 0 O-C-N 120.958 -1.089 . . . . 0.0 111.295 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.64 141.38 22.03 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.467 2.778 . . . . 0.0 111.647 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 34.4 tp -144.93 118.13 8.93 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.533 1.533 . . . . 0.0 110.303 173.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 58.7 24.77 12.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.321 1.448 . . . . 0.0 113.825 174.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.82 -5.59 83.36 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 125.472 1.511 . . . . 0.0 114.38 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -94.41 171.93 8.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.578 1.551 . . . . 0.0 110.726 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -99.43 -176.12 3.2 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 109.656 169.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.4 mt -141.68 120.03 12.31 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.302 1.441 . . . . 0.0 108.982 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.49 116.29 32.45 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.93 122.83 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.819 0.848 . . . . 0.0 111.335 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -141.88 161.66 37.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.772 2.029 . . . . 0.0 110.565 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -73.0 130.74 41.01 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.634 -0.666 . . . . 0.0 109.671 168.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.726 0 C-N-CA 124.561 1.144 . . . . 0.0 110.699 176.602 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 121.248 0.546 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -98.14 141.11 31.47 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.986 1.714 . . . . 0.0 112.561 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.44 141.92 50.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.82 2.048 . . . . 0.0 110.147 -172.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -100.66 140.38 35.02 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.193 2.197 . . . . 0.0 108.797 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.13 114.57 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.667 1.187 . . . . 0.0 108.951 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.33 164.57 12.28 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 125.488 1.518 . . . . 0.0 114.433 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.7 t30 70.57 20.35 5.85 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.593 1.957 . . . . 0.0 112.928 -177.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.9 mt -57.73 148.65 56.59 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.75 1.22 . . . . 0.0 113.082 -172.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 162.32 40.7 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.133 2.556 . . . . 0.0 111.444 172.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.94 -6.77 17.01 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.721 2.947 . . . . 0.0 112.174 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -99.76 8.29 44.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.676 1.991 . . . . 0.0 113.272 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.5 tp -81.86 145.46 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.01 -1.056 . . . . 0.0 110.909 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.2 p -134.3 167.66 20.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.236 1.814 . . . . 0.0 109.48 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -56.73 -34.51 67.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.106 0.563 . . . . 0.0 111.625 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.82 -26.93 49.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.478 1.111 . . . . 0.0 113.027 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -77.06 -39.02 51.38 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.933 0.788 . . . . 0.0 110.855 169.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.2 ttt -70.46 -37.48 74.3 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.32 -0.863 . . . . 0.0 112.195 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -62.64 -38.03 88.68 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.897 0.879 . . . . 0.0 111.507 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -73.34 -39.98 64.8 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.009 1.324 . . . . 0.0 113.092 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.6 mt -57.39 -27.39 62.28 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.958 1.303 . . . . 0.0 113.205 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -108.02 8.4 28.28 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.627 1.571 . . . . 0.0 112.753 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.9 -20.49 65.92 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -59.39 -22.73 61.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.636 1.174 . . . . 0.0 112.315 169.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -109.64 10.1 24.97 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.258 2.223 . . . . 0.0 112.321 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.45 -178.8 53.32 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.029 0.823 . . . . 0.0 112.448 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -71.04 144.57 50.34 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.699 -0.883 . . . . 0.0 111.664 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.64 152.27 30.1 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.166 0.986 . . . . 0.0 111.822 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.35 -8.22 71.58 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.82 1.2 . . . . 0.0 113.83 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -158.61 136.05 10.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.58 1.952 . . . . 0.0 108.582 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.73 128.65 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.493 1.517 . . . . 0.0 109.059 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -143.83 141.78 30.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.172 1.389 . . . . 0.0 111.579 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.3 mt -140.47 132.98 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.702 1.601 . . . . 0.0 108.67 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -129.1 109.02 10.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.93 0.892 . . . . 0.0 112.129 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -33.93 69.7 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.494 1.118 . . . . 0.0 112.798 -171.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.63 -26.22 68.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.367 1.067 . . . . 0.0 113.229 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -97.72 -32.58 11.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.176 0.99 . . . . 0.0 113.031 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.27 29.19 12.84 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 125.101 1.334 . . . . 0.0 114.055 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.95 158.84 43.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.266 1.426 . . . . 0.0 111.852 -171.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.46 168.78 26.63 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.275 1.417 . . . . 0.0 113.483 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.27 148.24 50.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.72 2.008 . . . . 0.0 109.828 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.9 tt -153.82 140.88 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.412 1.085 . . . . 0.0 110.583 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -123.94 124.89 43.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.863 0.865 . . . . 0.0 110.947 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.4 168.09 10.43 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.389 0.676 . . . . 0.0 110.935 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -72.85 -24.94 60.95 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.9 p -143.61 157.65 44.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.619 1.168 . . . . 0.0 111.881 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -58.73 -35.77 73.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 112.528 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -62.8 -49.46 74.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.054 1.342 . . . . 0.0 110.64 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.49 -42.86 99.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.217 0.607 . . . . 0.0 111.215 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.25 99.26 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -62.91 -49.78 73.44 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.087 0.858 . . . . 0.0 111.79 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.71 -48.95 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.104 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.01 91.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.333 0.653 . . . . 0.0 112.288 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -47.52 84.67 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.447 -0.783 . . . . 0.0 111.007 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.69 -36.49 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -84.79 -28.68 26.0 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -174.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.4 mt -101.18 -19.22 15.81 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -66.86 137.81 56.86 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.188 0.904 . . . . 0.0 110.661 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.5 t30 69.28 16.29 8.43 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.653 1.581 . . . . 0.0 113.636 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.0 ttp -89.83 134.02 32.86 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 120.866 -1.146 . . . . 0.0 111.148 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.28 141.42 18.22 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.299 2.666 . . . . 0.0 111.307 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.4 tp -144.92 114.59 7.24 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.827 1.651 . . . . 0.0 110.098 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 57.67 24.5 10.64 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.288 1.435 . . . . 0.0 113.738 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.73 -1.92 69.23 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.547 1.546 . . . . 0.0 114.836 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -102.9 145.86 29.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.285 1.434 . . . . 0.0 111.192 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -75.31 167.64 21.52 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.656 -0.653 . . . . 0.0 110.187 167.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.7 mt -133.96 135.8 43.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.5 1.12 . . . . 0.0 110.996 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.67 122.08 46.67 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.685 1.994 . . . . 0.0 109.096 175.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -131.94 125.63 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.773 0.829 . . . . 0.0 110.119 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.53 156.92 37.52 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.431 1.492 . . . . 0.0 111.706 -172.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -69.0 132.03 46.02 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.579 -0.701 . . . . 0.0 111.816 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.645 0 C-N-CA 123.616 0.766 . . . . 0.0 110.818 178.503 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -99.22 124.13 44.05 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.703 1.601 . . . . 0.0 111.851 -170.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.6 mt -111.75 149.82 31.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.709 2.004 . . . . 0.0 110.999 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -114.58 137.86 51.36 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.203 2.601 . . . . 0.0 108.472 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -131.29 113.37 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.167 0.987 . . . . 0.0 109.947 -173.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -113.02 169.64 13.03 Favored Glycine 0 N--CA 1.467 0.756 0 C-N-CA 126.042 1.782 . . . . 0.0 113.738 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 69.01 15.87 8.78 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.098 1.759 . . . . 0.0 112.582 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.8 mt -56.58 139.04 76.1 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.089 0.955 . . . . 0.0 112.048 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -68.15 160.92 46.69 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.748 2.298 . . . . 0.0 111.223 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.04 -2.79 12.09 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.815 3.01 . . . . 0.0 112.967 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -103.61 0.82 31.28 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.082 1.753 . . . . 0.0 113.792 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -76.41 146.32 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 119.453 1.024 . . . . 0.0 111.275 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 p -130.58 165.42 22.8 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.706 1.602 . . . . 0.0 110.409 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -62.85 -25.78 68.44 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.226 0.61 . . . . 0.0 111.822 172.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -72.64 -44.39 61.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.183 0.993 . . . . 0.0 111.474 172.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -66.09 -39.18 89.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.55 0.614 . . . . 0.0 111.696 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -69.21 -33.57 73.54 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.773 0.715 . . . . 0.0 112.471 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -67.61 -39.4 84.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.581 0.628 . . . . 0.0 111.643 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -72.92 -38.08 66.98 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.29 -0.881 . . . . 0.0 113.074 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.44 -25.06 49.34 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.358 1.463 . . . . 0.0 113.256 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -110.75 10.51 22.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.644 1.578 . . . . 0.0 112.673 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.21 -24.87 67.48 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -64.63 -19.33 65.63 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.334 1.054 . . . . 0.0 113.015 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.93 10.5 30.5 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.807 2.043 . . . . 0.0 112.141 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.44 -173.42 55.23 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.865 1.221 . . . . 0.0 113.021 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -71.73 145.07 49.02 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.836 -0.802 . . . . 0.0 112.274 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -89.19 150.39 22.69 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.415 1.086 . . . . 0.0 111.528 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.0 -11.05 70.76 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.823 1.202 . . . . 0.0 113.871 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -153.94 137.11 15.62 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.124 1.77 . . . . 0.0 109.073 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.46 129.36 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.906 1.682 . . . . 0.0 108.858 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -145.09 144.08 30.75 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.895 1.278 . . . . 0.0 111.87 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.2 mt -140.86 132.47 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.168 1.787 . . . . 0.0 108.459 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -126.43 111.82 14.89 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.887 0.875 . . . . 0.0 112.386 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -70.75 -31.95 68.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.424 1.09 . . . . 0.0 113.307 -171.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -73.63 -13.24 60.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.07 0.948 . . . . 0.0 113.51 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -112.75 -26.48 8.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.743 1.217 . . . . 0.0 113.311 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.0 29.84 24.73 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.613 1.102 . . . . 0.0 113.963 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -140.12 157.29 45.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.327 1.451 . . . . 0.0 112.202 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.41 169.19 25.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.755 1.645 . . . . 0.0 113.209 174.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -137.89 147.63 44.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.673 1.989 . . . . 0.0 109.425 -177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.0 tt -153.77 139.23 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.897 0.879 . . . . 0.0 110.601 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -128.92 118.68 23.06 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.622 0.769 . . . . 0.0 110.307 -172.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.67 -176.16 3.98 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.215 1.006 . . . . 0.0 111.893 -171.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -86.02 -25.84 25.72 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 49.7 p -149.42 144.4 26.33 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.138 1.375 . . . . 0.0 111.851 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -59.46 -35.91 74.97 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.248 1.019 . . . . 0.0 113.057 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.9 m -60.21 -47.69 84.87 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.773 1.229 . . . . 0.0 111.181 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.6 mt -65.65 -35.99 82.38 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.958 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.68 -36.76 81.28 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.08 0.854 . . . . 0.0 112.875 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.39 -49.48 71.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.128 0.971 . . . . 0.0 110.891 172.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.81 -48.74 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.082 0.553 . . . . 0.0 110.353 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.98 -46.02 85.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.626 0.77 . . . . 0.0 111.91 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -58.25 -48.69 79.62 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.319 -0.863 . . . . 0.0 111.345 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.15 -36.49 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.464 0.705 . . . . 0.0 112.16 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -80.6 -30.45 36.82 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.3 mt -102.72 -21.78 14.04 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -171.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.18 129.14 38.94 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.672 1.123 . . . . 0.0 111.456 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 67.98 14.25 9.32 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.73 2.412 . . . . 0.0 113.697 -173.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.2 ttp -73.83 135.91 77.31 Favored Pre-proline 0 N--CA 1.474 0.757 0 O-C-N 120.507 -1.371 . . . . 0.0 110.719 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.24 140.6 19.81 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.3 2.666 . . . . 0.0 111.325 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.3 tp -145.12 117.19 8.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.086 1.355 . . . . 0.0 110.106 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 69.9 mmt-85 57.11 27.38 13.34 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.929 1.291 . . . . 0.0 113.922 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.42 -6.23 83.82 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 125.521 1.534 . . . . 0.0 114.484 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -90.78 169.3 11.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.934 1.694 . . . . 0.0 110.333 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -100.98 -172.67 2.21 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.612 -0.68 . . . . 0.0 109.244 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.46 116.67 10.03 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.34 1.056 . . . . 0.0 109.079 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -91.58 118.07 30.28 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.44 123.94 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.647 0.779 . . . . 0.0 109.959 -173.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -154.78 163.98 39.47 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.087 1.355 . . . . 0.0 111.239 -173.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -71.36 144.1 49.99 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.769 -0.582 . . . . 0.0 111.043 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.957 0 C-N-CA 124.939 1.296 . . . . 0.0 112.94 -177.083 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 -84.15 133.41 34.61 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.434 1.494 . . . . 0.0 113.006 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.6 mt -113.81 134.52 54.73 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.034 1.733 . . . . 0.0 110.257 170.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -92.09 137.89 31.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.17 2.188 . . . . 0.0 107.748 169.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.6 t -130.47 110.92 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.072 0.949 . . . . 0.0 109.435 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.53 174.56 18.11 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.825 1.678 . . . . 0.0 113.501 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.8 m120 65.48 20.07 11.65 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.863 1.665 . . . . 0.0 112.808 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.19 140.12 97.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 O-C-N 121.05 -1.031 . . . . 0.0 112.103 -171.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.11 165.73 31.48 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.294 3.33 . . . . 0.0 111.837 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.51 -2.89 13.03 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.173 2.582 . . . . 0.0 113.179 172.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -108.19 12.55 26.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.028 1.731 . . . . 0.0 113.419 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.3 tp -91.32 140.08 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.254 1.022 . . . . 0.0 110.599 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.8 p -133.76 174.06 10.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.389 1.476 . . . . 0.0 108.695 168.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.33 -22.62 63.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.043 0.537 . . . . 0.0 112.421 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.71 -45.14 38.39 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.307 -0.871 . . . . 0.0 111.41 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -63.27 -43.8 96.93 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.058 0.543 . . . . 0.0 111.088 172.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.9 ttt -65.35 -37.31 86.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.997 0.519 . . . . 0.0 112.337 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.6 mtp-105 -66.46 -38.18 86.78 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.509 -0.744 . . . . 0.0 112.066 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -72.03 -40.32 68.49 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.411 -0.806 . . . . 0.0 112.557 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.9 mt -59.34 -29.58 67.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.986 1.714 . . . . 0.0 113.027 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -105.88 8.44 32.65 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.22 1.408 . . . . 0.0 112.656 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.03 -27.04 68.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.246 0.93 . . . . 0.0 113.214 -173.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -72.55 -5.54 37.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.775 1.23 . . . . 0.0 113.657 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -111.86 8.81 20.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.433 1.893 . . . . 0.0 111.83 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.11 -177.6 53.72 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.802 1.192 . . . . 0.0 112.253 -172.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -71.16 144.18 50.28 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.637 -0.919 . . . . 0.0 111.998 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.26 156.3 33.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.878 0.871 . . . . 0.0 111.857 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.96 -10.29 58.84 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.939 1.256 . . . . 0.0 113.87 175.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.65 135.83 5.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.699 2.0 . . . . 0.0 108.611 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.1 t -143.56 128.77 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.644 1.578 . . . . 0.0 109.43 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -145.1 142.31 29.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.382 1.473 . . . . 0.0 111.765 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.9 mt -138.51 127.18 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.559 1.544 . . . . 0.0 108.575 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -115.57 103.25 10.54 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.446 1.098 . . . . 0.0 111.831 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -69.79 -20.34 63.47 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -87.18 -15.17 39.12 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -117.6 -19.25 9.47 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.613 1.165 . . . . 0.0 113.985 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.25 29.79 21.42 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 124.665 1.126 . . . . 0.0 114.312 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -132.51 149.07 52.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.942 1.297 . . . . 0.0 111.832 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.68 169.5 25.17 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.875 1.702 . . . . 0.0 112.754 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -141.83 142.52 33.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.173 1.789 . . . . 0.0 109.566 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.6 tt -152.18 143.19 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.726 0.81 . . . . 0.0 110.686 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -121.3 124.32 44.32 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.922 0.889 . . . . 0.0 110.706 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.0 mt -97.31 171.2 8.57 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.582 0.753 . . . . 0.0 111.132 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -74.73 -26.46 59.82 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.3 p -144.7 159.29 43.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.686 1.194 . . . . 0.0 111.983 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -60.24 -31.35 70.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.844 0.857 . . . . 0.0 112.755 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -68.47 -46.79 68.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.019 1.328 . . . . 0.0 110.486 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.6 mt -62.39 -42.73 99.65 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.249 0.62 . . . . 0.0 111.125 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.59 -36.94 85.87 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.89 -47.93 73.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.508 1.123 . . . . 0.0 111.905 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.7 mt -62.35 -47.83 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.418 -0.802 . . . . 0.0 110.18 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.41 -42.49 98.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.277 0.631 . . . . 0.0 112.409 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -54.01 -51.87 62.59 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.421 1.009 . . . . 0.0 111.287 170.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.36 -34.91 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.151 0.432 . . . . 0.0 111.785 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -85.57 -23.98 27.4 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.0 mt -106.67 -22.17 12.82 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.24 128.84 37.92 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.476 1.034 . . . . 0.0 110.992 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.6 t30 70.48 12.75 7.45 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.27 2.228 . . . . 0.0 114.106 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.5 ttp -75.67 136.95 70.52 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.565 -1.334 . . . . 0.0 110.91 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.99 139.91 19.73 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.452 2.768 . . . . 0.0 111.169 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.8 tp -145.72 121.57 10.61 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.506 1.522 . . . . 0.0 109.893 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 59.17 23.09 11.35 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.902 1.281 . . . . 0.0 113.699 172.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.1 2.15 74.85 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.394 1.473 . . . . 0.0 114.728 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -111.73 156.98 21.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.233 1.813 . . . . 0.0 111.629 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.99 173.07 10.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.163 0.985 . . . . 0.0 111.137 169.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.2 mt -134.24 119.01 18.22 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.544 1.138 . . . . 0.0 109.148 169.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -92.67 122.51 35.15 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.85 128.32 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.194 0.906 . . . . 0.0 109.689 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -148.1 165.27 31.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.581 1.552 . . . . 0.0 110.986 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.19 137.87 41.58 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.633 -0.667 . . . . 0.0 110.566 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 123.234 0.614 . . . . 0.0 110.786 178.722 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.13 129.18 55.18 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.074 1.75 . . . . 0.0 110.744 -174.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.3 mt -108.15 130.61 55.11 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.585 1.554 . . . . 0.0 110.294 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -89.83 134.5 34.16 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.645 1.978 . . . . 0.0 107.949 169.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.9 t -129.16 121.88 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.996 0.918 . . . . 0.0 109.792 -174.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.43 172.66 14.56 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 125.921 1.724 . . . . 0.0 113.686 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 m120 65.32 17.08 10.86 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.169 1.788 . . . . 0.0 113.371 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 32.2 mt -58.19 143.48 78.92 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.409 1.084 . . . . 0.0 112.474 -171.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -70.32 158.06 57.37 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.199 2.6 . . . . 0.0 110.852 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.5 -9.67 25.54 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.316 2.677 . . . . 0.0 112.87 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.79 4.42 52.87 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.793 2.037 . . . . 0.0 113.409 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 tp -81.74 145.28 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 120.785 -1.197 . . . . 0.0 111.181 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.8 p -135.27 167.63 20.66 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.52 1.928 . . . . 0.0 109.139 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -57.7 -35.42 70.6 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.962 0.505 . . . . 0.0 111.887 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -80.23 -30.97 38.59 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.518 1.127 . . . . 0.0 113.076 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.08 -39.2 66.06 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.024 0.93 . . . . 0.0 111.309 172.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 4.3 tpt -61.86 -42.27 98.85 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.709 0.804 . . . . 0.0 111.074 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.0 ttp85 -63.26 -27.85 69.63 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.424 -0.798 . . . . 0.0 112.191 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -47.67 37.7 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.157 1.383 . . . . 0.0 112.494 171.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.7 mt -55.62 -34.27 64.74 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.01 1.324 . . . . 0.0 112.634 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -102.52 9.93 39.2 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.05 1.34 . . . . 0.0 113.267 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.63 -24.89 67.15 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -61.92 -25.21 67.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.555 1.142 . . . . 0.0 112.388 173.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -102.32 12.69 36.24 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.209 1.804 . . . . 0.0 112.478 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.55 -145.68 20.4 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.756 1.17 . . . . 0.0 111.93 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -103.54 131.14 50.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.599 1.159 . . . . 0.0 111.085 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.5 146.49 51.85 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.172 0.989 . . . . 0.0 111.844 176.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.81 -18.14 70.97 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.287 0.946 . . . . 0.0 113.454 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -158.68 146.38 17.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.569 1.548 . . . . 0.0 110.321 172.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.9 t -143.18 128.46 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.083 1.753 . . . . 0.0 109.542 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -140.65 142.35 34.97 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.401 1.481 . . . . 0.0 111.444 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.5 mt -142.12 128.97 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.004 1.721 . . . . 0.0 108.222 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -123.27 102.13 7.76 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.046 0.938 . . . . 0.0 111.985 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -73.6 -16.35 61.24 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.94 -20.53 60.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.305 1.042 . . . . 0.0 112.808 175.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -116.75 -23.22 8.22 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.832 1.253 . . . . 0.0 113.756 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.71 28.73 23.23 Favored Glycine 0 N--CA 1.477 1.371 0 C-N-CA 124.673 1.13 . . . . 0.0 114.25 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -136.78 155.16 50.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.389 1.476 . . . . 0.0 112.023 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.96 168.97 25.84 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.676 1.607 . . . . 0.0 113.055 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -140.56 140.2 35.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.703 2.001 . . . . 0.0 108.735 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.5 tt -150.6 132.27 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.685 -0.634 . . . . 0.0 111.487 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 123.1 47.63 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.749 1.22 . . . . 0.0 110.172 -177.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -99.73 157.12 16.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.246 0.618 . . . . 0.0 110.181 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.34 -18.47 63.08 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -169.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.9 p -151.01 151.54 32.21 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.667 1.587 . . . . 0.0 111.435 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 36.9 ptt-85 -55.27 -35.66 65.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.756 1.222 . . . . 0.0 114.24 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 m -60.92 -45.92 92.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.058 1.343 . . . . 0.0 111.265 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.09 -44.0 97.61 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.773 0.829 . . . . 0.0 110.915 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.85 79.41 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.297 0.639 . . . . 0.0 112.63 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.53 -48.32 67.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.861 0.865 . . . . 0.0 111.909 172.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.34 -46.56 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.522 -0.736 . . . . 0.0 110.279 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.99 99.54 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.759 0.824 . . . . 0.0 112.053 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -56.09 -50.65 70.43 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.566 1.076 . . . . 0.0 111.489 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.8 -35.15 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.793 0.724 . . . . 0.0 112.338 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -87.2 -33.44 19.35 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.0 mt -98.91 -22.68 15.66 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -171.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -70.2 122.71 20.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.0 0.818 . . . . 0.0 110.773 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 70.61 14.92 7.18 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 127.543 2.337 . . . . 0.0 114.262 -171.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.4 ttp -72.79 138.1 79.95 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 120.518 -1.364 . . . . 0.0 110.939 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.11 139.58 21.66 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.44 2.76 . . . . 0.0 111.402 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.8 tp -144.88 116.22 8.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.343 1.457 . . . . 0.0 109.969 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 59.03 18.88 6.69 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.211 1.404 . . . . 0.0 113.916 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.57 -6.73 80.26 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.665 1.602 . . . . 0.0 114.508 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -85.38 153.99 22.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.758 1.279 . . . . 0.0 110.557 170.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -86.11 163.41 17.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 167.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.0 mt -122.1 137.52 54.79 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.305 1.042 . . . . 0.0 110.046 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.4 135.67 46.36 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.382 1.073 . . . . 0.0 109.529 170.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.37 132.93 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.965 0.906 . . . . 0.0 110.955 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -147.73 165.61 30.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.163 1.385 . . . . 0.0 111.573 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -73.54 136.85 44.08 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.545 -0.722 . . . . 0.0 110.946 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 123.693 0.797 . . . . 0.0 110.572 174.712 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -86.11 135.01 33.77 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.233 1.413 . . . . 0.0 111.406 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.83 127.4 51.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.809 1.643 . . . . 0.0 110.206 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -89.65 135.7 33.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.731 2.013 . . . . 0.0 108.13 171.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.63 113.22 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.048 0.939 . . . . 0.0 109.46 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.16 174.41 21.33 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.606 1.574 . . . . 0.0 113.271 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 m120 66.48 16.61 10.46 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.028 1.731 . . . . 0.0 113.761 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.5 mt -60.8 140.52 93.25 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 121.156 -0.965 . . . . 0.0 113.033 -170.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -68.67 159.28 54.31 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.08 3.187 . . . . 0.0 111.745 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.95 -1.47 11.25 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.572 2.848 . . . . 0.0 114.031 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -116.84 12.49 14.79 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.682 1.593 . . . . 0.0 113.0 -174.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 tp -82.24 137.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.42 1.088 . . . . 0.0 110.734 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.5 p -128.86 176.18 8.05 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.261 1.424 . . . . 0.0 110.009 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -54.22 -32.82 56.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.913 0.885 . . . . 0.0 112.202 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -73.34 -34.01 65.43 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.784 0.834 . . . . 0.0 112.479 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -71.48 -44.13 65.3 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.654 0.661 . . . . 0.0 110.56 170.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.9 ttt -65.28 -33.26 75.57 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -63.98 -45.15 90.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.068 0.947 . . . . 0.0 111.318 169.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -70.84 -38.51 73.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.634 0.774 . . . . 0.0 112.825 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.8 mt -59.62 -24.21 63.63 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.551 1.54 . . . . 0.0 113.328 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -113.2 10.25 18.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.577 1.551 . . . . 0.0 112.539 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -21.33 65.42 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.63 -20.52 60.97 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.038 1.335 . . . . 0.0 112.593 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -112.47 11.59 19.87 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.257 2.223 . . . . 0.0 111.855 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.5 -169.99 52.98 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.479 1.037 . . . . 0.0 113.211 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -71.63 129.6 39.11 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.014 -0.698 . . . . 0.0 111.293 174.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.9 149.73 43.2 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.058 0.943 . . . . 0.0 111.439 172.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.23 -12.89 75.26 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.717 1.151 . . . . 0.0 113.78 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -156.12 138.08 14.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.88 1.672 . . . . 0.0 109.316 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -141.69 127.68 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.437 1.495 . . . . 0.0 108.801 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -145.2 139.15 27.0 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.562 1.145 . . . . 0.0 111.936 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.7 mt -139.86 137.8 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.485 1.914 . . . . 0.0 107.978 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -143.51 129.17 19.23 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 122.63 1.205 . . . . 0.0 113.897 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -74.21 -11.49 60.3 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.313 1.445 . . . . 0.0 113.463 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.17 -32.09 61.89 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.45 1.5 . . . . 0.0 113.031 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -123.73 -20.67 5.4 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.39 42.35 7.47 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 119.26 0.936 . . . . 0.0 113.252 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -137.78 154.75 49.54 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.734 1.614 . . . . 0.0 111.151 -177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.64 162.08 25.12 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.099 1.333 . . . . 0.0 113.647 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -137.27 139.71 41.13 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.921 2.088 . . . . 0.0 109.167 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.93 139.99 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.124 0.97 . . . . 0.0 110.313 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -125.88 116.17 21.11 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.95 0.9 . . . . 0.0 110.292 -172.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.5 mt -92.83 167.86 11.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.1 0.56 . . . . 0.0 111.242 -174.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -76.31 -19.53 58.16 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.2 p -143.8 155.11 44.03 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.643 1.177 . . . . 0.0 111.649 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 37.4 ptt-85 -60.11 -36.01 76.51 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.716 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.1 m -62.19 -50.62 71.08 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.351 1.46 . . . . 0.0 110.698 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.32 -37.6 87.6 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.692 -0.67 . . . . 0.0 111.758 176.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.02 89.55 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.106 0.866 . . . . 0.0 113.129 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -65.6 -49.57 68.29 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.678 0.791 . . . . 0.0 111.531 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.71 -48.45 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.967 -0.458 . . . . 0.0 110.125 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.56 86.29 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.596 0.758 . . . . 0.0 112.204 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -60.17 -42.42 94.96 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.247 -0.908 . . . . 0.0 112.15 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.17 -35.21 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.828 0.74 . . . . 0.0 112.049 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.69 -30.78 32.48 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.8 mt -104.73 -19.52 13.91 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -169.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.71 128.33 36.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.207 0.912 . . . . 0.0 111.664 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.1 t30 70.83 17.87 6.3 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.034 2.534 . . . . 0.0 113.348 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.6 ttp -76.49 138.17 67.33 Favored Pre-proline 0 N--CA 1.475 0.805 0 O-C-N 120.796 -1.19 . . . . 0.0 111.343 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.65 143.6 21.49 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.444 2.763 . . . . 0.0 111.708 175.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.2 tp -146.73 115.51 6.84 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.413 1.485 . . . . 0.0 110.247 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 57.08 25.68 11.11 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.513 1.525 . . . . 0.0 114.164 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.16 -1.96 78.07 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.225 1.393 . . . . 0.0 114.607 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -100.41 166.85 10.74 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.581 1.552 . . . . 0.0 111.191 169.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -92.66 175.21 6.9 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.481 1.112 . . . . 0.0 109.904 171.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.6 mt -136.9 110.25 7.89 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.745 1.218 . . . . 0.0 108.89 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.06 122.39 37.68 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.71 125.49 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.87 0.868 . . . . 0.0 110.846 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -139.67 166.71 23.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.885 1.674 . . . . 0.0 111.164 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -77.71 134.46 38.1 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.602 -0.687 . . . . 0.0 111.482 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.648 0 C-N-CA 124.173 0.989 . . . . 0.0 110.645 174.337 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.5 m . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -97.56 131.55 44.05 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.719 1.208 . . . . 0.0 112.026 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.9 mt -102.98 152.45 21.31 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.64 1.976 . . . . 0.0 110.586 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.418 ' CD2' ' HD3' ' A' ' 144' ' ' ARG . 12.1 t80 -124.48 126.28 45.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.778 2.431 . . . . 0.0 108.076 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.31 111.6 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.567 1.147 . . . . 0.0 109.478 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.57 167.23 25.75 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.79 1.186 . . . . 0.0 112.619 173.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 64.97 26.49 12.72 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.61 1.564 . . . . 0.0 113.217 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.53 144.01 95.91 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 121.074 -1.016 . . . . 0.0 111.345 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.38 161.8 44.71 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.79 2.993 . . . . 0.0 111.85 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.03 6.08 1.9 Allowed 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 124.157 3.238 . . . . 0.0 114.347 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -140.43 19.0 2.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.462 1.505 . . . . 0.0 114.335 -172.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -73.07 150.72 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.065 0.946 . . . . 0.0 110.151 169.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 p -126.83 163.54 23.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.081 1.352 . . . . 0.0 110.619 170.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -58.16 -32.96 68.71 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.14 0.576 . . . . 0.0 111.44 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -68.26 -42.44 79.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 111.673 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.11 -40.73 94.92 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.884 -0.51 . . . . 0.0 111.802 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.9 ttt -66.51 -38.6 87.59 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.656 0.662 . . . . 0.0 111.629 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -62.95 -38.73 92.25 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.52 1.128 . . . . 0.0 111.707 173.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.91 -45.45 61.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.96 1.304 . . . . 0.0 111.32 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.59 -29.09 58.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.007 1.323 . . . . 0.0 113.524 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -107.07 10.03 30.34 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.371 1.468 . . . . 0.0 112.792 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.06 -23.42 67.17 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -58.5 -26.72 63.77 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.976 1.31 . . . . 0.0 112.863 171.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -101.47 10.7 40.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.964 1.706 . . . . 0.0 112.729 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.18 -167.84 43.97 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.777 1.18 . . . . 0.0 112.625 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -79.06 123.73 27.62 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.952 -0.734 . . . . 0.0 110.265 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.82 143.64 54.52 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.8 0.84 . . . . 0.0 111.581 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.18 -9.32 76.88 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.792 1.187 . . . . 0.0 114.117 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -155.44 134.39 12.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.296 1.838 . . . . 0.0 108.48 173.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.5 t -140.54 125.77 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.196 1.398 . . . . 0.0 109.112 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -140.74 140.35 34.81 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.628 1.571 . . . . 0.0 111.238 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 62.0 mt -140.21 130.57 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.838 1.655 . . . . 0.0 108.211 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -120.34 108.16 13.81 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.798 0.839 . . . . 0.0 112.079 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.73 -17.86 61.06 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -171.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -78.98 -19.42 51.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.115 0.966 . . . . 0.0 112.758 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -108.28 -29.28 8.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.744 1.218 . . . . 0.0 113.615 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.79 28.18 27.11 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 124.608 1.099 . . . . 0.0 114.182 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -133.86 156.95 47.16 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.519 1.527 . . . . 0.0 111.893 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.75 165.8 27.53 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.865 1.221 . . . . 0.0 113.615 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.33 146.58 46.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.555 1.942 . . . . 0.0 109.78 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.6 tt -153.26 127.39 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.583 0.753 . . . . 0.0 111.43 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -114.0 121.15 43.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.155 0.982 . . . . 0.0 111.176 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.0 mt -97.42 167.15 11.17 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.74 0.816 . . . . 0.0 110.73 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -70.37 -24.07 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.7 p -145.52 160.7 41.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.466 1.506 . . . . 0.0 111.138 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -62.49 -31.76 72.56 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 119.01 -0.519 . . . . 0.0 111.985 173.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.0 m -61.24 -47.19 87.2 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.91 1.284 . . . . 0.0 110.564 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.06 -45.78 93.36 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.298 0.639 . . . . 0.0 111.076 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.46 -36.15 83.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -68.49 -44.26 75.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.064 1.345 . . . . 0.0 111.428 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.53 -52.0 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.432 -0.793 . . . . 0.0 109.883 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.15 90.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.625 0.77 . . . . 0.0 112.389 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -52.94 -50.05 64.8 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.032 0.933 . . . . 0.0 111.679 172.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.4 t -74.68 -36.23 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.389 0.54 . . . . 0.0 111.852 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -77.29 -21.32 53.73 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.5 mt -110.83 0.11 17.12 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.521 1.128 . . . . 0.0 113.758 -174.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.67 125.9 26.72 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.14 -0.975 . . . . 0.0 112.218 -176.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 57.51 22.4 8.05 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.479 1.912 . . . . 0.0 113.5 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 51.0 ttp -63.81 133.55 95.6 Favored Pre-proline 0 N--CA 1.472 0.652 0 O-C-N 120.777 -1.202 . . . . 0.0 111.09 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -73.54 127.33 11.65 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.003 2.469 . . . . 0.0 110.432 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 45.6 tp -135.51 107.46 7.11 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.813 1.645 . . . . 0.0 108.117 170.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 57.81 29.18 17.07 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.769 1.228 . . . . 0.0 113.202 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.74 -5.61 62.12 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.249 1.88 . . . . 0.0 115.066 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -101.23 142.19 33.02 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.151 1.38 . . . . 0.0 111.025 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -102.14 117.4 34.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.88 0.872 . . . . 0.0 109.736 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.42 119.15 23.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.665 1.186 . . . . 0.0 112.28 -169.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -97.29 106.63 18.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.3 0.64 . . . . 0.0 110.312 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.44 129.24 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.512 1.125 . . . . 0.0 110.595 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.418 ' HD3' ' CD2' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -134.11 170.4 15.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.518 1.927 . . . . 0.0 110.819 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -90.57 140.42 29.77 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.522 0.729 . . . . 0.0 110.952 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.791 0 C-N-CA 125.004 1.322 . . . . 0.0 111.791 -179.819 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.5 p . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -77.03 121.38 23.45 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.497 1.119 . . . . 0.0 110.599 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.4 mt -105.1 134.32 48.4 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.705 1.602 . . . . 0.0 110.354 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -91.94 135.31 34.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.049 2.14 . . . . 0.0 108.086 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.3 t -131.48 106.22 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.353 1.061 . . . . 0.0 108.884 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.01 163.08 15.19 Favored Glycine 0 N--CA 1.464 0.546 0 C-N-CA 124.991 1.281 . . . . 0.0 113.724 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 t30 68.7 27.56 5.87 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.85 1.66 . . . . 0.0 112.745 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.74 145.57 95.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 O-C-N 121.187 -0.946 . . . . 0.0 111.854 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.1 165.86 31.03 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.209 3.273 . . . . 0.0 111.777 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.19 -5.98 17.77 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.091 2.528 . . . . 0.0 113.4 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -106.87 0.48 23.96 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.124 1.37 . . . . 0.0 114.181 -172.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 tp -74.25 143.2 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.268 -0.895 . . . . 0.0 111.129 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 65.7 p -128.23 166.51 18.41 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.035 1.734 . . . . 0.0 110.074 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.96 -31.98 69.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.033 0.533 . . . . 0.0 111.536 171.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -70.76 -42.09 70.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.213 1.005 . . . . 0.0 111.924 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -66.28 -41.86 89.22 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.78 0.718 . . . . 0.0 111.302 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.8 tpt -65.11 -37.92 89.03 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.891 -0.505 . . . . 0.0 111.629 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -63.11 -48.4 78.71 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.404 -0.81 . . . . 0.0 110.273 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -60.49 -38.89 85.73 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.196 0.998 . . . . 0.0 113.296 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.6 mt -63.99 -29.78 70.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.38 1.472 . . . . 0.0 113.988 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -109.89 -4.0 16.26 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.69 1.196 . . . . 0.0 113.51 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.38 -27.52 67.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.927 1.691 . . . . 0.0 115.16 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -55.78 -24.43 35.62 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.961 1.304 . . . . 0.0 112.707 171.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -107.02 14.54 26.27 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.937 2.095 . . . . 0.0 112.029 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.02 172.66 44.97 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.137 1.827 . . . . 0.0 112.78 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.57 132.91 46.21 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.873 -0.78 . . . . 0.0 110.931 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.1 145.44 51.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.885 0.874 . . . . 0.0 112.163 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.05 -11.59 75.93 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.631 1.11 . . . . 0.0 113.905 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -157.69 135.92 11.01 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.712 2.005 . . . . 0.0 108.371 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.34 128.84 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.265 1.426 . . . . 0.0 108.609 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -140.87 139.88 34.5 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.147 1.379 . . . . 0.0 110.904 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.8 mt -139.1 120.6 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.371 1.469 . . . . 0.0 108.312 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -115.97 98.18 6.5 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.234 1.014 . . . . 0.0 112.12 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.07 -15.86 62.02 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.92 -23.61 60.72 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.278 1.031 . . . . 0.0 112.697 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -117.06 -25.27 7.23 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.59 27.7 18.97 Favored Glycine 0 N--CA 1.477 1.428 0 C-N-CA 124.569 1.081 . . . . 0.0 114.171 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.91 150.54 52.15 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.373 1.469 . . . . 0.0 111.46 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.64 167.4 25.32 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.56 1.552 . . . . 0.0 113.08 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -139.52 142.62 37.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.468 1.907 . . . . 0.0 109.402 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 tt -151.65 130.65 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.382 0.673 . . . . 0.0 111.454 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.49 122.38 45.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.611 1.164 . . . . 0.0 110.441 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -97.59 168.41 10.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.005 0.522 . . . . 0.0 111.085 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -67.58 -32.4 73.12 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -171.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.9 p -140.44 159.32 42.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.827 1.251 . . . . 0.0 112.102 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -60.88 -31.95 71.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.818 0.847 . . . . 0.0 113.001 173.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m -68.71 -47.93 65.14 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.161 1.384 . . . . 0.0 110.658 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.8 mt -58.88 -42.34 89.23 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.614 0.766 . . . . 0.0 111.261 173.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.67 -35.39 78.76 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.79 -47.25 75.76 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.742 1.155 . . . . 0.0 111.361 172.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.7 mt -59.43 -48.73 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.19 0.596 . . . . 0.0 110.316 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.98 93.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.203 0.601 . . . . 0.0 112.033 176.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -57.54 -49.0 77.76 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.412 1.005 . . . . 0.0 111.182 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.86 -35.87 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.192 0.597 . . . . 0.0 111.963 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -83.48 -24.32 31.82 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 55.3 mt -111.23 -18.48 12.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -171.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.67 128.39 35.77 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.897 1.226 . . . . 0.0 111.975 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 59.5 27.47 16.63 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.897 2.079 . . . . 0.0 113.364 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.8 ttp -74.72 137.43 73.73 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.535 -0.728 . . . . 0.0 109.664 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.31 136.3 15.81 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.315 2.677 . . . . 0.0 111.058 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -145.12 123.49 12.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.971 1.708 . . . . 0.0 109.0 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 58.83 22.87 10.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.775 1.23 . . . . 0.0 113.716 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.15 3.1 85.29 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.317 1.436 . . . . 0.0 114.474 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -106.17 148.91 27.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.17 1.788 . . . . 0.0 110.879 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -84.22 168.47 15.7 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.339 168.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.01 127.87 37.13 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.29 1.036 . . . . 0.0 110.701 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.63 111.34 23.52 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.84 0.856 . . . . 0.0 108.902 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.94 124.21 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.767 0.827 . . . . 0.0 109.822 -173.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.9 ptt85 -149.63 173.6 13.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.311 1.444 . . . . 0.0 111.247 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -75.2 144.97 42.41 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.616 -0.678 . . . . 0.0 111.85 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.979 0 C-N-CA 125.221 1.408 . . . . 0.0 113.095 178.772 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -85.88 122.19 29.59 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.05 1.34 . . . . 0.0 111.443 -176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.6 mt -105.15 135.85 45.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.329 1.852 . . . . 0.0 110.066 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -90.87 138.53 31.52 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.144 1.777 . . . . 0.0 108.723 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.93 106.06 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.24 1.016 . . . . 0.0 108.788 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.79 168.74 20.63 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 125.454 1.502 . . . . 0.0 112.83 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.1 m120 61.48 35.36 17.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.828 1.251 . . . . 0.0 112.045 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.7 mt -66.26 145.78 99.0 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 121.3 -0.875 . . . . 0.0 111.442 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -70.11 158.08 57.65 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.946 2.431 . . . . 0.0 111.338 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.24 -2.32 11.48 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.93 3.087 . . . . 0.0 113.333 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -112.99 14.13 19.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.556 1.943 . . . . 0.0 112.604 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.25 150.21 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 O-C-N 121.012 -1.055 . . . . 0.0 110.753 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.0 p -136.2 170.06 16.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.832 1.653 . . . . 0.0 109.683 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.27 -35.41 71.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.57 0.348 . . . . 0.0 111.464 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.44 -41.26 66.35 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.975 0.91 . . . . 0.0 111.806 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.29 -46.79 82.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.233 0.613 . . . . 0.0 111.261 173.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.2 ttt -64.42 -35.51 81.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.116 0.566 . . . . 0.0 112.264 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -64.91 -45.11 87.29 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.415 0.686 . . . . 0.0 110.97 171.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -64.35 -42.98 95.95 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.197 -0.94 . . . . 0.0 111.946 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.1 mt -57.65 -24.61 57.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.476 1.51 . . . . 0.0 113.964 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -115.14 -1.85 12.9 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.681 1.192 . . . . 0.0 113.572 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.27 -28.79 69.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.728 1.611 . . . . 0.0 115.164 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -61.11 -22.03 64.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.523 1.129 . . . . 0.0 112.91 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -103.49 24.99 10.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.912 2.085 . . . . 0.0 111.67 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.24 -176.82 45.52 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.934 1.73 . . . . 0.0 112.664 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.66 144.38 56.97 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.95 -0.735 . . . . 0.0 111.949 175.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.14 118.01 16.6 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.16 -15.15 75.27 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.807 1.194 . . . . 0.0 113.566 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -161.17 145.25 13.33 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.672 1.989 . . . . 0.0 108.677 168.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.8 t -144.35 130.73 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.32 1.448 . . . . 0.0 110.365 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -140.52 136.69 33.15 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.405 1.482 . . . . 0.0 110.844 171.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 63.7 mt -139.29 137.03 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.249 1.82 . . . . 0.0 107.84 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -139.55 125.29 19.51 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.135 0.969 . . . . 0.0 113.087 170.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.15 -18.68 62.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.441 1.096 . . . . 0.0 112.779 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.36 -38.72 63.57 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.337 1.855 . . . . 0.0 113.081 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -120.77 -15.32 8.4 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.67 41.16 5.77 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.787 1.184 . . . . 0.0 113.811 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -136.86 159.26 42.39 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.114 1.366 . . . . 0.0 112.223 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.96 167.37 29.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.496 1.046 . . . . 0.0 114.191 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -139.11 147.06 41.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.705 2.002 . . . . 0.0 109.571 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.2 tt -147.88 132.28 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.202 1.001 . . . . 0.0 110.646 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -101.63 128.42 47.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.965 0.906 . . . . 0.0 109.131 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.5 mt -98.68 165.99 11.54 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.361 0.528 . . . . 0.0 110.278 170.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -76.5 -18.05 58.95 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -169.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.2 p -144.4 154.3 42.83 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.828 1.251 . . . . 0.0 111.5 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -62.87 -33.15 74.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.61 0.764 . . . . 0.0 112.891 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.1 m -64.48 -47.66 78.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.691 1.196 . . . . 0.0 110.793 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -66.71 -35.89 81.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.338 0.655 . . . . 0.0 111.394 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.77 94.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.94 -47.76 76.51 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.489 1.041 . . . . 0.0 111.214 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 93.9 mt -59.54 -50.41 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.202 0.601 . . . . 0.0 110.272 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.64 -45.68 88.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.093 0.557 . . . . 0.0 111.806 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.38 -46.22 86.79 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.391 -0.818 . . . . 0.0 111.69 176.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.1 t -67.56 -35.77 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.516 0.598 . . . . 0.0 111.89 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -80.81 -24.35 38.58 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 48.9 mt -109.09 -16.71 14.05 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.02 133.71 49.47 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.05 1.295 . . . . 0.0 112.615 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 59.4 t30 65.71 15.83 10.22 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.939 2.496 . . . . 0.0 113.757 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.8 ttp -71.43 136.13 83.92 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 120.834 -1.166 . . . . 0.0 110.563 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.93 129.77 11.8 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.363 2.709 . . . . 0.0 110.607 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.9 tp -139.32 113.29 8.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.036 1.335 . . . . 0.0 109.557 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 58.81 23.62 11.45 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.906 1.282 . . . . 0.0 113.478 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.26 -3.37 76.09 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.847 1.689 . . . . 0.0 114.671 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -92.14 147.68 22.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.413 1.485 . . . . 0.0 110.7 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -102.67 110.46 22.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.749 0.82 . . . . 0.0 109.348 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 80.4 mt -73.56 121.21 20.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.699 0.8 . . . . 0.0 111.661 -172.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -92.07 112.7 24.73 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.919 0.888 . . . . 0.0 108.8 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.66 120.47 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.186 0.994 . . . . 0.0 110.131 -172.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -155.08 156.09 35.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.773 1.229 . . . . 0.0 111.473 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -67.85 133.03 48.47 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.672 -0.643 . . . . 0.0 111.435 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 124.121 0.968 . . . . 0.0 110.399 179.227 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -76.73 125.74 29.78 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.762 -1.211 . . . . 0.0 110.973 -175.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.2 mt -114.02 139.28 49.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.238 2.215 . . . . 0.0 110.26 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -100.74 142.56 32.04 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.238 2.215 . . . . 0.0 108.567 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.43 114.89 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.218 1.007 . . . . 0.0 110.001 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.88 173.73 17.03 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 126.021 1.772 . . . . 0.0 113.057 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.2 m120 66.64 11.79 8.38 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.462 1.905 . . . . 0.0 114.024 -175.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.5 mt -53.98 144.24 38.51 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.342 1.057 . . . . 0.0 113.41 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.03 165.29 33.04 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.257 3.305 . . . . 0.0 112.032 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.61 -8.14 20.19 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.389 2.726 . . . . 0.0 113.833 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -121.65 23.25 10.3 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.794 1.638 . . . . 0.0 113.561 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 tp -81.81 143.13 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.806 0.843 . . . . 0.0 110.53 173.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.0 p -136.52 167.65 20.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.557 1.943 . . . . 0.0 109.892 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -62.53 -28.54 69.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.32 0.648 . . . . 0.0 112.318 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -72.15 -47.62 49.59 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.993 -1.067 . . . . 0.0 112.496 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -57.82 -41.13 81.57 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.136 0.575 . . . . 0.0 111.86 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -70.07 -34.73 73.55 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.594 -0.691 . . . . 0.0 112.451 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -68.37 -37.05 80.06 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.518 -0.739 . . . . 0.0 111.906 169.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -68.97 -41.82 77.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.11 0.964 . . . . 0.0 112.449 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.3 mt -58.06 -26.52 62.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.101 1.36 . . . . 0.0 113.46 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -109.23 10.45 25.77 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.545 1.538 . . . . 0.0 112.526 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.78 -22.22 66.03 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -61.43 -21.7 64.35 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.602 1.161 . . . . 0.0 112.419 171.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.07 13.12 24.77 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.123 2.169 . . . . 0.0 112.131 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.37 -168.94 53.38 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.827 1.203 . . . . 0.0 112.916 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -76.57 124.75 28.09 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.55 0.74 . . . . 0.0 110.973 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.14 149.43 48.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.205 1.002 . . . . 0.0 111.681 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.07 -13.94 65.38 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.538 1.066 . . . . 0.0 113.914 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -154.79 136.21 14.16 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.853 1.661 . . . . 0.0 108.919 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 t -143.2 128.72 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.708 1.603 . . . . 0.0 109.066 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -145.35 144.32 30.64 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.062 1.345 . . . . 0.0 111.82 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.2 mt -137.68 128.1 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.352 1.461 . . . . 0.0 108.542 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -115.84 92.62 3.96 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.387 1.075 . . . . 0.0 110.542 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -74.54 -12.3 60.43 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.43 -23.24 62.7 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.073 1.349 . . . . 0.0 112.877 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -117.03 -22.37 8.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.729 1.212 . . . . 0.0 114.168 175.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.46 36.26 7.05 Favored Glycine 0 N--CA 1.475 1.288 0 C-N-CA 125.09 1.329 . . . . 0.0 114.276 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.13 152.08 44.44 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.113 1.365 . . . . 0.0 112.037 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.58 163.01 24.71 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.389 1.471 . . . . 0.0 113.375 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -142.3 140.66 32.26 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.642 1.977 . . . . 0.0 109.156 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.9 tt -154.32 148.12 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.829 0.852 . . . . 0.0 110.73 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -138.87 125.78 21.07 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.776 0.83 . . . . 0.0 110.58 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.28 176.85 5.05 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.24 1.016 . . . . 0.0 111.733 -170.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -76.9 -25.29 52.83 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.6 p -144.66 154.11 42.44 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.348 1.059 . . . . 0.0 112.147 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -58.49 -34.61 71.11 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.659 0.784 . . . . 0.0 112.884 172.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.1 m -62.22 -50.19 72.77 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.251 1.42 . . . . 0.0 110.445 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.11 -36.88 85.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.993 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.77 -37.24 85.79 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.115 0.87 . . . . 0.0 113.282 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -67.95 -45.27 74.72 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.771 0.828 . . . . 0.0 111.808 173.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.76 -48.0 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.57 -0.706 . . . . 0.0 110.243 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.88 91.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.929 0.891 . . . . 0.0 112.017 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -53.69 -53.77 47.33 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.016 0.826 . . . . 0.0 111.479 171.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.8 t -67.88 -33.03 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.582 0.628 . . . . 0.0 112.182 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.71 -36.03 44.03 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.06 -20.84 14.61 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.185 1.179 . . . . 0.0 114.185 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -67.07 134.01 51.0 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.114 0.87 . . . . 0.0 110.908 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . 0.3 0.4 OUTLIER 58.49 17.81 5.19 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.607 2.363 . . . . 0.0 115.246 -170.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.3 ttp -75.88 137.59 69.65 Favored Pre-proline 0 CA--C 1.545 0.771 0 O-C-N 120.873 -1.142 . . . . 0.0 110.947 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.73 140.8 21.21 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.467 2.778 . . . . 0.0 111.427 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 32.6 tp -146.56 119.3 8.61 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.459 1.504 . . . . 0.0 110.287 174.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? 58.98 23.9 12.04 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.065 1.346 . . . . 0.0 113.894 171.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.1 1.24 72.92 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.533 1.539 . . . . 0.0 114.734 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -107.66 165.15 11.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.669 1.988 . . . . 0.0 110.768 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -90.45 176.29 6.76 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.6 -0.688 . . . . 0.0 109.99 168.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.4 mt -133.85 116.11 15.27 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.6 1.16 . . . . 0.0 109.196 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -92.13 119.87 32.2 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.0 t -124.72 129.99 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.563 0.745 . . . . 0.0 109.926 -176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -146.98 164.4 33.11 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.304 1.442 . . . . 0.0 111.13 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -70.97 130.58 41.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 168.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 124.88 1.272 . . . . 0.0 110.759 -176.631 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -76.52 128.5 34.87 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.597 1.159 . . . . 0.0 111.311 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.02 140.28 49.42 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.181 1.792 . . . . 0.0 110.468 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -95.9 140.72 30.26 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.536 2.334 . . . . 0.0 108.814 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.2 110.46 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.94 0.896 . . . . 0.0 109.401 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.34 172.35 21.22 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.447 1.498 . . . . 0.0 113.321 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 m120 65.25 19.09 11.63 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.669 1.588 . . . . 0.0 113.128 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.1 mt -58.79 143.46 82.68 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.252 1.021 . . . . 0.0 111.857 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.7 158.57 56.57 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.696 2.93 . . . . 0.0 111.255 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.83 0.36 7.82 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.422 2.748 . . . . 0.0 113.568 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -114.64 4.75 15.18 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.943 1.697 . . . . 0.0 113.639 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.5 tp -74.03 142.41 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.28 -0.887 . . . . 0.0 111.247 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.7 p -123.72 165.59 17.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.971 1.708 . . . . 0.0 110.051 175.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.72 -27.78 68.16 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.699 0.399 . . . . 0.0 111.918 172.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.08 -40.27 62.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.168 0.987 . . . . 0.0 111.76 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -67.54 -37.81 83.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.637 0.653 . . . . 0.0 111.466 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.2 tpt -66.38 -40.98 90.03 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.641 -0.662 . . . . 0.0 111.657 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -60.56 -38.15 83.59 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.657 -0.652 . . . . 0.0 111.101 172.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -72.02 -40.3 68.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.05 0.94 . . . . 0.0 113.333 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 38.0 mt -56.02 -29.52 60.5 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.792 1.237 . . . . 0.0 112.766 173.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -109.05 12.88 24.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.446 1.498 . . . . 0.0 113.152 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -20.18 61.6 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.804 -1.185 . . . . 0.0 114.006 -174.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -64.53 -17.89 64.33 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.556 -0.715 . . . . 0.0 112.269 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -102.71 8.4 39.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.829 2.052 . . . . 0.0 112.178 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.08 -109.03 3.77 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.09 157.54 46.47 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.628 1.171 . . . . 0.0 112.413 170.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.97 151.11 26.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.742 0.817 . . . . 0.0 110.228 168.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.81 -14.31 61.27 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.697 1.142 . . . . 0.0 113.299 173.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -153.42 144.92 23.24 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.003 1.321 . . . . 0.0 110.622 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.29 128.8 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.549 1.94 . . . . 0.0 109.205 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -140.62 138.55 34.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.12 1.368 . . . . 0.0 111.514 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.4 mt -141.97 126.34 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.83 1.652 . . . . 0.0 107.816 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -118.18 106.81 13.22 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.932 0.872 . . . . 0.0 112.541 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -65.06 -27.18 68.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.989 1.316 . . . . 0.0 114.088 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.45 -9.08 59.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.851 1.261 . . . . 0.0 112.881 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -114.79 -32.7 5.72 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.132 1.373 . . . . 0.0 112.874 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.72 26.86 28.42 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.705 1.145 . . . . 0.0 113.753 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.65 155.18 48.51 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.717 1.607 . . . . 0.0 111.505 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.1 167.48 26.83 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.926 1.251 . . . . 0.0 113.677 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -139.18 148.14 42.75 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.729 2.011 . . . . 0.0 109.76 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.8 tt -154.76 138.93 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.955 0.902 . . . . 0.0 110.609 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -121.93 113.21 19.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.208 1.003 . . . . 0.0 109.87 -171.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.9 mt -88.48 167.05 13.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.135 0.574 . . . . 0.0 111.825 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -75.73 -17.32 59.96 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.7 p -145.44 159.92 42.36 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.369 1.467 . . . . 0.0 110.566 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -64.93 -34.35 78.2 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 171.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.8 m -55.71 -45.39 77.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.59 1.156 . . . . 0.0 111.119 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.2 -42.7 96.51 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.492 173.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.39 98.93 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.35 -51.25 70.16 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.353 1.433 . . . . 0.0 112.721 170.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.29 -45.9 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.905 -0.497 . . . . 0.0 110.293 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.81 94.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.362 0.665 . . . . 0.0 112.021 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.43 -45.1 94.86 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.397 -0.814 . . . . 0.0 111.564 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.76 -36.95 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.623 0.647 . . . . 0.0 112.006 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.08 -35.88 36.33 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.6 mt -96.78 -19.74 18.7 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -171.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -59.36 120.84 10.06 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.496 0.718 . . . . 0.0 111.762 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 64.32 21.59 12.55 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.964 2.106 . . . . 0.0 113.486 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.7 ttp -72.34 136.62 81.34 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 120.811 -1.181 . . . . 0.0 110.574 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.66 140.63 21.25 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.457 2.772 . . . . 0.0 111.628 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -148.44 116.43 6.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.619 1.568 . . . . 0.0 109.938 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 53.49 38.98 29.35 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.91 1.284 . . . . 0.0 113.288 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.88 77.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.379 1.466 . . . . 0.0 114.686 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -101.03 160.74 14.12 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.996 1.718 . . . . 0.0 110.45 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -93.89 173.14 7.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.985 0.914 . . . . 0.0 109.42 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 89.7 mt -133.0 110.35 10.19 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.214 1.005 . . . . 0.0 109.577 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 106.26 18.24 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.5 132.04 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 122.83 0.452 . . . . 0.0 111.602 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -139.22 169.1 18.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.547 1.939 . . . . 0.0 110.812 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -84.64 130.15 34.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.649 0.779 . . . . 0.0 111.077 169.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 125.75 1.62 . . . . 0.0 111.669 178.025 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.506 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.2 t -87.02 -162.23 0.77 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.864 0.866 . . . . 0.0 111.546 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -149.87 153.1 36.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.659 1.584 . . . . 0.0 111.612 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.62 -138.21 17.91 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.619 1.104 . . . . 0.0 112.237 -174.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.3 t -157.98 152.94 25.34 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.812 1.245 . . . . 0.0 111.454 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.0 p -81.29 -3.87 53.86 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 113.462 173.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.24 -19.76 7.62 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 126.401 1.953 . . . . 0.0 113.986 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.54 -135.31 35.99 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 118.257 1.029 . . . . 0.0 113.572 172.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -158.59 143.59 16.22 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.159 1.783 . . . . 0.0 109.675 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.76 142.08 30.07 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.072 0.949 . . . . 0.0 112.266 176.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.9 p -139.2 160.7 39.19 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.945 1.698 . . . . 0.0 111.449 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -68.42 -13.51 62.35 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.872 1.269 . . . . 0.0 114.188 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.2 m -140.07 134.85 31.93 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.205 2.202 . . . . 0.0 107.28 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -77.5 153.27 33.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.045 0.538 . . . . 0.0 111.267 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.38 50.23 1.07 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.701 1.2 . . . . 0.0 111.459 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.2 m -78.54 34.6 0.22 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.188 2.595 . . . . 0.0 113.102 -174.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -95.32 124.89 39.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.588 1.555 . . . . 0.0 111.253 -171.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.5 mt -109.03 134.82 51.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.241 1.817 . . . . 0.0 110.328 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -89.56 137.85 31.97 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 127.092 2.157 . . . . 0.0 107.717 169.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.41 111.07 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.841 0.856 . . . . 0.0 109.153 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.8 172.26 15.72 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.626 1.584 . . . . 0.0 113.097 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.6 m120 61.74 30.63 18.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.005 1.322 . . . . 0.0 111.807 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.54 140.66 96.63 Favored Pre-proline 0 CA--C 1.546 0.82 0 O-C-N 121.459 -0.776 . . . . 0.0 111.21 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.2 161.59 39.64 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.225 2.617 . . . . 0.0 111.165 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.87 -7.2 18.2 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.396 2.731 . . . . 0.0 112.676 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -102.87 11.47 37.43 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.797 2.039 . . . . 0.0 112.701 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.04 147.23 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 120.863 -1.148 . . . . 0.0 110.894 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.5 p -133.19 167.16 20.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.045 1.738 . . . . 0.0 109.671 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.55 -32.74 67.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.106 0.562 . . . . 0.0 111.488 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.52 -38.05 59.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.146 0.978 . . . . 0.0 112.473 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -63.95 -42.85 97.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.872 0.76 . . . . 0.0 110.659 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.8 ttt -68.99 -37.32 78.68 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.321 0.649 . . . . 0.0 112.127 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -62.68 -42.83 99.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.721 0.808 . . . . 0.0 111.225 171.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.92 -42.55 85.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.116 0.967 . . . . 0.0 113.212 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.6 mt -56.74 -25.02 53.79 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.74 1.216 . . . . 0.0 113.315 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -110.44 5.7 21.59 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.229 1.412 . . . . 0.0 113.464 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -67.33 -21.5 65.65 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.127 -0.983 . . . . 0.0 113.371 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -22.9 67.11 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.11 1.364 . . . . 0.0 112.388 172.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -105.67 7.26 32.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.568 1.947 . . . . 0.0 112.465 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.31 177.26 51.78 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.207 1.384 . . . . 0.0 113.069 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -71.37 130.08 40.44 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.805 -0.821 . . . . 0.0 111.347 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.21 153.4 42.49 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.351 1.06 . . . . 0.0 112.211 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.24 -17.29 67.18 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.816 1.198 . . . . 0.0 113.537 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -154.48 146.03 23.18 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.736 1.214 . . . . 0.0 110.809 170.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.2 t -145.22 126.47 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 126.456 1.902 . . . . 0.0 109.247 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -141.8 144.1 33.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.05 1.34 . . . . 0.0 112.316 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.3 mt -140.67 133.83 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 126.142 1.777 . . . . 0.0 108.483 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -124.88 107.49 10.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.954 0.902 . . . . 0.0 112.043 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -72.14 -27.24 62.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -171.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.67 -11.68 60.49 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.897 0.879 . . . . 0.0 113.27 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -114.8 -31.34 6.16 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.942 1.297 . . . . 0.0 113.204 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.5 29.34 19.42 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.744 1.164 . . . . 0.0 113.985 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -138.74 155.38 48.26 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.317 1.447 . . . . 0.0 112.022 -173.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.06 170.82 25.19 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.198 1.38 . . . . 0.0 113.49 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -144.78 144.03 30.96 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.197 1.799 . . . . 0.0 109.412 -173.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.1 tt -153.83 134.99 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.522 0.729 . . . . 0.0 110.6 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -125.79 117.99 24.58 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.898 0.879 . . . . 0.0 110.04 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.92 178.65 5.59 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.765 0.826 . . . . 0.0 111.965 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -80.85 -27.32 36.49 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.1 p -144.19 158.07 43.94 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.366 1.066 . . . . 0.0 111.792 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -57.44 -37.82 73.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.935 0.894 . . . . 0.0 112.404 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.0 m -62.06 -47.42 84.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.189 1.396 . . . . 0.0 110.794 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.03 -42.98 99.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.11 0.564 . . . . 0.0 111.305 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.53 -35.94 80.05 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.59 -47.74 71.77 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.2 1.0 . . . . 0.0 111.347 173.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.47 -47.63 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.715 -0.615 . . . . 0.0 110.14 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.06 -45.52 86.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.71 0.804 . . . . 0.0 112.249 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -55.58 -50.6 69.65 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.206 -0.934 . . . . 0.0 111.697 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.1 t -65.47 -34.01 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.762 0.71 . . . . 0.0 112.29 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -82.75 -32.69 27.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 61.0 mt -105.48 -20.42 13.48 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.275 1.584 . . . . 0.0 115.275 -168.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -70.5 128.61 36.73 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.514 1.052 . . . . 0.0 111.421 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 58.0 t30 69.02 13.73 8.79 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.394 2.278 . . . . 0.0 114.186 -171.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.5 ttp -72.48 138.65 80.85 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 120.569 -1.332 . . . . 0.0 110.894 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -74.37 134.31 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.448 2.766 . . . . 0.0 111.153 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 45.1 tp -143.22 115.99 8.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.49 1.516 . . . . 0.0 110.172 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 57.57 21.74 7.45 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.241 1.416 . . . . 0.0 113.471 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.28 -3.02 68.94 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.925 1.726 . . . . 0.0 115.083 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -97.08 156.15 16.5 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.723 1.609 . . . . 0.0 110.959 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -105.58 117.09 33.14 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.265 -0.897 . . . . 0.0 109.366 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.3 mt -72.71 136.01 45.48 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.96 0.904 . . . . 0.0 112.226 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.0 tpp180 -99.77 124.29 44.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.619 1.168 . . . . 0.0 108.767 169.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.74 128.06 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.985 0.914 . . . . 0.0 109.75 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -150.7 160.16 44.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.863 1.265 . . . . 0.0 111.192 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -68.69 132.61 47.14 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.721 -0.612 . . . . 0.0 110.356 170.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.62 -21.42 61.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 72.7 m -134.1 135.64 43.35 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.117 2.167 . . . . 0.0 108.651 171.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -155.97 -48.4 0.08 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.4 t -82.78 131.33 35.2 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.454 0.702 . . . . 0.0 110.455 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.58 154.0 34.85 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.04 0.936 . . . . 0.0 112.621 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.7 t -77.79 175.88 9.56 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.56 0.744 . . . . 0.0 112.456 173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.42 168.36 16.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.557 1.143 . . . . 0.0 112.943 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.1 t -156.54 156.89 34.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.531 1.532 . . . . 0.0 110.848 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 28.9 p -100.81 101.26 12.06 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.335 1.454 . . . . 0.0 111.175 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -172.3 86.94 0.08 OUTLIER Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.312 -1.271 . . . . 0.0 113.322 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.54 163.38 37.68 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.645 2.897 . . . . 0.0 111.17 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.1 m -137.79 136.1 36.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.755 1.222 . . . . 0.0 111.436 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.9 m -104.59 162.4 13.3 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.019 1.327 . . . . 0.0 112.476 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-O 118.047 -1.418 . . . . 0.0 113.256 -179.829 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t 73.58 5.2 4.9 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.211 1.804 . . . . 0.0 114.39 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.5 p -74.86 140.81 44.12 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.086 -1.634 . . . . 0.0 112.133 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.75 28.02 65.93 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.54 -0.725 . . . . 0.0 114.324 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -77.2 54.17 1.06 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.349 1.46 . . . . 0.0 112.58 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.5 m -83.78 86.18 7.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.495 1.518 . . . . 0.0 111.418 -177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.65 22.76 7.26 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.375 1.464 . . . . 0.0 115.283 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.9 41.99 9.23 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.494 1.147 . . . . 0.0 112.806 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -66.95 123.64 20.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.725 1.21 . . . . 0.0 111.798 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -87.97 71.87 9.35 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.493 1.117 . . . . 0.0 111.592 -175.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.5 p -69.44 159.98 32.23 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.488 1.515 . . . . 0.0 111.792 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -54.76 -36.47 64.87 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.406 1.483 . . . . 0.0 113.426 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.1 p -139.36 151.53 46.42 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 127.277 2.231 . . . . 0.0 108.737 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -146.7 150.84 36.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.38 1.872 . . . . 0.0 107.864 -169.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -143.18 129.72 20.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.987 0.899 . . . . 0.0 111.976 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 p -79.46 25.84 0.31 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 128.379 2.672 . . . . 0.0 113.413 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -83.27 129.01 34.98 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.335 1.454 . . . . 0.0 110.468 -176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.4 mt -113.98 134.38 54.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.146 1.778 . . . . 0.0 110.056 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -89.26 137.4 32.36 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.141 2.176 . . . . 0.0 108.529 170.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -130.06 109.93 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.126 0.97 . . . . 0.0 109.415 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.1 173.8 20.11 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.21 1.862 . . . . 0.0 113.328 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.1 m120 64.0 19.59 11.82 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.951 1.701 . . . . 0.0 113.276 -173.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.67 140.63 92.78 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.067 -1.021 . . . . 0.0 112.778 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -69.44 157.35 61.34 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.856 3.037 . . . . 0.0 110.991 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.66 -5.47 17.12 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.26 2.64 . . . . 0.0 113.164 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -104.38 9.74 35.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.338 1.855 . . . . 0.0 113.321 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.2 tp -82.04 144.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.091 -1.006 . . . . 0.0 111.016 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.9 p -135.12 166.57 22.76 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.492 1.917 . . . . 0.0 109.303 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -60.73 -27.34 67.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.859 0.464 . . . . 0.0 112.012 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -72.9 -40.0 65.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.983 0.913 . . . . 0.0 111.773 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -65.42 -42.3 92.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.409 0.55 . . . . 0.0 111.004 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.3 ttt -69.12 -36.76 77.86 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.621 0.768 . . . . 0.0 112.221 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -61.62 -46.61 89.07 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.742 0.817 . . . . 0.0 110.79 169.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -66.38 -39.8 89.31 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.0 mt -59.62 -22.85 62.42 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.074 1.35 . . . . 0.0 113.694 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -116.09 7.83 14.33 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.437 1.495 . . . . 0.0 112.569 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -68.72 -22.0 64.37 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -169.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -67.13 -22.28 65.8 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.286 -0.883 . . . . 0.0 112.207 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -93.92 10.8 31.88 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.414 1.886 . . . . 0.0 112.589 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.48 -175.94 53.55 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.334 1.445 . . . . 0.0 113.189 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -72.1 128.92 37.2 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.992 -0.71 . . . . 0.0 111.186 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.35 147.08 48.37 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.959 0.904 . . . . 0.0 111.673 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.05 -1.28 82.25 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.831 1.205 . . . . 0.0 113.819 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -162.76 128.63 3.34 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.496 1.918 . . . . 0.0 108.18 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.71 123.32 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.745 1.218 . . . . 0.0 108.917 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -141.22 137.79 32.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.976 1.311 . . . . 0.0 110.927 176.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.7 mt -137.76 126.77 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.42 1.488 . . . . 0.0 108.359 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -118.32 108.42 15.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.281 1.033 . . . . 0.0 112.02 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -71.62 -30.6 65.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.019 0.928 . . . . 0.0 113.285 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.78 -20.22 61.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.049 0.94 . . . . 0.0 113.454 -176.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -112.83 -24.47 9.55 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.54 38.15 7.76 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 124.76 1.172 . . . . 0.0 114.154 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -140.62 152.99 45.87 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.16 1.384 . . . . 0.0 112.122 -173.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.37 161.48 24.97 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.029 1.3 . . . . 0.0 113.553 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.45 138.11 34.43 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.486 1.914 . . . . 0.0 109.476 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.4 tt -147.81 135.13 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 110.713 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -118.71 123.52 45.08 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.543 0.737 . . . . 0.0 110.749 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.64 170.33 9.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.711 0.804 . . . . 0.0 110.887 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.43 -22.27 51.74 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.8 p -146.26 144.05 29.6 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.747 1.219 . . . . 0.0 111.951 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -32.53 71.45 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 m -63.92 -48.15 77.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.578 1.151 . . . . 0.0 110.756 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.18 -35.77 82.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.844 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.17 86.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.033 0.833 . . . . 0.0 112.736 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.09 -47.39 71.36 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.176 0.898 . . . . 0.0 111.812 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.9 mt -60.08 -50.12 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.778 -0.576 . . . . 0.0 110.044 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.02 -43.55 91.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.626 0.77 . . . . 0.0 111.87 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -57.24 -47.91 80.16 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.076 0.853 . . . . 0.0 111.586 174.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 78.6 t -71.09 -34.94 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 118.802 0.728 . . . . 0.0 112.176 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -82.79 -28.86 30.0 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 55.5 mt -99.31 -16.25 18.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.165 0.986 . . . . 0.0 113.374 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.96 116.6 2.84 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.022 1.729 . . . . 0.0 111.885 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.0 m120 64.32 19.47 11.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.138 2.175 . . . . 0.0 114.286 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.9 ttp -70.5 137.12 86.04 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 120.703 -1.248 . . . . 0.0 110.858 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.27 139.28 23.42 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.356 2.704 . . . . 0.0 111.437 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.9 tp -142.08 115.2 8.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.684 1.594 . . . . 0.0 109.801 173.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 57.18 25.22 10.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.931 1.292 . . . . 0.0 113.768 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.54 -3.67 83.64 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.542 1.544 . . . . 0.0 114.706 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -95.66 161.39 14.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.551 1.54 . . . . 0.0 111.047 172.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -88.24 176.05 7.41 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.79 169.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.0 mt -134.51 115.07 13.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.525 1.13 . . . . 0.0 109.704 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -91.97 115.91 28.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.629 0.771 . . . . 0.0 109.064 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.4 t -119.6 123.31 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.904 0.882 . . . . 0.0 110.503 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -139.94 164.61 29.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.029 1.732 . . . . 0.0 111.387 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -79.04 126.84 31.23 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.532 -0.73 . . . . 0.0 111.051 169.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.99 66.03 4.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.74 1.616 . . . . 0.0 110.603 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 27.5 t -144.43 132.03 21.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.718 1.207 . . . . 0.0 111.474 -173.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -164.26 159.93 20.55 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.509 2.323 . . . . 0.0 110.428 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.0 t -152.86 118.32 5.27 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.182 0.993 . . . . 0.0 110.601 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.0 131.96 36.48 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.8 0.84 . . . . 0.0 110.569 174.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 60.4 p -158.69 144.0 16.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.64 1.176 . . . . 0.0 111.198 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 30.4 tp -105.41 66.4 0.74 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.656 1.183 . . . . 0.0 110.058 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.4 p -77.19 77.12 3.73 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.751 1.62 . . . . 0.0 110.865 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.1 t -70.78 -10.61 59.86 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.295 1.038 . . . . 0.0 113.626 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.28 168.34 44.68 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.815 1.674 . . . . 0.0 114.334 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.47 169.11 22.53 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.251 3.301 . . . . 0.0 111.45 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 61.1 p -155.52 142.12 18.77 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.497 1.119 . . . . 0.0 111.852 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.9 t -164.33 152.21 12.33 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.364 1.466 . . . . 0.0 110.904 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.199 0 C-N-CA 125.203 1.382 . . . . 0.0 113.769 -176.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.478 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.4 m -84.44 161.7 20.22 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.241 1.016 . . . . 0.0 113.16 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.1 m -139.55 149.8 44.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.932 1.693 . . . . 0.0 110.531 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.34 -35.19 48.78 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -169.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 t -169.98 155.5 5.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.855 1.262 . . . . 0.0 112.125 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 72.7 p -86.32 -5.33 59.2 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.266 1.426 . . . . 0.0 113.181 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.47 0.72 62.69 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.665 1.603 . . . . 0.0 113.23 -169.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.78 16.72 67.34 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.724 1.154 . . . . 0.0 114.931 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -139.99 144.85 37.19 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.198 1.399 . . . . 0.0 110.869 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.83 147.51 45.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.251 1.02 . . . . 0.0 113.372 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.6 p -116.38 -39.5 3.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.21 1.804 . . . . 0.0 112.254 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -149.99 152.28 34.66 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.017 2.127 . . . . 0.0 110.561 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.7 m -136.87 120.34 17.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.238 1.415 . . . . 0.0 108.997 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -125.01 47.13 2.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.296 1.439 . . . . 0.0 109.532 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -96.56 76.98 2.9 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.747 1.219 . . . . 0.0 109.079 175.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.7 p -72.25 36.2 0.07 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.888 2.875 . . . . 0.0 113.511 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -95.11 128.27 41.81 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.829 1.652 . . . . 0.0 111.257 -169.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -111.18 137.98 48.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.381 1.872 . . . . 0.0 110.474 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -92.47 136.3 33.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.371 2.268 . . . . 0.0 108.596 169.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.8 t -128.71 116.06 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.469 1.108 . . . . 0.0 109.024 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.88 165.51 14.03 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 125.013 1.292 . . . . 0.0 114.561 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 64.76 33.1 10.59 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.691 1.596 . . . . 0.0 111.658 -174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 mt -66.19 143.29 98.28 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 121.143 -0.973 . . . . 0.0 112.144 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.27 163.81 37.34 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.167 3.245 . . . . 0.0 111.506 174.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.0 -7.68 19.39 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.243 2.629 . . . . 0.0 113.195 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -94.87 7.75 44.96 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.725 1.61 . . . . 0.0 113.528 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 tp -97.43 135.95 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.644 1.178 . . . . 0.0 111.398 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.8 p -131.23 179.6 5.92 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.594 1.558 . . . . 0.0 109.235 169.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -57.31 -25.37 59.21 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.712 0.805 . . . . 0.0 112.549 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.45 -47.79 38.77 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.979 -1.076 . . . . 0.0 111.808 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -63.72 -41.54 98.05 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.078 0.551 . . . . 0.0 111.115 174.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.9 ttt -67.78 -33.14 74.24 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -67.56 -40.05 84.92 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.877 0.762 . . . . 0.0 111.447 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.8 -42.42 81.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.9 0.88 . . . . 0.0 112.683 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.7 mt -57.4 -28.18 63.01 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.404 1.482 . . . . 0.0 113.526 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -110.49 9.18 23.27 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.339 1.456 . . . . 0.0 112.677 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.29 -25.12 67.91 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -62.57 -22.82 66.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.955 1.302 . . . . 0.0 112.987 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -102.88 9.88 38.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.324 1.85 . . . . 0.0 112.644 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.78 -179.05 53.52 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.233 0.921 . . . . 0.0 112.612 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.52 141.28 50.13 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.79 -0.829 . . . . 0.0 112.175 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.41 150.42 27.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.483 1.113 . . . . 0.0 112.133 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.06 -9.42 73.69 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.205 1.384 . . . . 0.0 113.886 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -155.91 137.41 14.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.577 1.951 . . . . 0.0 108.409 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.2 t -143.87 127.24 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.448 1.499 . . . . 0.0 109.174 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -144.9 142.56 29.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.312 1.445 . . . . 0.0 112.201 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 57.4 mt -141.02 131.84 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.455 1.902 . . . . 0.0 108.838 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -125.28 113.17 17.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.094 0.957 . . . . 0.0 111.86 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -72.79 -36.19 67.56 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -170.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.39 -24.6 62.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.741 0.817 . . . . 0.0 113.043 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -100.19 -27.87 13.3 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.237 1.015 . . . . 0.0 113.346 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.81 29.78 19.91 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.798 1.19 . . . . 0.0 114.304 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -137.8 156.59 47.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.245 1.418 . . . . 0.0 112.267 -172.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.28 168.79 26.54 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.215 1.388 . . . . 0.0 113.417 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -142.52 149.68 39.45 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.034 1.733 . . . . 0.0 110.402 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.6 tt -155.31 141.92 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.233 1.013 . . . . 0.0 110.492 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -123.7 123.93 41.61 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.944 0.793 . . . . 0.0 111.308 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.4 mt -95.44 167.43 11.32 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.998 0.919 . . . . 0.0 110.639 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.29 -13.25 61.09 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.2 p -147.32 157.72 43.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.288 1.435 . . . . 0.0 111.684 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -60.12 -32.27 70.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.758 0.823 . . . . 0.0 113.1 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 m -63.97 -48.49 76.25 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.394 1.478 . . . . 0.0 110.506 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.66 -41.45 99.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.136 0.574 . . . . 0.0 111.202 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.63 87.26 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.48 -50.29 70.23 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.306 0.957 . . . . 0.0 111.969 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 83.4 mt -61.31 -47.92 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.752 -0.593 . . . . 0.0 110.289 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.14 95.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.703 0.801 . . . . 0.0 111.998 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.26 -44.57 92.41 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.213 -0.929 . . . . 0.0 112.042 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.2 t -66.72 -36.89 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.268 0.627 . . . . 0.0 111.918 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -85.23 -28.55 25.32 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.5 mt -103.69 -18.84 14.54 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.64 140.83 58.91 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.4 1.0 . . . . 0.0 111.127 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . 0.298 12.0 p30 55.15 18.99 2.62 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.327 2.251 . . . . 0.0 114.966 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.2 ttp -76.29 139.5 68.32 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.092 1.357 . . . . 0.0 111.109 173.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.83 138.88 19.19 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.546 2.831 . . . . 0.0 111.371 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -149.11 122.63 9.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.698 1.599 . . . . 0.0 109.726 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 56.51 32.19 20.33 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.758 1.223 . . . . 0.0 113.235 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.36 4.46 89.96 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.122 1.344 . . . . 0.0 114.637 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.45 156.92 20.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.492 1.917 . . . . 0.0 110.633 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -90.08 167.83 12.45 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.764 -0.585 . . . . 0.0 109.893 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.9 mt -129.77 140.32 51.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.69 1.196 . . . . 0.0 110.857 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -102.93 130.59 50.04 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.868 1.267 . . . . 0.0 108.312 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.39 120.42 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.136 0.88 . . . . 0.0 110.347 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -140.02 167.76 21.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.427 1.891 . . . . 0.0 110.554 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -75.94 134.44 40.22 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.575 -0.703 . . . . 0.0 111.127 169.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.61 -7.52 57.38 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.552 1.141 . . . . 0.0 113.054 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 46.7 t -73.78 143.09 46.17 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.395 1.478 . . . . 0.0 112.008 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -81.18 -165.55 0.95 Allowed 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.863 1.665 . . . . 0.0 113.069 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 30.1 t -156.38 -47.09 0.07 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.79 -1.194 . . . . 0.0 112.277 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.67 162.82 33.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.667 1.587 . . . . 0.0 111.669 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.9 m -73.78 -14.14 61.06 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -170.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -117.31 132.65 56.56 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.696 1.598 . . . . 0.0 110.185 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.0 t -85.62 -19.56 30.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.78 1.232 . . . . 0.0 113.248 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.3 t -163.89 163.67 23.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.755 1.622 . . . . 0.0 110.945 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 144.05 175.3 17.05 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.747 1.641 . . . . 0.0 113.445 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.35 127.6 12.8 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.659 2.906 . . . . 0.0 110.996 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.6 m -167.53 153.06 7.33 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.927 2.091 . . . . 0.0 110.724 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.9 m 68.29 7.91 6.24 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 169.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.337 0 C-N-CA 125.893 1.711 . . . . 0.0 113.458 177.758 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 112.006 -0.437 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.6 p -85.64 -13.55 48.31 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.0 p -92.7 142.41 27.39 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.505 1.522 . . . . 0.0 112.078 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.8 -169.74 47.05 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.284 0.945 . . . . 0.0 113.459 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.7 t -166.67 -159.7 0.37 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.028 1.731 . . . . 0.0 110.709 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.2 t -143.2 146.88 34.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.666 1.586 . . . . 0.0 111.356 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.93 163.06 18.23 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.464 1.507 . . . . 0.0 113.153 -172.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.17 72.7 2.76 Favored Glycine 0 N--CA 1.471 1.006 0 C-N-CA 124.988 1.28 . . . . 0.0 113.311 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 55.95 11.81 0.79 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 128.554 2.742 . . . . 0.0 116.566 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -68.53 123.69 21.52 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.588 -1.32 . . . . 0.0 112.096 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.7 p -146.75 160.43 42.25 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.717 2.007 . . . . 0.0 110.633 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -84.62 -17.5 38.45 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.6 t -170.42 159.97 7.29 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.156 2.182 . . . . 0.0 109.973 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -90.63 99.65 12.64 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.966 0.906 . . . . 0.0 109.618 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -78.83 56.19 1.86 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.002 1.321 . . . . 0.0 111.76 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.0 m -77.53 58.85 1.82 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.877 2.071 . . . . 0.0 113.397 -174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.64 134.73 34.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.705 1.202 . . . . 0.0 110.483 172.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.1 mt -111.54 133.98 53.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.147 1.379 . . . . 0.0 110.056 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -85.57 144.76 27.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.225 2.21 . . . . 0.0 108.004 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.53 110.02 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.192 0.997 . . . . 0.0 109.185 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.65 169.94 13.69 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.501 1.524 . . . . 0.0 113.249 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 65.47 29.04 11.43 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.381 1.473 . . . . 0.0 111.819 -173.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.8 mt -65.6 144.08 98.81 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.848 -1.157 . . . . 0.0 111.928 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.4 159.39 50.55 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.224 2.616 . . . . 0.0 111.292 174.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.08 -0.47 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.484 2.789 . . . . 0.0 113.299 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -114.38 7.35 16.31 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.732 1.613 . . . . 0.0 113.083 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.9 tp -73.28 145.54 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.789 0.836 . . . . 0.0 111.126 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.8 p -127.7 163.03 25.18 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.654 1.582 . . . . 0.0 110.079 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.98 -28.09 67.39 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.323 0.649 . . . . 0.0 111.687 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.24 -41.94 69.49 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.122 0.969 . . . . 0.0 111.507 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -66.07 -37.56 86.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.84 -0.537 . . . . 0.0 111.494 172.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.9 ttt -68.07 -38.98 83.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.536 0.734 . . . . 0.0 112.064 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -62.39 -37.55 86.17 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.107 0.963 . . . . 0.0 111.939 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -71.52 -42.74 67.59 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.412 -0.805 . . . . 0.0 112.453 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.6 mt -57.94 -27.86 63.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.862 1.265 . . . . 0.0 113.082 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -108.82 11.94 25.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.371 1.469 . . . . 0.0 112.769 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.73 -22.31 66.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.093 -1.004 . . . . 0.0 113.684 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -61.1 -22.79 64.98 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.895 1.278 . . . . 0.0 112.616 171.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -108.39 12.14 26.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.784 2.033 . . . . 0.0 112.375 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.18 -172.36 55.18 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.465 1.031 . . . . 0.0 112.94 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -71.47 133.73 46.06 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.989 0.916 . . . . 0.0 111.026 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.11 150.68 31.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.592 1.157 . . . . 0.0 112.02 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.45 -11.84 74.14 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.614 1.102 . . . . 0.0 114.138 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -159.87 138.77 10.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.065 1.746 . . . . 0.0 109.28 174.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.0 t -139.09 130.92 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.934 1.693 . . . . 0.0 109.222 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -141.59 141.03 33.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.21 1.404 . . . . 0.0 111.443 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.3 mt -140.6 129.34 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.011 1.724 . . . . 0.0 107.929 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -118.15 108.7 15.5 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.721 0.772 . . . . 0.0 112.324 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -72.26 -19.65 61.66 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -81.2 -13.75 58.25 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.192 0.997 . . . . 0.0 112.992 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -117.07 -25.66 7.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.916 1.286 . . . . 0.0 113.987 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.43 27.73 35.18 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 124.482 1.039 . . . . 0.0 114.257 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -134.5 149.96 50.75 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.419 1.488 . . . . 0.0 111.616 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.67 166.87 25.23 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.38 1.467 . . . . 0.0 113.134 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -146.19 143.28 29.17 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.342 1.857 . . . . 0.0 109.745 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.1 tt -150.95 133.39 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.078 0.951 . . . . 0.0 110.974 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -112.88 122.12 46.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.172 0.989 . . . . 0.0 110.541 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.27 163.48 12.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.688 0.795 . . . . 0.0 111.063 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.6 -23.77 53.45 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -171.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.5 p -148.71 143.6 26.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.402 1.481 . . . . 0.0 111.642 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -58.95 -32.92 70.06 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.7 m -59.43 -48.59 81.06 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.987 1.315 . . . . 0.0 111.032 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.07 -37.9 89.11 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.388 0.675 . . . . 0.0 111.817 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.51 -33.62 73.1 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.2 -46.78 72.88 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.831 0.852 . . . . 0.0 111.545 171.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.75 -47.46 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.72 -0.613 . . . . 0.0 110.061 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.96 -45.18 91.15 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.899 0.88 . . . . 0.0 112.218 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -55.47 -50.55 69.58 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.076 -1.015 . . . . 0.0 111.66 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.62 -34.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.695 0.68 . . . . 0.0 112.287 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -82.37 -32.89 29.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.8 mt -105.91 -19.57 13.7 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -168.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -71.97 127.46 32.63 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.696 1.135 . . . . 0.0 111.235 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 71.49 12.37 6.53 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.843 2.457 . . . . 0.0 113.736 -169.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.6 ttp -72.63 134.35 81.91 Favored Pre-proline 0 N--CA 1.473 0.691 0 O-C-N 120.574 -1.329 . . . . 0.0 110.767 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.61 132.29 15.8 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.065 2.51 . . . . 0.0 110.801 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 tp -137.29 104.76 5.49 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.514 1.126 . . . . 0.0 110.235 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.5 mtp-105 58.93 26.42 14.93 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.043 1.337 . . . . 0.0 113.691 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.94 -12.53 60.74 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.112 1.815 . . . . 0.0 114.576 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -82.09 163.86 21.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.578 1.189 . . . . 0.0 111.512 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -128.98 105.52 8.26 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.816 1.247 . . . . 0.0 108.878 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.81 125.13 25.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.008 1.323 . . . . 0.0 112.749 -168.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -93.06 118.02 30.72 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.264 1.025 . . . . 0.0 109.313 173.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.32 126.23 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.068 0.947 . . . . 0.0 109.943 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -143.33 159.73 41.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.753 1.621 . . . . 0.0 110.475 -173.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -81.31 124.62 29.5 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.504 -0.747 . . . . 0.0 110.792 170.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.86 74.13 8.86 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.149 0.98 . . . . 0.0 111.231 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 86.7 m -86.17 34.77 0.63 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.075 1.75 . . . . 0.0 113.29 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -62.27 138.15 58.38 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 121.141 -0.974 . . . . 0.0 113.339 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.9 m -153.16 165.54 35.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.587 1.955 . . . . 0.0 110.518 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -139.8 98.85 3.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.586 1.154 . . . . 0.0 110.779 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.8 t -168.35 170.37 9.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.575 1.95 . . . . 0.0 110.555 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -155.93 32.74 0.35 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.576 1.55 . . . . 0.0 113.298 -172.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.7 p -59.4 141.04 55.55 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.091 1.356 . . . . 0.0 111.567 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 77.3 p -167.68 171.05 10.48 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.385 1.474 . . . . 0.0 111.805 -171.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 93.59 90.24 1.6 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.969 1.271 . . . . 0.0 112.089 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.26 119.73 5.94 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.218 2.612 . . . . 0.0 110.662 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.1 t 66.31 8.53 5.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.653 1.581 . . . . 0.0 114.158 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.2 t -159.77 117.33 2.65 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.4 -1.438 . . . . 0.0 111.111 -173.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.471 1.51 . . . . 0.0 112.754 178.776 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.8 m -92.47 124.56 36.6 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.931 0.866 . . . . 0.0 111.293 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.2 p -166.89 167.51 14.8 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.829 1.652 . . . . 0.0 111.143 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.07 47.29 13.62 Favored Glycine 0 N--CA 1.472 1.064 0 O-C-N 121.598 -0.688 . . . . 0.0 112.794 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 m -64.25 -15.7 60.6 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.9 m -101.86 6.42 41.48 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.867 1.267 . . . . 0.0 113.468 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.87 -37.1 1.98 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.465 1.983 . . . . 0.0 113.475 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.37 -152.77 51.2 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.578 1.085 . . . . 0.0 113.815 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -78.72 170.37 16.77 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.883 1.273 . . . . 0.0 111.788 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -60.83 142.32 56.24 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.176 -0.953 . . . . 0.0 112.647 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.0 p -143.35 171.33 14.26 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.025 2.13 . . . . 0.0 111.076 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -63.33 153.58 34.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.988 1.315 . . . . 0.0 112.814 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.7 t -88.11 161.57 17.23 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.852 1.261 . . . . 0.0 111.576 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 pt20 -93.0 21.49 5.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.473 1.509 . . . . 0.0 113.085 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -62.86 -18.15 62.5 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.632 -1.292 . . . . 0.0 114.353 -173.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 m -78.95 8.63 5.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.717 1.607 . . . . 0.0 114.056 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -76.91 128.82 35.26 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.092 1.357 . . . . 0.0 111.848 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.5 mt -105.26 141.58 36.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.574 1.95 . . . . 0.0 110.437 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -96.94 143.68 27.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.526 2.33 . . . . 0.0 108.474 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.2 t -132.56 115.89 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.184 0.994 . . . . 0.0 109.782 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.98 173.26 16.5 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 125.912 1.72 . . . . 0.0 113.226 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m120 64.95 20.47 12.12 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.956 1.702 . . . . 0.0 113.093 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.9 mt -61.6 140.75 95.05 Favored Pre-proline 0 CA--C 1.549 0.936 0 O-C-N 121.198 -0.939 . . . . 0.0 112.319 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.41 164.4 35.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.369 3.38 . . . . 0.0 111.898 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.88 5.8 4.19 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.837 3.024 . . . . 0.0 113.691 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.3 p30 -128.15 13.9 6.71 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.969 1.708 . . . . 0.0 114.042 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.8 tp -80.12 143.63 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.123 0.969 . . . . 0.0 110.423 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.3 p -132.8 167.25 20.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.126 1.77 . . . . 0.0 109.677 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.67 -28.47 68.63 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.641 0.376 . . . . 0.0 111.82 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -70.43 -45.56 65.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.346 1.058 . . . . 0.0 110.975 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -65.2 -38.66 91.16 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.719 -0.613 . . . . 0.0 111.695 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.6 ttt -69.44 -38.2 77.73 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.646 0.657 . . . . 0.0 111.98 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -63.66 -37.22 86.5 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.435 -0.791 . . . . 0.0 111.992 170.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.3 -43.1 64.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.087 0.955 . . . . 0.0 111.872 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.6 mt -57.02 -28.85 62.86 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.058 1.343 . . . . 0.0 113.343 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -105.45 8.17 33.4 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.311 1.444 . . . . 0.0 112.693 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.09 -25.74 67.92 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -169.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -64.41 -21.54 66.67 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.696 0.798 . . . . 0.0 112.724 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -102.96 6.33 38.85 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.096 1.758 . . . . 0.0 112.097 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.13 173.7 46.26 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.174 1.369 . . . . 0.0 112.587 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -67.18 136.04 54.43 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.497 -1.001 . . . . 0.0 111.317 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.08 157.24 37.22 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.927 0.891 . . . . 0.0 112.071 173.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.06 -12.07 62.37 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.048 1.308 . . . . 0.0 113.753 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -152.77 137.09 16.61 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.901 1.68 . . . . 0.0 109.28 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.0 127.81 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.06 1.744 . . . . 0.0 108.853 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -143.96 140.48 29.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.836 1.254 . . . . 0.0 111.454 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.7 mt -139.85 129.4 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.859 1.664 . . . . 0.0 108.276 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -122.23 112.95 18.79 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.841 0.857 . . . . 0.0 112.56 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -70.5 -35.19 73.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 113.613 -173.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.23 -23.66 61.27 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.805 0.842 . . . . 0.0 113.044 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -103.3 -26.48 12.93 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.23 35.68 14.34 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 124.876 1.227 . . . . 0.0 114.115 175.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -140.64 153.16 45.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.21 1.404 . . . . 0.0 112.366 -172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.06 158.14 22.99 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.359 1.456 . . . . 0.0 113.092 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -138.67 137.84 37.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.83 2.052 . . . . 0.0 109.012 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.3 tt -151.81 130.39 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.535 0.734 . . . . 0.0 110.971 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -119.15 113.56 21.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.948 0.899 . . . . 0.0 110.409 -170.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.0 mt -90.73 166.07 13.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.641 0.777 . . . . 0.0 111.124 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -78.56 -17.95 55.36 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.0 p -144.04 157.32 44.4 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.773 1.229 . . . . 0.0 111.616 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -59.6 -40.33 87.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.789 0.835 . . . . 0.0 111.429 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.7 m -58.88 -47.53 84.62 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.011 1.325 . . . . 0.0 111.212 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.3 -42.9 99.08 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.265 0.626 . . . . 0.0 111.179 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.03 -36.27 83.84 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.03 -46.5 71.03 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.888 0.875 . . . . 0.0 111.697 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.95 -47.96 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.633 -0.667 . . . . 0.0 110.102 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.76 -44.35 93.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.423 0.689 . . . . 0.0 112.104 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -54.57 -52.58 61.66 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.258 0.935 . . . . 0.0 111.507 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.29 -34.3 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.382 0.537 . . . . 0.0 111.961 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -81.03 -36.05 31.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.5 -21.78 17.5 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -170.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.31 127.24 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.02 0.827 . . . . 0.0 111.276 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 71.2 11.75 6.82 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.28 2.232 . . . . 0.0 113.786 -173.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.9 ttp -74.33 137.34 75.02 Favored Pre-proline 0 N--CA 1.475 0.796 0 O-C-N 120.549 -1.344 . . . . 0.0 110.893 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.67 141.07 24.37 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.256 2.637 . . . . 0.0 111.191 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.6 tp -137.04 104.25 5.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.512 1.525 . . . . 0.0 110.059 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 59.03 22.56 10.6 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.594 1.558 . . . . 0.0 114.256 172.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.37 -9.97 49.9 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.994 1.759 . . . . 0.0 114.788 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -94.27 166.44 12.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.796 1.298 . . . . 0.0 111.254 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -96.62 176.18 6.11 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.089 0.956 . . . . 0.0 110.401 169.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.8 mt -135.7 116.66 14.22 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.608 1.163 . . . . 0.0 109.723 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -95.77 111.09 23.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.734 0.814 . . . . 0.0 108.955 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.81 130.51 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.127 0.971 . . . . 0.0 109.54 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -150.99 163.76 37.98 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.401 1.48 . . . . 0.0 111.077 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -72.67 137.76 46.23 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.535 -0.728 . . . . 0.0 110.83 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.75 4.78 53.13 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.979 1.312 . . . . 0.0 113.084 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 75.9 m -139.51 17.79 2.55 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.988 2.115 . . . . 0.0 112.556 -173.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -165.04 137.4 4.39 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.744 2.418 . . . . 0.0 109.489 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.1 t -151.5 82.82 1.3 Allowed 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.138 -0.976 . . . . 0.0 110.57 -172.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 58.91 22.9 10.8 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.813 1.645 . . . . 0.0 113.334 -175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 m -76.6 30.66 0.13 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.543 1.937 . . . . 0.0 114.103 -169.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.55 69.97 8.33 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.469 1.908 . . . . 0.0 111.137 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 m -76.91 75.81 3.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.316 1.447 . . . . 0.0 109.869 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 25.9 t -163.95 145.85 9.1 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.911 1.685 . . . . 0.0 111.065 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -121.36 78.92 0.33 Allowed Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.254 1.407 . . . . 0.0 112.279 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.31 171.22 17.39 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.6 2.867 . . . . 0.0 111.413 174.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 t -148.22 136.66 21.43 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.215 1.006 . . . . 0.0 111.352 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.1 t -166.74 163.24 16.55 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.144 1.778 . . . . 0.0 110.733 -175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.126 1.346 . . . . 0.0 113.008 -178.357 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 p -73.54 161.33 30.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.54 1.136 . . . . 0.0 112.359 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.1 m -79.87 -27.92 40.03 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.702 -1.249 . . . . 0.0 112.778 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.36 41.72 77.04 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.013 0.816 . . . . 0.0 113.689 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.8 p -62.73 152.01 36.87 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.694 1.198 . . . . 0.0 113.492 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 t -108.89 161.08 15.46 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.83 1.252 . . . . 0.0 112.533 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.43 159.66 35.71 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.121 1.82 . . . . 0.0 113.016 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.87 179.59 45.69 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.969 1.271 . . . . 0.0 113.662 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.02 153.91 22.98 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.049 1.74 . . . . 0.0 110.497 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -98.13 126.12 43.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.967 0.907 . . . . 0.0 110.697 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.5 p -147.45 155.11 41.61 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.158 1.783 . . . . 0.0 110.988 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -82.37 39.0 0.57 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.542 1.937 . . . . 0.0 112.657 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.9 p -128.16 -176.4 3.79 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.241 1.816 . . . . 0.0 111.659 -170.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -150.47 156.32 41.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.228 1.411 . . . . 0.0 111.106 -173.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -136.97 43.24 2.39 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.418 1.487 . . . . 0.0 111.095 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.0 p -82.41 0.54 41.61 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.914 -1.116 . . . . 0.0 113.729 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -80.97 123.33 28.24 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.367 1.467 . . . . 0.0 111.015 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -115.07 140.78 48.78 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.829 1.652 . . . . 0.0 110.795 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -95.92 140.17 31.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.257 2.223 . . . . 0.0 108.669 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.52 108.38 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.301 1.04 . . . . 0.0 109.31 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.06 171.63 19.93 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.337 1.446 . . . . 0.0 112.873 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.0 m120 62.09 31.15 17.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.007 1.323 . . . . 0.0 111.923 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.9 mt -66.67 143.32 98.06 Favored Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 121.457 -0.777 . . . . 0.0 111.395 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.35 162.06 40.44 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.193 2.595 . . . . 0.0 111.158 170.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.99 -7.61 18.37 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.249 2.633 . . . . 0.0 112.413 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -96.14 6.95 47.68 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.559 1.944 . . . . 0.0 113.332 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -81.97 146.56 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.211 -0.931 . . . . 0.0 111.029 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.7 p -134.0 166.34 22.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.073 1.749 . . . . 0.0 109.351 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -61.58 -25.54 67.39 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.13 -40.8 59.47 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.164 0.986 . . . . 0.0 111.67 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -64.38 -41.97 96.41 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.494 0.588 . . . . 0.0 110.637 171.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.3 ttt -68.43 -36.55 79.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.534 0.734 . . . . 0.0 112.394 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -62.51 -41.55 98.92 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.716 0.689 . . . . 0.0 111.567 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -71.43 -39.75 70.85 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.976 0.807 . . . . 0.0 112.919 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -57.65 -22.59 46.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.148 1.379 . . . . 0.0 113.581 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -114.57 11.45 17.04 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.752 1.621 . . . . 0.0 112.616 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.4 -23.38 67.27 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -63.33 -23.33 67.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.177 1.391 . . . . 0.0 112.989 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -106.56 9.83 31.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.048 1.739 . . . . 0.0 112.598 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.44 -175.45 50.99 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.026 1.298 . . . . 0.0 113.121 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -73.77 128.48 35.63 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.094 -0.651 . . . . 0.0 110.944 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.05 143.34 47.52 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.239 1.015 . . . . 0.0 111.562 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.22 -11.9 82.94 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.973 0.797 . . . . 0.0 113.936 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -158.71 138.03 11.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.095 1.758 . . . . 0.0 109.389 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.56 127.39 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.873 1.669 . . . . 0.0 108.534 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -144.79 143.84 30.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.843 1.257 . . . . 0.0 112.018 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.1 mt -140.77 132.79 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.144 1.777 . . . . 0.0 108.687 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -125.59 104.95 8.67 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.936 0.895 . . . . 0.0 112.066 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.08 -23.97 60.6 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -172.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -72.92 -14.22 61.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.24 1.016 . . . . 0.0 113.339 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -117.22 -19.87 9.46 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.958 1.303 . . . . 0.0 114.005 173.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.2 26.45 40.3 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 124.826 1.203 . . . . 0.0 114.213 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -130.87 145.98 52.16 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.013 1.325 . . . . 0.0 112.196 -172.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.05 162.38 24.24 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.691 1.615 . . . . 0.0 112.576 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -143.19 136.47 28.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.485 1.914 . . . . 0.0 108.632 -170.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.2 tt -149.23 143.36 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.455 0.702 . . . . 0.0 111.099 -175.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.2 112.68 17.97 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.976 1.31 . . . . 0.0 110.135 -172.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.0 mt -89.67 175.76 7.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.389 0.54 . . . . 0.0 111.726 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.23 -26.43 58.91 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.3 p -144.54 159.27 43.06 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.684 1.193 . . . . 0.0 111.95 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -60.59 -33.64 73.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.804 0.842 . . . . 0.0 112.357 170.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.8 m -67.2 -45.88 75.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.461 1.504 . . . . 0.0 111.024 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.7 mt -61.19 -39.88 91.83 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.182 0.593 . . . . 0.0 111.131 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.84 -35.69 77.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -60.93 -51.56 68.75 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.398 0.999 . . . . 0.0 110.882 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.33 -49.09 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.3 0.64 . . . . 0.0 110.565 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.46 86.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.517 0.727 . . . . 0.0 111.819 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.44 -45.29 91.98 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.272 -0.892 . . . . 0.0 111.748 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.12 -33.27 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.837 0.855 . . . . 0.0 112.31 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -86.12 -24.66 26.14 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.9 mt -107.03 -16.95 14.31 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -170.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.81 134.2 52.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.204 1.365 . . . . 0.0 112.074 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.2 t30 65.57 14.31 9.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.901 2.08 . . . . 0.0 113.845 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.1 ttp -72.77 135.84 80.63 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 120.56 -1.337 . . . . 0.0 110.559 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.71 131.8 13.86 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.488 2.792 . . . . 0.0 110.869 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.9 tp -143.47 115.44 8.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.151 1.38 . . . . 0.0 109.55 174.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 53.55 35.51 21.06 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.789 1.236 . . . . 0.0 112.951 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.7 1.84 89.94 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.556 1.55 . . . . 0.0 115.204 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -105.91 149.5 26.51 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.762 1.625 . . . . 0.0 110.854 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -104.44 110.85 23.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.029 0.932 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 82.1 mt -72.23 125.69 27.94 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.874 0.87 . . . . 0.0 112.513 -169.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.17 105.97 18.2 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.979 0.912 . . . . 0.0 109.04 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.7 t -114.66 131.39 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.023 0.929 . . . . 0.0 110.123 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -153.37 169.27 23.52 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.569 1.548 . . . . 0.0 111.218 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -70.62 138.88 51.15 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.519 -0.738 . . . . 0.0 111.572 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.05 98.03 11.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.96 0.904 . . . . 0.0 108.835 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 34.2 t -161.46 150.25 15.94 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.224 1.409 . . . . 0.0 110.748 -171.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -150.52 110.76 4.16 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.213 1.405 . . . . 0.0 110.884 175.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.3 t -90.53 129.7 36.65 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.403 0.681 . . . . 0.0 109.631 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.82 -46.43 75.18 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.993 -0.442 . . . . 0.0 112.058 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 89.7 p 54.86 11.87 0.53 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 127.74 2.416 . . . . 0.0 115.24 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.8 tp -76.75 147.08 37.53 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.058 1.743 . . . . 0.0 111.955 -171.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 30.0 p -75.47 -15.56 60.4 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.653 1.581 . . . . 0.0 114.34 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 75.0 m -87.11 123.49 32.23 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.384 1.073 . . . . 0.0 110.763 172.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 166.11 -158.14 30.92 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.613 1.102 . . . . 0.0 113.107 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -80.0 36.35 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 124.745 3.63 . . . . 0.0 112.843 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.6 t -165.02 167.31 18.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.965 1.706 . . . . 0.0 111.019 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.9 p -164.76 131.05 2.88 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.361 1.464 . . . . 0.0 111.277 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.248 0 CA-C-O 117.417 -1.768 . . . . 0.0 112.891 178.53 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.7 t 68.78 28.15 5.57 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.415 1.486 . . . . 0.0 113.754 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 m -138.77 148.76 44.24 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.363 1.465 . . . . 0.0 111.38 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.09 75.51 1.23 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.557 1.075 . . . . 0.0 111.893 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m -80.84 -8.26 59.66 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.0 m -146.03 150.55 36.2 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.436 1.894 . . . . 0.0 110.447 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.98 -177.26 37.38 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.325 0.964 . . . . 0.0 114.232 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.47 -167.61 37.1 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.12 1.343 . . . . 0.0 113.18 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -87.91 148.5 24.57 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.261 1.024 . . . . 0.0 111.85 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? 54.49 45.09 27.75 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.16 1.384 . . . . 0.0 113.401 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.8 p -61.99 159.72 13.73 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.068 1.747 . . . . 0.0 112.275 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -79.89 5.77 12.93 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.086 1.354 . . . . 0.0 114.427 -171.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.1 p -65.61 145.76 55.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.046 1.738 . . . . 0.0 111.121 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -101.35 73.46 1.49 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.254 1.022 . . . . 0.0 111.584 -168.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -68.41 -28.3 66.97 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m -132.04 29.45 4.38 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.345 1.058 . . . . 0.0 113.361 -168.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -89.78 125.65 35.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.867 1.267 . . . . 0.0 112.057 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.31 146.45 35.7 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.859 2.063 . . . . 0.0 110.988 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -97.62 143.12 28.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.985 2.514 . . . . 0.0 108.658 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.1 t -135.38 112.99 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.148 0.979 . . . . 0.0 109.861 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -111.29 174.41 16.75 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 125.748 1.642 . . . . 0.0 113.498 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 m120 64.93 20.92 12.24 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.988 1.715 . . . . 0.0 113.161 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.17 142.7 95.6 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 121.206 -0.934 . . . . 0.0 112.21 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.77 163.71 38.04 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.207 3.271 . . . . 0.0 111.9 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.39 5.84 2.57 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 123.715 2.943 . . . . 0.0 113.557 171.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -124.15 12.13 8.89 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.168 1.787 . . . . 0.0 113.486 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.1 tp -82.06 145.28 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 120.911 -1.118 . . . . 0.0 110.828 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 31.5 p -133.2 168.27 18.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.198 1.799 . . . . 0.0 109.623 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.11 -31.61 70.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.818 0.447 . . . . 0.0 111.824 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.08 -40.41 65.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.092 0.957 . . . . 0.0 111.709 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -66.2 -38.43 87.94 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.568 0.622 . . . . 0.0 111.31 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 6.0 ttt -68.74 -36.1 77.95 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.612 -0.68 . . . . 0.0 112.201 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -64.52 -40.23 95.23 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.692 0.797 . . . . 0.0 111.688 169.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -68.81 -41.85 78.06 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.305 1.042 . . . . 0.0 112.699 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.13 -24.36 62.93 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.435 1.494 . . . . 0.0 113.596 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -112.42 11.47 19.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.503 1.521 . . . . 0.0 112.654 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.44 -21.66 66.68 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -171.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -62.69 -24.57 67.72 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.253 1.021 . . . . 0.0 112.517 172.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -104.11 14.02 31.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.528 1.931 . . . . 0.0 112.307 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.53 -173.64 54.83 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.386 0.993 . . . . 0.0 112.176 -173.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -71.54 147.25 47.88 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.66 -0.906 . . . . 0.0 111.88 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.95 147.13 37.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.495 0.718 . . . . 0.0 111.577 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.27 -17.39 66.92 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.062 1.315 . . . . 0.0 113.553 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -157.94 147.76 20.09 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.318 1.447 . . . . 0.0 110.645 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -142.31 129.07 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 126.992 2.117 . . . . 0.0 109.643 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -140.99 138.64 33.88 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.03 1.332 . . . . 0.0 111.387 171.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 61.6 mt -138.84 124.58 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.59 1.556 . . . . 0.0 108.211 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -121.36 102.19 8.12 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.075 0.94 . . . . 0.0 112.379 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.33 -18.77 61.74 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -77.53 -14.54 59.64 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.282 1.033 . . . . 0.0 112.96 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -116.78 -27.14 6.72 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.83 1.252 . . . . 0.0 113.498 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.4 27.19 23.39 Favored Glycine 0 N--CA 1.476 1.342 0 C-N-CA 124.896 1.236 . . . . 0.0 114.078 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -137.04 154.37 50.39 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.354 1.462 . . . . 0.0 111.822 -173.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.79 170.13 25.34 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.501 1.524 . . . . 0.0 113.038 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -143.83 148.72 35.93 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.312 1.845 . . . . 0.0 109.874 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 tt -153.87 137.75 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.786 0.834 . . . . 0.0 110.317 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -115.59 125.37 52.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.791 0.836 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -96.01 170.03 9.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.998 0.519 . . . . 0.0 111.438 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -72.74 -26.6 61.62 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.4 p -142.64 155.9 45.0 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.137 1.375 . . . . 0.0 110.931 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -69.38 -27.46 65.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.911 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.8 m -62.32 -47.49 84.04 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.955 1.302 . . . . 0.0 110.54 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.55 -39.01 93.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.946 -0.55 . . . . 0.0 111.427 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.99 89.43 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -64.59 -50.38 67.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.315 0.961 . . . . 0.0 111.226 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.06 -49.42 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 122.891 0.476 . . . . 0.0 110.25 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.28 -46.1 89.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.497 0.719 . . . . 0.0 111.979 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.53 -43.4 93.47 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.182 -0.949 . . . . 0.0 111.802 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.35 -32.93 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.932 0.893 . . . . 0.0 112.388 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -88.8 -24.5 22.58 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.1 mt -102.92 -18.12 15.19 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.43 131.21 45.85 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.944 1.247 . . . . 0.0 111.739 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.0 t30 65.07 17.26 10.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.517 1.927 . . . . 0.0 113.834 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.5 ttp -72.83 134.76 81.14 Favored Pre-proline 0 CA--C 1.544 0.718 0 O-C-N 120.609 -1.307 . . . . 0.0 110.223 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.52 138.79 19.85 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.159 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.0 tp -138.07 105.85 5.63 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.504 1.522 . . . . 0.0 109.821 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 55.57 27.53 10.54 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.491 1.516 . . . . 0.0 113.798 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.49 -8.46 69.0 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.729 1.633 . . . . 0.0 114.812 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -89.08 155.92 19.16 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.868 1.334 . . . . 0.0 110.653 170.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.53 172.16 9.97 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.643 0.777 . . . . 0.0 109.814 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.0 mt -132.57 117.41 17.92 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 110.364 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -92.87 113.68 26.02 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.833 0.853 . . . . 0.0 109.188 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.9 t -123.55 126.02 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.882 0.873 . . . . 0.0 110.141 -174.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -149.44 168.74 22.59 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.52 1.528 . . . . 0.0 111.661 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -78.54 136.98 37.68 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.352 0.661 . . . . 0.0 111.671 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.57 26.89 2.16 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.351 1.46 . . . . 0.0 112.553 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 17.6 t -74.13 -31.56 62.8 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.065 1.346 . . . . 0.0 113.313 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -80.64 162.7 24.09 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.362 1.065 . . . . 0.0 112.481 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 81.7 p -153.47 158.82 41.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.549 1.14 . . . . 0.0 112.483 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.0 125.34 29.21 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.177 0.991 . . . . 0.0 111.748 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.5 t -168.24 171.95 8.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.172 1.789 . . . . 0.0 110.799 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.5 mt -75.25 150.29 38.62 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.209 1.004 . . . . 0.0 111.352 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.0 t -71.09 154.72 41.53 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.519 1.128 . . . . 0.0 111.824 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 98.6 p -165.66 176.14 8.29 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.93 1.692 . . . . 0.0 111.857 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.5 -152.76 19.82 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 124.791 1.186 . . . . 0.0 112.426 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.99 150.95 61.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.429 2.752 . . . . 0.0 111.611 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.6 m -105.79 132.33 52.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.535 1.134 . . . . 0.0 111.347 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.3 t -163.28 153.32 15.66 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.228 1.411 . . . . 0.0 111.038 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.28 0 C-N-CA 125.053 1.311 . . . . 0.0 113.583 177.907 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m -149.4 155.85 41.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.296 1.438 . . . . 0.0 111.425 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.1 p -92.08 152.32 20.0 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.594 1.158 . . . . 0.0 112.895 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.17 156.94 15.57 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.407 1.479 . . . . 0.0 112.714 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.3 m -75.59 143.47 42.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.204 1.002 . . . . 0.0 112.567 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 p -84.37 138.76 32.68 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.304 1.041 . . . . 0.0 112.36 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -95.46 -14.97 45.57 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 124.346 0.974 . . . . 0.0 115.101 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.42 -156.03 53.2 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.665 1.232 . . . . 0.0 113.0 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 61.25 46.35 7.98 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.449 1.5 . . . . 0.0 112.435 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -145.64 142.33 28.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.022 1.329 . . . . 0.0 111.959 -173.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 m -138.86 57.9 1.66 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.974 1.71 . . . . 0.0 109.649 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -144.89 130.72 19.15 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.667 1.587 . . . . 0.0 109.868 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.0 m -68.05 -44.44 76.4 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.816 1.246 . . . . 0.0 112.718 -170.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -152.88 153.97 34.13 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.376 1.87 . . . . 0.0 109.527 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -73.87 74.86 1.63 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.372 1.082 . . . . 0.0 111.216 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 m -86.17 39.82 0.84 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.157 1.783 . . . . 0.0 112.315 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -99.13 132.36 44.49 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.315 1.846 . . . . 0.0 111.739 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -117.78 143.94 45.79 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.67 1.588 . . . . 0.0 111.352 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -102.6 139.41 38.23 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.178 2.591 . . . . 0.0 108.441 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.76 116.71 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.306 1.043 . . . . 0.0 108.978 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.89 167.81 13.19 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.31 1.433 . . . . 0.0 114.053 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.66 31.51 9.77 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.504 1.522 . . . . 0.0 111.836 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.5 mt -66.21 143.64 98.42 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.969 0.908 . . . . 0.0 112.432 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -69.6 159.44 53.51 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.166 2.578 . . . . 0.0 111.271 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.44 -9.12 23.74 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.414 2.742 . . . . 0.0 113.275 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -94.41 5.33 52.12 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.709 1.604 . . . . 0.0 113.461 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.3 tp -86.78 137.59 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 121.051 -1.03 . . . . 0.0 111.65 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.0 p -133.74 176.98 8.07 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.593 1.557 . . . . 0.0 108.786 168.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.31 -21.74 62.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.44 0.696 . . . . 0.0 112.548 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -73.68 -47.82 36.89 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.125 0.875 . . . . 0.0 111.249 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -63.04 -42.56 99.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.144 0.578 . . . . 0.0 110.874 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.5 ttt -66.12 -33.86 76.75 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -69.35 -36.27 76.71 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.14 0.882 . . . . 0.0 112.336 170.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -44.14 67.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.117 0.967 . . . . 0.0 111.344 178.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.4 mt -56.33 -28.14 57.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.68 1.592 . . . . 0.0 113.343 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.84 10.54 26.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.406 1.483 . . . . 0.0 112.93 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.81 -23.03 66.61 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -170.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -62.88 -23.3 67.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.445 1.098 . . . . 0.0 112.375 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.64 12.97 30.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.589 1.956 . . . . 0.0 112.2 -175.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.08 -171.06 54.98 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.76 1.171 . . . . 0.0 112.488 -176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -71.45 142.07 50.24 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.746 -0.855 . . . . 0.0 111.723 172.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.14 148.23 32.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.779 0.831 . . . . 0.0 111.302 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.51 -11.39 71.71 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.918 1.247 . . . . 0.0 113.962 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -158.83 137.94 11.37 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.454 1.902 . . . . 0.0 108.607 173.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.7 t -140.05 128.65 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.311 1.444 . . . . 0.0 109.055 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -143.03 139.42 30.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.92 1.288 . . . . 0.0 111.796 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.2 mt -140.45 128.23 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.375 1.87 . . . . 0.0 107.702 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -125.46 112.54 16.38 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.659 0.742 . . . . 0.0 112.864 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -75.92 -20.13 58.25 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -171.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.86 -21.21 51.74 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.87 0.868 . . . . 0.0 112.515 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -104.31 -32.58 9.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.816 1.247 . . . . 0.0 113.143 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.28 29.01 26.19 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 124.641 1.115 . . . . 0.0 113.857 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -140.92 156.47 46.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.671 1.588 . . . . 0.0 111.767 -171.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.95 166.52 27.03 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.085 1.326 . . . . 0.0 113.507 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -142.48 147.6 36.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.475 1.91 . . . . 0.0 109.806 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.9 tt -154.3 132.21 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.912 0.885 . . . . 0.0 110.738 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 -107.81 125.66 51.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.765 0.826 . . . . 0.0 110.074 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.6 mt -97.87 164.56 12.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.465 0.706 . . . . 0.0 109.684 173.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -82.58 -11.58 58.32 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 65.9 p -148.47 146.72 28.51 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.172 1.389 . . . . 0.0 111.741 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.57 -33.09 69.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.466 1.106 . . . . 0.0 113.592 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 m -68.24 -46.86 69.34 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.756 1.222 . . . . 0.0 110.573 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.38 -37.02 85.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.76 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.21 93.46 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.046 0.839 . . . . 0.0 112.718 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.3 -50.88 68.35 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.169 0.988 . . . . 0.0 111.381 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.28 -46.91 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.855 -0.528 . . . . 0.0 110.379 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.68 90.83 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.63 0.772 . . . . 0.0 112.015 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -48.86 78.17 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.258 0.936 . . . . 0.0 111.219 174.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.76 -36.6 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.593 0.757 . . . . 0.0 112.225 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.31 -29.47 34.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.6 mt -106.26 -22.89 12.71 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -169.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.06 130.41 43.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.417 1.008 . . . . 0.0 110.781 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.0 t30 73.86 8.93 4.83 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.38 2.272 . . . . 0.0 114.074 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.3 ttp -76.15 137.35 68.73 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.462 -1.399 . . . . 0.0 111.528 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.67 135.29 15.96 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.449 2.766 . . . . 0.0 111.319 175.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.6 tp -145.89 120.21 9.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.442 1.497 . . . . 0.0 109.848 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 58.3 23.59 10.59 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.813 1.245 . . . . 0.0 113.619 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.42 -2.85 85.22 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.583 1.563 . . . . 0.0 114.593 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -93.61 148.4 22.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.491 1.517 . . . . 0.0 110.936 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -98.56 109.38 22.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.552 1.541 . . . . 0.0 107.182 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.75 147.46 47.3 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.664 0.786 . . . . 0.0 111.693 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 130.88 53.62 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.246 1.418 . . . . 0.0 109.054 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.7 t -134.02 129.23 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.857 0.863 . . . . 0.0 110.855 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -140.18 170.22 16.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.112 1.765 . . . . 0.0 110.387 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -77.61 134.54 38.19 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.502 -0.749 . . . . 0.0 110.373 168.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -90.05 114.59 26.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.294 1.037 . . . . 0.0 109.432 172.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 22.7 p -161.85 152.19 17.23 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.175 0.99 . . . . 0.0 112.981 -169.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -144.12 154.81 43.57 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.15 1.78 . . . . 0.0 111.455 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -163.5 171.01 16.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.91 1.284 . . . . 0.0 111.992 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -156.81 170.03 23.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.864 1.665 . . . . 0.0 111.255 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.8 t -156.25 144.51 19.84 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.014 1.325 . . . . 0.0 110.586 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.5 mp -90.33 91.9 8.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.052 0.941 . . . . 0.0 109.238 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.0 m -61.72 142.31 57.32 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.634 1.574 . . . . 0.0 110.323 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 28.5 t -147.25 134.13 20.17 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.368 1.067 . . . . 0.0 111.315 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -118.73 83.59 0.35 Allowed Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.618 1.58 . . . . 0.0 111.447 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.95 156.87 55.79 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.492 2.795 . . . . 0.0 111.392 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.3 t -78.71 138.65 38.37 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.447 0.699 . . . . 0.0 111.729 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 73.9 p -162.28 159.7 25.9 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.978 1.311 . . . . 0.0 112.31 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.19 0 C-N-CA 125.049 1.309 . . . . 0.0 112.966 -179.343 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.47 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.4 m -151.13 146.49 26.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.037 1.335 . . . . 0.0 110.647 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -163.37 166.85 22.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.012 1.325 . . . . 0.0 111.486 -177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.97 -158.89 27.88 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.97 1.747 . . . . 0.0 112.815 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 p -74.73 160.75 30.36 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.42 1.088 . . . . 0.0 112.627 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 t -110.03 126.59 54.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.256 1.022 . . . . 0.0 110.73 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.83 116.62 1.43 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.262 1.411 . . . . 0.0 111.794 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -97.9 -142.47 13.38 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.308 1.433 . . . . 0.0 112.33 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -113.87 134.41 54.82 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.266 1.426 . . . . 0.0 109.889 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -155.5 117.75 4.15 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.547 1.139 . . . . 0.0 111.428 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 p -91.7 -59.96 1.99 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.028 1.731 . . . . 0.0 110.615 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -81.31 101.46 9.79 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.389 1.076 . . . . 0.0 110.935 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.7 t -96.48 19.93 11.41 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.143 1.777 . . . . 0.0 112.313 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -84.69 13.4 5.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.893 1.677 . . . . 0.0 113.422 -170.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -122.4 109.29 14.21 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.048 1.339 . . . . 0.0 109.849 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m -81.84 33.63 0.38 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.346 1.858 . . . . 0.0 113.251 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 -86.97 129.44 34.88 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.372 1.469 . . . . 0.0 111.513 -176.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.9 mt -116.54 135.46 53.8 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.25 1.82 . . . . 0.0 110.544 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -89.4 142.48 27.62 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.347 2.259 . . . . 0.0 108.608 171.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.1 103.29 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.06 168.53 15.79 Favored Glycine 0 N--CA 1.464 0.565 0 C-N-CA 125.315 1.436 . . . . 0.0 112.986 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 60.09 32.45 20.99 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.897 1.279 . . . . 0.0 111.969 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.4 mt -63.25 143.37 97.72 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 121.269 -0.894 . . . . 0.0 111.347 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -66.93 158.0 58.81 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.801 2.334 . . . . 0.0 110.655 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.13 -7.32 20.4 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.699 2.933 . . . . 0.0 113.163 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -104.15 5.55 35.09 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.986 1.714 . . . . 0.0 113.264 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -75.18 146.67 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.274 -0.891 . . . . 0.0 111.247 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.5 p -131.73 165.55 23.5 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.961 1.704 . . . . 0.0 109.875 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.16 -32.85 66.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.245 0.618 . . . . 0.0 111.419 172.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -70.09 -36.79 75.15 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.242 1.017 . . . . 0.0 112.294 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -72.1 -36.7 69.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.78 0.718 . . . . 0.0 111.91 173.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.6 ttm -66.52 -38.62 87.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.24 0.927 . . . . 0.0 111.989 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -61.68 -40.44 94.98 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.09 0.956 . . . . 0.0 111.45 170.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -73.35 -41.19 63.76 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.1 mt -56.48 -24.98 49.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.118 1.367 . . . . 0.0 113.389 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -112.38 11.04 19.92 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.536 1.534 . . . . 0.0 112.802 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.97 -22.42 65.92 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -171.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.13 -25.36 67.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.978 0.911 . . . . 0.0 112.343 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.01 11.27 37.53 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.49 1.916 . . . . 0.0 112.672 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.87 -171.03 55.04 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.633 1.111 . . . . 0.0 112.974 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -71.76 134.61 46.31 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.989 -0.712 . . . . 0.0 111.561 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.14 148.86 35.75 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.438 1.095 . . . . 0.0 111.37 174.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.99 -15.34 75.19 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.166 0.888 . . . . 0.0 113.393 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -155.39 145.25 21.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.433 1.093 . . . . 0.0 111.547 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.0 127.9 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.651 1.98 . . . . 0.0 110.057 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -142.3 142.5 32.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.735 1.614 . . . . 0.0 112.006 171.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 68.9 mt -138.15 125.91 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.909 1.683 . . . . 0.0 107.995 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -119.59 102.62 8.76 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.36 1.064 . . . . 0.0 111.776 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -74.11 -24.22 59.43 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.96 -23.11 63.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.307 1.043 . . . . 0.0 113.053 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -109.45 -26.47 9.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.416 1.086 . . . . 0.0 113.488 174.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.69 29.23 13.95 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 124.957 1.265 . . . . 0.0 114.274 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.68 148.47 45.74 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.229 1.412 . . . . 0.0 111.788 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.71 168.9 23.74 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.696 1.617 . . . . 0.0 112.939 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -146.1 140.71 26.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.131 1.772 . . . . 0.0 109.449 -170.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.9 tt -148.7 146.75 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.115 0.966 . . . . 0.0 110.559 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.66 117.3 22.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.487 1.115 . . . . 0.0 109.407 -178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.72 163.56 13.71 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.104 0.562 . . . . 0.0 110.516 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.65 -21.55 59.37 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.5 p -141.69 151.97 43.47 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.383 1.073 . . . . 0.0 112.354 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -57.22 -38.63 74.04 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.733 1.213 . . . . 0.0 112.869 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -63.29 -50.44 70.07 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.814 1.246 . . . . 0.0 110.85 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.85 -38.77 92.08 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.64 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.17 -39.88 94.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.65 -47.87 76.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.206 0.912 . . . . 0.0 111.759 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.5 mt -59.31 -48.49 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.092 0.557 . . . . 0.0 110.262 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.3 94.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.146 0.579 . . . . 0.0 112.322 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -46.29 88.54 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.961 -1.087 . . . . 0.0 111.131 174.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.19 -38.82 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.211 0.605 . . . . 0.0 112.002 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -82.33 -23.58 35.02 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.2 mt -108.63 -22.16 12.38 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.53 133.0 48.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.924 1.238 . . . . 0.0 111.142 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.5 t30 68.64 11.28 8.29 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.565 1.946 . . . . 0.0 113.732 -175.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.1 ttp -75.72 137.61 70.23 Favored Pre-proline 0 CA--C 1.544 0.719 0 O-C-N 120.611 -1.305 . . . . 0.0 110.933 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.46 134.23 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.365 2.71 . . . . 0.0 111.038 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.2 tp -140.14 113.61 8.56 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.28 1.432 . . . . 0.0 109.96 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.88 24.18 7.26 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.163 1.385 . . . . 0.0 113.344 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.27 -5.55 74.94 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.887 1.708 . . . . 0.0 114.771 -176.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -88.66 146.75 24.9 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.242 1.417 . . . . 0.0 110.451 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -92.56 119.56 32.14 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 69.2 mt -78.15 134.64 37.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.398 0.544 . . . . 0.0 111.669 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -99.17 125.25 44.7 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.823 1.249 . . . . 0.0 108.465 169.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.4 t -135.2 126.25 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.3 0.955 . . . . 0.0 110.362 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -146.13 168.98 19.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.159 1.783 . . . . 0.0 110.848 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -77.12 140.07 40.14 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.607 -0.683 . . . . 0.0 111.053 169.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.11 118.95 38.09 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.877 1.271 . . . . 0.0 111.347 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 71.4 m -142.03 167.98 20.83 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.699 1.599 . . . . 0.0 111.621 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -130.25 158.1 40.68 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.282 1.833 . . . . 0.0 111.331 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t -121.57 120.55 35.16 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.269 1.028 . . . . 0.0 110.566 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.73 -36.53 28.49 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t 56.21 28.29 12.96 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.171 1.388 . . . . 0.0 113.025 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.1 tt -60.81 -42.32 97.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.68 1.592 . . . . 0.0 112.748 -169.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.2 t -164.12 151.93 12.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.101 1.76 . . . . 0.0 110.491 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.7 t -168.0 152.35 6.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.684 1.993 . . . . 0.0 110.13 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -174.67 -179.71 45.44 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 123.922 0.772 . . . . 0.0 114.787 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -83.39 -2.17 10.47 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.432 3.422 . . . . 0.0 114.251 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.3 t -70.14 136.55 50.24 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.434 1.015 . . . . 0.0 112.222 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.4 m -68.41 124.09 22.57 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.337 1.055 . . . . 0.0 112.89 -175.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.272 1.415 . . . . 0.0 113.222 177.696 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.3 m -149.84 162.54 40.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.984 1.314 . . . . 0.0 111.508 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 t -155.22 134.94 12.72 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.534 1.134 . . . . 0.0 110.927 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.32 -161.05 30.32 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.167 1.365 . . . . 0.0 113.246 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 t -103.5 136.89 42.39 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.759 1.224 . . . . 0.0 110.572 173.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.9 p -82.72 151.11 26.34 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.409 1.084 . . . . 0.0 113.21 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.95 174.46 45.85 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.662 1.125 . . . . 0.0 113.951 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.9 -177.63 54.31 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.769 1.176 . . . . 0.0 113.399 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -119.01 131.06 55.97 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.173 1.389 . . . . 0.0 110.144 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.21 172.2 9.64 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.712 1.205 . . . . 0.0 113.205 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.43 -179.09 6.43 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.454 1.502 . . . . 0.0 111.143 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -69.07 150.23 47.84 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.127 1.371 . . . . 0.0 111.999 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -162.62 140.45 8.32 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.033 1.333 . . . . 0.0 111.55 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -166.17 136.25 3.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.279 2.232 . . . . 0.0 108.284 175.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -80.93 144.39 31.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.917 0.887 . . . . 0.0 111.064 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.2 p -92.14 6.04 48.05 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.134 0.973 . . . . 0.0 113.293 170.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -77.45 122.37 25.11 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.746 1.618 . . . . 0.0 110.321 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -103.45 135.47 45.0 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.771 1.628 . . . . 0.0 110.027 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -90.57 137.63 32.2 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.103 2.161 . . . . 0.0 108.549 169.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.1 110.07 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.513 1.125 . . . . 0.0 109.388 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.75 170.8 14.13 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.58 1.562 . . . . 0.0 114.151 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 69.74 20.05 7.0 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.415 1.886 . . . . 0.0 113.006 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -61.72 143.48 93.93 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.823 0.849 . . . . 0.0 112.321 -171.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.03 165.08 33.53 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.405 3.403 . . . . 0.0 111.535 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.18 -3.61 14.09 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.111 2.541 . . . . 0.0 113.162 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -106.92 5.52 28.37 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.231 1.813 . . . . 0.0 113.739 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 tp -82.25 144.97 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.057 -1.027 . . . . 0.0 110.862 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.4 p -132.81 168.82 17.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.225 1.81 . . . . 0.0 109.037 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.56 -26.92 67.28 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -76.21 -40.06 53.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.948 0.899 . . . . 0.0 111.658 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -64.62 -37.17 86.66 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.963 -0.46 . . . . 0.0 111.193 171.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.3 tpt -66.11 -44.56 83.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.648 0.779 . . . . 0.0 111.416 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -59.58 -33.57 71.62 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.97 0.908 . . . . 0.0 112.097 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -74.62 -45.53 44.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.75 0.82 . . . . 0.0 112.579 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.95 -31.08 64.62 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.981 1.312 . . . . 0.0 113.097 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -106.92 10.85 30.43 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.211 1.404 . . . . 0.0 113.12 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -63.47 -28.81 70.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -16.26 63.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.582 0.753 . . . . 0.0 112.618 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -100.83 9.82 41.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.545 1.938 . . . . 0.0 112.458 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.73 -177.46 54.36 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.749 1.166 . . . . 0.0 112.962 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -71.32 134.91 47.09 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.708 -0.878 . . . . 0.0 111.111 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.63 148.82 34.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.609 1.164 . . . . 0.0 112.194 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.89 -10.23 79.26 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.865 1.221 . . . . 0.0 113.923 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -158.92 137.64 11.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.379 1.872 . . . . 0.0 108.983 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.14 130.05 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.602 1.561 . . . . 0.0 108.808 174.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -144.29 139.24 28.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.592 1.157 . . . . 0.0 111.295 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 86.9 mt -138.8 126.66 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.455 1.502 . . . . 0.0 108.518 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -120.11 104.43 10.11 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.522 1.129 . . . . 0.0 111.846 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -73.76 -26.4 60.64 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -171.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.86 -22.03 62.35 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.957 0.903 . . . . 0.0 113.086 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -107.42 -29.12 9.43 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.475 1.11 . . . . 0.0 113.465 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.05 28.44 17.96 Favored Glycine 0 N--CA 1.477 1.374 0 C-N-CA 124.891 1.234 . . . . 0.0 114.152 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -137.6 155.79 48.8 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.339 1.455 . . . . 0.0 111.788 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.16 176.74 30.32 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.111 1.339 . . . . 0.0 113.576 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -144.37 153.71 42.24 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.306 1.842 . . . . 0.0 110.779 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 tt -155.23 132.36 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.54 1.136 . . . . 0.0 110.607 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -113.52 121.93 45.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.904 0.881 . . . . 0.0 110.961 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.39 165.64 12.46 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.236 0.614 . . . . 0.0 111.305 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.61 -23.72 60.98 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -172.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.6 p -145.11 146.47 31.83 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.118 1.367 . . . . 0.0 111.513 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -55.88 -43.42 77.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.059 1.344 . . . . 0.0 112.246 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.4 m -59.2 -45.87 89.93 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.924 1.289 . . . . 0.0 112.081 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.76 -35.89 82.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 119.158 -0.448 . . . . 0.0 112.088 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.06 -33.44 74.57 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -64.55 -49.55 70.76 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.21 0.914 . . . . 0.0 110.22 172.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.8 mt -60.94 -48.47 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.604 0.762 . . . . 0.0 110.399 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.22 91.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.238 0.615 . . . . 0.0 111.819 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -57.19 -49.61 75.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.29 0.95 . . . . 0.0 111.332 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.71 -36.17 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.438 0.695 . . . . 0.0 112.095 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -81.65 -25.14 35.84 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.5 mt -109.61 -23.99 11.18 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -170.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.42 121.98 16.95 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.843 1.202 . . . . 0.0 110.839 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 74.59 15.52 3.32 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 128.142 2.577 . . . . 0.0 114.01 -173.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.0 ttp -76.44 137.12 67.74 Favored Pre-proline 0 N--CA 1.475 0.782 0 O-C-N 120.958 -1.089 . . . . 0.0 111.295 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.64 141.38 22.03 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.467 2.778 . . . . 0.0 111.647 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 34.4 tp -144.93 118.13 8.93 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.533 1.533 . . . . 0.0 110.303 173.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 58.7 24.77 12.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.321 1.448 . . . . 0.0 113.825 174.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.82 -5.59 83.36 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 125.472 1.511 . . . . 0.0 114.38 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -94.41 171.93 8.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.578 1.551 . . . . 0.0 110.726 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -99.43 -176.12 3.2 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 109.656 169.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.4 mt -141.68 120.03 12.31 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.302 1.441 . . . . 0.0 108.982 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.49 116.29 32.45 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.93 122.83 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.819 0.848 . . . . 0.0 111.335 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -141.88 161.66 37.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.772 2.029 . . . . 0.0 110.565 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -73.0 130.74 41.01 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.634 -0.666 . . . . 0.0 109.671 168.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.07 73.76 3.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.561 1.144 . . . . 0.0 110.699 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 76.5 m -78.91 50.76 1.04 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.184 1.794 . . . . 0.0 112.433 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -58.25 144.08 42.24 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.594 1.158 . . . . 0.0 112.967 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.5 t -154.87 153.27 30.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.254 1.421 . . . . 0.0 110.576 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -117.22 12.63 14.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.349 1.46 . . . . 0.0 113.498 -172.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.1 p -145.25 140.8 28.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.845 1.258 . . . . 0.0 112.172 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.32 145.94 29.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.372 1.069 . . . . 0.0 111.049 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.3 p 71.13 -4.88 1.67 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.661 2.784 . . . . 0.0 115.163 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.5 m -70.72 101.45 2.08 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.557 1.143 . . . . 0.0 111.662 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -93.64 -90.56 1.6 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.072 1.32 . . . . 0.0 111.392 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -76.49 -13.04 18.55 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.632 2.888 . . . . 0.0 112.835 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.7 p -83.52 150.97 25.64 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.911 1.684 . . . . 0.0 113.005 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.9 p -85.3 -15.99 41.56 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 C-N-CA 126.053 1.787 . . . . 0.0 112.848 177.769 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.4 p -166.99 163.99 16.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.259 1.424 . . . . 0.0 111.524 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -81.51 46.34 0.95 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.138 1.375 . . . . 0.0 112.889 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.1 71.64 1.7 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.706 1.622 . . . . 0.0 112.406 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.7 m -143.73 163.4 33.41 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.919 1.688 . . . . 0.0 111.669 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.6 m -161.04 162.34 31.67 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.762 1.625 . . . . 0.0 111.259 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.5 -34.52 0.12 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.112 0.863 . . . . 0.0 114.506 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.0 175.17 43.06 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.85 1.214 . . . . 0.0 113.293 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.12 5.93 20.87 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.785 1.234 . . . . 0.0 113.736 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -149.95 162.25 40.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.233 1.813 . . . . 0.0 112.337 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.9 p -140.82 158.35 44.08 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.905 1.682 . . . . 0.0 110.935 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -83.89 148.18 27.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.103 0.961 . . . . 0.0 111.935 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.4 m -73.98 128.45 35.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.51 1.124 . . . . 0.0 109.383 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -69.45 125.12 25.72 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.637 0.375 . . . . 0.0 110.044 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.28 133.35 55.6 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -173.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.6 m -118.68 25.18 10.42 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.998 1.719 . . . . 0.0 111.835 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -98.14 141.11 31.47 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.986 1.714 . . . . 0.0 112.561 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.44 141.92 50.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.82 2.048 . . . . 0.0 110.147 -172.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -100.66 140.38 35.02 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.193 2.197 . . . . 0.0 108.797 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.13 114.57 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.667 1.187 . . . . 0.0 108.951 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.33 164.57 12.28 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 125.488 1.518 . . . . 0.0 114.433 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.7 t30 70.57 20.35 5.85 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.593 1.957 . . . . 0.0 112.928 -177.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.9 mt -57.73 148.65 56.59 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.75 1.22 . . . . 0.0 113.082 -172.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 162.32 40.7 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.133 2.556 . . . . 0.0 111.444 172.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.94 -6.77 17.01 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.721 2.947 . . . . 0.0 112.174 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -99.76 8.29 44.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.676 1.991 . . . . 0.0 113.272 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.5 tp -81.86 145.46 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.01 -1.056 . . . . 0.0 110.909 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.2 p -134.3 167.66 20.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.236 1.814 . . . . 0.0 109.48 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -56.73 -34.51 67.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.106 0.563 . . . . 0.0 111.625 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.82 -26.93 49.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.478 1.111 . . . . 0.0 113.027 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -77.06 -39.02 51.38 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.933 0.788 . . . . 0.0 110.855 169.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.2 ttt -70.46 -37.48 74.3 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.32 -0.863 . . . . 0.0 112.195 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -62.64 -38.03 88.68 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.897 0.879 . . . . 0.0 111.507 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -73.34 -39.98 64.8 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.009 1.324 . . . . 0.0 113.092 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.6 mt -57.39 -27.39 62.28 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.958 1.303 . . . . 0.0 113.205 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -108.02 8.4 28.28 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.627 1.571 . . . . 0.0 112.753 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.9 -20.49 65.92 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -59.39 -22.73 61.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.636 1.174 . . . . 0.0 112.315 169.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -109.64 10.1 24.97 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.258 2.223 . . . . 0.0 112.321 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.45 -178.8 53.32 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.029 0.823 . . . . 0.0 112.448 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -71.04 144.57 50.34 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.699 -0.883 . . . . 0.0 111.664 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.64 152.27 30.1 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.166 0.986 . . . . 0.0 111.822 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.35 -8.22 71.58 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.82 1.2 . . . . 0.0 113.83 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -158.61 136.05 10.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.58 1.952 . . . . 0.0 108.582 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.73 128.65 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.493 1.517 . . . . 0.0 109.059 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -143.83 141.78 30.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.172 1.389 . . . . 0.0 111.579 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.3 mt -140.47 132.98 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.702 1.601 . . . . 0.0 108.67 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -129.1 109.02 10.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.93 0.892 . . . . 0.0 112.129 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -33.93 69.7 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.494 1.118 . . . . 0.0 112.798 -171.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.63 -26.22 68.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.367 1.067 . . . . 0.0 113.229 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -97.72 -32.58 11.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.176 0.99 . . . . 0.0 113.031 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.27 29.19 12.84 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 125.101 1.334 . . . . 0.0 114.055 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.95 158.84 43.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.266 1.426 . . . . 0.0 111.852 -171.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.46 168.78 26.63 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.275 1.417 . . . . 0.0 113.483 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.27 148.24 50.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.72 2.008 . . . . 0.0 109.828 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.9 tt -153.82 140.88 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.412 1.085 . . . . 0.0 110.583 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -123.94 124.89 43.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.863 0.865 . . . . 0.0 110.947 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.4 168.09 10.43 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.389 0.676 . . . . 0.0 110.935 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -72.85 -24.94 60.95 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.9 p -143.61 157.65 44.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.619 1.168 . . . . 0.0 111.881 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -58.73 -35.77 73.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 112.528 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -62.8 -49.46 74.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.054 1.342 . . . . 0.0 110.64 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.49 -42.86 99.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.217 0.607 . . . . 0.0 111.215 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.25 99.26 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -62.91 -49.78 73.44 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.087 0.858 . . . . 0.0 111.79 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.71 -48.95 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.104 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.01 91.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.333 0.653 . . . . 0.0 112.288 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -47.52 84.67 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.447 -0.783 . . . . 0.0 111.007 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.69 -36.49 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -84.79 -28.68 26.0 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -174.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.4 mt -101.18 -19.22 15.81 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -66.86 137.81 56.86 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.188 0.904 . . . . 0.0 110.661 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.5 t30 69.28 16.29 8.43 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.653 1.581 . . . . 0.0 113.636 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.0 ttp -89.83 134.02 32.86 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 120.866 -1.146 . . . . 0.0 111.148 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.28 141.42 18.22 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.299 2.666 . . . . 0.0 111.307 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.4 tp -144.92 114.59 7.24 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.827 1.651 . . . . 0.0 110.098 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 57.67 24.5 10.64 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.288 1.435 . . . . 0.0 113.738 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.73 -1.92 69.23 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.547 1.546 . . . . 0.0 114.836 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -102.9 145.86 29.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.285 1.434 . . . . 0.0 111.192 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -75.31 167.64 21.52 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.656 -0.653 . . . . 0.0 110.187 167.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.7 mt -133.96 135.8 43.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.5 1.12 . . . . 0.0 110.996 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.67 122.08 46.67 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.685 1.994 . . . . 0.0 109.096 175.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -131.94 125.63 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.773 0.829 . . . . 0.0 110.119 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.53 156.92 37.52 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.431 1.492 . . . . 0.0 111.706 -172.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -69.0 132.03 46.02 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.579 -0.701 . . . . 0.0 111.816 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -86.31 83.62 7.65 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.616 0.766 . . . . 0.0 110.818 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 24.5 p -164.21 152.81 13.14 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.127 1.371 . . . . 0.0 112.718 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -100.21 156.07 17.41 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.135 1.374 . . . . 0.0 110.829 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 p -73.49 123.36 23.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.053 0.941 . . . . 0.0 111.752 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.45 -13.39 60.11 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.004 0.922 . . . . 0.0 113.459 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 78.9 p -161.44 159.77 28.52 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.952 2.501 . . . . 0.0 109.221 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 pp -128.25 168.16 15.87 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.369 1.067 . . . . 0.0 112.718 -171.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.0 t -65.51 133.01 50.33 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.244 1.018 . . . . 0.0 110.858 -176.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.4 m -172.38 167.55 5.66 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.799 2.04 . . . . 0.0 110.801 -170.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 119.24 74.7 0.45 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.299 1.428 . . . . 0.0 112.097 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.1 -11.75 29.44 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.524 2.816 . . . . 0.0 113.793 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.5 t -80.34 -5.37 56.27 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.782 0.833 . . . . 0.0 113.201 173.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.2 m -95.63 124.74 39.8 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.75 -1.219 . . . . 0.0 111.314 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.915 -179.272 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 m -68.84 155.49 40.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.379 1.072 . . . . 0.0 113.092 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.5 t -159.86 171.92 18.56 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.182 1.393 . . . . 0.0 111.428 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.45 -178.26 35.3 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.464 1.507 . . . . 0.0 113.515 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -136.71 27.16 3.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.98 1.312 . . . . 0.0 112.689 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 t -155.01 177.49 11.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.29 1.436 . . . . 0.0 112.054 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.13 62.44 0.67 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.687 1.613 . . . . 0.0 112.327 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.98 171.09 40.16 Favored Glycine 0 N--CA 1.473 1.123 0 C-N-CA 125.28 1.419 . . . . 0.0 113.752 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -77.7 -18.57 56.48 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.171 0.989 . . . . 0.0 113.275 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.64 154.41 47.93 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.06 1.744 . . . . 0.0 111.011 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.69 -14.11 62.33 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.143 1.777 . . . . 0.0 113.451 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -135.14 145.56 47.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.759 1.224 . . . . 0.0 112.022 -169.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.5 p -145.29 173.02 12.33 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.704 2.002 . . . . 0.0 110.863 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -124.32 107.51 11.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.511 1.125 . . . . 0.0 110.167 -173.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.64 54.8 3.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.632 1.173 . . . . 0.0 111.091 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m -75.13 40.18 0.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.059 2.144 . . . . 0.0 114.283 -173.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -99.22 124.13 44.05 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.703 1.601 . . . . 0.0 111.851 -170.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.6 mt -111.75 149.82 31.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.709 2.004 . . . . 0.0 110.999 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -114.58 137.86 51.36 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.203 2.601 . . . . 0.0 108.472 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -131.29 113.37 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.167 0.987 . . . . 0.0 109.947 -173.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -113.02 169.64 13.03 Favored Glycine 0 N--CA 1.467 0.756 0 C-N-CA 126.042 1.782 . . . . 0.0 113.738 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 69.01 15.87 8.78 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.098 1.759 . . . . 0.0 112.582 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.8 mt -56.58 139.04 76.1 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.089 0.955 . . . . 0.0 112.048 -174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -68.15 160.92 46.69 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.748 2.298 . . . . 0.0 111.223 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.04 -2.79 12.09 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.815 3.01 . . . . 0.0 112.967 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -103.61 0.82 31.28 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.082 1.753 . . . . 0.0 113.792 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -76.41 146.32 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 119.453 1.024 . . . . 0.0 111.275 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 p -130.58 165.42 22.8 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.706 1.602 . . . . 0.0 110.409 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -62.85 -25.78 68.44 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.226 0.61 . . . . 0.0 111.822 172.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -72.64 -44.39 61.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.183 0.993 . . . . 0.0 111.474 172.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -66.09 -39.18 89.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.55 0.614 . . . . 0.0 111.696 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -69.21 -33.57 73.54 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.773 0.715 . . . . 0.0 112.471 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -67.61 -39.4 84.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.581 0.628 . . . . 0.0 111.643 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -72.92 -38.08 66.98 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.29 -0.881 . . . . 0.0 113.074 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.44 -25.06 49.34 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.358 1.463 . . . . 0.0 113.256 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -110.75 10.51 22.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.644 1.578 . . . . 0.0 112.673 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.21 -24.87 67.48 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -64.63 -19.33 65.63 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.334 1.054 . . . . 0.0 113.015 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.93 10.5 30.5 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.807 2.043 . . . . 0.0 112.141 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.44 -173.42 55.23 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.865 1.221 . . . . 0.0 113.021 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -71.73 145.07 49.02 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.836 -0.802 . . . . 0.0 112.274 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -89.19 150.39 22.69 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.415 1.086 . . . . 0.0 111.528 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.0 -11.05 70.76 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.823 1.202 . . . . 0.0 113.871 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -153.94 137.11 15.62 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.124 1.77 . . . . 0.0 109.073 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.46 129.36 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.906 1.682 . . . . 0.0 108.858 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -145.09 144.08 30.75 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.895 1.278 . . . . 0.0 111.87 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.2 mt -140.86 132.47 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.168 1.787 . . . . 0.0 108.459 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -126.43 111.82 14.89 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.887 0.875 . . . . 0.0 112.386 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -70.75 -31.95 68.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.424 1.09 . . . . 0.0 113.307 -171.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -73.63 -13.24 60.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.07 0.948 . . . . 0.0 113.51 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -112.75 -26.48 8.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.743 1.217 . . . . 0.0 113.311 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.0 29.84 24.73 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.613 1.102 . . . . 0.0 113.963 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -140.12 157.29 45.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.327 1.451 . . . . 0.0 112.202 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.41 169.19 25.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.755 1.645 . . . . 0.0 113.209 174.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -137.89 147.63 44.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.673 1.989 . . . . 0.0 109.425 -177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.0 tt -153.77 139.23 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.897 0.879 . . . . 0.0 110.601 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -128.92 118.68 23.06 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.622 0.769 . . . . 0.0 110.307 -172.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.67 -176.16 3.98 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.215 1.006 . . . . 0.0 111.893 -171.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -86.02 -25.84 25.72 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 49.7 p -149.42 144.4 26.33 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.138 1.375 . . . . 0.0 111.851 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -59.46 -35.91 74.97 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.248 1.019 . . . . 0.0 113.057 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.9 m -60.21 -47.69 84.87 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.773 1.229 . . . . 0.0 111.181 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.6 mt -65.65 -35.99 82.38 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.958 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.68 -36.76 81.28 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.08 0.854 . . . . 0.0 112.875 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.39 -49.48 71.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.128 0.971 . . . . 0.0 110.891 172.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.81 -48.74 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.082 0.553 . . . . 0.0 110.353 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.98 -46.02 85.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.626 0.77 . . . . 0.0 111.91 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -58.25 -48.69 79.62 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.319 -0.863 . . . . 0.0 111.345 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.15 -36.49 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.464 0.705 . . . . 0.0 112.16 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -80.6 -30.45 36.82 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.3 mt -102.72 -21.78 14.04 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -171.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.18 129.14 38.94 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.672 1.123 . . . . 0.0 111.456 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 67.98 14.25 9.32 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.73 2.412 . . . . 0.0 113.697 -173.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.2 ttp -73.83 135.91 77.31 Favored Pre-proline 0 N--CA 1.474 0.757 0 O-C-N 120.507 -1.371 . . . . 0.0 110.719 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.24 140.6 19.81 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.3 2.666 . . . . 0.0 111.325 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.3 tp -145.12 117.19 8.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.086 1.355 . . . . 0.0 110.106 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 69.9 mmt-85 57.11 27.38 13.34 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.929 1.291 . . . . 0.0 113.922 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.42 -6.23 83.82 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 125.521 1.534 . . . . 0.0 114.484 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -90.78 169.3 11.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.934 1.694 . . . . 0.0 110.333 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -100.98 -172.67 2.21 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.612 -0.68 . . . . 0.0 109.244 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.46 116.67 10.03 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.34 1.056 . . . . 0.0 109.079 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -91.58 118.07 30.28 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.44 123.94 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.647 0.779 . . . . 0.0 109.959 -173.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -154.78 163.98 39.47 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.087 1.355 . . . . 0.0 111.239 -173.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -71.36 144.1 49.99 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.769 -0.582 . . . . 0.0 111.043 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.51 42.97 0.53 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.939 1.296 . . . . 0.0 112.94 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 28.2 p -64.86 -21.64 66.84 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -80.62 -10.45 59.73 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.379 1.072 . . . . 0.0 113.128 172.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.4 m -114.28 60.78 0.67 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.26 1.824 . . . . 0.0 110.278 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.33 161.0 41.17 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.715 2.006 . . . . 0.0 110.744 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 20.1 t -74.76 121.16 21.32 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.539 -0.725 . . . . 0.0 111.605 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -158.76 117.72 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.557 1.543 . . . . 0.0 109.22 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.6 m -147.2 147.37 30.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.291 1.837 . . . . 0.0 109.038 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.9 t -145.44 127.4 15.49 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.226 1.01 . . . . 0.0 110.743 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -92.71 -174.74 41.41 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.091 1.329 . . . . 0.0 113.516 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.19 139.92 43.46 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.702 2.935 . . . . 0.0 110.616 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 t -73.32 -28.96 62.36 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.2 t 67.89 4.92 4.22 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.523 1.929 . . . . 0.0 115.224 171.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.159 0 C-N-CA 125.271 1.415 . . . . 0.0 113.059 179.271 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.508 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.8 m -146.84 154.81 41.77 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.137 1.375 . . . . 0.0 110.952 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 t -159.58 158.29 31.42 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.526 1.13 . . . . 0.0 111.75 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.78 139.98 7.8 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.601 1.572 . . . . 0.0 112.468 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 p -91.57 140.03 30.13 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.751 1.221 . . . . 0.0 112.062 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -68.14 130.46 42.99 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.992 -1.068 . . . . 0.0 112.194 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.04 170.57 49.65 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.439 1.019 . . . . 0.0 113.822 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.94 -173.18 48.66 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.879 1.228 . . . . 0.0 113.769 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -108.84 153.57 23.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.265 1.426 . . . . 0.0 111.704 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -68.85 145.81 53.39 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.608 -0.683 . . . . 0.0 112.066 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.9 p -140.65 172.71 12.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.97 2.108 . . . . 0.0 110.1 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -58.78 134.01 56.48 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.207 0.603 . . . . 0.0 111.529 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.3 m -138.92 148.65 43.85 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.084 1.754 . . . . 0.0 109.394 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -142.3 143.19 32.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.872 1.269 . . . . 0.0 110.621 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.54 142.22 53.68 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.429 0.692 . . . . 0.0 112.559 -174.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m -86.47 41.38 0.94 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.298 1.439 . . . . 0.0 112.706 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 -84.15 133.41 34.61 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.434 1.494 . . . . 0.0 113.006 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.6 mt -113.81 134.52 54.73 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.034 1.733 . . . . 0.0 110.257 170.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -92.09 137.89 31.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.17 2.188 . . . . 0.0 107.748 169.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.6 t -130.47 110.92 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.072 0.949 . . . . 0.0 109.435 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.53 174.56 18.11 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.825 1.678 . . . . 0.0 113.501 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.8 m120 65.48 20.07 11.65 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.863 1.665 . . . . 0.0 112.808 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.19 140.12 97.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 O-C-N 121.05 -1.031 . . . . 0.0 112.103 -171.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.11 165.73 31.48 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.294 3.33 . . . . 0.0 111.837 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.51 -2.89 13.03 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.173 2.582 . . . . 0.0 113.179 172.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -108.19 12.55 26.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.028 1.731 . . . . 0.0 113.419 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.3 tp -91.32 140.08 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.254 1.022 . . . . 0.0 110.599 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.8 p -133.76 174.06 10.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.389 1.476 . . . . 0.0 108.695 168.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.33 -22.62 63.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.043 0.537 . . . . 0.0 112.421 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.71 -45.14 38.39 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.307 -0.871 . . . . 0.0 111.41 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -63.27 -43.8 96.93 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.058 0.543 . . . . 0.0 111.088 172.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.9 ttt -65.35 -37.31 86.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.997 0.519 . . . . 0.0 112.337 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.6 mtp-105 -66.46 -38.18 86.78 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.509 -0.744 . . . . 0.0 112.066 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -72.03 -40.32 68.49 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.411 -0.806 . . . . 0.0 112.557 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.9 mt -59.34 -29.58 67.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.986 1.714 . . . . 0.0 113.027 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -105.88 8.44 32.65 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.22 1.408 . . . . 0.0 112.656 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.03 -27.04 68.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.246 0.93 . . . . 0.0 113.214 -173.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -72.55 -5.54 37.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.775 1.23 . . . . 0.0 113.657 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -111.86 8.81 20.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.433 1.893 . . . . 0.0 111.83 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.11 -177.6 53.72 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.802 1.192 . . . . 0.0 112.253 -172.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -71.16 144.18 50.28 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.637 -0.919 . . . . 0.0 111.998 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.26 156.3 33.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.878 0.871 . . . . 0.0 111.857 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.96 -10.29 58.84 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.939 1.256 . . . . 0.0 113.87 175.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.65 135.83 5.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.699 2.0 . . . . 0.0 108.611 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.1 t -143.56 128.77 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.644 1.578 . . . . 0.0 109.43 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -145.1 142.31 29.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.382 1.473 . . . . 0.0 111.765 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.9 mt -138.51 127.18 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.559 1.544 . . . . 0.0 108.575 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -115.57 103.25 10.54 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.446 1.098 . . . . 0.0 111.831 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -69.79 -20.34 63.47 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -87.18 -15.17 39.12 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -117.6 -19.25 9.47 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.613 1.165 . . . . 0.0 113.985 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.25 29.79 21.42 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 124.665 1.126 . . . . 0.0 114.312 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -132.51 149.07 52.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.942 1.297 . . . . 0.0 111.832 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.68 169.5 25.17 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.875 1.702 . . . . 0.0 112.754 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -141.83 142.52 33.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.173 1.789 . . . . 0.0 109.566 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.6 tt -152.18 143.19 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.726 0.81 . . . . 0.0 110.686 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -121.3 124.32 44.32 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.922 0.889 . . . . 0.0 110.706 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.0 mt -97.31 171.2 8.57 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.582 0.753 . . . . 0.0 111.132 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -74.73 -26.46 59.82 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.3 p -144.7 159.29 43.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.686 1.194 . . . . 0.0 111.983 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -60.24 -31.35 70.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.844 0.857 . . . . 0.0 112.755 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -68.47 -46.79 68.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.019 1.328 . . . . 0.0 110.486 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.6 mt -62.39 -42.73 99.65 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.249 0.62 . . . . 0.0 111.125 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.59 -36.94 85.87 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.89 -47.93 73.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.508 1.123 . . . . 0.0 111.905 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.7 mt -62.35 -47.83 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.418 -0.802 . . . . 0.0 110.18 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.41 -42.49 98.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.277 0.631 . . . . 0.0 112.409 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -54.01 -51.87 62.59 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.421 1.009 . . . . 0.0 111.287 170.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.36 -34.91 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.151 0.432 . . . . 0.0 111.785 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -85.57 -23.98 27.4 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.0 mt -106.67 -22.17 12.82 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.24 128.84 37.92 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.476 1.034 . . . . 0.0 110.992 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.6 t30 70.48 12.75 7.45 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.27 2.228 . . . . 0.0 114.106 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.5 ttp -75.67 136.95 70.52 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.565 -1.334 . . . . 0.0 110.91 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.99 139.91 19.73 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.452 2.768 . . . . 0.0 111.169 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.8 tp -145.72 121.57 10.61 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.506 1.522 . . . . 0.0 109.893 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 59.17 23.09 11.35 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.902 1.281 . . . . 0.0 113.699 172.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.1 2.15 74.85 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.394 1.473 . . . . 0.0 114.728 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -111.73 156.98 21.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.233 1.813 . . . . 0.0 111.629 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.99 173.07 10.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.163 0.985 . . . . 0.0 111.137 169.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.2 mt -134.24 119.01 18.22 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.544 1.138 . . . . 0.0 109.148 169.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -92.67 122.51 35.15 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.85 128.32 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.194 0.906 . . . . 0.0 109.689 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -148.1 165.27 31.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.581 1.552 . . . . 0.0 110.986 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.19 137.87 41.58 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.633 -0.667 . . . . 0.0 110.566 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -86.24 111.33 20.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.234 0.614 . . . . 0.0 110.786 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 73.5 m -109.48 136.34 49.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.063 1.345 . . . . 0.0 111.474 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -74.8 -23.24 58.46 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.2 m -153.03 162.23 41.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.115 1.766 . . . . 0.0 111.142 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.89 163.98 26.31 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.935 0.894 . . . . 0.0 112.258 171.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.4 t -157.23 169.83 23.87 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.899 1.279 . . . . 0.0 111.483 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.9 mt -130.26 168.63 16.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.083 1.753 . . . . 0.0 111.428 -172.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.0 t -156.49 154.68 30.74 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.785 1.634 . . . . 0.0 110.91 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.4 t -75.47 157.99 33.24 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.822 0.849 . . . . 0.0 112.072 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.72 -77.33 0.2 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.867 1.222 . . . . 0.0 112.22 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.94 115.52 4.35 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.532 2.821 . . . . 0.0 110.251 176.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 79.5 p -170.43 169.87 7.27 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.86 1.664 . . . . 0.0 111.58 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 73.2 m -77.35 141.92 39.62 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.98 -1.075 . . . . 0.0 111.943 174.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.192 0 CA-C-O 118.268 -1.296 . . . . 0.0 112.871 -179.642 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.322 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.6 p -75.07 163.55 27.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.691 1.197 . . . . 0.0 113.355 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.5 t -74.05 -17.7 60.93 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 120.851 -1.156 . . . . 0.0 113.689 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.19 157.66 29.97 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.755 1.645 . . . . 0.0 113.437 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.9 m -94.87 -3.44 48.79 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -173.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.9 p -90.97 152.32 20.74 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.474 1.51 . . . . 0.0 113.23 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.98 -175.91 39.84 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.064 1.316 . . . . 0.0 113.613 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.78 36.62 18.7 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.061 0.839 . . . . 0.0 113.723 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -110.51 150.16 29.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.536 1.534 . . . . 0.0 111.981 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.58 157.2 38.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.514 1.126 . . . . 0.0 112.97 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -76.38 -10.19 59.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.011 1.725 . . . . 0.0 113.743 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -153.94 149.45 27.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.349 1.859 . . . . 0.0 110.204 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.6 p -147.96 133.08 18.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.172 1.389 . . . . 0.0 110.545 -174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -91.08 45.06 1.22 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.477 1.111 . . . . 0.0 112.877 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -75.3 37.82 0.13 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.51 1.524 . . . . 0.0 112.713 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 m -78.79 36.33 0.27 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.89 2.076 . . . . 0.0 112.589 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.13 129.18 55.18 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.074 1.75 . . . . 0.0 110.744 -174.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.3 mt -108.15 130.61 55.11 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.585 1.554 . . . . 0.0 110.294 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -89.83 134.5 34.16 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.645 1.978 . . . . 0.0 107.949 169.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.9 t -129.16 121.88 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.996 0.918 . . . . 0.0 109.792 -174.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.43 172.66 14.56 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 125.921 1.724 . . . . 0.0 113.686 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 m120 65.32 17.08 10.86 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.169 1.788 . . . . 0.0 113.371 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 32.2 mt -58.19 143.48 78.92 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.409 1.084 . . . . 0.0 112.474 -171.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -70.32 158.06 57.37 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.199 2.6 . . . . 0.0 110.852 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.5 -9.67 25.54 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.316 2.677 . . . . 0.0 112.87 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.79 4.42 52.87 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.793 2.037 . . . . 0.0 113.409 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 tp -81.74 145.28 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 120.785 -1.197 . . . . 0.0 111.181 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.8 p -135.27 167.63 20.66 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.52 1.928 . . . . 0.0 109.139 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -57.7 -35.42 70.6 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.962 0.505 . . . . 0.0 111.887 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -80.23 -30.97 38.59 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.518 1.127 . . . . 0.0 113.076 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.08 -39.2 66.06 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.024 0.93 . . . . 0.0 111.309 172.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 4.3 tpt -61.86 -42.27 98.85 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.709 0.804 . . . . 0.0 111.074 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.0 ttp85 -63.26 -27.85 69.63 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.424 -0.798 . . . . 0.0 112.191 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -47.67 37.7 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.157 1.383 . . . . 0.0 112.494 171.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.7 mt -55.62 -34.27 64.74 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.01 1.324 . . . . 0.0 112.634 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -102.52 9.93 39.2 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.05 1.34 . . . . 0.0 113.267 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.63 -24.89 67.15 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -61.92 -25.21 67.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.555 1.142 . . . . 0.0 112.388 173.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -102.32 12.69 36.24 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.209 1.804 . . . . 0.0 112.478 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.55 -145.68 20.4 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.756 1.17 . . . . 0.0 111.93 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -103.54 131.14 50.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.599 1.159 . . . . 0.0 111.085 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.5 146.49 51.85 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.172 0.989 . . . . 0.0 111.844 176.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.81 -18.14 70.97 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.287 0.946 . . . . 0.0 113.454 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -158.68 146.38 17.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.569 1.548 . . . . 0.0 110.321 172.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.9 t -143.18 128.46 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.083 1.753 . . . . 0.0 109.542 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -140.65 142.35 34.97 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.401 1.481 . . . . 0.0 111.444 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.5 mt -142.12 128.97 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.004 1.721 . . . . 0.0 108.222 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -123.27 102.13 7.76 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.046 0.938 . . . . 0.0 111.985 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -73.6 -16.35 61.24 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.94 -20.53 60.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.305 1.042 . . . . 0.0 112.808 175.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -116.75 -23.22 8.22 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.832 1.253 . . . . 0.0 113.756 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.71 28.73 23.23 Favored Glycine 0 N--CA 1.477 1.371 0 C-N-CA 124.673 1.13 . . . . 0.0 114.25 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -136.78 155.16 50.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.389 1.476 . . . . 0.0 112.023 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.96 168.97 25.84 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.676 1.607 . . . . 0.0 113.055 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -140.56 140.2 35.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.703 2.001 . . . . 0.0 108.735 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.5 tt -150.6 132.27 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.685 -0.634 . . . . 0.0 111.487 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 123.1 47.63 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.749 1.22 . . . . 0.0 110.172 -177.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -99.73 157.12 16.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.246 0.618 . . . . 0.0 110.181 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.34 -18.47 63.08 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -169.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.9 p -151.01 151.54 32.21 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.667 1.587 . . . . 0.0 111.435 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 36.9 ptt-85 -55.27 -35.66 65.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.756 1.222 . . . . 0.0 114.24 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 m -60.92 -45.92 92.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.058 1.343 . . . . 0.0 111.265 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.09 -44.0 97.61 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.773 0.829 . . . . 0.0 110.915 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.85 79.41 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.297 0.639 . . . . 0.0 112.63 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.53 -48.32 67.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.861 0.865 . . . . 0.0 111.909 172.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.34 -46.56 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.522 -0.736 . . . . 0.0 110.279 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.99 99.54 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.759 0.824 . . . . 0.0 112.053 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -56.09 -50.65 70.43 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.566 1.076 . . . . 0.0 111.489 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.8 -35.15 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.793 0.724 . . . . 0.0 112.338 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -87.2 -33.44 19.35 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.0 mt -98.91 -22.68 15.66 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -171.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -70.2 122.71 20.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.0 0.818 . . . . 0.0 110.773 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 70.61 14.92 7.18 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 127.543 2.337 . . . . 0.0 114.262 -171.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.4 ttp -72.79 138.1 79.95 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 120.518 -1.364 . . . . 0.0 110.939 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.11 139.58 21.66 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.44 2.76 . . . . 0.0 111.402 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.8 tp -144.88 116.22 8.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.343 1.457 . . . . 0.0 109.969 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 59.03 18.88 6.69 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.211 1.404 . . . . 0.0 113.916 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.57 -6.73 80.26 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.665 1.602 . . . . 0.0 114.508 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -85.38 153.99 22.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.758 1.279 . . . . 0.0 110.557 170.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -86.11 163.41 17.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 167.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.0 mt -122.1 137.52 54.79 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.305 1.042 . . . . 0.0 110.046 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.4 135.67 46.36 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.382 1.073 . . . . 0.0 109.529 170.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.37 132.93 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.965 0.906 . . . . 0.0 110.955 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -147.73 165.61 30.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.163 1.385 . . . . 0.0 111.573 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -73.54 136.85 44.08 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.545 -0.722 . . . . 0.0 110.946 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.5 126.11 30.39 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.693 0.797 . . . . 0.0 110.572 174.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 37.5 t -160.3 140.26 11.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.365 1.466 . . . . 0.0 110.971 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -146.99 136.03 22.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.741 1.616 . . . . 0.0 111.393 -173.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 33.5 t -165.19 135.21 3.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.668 1.187 . . . . 0.0 111.266 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.69 53.37 1.88 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.981 1.313 . . . . 0.0 111.44 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.3 t -82.3 111.15 18.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.067 0.947 . . . . 0.0 111.227 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.61 149.73 25.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.571 1.148 . . . . 0.0 110.747 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.5 t -80.26 -173.84 4.23 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.828 1.251 . . . . 0.0 111.334 174.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.9 t -149.14 177.13 9.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.466 1.506 . . . . 0.0 111.878 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -71.18 162.74 54.17 Favored Glycine 0 CA--C 1.543 1.833 0 C-N-CA 124.5 1.048 . . . . 0.0 114.133 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.73 8.71 4.1 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.663 3.575 . . . . 0.0 113.886 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.8 p -69.34 153.47 43.56 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.006 1.323 . . . . 0.0 113.268 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.6 p -78.7 148.16 33.2 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.865 -1.147 . . . . 0.0 113.472 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 C-N-CA 125.213 1.387 . . . . 0.0 112.821 -179.3 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.6 m -146.61 141.34 26.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.978 1.311 . . . . 0.0 110.998 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m 69.01 -5.64 1.01 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.736 2.015 . . . . 0.0 115.747 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.23 169.36 30.52 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.893 1.711 . . . . 0.0 113.377 175.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.6 t -163.82 172.96 13.35 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.697 1.599 . . . . 0.0 111.074 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.3 p -84.61 151.83 24.24 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.805 1.242 . . . . 0.0 112.711 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.04 117.25 4.42 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.975 0.798 . . . . 0.0 112.065 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.64 163.88 31.28 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.932 1.254 . . . . 0.0 112.43 172.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -143.93 140.23 29.58 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.022 1.329 . . . . 0.0 110.782 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -93.06 33.85 1.15 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.353 1.461 . . . . 0.0 113.831 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.9 p -65.77 -15.96 63.34 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.313 1.845 . . . . 0.0 114.228 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -154.45 171.81 18.76 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.317 1.847 . . . . 0.0 110.649 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.5 m -55.01 128.07 31.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.344 1.458 . . . . 0.0 110.537 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -60.07 131.59 51.31 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.44 1.096 . . . . 0.0 110.797 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -70.17 -59.03 3.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.103 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.5 p 49.61 29.13 2.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.693 1.597 . . . . 0.0 114.832 174.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -86.11 135.01 33.77 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.233 1.413 . . . . 0.0 111.406 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.83 127.4 51.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.809 1.643 . . . . 0.0 110.206 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -89.65 135.7 33.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.731 2.013 . . . . 0.0 108.13 171.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.63 113.22 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.048 0.939 . . . . 0.0 109.46 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.16 174.41 21.33 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.606 1.574 . . . . 0.0 113.271 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 m120 66.48 16.61 10.46 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.028 1.731 . . . . 0.0 113.761 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.5 mt -60.8 140.52 93.25 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 121.156 -0.965 . . . . 0.0 113.033 -170.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -68.67 159.28 54.31 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.08 3.187 . . . . 0.0 111.745 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.95 -1.47 11.25 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.572 2.848 . . . . 0.0 114.031 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -116.84 12.49 14.79 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.682 1.593 . . . . 0.0 113.0 -174.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 tp -82.24 137.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.42 1.088 . . . . 0.0 110.734 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.5 p -128.86 176.18 8.05 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.261 1.424 . . . . 0.0 110.009 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -54.22 -32.82 56.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.913 0.885 . . . . 0.0 112.202 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -73.34 -34.01 65.43 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.784 0.834 . . . . 0.0 112.479 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -71.48 -44.13 65.3 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.654 0.661 . . . . 0.0 110.56 170.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.9 ttt -65.28 -33.26 75.57 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -63.98 -45.15 90.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.068 0.947 . . . . 0.0 111.318 169.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -70.84 -38.51 73.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.634 0.774 . . . . 0.0 112.825 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.8 mt -59.62 -24.21 63.63 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.551 1.54 . . . . 0.0 113.328 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -113.2 10.25 18.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.577 1.551 . . . . 0.0 112.539 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -21.33 65.42 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.63 -20.52 60.97 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.038 1.335 . . . . 0.0 112.593 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -112.47 11.59 19.87 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.257 2.223 . . . . 0.0 111.855 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.5 -169.99 52.98 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.479 1.037 . . . . 0.0 113.211 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -71.63 129.6 39.11 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.014 -0.698 . . . . 0.0 111.293 174.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.9 149.73 43.2 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.058 0.943 . . . . 0.0 111.439 172.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.23 -12.89 75.26 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.717 1.151 . . . . 0.0 113.78 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -156.12 138.08 14.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.88 1.672 . . . . 0.0 109.316 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -141.69 127.68 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.437 1.495 . . . . 0.0 108.801 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -145.2 139.15 27.0 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.562 1.145 . . . . 0.0 111.936 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.7 mt -139.86 137.8 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.485 1.914 . . . . 0.0 107.978 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -143.51 129.17 19.23 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 122.63 1.205 . . . . 0.0 113.897 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -74.21 -11.49 60.3 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.313 1.445 . . . . 0.0 113.463 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.17 -32.09 61.89 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.45 1.5 . . . . 0.0 113.031 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -123.73 -20.67 5.4 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.39 42.35 7.47 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 119.26 0.936 . . . . 0.0 113.252 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -137.78 154.75 49.54 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.734 1.614 . . . . 0.0 111.151 -177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.64 162.08 25.12 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.099 1.333 . . . . 0.0 113.647 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -137.27 139.71 41.13 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.921 2.088 . . . . 0.0 109.167 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.93 139.99 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.124 0.97 . . . . 0.0 110.313 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -125.88 116.17 21.11 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.95 0.9 . . . . 0.0 110.292 -172.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.5 mt -92.83 167.86 11.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.1 0.56 . . . . 0.0 111.242 -174.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -76.31 -19.53 58.16 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.2 p -143.8 155.11 44.03 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.643 1.177 . . . . 0.0 111.649 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 37.4 ptt-85 -60.11 -36.01 76.51 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.716 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.1 m -62.19 -50.62 71.08 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.351 1.46 . . . . 0.0 110.698 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.32 -37.6 87.6 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.692 -0.67 . . . . 0.0 111.758 176.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.02 89.55 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.106 0.866 . . . . 0.0 113.129 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -65.6 -49.57 68.29 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.678 0.791 . . . . 0.0 111.531 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.71 -48.45 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.967 -0.458 . . . . 0.0 110.125 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.56 86.29 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.596 0.758 . . . . 0.0 112.204 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -60.17 -42.42 94.96 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.247 -0.908 . . . . 0.0 112.15 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.17 -35.21 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.828 0.74 . . . . 0.0 112.049 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.69 -30.78 32.48 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.8 mt -104.73 -19.52 13.91 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -169.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.71 128.33 36.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.207 0.912 . . . . 0.0 111.664 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.1 t30 70.83 17.87 6.3 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.034 2.534 . . . . 0.0 113.348 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.6 ttp -76.49 138.17 67.33 Favored Pre-proline 0 N--CA 1.475 0.805 0 O-C-N 120.796 -1.19 . . . . 0.0 111.343 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.65 143.6 21.49 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.444 2.763 . . . . 0.0 111.708 175.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.2 tp -146.73 115.51 6.84 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.413 1.485 . . . . 0.0 110.247 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 57.08 25.68 11.11 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.513 1.525 . . . . 0.0 114.164 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.16 -1.96 78.07 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.225 1.393 . . . . 0.0 114.607 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -100.41 166.85 10.74 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.581 1.552 . . . . 0.0 111.191 169.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -92.66 175.21 6.9 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.481 1.112 . . . . 0.0 109.904 171.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.6 mt -136.9 110.25 7.89 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.745 1.218 . . . . 0.0 108.89 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.06 122.39 37.68 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.71 125.49 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.87 0.868 . . . . 0.0 110.846 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -139.67 166.71 23.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.885 1.674 . . . . 0.0 111.164 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -77.71 134.46 38.1 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.602 -0.687 . . . . 0.0 111.482 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.72 80.4 5.32 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.173 0.989 . . . . 0.0 110.645 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 10.5 t -163.38 160.01 23.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.18 1.792 . . . . 0.0 110.686 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -61.12 -23.85 65.82 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 37.1 m 61.48 29.54 18.44 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.198 1.399 . . . . 0.0 113.626 170.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.21 146.26 35.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.45 1.5 . . . . 0.0 111.809 -173.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.4 p -169.5 166.63 10.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.361 1.864 . . . . 0.0 110.608 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -66.1 144.03 56.94 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.619 -0.676 . . . . 0.0 112.178 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 20.6 p -87.94 149.61 23.96 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.139 1.376 . . . . 0.0 110.48 172.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 18.4 p -67.8 142.76 56.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.233 0.613 . . . . 0.0 111.551 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.27 145.93 48.21 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-O 118.796 -1.002 . . . . 0.0 112.223 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.4 139.22 48.82 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.23 2.62 . . . . 0.0 110.907 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.7 t -123.63 33.48 5.32 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.053 1.341 . . . . 0.0 111.174 -173.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.1 t -149.34 134.84 18.5 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.975 1.71 . . . . 0.0 110.276 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.193 1.378 . . . . 0.0 113.256 -173.801 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 t 63.53 35.63 11.72 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.066 1.347 . . . . 0.0 113.431 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 t -149.4 140.15 22.69 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.676 -1.265 . . . . 0.0 111.923 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.89 -101.54 2.38 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 125.91 1.719 . . . . 0.0 111.475 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.5 m 67.31 25.45 8.77 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.394 1.477 . . . . 0.0 113.913 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 t -155.28 152.5 29.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.396 1.479 . . . . 0.0 111.465 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 164.5 -159.14 32.04 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.031 1.3 . . . . 0.0 113.552 -176.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.83 -179.33 42.81 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.951 1.263 . . . . 0.0 113.887 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -165.11 146.09 7.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.579 1.951 . . . . 0.0 109.285 -175.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.57 136.77 36.62 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.09 0.956 . . . . 0.0 110.794 173.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.2 m -60.65 -29.74 69.45 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.557 1.543 . . . . 0.0 112.489 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -134.72 129.85 35.34 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.731 1.612 . . . . 0.0 109.372 176.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.6 t -165.68 171.67 12.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.664 1.586 . . . . 0.0 110.82 -174.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -140.94 77.69 1.61 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.837 1.655 . . . . 0.0 109.169 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.5 mtm-85 -68.82 142.49 54.85 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.839 0.828 . . . . 0.0 112.629 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.5 m -98.06 28.51 3.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.619 1.568 . . . . 0.0 112.181 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -97.56 131.55 44.05 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.719 1.208 . . . . 0.0 112.026 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.9 mt -102.98 152.45 21.31 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.64 1.976 . . . . 0.0 110.586 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.418 ' CD2' ' HD3' ' A' ' 144' ' ' ARG . 12.1 t80 -124.48 126.28 45.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.778 2.431 . . . . 0.0 108.076 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.31 111.6 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.567 1.147 . . . . 0.0 109.478 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.57 167.23 25.75 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.79 1.186 . . . . 0.0 112.619 173.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 64.97 26.49 12.72 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.61 1.564 . . . . 0.0 113.217 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.53 144.01 95.91 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 121.074 -1.016 . . . . 0.0 111.345 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.38 161.8 44.71 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.79 2.993 . . . . 0.0 111.85 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.03 6.08 1.9 Allowed 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 124.157 3.238 . . . . 0.0 114.347 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -140.43 19.0 2.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.462 1.505 . . . . 0.0 114.335 -172.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -73.07 150.72 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.065 0.946 . . . . 0.0 110.151 169.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 p -126.83 163.54 23.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.081 1.352 . . . . 0.0 110.619 170.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -58.16 -32.96 68.71 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.14 0.576 . . . . 0.0 111.44 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -68.26 -42.44 79.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 111.673 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.11 -40.73 94.92 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.884 -0.51 . . . . 0.0 111.802 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.9 ttt -66.51 -38.6 87.59 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.656 0.662 . . . . 0.0 111.629 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -62.95 -38.73 92.25 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.52 1.128 . . . . 0.0 111.707 173.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.91 -45.45 61.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.96 1.304 . . . . 0.0 111.32 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.59 -29.09 58.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.007 1.323 . . . . 0.0 113.524 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -107.07 10.03 30.34 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.371 1.468 . . . . 0.0 112.792 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.06 -23.42 67.17 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -58.5 -26.72 63.77 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.976 1.31 . . . . 0.0 112.863 171.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -101.47 10.7 40.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.964 1.706 . . . . 0.0 112.729 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.18 -167.84 43.97 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.777 1.18 . . . . 0.0 112.625 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -79.06 123.73 27.62 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.952 -0.734 . . . . 0.0 110.265 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.82 143.64 54.52 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.8 0.84 . . . . 0.0 111.581 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.18 -9.32 76.88 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.792 1.187 . . . . 0.0 114.117 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -155.44 134.39 12.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.296 1.838 . . . . 0.0 108.48 173.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.5 t -140.54 125.77 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.196 1.398 . . . . 0.0 109.112 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -140.74 140.35 34.81 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.628 1.571 . . . . 0.0 111.238 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 62.0 mt -140.21 130.57 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.838 1.655 . . . . 0.0 108.211 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -120.34 108.16 13.81 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.798 0.839 . . . . 0.0 112.079 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.73 -17.86 61.06 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -171.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -78.98 -19.42 51.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.115 0.966 . . . . 0.0 112.758 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -108.28 -29.28 8.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.744 1.218 . . . . 0.0 113.615 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.79 28.18 27.11 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 124.608 1.099 . . . . 0.0 114.182 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -133.86 156.95 47.16 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.519 1.527 . . . . 0.0 111.893 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.75 165.8 27.53 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.865 1.221 . . . . 0.0 113.615 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.33 146.58 46.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.555 1.942 . . . . 0.0 109.78 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.6 tt -153.26 127.39 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.583 0.753 . . . . 0.0 111.43 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -114.0 121.15 43.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.155 0.982 . . . . 0.0 111.176 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.0 mt -97.42 167.15 11.17 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.74 0.816 . . . . 0.0 110.73 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -70.37 -24.07 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.7 p -145.52 160.7 41.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.466 1.506 . . . . 0.0 111.138 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -62.49 -31.76 72.56 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 119.01 -0.519 . . . . 0.0 111.985 173.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.0 m -61.24 -47.19 87.2 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.91 1.284 . . . . 0.0 110.564 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.06 -45.78 93.36 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.298 0.639 . . . . 0.0 111.076 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.46 -36.15 83.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -68.49 -44.26 75.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.064 1.345 . . . . 0.0 111.428 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.53 -52.0 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.432 -0.793 . . . . 0.0 109.883 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.15 90.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.625 0.77 . . . . 0.0 112.389 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -52.94 -50.05 64.8 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.032 0.933 . . . . 0.0 111.679 172.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.4 t -74.68 -36.23 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.389 0.54 . . . . 0.0 111.852 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -77.29 -21.32 53.73 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.5 mt -110.83 0.11 17.12 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.521 1.128 . . . . 0.0 113.758 -174.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.67 125.9 26.72 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.14 -0.975 . . . . 0.0 112.218 -176.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 57.51 22.4 8.05 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.479 1.912 . . . . 0.0 113.5 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 51.0 ttp -63.81 133.55 95.6 Favored Pre-proline 0 N--CA 1.472 0.652 0 O-C-N 120.777 -1.202 . . . . 0.0 111.09 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -73.54 127.33 11.65 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.003 2.469 . . . . 0.0 110.432 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 45.6 tp -135.51 107.46 7.11 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.813 1.645 . . . . 0.0 108.117 170.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 57.81 29.18 17.07 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.769 1.228 . . . . 0.0 113.202 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.74 -5.61 62.12 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.249 1.88 . . . . 0.0 115.066 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -101.23 142.19 33.02 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.151 1.38 . . . . 0.0 111.025 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -102.14 117.4 34.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.88 0.872 . . . . 0.0 109.736 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.42 119.15 23.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.665 1.186 . . . . 0.0 112.28 -169.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -97.29 106.63 18.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.3 0.64 . . . . 0.0 110.312 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.44 129.24 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.512 1.125 . . . . 0.0 110.595 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.418 ' HD3' ' CD2' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -134.11 170.4 15.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.518 1.927 . . . . 0.0 110.819 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -90.57 140.42 29.77 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.522 0.729 . . . . 0.0 110.952 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -94.07 64.58 3.33 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.004 1.322 . . . . 0.0 111.791 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 29.9 p -158.51 173.78 16.09 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.68 1.592 . . . . 0.0 112.634 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -153.77 138.38 16.91 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.678 1.591 . . . . 0.0 111.731 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.5 t -168.68 -172.81 1.72 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.216 1.806 . . . . 0.0 110.372 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.71 115.98 11.12 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.795 1.638 . . . . 0.0 110.045 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.8 t -104.25 37.88 1.99 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.168 1.387 . . . . 0.0 111.319 -176.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.6 mt -134.63 167.31 21.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.732 2.013 . . . . 0.0 111.252 -171.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.5 t -156.5 160.39 39.48 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.052 1.741 . . . . 0.0 110.321 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 27.4 p -80.81 140.0 35.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.528 1.131 . . . . 0.0 112.63 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.25 -54.72 27.99 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 118.108 -1.385 . . . . 0.0 114.051 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -83.1 62.68 7.66 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.754 2.969 . . . . 0.0 110.824 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 62.8 p -81.78 151.24 27.52 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.594 1.158 . . . . 0.0 113.075 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 75.6 m -146.34 143.79 29.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.331 1.452 . . . . 0.0 111.161 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 C-N-CA 125.0 1.286 . . . . 0.0 113.146 178.781 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.8 t -85.99 131.33 34.3 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.625 -0.926 . . . . 0.0 111.279 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 p -82.41 98.63 8.97 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.253 1.021 . . . . 0.0 111.295 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.19 -134.58 7.02 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.381 1.467 . . . . 0.0 112.882 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.5 p -159.68 -179.5 7.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.609 1.563 . . . . 0.0 111.62 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.2 t -151.35 152.13 32.72 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.89 1.276 . . . . 0.0 110.978 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.29 13.12 77.45 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.3 0.953 . . . . 0.0 114.316 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.94 -148.77 19.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.406 1.479 . . . . 0.0 113.002 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -155.2 144.98 21.44 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.544 1.537 . . . . 0.0 109.806 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -83.23 -12.72 56.54 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -169.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.6 p -90.37 173.96 7.83 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.003 1.721 . . . . 0.0 111.578 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -57.38 131.21 49.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.038 0.935 . . . . 0.0 111.321 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 100.0 m -130.15 139.81 50.84 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.792 1.637 . . . . 0.0 109.824 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -69.15 150.56 47.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.988 1.315 . . . . 0.0 113.178 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -99.93 23.96 9.12 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.728 1.211 . . . . 0.0 113.952 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.5 p -78.38 8.26 5.33 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -77.03 121.38 23.45 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.497 1.119 . . . . 0.0 110.599 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.4 mt -105.1 134.32 48.4 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.705 1.602 . . . . 0.0 110.354 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -91.94 135.31 34.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.049 2.14 . . . . 0.0 108.086 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.3 t -131.48 106.22 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.353 1.061 . . . . 0.0 108.884 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.01 163.08 15.19 Favored Glycine 0 N--CA 1.464 0.546 0 C-N-CA 124.991 1.281 . . . . 0.0 113.724 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 t30 68.7 27.56 5.87 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.85 1.66 . . . . 0.0 112.745 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.74 145.57 95.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 O-C-N 121.187 -0.946 . . . . 0.0 111.854 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.1 165.86 31.03 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.209 3.273 . . . . 0.0 111.777 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.19 -5.98 17.77 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.091 2.528 . . . . 0.0 113.4 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -106.87 0.48 23.96 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.124 1.37 . . . . 0.0 114.181 -172.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 tp -74.25 143.2 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.268 -0.895 . . . . 0.0 111.129 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 65.7 p -128.23 166.51 18.41 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.035 1.734 . . . . 0.0 110.074 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.96 -31.98 69.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.033 0.533 . . . . 0.0 111.536 171.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -70.76 -42.09 70.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.213 1.005 . . . . 0.0 111.924 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -66.28 -41.86 89.22 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.78 0.718 . . . . 0.0 111.302 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.8 tpt -65.11 -37.92 89.03 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.891 -0.505 . . . . 0.0 111.629 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -63.11 -48.4 78.71 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.404 -0.81 . . . . 0.0 110.273 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -60.49 -38.89 85.73 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.196 0.998 . . . . 0.0 113.296 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.6 mt -63.99 -29.78 70.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.38 1.472 . . . . 0.0 113.988 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -109.89 -4.0 16.26 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.69 1.196 . . . . 0.0 113.51 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.38 -27.52 67.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.927 1.691 . . . . 0.0 115.16 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -55.78 -24.43 35.62 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.961 1.304 . . . . 0.0 112.707 171.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -107.02 14.54 26.27 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.937 2.095 . . . . 0.0 112.029 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.02 172.66 44.97 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.137 1.827 . . . . 0.0 112.78 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.57 132.91 46.21 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.873 -0.78 . . . . 0.0 110.931 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.1 145.44 51.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.885 0.874 . . . . 0.0 112.163 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.05 -11.59 75.93 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.631 1.11 . . . . 0.0 113.905 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -157.69 135.92 11.01 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.712 2.005 . . . . 0.0 108.371 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.34 128.84 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.265 1.426 . . . . 0.0 108.609 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -140.87 139.88 34.5 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.147 1.379 . . . . 0.0 110.904 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.8 mt -139.1 120.6 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.371 1.469 . . . . 0.0 108.312 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -115.97 98.18 6.5 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.234 1.014 . . . . 0.0 112.12 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.07 -15.86 62.02 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.92 -23.61 60.72 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.278 1.031 . . . . 0.0 112.697 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -117.06 -25.27 7.23 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.59 27.7 18.97 Favored Glycine 0 N--CA 1.477 1.428 0 C-N-CA 124.569 1.081 . . . . 0.0 114.171 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.91 150.54 52.15 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.373 1.469 . . . . 0.0 111.46 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.64 167.4 25.32 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.56 1.552 . . . . 0.0 113.08 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -139.52 142.62 37.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.468 1.907 . . . . 0.0 109.402 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 tt -151.65 130.65 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.382 0.673 . . . . 0.0 111.454 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.49 122.38 45.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.611 1.164 . . . . 0.0 110.441 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -97.59 168.41 10.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.005 0.522 . . . . 0.0 111.085 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -67.58 -32.4 73.12 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -171.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.9 p -140.44 159.32 42.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.827 1.251 . . . . 0.0 112.102 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -60.88 -31.95 71.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.818 0.847 . . . . 0.0 113.001 173.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m -68.71 -47.93 65.14 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.161 1.384 . . . . 0.0 110.658 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.8 mt -58.88 -42.34 89.23 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.614 0.766 . . . . 0.0 111.261 173.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.67 -35.39 78.76 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.79 -47.25 75.76 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.742 1.155 . . . . 0.0 111.361 172.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.7 mt -59.43 -48.73 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.19 0.596 . . . . 0.0 110.316 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.98 93.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.203 0.601 . . . . 0.0 112.033 176.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -57.54 -49.0 77.76 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.412 1.005 . . . . 0.0 111.182 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.86 -35.87 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.192 0.597 . . . . 0.0 111.963 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -83.48 -24.32 31.82 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 55.3 mt -111.23 -18.48 12.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -171.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.67 128.39 35.77 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.897 1.226 . . . . 0.0 111.975 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 59.5 27.47 16.63 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.897 2.079 . . . . 0.0 113.364 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.8 ttp -74.72 137.43 73.73 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.535 -0.728 . . . . 0.0 109.664 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.31 136.3 15.81 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.315 2.677 . . . . 0.0 111.058 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -145.12 123.49 12.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.971 1.708 . . . . 0.0 109.0 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 58.83 22.87 10.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.775 1.23 . . . . 0.0 113.716 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.15 3.1 85.29 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.317 1.436 . . . . 0.0 114.474 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -106.17 148.91 27.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.17 1.788 . . . . 0.0 110.879 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -84.22 168.47 15.7 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.339 168.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.01 127.87 37.13 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.29 1.036 . . . . 0.0 110.701 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.63 111.34 23.52 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.84 0.856 . . . . 0.0 108.902 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.94 124.21 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.767 0.827 . . . . 0.0 109.822 -173.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.9 ptt85 -149.63 173.6 13.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.311 1.444 . . . . 0.0 111.247 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -75.2 144.97 42.41 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.616 -0.678 . . . . 0.0 111.85 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.02 17.99 3.84 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.221 1.408 . . . . 0.0 113.095 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 89.3 m -53.5 128.64 29.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.919 1.687 . . . . 0.0 112.99 -177.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -76.34 160.95 29.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.14 0.976 . . . . 0.0 112.025 171.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.3 t -149.25 119.09 7.07 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.44 0.696 . . . . 0.0 110.373 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.34 113.65 1.85 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.836 1.654 . . . . 0.0 109.747 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.1 t -169.03 163.26 11.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.113 1.765 . . . . 0.0 110.266 -177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.16 134.56 54.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.166 1.386 . . . . 0.0 110.109 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.8 m -70.51 -28.49 65.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.863 1.265 . . . . 0.0 112.115 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 21.1 t -77.65 120.6 22.81 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.699 0.8 . . . . 0.0 110.876 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 164.2 90.11 0.08 OUTLIER Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.402 -1.221 . . . . 0.0 111.999 -177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.11 156.06 38.02 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.562 2.841 . . . . 0.0 111.904 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.9 t -80.84 146.89 30.66 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.871 0.868 . . . . 0.0 111.677 173.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.4 p -73.51 145.47 45.59 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.003 -1.061 . . . . 0.0 112.843 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 125.154 1.359 . . . . 0.0 112.899 -179.469 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.0 t -81.76 167.24 19.3 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.541 -0.976 . . . . 0.0 111.929 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.3 t -169.15 -165.18 0.51 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.183 1.793 . . . . 0.0 110.55 -173.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.88 -105.69 1.33 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.283 1.42 . . . . 0.0 111.969 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -64.62 -15.75 61.66 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.694 1.198 . . . . 0.0 113.39 172.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.8 m -123.98 59.7 1.14 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.675 1.59 . . . . 0.0 110.903 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.07 55.09 3.92 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.719 1.628 . . . . 0.0 113.246 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.59 -177.86 45.47 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.739 1.638 . . . . 0.0 113.518 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -79.38 135.76 36.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.383 1.073 . . . . 0.0 111.061 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 160.73 26.97 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.3 p -128.2 157.8 39.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.882 1.673 . . . . 0.0 110.834 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -82.03 155.08 25.33 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.078 0.951 . . . . 0.0 111.636 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.4 p -141.59 144.69 34.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.639 1.576 . . . . 0.0 110.504 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -104.85 29.34 6.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.202 1.401 . . . . 0.0 112.123 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.4 ttm105 -142.71 125.8 16.35 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.571 1.548 . . . . 0.0 111.04 -172.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.4 m -93.28 28.27 2.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.519 1.527 . . . . 0.0 113.409 -173.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -85.88 122.19 29.59 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.05 1.34 . . . . 0.0 111.443 -176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.6 mt -105.15 135.85 45.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.329 1.852 . . . . 0.0 110.066 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -90.87 138.53 31.52 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.144 1.777 . . . . 0.0 108.723 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.93 106.06 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.24 1.016 . . . . 0.0 108.788 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.79 168.74 20.63 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 125.454 1.502 . . . . 0.0 112.83 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.1 m120 61.48 35.36 17.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.828 1.251 . . . . 0.0 112.045 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.7 mt -66.26 145.78 99.0 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 121.3 -0.875 . . . . 0.0 111.442 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -70.11 158.08 57.65 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.946 2.431 . . . . 0.0 111.338 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.24 -2.32 11.48 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.93 3.087 . . . . 0.0 113.333 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -112.99 14.13 19.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.556 1.943 . . . . 0.0 112.604 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.25 150.21 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 O-C-N 121.012 -1.055 . . . . 0.0 110.753 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.0 p -136.2 170.06 16.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.832 1.653 . . . . 0.0 109.683 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.27 -35.41 71.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.57 0.348 . . . . 0.0 111.464 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.44 -41.26 66.35 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.975 0.91 . . . . 0.0 111.806 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.29 -46.79 82.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.233 0.613 . . . . 0.0 111.261 173.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.2 ttt -64.42 -35.51 81.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.116 0.566 . . . . 0.0 112.264 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -64.91 -45.11 87.29 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.415 0.686 . . . . 0.0 110.97 171.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -64.35 -42.98 95.95 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.197 -0.94 . . . . 0.0 111.946 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.1 mt -57.65 -24.61 57.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.476 1.51 . . . . 0.0 113.964 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -115.14 -1.85 12.9 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.681 1.192 . . . . 0.0 113.572 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.27 -28.79 69.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.728 1.611 . . . . 0.0 115.164 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -61.11 -22.03 64.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.523 1.129 . . . . 0.0 112.91 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -103.49 24.99 10.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.912 2.085 . . . . 0.0 111.67 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.24 -176.82 45.52 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.934 1.73 . . . . 0.0 112.664 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.66 144.38 56.97 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.95 -0.735 . . . . 0.0 111.949 175.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.14 118.01 16.6 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.16 -15.15 75.27 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.807 1.194 . . . . 0.0 113.566 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -161.17 145.25 13.33 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.672 1.989 . . . . 0.0 108.677 168.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.8 t -144.35 130.73 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.32 1.448 . . . . 0.0 110.365 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -140.52 136.69 33.15 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.405 1.482 . . . . 0.0 110.844 171.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 63.7 mt -139.29 137.03 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.249 1.82 . . . . 0.0 107.84 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -139.55 125.29 19.51 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.135 0.969 . . . . 0.0 113.087 170.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.15 -18.68 62.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.441 1.096 . . . . 0.0 112.779 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.36 -38.72 63.57 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.337 1.855 . . . . 0.0 113.081 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -120.77 -15.32 8.4 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.67 41.16 5.77 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.787 1.184 . . . . 0.0 113.811 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -136.86 159.26 42.39 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.114 1.366 . . . . 0.0 112.223 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.96 167.37 29.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.496 1.046 . . . . 0.0 114.191 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -139.11 147.06 41.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.705 2.002 . . . . 0.0 109.571 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.2 tt -147.88 132.28 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.202 1.001 . . . . 0.0 110.646 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -101.63 128.42 47.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.965 0.906 . . . . 0.0 109.131 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.5 mt -98.68 165.99 11.54 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.361 0.528 . . . . 0.0 110.278 170.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -76.5 -18.05 58.95 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -169.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.2 p -144.4 154.3 42.83 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.828 1.251 . . . . 0.0 111.5 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -62.87 -33.15 74.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.61 0.764 . . . . 0.0 112.891 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.1 m -64.48 -47.66 78.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.691 1.196 . . . . 0.0 110.793 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -66.71 -35.89 81.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.338 0.655 . . . . 0.0 111.394 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.77 94.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.94 -47.76 76.51 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.489 1.041 . . . . 0.0 111.214 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 93.9 mt -59.54 -50.41 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.202 0.601 . . . . 0.0 110.272 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.64 -45.68 88.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.093 0.557 . . . . 0.0 111.806 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.38 -46.22 86.79 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.391 -0.818 . . . . 0.0 111.69 176.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.1 t -67.56 -35.77 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.516 0.598 . . . . 0.0 111.89 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -80.81 -24.35 38.58 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 48.9 mt -109.09 -16.71 14.05 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.02 133.71 49.47 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.05 1.295 . . . . 0.0 112.615 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 59.4 t30 65.71 15.83 10.22 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.939 2.496 . . . . 0.0 113.757 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.8 ttp -71.43 136.13 83.92 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 120.834 -1.166 . . . . 0.0 110.563 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.93 129.77 11.8 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.363 2.709 . . . . 0.0 110.607 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.9 tp -139.32 113.29 8.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.036 1.335 . . . . 0.0 109.557 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 58.81 23.62 11.45 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.906 1.282 . . . . 0.0 113.478 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.26 -3.37 76.09 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.847 1.689 . . . . 0.0 114.671 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -92.14 147.68 22.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.413 1.485 . . . . 0.0 110.7 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -102.67 110.46 22.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.749 0.82 . . . . 0.0 109.348 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 80.4 mt -73.56 121.21 20.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.699 0.8 . . . . 0.0 111.661 -172.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -92.07 112.7 24.73 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.919 0.888 . . . . 0.0 108.8 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.66 120.47 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.186 0.994 . . . . 0.0 110.131 -172.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -155.08 156.09 35.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.773 1.229 . . . . 0.0 111.473 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -67.85 133.03 48.47 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.672 -0.643 . . . . 0.0 111.435 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -85.33 121.74 28.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.121 0.968 . . . . 0.0 110.399 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 27.5 p -158.91 170.51 21.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.061 1.344 . . . . 0.0 112.596 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -158.23 -168.16 2.4 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.932 1.693 . . . . 0.0 112.234 -175.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 80.6 p -151.17 156.42 40.91 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.779 1.232 . . . . 0.0 111.573 174.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.19 134.44 16.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.73 1.212 . . . . 0.0 111.138 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.1 t -104.27 1.28 30.28 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.57 1.148 . . . . 0.0 112.865 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.7 mt -53.48 112.63 0.94 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.873 1.669 . . . . 0.0 111.424 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.3 p 50.17 27.38 2.56 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.872 2.469 . . . . 0.0 114.258 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.5 t -112.23 87.57 2.6 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.687 1.195 . . . . 0.0 111.241 -173.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -141.84 95.36 0.19 Allowed Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.268 -1.296 . . . . 0.0 112.331 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -82.14 -8.61 11.87 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.807 3.005 . . . . 0.0 113.438 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.3 m -61.68 145.23 52.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.038 1.335 . . . . 0.0 113.143 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.4 m -62.68 123.05 17.39 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.155 0.982 . . . . 0.0 112.948 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.246 0 C-N-CA 125.377 1.465 . . . . 0.0 113.092 179.381 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.3 m -145.59 154.27 41.96 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.507 1.523 . . . . 0.0 111.168 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.4 t -162.22 165.5 26.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.288 1.435 . . . . 0.0 110.952 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.55 -128.6 8.77 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.309 0.956 . . . . 0.0 111.72 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 p -157.61 136.8 11.78 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.798 1.239 . . . . 0.0 111.438 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.6 m -79.41 136.21 36.9 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.292 -0.88 . . . . 0.0 112.695 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.74 155.88 34.07 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.44 1.019 . . . . 0.0 112.593 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -93.2 -139.1 9.15 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.019 1.295 . . . . 0.0 112.166 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -72.95 1.9 7.92 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.594 1.557 . . . . 0.0 113.54 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -146.0 158.01 43.87 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.249 1.82 . . . . 0.0 112.152 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.2 m -112.73 97.23 6.43 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.628 1.571 . . . . 0.0 109.728 -175.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -138.06 60.22 1.63 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.606 1.562 . . . . 0.0 109.621 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.4 p -78.93 115.9 18.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.476 1.51 . . . . 0.0 109.884 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -165.75 168.01 16.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.582 1.553 . . . . 0.0 111.157 -173.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -139.16 45.29 1.98 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.767 1.627 . . . . 0.0 111.94 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 t -92.59 -0.8 57.27 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.337 1.855 . . . . 0.0 113.58 -174.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -76.73 125.74 29.78 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.762 -1.211 . . . . 0.0 110.973 -175.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.2 mt -114.02 139.28 49.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.238 2.215 . . . . 0.0 110.26 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -100.74 142.56 32.04 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.238 2.215 . . . . 0.0 108.567 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.43 114.89 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.218 1.007 . . . . 0.0 110.001 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.88 173.73 17.03 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 126.021 1.772 . . . . 0.0 113.057 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.2 m120 66.64 11.79 8.38 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.462 1.905 . . . . 0.0 114.024 -175.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.5 mt -53.98 144.24 38.51 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.342 1.057 . . . . 0.0 113.41 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.03 165.29 33.04 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.257 3.305 . . . . 0.0 112.032 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.61 -8.14 20.19 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.389 2.726 . . . . 0.0 113.833 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -121.65 23.25 10.3 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.794 1.638 . . . . 0.0 113.561 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 tp -81.81 143.13 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.806 0.843 . . . . 0.0 110.53 173.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.0 p -136.52 167.65 20.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.557 1.943 . . . . 0.0 109.892 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -62.53 -28.54 69.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.32 0.648 . . . . 0.0 112.318 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -72.15 -47.62 49.59 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.993 -1.067 . . . . 0.0 112.496 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -57.82 -41.13 81.57 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.136 0.575 . . . . 0.0 111.86 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -70.07 -34.73 73.55 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.594 -0.691 . . . . 0.0 112.451 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -68.37 -37.05 80.06 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.518 -0.739 . . . . 0.0 111.906 169.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -68.97 -41.82 77.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.11 0.964 . . . . 0.0 112.449 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.3 mt -58.06 -26.52 62.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.101 1.36 . . . . 0.0 113.46 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -109.23 10.45 25.77 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.545 1.538 . . . . 0.0 112.526 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.78 -22.22 66.03 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -61.43 -21.7 64.35 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.602 1.161 . . . . 0.0 112.419 171.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.07 13.12 24.77 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.123 2.169 . . . . 0.0 112.131 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.37 -168.94 53.38 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.827 1.203 . . . . 0.0 112.916 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -76.57 124.75 28.09 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.55 0.74 . . . . 0.0 110.973 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.14 149.43 48.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.205 1.002 . . . . 0.0 111.681 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.07 -13.94 65.38 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.538 1.066 . . . . 0.0 113.914 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -154.79 136.21 14.16 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.853 1.661 . . . . 0.0 108.919 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 t -143.2 128.72 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.708 1.603 . . . . 0.0 109.066 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -145.35 144.32 30.64 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.062 1.345 . . . . 0.0 111.82 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.2 mt -137.68 128.1 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.352 1.461 . . . . 0.0 108.542 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -115.84 92.62 3.96 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.387 1.075 . . . . 0.0 110.542 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -74.54 -12.3 60.43 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.43 -23.24 62.7 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.073 1.349 . . . . 0.0 112.877 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -117.03 -22.37 8.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.729 1.212 . . . . 0.0 114.168 175.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.46 36.26 7.05 Favored Glycine 0 N--CA 1.475 1.288 0 C-N-CA 125.09 1.329 . . . . 0.0 114.276 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.13 152.08 44.44 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.113 1.365 . . . . 0.0 112.037 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.58 163.01 24.71 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.389 1.471 . . . . 0.0 113.375 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -142.3 140.66 32.26 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.642 1.977 . . . . 0.0 109.156 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.9 tt -154.32 148.12 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.829 0.852 . . . . 0.0 110.73 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -138.87 125.78 21.07 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.776 0.83 . . . . 0.0 110.58 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.28 176.85 5.05 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.24 1.016 . . . . 0.0 111.733 -170.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -76.9 -25.29 52.83 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.6 p -144.66 154.11 42.44 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.348 1.059 . . . . 0.0 112.147 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -58.49 -34.61 71.11 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.659 0.784 . . . . 0.0 112.884 172.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.1 m -62.22 -50.19 72.77 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.251 1.42 . . . . 0.0 110.445 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.11 -36.88 85.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.993 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.77 -37.24 85.79 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.115 0.87 . . . . 0.0 113.282 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -67.95 -45.27 74.72 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.771 0.828 . . . . 0.0 111.808 173.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.76 -48.0 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.57 -0.706 . . . . 0.0 110.243 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.88 91.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.929 0.891 . . . . 0.0 112.017 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -53.69 -53.77 47.33 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.016 0.826 . . . . 0.0 111.479 171.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.8 t -67.88 -33.03 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.582 0.628 . . . . 0.0 112.182 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.71 -36.03 44.03 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.06 -20.84 14.61 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.185 1.179 . . . . 0.0 114.185 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -67.07 134.01 51.0 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.114 0.87 . . . . 0.0 110.908 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . 0.3 0.4 OUTLIER 58.49 17.81 5.19 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.607 2.363 . . . . 0.0 115.246 -170.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.3 ttp -75.88 137.59 69.65 Favored Pre-proline 0 CA--C 1.545 0.771 0 O-C-N 120.873 -1.142 . . . . 0.0 110.947 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.73 140.8 21.21 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.467 2.778 . . . . 0.0 111.427 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 32.6 tp -146.56 119.3 8.61 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.459 1.504 . . . . 0.0 110.287 174.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? 58.98 23.9 12.04 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.065 1.346 . . . . 0.0 113.894 171.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.1 1.24 72.92 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.533 1.539 . . . . 0.0 114.734 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -107.66 165.15 11.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.669 1.988 . . . . 0.0 110.768 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -90.45 176.29 6.76 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.6 -0.688 . . . . 0.0 109.99 168.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.4 mt -133.85 116.11 15.27 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.6 1.16 . . . . 0.0 109.196 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -92.13 119.87 32.2 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.0 t -124.72 129.99 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.563 0.745 . . . . 0.0 109.926 -176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -146.98 164.4 33.11 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.304 1.442 . . . . 0.0 111.13 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -70.97 130.58 41.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 168.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.87 71.12 8.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.88 1.272 . . . . 0.0 110.759 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 6.1 t -155.44 169.58 23.93 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.34 1.456 . . . . 0.0 112.016 -170.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.77 176.92 11.75 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.56 2.344 . . . . 0.0 110.935 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.4 t -148.34 143.17 26.7 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.977 -1.077 . . . . 0.0 112.428 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.85 45.54 0.82 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.945 1.698 . . . . 0.0 112.811 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 67.8 m -77.91 105.46 9.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.269 1.028 . . . . 0.0 111.102 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.52 142.64 33.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.112 0.965 . . . . 0.0 110.101 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 56.7 m -145.57 131.97 19.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.998 1.719 . . . . 0.0 108.783 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.0 t -162.06 148.52 13.55 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.923 1.289 . . . . 0.0 111.004 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -163.63 79.9 0.13 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.468 -1.185 . . . . 0.0 112.702 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.81 -8.55 14.54 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.911 3.074 . . . . 0.0 113.461 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.6 m -61.2 138.9 58.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.051 1.34 . . . . 0.0 113.126 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.3 p -73.19 126.49 30.18 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.121 -0.987 . . . . 0.0 112.403 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.255 0 C-N-CA 125.211 1.386 . . . . 0.0 112.988 178.94 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.465 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.6 m -142.65 123.34 14.18 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.668 1.187 . . . . 0.0 110.926 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -168.07 152.13 6.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.531 1.532 . . . . 0.0 110.899 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.97 175.35 53.07 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.322 0.963 . . . . 0.0 112.451 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.9 p -76.76 152.54 35.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.97 0.908 . . . . 0.0 112.465 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.4 t -96.37 3.41 52.92 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.963 -1.085 . . . . 0.0 113.86 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.51 -156.57 43.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.698 1.142 . . . . 0.0 112.69 -175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.9 -150.78 32.91 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.434 1.016 . . . . 0.0 112.973 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -72.88 152.41 41.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.167 0.987 . . . . 0.0 111.902 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.69 158.13 25.43 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.7 p -104.72 170.64 7.77 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.747 1.619 . . . . 0.0 111.337 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -143.26 140.44 30.65 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.275 1.43 . . . . 0.0 110.564 -170.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -89.31 152.56 21.47 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.853 0.861 . . . . 0.0 111.417 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -95.65 -11.11 27.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.034 1.334 . . . . 0.0 112.414 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -140.44 141.84 35.44 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.182 1.393 . . . . 0.0 111.696 -171.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.8 p -98.29 20.09 13.15 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.17 1.788 . . . . 0.0 113.189 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -76.52 128.5 34.87 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.597 1.159 . . . . 0.0 111.311 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.02 140.28 49.42 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.181 1.792 . . . . 0.0 110.468 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -95.9 140.72 30.26 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.536 2.334 . . . . 0.0 108.814 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.2 110.46 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.94 0.896 . . . . 0.0 109.401 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.34 172.35 21.22 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.447 1.498 . . . . 0.0 113.321 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 m120 65.25 19.09 11.63 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.669 1.588 . . . . 0.0 113.128 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.1 mt -58.79 143.46 82.68 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.252 1.021 . . . . 0.0 111.857 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.7 158.57 56.57 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.696 2.93 . . . . 0.0 111.255 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.83 0.36 7.82 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.422 2.748 . . . . 0.0 113.568 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -114.64 4.75 15.18 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.943 1.697 . . . . 0.0 113.639 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.5 tp -74.03 142.41 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.28 -0.887 . . . . 0.0 111.247 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.7 p -123.72 165.59 17.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.971 1.708 . . . . 0.0 110.051 175.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.72 -27.78 68.16 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.699 0.399 . . . . 0.0 111.918 172.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.08 -40.27 62.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.168 0.987 . . . . 0.0 111.76 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -67.54 -37.81 83.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.637 0.653 . . . . 0.0 111.466 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.2 tpt -66.38 -40.98 90.03 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.641 -0.662 . . . . 0.0 111.657 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -60.56 -38.15 83.59 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.657 -0.652 . . . . 0.0 111.101 172.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -72.02 -40.3 68.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.05 0.94 . . . . 0.0 113.333 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 38.0 mt -56.02 -29.52 60.5 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.792 1.237 . . . . 0.0 112.766 173.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -109.05 12.88 24.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.446 1.498 . . . . 0.0 113.152 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -20.18 61.6 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.804 -1.185 . . . . 0.0 114.006 -174.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -64.53 -17.89 64.33 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.556 -0.715 . . . . 0.0 112.269 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -102.71 8.4 39.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.829 2.052 . . . . 0.0 112.178 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.08 -109.03 3.77 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.09 157.54 46.47 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.628 1.171 . . . . 0.0 112.413 170.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.97 151.11 26.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.742 0.817 . . . . 0.0 110.228 168.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.81 -14.31 61.27 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.697 1.142 . . . . 0.0 113.299 173.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -153.42 144.92 23.24 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.003 1.321 . . . . 0.0 110.622 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.29 128.8 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.549 1.94 . . . . 0.0 109.205 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -140.62 138.55 34.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.12 1.368 . . . . 0.0 111.514 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.4 mt -141.97 126.34 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.83 1.652 . . . . 0.0 107.816 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -118.18 106.81 13.22 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.932 0.872 . . . . 0.0 112.541 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -65.06 -27.18 68.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.989 1.316 . . . . 0.0 114.088 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.45 -9.08 59.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.851 1.261 . . . . 0.0 112.881 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -114.79 -32.7 5.72 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.132 1.373 . . . . 0.0 112.874 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.72 26.86 28.42 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.705 1.145 . . . . 0.0 113.753 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.65 155.18 48.51 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.717 1.607 . . . . 0.0 111.505 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.1 167.48 26.83 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.926 1.251 . . . . 0.0 113.677 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -139.18 148.14 42.75 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.729 2.011 . . . . 0.0 109.76 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.8 tt -154.76 138.93 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.955 0.902 . . . . 0.0 110.609 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -121.93 113.21 19.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.208 1.003 . . . . 0.0 109.87 -171.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.9 mt -88.48 167.05 13.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.135 0.574 . . . . 0.0 111.825 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -75.73 -17.32 59.96 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.7 p -145.44 159.92 42.36 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.369 1.467 . . . . 0.0 110.566 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -64.93 -34.35 78.2 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 171.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.8 m -55.71 -45.39 77.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.59 1.156 . . . . 0.0 111.119 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.2 -42.7 96.51 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.492 173.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.39 98.93 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.35 -51.25 70.16 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.353 1.433 . . . . 0.0 112.721 170.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.29 -45.9 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.905 -0.497 . . . . 0.0 110.293 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.81 94.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.362 0.665 . . . . 0.0 112.021 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.43 -45.1 94.86 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.397 -0.814 . . . . 0.0 111.564 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.76 -36.95 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.623 0.647 . . . . 0.0 112.006 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.08 -35.88 36.33 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.6 mt -96.78 -19.74 18.7 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -171.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -59.36 120.84 10.06 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.496 0.718 . . . . 0.0 111.762 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 64.32 21.59 12.55 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.964 2.106 . . . . 0.0 113.486 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.7 ttp -72.34 136.62 81.34 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 120.811 -1.181 . . . . 0.0 110.574 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.66 140.63 21.25 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.457 2.772 . . . . 0.0 111.628 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -148.44 116.43 6.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.619 1.568 . . . . 0.0 109.938 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 53.49 38.98 29.35 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.91 1.284 . . . . 0.0 113.288 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.88 77.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.379 1.466 . . . . 0.0 114.686 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -101.03 160.74 14.12 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.996 1.718 . . . . 0.0 110.45 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -93.89 173.14 7.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.985 0.914 . . . . 0.0 109.42 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 89.7 mt -133.0 110.35 10.19 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.214 1.005 . . . . 0.0 109.577 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 106.26 18.24 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.5 132.04 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 122.83 0.452 . . . . 0.0 111.602 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -139.22 169.1 18.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.547 1.939 . . . . 0.0 110.812 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -84.64 130.15 34.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.649 0.779 . . . . 0.0 111.077 169.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -97.97 53.63 1.1 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.75 1.62 . . . . 0.0 111.669 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 85.6 m -83.32 140.5 32.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.442 1.097 . . . . 0.0 112.075 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.27 5.49 51.59 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -174.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.9 m -138.32 168.33 19.97 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.122 1.769 . . . . 0.0 111.872 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -145.48 163.99 32.96 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.459 1.504 . . . . 0.0 112.086 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 74.1 m -145.26 158.63 43.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.839 1.656 . . . . 0.0 111.45 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 93.7 mt -104.85 124.05 48.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.798 1.239 . . . . 0.0 110.745 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 12.0 m -85.38 -19.19 31.77 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.111 1.364 . . . . 0.0 112.606 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 42.4 p -128.37 139.86 52.16 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.478 1.511 . . . . 0.0 112.086 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -170.02 86.49 0.09 OUTLIER Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.391 -1.227 . . . . 0.0 112.712 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.99 152.83 32.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.842 3.028 . . . . 0.0 111.587 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.7 m -149.68 130.9 14.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.034 1.334 . . . . 0.0 110.752 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 52.0 p 67.49 -0.71 1.79 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 127.601 2.36 . . . . 0.0 116.244 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 C-N-CA 125.624 1.583 . . . . 0.0 113.062 179.848 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -95.32 124.89 39.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.588 1.555 . . . . 0.0 111.253 -171.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.5 mt -109.03 134.82 51.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.241 1.817 . . . . 0.0 110.328 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -89.56 137.85 31.97 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 127.092 2.157 . . . . 0.0 107.717 169.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.41 111.07 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.841 0.856 . . . . 0.0 109.153 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.8 172.26 15.72 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.626 1.584 . . . . 0.0 113.097 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.6 m120 61.74 30.63 18.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.005 1.322 . . . . 0.0 111.807 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.54 140.66 96.63 Favored Pre-proline 0 CA--C 1.546 0.82 0 O-C-N 121.459 -0.776 . . . . 0.0 111.21 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.2 161.59 39.64 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.225 2.617 . . . . 0.0 111.165 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.87 -7.2 18.2 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.396 2.731 . . . . 0.0 112.676 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -102.87 11.47 37.43 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.797 2.039 . . . . 0.0 112.701 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.04 147.23 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 120.863 -1.148 . . . . 0.0 110.894 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.5 p -133.19 167.16 20.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.045 1.738 . . . . 0.0 109.671 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.55 -32.74 67.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.106 0.562 . . . . 0.0 111.488 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.52 -38.05 59.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.146 0.978 . . . . 0.0 112.473 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -63.95 -42.85 97.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.872 0.76 . . . . 0.0 110.659 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.8 ttt -68.99 -37.32 78.68 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.321 0.649 . . . . 0.0 112.127 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -62.68 -42.83 99.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.721 0.808 . . . . 0.0 111.225 171.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.92 -42.55 85.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.116 0.967 . . . . 0.0 113.212 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.6 mt -56.74 -25.02 53.79 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.74 1.216 . . . . 0.0 113.315 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -110.44 5.7 21.59 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.229 1.412 . . . . 0.0 113.464 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -67.33 -21.5 65.65 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.127 -0.983 . . . . 0.0 113.371 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -22.9 67.11 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.11 1.364 . . . . 0.0 112.388 172.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -105.67 7.26 32.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.568 1.947 . . . . 0.0 112.465 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.31 177.26 51.78 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.207 1.384 . . . . 0.0 113.069 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -71.37 130.08 40.44 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.805 -0.821 . . . . 0.0 111.347 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.21 153.4 42.49 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.351 1.06 . . . . 0.0 112.211 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.24 -17.29 67.18 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.816 1.198 . . . . 0.0 113.537 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -154.48 146.03 23.18 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.736 1.214 . . . . 0.0 110.809 170.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.2 t -145.22 126.47 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 126.456 1.902 . . . . 0.0 109.247 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -141.8 144.1 33.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.05 1.34 . . . . 0.0 112.316 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.3 mt -140.67 133.83 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 126.142 1.777 . . . . 0.0 108.483 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -124.88 107.49 10.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.954 0.902 . . . . 0.0 112.043 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -72.14 -27.24 62.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -171.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.67 -11.68 60.49 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.897 0.879 . . . . 0.0 113.27 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -114.8 -31.34 6.16 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.942 1.297 . . . . 0.0 113.204 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.5 29.34 19.42 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.744 1.164 . . . . 0.0 113.985 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -138.74 155.38 48.26 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.317 1.447 . . . . 0.0 112.022 -173.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.06 170.82 25.19 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.198 1.38 . . . . 0.0 113.49 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -144.78 144.03 30.96 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.197 1.799 . . . . 0.0 109.412 -173.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.1 tt -153.83 134.99 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.522 0.729 . . . . 0.0 110.6 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -125.79 117.99 24.58 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.898 0.879 . . . . 0.0 110.04 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.92 178.65 5.59 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.765 0.826 . . . . 0.0 111.965 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -80.85 -27.32 36.49 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.1 p -144.19 158.07 43.94 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.366 1.066 . . . . 0.0 111.792 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -57.44 -37.82 73.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.935 0.894 . . . . 0.0 112.404 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.0 m -62.06 -47.42 84.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.189 1.396 . . . . 0.0 110.794 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.03 -42.98 99.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.11 0.564 . . . . 0.0 111.305 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.53 -35.94 80.05 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.59 -47.74 71.77 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.2 1.0 . . . . 0.0 111.347 173.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.47 -47.63 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.715 -0.615 . . . . 0.0 110.14 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.06 -45.52 86.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.71 0.804 . . . . 0.0 112.249 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -55.58 -50.6 69.65 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.206 -0.934 . . . . 0.0 111.697 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.1 t -65.47 -34.01 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.762 0.71 . . . . 0.0 112.29 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -82.75 -32.69 27.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 61.0 mt -105.48 -20.42 13.48 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.275 1.584 . . . . 0.0 115.275 -168.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -70.5 128.61 36.73 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.514 1.052 . . . . 0.0 111.421 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 58.0 t30 69.02 13.73 8.79 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.394 2.278 . . . . 0.0 114.186 -171.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.5 ttp -72.48 138.65 80.85 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 120.569 -1.332 . . . . 0.0 110.894 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -74.37 134.31 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.448 2.766 . . . . 0.0 111.153 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 45.1 tp -143.22 115.99 8.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.49 1.516 . . . . 0.0 110.172 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 57.57 21.74 7.45 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.241 1.416 . . . . 0.0 113.471 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.28 -3.02 68.94 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.925 1.726 . . . . 0.0 115.083 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -97.08 156.15 16.5 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.723 1.609 . . . . 0.0 110.959 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -105.58 117.09 33.14 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.265 -0.897 . . . . 0.0 109.366 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.3 mt -72.71 136.01 45.48 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.96 0.904 . . . . 0.0 112.226 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.0 tpp180 -99.77 124.29 44.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.619 1.168 . . . . 0.0 108.767 169.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.74 128.06 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.985 0.914 . . . . 0.0 109.75 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -150.7 160.16 44.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.863 1.265 . . . . 0.0 111.192 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -68.69 132.61 47.14 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.721 -0.612 . . . . 0.0 110.356 170.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.183 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -83.27 129.01 34.98 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.335 1.454 . . . . 0.0 110.468 -176.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.4 mt -113.98 134.38 54.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.146 1.778 . . . . 0.0 110.056 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -89.26 137.4 32.36 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.141 2.176 . . . . 0.0 108.529 170.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -130.06 109.93 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.126 0.97 . . . . 0.0 109.415 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.1 173.8 20.11 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.21 1.862 . . . . 0.0 113.328 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.1 m120 64.0 19.59 11.82 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.951 1.701 . . . . 0.0 113.276 -173.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.67 140.63 92.78 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.067 -1.021 . . . . 0.0 112.778 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -69.44 157.35 61.34 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.856 3.037 . . . . 0.0 110.991 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.66 -5.47 17.12 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.26 2.64 . . . . 0.0 113.164 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -104.38 9.74 35.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.338 1.855 . . . . 0.0 113.321 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.2 tp -82.04 144.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.091 -1.006 . . . . 0.0 111.016 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.9 p -135.12 166.57 22.76 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.492 1.917 . . . . 0.0 109.303 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -60.73 -27.34 67.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.859 0.464 . . . . 0.0 112.012 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -72.9 -40.0 65.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.983 0.913 . . . . 0.0 111.773 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -65.42 -42.3 92.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.409 0.55 . . . . 0.0 111.004 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.3 ttt -69.12 -36.76 77.86 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.621 0.768 . . . . 0.0 112.221 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -61.62 -46.61 89.07 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.742 0.817 . . . . 0.0 110.79 169.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -66.38 -39.8 89.31 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.0 mt -59.62 -22.85 62.42 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.074 1.35 . . . . 0.0 113.694 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -116.09 7.83 14.33 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.437 1.495 . . . . 0.0 112.569 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -68.72 -22.0 64.37 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -169.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -67.13 -22.28 65.8 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.286 -0.883 . . . . 0.0 112.207 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -93.92 10.8 31.88 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.414 1.886 . . . . 0.0 112.589 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.48 -175.94 53.55 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.334 1.445 . . . . 0.0 113.189 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -72.1 128.92 37.2 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.992 -0.71 . . . . 0.0 111.186 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.35 147.08 48.37 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.959 0.904 . . . . 0.0 111.673 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.05 -1.28 82.25 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.831 1.205 . . . . 0.0 113.819 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -162.76 128.63 3.34 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.496 1.918 . . . . 0.0 108.18 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.71 123.32 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.745 1.218 . . . . 0.0 108.917 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -141.22 137.79 32.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.976 1.311 . . . . 0.0 110.927 176.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.7 mt -137.76 126.77 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.42 1.488 . . . . 0.0 108.359 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -118.32 108.42 15.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.281 1.033 . . . . 0.0 112.02 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -71.62 -30.6 65.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.019 0.928 . . . . 0.0 113.285 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.78 -20.22 61.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.049 0.94 . . . . 0.0 113.454 -176.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -112.83 -24.47 9.55 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.54 38.15 7.76 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 124.76 1.172 . . . . 0.0 114.154 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -140.62 152.99 45.87 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.16 1.384 . . . . 0.0 112.122 -173.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.37 161.48 24.97 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.029 1.3 . . . . 0.0 113.553 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.45 138.11 34.43 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.486 1.914 . . . . 0.0 109.476 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.4 tt -147.81 135.13 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 110.713 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -118.71 123.52 45.08 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.543 0.737 . . . . 0.0 110.749 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.64 170.33 9.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.711 0.804 . . . . 0.0 110.887 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.43 -22.27 51.74 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.8 p -146.26 144.05 29.6 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.747 1.219 . . . . 0.0 111.951 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.416 ' HD2' ' H ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -60.43 -32.53 71.45 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 m -63.92 -48.15 77.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.578 1.151 . . . . 0.0 110.756 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.18 -35.77 82.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.844 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.17 86.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.033 0.833 . . . . 0.0 112.736 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.09 -47.39 71.36 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.176 0.898 . . . . 0.0 111.812 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.9 mt -60.08 -50.12 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.778 -0.576 . . . . 0.0 110.044 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.02 -43.55 91.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.626 0.77 . . . . 0.0 111.87 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -57.24 -47.91 80.16 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.076 0.853 . . . . 0.0 111.586 174.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 78.6 t -71.09 -34.94 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 118.802 0.728 . . . . 0.0 112.176 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -82.79 -28.86 30.0 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 55.5 mt -99.31 -16.25 18.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.165 0.986 . . . . 0.0 113.374 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.96 116.6 2.84 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.022 1.729 . . . . 0.0 111.885 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.0 m120 64.32 19.47 11.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.138 2.175 . . . . 0.0 114.286 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.9 ttp -70.5 137.12 86.04 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 120.703 -1.248 . . . . 0.0 110.858 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.27 139.28 23.42 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.356 2.704 . . . . 0.0 111.437 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.9 tp -142.08 115.2 8.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.684 1.594 . . . . 0.0 109.801 173.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 57.18 25.22 10.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.931 1.292 . . . . 0.0 113.768 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.54 -3.67 83.64 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.542 1.544 . . . . 0.0 114.706 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -95.66 161.39 14.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.551 1.54 . . . . 0.0 111.047 172.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -88.24 176.05 7.41 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.79 169.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.0 mt -134.51 115.07 13.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.525 1.13 . . . . 0.0 109.704 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -91.97 115.91 28.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.629 0.771 . . . . 0.0 109.064 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.4 t -119.6 123.31 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.904 0.882 . . . . 0.0 110.503 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -139.94 164.61 29.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.029 1.732 . . . . 0.0 111.387 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -79.04 126.84 31.23 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.532 -0.73 . . . . 0.0 111.051 169.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 125.74 1.616 . . . . 0.0 110.603 176.068 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.7 p . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -95.11 128.27 41.81 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.829 1.652 . . . . 0.0 111.257 -169.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -111.18 137.98 48.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.381 1.872 . . . . 0.0 110.474 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -92.47 136.3 33.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.371 2.268 . . . . 0.0 108.596 169.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.8 t -128.71 116.06 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.469 1.108 . . . . 0.0 109.024 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.88 165.51 14.03 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 125.013 1.292 . . . . 0.0 114.561 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 64.76 33.1 10.59 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.691 1.596 . . . . 0.0 111.658 -174.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 mt -66.19 143.29 98.28 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 121.143 -0.973 . . . . 0.0 112.144 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.27 163.81 37.34 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.167 3.245 . . . . 0.0 111.506 174.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.0 -7.68 19.39 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.243 2.629 . . . . 0.0 113.195 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -94.87 7.75 44.96 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.725 1.61 . . . . 0.0 113.528 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 tp -97.43 135.95 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.644 1.178 . . . . 0.0 111.398 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.8 p -131.23 179.6 5.92 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.594 1.558 . . . . 0.0 109.235 169.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -57.31 -25.37 59.21 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.712 0.805 . . . . 0.0 112.549 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.45 -47.79 38.77 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.979 -1.076 . . . . 0.0 111.808 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -63.72 -41.54 98.05 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.078 0.551 . . . . 0.0 111.115 174.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.9 ttt -67.78 -33.14 74.24 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -67.56 -40.05 84.92 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.877 0.762 . . . . 0.0 111.447 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.8 -42.42 81.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.9 0.88 . . . . 0.0 112.683 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.7 mt -57.4 -28.18 63.01 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.404 1.482 . . . . 0.0 113.526 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -110.49 9.18 23.27 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.339 1.456 . . . . 0.0 112.677 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.29 -25.12 67.91 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -62.57 -22.82 66.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.955 1.302 . . . . 0.0 112.987 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -102.88 9.88 38.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.324 1.85 . . . . 0.0 112.644 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.78 -179.05 53.52 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.233 0.921 . . . . 0.0 112.612 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.52 141.28 50.13 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.79 -0.829 . . . . 0.0 112.175 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.41 150.42 27.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.483 1.113 . . . . 0.0 112.133 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.06 -9.42 73.69 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.205 1.384 . . . . 0.0 113.886 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -155.91 137.41 14.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.577 1.951 . . . . 0.0 108.409 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.2 t -143.87 127.24 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.448 1.499 . . . . 0.0 109.174 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -144.9 142.56 29.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.312 1.445 . . . . 0.0 112.201 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 57.4 mt -141.02 131.84 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.455 1.902 . . . . 0.0 108.838 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -125.28 113.17 17.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.094 0.957 . . . . 0.0 111.86 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -72.79 -36.19 67.56 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -170.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.39 -24.6 62.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.741 0.817 . . . . 0.0 113.043 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -100.19 -27.87 13.3 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.237 1.015 . . . . 0.0 113.346 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.81 29.78 19.91 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.798 1.19 . . . . 0.0 114.304 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -137.8 156.59 47.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.245 1.418 . . . . 0.0 112.267 -172.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.28 168.79 26.54 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.215 1.388 . . . . 0.0 113.417 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -142.52 149.68 39.45 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.034 1.733 . . . . 0.0 110.402 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.6 tt -155.31 141.92 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.233 1.013 . . . . 0.0 110.492 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -123.7 123.93 41.61 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.944 0.793 . . . . 0.0 111.308 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.4 mt -95.44 167.43 11.32 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.998 0.919 . . . . 0.0 110.639 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.29 -13.25 61.09 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.2 p -147.32 157.72 43.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.288 1.435 . . . . 0.0 111.684 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -60.12 -32.27 70.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.758 0.823 . . . . 0.0 113.1 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 m -63.97 -48.49 76.25 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.394 1.478 . . . . 0.0 110.506 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.66 -41.45 99.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.136 0.574 . . . . 0.0 111.202 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.63 87.26 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.48 -50.29 70.23 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.306 0.957 . . . . 0.0 111.969 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 83.4 mt -61.31 -47.92 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.752 -0.593 . . . . 0.0 110.289 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.14 95.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.703 0.801 . . . . 0.0 111.998 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.26 -44.57 92.41 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.213 -0.929 . . . . 0.0 112.042 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.2 t -66.72 -36.89 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.268 0.627 . . . . 0.0 111.918 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -85.23 -28.55 25.32 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.5 mt -103.69 -18.84 14.54 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.64 140.83 58.91 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.4 1.0 . . . . 0.0 111.127 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . 0.298 12.0 p30 55.15 18.99 2.62 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.327 2.251 . . . . 0.0 114.966 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.2 ttp -76.29 139.5 68.32 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.092 1.357 . . . . 0.0 111.109 173.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.83 138.88 19.19 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.546 2.831 . . . . 0.0 111.371 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -149.11 122.63 9.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.698 1.599 . . . . 0.0 109.726 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 56.51 32.19 20.33 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.758 1.223 . . . . 0.0 113.235 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.36 4.46 89.96 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.122 1.344 . . . . 0.0 114.637 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.45 156.92 20.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.492 1.917 . . . . 0.0 110.633 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -90.08 167.83 12.45 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.764 -0.585 . . . . 0.0 109.893 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.9 mt -129.77 140.32 51.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.69 1.196 . . . . 0.0 110.857 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -102.93 130.59 50.04 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.868 1.267 . . . . 0.0 108.312 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.39 120.42 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.136 0.88 . . . . 0.0 110.347 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -140.02 167.76 21.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.427 1.891 . . . . 0.0 110.554 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -75.94 134.44 40.22 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.575 -0.703 . . . . 0.0 111.127 169.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.886 0 C-N-CA 124.552 1.141 . . . . 0.0 113.054 172.765 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.64 134.73 34.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.705 1.202 . . . . 0.0 110.483 172.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.1 mt -111.54 133.98 53.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.147 1.379 . . . . 0.0 110.056 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -85.57 144.76 27.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.225 2.21 . . . . 0.0 108.004 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.53 110.02 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.192 0.997 . . . . 0.0 109.185 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.65 169.94 13.69 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.501 1.524 . . . . 0.0 113.249 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 65.47 29.04 11.43 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.381 1.473 . . . . 0.0 111.819 -173.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.8 mt -65.6 144.08 98.81 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.848 -1.157 . . . . 0.0 111.928 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.4 159.39 50.55 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.224 2.616 . . . . 0.0 111.292 174.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.08 -0.47 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.484 2.789 . . . . 0.0 113.299 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -114.38 7.35 16.31 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.732 1.613 . . . . 0.0 113.083 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.9 tp -73.28 145.54 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.789 0.836 . . . . 0.0 111.126 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.8 p -127.7 163.03 25.18 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.654 1.582 . . . . 0.0 110.079 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.98 -28.09 67.39 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.323 0.649 . . . . 0.0 111.687 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.24 -41.94 69.49 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.122 0.969 . . . . 0.0 111.507 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -66.07 -37.56 86.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.84 -0.537 . . . . 0.0 111.494 172.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.9 ttt -68.07 -38.98 83.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.536 0.734 . . . . 0.0 112.064 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -62.39 -37.55 86.17 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.107 0.963 . . . . 0.0 111.939 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -71.52 -42.74 67.59 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.412 -0.805 . . . . 0.0 112.453 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.6 mt -57.94 -27.86 63.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.862 1.265 . . . . 0.0 113.082 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -108.82 11.94 25.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.371 1.469 . . . . 0.0 112.769 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.73 -22.31 66.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.093 -1.004 . . . . 0.0 113.684 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -61.1 -22.79 64.98 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.895 1.278 . . . . 0.0 112.616 171.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -108.39 12.14 26.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.784 2.033 . . . . 0.0 112.375 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.18 -172.36 55.18 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.465 1.031 . . . . 0.0 112.94 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -71.47 133.73 46.06 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.989 0.916 . . . . 0.0 111.026 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.11 150.68 31.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.592 1.157 . . . . 0.0 112.02 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.45 -11.84 74.14 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.614 1.102 . . . . 0.0 114.138 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -159.87 138.77 10.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.065 1.746 . . . . 0.0 109.28 174.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.0 t -139.09 130.92 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.934 1.693 . . . . 0.0 109.222 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -141.59 141.03 33.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.21 1.404 . . . . 0.0 111.443 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.3 mt -140.6 129.34 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.011 1.724 . . . . 0.0 107.929 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -118.15 108.7 15.5 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.721 0.772 . . . . 0.0 112.324 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -72.26 -19.65 61.66 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -81.2 -13.75 58.25 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.192 0.997 . . . . 0.0 112.992 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -117.07 -25.66 7.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.916 1.286 . . . . 0.0 113.987 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.43 27.73 35.18 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 124.482 1.039 . . . . 0.0 114.257 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -134.5 149.96 50.75 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.419 1.488 . . . . 0.0 111.616 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.67 166.87 25.23 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.38 1.467 . . . . 0.0 113.134 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -146.19 143.28 29.17 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.342 1.857 . . . . 0.0 109.745 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.1 tt -150.95 133.39 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.078 0.951 . . . . 0.0 110.974 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -112.88 122.12 46.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.172 0.989 . . . . 0.0 110.541 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.27 163.48 12.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.688 0.795 . . . . 0.0 111.063 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.6 -23.77 53.45 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -171.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.5 p -148.71 143.6 26.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.402 1.481 . . . . 0.0 111.642 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -58.95 -32.92 70.06 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.7 m -59.43 -48.59 81.06 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.987 1.315 . . . . 0.0 111.032 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.07 -37.9 89.11 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.388 0.675 . . . . 0.0 111.817 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.51 -33.62 73.1 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.2 -46.78 72.88 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.831 0.852 . . . . 0.0 111.545 171.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.75 -47.46 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.72 -0.613 . . . . 0.0 110.061 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.96 -45.18 91.15 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.899 0.88 . . . . 0.0 112.218 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -55.47 -50.55 69.58 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.076 -1.015 . . . . 0.0 111.66 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.62 -34.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.695 0.68 . . . . 0.0 112.287 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -82.37 -32.89 29.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.8 mt -105.91 -19.57 13.7 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -168.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -71.97 127.46 32.63 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.696 1.135 . . . . 0.0 111.235 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 71.49 12.37 6.53 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.843 2.457 . . . . 0.0 113.736 -169.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.6 ttp -72.63 134.35 81.91 Favored Pre-proline 0 N--CA 1.473 0.691 0 O-C-N 120.574 -1.329 . . . . 0.0 110.767 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.61 132.29 15.8 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.065 2.51 . . . . 0.0 110.801 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 tp -137.29 104.76 5.49 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.514 1.126 . . . . 0.0 110.235 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.5 mtp-105 58.93 26.42 14.93 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.043 1.337 . . . . 0.0 113.691 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.94 -12.53 60.74 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.112 1.815 . . . . 0.0 114.576 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -82.09 163.86 21.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.578 1.189 . . . . 0.0 111.512 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -128.98 105.52 8.26 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.816 1.247 . . . . 0.0 108.878 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.81 125.13 25.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.008 1.323 . . . . 0.0 112.749 -168.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -93.06 118.02 30.72 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.264 1.025 . . . . 0.0 109.313 173.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.32 126.23 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.068 0.947 . . . . 0.0 109.943 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -143.33 159.73 41.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.753 1.621 . . . . 0.0 110.475 -173.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -81.31 124.62 29.5 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.504 -0.747 . . . . 0.0 110.792 170.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.823 0 C-N-CA 124.149 0.98 . . . . 0.0 111.231 174.899 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -76.91 128.82 35.26 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.092 1.357 . . . . 0.0 111.848 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.5 mt -105.26 141.58 36.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.574 1.95 . . . . 0.0 110.437 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -96.94 143.68 27.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.526 2.33 . . . . 0.0 108.474 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.2 t -132.56 115.89 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.184 0.994 . . . . 0.0 109.782 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.98 173.26 16.5 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 125.912 1.72 . . . . 0.0 113.226 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m120 64.95 20.47 12.12 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.956 1.702 . . . . 0.0 113.093 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.9 mt -61.6 140.75 95.05 Favored Pre-proline 0 CA--C 1.549 0.936 0 O-C-N 121.198 -0.939 . . . . 0.0 112.319 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.41 164.4 35.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.369 3.38 . . . . 0.0 111.898 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.88 5.8 4.19 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.837 3.024 . . . . 0.0 113.691 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.3 p30 -128.15 13.9 6.71 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.969 1.708 . . . . 0.0 114.042 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.8 tp -80.12 143.63 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.123 0.969 . . . . 0.0 110.423 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.3 p -132.8 167.25 20.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.126 1.77 . . . . 0.0 109.677 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.67 -28.47 68.63 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.641 0.376 . . . . 0.0 111.82 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -70.43 -45.56 65.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.346 1.058 . . . . 0.0 110.975 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -65.2 -38.66 91.16 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.719 -0.613 . . . . 0.0 111.695 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.6 ttt -69.44 -38.2 77.73 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.646 0.657 . . . . 0.0 111.98 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -63.66 -37.22 86.5 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.435 -0.791 . . . . 0.0 111.992 170.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.3 -43.1 64.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.087 0.955 . . . . 0.0 111.872 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.6 mt -57.02 -28.85 62.86 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.058 1.343 . . . . 0.0 113.343 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -105.45 8.17 33.4 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.311 1.444 . . . . 0.0 112.693 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.09 -25.74 67.92 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -169.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -64.41 -21.54 66.67 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.696 0.798 . . . . 0.0 112.724 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -102.96 6.33 38.85 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.096 1.758 . . . . 0.0 112.097 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.13 173.7 46.26 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.174 1.369 . . . . 0.0 112.587 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -67.18 136.04 54.43 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.497 -1.001 . . . . 0.0 111.317 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.08 157.24 37.22 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.927 0.891 . . . . 0.0 112.071 173.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.06 -12.07 62.37 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.048 1.308 . . . . 0.0 113.753 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -152.77 137.09 16.61 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.901 1.68 . . . . 0.0 109.28 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.0 127.81 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.06 1.744 . . . . 0.0 108.853 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -143.96 140.48 29.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.836 1.254 . . . . 0.0 111.454 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.7 mt -139.85 129.4 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.859 1.664 . . . . 0.0 108.276 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -122.23 112.95 18.79 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.841 0.857 . . . . 0.0 112.56 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -70.5 -35.19 73.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 113.613 -173.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.23 -23.66 61.27 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.805 0.842 . . . . 0.0 113.044 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -103.3 -26.48 12.93 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.23 35.68 14.34 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 124.876 1.227 . . . . 0.0 114.115 175.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -140.64 153.16 45.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.21 1.404 . . . . 0.0 112.366 -172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.06 158.14 22.99 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.359 1.456 . . . . 0.0 113.092 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -138.67 137.84 37.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.83 2.052 . . . . 0.0 109.012 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.3 tt -151.81 130.39 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.535 0.734 . . . . 0.0 110.971 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -119.15 113.56 21.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.948 0.899 . . . . 0.0 110.409 -170.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.0 mt -90.73 166.07 13.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.641 0.777 . . . . 0.0 111.124 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -78.56 -17.95 55.36 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.0 p -144.04 157.32 44.4 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.773 1.229 . . . . 0.0 111.616 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -59.6 -40.33 87.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.789 0.835 . . . . 0.0 111.429 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.7 m -58.88 -47.53 84.62 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.011 1.325 . . . . 0.0 111.212 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.3 -42.9 99.08 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.265 0.626 . . . . 0.0 111.179 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.03 -36.27 83.84 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.03 -46.5 71.03 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.888 0.875 . . . . 0.0 111.697 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.95 -47.96 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.633 -0.667 . . . . 0.0 110.102 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.76 -44.35 93.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.423 0.689 . . . . 0.0 112.104 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -54.57 -52.58 61.66 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.258 0.935 . . . . 0.0 111.507 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.29 -34.3 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.382 0.537 . . . . 0.0 111.961 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -81.03 -36.05 31.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.5 -21.78 17.5 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -170.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.31 127.24 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.02 0.827 . . . . 0.0 111.276 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 71.2 11.75 6.82 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.28 2.232 . . . . 0.0 113.786 -173.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.9 ttp -74.33 137.34 75.02 Favored Pre-proline 0 N--CA 1.475 0.796 0 O-C-N 120.549 -1.344 . . . . 0.0 110.893 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.67 141.07 24.37 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.256 2.637 . . . . 0.0 111.191 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.6 tp -137.04 104.25 5.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.512 1.525 . . . . 0.0 110.059 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 59.03 22.56 10.6 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.594 1.558 . . . . 0.0 114.256 172.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.37 -9.97 49.9 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.994 1.759 . . . . 0.0 114.788 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -94.27 166.44 12.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.796 1.298 . . . . 0.0 111.254 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -96.62 176.18 6.11 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.089 0.956 . . . . 0.0 110.401 169.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.8 mt -135.7 116.66 14.22 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.608 1.163 . . . . 0.0 109.723 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -95.77 111.09 23.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.734 0.814 . . . . 0.0 108.955 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.81 130.51 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.127 0.971 . . . . 0.0 109.54 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -150.99 163.76 37.98 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.401 1.48 . . . . 0.0 111.077 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -72.67 137.76 46.23 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.535 -0.728 . . . . 0.0 110.83 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.829 0 C-N-CA 124.979 1.312 . . . . 0.0 113.084 177.001 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -80.97 123.33 28.24 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.367 1.467 . . . . 0.0 111.015 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -115.07 140.78 48.78 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.829 1.652 . . . . 0.0 110.795 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -95.92 140.17 31.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.257 2.223 . . . . 0.0 108.669 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.52 108.38 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.301 1.04 . . . . 0.0 109.31 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.06 171.63 19.93 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.337 1.446 . . . . 0.0 112.873 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.0 m120 62.09 31.15 17.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.007 1.323 . . . . 0.0 111.923 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.9 mt -66.67 143.32 98.06 Favored Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 121.457 -0.777 . . . . 0.0 111.395 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.35 162.06 40.44 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.193 2.595 . . . . 0.0 111.158 170.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.99 -7.61 18.37 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.249 2.633 . . . . 0.0 112.413 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -96.14 6.95 47.68 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.559 1.944 . . . . 0.0 113.332 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -81.97 146.56 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.211 -0.931 . . . . 0.0 111.029 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.7 p -134.0 166.34 22.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.073 1.749 . . . . 0.0 109.351 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -61.58 -25.54 67.39 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.13 -40.8 59.47 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.164 0.986 . . . . 0.0 111.67 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -64.38 -41.97 96.41 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.494 0.588 . . . . 0.0 110.637 171.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.3 ttt -68.43 -36.55 79.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.534 0.734 . . . . 0.0 112.394 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -62.51 -41.55 98.92 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.716 0.689 . . . . 0.0 111.567 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -71.43 -39.75 70.85 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.976 0.807 . . . . 0.0 112.919 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -57.65 -22.59 46.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.148 1.379 . . . . 0.0 113.581 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -114.57 11.45 17.04 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.752 1.621 . . . . 0.0 112.616 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.4 -23.38 67.27 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -63.33 -23.33 67.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.177 1.391 . . . . 0.0 112.989 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -106.56 9.83 31.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.048 1.739 . . . . 0.0 112.598 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.44 -175.45 50.99 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.026 1.298 . . . . 0.0 113.121 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -73.77 128.48 35.63 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.094 -0.651 . . . . 0.0 110.944 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.05 143.34 47.52 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.239 1.015 . . . . 0.0 111.562 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.22 -11.9 82.94 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.973 0.797 . . . . 0.0 113.936 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -158.71 138.03 11.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.095 1.758 . . . . 0.0 109.389 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.56 127.39 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.873 1.669 . . . . 0.0 108.534 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -144.79 143.84 30.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.843 1.257 . . . . 0.0 112.018 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.1 mt -140.77 132.79 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.144 1.777 . . . . 0.0 108.687 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -125.59 104.95 8.67 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.936 0.895 . . . . 0.0 112.066 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.08 -23.97 60.6 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -172.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -72.92 -14.22 61.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.24 1.016 . . . . 0.0 113.339 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -117.22 -19.87 9.46 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.958 1.303 . . . . 0.0 114.005 173.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.2 26.45 40.3 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 124.826 1.203 . . . . 0.0 114.213 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -130.87 145.98 52.16 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.013 1.325 . . . . 0.0 112.196 -172.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.05 162.38 24.24 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.691 1.615 . . . . 0.0 112.576 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -143.19 136.47 28.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.485 1.914 . . . . 0.0 108.632 -170.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.2 tt -149.23 143.36 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.455 0.702 . . . . 0.0 111.099 -175.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.2 112.68 17.97 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.976 1.31 . . . . 0.0 110.135 -172.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.0 mt -89.67 175.76 7.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.389 0.54 . . . . 0.0 111.726 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.23 -26.43 58.91 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.3 p -144.54 159.27 43.06 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.684 1.193 . . . . 0.0 111.95 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -60.59 -33.64 73.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.804 0.842 . . . . 0.0 112.357 170.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.8 m -67.2 -45.88 75.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.461 1.504 . . . . 0.0 111.024 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.7 mt -61.19 -39.88 91.83 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.182 0.593 . . . . 0.0 111.131 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.84 -35.69 77.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -60.93 -51.56 68.75 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.398 0.999 . . . . 0.0 110.882 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.33 -49.09 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.3 0.64 . . . . 0.0 110.565 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.46 86.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.517 0.727 . . . . 0.0 111.819 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.44 -45.29 91.98 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.272 -0.892 . . . . 0.0 111.748 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.12 -33.27 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.837 0.855 . . . . 0.0 112.31 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -86.12 -24.66 26.14 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.9 mt -107.03 -16.95 14.31 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -170.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.81 134.2 52.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.204 1.365 . . . . 0.0 112.074 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.2 t30 65.57 14.31 9.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.901 2.08 . . . . 0.0 113.845 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.1 ttp -72.77 135.84 80.63 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 120.56 -1.337 . . . . 0.0 110.559 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.71 131.8 13.86 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.488 2.792 . . . . 0.0 110.869 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.9 tp -143.47 115.44 8.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.151 1.38 . . . . 0.0 109.55 174.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 53.55 35.51 21.06 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.789 1.236 . . . . 0.0 112.951 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.7 1.84 89.94 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.556 1.55 . . . . 0.0 115.204 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -105.91 149.5 26.51 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.762 1.625 . . . . 0.0 110.854 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -104.44 110.85 23.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.029 0.932 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 82.1 mt -72.23 125.69 27.94 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.874 0.87 . . . . 0.0 112.513 -169.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.17 105.97 18.2 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.979 0.912 . . . . 0.0 109.04 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.7 t -114.66 131.39 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.023 0.929 . . . . 0.0 110.123 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -153.37 169.27 23.52 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.569 1.548 . . . . 0.0 111.218 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -70.62 138.88 51.15 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.519 -0.738 . . . . 0.0 111.572 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.542 0 C-N-CA 123.96 0.904 . . . . 0.0 108.835 171.424 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -89.78 125.65 35.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.867 1.267 . . . . 0.0 112.057 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.31 146.45 35.7 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.859 2.063 . . . . 0.0 110.988 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -97.62 143.12 28.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.985 2.514 . . . . 0.0 108.658 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.1 t -135.38 112.99 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.148 0.979 . . . . 0.0 109.861 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -111.29 174.41 16.75 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 125.748 1.642 . . . . 0.0 113.498 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 m120 64.93 20.92 12.24 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.988 1.715 . . . . 0.0 113.161 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.17 142.7 95.6 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 121.206 -0.934 . . . . 0.0 112.21 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.77 163.71 38.04 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.207 3.271 . . . . 0.0 111.9 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.39 5.84 2.57 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 123.715 2.943 . . . . 0.0 113.557 171.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -124.15 12.13 8.89 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.168 1.787 . . . . 0.0 113.486 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.1 tp -82.06 145.28 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 120.911 -1.118 . . . . 0.0 110.828 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 31.5 p -133.2 168.27 18.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.198 1.799 . . . . 0.0 109.623 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.11 -31.61 70.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.818 0.447 . . . . 0.0 111.824 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.08 -40.41 65.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.092 0.957 . . . . 0.0 111.709 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -66.2 -38.43 87.94 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.568 0.622 . . . . 0.0 111.31 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 6.0 ttt -68.74 -36.1 77.95 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.612 -0.68 . . . . 0.0 112.201 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -64.52 -40.23 95.23 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.692 0.797 . . . . 0.0 111.688 169.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -68.81 -41.85 78.06 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.305 1.042 . . . . 0.0 112.699 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.13 -24.36 62.93 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.435 1.494 . . . . 0.0 113.596 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -112.42 11.47 19.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.503 1.521 . . . . 0.0 112.654 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.44 -21.66 66.68 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -171.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -62.69 -24.57 67.72 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.253 1.021 . . . . 0.0 112.517 172.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -104.11 14.02 31.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.528 1.931 . . . . 0.0 112.307 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.53 -173.64 54.83 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.386 0.993 . . . . 0.0 112.176 -173.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -71.54 147.25 47.88 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.66 -0.906 . . . . 0.0 111.88 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.95 147.13 37.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.495 0.718 . . . . 0.0 111.577 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.27 -17.39 66.92 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.062 1.315 . . . . 0.0 113.553 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -157.94 147.76 20.09 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.318 1.447 . . . . 0.0 110.645 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -142.31 129.07 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 126.992 2.117 . . . . 0.0 109.643 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -140.99 138.64 33.88 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.03 1.332 . . . . 0.0 111.387 171.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 61.6 mt -138.84 124.58 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.59 1.556 . . . . 0.0 108.211 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -121.36 102.19 8.12 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.075 0.94 . . . . 0.0 112.379 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.33 -18.77 61.74 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -77.53 -14.54 59.64 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.282 1.033 . . . . 0.0 112.96 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -116.78 -27.14 6.72 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.83 1.252 . . . . 0.0 113.498 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.4 27.19 23.39 Favored Glycine 0 N--CA 1.476 1.342 0 C-N-CA 124.896 1.236 . . . . 0.0 114.078 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -137.04 154.37 50.39 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.354 1.462 . . . . 0.0 111.822 -173.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.79 170.13 25.34 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.501 1.524 . . . . 0.0 113.038 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -143.83 148.72 35.93 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.312 1.845 . . . . 0.0 109.874 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 tt -153.87 137.75 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.786 0.834 . . . . 0.0 110.317 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -115.59 125.37 52.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.791 0.836 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -96.01 170.03 9.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.998 0.519 . . . . 0.0 111.438 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -72.74 -26.6 61.62 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.4 p -142.64 155.9 45.0 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.137 1.375 . . . . 0.0 110.931 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -69.38 -27.46 65.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.911 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.8 m -62.32 -47.49 84.04 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.955 1.302 . . . . 0.0 110.54 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.55 -39.01 93.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.946 -0.55 . . . . 0.0 111.427 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.99 89.43 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -64.59 -50.38 67.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.315 0.961 . . . . 0.0 111.226 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.06 -49.42 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 122.891 0.476 . . . . 0.0 110.25 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.28 -46.1 89.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.497 0.719 . . . . 0.0 111.979 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.53 -43.4 93.47 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.182 -0.949 . . . . 0.0 111.802 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.35 -32.93 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.932 0.893 . . . . 0.0 112.388 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -88.8 -24.5 22.58 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.1 mt -102.92 -18.12 15.19 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.43 131.21 45.85 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.944 1.247 . . . . 0.0 111.739 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.0 t30 65.07 17.26 10.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.517 1.927 . . . . 0.0 113.834 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.5 ttp -72.83 134.76 81.14 Favored Pre-proline 0 CA--C 1.544 0.718 0 O-C-N 120.609 -1.307 . . . . 0.0 110.223 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.52 138.79 19.85 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.159 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.0 tp -138.07 105.85 5.63 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.504 1.522 . . . . 0.0 109.821 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 55.57 27.53 10.54 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.491 1.516 . . . . 0.0 113.798 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.49 -8.46 69.0 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.729 1.633 . . . . 0.0 114.812 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -89.08 155.92 19.16 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.868 1.334 . . . . 0.0 110.653 170.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.53 172.16 9.97 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.643 0.777 . . . . 0.0 109.814 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.0 mt -132.57 117.41 17.92 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 110.364 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -92.87 113.68 26.02 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.833 0.853 . . . . 0.0 109.188 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.9 t -123.55 126.02 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.882 0.873 . . . . 0.0 110.141 -174.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -149.44 168.74 22.59 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.52 1.528 . . . . 0.0 111.661 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -78.54 136.98 37.68 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.352 0.661 . . . . 0.0 111.671 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 125.351 1.46 . . . . 0.0 112.553 172.736 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 m . . . . . 0 CA--C 1.548 0.882 0 CA-C-O 121.728 0.775 . . . . 0.0 112.315 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -99.13 132.36 44.49 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.315 1.846 . . . . 0.0 111.739 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -117.78 143.94 45.79 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.67 1.588 . . . . 0.0 111.352 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -102.6 139.41 38.23 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.178 2.591 . . . . 0.0 108.441 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.76 116.71 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.306 1.043 . . . . 0.0 108.978 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.89 167.81 13.19 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.31 1.433 . . . . 0.0 114.053 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.66 31.51 9.77 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.504 1.522 . . . . 0.0 111.836 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.5 mt -66.21 143.64 98.42 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.969 0.908 . . . . 0.0 112.432 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -69.6 159.44 53.51 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.166 2.578 . . . . 0.0 111.271 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.44 -9.12 23.74 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.414 2.742 . . . . 0.0 113.275 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -94.41 5.33 52.12 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.709 1.604 . . . . 0.0 113.461 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.3 tp -86.78 137.59 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 121.051 -1.03 . . . . 0.0 111.65 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.0 p -133.74 176.98 8.07 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.593 1.557 . . . . 0.0 108.786 168.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.31 -21.74 62.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.44 0.696 . . . . 0.0 112.548 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -73.68 -47.82 36.89 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.125 0.875 . . . . 0.0 111.249 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -63.04 -42.56 99.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.144 0.578 . . . . 0.0 110.874 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.5 ttt -66.12 -33.86 76.75 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -69.35 -36.27 76.71 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.14 0.882 . . . . 0.0 112.336 170.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -44.14 67.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.117 0.967 . . . . 0.0 111.344 178.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.4 mt -56.33 -28.14 57.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.68 1.592 . . . . 0.0 113.343 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.84 10.54 26.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.406 1.483 . . . . 0.0 112.93 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.81 -23.03 66.61 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -170.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -62.88 -23.3 67.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.445 1.098 . . . . 0.0 112.375 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.64 12.97 30.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.589 1.956 . . . . 0.0 112.2 -175.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.08 -171.06 54.98 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.76 1.171 . . . . 0.0 112.488 -176.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -71.45 142.07 50.24 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.746 -0.855 . . . . 0.0 111.723 172.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.14 148.23 32.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.779 0.831 . . . . 0.0 111.302 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.51 -11.39 71.71 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.918 1.247 . . . . 0.0 113.962 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -158.83 137.94 11.37 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.454 1.902 . . . . 0.0 108.607 173.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.7 t -140.05 128.65 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.311 1.444 . . . . 0.0 109.055 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -143.03 139.42 30.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.92 1.288 . . . . 0.0 111.796 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.2 mt -140.45 128.23 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.375 1.87 . . . . 0.0 107.702 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -125.46 112.54 16.38 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.659 0.742 . . . . 0.0 112.864 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -75.92 -20.13 58.25 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -171.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.86 -21.21 51.74 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.87 0.868 . . . . 0.0 112.515 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -104.31 -32.58 9.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.816 1.247 . . . . 0.0 113.143 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.28 29.01 26.19 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 124.641 1.115 . . . . 0.0 113.857 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -140.92 156.47 46.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.671 1.588 . . . . 0.0 111.767 -171.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.95 166.52 27.03 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.085 1.326 . . . . 0.0 113.507 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -142.48 147.6 36.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.475 1.91 . . . . 0.0 109.806 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.9 tt -154.3 132.21 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.912 0.885 . . . . 0.0 110.738 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 -107.81 125.66 51.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.765 0.826 . . . . 0.0 110.074 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.6 mt -97.87 164.56 12.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.465 0.706 . . . . 0.0 109.684 173.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -82.58 -11.58 58.32 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 65.9 p -148.47 146.72 28.51 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.172 1.389 . . . . 0.0 111.741 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.57 -33.09 69.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.466 1.106 . . . . 0.0 113.592 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 m -68.24 -46.86 69.34 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.756 1.222 . . . . 0.0 110.573 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.38 -37.02 85.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.76 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.21 93.46 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.046 0.839 . . . . 0.0 112.718 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.3 -50.88 68.35 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.169 0.988 . . . . 0.0 111.381 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.28 -46.91 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.855 -0.528 . . . . 0.0 110.379 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.68 90.83 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.63 0.772 . . . . 0.0 112.015 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -48.86 78.17 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.258 0.936 . . . . 0.0 111.219 174.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.76 -36.6 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.593 0.757 . . . . 0.0 112.225 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.31 -29.47 34.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.6 mt -106.26 -22.89 12.71 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -169.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.06 130.41 43.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.417 1.008 . . . . 0.0 110.781 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.0 t30 73.86 8.93 4.83 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.38 2.272 . . . . 0.0 114.074 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.3 ttp -76.15 137.35 68.73 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.462 -1.399 . . . . 0.0 111.528 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.67 135.29 15.96 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.449 2.766 . . . . 0.0 111.319 175.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.6 tp -145.89 120.21 9.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.442 1.497 . . . . 0.0 109.848 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 58.3 23.59 10.59 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.813 1.245 . . . . 0.0 113.619 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.42 -2.85 85.22 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.583 1.563 . . . . 0.0 114.593 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -93.61 148.4 22.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.491 1.517 . . . . 0.0 110.936 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -98.56 109.38 22.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.552 1.541 . . . . 0.0 107.182 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.75 147.46 47.3 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.664 0.786 . . . . 0.0 111.693 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 130.88 53.62 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.246 1.418 . . . . 0.0 109.054 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.7 t -134.02 129.23 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.857 0.863 . . . . 0.0 110.855 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -140.18 170.22 16.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.112 1.765 . . . . 0.0 110.387 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -77.61 134.54 38.19 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.502 -0.749 . . . . 0.0 110.373 168.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.584 0 C-N-CA 124.294 1.037 . . . . 0.0 109.432 172.471 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 -86.97 129.44 34.88 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.372 1.469 . . . . 0.0 111.513 -176.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.9 mt -116.54 135.46 53.8 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.25 1.82 . . . . 0.0 110.544 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -89.4 142.48 27.62 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.347 2.259 . . . . 0.0 108.608 171.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.1 103.29 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.06 168.53 15.79 Favored Glycine 0 N--CA 1.464 0.565 0 C-N-CA 125.315 1.436 . . . . 0.0 112.986 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 60.09 32.45 20.99 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.897 1.279 . . . . 0.0 111.969 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.4 mt -63.25 143.37 97.72 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 121.269 -0.894 . . . . 0.0 111.347 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -66.93 158.0 58.81 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.801 2.334 . . . . 0.0 110.655 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.13 -7.32 20.4 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.699 2.933 . . . . 0.0 113.163 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -104.15 5.55 35.09 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.986 1.714 . . . . 0.0 113.264 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -75.18 146.67 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.274 -0.891 . . . . 0.0 111.247 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.5 p -131.73 165.55 23.5 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.961 1.704 . . . . 0.0 109.875 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.16 -32.85 66.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.245 0.618 . . . . 0.0 111.419 172.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -70.09 -36.79 75.15 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.242 1.017 . . . . 0.0 112.294 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -72.1 -36.7 69.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.78 0.718 . . . . 0.0 111.91 173.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.6 ttm -66.52 -38.62 87.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.24 0.927 . . . . 0.0 111.989 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -61.68 -40.44 94.98 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.09 0.956 . . . . 0.0 111.45 170.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -73.35 -41.19 63.76 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.1 mt -56.48 -24.98 49.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.118 1.367 . . . . 0.0 113.389 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -112.38 11.04 19.92 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.536 1.534 . . . . 0.0 112.802 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.97 -22.42 65.92 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -171.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.13 -25.36 67.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.978 0.911 . . . . 0.0 112.343 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.01 11.27 37.53 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.49 1.916 . . . . 0.0 112.672 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.87 -171.03 55.04 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.633 1.111 . . . . 0.0 112.974 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -71.76 134.61 46.31 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.989 -0.712 . . . . 0.0 111.561 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.14 148.86 35.75 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.438 1.095 . . . . 0.0 111.37 174.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.99 -15.34 75.19 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.166 0.888 . . . . 0.0 113.393 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -155.39 145.25 21.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.433 1.093 . . . . 0.0 111.547 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.0 127.9 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.651 1.98 . . . . 0.0 110.057 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -142.3 142.5 32.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.735 1.614 . . . . 0.0 112.006 171.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 68.9 mt -138.15 125.91 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.909 1.683 . . . . 0.0 107.995 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -119.59 102.62 8.76 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.36 1.064 . . . . 0.0 111.776 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -74.11 -24.22 59.43 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.96 -23.11 63.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.307 1.043 . . . . 0.0 113.053 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -109.45 -26.47 9.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.416 1.086 . . . . 0.0 113.488 174.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.69 29.23 13.95 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 124.957 1.265 . . . . 0.0 114.274 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.68 148.47 45.74 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.229 1.412 . . . . 0.0 111.788 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.71 168.9 23.74 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.696 1.617 . . . . 0.0 112.939 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -146.1 140.71 26.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.131 1.772 . . . . 0.0 109.449 -170.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.9 tt -148.7 146.75 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.115 0.966 . . . . 0.0 110.559 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.66 117.3 22.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.487 1.115 . . . . 0.0 109.407 -178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.72 163.56 13.71 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.104 0.562 . . . . 0.0 110.516 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.65 -21.55 59.37 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.5 p -141.69 151.97 43.47 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.383 1.073 . . . . 0.0 112.354 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -57.22 -38.63 74.04 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.733 1.213 . . . . 0.0 112.869 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -63.29 -50.44 70.07 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.814 1.246 . . . . 0.0 110.85 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.85 -38.77 92.08 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.64 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.17 -39.88 94.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.65 -47.87 76.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.206 0.912 . . . . 0.0 111.759 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.5 mt -59.31 -48.49 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.092 0.557 . . . . 0.0 110.262 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.3 94.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.146 0.579 . . . . 0.0 112.322 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -46.29 88.54 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.961 -1.087 . . . . 0.0 111.131 174.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.19 -38.82 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.211 0.605 . . . . 0.0 112.002 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -82.33 -23.58 35.02 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.2 mt -108.63 -22.16 12.38 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.53 133.0 48.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.924 1.238 . . . . 0.0 111.142 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.5 t30 68.64 11.28 8.29 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.565 1.946 . . . . 0.0 113.732 -175.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.1 ttp -75.72 137.61 70.23 Favored Pre-proline 0 CA--C 1.544 0.719 0 O-C-N 120.611 -1.305 . . . . 0.0 110.933 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.46 134.23 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.365 2.71 . . . . 0.0 111.038 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.2 tp -140.14 113.61 8.56 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.28 1.432 . . . . 0.0 109.96 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.88 24.18 7.26 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.163 1.385 . . . . 0.0 113.344 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.27 -5.55 74.94 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.887 1.708 . . . . 0.0 114.771 -176.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -88.66 146.75 24.9 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.242 1.417 . . . . 0.0 110.451 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -92.56 119.56 32.14 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 69.2 mt -78.15 134.64 37.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.398 0.544 . . . . 0.0 111.669 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -99.17 125.25 44.7 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.823 1.249 . . . . 0.0 108.465 169.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.4 t -135.2 126.25 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.3 0.955 . . . . 0.0 110.362 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -146.13 168.98 19.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.159 1.783 . . . . 0.0 110.848 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -77.12 140.07 40.14 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.607 -0.683 . . . . 0.0 111.053 169.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.497 0 C-N-CA 124.877 1.271 . . . . 0.0 111.347 178.168 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.2 p . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -77.45 122.37 25.11 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.746 1.618 . . . . 0.0 110.321 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -103.45 135.47 45.0 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.771 1.628 . . . . 0.0 110.027 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -90.57 137.63 32.2 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.103 2.161 . . . . 0.0 108.549 169.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.1 110.07 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.513 1.125 . . . . 0.0 109.388 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.75 170.8 14.13 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.58 1.562 . . . . 0.0 114.151 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 69.74 20.05 7.0 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.415 1.886 . . . . 0.0 113.006 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -61.72 143.48 93.93 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.823 0.849 . . . . 0.0 112.321 -171.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.03 165.08 33.53 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.405 3.403 . . . . 0.0 111.535 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.18 -3.61 14.09 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.111 2.541 . . . . 0.0 113.162 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -106.92 5.52 28.37 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.231 1.813 . . . . 0.0 113.739 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 tp -82.25 144.97 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.057 -1.027 . . . . 0.0 110.862 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.4 p -132.81 168.82 17.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.225 1.81 . . . . 0.0 109.037 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.56 -26.92 67.28 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -76.21 -40.06 53.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.948 0.899 . . . . 0.0 111.658 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -64.62 -37.17 86.66 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.963 -0.46 . . . . 0.0 111.193 171.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.3 tpt -66.11 -44.56 83.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.648 0.779 . . . . 0.0 111.416 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -59.58 -33.57 71.62 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.97 0.908 . . . . 0.0 112.097 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -74.62 -45.53 44.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.75 0.82 . . . . 0.0 112.579 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.95 -31.08 64.62 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.981 1.312 . . . . 0.0 113.097 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -106.92 10.85 30.43 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.211 1.404 . . . . 0.0 113.12 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -63.47 -28.81 70.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -16.26 63.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.582 0.753 . . . . 0.0 112.618 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -100.83 9.82 41.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.545 1.938 . . . . 0.0 112.458 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.73 -177.46 54.36 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.749 1.166 . . . . 0.0 112.962 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -71.32 134.91 47.09 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.708 -0.878 . . . . 0.0 111.111 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.63 148.82 34.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.609 1.164 . . . . 0.0 112.194 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.89 -10.23 79.26 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.865 1.221 . . . . 0.0 113.923 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -158.92 137.64 11.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.379 1.872 . . . . 0.0 108.983 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.14 130.05 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.602 1.561 . . . . 0.0 108.808 174.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -144.29 139.24 28.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.592 1.157 . . . . 0.0 111.295 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 86.9 mt -138.8 126.66 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.455 1.502 . . . . 0.0 108.518 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -120.11 104.43 10.11 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.522 1.129 . . . . 0.0 111.846 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -73.76 -26.4 60.64 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -171.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.86 -22.03 62.35 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.957 0.903 . . . . 0.0 113.086 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -107.42 -29.12 9.43 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.475 1.11 . . . . 0.0 113.465 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.05 28.44 17.96 Favored Glycine 0 N--CA 1.477 1.374 0 C-N-CA 124.891 1.234 . . . . 0.0 114.152 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -137.6 155.79 48.8 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.339 1.455 . . . . 0.0 111.788 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.16 176.74 30.32 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.111 1.339 . . . . 0.0 113.576 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -144.37 153.71 42.24 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.306 1.842 . . . . 0.0 110.779 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 tt -155.23 132.36 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.54 1.136 . . . . 0.0 110.607 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -113.52 121.93 45.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.904 0.881 . . . . 0.0 110.961 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.39 165.64 12.46 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.236 0.614 . . . . 0.0 111.305 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.61 -23.72 60.98 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -172.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.6 p -145.11 146.47 31.83 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.118 1.367 . . . . 0.0 111.513 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -55.88 -43.42 77.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.059 1.344 . . . . 0.0 112.246 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.4 m -59.2 -45.87 89.93 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.924 1.289 . . . . 0.0 112.081 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.76 -35.89 82.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 119.158 -0.448 . . . . 0.0 112.088 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.06 -33.44 74.57 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -64.55 -49.55 70.76 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.21 0.914 . . . . 0.0 110.22 172.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.8 mt -60.94 -48.47 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.604 0.762 . . . . 0.0 110.399 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.22 91.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.238 0.615 . . . . 0.0 111.819 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -57.19 -49.61 75.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.29 0.95 . . . . 0.0 111.332 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.71 -36.17 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.438 0.695 . . . . 0.0 112.095 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -81.65 -25.14 35.84 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.5 mt -109.61 -23.99 11.18 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -170.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.42 121.98 16.95 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.843 1.202 . . . . 0.0 110.839 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 74.59 15.52 3.32 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 128.142 2.577 . . . . 0.0 114.01 -173.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.0 ttp -76.44 137.12 67.74 Favored Pre-proline 0 N--CA 1.475 0.782 0 O-C-N 120.958 -1.089 . . . . 0.0 111.295 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.64 141.38 22.03 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.467 2.778 . . . . 0.0 111.647 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 34.4 tp -144.93 118.13 8.93 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.533 1.533 . . . . 0.0 110.303 173.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 58.7 24.77 12.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.321 1.448 . . . . 0.0 113.825 174.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.82 -5.59 83.36 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 125.472 1.511 . . . . 0.0 114.38 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -94.41 171.93 8.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.578 1.551 . . . . 0.0 110.726 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -99.43 -176.12 3.2 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 109.656 169.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.4 mt -141.68 120.03 12.31 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.302 1.441 . . . . 0.0 108.982 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.49 116.29 32.45 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.93 122.83 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.819 0.848 . . . . 0.0 111.335 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -141.88 161.66 37.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.772 2.029 . . . . 0.0 110.565 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -73.0 130.74 41.01 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.634 -0.666 . . . . 0.0 109.671 168.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.726 0 C-N-CA 124.561 1.144 . . . . 0.0 110.699 176.602 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 121.248 0.546 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -98.14 141.11 31.47 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.986 1.714 . . . . 0.0 112.561 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.44 141.92 50.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.82 2.048 . . . . 0.0 110.147 -172.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -100.66 140.38 35.02 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.193 2.197 . . . . 0.0 108.797 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.13 114.57 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.667 1.187 . . . . 0.0 108.951 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.33 164.57 12.28 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 125.488 1.518 . . . . 0.0 114.433 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.7 t30 70.57 20.35 5.85 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.593 1.957 . . . . 0.0 112.928 -177.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.9 mt -57.73 148.65 56.59 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.75 1.22 . . . . 0.0 113.082 -172.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 162.32 40.7 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.133 2.556 . . . . 0.0 111.444 172.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.94 -6.77 17.01 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.721 2.947 . . . . 0.0 112.174 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -99.76 8.29 44.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.676 1.991 . . . . 0.0 113.272 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.5 tp -81.86 145.46 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.01 -1.056 . . . . 0.0 110.909 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.2 p -134.3 167.66 20.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.236 1.814 . . . . 0.0 109.48 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -56.73 -34.51 67.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.106 0.563 . . . . 0.0 111.625 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.82 -26.93 49.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.478 1.111 . . . . 0.0 113.027 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -77.06 -39.02 51.38 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.933 0.788 . . . . 0.0 110.855 169.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.2 ttt -70.46 -37.48 74.3 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.32 -0.863 . . . . 0.0 112.195 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -62.64 -38.03 88.68 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.897 0.879 . . . . 0.0 111.507 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -73.34 -39.98 64.8 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.009 1.324 . . . . 0.0 113.092 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.6 mt -57.39 -27.39 62.28 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.958 1.303 . . . . 0.0 113.205 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -108.02 8.4 28.28 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.627 1.571 . . . . 0.0 112.753 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.9 -20.49 65.92 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -59.39 -22.73 61.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.636 1.174 . . . . 0.0 112.315 169.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -109.64 10.1 24.97 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.258 2.223 . . . . 0.0 112.321 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.45 -178.8 53.32 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.029 0.823 . . . . 0.0 112.448 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -71.04 144.57 50.34 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.699 -0.883 . . . . 0.0 111.664 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.64 152.27 30.1 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.166 0.986 . . . . 0.0 111.822 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.35 -8.22 71.58 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.82 1.2 . . . . 0.0 113.83 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -158.61 136.05 10.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.58 1.952 . . . . 0.0 108.582 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.73 128.65 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.493 1.517 . . . . 0.0 109.059 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -143.83 141.78 30.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.172 1.389 . . . . 0.0 111.579 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.3 mt -140.47 132.98 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.702 1.601 . . . . 0.0 108.67 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -129.1 109.02 10.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.93 0.892 . . . . 0.0 112.129 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -33.93 69.7 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.494 1.118 . . . . 0.0 112.798 -171.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.63 -26.22 68.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.367 1.067 . . . . 0.0 113.229 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -97.72 -32.58 11.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.176 0.99 . . . . 0.0 113.031 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.27 29.19 12.84 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 125.101 1.334 . . . . 0.0 114.055 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.95 158.84 43.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.266 1.426 . . . . 0.0 111.852 -171.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.46 168.78 26.63 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.275 1.417 . . . . 0.0 113.483 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.27 148.24 50.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.72 2.008 . . . . 0.0 109.828 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.9 tt -153.82 140.88 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.412 1.085 . . . . 0.0 110.583 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -123.94 124.89 43.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.863 0.865 . . . . 0.0 110.947 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.4 168.09 10.43 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.389 0.676 . . . . 0.0 110.935 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -72.85 -24.94 60.95 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.9 p -143.61 157.65 44.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.619 1.168 . . . . 0.0 111.881 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -58.73 -35.77 73.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 112.528 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -62.8 -49.46 74.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.054 1.342 . . . . 0.0 110.64 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.49 -42.86 99.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.217 0.607 . . . . 0.0 111.215 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.25 99.26 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -62.91 -49.78 73.44 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.087 0.858 . . . . 0.0 111.79 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.71 -48.95 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.104 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.01 91.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.333 0.653 . . . . 0.0 112.288 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -47.52 84.67 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.447 -0.783 . . . . 0.0 111.007 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.69 -36.49 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -84.79 -28.68 26.0 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -174.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.4 mt -101.18 -19.22 15.81 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -66.86 137.81 56.86 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.188 0.904 . . . . 0.0 110.661 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.5 t30 69.28 16.29 8.43 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.653 1.581 . . . . 0.0 113.636 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.0 ttp -89.83 134.02 32.86 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 120.866 -1.146 . . . . 0.0 111.148 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.28 141.42 18.22 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.299 2.666 . . . . 0.0 111.307 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.4 tp -144.92 114.59 7.24 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.827 1.651 . . . . 0.0 110.098 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 57.67 24.5 10.64 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.288 1.435 . . . . 0.0 113.738 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.73 -1.92 69.23 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.547 1.546 . . . . 0.0 114.836 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -102.9 145.86 29.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.285 1.434 . . . . 0.0 111.192 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -75.31 167.64 21.52 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.656 -0.653 . . . . 0.0 110.187 167.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.7 mt -133.96 135.8 43.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.5 1.12 . . . . 0.0 110.996 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.67 122.08 46.67 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.685 1.994 . . . . 0.0 109.096 175.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -131.94 125.63 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.773 0.829 . . . . 0.0 110.119 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.53 156.92 37.52 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.431 1.492 . . . . 0.0 111.706 -172.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -69.0 132.03 46.02 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.579 -0.701 . . . . 0.0 111.816 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.645 0 C-N-CA 123.616 0.766 . . . . 0.0 110.818 178.503 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -99.22 124.13 44.05 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.703 1.601 . . . . 0.0 111.851 -170.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.6 mt -111.75 149.82 31.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.709 2.004 . . . . 0.0 110.999 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -114.58 137.86 51.36 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.203 2.601 . . . . 0.0 108.472 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -131.29 113.37 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.167 0.987 . . . . 0.0 109.947 -173.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -113.02 169.64 13.03 Favored Glycine 0 N--CA 1.467 0.756 0 C-N-CA 126.042 1.782 . . . . 0.0 113.738 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 69.01 15.87 8.78 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.098 1.759 . . . . 0.0 112.582 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 28.8 mt -56.58 139.04 76.1 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.089 0.955 . . . . 0.0 112.048 -174.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 83' ' ' LEU . 12.8 Cg_exo -68.15 160.92 46.69 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.748 2.298 . . . . 0.0 111.223 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.04 -2.79 12.09 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.815 3.01 . . . . 0.0 112.967 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -103.61 0.82 31.28 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.082 1.753 . . . . 0.0 113.792 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -76.41 146.32 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 119.453 1.024 . . . . 0.0 111.275 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 p -130.58 165.42 22.8 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.706 1.602 . . . . 0.0 110.409 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -62.85 -25.78 68.44 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.226 0.61 . . . . 0.0 111.822 172.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -72.64 -44.39 61.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.183 0.993 . . . . 0.0 111.474 172.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -66.09 -39.18 89.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.55 0.614 . . . . 0.0 111.696 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -69.21 -33.57 73.54 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.773 0.715 . . . . 0.0 112.471 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -67.61 -39.4 84.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.581 0.628 . . . . 0.0 111.643 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -72.92 -38.08 66.98 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.29 -0.881 . . . . 0.0 113.074 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.44 -25.06 49.34 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.358 1.463 . . . . 0.0 113.256 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -110.75 10.51 22.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.644 1.578 . . . . 0.0 112.673 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.21 -24.87 67.48 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -64.63 -19.33 65.63 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.334 1.054 . . . . 0.0 113.015 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.93 10.5 30.5 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.807 2.043 . . . . 0.0 112.141 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.44 -173.42 55.23 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.865 1.221 . . . . 0.0 113.021 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -71.73 145.07 49.02 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.836 -0.802 . . . . 0.0 112.274 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -89.19 150.39 22.69 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.415 1.086 . . . . 0.0 111.528 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.0 -11.05 70.76 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.823 1.202 . . . . 0.0 113.871 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -153.94 137.11 15.62 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.124 1.77 . . . . 0.0 109.073 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.46 129.36 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.906 1.682 . . . . 0.0 108.858 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -145.09 144.08 30.75 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.895 1.278 . . . . 0.0 111.87 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.2 mt -140.86 132.47 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.168 1.787 . . . . 0.0 108.459 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -126.43 111.82 14.89 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.887 0.875 . . . . 0.0 112.386 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -70.75 -31.95 68.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.424 1.09 . . . . 0.0 113.307 -171.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -73.63 -13.24 60.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.07 0.948 . . . . 0.0 113.51 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -112.75 -26.48 8.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.743 1.217 . . . . 0.0 113.311 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.0 29.84 24.73 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.613 1.102 . . . . 0.0 113.963 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -140.12 157.29 45.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.327 1.451 . . . . 0.0 112.202 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.41 169.19 25.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.755 1.645 . . . . 0.0 113.209 174.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -137.89 147.63 44.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.673 1.989 . . . . 0.0 109.425 -177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.0 tt -153.77 139.23 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.897 0.879 . . . . 0.0 110.601 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -128.92 118.68 23.06 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.622 0.769 . . . . 0.0 110.307 -172.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.67 -176.16 3.98 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.215 1.006 . . . . 0.0 111.893 -171.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -86.02 -25.84 25.72 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 49.7 p -149.42 144.4 26.33 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.138 1.375 . . . . 0.0 111.851 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -59.46 -35.91 74.97 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.248 1.019 . . . . 0.0 113.057 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.9 m -60.21 -47.69 84.87 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.773 1.229 . . . . 0.0 111.181 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.6 mt -65.65 -35.99 82.38 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.958 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.68 -36.76 81.28 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.08 0.854 . . . . 0.0 112.875 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.39 -49.48 71.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.128 0.971 . . . . 0.0 110.891 172.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.81 -48.74 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.082 0.553 . . . . 0.0 110.353 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.98 -46.02 85.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.626 0.77 . . . . 0.0 111.91 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -58.25 -48.69 79.62 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.319 -0.863 . . . . 0.0 111.345 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.15 -36.49 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.464 0.705 . . . . 0.0 112.16 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -80.6 -30.45 36.82 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.3 mt -102.72 -21.78 14.04 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -171.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.18 129.14 38.94 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.672 1.123 . . . . 0.0 111.456 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 67.98 14.25 9.32 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.73 2.412 . . . . 0.0 113.697 -173.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.2 ttp -73.83 135.91 77.31 Favored Pre-proline 0 N--CA 1.474 0.757 0 O-C-N 120.507 -1.371 . . . . 0.0 110.719 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.24 140.6 19.81 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.3 2.666 . . . . 0.0 111.325 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.3 tp -145.12 117.19 8.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.086 1.355 . . . . 0.0 110.106 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 69.9 mmt-85 57.11 27.38 13.34 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.929 1.291 . . . . 0.0 113.922 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.42 -6.23 83.82 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 125.521 1.534 . . . . 0.0 114.484 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -90.78 169.3 11.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.934 1.694 . . . . 0.0 110.333 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -100.98 -172.67 2.21 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.612 -0.68 . . . . 0.0 109.244 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.46 116.67 10.03 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.34 1.056 . . . . 0.0 109.079 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -91.58 118.07 30.28 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.44 123.94 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.647 0.779 . . . . 0.0 109.959 -173.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -154.78 163.98 39.47 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.087 1.355 . . . . 0.0 111.239 -173.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -71.36 144.1 49.99 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.769 -0.582 . . . . 0.0 111.043 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.957 0 C-N-CA 124.939 1.296 . . . . 0.0 112.94 -177.083 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 -84.15 133.41 34.61 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.434 1.494 . . . . 0.0 113.006 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.6 mt -113.81 134.52 54.73 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.034 1.733 . . . . 0.0 110.257 170.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -92.09 137.89 31.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.17 2.188 . . . . 0.0 107.748 169.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.6 t -130.47 110.92 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.072 0.949 . . . . 0.0 109.435 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.53 174.56 18.11 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.825 1.678 . . . . 0.0 113.501 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.8 m120 65.48 20.07 11.65 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.863 1.665 . . . . 0.0 112.808 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.19 140.12 97.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 O-C-N 121.05 -1.031 . . . . 0.0 112.103 -171.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.11 165.73 31.48 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.294 3.33 . . . . 0.0 111.837 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.51 -2.89 13.03 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.173 2.582 . . . . 0.0 113.179 172.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -108.19 12.55 26.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.028 1.731 . . . . 0.0 113.419 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.3 tp -91.32 140.08 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.254 1.022 . . . . 0.0 110.599 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.8 p -133.76 174.06 10.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.389 1.476 . . . . 0.0 108.695 168.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.33 -22.62 63.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.043 0.537 . . . . 0.0 112.421 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.71 -45.14 38.39 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.307 -0.871 . . . . 0.0 111.41 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -63.27 -43.8 96.93 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.058 0.543 . . . . 0.0 111.088 172.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.9 ttt -65.35 -37.31 86.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.997 0.519 . . . . 0.0 112.337 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.6 mtp-105 -66.46 -38.18 86.78 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.509 -0.744 . . . . 0.0 112.066 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -72.03 -40.32 68.49 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.411 -0.806 . . . . 0.0 112.557 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.9 mt -59.34 -29.58 67.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.986 1.714 . . . . 0.0 113.027 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -105.88 8.44 32.65 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.22 1.408 . . . . 0.0 112.656 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.03 -27.04 68.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.246 0.93 . . . . 0.0 113.214 -173.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -72.55 -5.54 37.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.775 1.23 . . . . 0.0 113.657 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -111.86 8.81 20.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.433 1.893 . . . . 0.0 111.83 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.11 -177.6 53.72 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.802 1.192 . . . . 0.0 112.253 -172.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -71.16 144.18 50.28 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.637 -0.919 . . . . 0.0 111.998 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.26 156.3 33.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.878 0.871 . . . . 0.0 111.857 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.96 -10.29 58.84 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.939 1.256 . . . . 0.0 113.87 175.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.65 135.83 5.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.699 2.0 . . . . 0.0 108.611 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.1 t -143.56 128.77 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.644 1.578 . . . . 0.0 109.43 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -145.1 142.31 29.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.382 1.473 . . . . 0.0 111.765 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.9 mt -138.51 127.18 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.559 1.544 . . . . 0.0 108.575 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -115.57 103.25 10.54 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.446 1.098 . . . . 0.0 111.831 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -69.79 -20.34 63.47 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -87.18 -15.17 39.12 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -117.6 -19.25 9.47 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.613 1.165 . . . . 0.0 113.985 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.25 29.79 21.42 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 124.665 1.126 . . . . 0.0 114.312 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -132.51 149.07 52.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.942 1.297 . . . . 0.0 111.832 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.68 169.5 25.17 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.875 1.702 . . . . 0.0 112.754 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -141.83 142.52 33.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.173 1.789 . . . . 0.0 109.566 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.6 tt -152.18 143.19 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.726 0.81 . . . . 0.0 110.686 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -121.3 124.32 44.32 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.922 0.889 . . . . 0.0 110.706 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.0 mt -97.31 171.2 8.57 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.582 0.753 . . . . 0.0 111.132 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -74.73 -26.46 59.82 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.3 p -144.7 159.29 43.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.686 1.194 . . . . 0.0 111.983 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -60.24 -31.35 70.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.844 0.857 . . . . 0.0 112.755 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -68.47 -46.79 68.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.019 1.328 . . . . 0.0 110.486 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.6 mt -62.39 -42.73 99.65 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.249 0.62 . . . . 0.0 111.125 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.59 -36.94 85.87 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.89 -47.93 73.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.508 1.123 . . . . 0.0 111.905 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.7 mt -62.35 -47.83 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.418 -0.802 . . . . 0.0 110.18 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.41 -42.49 98.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.277 0.631 . . . . 0.0 112.409 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -54.01 -51.87 62.59 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.421 1.009 . . . . 0.0 111.287 170.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.36 -34.91 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.151 0.432 . . . . 0.0 111.785 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -85.57 -23.98 27.4 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.0 mt -106.67 -22.17 12.82 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.24 128.84 37.92 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.476 1.034 . . . . 0.0 110.992 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.6 t30 70.48 12.75 7.45 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.27 2.228 . . . . 0.0 114.106 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.5 ttp -75.67 136.95 70.52 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.565 -1.334 . . . . 0.0 110.91 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.99 139.91 19.73 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.452 2.768 . . . . 0.0 111.169 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.8 tp -145.72 121.57 10.61 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.506 1.522 . . . . 0.0 109.893 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 59.17 23.09 11.35 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.902 1.281 . . . . 0.0 113.699 172.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.1 2.15 74.85 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.394 1.473 . . . . 0.0 114.728 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -111.73 156.98 21.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.233 1.813 . . . . 0.0 111.629 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.99 173.07 10.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.163 0.985 . . . . 0.0 111.137 169.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.2 mt -134.24 119.01 18.22 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.544 1.138 . . . . 0.0 109.148 169.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -92.67 122.51 35.15 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.85 128.32 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.194 0.906 . . . . 0.0 109.689 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -148.1 165.27 31.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.581 1.552 . . . . 0.0 110.986 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.19 137.87 41.58 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.633 -0.667 . . . . 0.0 110.566 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 123.234 0.614 . . . . 0.0 110.786 178.722 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.13 129.18 55.18 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.074 1.75 . . . . 0.0 110.744 -174.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.3 mt -108.15 130.61 55.11 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.585 1.554 . . . . 0.0 110.294 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -89.83 134.5 34.16 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.645 1.978 . . . . 0.0 107.949 169.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.9 t -129.16 121.88 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.996 0.918 . . . . 0.0 109.792 -174.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.43 172.66 14.56 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 125.921 1.724 . . . . 0.0 113.686 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 m120 65.32 17.08 10.86 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.169 1.788 . . . . 0.0 113.371 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 32.2 mt -58.19 143.48 78.92 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.409 1.084 . . . . 0.0 112.474 -171.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -70.32 158.06 57.37 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.199 2.6 . . . . 0.0 110.852 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.5 -9.67 25.54 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.316 2.677 . . . . 0.0 112.87 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.79 4.42 52.87 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.793 2.037 . . . . 0.0 113.409 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 tp -81.74 145.28 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 120.785 -1.197 . . . . 0.0 111.181 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.8 p -135.27 167.63 20.66 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.52 1.928 . . . . 0.0 109.139 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -57.7 -35.42 70.6 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.962 0.505 . . . . 0.0 111.887 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -80.23 -30.97 38.59 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.518 1.127 . . . . 0.0 113.076 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.08 -39.2 66.06 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.024 0.93 . . . . 0.0 111.309 172.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 4.3 tpt -61.86 -42.27 98.85 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.709 0.804 . . . . 0.0 111.074 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.0 ttp85 -63.26 -27.85 69.63 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.424 -0.798 . . . . 0.0 112.191 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -47.67 37.7 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.157 1.383 . . . . 0.0 112.494 171.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.7 mt -55.62 -34.27 64.74 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.01 1.324 . . . . 0.0 112.634 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -102.52 9.93 39.2 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.05 1.34 . . . . 0.0 113.267 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.63 -24.89 67.15 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -61.92 -25.21 67.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.555 1.142 . . . . 0.0 112.388 173.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -102.32 12.69 36.24 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.209 1.804 . . . . 0.0 112.478 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.55 -145.68 20.4 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.756 1.17 . . . . 0.0 111.93 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -103.54 131.14 50.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.599 1.159 . . . . 0.0 111.085 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.5 146.49 51.85 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.172 0.989 . . . . 0.0 111.844 176.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.81 -18.14 70.97 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.287 0.946 . . . . 0.0 113.454 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -158.68 146.38 17.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.569 1.548 . . . . 0.0 110.321 172.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.9 t -143.18 128.46 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.083 1.753 . . . . 0.0 109.542 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -140.65 142.35 34.97 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.401 1.481 . . . . 0.0 111.444 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.5 mt -142.12 128.97 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.004 1.721 . . . . 0.0 108.222 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -123.27 102.13 7.76 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.046 0.938 . . . . 0.0 111.985 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -73.6 -16.35 61.24 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.94 -20.53 60.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.305 1.042 . . . . 0.0 112.808 175.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -116.75 -23.22 8.22 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.832 1.253 . . . . 0.0 113.756 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.71 28.73 23.23 Favored Glycine 0 N--CA 1.477 1.371 0 C-N-CA 124.673 1.13 . . . . 0.0 114.25 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -136.78 155.16 50.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.389 1.476 . . . . 0.0 112.023 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.96 168.97 25.84 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.676 1.607 . . . . 0.0 113.055 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -140.56 140.2 35.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.703 2.001 . . . . 0.0 108.735 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.5 tt -150.6 132.27 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.685 -0.634 . . . . 0.0 111.487 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 123.1 47.63 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.749 1.22 . . . . 0.0 110.172 -177.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -99.73 157.12 16.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.246 0.618 . . . . 0.0 110.181 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.34 -18.47 63.08 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -169.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.9 p -151.01 151.54 32.21 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.667 1.587 . . . . 0.0 111.435 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 36.9 ptt-85 -55.27 -35.66 65.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.756 1.222 . . . . 0.0 114.24 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 m -60.92 -45.92 92.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.058 1.343 . . . . 0.0 111.265 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.09 -44.0 97.61 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.773 0.829 . . . . 0.0 110.915 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.85 79.41 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.297 0.639 . . . . 0.0 112.63 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.53 -48.32 67.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.861 0.865 . . . . 0.0 111.909 172.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.34 -46.56 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.522 -0.736 . . . . 0.0 110.279 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.99 99.54 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.759 0.824 . . . . 0.0 112.053 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -56.09 -50.65 70.43 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.566 1.076 . . . . 0.0 111.489 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.8 -35.15 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.793 0.724 . . . . 0.0 112.338 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -87.2 -33.44 19.35 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.0 mt -98.91 -22.68 15.66 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -171.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -70.2 122.71 20.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.0 0.818 . . . . 0.0 110.773 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 70.61 14.92 7.18 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 127.543 2.337 . . . . 0.0 114.262 -171.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.4 ttp -72.79 138.1 79.95 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 120.518 -1.364 . . . . 0.0 110.939 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.11 139.58 21.66 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.44 2.76 . . . . 0.0 111.402 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.8 tp -144.88 116.22 8.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.343 1.457 . . . . 0.0 109.969 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 59.03 18.88 6.69 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.211 1.404 . . . . 0.0 113.916 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.57 -6.73 80.26 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.665 1.602 . . . . 0.0 114.508 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -85.38 153.99 22.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.758 1.279 . . . . 0.0 110.557 170.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -86.11 163.41 17.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 167.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.0 mt -122.1 137.52 54.79 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.305 1.042 . . . . 0.0 110.046 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.4 135.67 46.36 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.382 1.073 . . . . 0.0 109.529 170.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.37 132.93 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.965 0.906 . . . . 0.0 110.955 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -147.73 165.61 30.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.163 1.385 . . . . 0.0 111.573 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -73.54 136.85 44.08 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.545 -0.722 . . . . 0.0 110.946 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 123.693 0.797 . . . . 0.0 110.572 174.712 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -86.11 135.01 33.77 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.233 1.413 . . . . 0.0 111.406 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.83 127.4 51.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.809 1.643 . . . . 0.0 110.206 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -89.65 135.7 33.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.731 2.013 . . . . 0.0 108.13 171.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.63 113.22 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.048 0.939 . . . . 0.0 109.46 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.16 174.41 21.33 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.606 1.574 . . . . 0.0 113.271 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 m120 66.48 16.61 10.46 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.028 1.731 . . . . 0.0 113.761 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.5 mt -60.8 140.52 93.25 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 121.156 -0.965 . . . . 0.0 113.033 -170.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -68.67 159.28 54.31 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.08 3.187 . . . . 0.0 111.745 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.95 -1.47 11.25 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.572 2.848 . . . . 0.0 114.031 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -116.84 12.49 14.79 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.682 1.593 . . . . 0.0 113.0 -174.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 tp -82.24 137.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.42 1.088 . . . . 0.0 110.734 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.5 p -128.86 176.18 8.05 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.261 1.424 . . . . 0.0 110.009 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -54.22 -32.82 56.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.913 0.885 . . . . 0.0 112.202 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -73.34 -34.01 65.43 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.784 0.834 . . . . 0.0 112.479 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -71.48 -44.13 65.3 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.654 0.661 . . . . 0.0 110.56 170.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.9 ttt -65.28 -33.26 75.57 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -63.98 -45.15 90.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.068 0.947 . . . . 0.0 111.318 169.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -70.84 -38.51 73.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.634 0.774 . . . . 0.0 112.825 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.8 mt -59.62 -24.21 63.63 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.551 1.54 . . . . 0.0 113.328 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -113.2 10.25 18.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.577 1.551 . . . . 0.0 112.539 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -21.33 65.42 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.63 -20.52 60.97 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.038 1.335 . . . . 0.0 112.593 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -112.47 11.59 19.87 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.257 2.223 . . . . 0.0 111.855 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.5 -169.99 52.98 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.479 1.037 . . . . 0.0 113.211 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -71.63 129.6 39.11 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.014 -0.698 . . . . 0.0 111.293 174.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.9 149.73 43.2 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.058 0.943 . . . . 0.0 111.439 172.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.23 -12.89 75.26 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.717 1.151 . . . . 0.0 113.78 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -156.12 138.08 14.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.88 1.672 . . . . 0.0 109.316 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -141.69 127.68 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.437 1.495 . . . . 0.0 108.801 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -145.2 139.15 27.0 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.562 1.145 . . . . 0.0 111.936 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.7 mt -139.86 137.8 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.485 1.914 . . . . 0.0 107.978 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -143.51 129.17 19.23 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 122.63 1.205 . . . . 0.0 113.897 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -74.21 -11.49 60.3 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.313 1.445 . . . . 0.0 113.463 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.17 -32.09 61.89 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.45 1.5 . . . . 0.0 113.031 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -123.73 -20.67 5.4 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.39 42.35 7.47 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 119.26 0.936 . . . . 0.0 113.252 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -137.78 154.75 49.54 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.734 1.614 . . . . 0.0 111.151 -177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.64 162.08 25.12 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.099 1.333 . . . . 0.0 113.647 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -137.27 139.71 41.13 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.921 2.088 . . . . 0.0 109.167 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.93 139.99 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.124 0.97 . . . . 0.0 110.313 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -125.88 116.17 21.11 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.95 0.9 . . . . 0.0 110.292 -172.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.5 mt -92.83 167.86 11.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.1 0.56 . . . . 0.0 111.242 -174.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -76.31 -19.53 58.16 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.2 p -143.8 155.11 44.03 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.643 1.177 . . . . 0.0 111.649 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 37.4 ptt-85 -60.11 -36.01 76.51 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.716 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.1 m -62.19 -50.62 71.08 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.351 1.46 . . . . 0.0 110.698 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.32 -37.6 87.6 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.692 -0.67 . . . . 0.0 111.758 176.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.02 89.55 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.106 0.866 . . . . 0.0 113.129 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -65.6 -49.57 68.29 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.678 0.791 . . . . 0.0 111.531 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.71 -48.45 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.967 -0.458 . . . . 0.0 110.125 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.56 86.29 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.596 0.758 . . . . 0.0 112.204 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -60.17 -42.42 94.96 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.247 -0.908 . . . . 0.0 112.15 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.17 -35.21 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.828 0.74 . . . . 0.0 112.049 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.69 -30.78 32.48 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.8 mt -104.73 -19.52 13.91 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -169.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.71 128.33 36.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.207 0.912 . . . . 0.0 111.664 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.1 t30 70.83 17.87 6.3 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.034 2.534 . . . . 0.0 113.348 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.6 ttp -76.49 138.17 67.33 Favored Pre-proline 0 N--CA 1.475 0.805 0 O-C-N 120.796 -1.19 . . . . 0.0 111.343 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.65 143.6 21.49 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.444 2.763 . . . . 0.0 111.708 175.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.2 tp -146.73 115.51 6.84 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.413 1.485 . . . . 0.0 110.247 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 57.08 25.68 11.11 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.513 1.525 . . . . 0.0 114.164 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.16 -1.96 78.07 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.225 1.393 . . . . 0.0 114.607 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -100.41 166.85 10.74 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.581 1.552 . . . . 0.0 111.191 169.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -92.66 175.21 6.9 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.481 1.112 . . . . 0.0 109.904 171.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.6 mt -136.9 110.25 7.89 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.745 1.218 . . . . 0.0 108.89 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.06 122.39 37.68 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.71 125.49 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.87 0.868 . . . . 0.0 110.846 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -139.67 166.71 23.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.885 1.674 . . . . 0.0 111.164 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -77.71 134.46 38.1 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.602 -0.687 . . . . 0.0 111.482 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.648 0 C-N-CA 124.173 0.989 . . . . 0.0 110.645 174.337 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.5 m . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -97.56 131.55 44.05 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.719 1.208 . . . . 0.0 112.026 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.9 mt -102.98 152.45 21.31 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.64 1.976 . . . . 0.0 110.586 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.428 ' CD2' ' HD3' ' A' ' 144' ' ' ARG . 12.1 t80 -124.48 126.28 45.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.778 2.431 . . . . 0.0 108.076 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.31 111.6 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.567 1.147 . . . . 0.0 109.478 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.57 167.23 25.75 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.79 1.186 . . . . 0.0 112.619 173.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 64.97 26.49 12.72 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.61 1.564 . . . . 0.0 113.217 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.53 144.01 95.91 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 121.074 -1.016 . . . . 0.0 111.345 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.38 161.8 44.71 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.79 2.993 . . . . 0.0 111.85 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.03 6.08 1.9 Allowed 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 124.157 3.238 . . . . 0.0 114.347 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -140.43 19.0 2.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.462 1.505 . . . . 0.0 114.335 -172.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -73.07 150.72 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.065 0.946 . . . . 0.0 110.151 169.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 p -126.83 163.54 23.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.081 1.352 . . . . 0.0 110.619 170.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -58.16 -32.96 68.71 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.14 0.576 . . . . 0.0 111.44 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -68.26 -42.44 79.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 111.673 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.11 -40.73 94.92 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.884 -0.51 . . . . 0.0 111.802 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.9 ttt -66.51 -38.6 87.59 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.656 0.662 . . . . 0.0 111.629 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -62.95 -38.73 92.25 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.52 1.128 . . . . 0.0 111.707 173.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.91 -45.45 61.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.96 1.304 . . . . 0.0 111.32 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.59 -29.09 58.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.007 1.323 . . . . 0.0 113.524 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -107.07 10.03 30.34 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.371 1.468 . . . . 0.0 112.792 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.06 -23.42 67.17 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -58.5 -26.72 63.77 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.976 1.31 . . . . 0.0 112.863 171.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -101.47 10.7 40.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.964 1.706 . . . . 0.0 112.729 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.18 -167.84 43.97 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.777 1.18 . . . . 0.0 112.625 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -79.06 123.73 27.62 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.952 -0.734 . . . . 0.0 110.265 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.82 143.64 54.52 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.8 0.84 . . . . 0.0 111.581 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.18 -9.32 76.88 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.792 1.187 . . . . 0.0 114.117 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -155.44 134.39 12.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.296 1.838 . . . . 0.0 108.48 173.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.5 t -140.54 125.77 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.196 1.398 . . . . 0.0 109.112 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -140.74 140.35 34.81 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.628 1.571 . . . . 0.0 111.238 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 62.0 mt -140.21 130.57 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.838 1.655 . . . . 0.0 108.211 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -120.34 108.16 13.81 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.798 0.839 . . . . 0.0 112.079 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.73 -17.86 61.06 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -171.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -78.98 -19.42 51.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.115 0.966 . . . . 0.0 112.758 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -108.28 -29.28 8.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.744 1.218 . . . . 0.0 113.615 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.79 28.18 27.11 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 124.608 1.099 . . . . 0.0 114.182 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -133.86 156.95 47.16 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.519 1.527 . . . . 0.0 111.893 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.75 165.8 27.53 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.865 1.221 . . . . 0.0 113.615 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.33 146.58 46.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.555 1.942 . . . . 0.0 109.78 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.6 tt -153.26 127.39 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.583 0.753 . . . . 0.0 111.43 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -114.0 121.15 43.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.155 0.982 . . . . 0.0 111.176 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.0 mt -97.42 167.15 11.17 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.74 0.816 . . . . 0.0 110.73 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -70.37 -24.07 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.7 p -145.52 160.7 41.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.466 1.506 . . . . 0.0 111.138 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -62.49 -31.76 72.56 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 119.01 -0.519 . . . . 0.0 111.985 173.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.0 m -61.24 -47.19 87.2 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.91 1.284 . . . . 0.0 110.564 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.06 -45.78 93.36 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.298 0.639 . . . . 0.0 111.076 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.46 -36.15 83.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -68.49 -44.26 75.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.064 1.345 . . . . 0.0 111.428 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.53 -52.0 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.432 -0.793 . . . . 0.0 109.883 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.15 90.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.625 0.77 . . . . 0.0 112.389 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -52.94 -50.05 64.8 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.032 0.933 . . . . 0.0 111.679 172.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.4 t -74.68 -36.23 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.389 0.54 . . . . 0.0 111.852 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -77.29 -21.32 53.73 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.5 mt -110.83 0.11 17.12 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.521 1.128 . . . . 0.0 113.758 -174.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.67 125.9 26.72 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.14 -0.975 . . . . 0.0 112.218 -176.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 57.51 22.4 8.05 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.479 1.912 . . . . 0.0 113.5 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 51.0 ttp -63.81 133.55 95.6 Favored Pre-proline 0 N--CA 1.472 0.652 0 O-C-N 120.777 -1.202 . . . . 0.0 111.09 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -73.54 127.33 11.65 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.003 2.469 . . . . 0.0 110.432 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 45.6 tp -135.51 107.46 7.11 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.813 1.645 . . . . 0.0 108.117 170.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 57.81 29.18 17.07 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.769 1.228 . . . . 0.0 113.202 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.74 -5.61 62.12 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.249 1.88 . . . . 0.0 115.066 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -101.23 142.19 33.02 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.151 1.38 . . . . 0.0 111.025 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -102.14 117.4 34.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.88 0.872 . . . . 0.0 109.736 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.42 119.15 23.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.665 1.186 . . . . 0.0 112.28 -169.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -97.29 106.63 18.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.3 0.64 . . . . 0.0 110.312 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.44 129.24 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.512 1.125 . . . . 0.0 110.595 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.428 ' HD3' ' CD2' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -134.11 170.4 15.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.518 1.927 . . . . 0.0 110.819 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -90.57 140.42 29.77 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.522 0.729 . . . . 0.0 110.952 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.791 0 C-N-CA 125.004 1.322 . . . . 0.0 111.791 -179.819 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.5 p . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -77.03 121.38 23.45 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.497 1.119 . . . . 0.0 110.599 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.4 mt -105.1 134.32 48.4 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.705 1.602 . . . . 0.0 110.354 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -91.94 135.31 34.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.049 2.14 . . . . 0.0 108.086 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.3 t -131.48 106.22 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.353 1.061 . . . . 0.0 108.884 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.01 163.08 15.19 Favored Glycine 0 N--CA 1.464 0.546 0 C-N-CA 124.991 1.281 . . . . 0.0 113.724 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 t30 68.7 27.56 5.87 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.85 1.66 . . . . 0.0 112.745 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.74 145.57 95.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 O-C-N 121.187 -0.946 . . . . 0.0 111.854 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.1 165.86 31.03 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.209 3.273 . . . . 0.0 111.777 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.19 -5.98 17.77 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.091 2.528 . . . . 0.0 113.4 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -106.87 0.48 23.96 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.124 1.37 . . . . 0.0 114.181 -172.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 tp -74.25 143.2 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.268 -0.895 . . . . 0.0 111.129 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 65.7 p -128.23 166.51 18.41 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.035 1.734 . . . . 0.0 110.074 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.96 -31.98 69.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.033 0.533 . . . . 0.0 111.536 171.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -70.76 -42.09 70.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.213 1.005 . . . . 0.0 111.924 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -66.28 -41.86 89.22 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.78 0.718 . . . . 0.0 111.302 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.8 tpt -65.11 -37.92 89.03 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.891 -0.505 . . . . 0.0 111.629 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -63.11 -48.4 78.71 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.404 -0.81 . . . . 0.0 110.273 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -60.49 -38.89 85.73 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.196 0.998 . . . . 0.0 113.296 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.6 mt -63.99 -29.78 70.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.38 1.472 . . . . 0.0 113.988 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.434 ' CZ ' HD13 ' A' ' 131' ' ' LEU . 47.8 m-85 -109.89 -4.0 16.26 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.69 1.196 . . . . 0.0 113.51 -176.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.38 -27.52 67.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.927 1.691 . . . . 0.0 115.16 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -55.78 -24.43 35.62 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.961 1.304 . . . . 0.0 112.707 171.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -107.02 14.54 26.27 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.937 2.095 . . . . 0.0 112.029 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.02 172.66 44.97 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.137 1.827 . . . . 0.0 112.78 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.57 132.91 46.21 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.873 -0.78 . . . . 0.0 110.931 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.1 145.44 51.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.885 0.874 . . . . 0.0 112.163 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.05 -11.59 75.93 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.631 1.11 . . . . 0.0 113.905 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -157.69 135.92 11.01 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.712 2.005 . . . . 0.0 108.371 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.34 128.84 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.265 1.426 . . . . 0.0 108.609 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -140.87 139.88 34.5 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.147 1.379 . . . . 0.0 110.904 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.8 mt -139.1 120.6 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.371 1.469 . . . . 0.0 108.312 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -115.97 98.18 6.5 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.234 1.014 . . . . 0.0 112.12 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.07 -15.86 62.02 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.92 -23.61 60.72 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.278 1.031 . . . . 0.0 112.697 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -117.06 -25.27 7.23 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.59 27.7 18.97 Favored Glycine 0 N--CA 1.477 1.428 0 C-N-CA 124.569 1.081 . . . . 0.0 114.171 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.91 150.54 52.15 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.373 1.469 . . . . 0.0 111.46 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.64 167.4 25.32 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.56 1.552 . . . . 0.0 113.08 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -139.52 142.62 37.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.468 1.907 . . . . 0.0 109.402 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 tt -151.65 130.65 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.382 0.673 . . . . 0.0 111.454 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.49 122.38 45.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.611 1.164 . . . . 0.0 110.441 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -97.59 168.41 10.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.005 0.522 . . . . 0.0 111.085 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -67.58 -32.4 73.12 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -171.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.9 p -140.44 159.32 42.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.827 1.251 . . . . 0.0 112.102 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -60.88 -31.95 71.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.818 0.847 . . . . 0.0 113.001 173.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m -68.71 -47.93 65.14 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.161 1.384 . . . . 0.0 110.658 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.8 mt -58.88 -42.34 89.23 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.614 0.766 . . . . 0.0 111.261 173.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.67 -35.39 78.76 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.79 -47.25 75.76 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.742 1.155 . . . . 0.0 111.361 172.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.7 mt -59.43 -48.73 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.19 0.596 . . . . 0.0 110.316 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.98 93.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.203 0.601 . . . . 0.0 112.033 176.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -57.54 -49.0 77.76 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.412 1.005 . . . . 0.0 111.182 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.86 -35.87 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.192 0.597 . . . . 0.0 111.963 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -83.48 -24.32 31.82 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.434 HD13 ' CZ ' ' A' ' 96' ' ' PHE . 55.3 mt -111.23 -18.48 12.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -171.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.67 128.39 35.77 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.897 1.226 . . . . 0.0 111.975 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 59.5 27.47 16.63 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.897 2.079 . . . . 0.0 113.364 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.8 ttp -74.72 137.43 73.73 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.535 -0.728 . . . . 0.0 109.664 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.31 136.3 15.81 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.315 2.677 . . . . 0.0 111.058 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -145.12 123.49 12.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.971 1.708 . . . . 0.0 109.0 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 58.83 22.87 10.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.775 1.23 . . . . 0.0 113.716 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.15 3.1 85.29 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.317 1.436 . . . . 0.0 114.474 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -106.17 148.91 27.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.17 1.788 . . . . 0.0 110.879 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -84.22 168.47 15.7 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.339 168.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.01 127.87 37.13 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.29 1.036 . . . . 0.0 110.701 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.63 111.34 23.52 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.84 0.856 . . . . 0.0 108.902 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.94 124.21 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.767 0.827 . . . . 0.0 109.822 -173.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.9 ptt85 -149.63 173.6 13.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.311 1.444 . . . . 0.0 111.247 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -75.2 144.97 42.41 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.616 -0.678 . . . . 0.0 111.85 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.979 0 C-N-CA 125.221 1.408 . . . . 0.0 113.095 178.772 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -85.88 122.19 29.59 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.05 1.34 . . . . 0.0 111.443 -176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.6 mt -105.15 135.85 45.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.329 1.852 . . . . 0.0 110.066 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -90.87 138.53 31.52 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.144 1.777 . . . . 0.0 108.723 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.93 106.06 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.24 1.016 . . . . 0.0 108.788 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.79 168.74 20.63 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 125.454 1.502 . . . . 0.0 112.83 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.1 m120 61.48 35.36 17.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.828 1.251 . . . . 0.0 112.045 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.7 mt -66.26 145.78 99.0 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 121.3 -0.875 . . . . 0.0 111.442 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -70.11 158.08 57.65 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.946 2.431 . . . . 0.0 111.338 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.24 -2.32 11.48 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.93 3.087 . . . . 0.0 113.333 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -112.99 14.13 19.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.556 1.943 . . . . 0.0 112.604 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.25 150.21 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 O-C-N 121.012 -1.055 . . . . 0.0 110.753 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.0 p -136.2 170.06 16.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.832 1.653 . . . . 0.0 109.683 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.27 -35.41 71.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.57 0.348 . . . . 0.0 111.464 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.44 -41.26 66.35 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.975 0.91 . . . . 0.0 111.806 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.29 -46.79 82.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.233 0.613 . . . . 0.0 111.261 173.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.2 ttt -64.42 -35.51 81.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.116 0.566 . . . . 0.0 112.264 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -64.91 -45.11 87.29 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.415 0.686 . . . . 0.0 110.97 171.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -64.35 -42.98 95.95 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.197 -0.94 . . . . 0.0 111.946 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.1 mt -57.65 -24.61 57.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.476 1.51 . . . . 0.0 113.964 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -115.14 -1.85 12.9 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.681 1.192 . . . . 0.0 113.572 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.27 -28.79 69.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.728 1.611 . . . . 0.0 115.164 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -61.11 -22.03 64.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.523 1.129 . . . . 0.0 112.91 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -103.49 24.99 10.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.912 2.085 . . . . 0.0 111.67 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.24 -176.82 45.52 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.934 1.73 . . . . 0.0 112.664 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.66 144.38 56.97 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.95 -0.735 . . . . 0.0 111.949 175.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.14 118.01 16.6 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.16 -15.15 75.27 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.807 1.194 . . . . 0.0 113.566 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -161.17 145.25 13.33 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.672 1.989 . . . . 0.0 108.677 168.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.8 t -144.35 130.73 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.32 1.448 . . . . 0.0 110.365 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -140.52 136.69 33.15 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.405 1.482 . . . . 0.0 110.844 171.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 63.7 mt -139.29 137.03 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.249 1.82 . . . . 0.0 107.84 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -139.55 125.29 19.51 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.135 0.969 . . . . 0.0 113.087 170.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.15 -18.68 62.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.441 1.096 . . . . 0.0 112.779 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.36 -38.72 63.57 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.337 1.855 . . . . 0.0 113.081 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -120.77 -15.32 8.4 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.67 41.16 5.77 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.787 1.184 . . . . 0.0 113.811 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -136.86 159.26 42.39 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.114 1.366 . . . . 0.0 112.223 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.96 167.37 29.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.496 1.046 . . . . 0.0 114.191 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -139.11 147.06 41.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.705 2.002 . . . . 0.0 109.571 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.2 tt -147.88 132.28 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.202 1.001 . . . . 0.0 110.646 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -101.63 128.42 47.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.965 0.906 . . . . 0.0 109.131 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 124' ' ' ALA . 12.5 mt -98.68 165.99 11.54 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.361 0.528 . . . . 0.0 110.278 170.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -76.5 -18.05 58.95 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -169.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.2 p -144.4 154.3 42.83 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.828 1.251 . . . . 0.0 111.5 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -62.87 -33.15 74.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.61 0.764 . . . . 0.0 112.891 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.1 m -64.48 -47.66 78.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.691 1.196 . . . . 0.0 110.793 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -66.71 -35.89 81.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.338 0.655 . . . . 0.0 111.394 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.45 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -64.8 -39.77 94.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 173.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.94 -47.76 76.51 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.489 1.041 . . . . 0.0 111.214 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 93.9 mt -59.54 -50.41 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.202 0.601 . . . . 0.0 110.272 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.64 -45.68 88.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.093 0.557 . . . . 0.0 111.806 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.38 -46.22 86.79 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.391 -0.818 . . . . 0.0 111.69 176.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.1 t -67.56 -35.77 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.516 0.598 . . . . 0.0 111.89 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -80.81 -24.35 38.58 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 48.9 mt -109.09 -16.71 14.05 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.02 133.71 49.47 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.05 1.295 . . . . 0.0 112.615 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 59.4 t30 65.71 15.83 10.22 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.939 2.496 . . . . 0.0 113.757 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.8 ttp -71.43 136.13 83.92 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 120.834 -1.166 . . . . 0.0 110.563 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.93 129.77 11.8 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.363 2.709 . . . . 0.0 110.607 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.9 tp -139.32 113.29 8.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.036 1.335 . . . . 0.0 109.557 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 58.81 23.62 11.45 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.906 1.282 . . . . 0.0 113.478 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.26 -3.37 76.09 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.847 1.689 . . . . 0.0 114.671 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -92.14 147.68 22.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.413 1.485 . . . . 0.0 110.7 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -102.67 110.46 22.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.749 0.82 . . . . 0.0 109.348 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 80.4 mt -73.56 121.21 20.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.699 0.8 . . . . 0.0 111.661 -172.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -92.07 112.7 24.73 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.919 0.888 . . . . 0.0 108.8 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.66 120.47 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.186 0.994 . . . . 0.0 110.131 -172.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -155.08 156.09 35.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.773 1.229 . . . . 0.0 111.473 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -67.85 133.03 48.47 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.672 -0.643 . . . . 0.0 111.435 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 124.121 0.968 . . . . 0.0 110.399 179.227 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -76.73 125.74 29.78 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.762 -1.211 . . . . 0.0 110.973 -175.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.2 mt -114.02 139.28 49.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.238 2.215 . . . . 0.0 110.26 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -100.74 142.56 32.04 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.238 2.215 . . . . 0.0 108.567 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.43 114.89 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.218 1.007 . . . . 0.0 110.001 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.88 173.73 17.03 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 126.021 1.772 . . . . 0.0 113.057 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.2 m120 66.64 11.79 8.38 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.462 1.905 . . . . 0.0 114.024 -175.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.5 mt -53.98 144.24 38.51 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.342 1.057 . . . . 0.0 113.41 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.03 165.29 33.04 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.257 3.305 . . . . 0.0 112.032 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.61 -8.14 20.19 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.389 2.726 . . . . 0.0 113.833 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -121.65 23.25 10.3 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.794 1.638 . . . . 0.0 113.561 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 tp -81.81 143.13 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.806 0.843 . . . . 0.0 110.53 173.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.0 p -136.52 167.65 20.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.557 1.943 . . . . 0.0 109.892 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -62.53 -28.54 69.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.32 0.648 . . . . 0.0 112.318 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -72.15 -47.62 49.59 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.993 -1.067 . . . . 0.0 112.496 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -57.82 -41.13 81.57 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.136 0.575 . . . . 0.0 111.86 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -70.07 -34.73 73.55 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.594 -0.691 . . . . 0.0 112.451 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -68.37 -37.05 80.06 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.518 -0.739 . . . . 0.0 111.906 169.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -68.97 -41.82 77.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.11 0.964 . . . . 0.0 112.449 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.3 mt -58.06 -26.52 62.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.101 1.36 . . . . 0.0 113.46 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -109.23 10.45 25.77 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.545 1.538 . . . . 0.0 112.526 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.78 -22.22 66.03 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -61.43 -21.7 64.35 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.602 1.161 . . . . 0.0 112.419 171.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.07 13.12 24.77 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.123 2.169 . . . . 0.0 112.131 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.37 -168.94 53.38 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.827 1.203 . . . . 0.0 112.916 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -76.57 124.75 28.09 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.55 0.74 . . . . 0.0 110.973 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.14 149.43 48.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.205 1.002 . . . . 0.0 111.681 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.07 -13.94 65.38 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.538 1.066 . . . . 0.0 113.914 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -154.79 136.21 14.16 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.853 1.661 . . . . 0.0 108.919 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 t -143.2 128.72 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.708 1.603 . . . . 0.0 109.066 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -145.35 144.32 30.64 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.062 1.345 . . . . 0.0 111.82 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.2 mt -137.68 128.1 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.352 1.461 . . . . 0.0 108.542 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -115.84 92.62 3.96 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.387 1.075 . . . . 0.0 110.542 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -74.54 -12.3 60.43 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.43 -23.24 62.7 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.073 1.349 . . . . 0.0 112.877 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -117.03 -22.37 8.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.729 1.212 . . . . 0.0 114.168 175.484 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.46 36.26 7.05 Favored Glycine 0 N--CA 1.475 1.288 0 C-N-CA 125.09 1.329 . . . . 0.0 114.276 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.13 152.08 44.44 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.113 1.365 . . . . 0.0 112.037 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.58 163.01 24.71 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.389 1.471 . . . . 0.0 113.375 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -142.3 140.66 32.26 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.642 1.977 . . . . 0.0 109.156 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.9 tt -154.32 148.12 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.829 0.852 . . . . 0.0 110.73 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -138.87 125.78 21.07 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.776 0.83 . . . . 0.0 110.58 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.28 176.85 5.05 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.24 1.016 . . . . 0.0 111.733 -170.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -76.9 -25.29 52.83 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.6 p -144.66 154.11 42.44 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.348 1.059 . . . . 0.0 112.147 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -58.49 -34.61 71.11 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.659 0.784 . . . . 0.0 112.884 172.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.1 m -62.22 -50.19 72.77 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.251 1.42 . . . . 0.0 110.445 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.11 -36.88 85.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.993 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.77 -37.24 85.79 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.115 0.87 . . . . 0.0 113.282 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -67.95 -45.27 74.72 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.771 0.828 . . . . 0.0 111.808 173.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.76 -48.0 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.57 -0.706 . . . . 0.0 110.243 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.88 91.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.929 0.891 . . . . 0.0 112.017 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -53.69 -53.77 47.33 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.016 0.826 . . . . 0.0 111.479 171.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.8 t -67.88 -33.03 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.582 0.628 . . . . 0.0 112.182 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.71 -36.03 44.03 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.06 -20.84 14.61 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.185 1.179 . . . . 0.0 114.185 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -67.07 134.01 51.0 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.114 0.87 . . . . 0.0 110.908 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . 0.3 0.4 OUTLIER 58.49 17.81 5.19 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.607 2.363 . . . . 0.0 115.246 -170.654 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.3 ttp -75.88 137.59 69.65 Favored Pre-proline 0 CA--C 1.545 0.771 0 O-C-N 120.873 -1.142 . . . . 0.0 110.947 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.73 140.8 21.21 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.467 2.778 . . . . 0.0 111.427 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 32.6 tp -146.56 119.3 8.61 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.459 1.504 . . . . 0.0 110.287 174.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? 58.98 23.9 12.04 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.065 1.346 . . . . 0.0 113.894 171.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.1 1.24 72.92 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.533 1.539 . . . . 0.0 114.734 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -107.66 165.15 11.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.669 1.988 . . . . 0.0 110.768 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -90.45 176.29 6.76 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.6 -0.688 . . . . 0.0 109.99 168.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.4 mt -133.85 116.11 15.27 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.6 1.16 . . . . 0.0 109.196 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -92.13 119.87 32.2 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.0 t -124.72 129.99 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.563 0.745 . . . . 0.0 109.926 -176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -146.98 164.4 33.11 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.304 1.442 . . . . 0.0 111.13 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -70.97 130.58 41.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 168.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 124.88 1.272 . . . . 0.0 110.759 -176.631 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -76.52 128.5 34.87 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.597 1.159 . . . . 0.0 111.311 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.02 140.28 49.42 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.181 1.792 . . . . 0.0 110.468 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -95.9 140.72 30.26 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.536 2.334 . . . . 0.0 108.814 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.2 110.46 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.94 0.896 . . . . 0.0 109.401 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.34 172.35 21.22 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.447 1.498 . . . . 0.0 113.321 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 m120 65.25 19.09 11.63 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.669 1.588 . . . . 0.0 113.128 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.1 mt -58.79 143.46 82.68 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.252 1.021 . . . . 0.0 111.857 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.7 158.57 56.57 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.696 2.93 . . . . 0.0 111.255 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.83 0.36 7.82 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.422 2.748 . . . . 0.0 113.568 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -114.64 4.75 15.18 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.943 1.697 . . . . 0.0 113.639 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.5 tp -74.03 142.41 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.28 -0.887 . . . . 0.0 111.247 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.7 p -123.72 165.59 17.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.971 1.708 . . . . 0.0 110.051 175.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.72 -27.78 68.16 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.699 0.399 . . . . 0.0 111.918 172.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.08 -40.27 62.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.168 0.987 . . . . 0.0 111.76 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -67.54 -37.81 83.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.637 0.653 . . . . 0.0 111.466 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.2 tpt -66.38 -40.98 90.03 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.641 -0.662 . . . . 0.0 111.657 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -60.56 -38.15 83.59 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.657 -0.652 . . . . 0.0 111.101 172.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -72.02 -40.3 68.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.05 0.94 . . . . 0.0 113.333 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 38.0 mt -56.02 -29.52 60.5 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.792 1.237 . . . . 0.0 112.766 173.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -109.05 12.88 24.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.446 1.498 . . . . 0.0 113.152 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -20.18 61.6 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.804 -1.185 . . . . 0.0 114.006 -174.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -64.53 -17.89 64.33 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.556 -0.715 . . . . 0.0 112.269 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -102.71 8.4 39.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.829 2.052 . . . . 0.0 112.178 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.08 -109.03 3.77 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.09 157.54 46.47 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.628 1.171 . . . . 0.0 112.413 170.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.97 151.11 26.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.742 0.817 . . . . 0.0 110.228 168.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.81 -14.31 61.27 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.697 1.142 . . . . 0.0 113.299 173.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -153.42 144.92 23.24 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.003 1.321 . . . . 0.0 110.622 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.29 128.8 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.549 1.94 . . . . 0.0 109.205 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -140.62 138.55 34.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.12 1.368 . . . . 0.0 111.514 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.4 mt -141.97 126.34 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.83 1.652 . . . . 0.0 107.816 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -118.18 106.81 13.22 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.932 0.872 . . . . 0.0 112.541 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -65.06 -27.18 68.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.989 1.316 . . . . 0.0 114.088 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.45 -9.08 59.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.851 1.261 . . . . 0.0 112.881 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -114.79 -32.7 5.72 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.132 1.373 . . . . 0.0 112.874 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.72 26.86 28.42 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.705 1.145 . . . . 0.0 113.753 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.65 155.18 48.51 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.717 1.607 . . . . 0.0 111.505 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.1 167.48 26.83 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.926 1.251 . . . . 0.0 113.677 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -139.18 148.14 42.75 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.729 2.011 . . . . 0.0 109.76 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.8 tt -154.76 138.93 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.955 0.902 . . . . 0.0 110.609 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -121.93 113.21 19.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.208 1.003 . . . . 0.0 109.87 -171.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.9 mt -88.48 167.05 13.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.135 0.574 . . . . 0.0 111.825 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -75.73 -17.32 59.96 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.7 p -145.44 159.92 42.36 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.369 1.467 . . . . 0.0 110.566 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -64.93 -34.35 78.2 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 171.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.8 m -55.71 -45.39 77.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.59 1.156 . . . . 0.0 111.119 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.2 -42.7 96.51 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.492 173.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.39 98.93 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.35 -51.25 70.16 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.353 1.433 . . . . 0.0 112.721 170.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.29 -45.9 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.905 -0.497 . . . . 0.0 110.293 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.81 94.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.362 0.665 . . . . 0.0 112.021 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.43 -45.1 94.86 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.397 -0.814 . . . . 0.0 111.564 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.76 -36.95 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.623 0.647 . . . . 0.0 112.006 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.08 -35.88 36.33 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.6 mt -96.78 -19.74 18.7 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -171.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -59.36 120.84 10.06 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.496 0.718 . . . . 0.0 111.762 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 64.32 21.59 12.55 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.964 2.106 . . . . 0.0 113.486 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.7 ttp -72.34 136.62 81.34 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 120.811 -1.181 . . . . 0.0 110.574 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.66 140.63 21.25 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.457 2.772 . . . . 0.0 111.628 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -148.44 116.43 6.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.619 1.568 . . . . 0.0 109.938 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 53.49 38.98 29.35 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.91 1.284 . . . . 0.0 113.288 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.88 77.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.379 1.466 . . . . 0.0 114.686 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -101.03 160.74 14.12 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.996 1.718 . . . . 0.0 110.45 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -93.89 173.14 7.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.985 0.914 . . . . 0.0 109.42 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 89.7 mt -133.0 110.35 10.19 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.214 1.005 . . . . 0.0 109.577 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 106.26 18.24 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.5 132.04 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 122.83 0.452 . . . . 0.0 111.602 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -139.22 169.1 18.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.547 1.939 . . . . 0.0 110.812 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -84.64 130.15 34.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.649 0.779 . . . . 0.0 111.077 169.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 125.75 1.62 . . . . 0.0 111.669 178.025 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.506 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.2 t -87.02 -162.23 0.77 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.864 0.866 . . . . 0.0 111.546 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -149.87 153.1 36.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.659 1.584 . . . . 0.0 111.612 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.62 -138.21 17.91 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.619 1.104 . . . . 0.0 112.237 -174.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.3 t -157.98 152.94 25.34 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.812 1.245 . . . . 0.0 111.454 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.0 p -81.29 -3.87 53.86 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 113.462 173.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.24 -19.76 7.62 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 126.401 1.953 . . . . 0.0 113.986 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.54 -135.31 35.99 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 118.257 1.029 . . . . 0.0 113.572 172.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -158.59 143.59 16.22 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.159 1.783 . . . . 0.0 109.675 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.76 142.08 30.07 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.072 0.949 . . . . 0.0 112.266 176.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.9 p -139.2 160.7 39.19 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.945 1.698 . . . . 0.0 111.449 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -68.42 -13.51 62.35 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.872 1.269 . . . . 0.0 114.188 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.2 m -140.07 134.85 31.93 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.205 2.202 . . . . 0.0 107.28 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -77.5 153.27 33.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.045 0.538 . . . . 0.0 111.267 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.38 50.23 1.07 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.701 1.2 . . . . 0.0 111.459 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.2 m -78.54 34.6 0.22 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.188 2.595 . . . . 0.0 113.102 -174.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -95.32 124.89 39.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.588 1.555 . . . . 0.0 111.253 -171.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.5 mt -109.03 134.82 51.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.241 1.817 . . . . 0.0 110.328 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -89.56 137.85 31.97 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 127.092 2.157 . . . . 0.0 107.717 169.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.41 111.07 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.841 0.856 . . . . 0.0 109.153 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.8 172.26 15.72 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.626 1.584 . . . . 0.0 113.097 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.6 m120 61.74 30.63 18.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.005 1.322 . . . . 0.0 111.807 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.54 140.66 96.63 Favored Pre-proline 0 CA--C 1.546 0.82 0 O-C-N 121.459 -0.776 . . . . 0.0 111.21 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.2 161.59 39.64 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.225 2.617 . . . . 0.0 111.165 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.87 -7.2 18.2 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.396 2.731 . . . . 0.0 112.676 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -102.87 11.47 37.43 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.797 2.039 . . . . 0.0 112.701 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.04 147.23 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 120.863 -1.148 . . . . 0.0 110.894 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.5 p -133.19 167.16 20.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.045 1.738 . . . . 0.0 109.671 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.55 -32.74 67.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.106 0.562 . . . . 0.0 111.488 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.52 -38.05 59.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.146 0.978 . . . . 0.0 112.473 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -63.95 -42.85 97.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.872 0.76 . . . . 0.0 110.659 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.8 ttt -68.99 -37.32 78.68 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.321 0.649 . . . . 0.0 112.127 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -62.68 -42.83 99.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.721 0.808 . . . . 0.0 111.225 171.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.92 -42.55 85.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.116 0.967 . . . . 0.0 113.212 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.6 mt -56.74 -25.02 53.79 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.74 1.216 . . . . 0.0 113.315 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -110.44 5.7 21.59 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.229 1.412 . . . . 0.0 113.464 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -67.33 -21.5 65.65 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.127 -0.983 . . . . 0.0 113.371 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -22.9 67.11 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.11 1.364 . . . . 0.0 112.388 172.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -105.67 7.26 32.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.568 1.947 . . . . 0.0 112.465 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.31 177.26 51.78 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.207 1.384 . . . . 0.0 113.069 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -71.37 130.08 40.44 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.805 -0.821 . . . . 0.0 111.347 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.21 153.4 42.49 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.351 1.06 . . . . 0.0 112.211 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.24 -17.29 67.18 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.816 1.198 . . . . 0.0 113.537 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -154.48 146.03 23.18 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.736 1.214 . . . . 0.0 110.809 170.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.2 t -145.22 126.47 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 126.456 1.902 . . . . 0.0 109.247 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -141.8 144.1 33.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.05 1.34 . . . . 0.0 112.316 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.3 mt -140.67 133.83 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 126.142 1.777 . . . . 0.0 108.483 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -124.88 107.49 10.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.954 0.902 . . . . 0.0 112.043 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -72.14 -27.24 62.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -171.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.67 -11.68 60.49 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.897 0.879 . . . . 0.0 113.27 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -114.8 -31.34 6.16 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.942 1.297 . . . . 0.0 113.204 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.5 29.34 19.42 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.744 1.164 . . . . 0.0 113.985 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -138.74 155.38 48.26 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.317 1.447 . . . . 0.0 112.022 -173.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.06 170.82 25.19 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.198 1.38 . . . . 0.0 113.49 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -144.78 144.03 30.96 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.197 1.799 . . . . 0.0 109.412 -173.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.1 tt -153.83 134.99 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.522 0.729 . . . . 0.0 110.6 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -125.79 117.99 24.58 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.898 0.879 . . . . 0.0 110.04 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.92 178.65 5.59 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.765 0.826 . . . . 0.0 111.965 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -80.85 -27.32 36.49 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.1 p -144.19 158.07 43.94 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.366 1.066 . . . . 0.0 111.792 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -57.44 -37.82 73.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.935 0.894 . . . . 0.0 112.404 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.0 m -62.06 -47.42 84.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.189 1.396 . . . . 0.0 110.794 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.03 -42.98 99.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.11 0.564 . . . . 0.0 111.305 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.53 -35.94 80.05 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.59 -47.74 71.77 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.2 1.0 . . . . 0.0 111.347 173.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.47 -47.63 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.715 -0.615 . . . . 0.0 110.14 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.06 -45.52 86.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.71 0.804 . . . . 0.0 112.249 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -55.58 -50.6 69.65 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.206 -0.934 . . . . 0.0 111.697 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.1 t -65.47 -34.01 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.762 0.71 . . . . 0.0 112.29 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -82.75 -32.69 27.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 61.0 mt -105.48 -20.42 13.48 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.275 1.584 . . . . 0.0 115.275 -168.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -70.5 128.61 36.73 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.514 1.052 . . . . 0.0 111.421 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 58.0 t30 69.02 13.73 8.79 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.394 2.278 . . . . 0.0 114.186 -171.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.5 ttp -72.48 138.65 80.85 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 120.569 -1.332 . . . . 0.0 110.894 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -74.37 134.31 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.448 2.766 . . . . 0.0 111.153 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 45.1 tp -143.22 115.99 8.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.49 1.516 . . . . 0.0 110.172 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 57.57 21.74 7.45 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.241 1.416 . . . . 0.0 113.471 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.28 -3.02 68.94 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.925 1.726 . . . . 0.0 115.083 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -97.08 156.15 16.5 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.723 1.609 . . . . 0.0 110.959 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -105.58 117.09 33.14 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.265 -0.897 . . . . 0.0 109.366 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.3 mt -72.71 136.01 45.48 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.96 0.904 . . . . 0.0 112.226 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.0 tpp180 -99.77 124.29 44.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.619 1.168 . . . . 0.0 108.767 169.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.74 128.06 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.985 0.914 . . . . 0.0 109.75 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -150.7 160.16 44.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.863 1.265 . . . . 0.0 111.192 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -68.69 132.61 47.14 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.721 -0.612 . . . . 0.0 110.356 170.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.62 -21.42 61.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 72.7 m -134.1 135.64 43.35 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.117 2.167 . . . . 0.0 108.651 171.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -155.97 -48.4 0.08 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.4 t -82.78 131.33 35.2 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.454 0.702 . . . . 0.0 110.455 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.58 154.0 34.85 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.04 0.936 . . . . 0.0 112.621 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.7 t -77.79 175.88 9.56 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.56 0.744 . . . . 0.0 112.456 173.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.42 168.36 16.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.557 1.143 . . . . 0.0 112.943 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.1 t -156.54 156.89 34.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.531 1.532 . . . . 0.0 110.848 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 28.9 p -100.81 101.26 12.06 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.335 1.454 . . . . 0.0 111.175 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -172.3 86.94 0.08 OUTLIER Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.312 -1.271 . . . . 0.0 113.322 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.54 163.38 37.68 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.645 2.897 . . . . 0.0 111.17 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.1 m -137.79 136.1 36.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.755 1.222 . . . . 0.0 111.436 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.9 m -104.59 162.4 13.3 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.019 1.327 . . . . 0.0 112.476 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-O 118.047 -1.418 . . . . 0.0 113.256 -179.829 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t 73.58 5.2 4.9 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.211 1.804 . . . . 0.0 114.39 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.5 p -74.86 140.81 44.12 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.086 -1.634 . . . . 0.0 112.133 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.75 28.02 65.93 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.54 -0.725 . . . . 0.0 114.324 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -77.2 54.17 1.06 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.349 1.46 . . . . 0.0 112.58 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.5 m -83.78 86.18 7.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.495 1.518 . . . . 0.0 111.418 -177.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.65 22.76 7.26 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.375 1.464 . . . . 0.0 115.283 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.9 41.99 9.23 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.494 1.147 . . . . 0.0 112.806 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -66.95 123.64 20.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.725 1.21 . . . . 0.0 111.798 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -87.97 71.87 9.35 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.493 1.117 . . . . 0.0 111.592 -175.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.5 p -69.44 159.98 32.23 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.488 1.515 . . . . 0.0 111.792 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -54.76 -36.47 64.87 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.406 1.483 . . . . 0.0 113.426 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.1 p -139.36 151.53 46.42 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 127.277 2.231 . . . . 0.0 108.737 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -146.7 150.84 36.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.38 1.872 . . . . 0.0 107.864 -169.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -143.18 129.72 20.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.987 0.899 . . . . 0.0 111.976 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 p -79.46 25.84 0.31 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 128.379 2.672 . . . . 0.0 113.413 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -83.27 129.01 34.98 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.335 1.454 . . . . 0.0 110.468 -176.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.4 mt -113.98 134.38 54.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.146 1.778 . . . . 0.0 110.056 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -89.26 137.4 32.36 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.141 2.176 . . . . 0.0 108.529 170.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -130.06 109.93 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.126 0.97 . . . . 0.0 109.415 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.1 173.8 20.11 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.21 1.862 . . . . 0.0 113.328 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.1 m120 64.0 19.59 11.82 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.951 1.701 . . . . 0.0 113.276 -173.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.67 140.63 92.78 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.067 -1.021 . . . . 0.0 112.778 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -69.44 157.35 61.34 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.856 3.037 . . . . 0.0 110.991 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.66 -5.47 17.12 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.26 2.64 . . . . 0.0 113.164 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -104.38 9.74 35.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.338 1.855 . . . . 0.0 113.321 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.2 tp -82.04 144.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.091 -1.006 . . . . 0.0 111.016 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.9 p -135.12 166.57 22.76 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.492 1.917 . . . . 0.0 109.303 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -60.73 -27.34 67.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.859 0.464 . . . . 0.0 112.012 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -72.9 -40.0 65.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.983 0.913 . . . . 0.0 111.773 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -65.42 -42.3 92.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.409 0.55 . . . . 0.0 111.004 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.3 ttt -69.12 -36.76 77.86 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.621 0.768 . . . . 0.0 112.221 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -61.62 -46.61 89.07 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.742 0.817 . . . . 0.0 110.79 169.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -66.38 -39.8 89.31 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.0 mt -59.62 -22.85 62.42 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.074 1.35 . . . . 0.0 113.694 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -116.09 7.83 14.33 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.437 1.495 . . . . 0.0 112.569 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -68.72 -22.0 64.37 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -169.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -67.13 -22.28 65.8 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.286 -0.883 . . . . 0.0 112.207 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -93.92 10.8 31.88 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.414 1.886 . . . . 0.0 112.589 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.48 -175.94 53.55 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.334 1.445 . . . . 0.0 113.189 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -72.1 128.92 37.2 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.992 -0.71 . . . . 0.0 111.186 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.35 147.08 48.37 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.959 0.904 . . . . 0.0 111.673 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.05 -1.28 82.25 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.831 1.205 . . . . 0.0 113.819 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -162.76 128.63 3.34 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.496 1.918 . . . . 0.0 108.18 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.71 123.32 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.745 1.218 . . . . 0.0 108.917 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -141.22 137.79 32.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.976 1.311 . . . . 0.0 110.927 176.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.7 mt -137.76 126.77 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.42 1.488 . . . . 0.0 108.359 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -118.32 108.42 15.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.281 1.033 . . . . 0.0 112.02 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -71.62 -30.6 65.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.019 0.928 . . . . 0.0 113.285 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.78 -20.22 61.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.049 0.94 . . . . 0.0 113.454 -176.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -112.83 -24.47 9.55 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.54 38.15 7.76 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 124.76 1.172 . . . . 0.0 114.154 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -140.62 152.99 45.87 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.16 1.384 . . . . 0.0 112.122 -173.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.37 161.48 24.97 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.029 1.3 . . . . 0.0 113.553 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.45 138.11 34.43 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.486 1.914 . . . . 0.0 109.476 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.4 tt -147.81 135.13 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 110.713 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -118.71 123.52 45.08 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.543 0.737 . . . . 0.0 110.749 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.64 170.33 9.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.711 0.804 . . . . 0.0 110.887 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.43 -22.27 51.74 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.8 p -146.26 144.05 29.6 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.747 1.219 . . . . 0.0 111.951 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.416 ' HD2' ' H ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -60.43 -32.53 71.45 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 m -63.92 -48.15 77.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.578 1.151 . . . . 0.0 110.756 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.18 -35.77 82.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.844 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.17 86.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.033 0.833 . . . . 0.0 112.736 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.09 -47.39 71.36 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.176 0.898 . . . . 0.0 111.812 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.9 mt -60.08 -50.12 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.778 -0.576 . . . . 0.0 110.044 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.02 -43.55 91.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.626 0.77 . . . . 0.0 111.87 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -57.24 -47.91 80.16 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.076 0.853 . . . . 0.0 111.586 174.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 78.6 t -71.09 -34.94 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 118.802 0.728 . . . . 0.0 112.176 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -82.79 -28.86 30.0 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 55.5 mt -99.31 -16.25 18.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.165 0.986 . . . . 0.0 113.374 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.96 116.6 2.84 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.022 1.729 . . . . 0.0 111.885 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.0 m120 64.32 19.47 11.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.138 2.175 . . . . 0.0 114.286 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.9 ttp -70.5 137.12 86.04 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 120.703 -1.248 . . . . 0.0 110.858 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.27 139.28 23.42 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.356 2.704 . . . . 0.0 111.437 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.9 tp -142.08 115.2 8.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.684 1.594 . . . . 0.0 109.801 173.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 57.18 25.22 10.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.931 1.292 . . . . 0.0 113.768 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.54 -3.67 83.64 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.542 1.544 . . . . 0.0 114.706 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -95.66 161.39 14.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.551 1.54 . . . . 0.0 111.047 172.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -88.24 176.05 7.41 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.79 169.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.0 mt -134.51 115.07 13.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.525 1.13 . . . . 0.0 109.704 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -91.97 115.91 28.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.629 0.771 . . . . 0.0 109.064 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.4 t -119.6 123.31 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.904 0.882 . . . . 0.0 110.503 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -139.94 164.61 29.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.029 1.732 . . . . 0.0 111.387 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -79.04 126.84 31.23 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.532 -0.73 . . . . 0.0 111.051 169.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.99 66.03 4.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.74 1.616 . . . . 0.0 110.603 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 27.5 t -144.43 132.03 21.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.718 1.207 . . . . 0.0 111.474 -173.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -164.26 159.93 20.55 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.509 2.323 . . . . 0.0 110.428 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.0 t -152.86 118.32 5.27 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.182 0.993 . . . . 0.0 110.601 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.0 131.96 36.48 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.8 0.84 . . . . 0.0 110.569 174.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 60.4 p -158.69 144.0 16.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.64 1.176 . . . . 0.0 111.198 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 30.4 tp -105.41 66.4 0.74 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.656 1.183 . . . . 0.0 110.058 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.4 p -77.19 77.12 3.73 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.751 1.62 . . . . 0.0 110.865 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.1 t -70.78 -10.61 59.86 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.295 1.038 . . . . 0.0 113.626 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.28 168.34 44.68 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.815 1.674 . . . . 0.0 114.334 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.47 169.11 22.53 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.251 3.301 . . . . 0.0 111.45 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 61.1 p -155.52 142.12 18.77 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.497 1.119 . . . . 0.0 111.852 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.9 t -164.33 152.21 12.33 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.364 1.466 . . . . 0.0 110.904 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.199 0 C-N-CA 125.203 1.382 . . . . 0.0 113.769 -176.929 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.478 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.4 m -84.44 161.7 20.22 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.241 1.016 . . . . 0.0 113.16 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.1 m -139.55 149.8 44.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.932 1.693 . . . . 0.0 110.531 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.34 -35.19 48.78 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -169.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 t -169.98 155.5 5.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.855 1.262 . . . . 0.0 112.125 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 72.7 p -86.32 -5.33 59.2 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.266 1.426 . . . . 0.0 113.181 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.47 0.72 62.69 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.665 1.603 . . . . 0.0 113.23 -169.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.78 16.72 67.34 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.724 1.154 . . . . 0.0 114.931 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -139.99 144.85 37.19 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.198 1.399 . . . . 0.0 110.869 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.83 147.51 45.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.251 1.02 . . . . 0.0 113.372 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.6 p -116.38 -39.5 3.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.21 1.804 . . . . 0.0 112.254 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -149.99 152.28 34.66 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.017 2.127 . . . . 0.0 110.561 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.7 m -136.87 120.34 17.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.238 1.415 . . . . 0.0 108.997 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -125.01 47.13 2.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.296 1.439 . . . . 0.0 109.532 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -96.56 76.98 2.9 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.747 1.219 . . . . 0.0 109.079 175.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.7 p -72.25 36.2 0.07 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.888 2.875 . . . . 0.0 113.511 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -95.11 128.27 41.81 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.829 1.652 . . . . 0.0 111.257 -169.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -111.18 137.98 48.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.381 1.872 . . . . 0.0 110.474 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -92.47 136.3 33.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.371 2.268 . . . . 0.0 108.596 169.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.8 t -128.71 116.06 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.469 1.108 . . . . 0.0 109.024 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.88 165.51 14.03 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 125.013 1.292 . . . . 0.0 114.561 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 64.76 33.1 10.59 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.691 1.596 . . . . 0.0 111.658 -174.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 mt -66.19 143.29 98.28 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 121.143 -0.973 . . . . 0.0 112.144 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.27 163.81 37.34 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.167 3.245 . . . . 0.0 111.506 174.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.0 -7.68 19.39 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.243 2.629 . . . . 0.0 113.195 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -94.87 7.75 44.96 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.725 1.61 . . . . 0.0 113.528 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 tp -97.43 135.95 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.644 1.178 . . . . 0.0 111.398 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.8 p -131.23 179.6 5.92 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.594 1.558 . . . . 0.0 109.235 169.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -57.31 -25.37 59.21 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.712 0.805 . . . . 0.0 112.549 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.45 -47.79 38.77 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.979 -1.076 . . . . 0.0 111.808 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -63.72 -41.54 98.05 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.078 0.551 . . . . 0.0 111.115 174.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.9 ttt -67.78 -33.14 74.24 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -67.56 -40.05 84.92 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.877 0.762 . . . . 0.0 111.447 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.8 -42.42 81.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.9 0.88 . . . . 0.0 112.683 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.7 mt -57.4 -28.18 63.01 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.404 1.482 . . . . 0.0 113.526 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -110.49 9.18 23.27 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.339 1.456 . . . . 0.0 112.677 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.29 -25.12 67.91 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -62.57 -22.82 66.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.955 1.302 . . . . 0.0 112.987 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -102.88 9.88 38.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.324 1.85 . . . . 0.0 112.644 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.78 -179.05 53.52 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.233 0.921 . . . . 0.0 112.612 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.52 141.28 50.13 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.79 -0.829 . . . . 0.0 112.175 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.41 150.42 27.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.483 1.113 . . . . 0.0 112.133 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.06 -9.42 73.69 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.205 1.384 . . . . 0.0 113.886 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -155.91 137.41 14.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.577 1.951 . . . . 0.0 108.409 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.2 t -143.87 127.24 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.448 1.499 . . . . 0.0 109.174 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -144.9 142.56 29.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.312 1.445 . . . . 0.0 112.201 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 57.4 mt -141.02 131.84 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.455 1.902 . . . . 0.0 108.838 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -125.28 113.17 17.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.094 0.957 . . . . 0.0 111.86 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -72.79 -36.19 67.56 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -170.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.39 -24.6 62.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.741 0.817 . . . . 0.0 113.043 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -100.19 -27.87 13.3 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.237 1.015 . . . . 0.0 113.346 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.81 29.78 19.91 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.798 1.19 . . . . 0.0 114.304 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -137.8 156.59 47.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.245 1.418 . . . . 0.0 112.267 -172.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.28 168.79 26.54 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.215 1.388 . . . . 0.0 113.417 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -142.52 149.68 39.45 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.034 1.733 . . . . 0.0 110.402 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.6 tt -155.31 141.92 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.233 1.013 . . . . 0.0 110.492 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -123.7 123.93 41.61 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.944 0.793 . . . . 0.0 111.308 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.4 mt -95.44 167.43 11.32 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.998 0.919 . . . . 0.0 110.639 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.29 -13.25 61.09 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.2 p -147.32 157.72 43.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.288 1.435 . . . . 0.0 111.684 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -60.12 -32.27 70.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.758 0.823 . . . . 0.0 113.1 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 m -63.97 -48.49 76.25 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.394 1.478 . . . . 0.0 110.506 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.66 -41.45 99.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.136 0.574 . . . . 0.0 111.202 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.63 87.26 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.48 -50.29 70.23 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.306 0.957 . . . . 0.0 111.969 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 83.4 mt -61.31 -47.92 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.752 -0.593 . . . . 0.0 110.289 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.14 95.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.703 0.801 . . . . 0.0 111.998 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.26 -44.57 92.41 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.213 -0.929 . . . . 0.0 112.042 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.2 t -66.72 -36.89 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.268 0.627 . . . . 0.0 111.918 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -85.23 -28.55 25.32 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.5 mt -103.69 -18.84 14.54 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.64 140.83 58.91 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.4 1.0 . . . . 0.0 111.127 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . 0.298 12.0 p30 55.15 18.99 2.62 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.327 2.251 . . . . 0.0 114.966 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.2 ttp -76.29 139.5 68.32 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.092 1.357 . . . . 0.0 111.109 173.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.83 138.88 19.19 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.546 2.831 . . . . 0.0 111.371 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -149.11 122.63 9.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.698 1.599 . . . . 0.0 109.726 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 56.51 32.19 20.33 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.758 1.223 . . . . 0.0 113.235 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.36 4.46 89.96 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.122 1.344 . . . . 0.0 114.637 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.45 156.92 20.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.492 1.917 . . . . 0.0 110.633 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -90.08 167.83 12.45 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.764 -0.585 . . . . 0.0 109.893 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.9 mt -129.77 140.32 51.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.69 1.196 . . . . 0.0 110.857 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -102.93 130.59 50.04 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.868 1.267 . . . . 0.0 108.312 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.39 120.42 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.136 0.88 . . . . 0.0 110.347 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -140.02 167.76 21.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.427 1.891 . . . . 0.0 110.554 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -75.94 134.44 40.22 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.575 -0.703 . . . . 0.0 111.127 169.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.61 -7.52 57.38 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.552 1.141 . . . . 0.0 113.054 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 46.7 t -73.78 143.09 46.17 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.395 1.478 . . . . 0.0 112.008 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -81.18 -165.55 0.95 Allowed 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.863 1.665 . . . . 0.0 113.069 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 30.1 t -156.38 -47.09 0.07 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.79 -1.194 . . . . 0.0 112.277 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.67 162.82 33.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.667 1.587 . . . . 0.0 111.669 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.9 m -73.78 -14.14 61.06 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -170.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -117.31 132.65 56.56 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.696 1.598 . . . . 0.0 110.185 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.0 t -85.62 -19.56 30.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.78 1.232 . . . . 0.0 113.248 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.3 t -163.89 163.67 23.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.755 1.622 . . . . 0.0 110.945 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 144.05 175.3 17.05 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.747 1.641 . . . . 0.0 113.445 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.35 127.6 12.8 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.659 2.906 . . . . 0.0 110.996 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.6 m -167.53 153.06 7.33 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.927 2.091 . . . . 0.0 110.724 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.9 m 68.29 7.91 6.24 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 169.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.337 0 C-N-CA 125.893 1.711 . . . . 0.0 113.458 177.758 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 112.006 -0.437 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.6 p -85.64 -13.55 48.31 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.0 p -92.7 142.41 27.39 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.505 1.522 . . . . 0.0 112.078 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.8 -169.74 47.05 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.284 0.945 . . . . 0.0 113.459 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.7 t -166.67 -159.7 0.37 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.028 1.731 . . . . 0.0 110.709 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.2 t -143.2 146.88 34.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.666 1.586 . . . . 0.0 111.356 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.93 163.06 18.23 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.464 1.507 . . . . 0.0 113.153 -172.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.17 72.7 2.76 Favored Glycine 0 N--CA 1.471 1.006 0 C-N-CA 124.988 1.28 . . . . 0.0 113.311 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 55.95 11.81 0.79 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 128.554 2.742 . . . . 0.0 116.566 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -68.53 123.69 21.52 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.588 -1.32 . . . . 0.0 112.096 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.7 p -146.75 160.43 42.25 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.717 2.007 . . . . 0.0 110.633 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -84.62 -17.5 38.45 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.6 t -170.42 159.97 7.29 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.156 2.182 . . . . 0.0 109.973 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -90.63 99.65 12.64 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.966 0.906 . . . . 0.0 109.618 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -78.83 56.19 1.86 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.002 1.321 . . . . 0.0 111.76 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.0 m -77.53 58.85 1.82 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.877 2.071 . . . . 0.0 113.397 -174.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.64 134.73 34.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.705 1.202 . . . . 0.0 110.483 172.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.1 mt -111.54 133.98 53.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.147 1.379 . . . . 0.0 110.056 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -85.57 144.76 27.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.225 2.21 . . . . 0.0 108.004 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.53 110.02 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.192 0.997 . . . . 0.0 109.185 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.65 169.94 13.69 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.501 1.524 . . . . 0.0 113.249 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 65.47 29.04 11.43 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.381 1.473 . . . . 0.0 111.819 -173.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.8 mt -65.6 144.08 98.81 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.848 -1.157 . . . . 0.0 111.928 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.4 159.39 50.55 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.224 2.616 . . . . 0.0 111.292 174.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.08 -0.47 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.484 2.789 . . . . 0.0 113.299 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -114.38 7.35 16.31 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.732 1.613 . . . . 0.0 113.083 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.9 tp -73.28 145.54 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.789 0.836 . . . . 0.0 111.126 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.8 p -127.7 163.03 25.18 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.654 1.582 . . . . 0.0 110.079 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.98 -28.09 67.39 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.323 0.649 . . . . 0.0 111.687 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.24 -41.94 69.49 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.122 0.969 . . . . 0.0 111.507 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -66.07 -37.56 86.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.84 -0.537 . . . . 0.0 111.494 172.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.9 ttt -68.07 -38.98 83.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.536 0.734 . . . . 0.0 112.064 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -62.39 -37.55 86.17 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.107 0.963 . . . . 0.0 111.939 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -71.52 -42.74 67.59 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.412 -0.805 . . . . 0.0 112.453 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.6 mt -57.94 -27.86 63.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.862 1.265 . . . . 0.0 113.082 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -108.82 11.94 25.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.371 1.469 . . . . 0.0 112.769 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.73 -22.31 66.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.093 -1.004 . . . . 0.0 113.684 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -61.1 -22.79 64.98 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.895 1.278 . . . . 0.0 112.616 171.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -108.39 12.14 26.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.784 2.033 . . . . 0.0 112.375 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.18 -172.36 55.18 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.465 1.031 . . . . 0.0 112.94 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -71.47 133.73 46.06 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.989 0.916 . . . . 0.0 111.026 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.11 150.68 31.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.592 1.157 . . . . 0.0 112.02 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.45 -11.84 74.14 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.614 1.102 . . . . 0.0 114.138 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -159.87 138.77 10.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.065 1.746 . . . . 0.0 109.28 174.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.0 t -139.09 130.92 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.934 1.693 . . . . 0.0 109.222 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -141.59 141.03 33.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.21 1.404 . . . . 0.0 111.443 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.3 mt -140.6 129.34 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.011 1.724 . . . . 0.0 107.929 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -118.15 108.7 15.5 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.721 0.772 . . . . 0.0 112.324 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -72.26 -19.65 61.66 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -81.2 -13.75 58.25 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.192 0.997 . . . . 0.0 112.992 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -117.07 -25.66 7.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.916 1.286 . . . . 0.0 113.987 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.43 27.73 35.18 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 124.482 1.039 . . . . 0.0 114.257 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -134.5 149.96 50.75 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.419 1.488 . . . . 0.0 111.616 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.67 166.87 25.23 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.38 1.467 . . . . 0.0 113.134 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -146.19 143.28 29.17 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.342 1.857 . . . . 0.0 109.745 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.1 tt -150.95 133.39 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.078 0.951 . . . . 0.0 110.974 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -112.88 122.12 46.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.172 0.989 . . . . 0.0 110.541 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.27 163.48 12.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.688 0.795 . . . . 0.0 111.063 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.6 -23.77 53.45 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -171.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.5 p -148.71 143.6 26.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.402 1.481 . . . . 0.0 111.642 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -58.95 -32.92 70.06 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.7 m -59.43 -48.59 81.06 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.987 1.315 . . . . 0.0 111.032 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.07 -37.9 89.11 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.388 0.675 . . . . 0.0 111.817 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.51 -33.62 73.1 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.2 -46.78 72.88 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.831 0.852 . . . . 0.0 111.545 171.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.75 -47.46 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.72 -0.613 . . . . 0.0 110.061 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.96 -45.18 91.15 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.899 0.88 . . . . 0.0 112.218 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -55.47 -50.55 69.58 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.076 -1.015 . . . . 0.0 111.66 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.62 -34.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.695 0.68 . . . . 0.0 112.287 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -82.37 -32.89 29.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.8 mt -105.91 -19.57 13.7 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -168.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -71.97 127.46 32.63 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.696 1.135 . . . . 0.0 111.235 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 71.49 12.37 6.53 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.843 2.457 . . . . 0.0 113.736 -169.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.6 ttp -72.63 134.35 81.91 Favored Pre-proline 0 N--CA 1.473 0.691 0 O-C-N 120.574 -1.329 . . . . 0.0 110.767 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.61 132.29 15.8 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.065 2.51 . . . . 0.0 110.801 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 tp -137.29 104.76 5.49 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.514 1.126 . . . . 0.0 110.235 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.5 mtp-105 58.93 26.42 14.93 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.043 1.337 . . . . 0.0 113.691 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.94 -12.53 60.74 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.112 1.815 . . . . 0.0 114.576 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -82.09 163.86 21.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.578 1.189 . . . . 0.0 111.512 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -128.98 105.52 8.26 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.816 1.247 . . . . 0.0 108.878 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.81 125.13 25.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.008 1.323 . . . . 0.0 112.749 -168.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -93.06 118.02 30.72 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.264 1.025 . . . . 0.0 109.313 173.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.32 126.23 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.068 0.947 . . . . 0.0 109.943 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -143.33 159.73 41.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.753 1.621 . . . . 0.0 110.475 -173.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -81.31 124.62 29.5 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.504 -0.747 . . . . 0.0 110.792 170.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.86 74.13 8.86 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.149 0.98 . . . . 0.0 111.231 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 86.7 m -86.17 34.77 0.63 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.075 1.75 . . . . 0.0 113.29 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -62.27 138.15 58.38 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 121.141 -0.974 . . . . 0.0 113.339 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.9 m -153.16 165.54 35.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.587 1.955 . . . . 0.0 110.518 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -139.8 98.85 3.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.586 1.154 . . . . 0.0 110.779 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.8 t -168.35 170.37 9.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.575 1.95 . . . . 0.0 110.555 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -155.93 32.74 0.35 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.576 1.55 . . . . 0.0 113.298 -172.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.7 p -59.4 141.04 55.55 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.091 1.356 . . . . 0.0 111.567 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 77.3 p -167.68 171.05 10.48 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.385 1.474 . . . . 0.0 111.805 -171.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 93.59 90.24 1.6 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.969 1.271 . . . . 0.0 112.089 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.26 119.73 5.94 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.218 2.612 . . . . 0.0 110.662 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.1 t 66.31 8.53 5.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.653 1.581 . . . . 0.0 114.158 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.2 t -159.77 117.33 2.65 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.4 -1.438 . . . . 0.0 111.111 -173.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.471 1.51 . . . . 0.0 112.754 178.776 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.8 m -92.47 124.56 36.6 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.931 0.866 . . . . 0.0 111.293 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.2 p -166.89 167.51 14.8 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.829 1.652 . . . . 0.0 111.143 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.07 47.29 13.62 Favored Glycine 0 N--CA 1.472 1.064 0 O-C-N 121.598 -0.688 . . . . 0.0 112.794 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 m -64.25 -15.7 60.6 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.9 m -101.86 6.42 41.48 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.867 1.267 . . . . 0.0 113.468 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.87 -37.1 1.98 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.465 1.983 . . . . 0.0 113.475 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.37 -152.77 51.2 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.578 1.085 . . . . 0.0 113.815 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -78.72 170.37 16.77 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.883 1.273 . . . . 0.0 111.788 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -60.83 142.32 56.24 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.176 -0.953 . . . . 0.0 112.647 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.0 p -143.35 171.33 14.26 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.025 2.13 . . . . 0.0 111.076 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -63.33 153.58 34.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.988 1.315 . . . . 0.0 112.814 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.7 t -88.11 161.57 17.23 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.852 1.261 . . . . 0.0 111.576 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 pt20 -93.0 21.49 5.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.473 1.509 . . . . 0.0 113.085 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -62.86 -18.15 62.5 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.632 -1.292 . . . . 0.0 114.353 -173.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 m -78.95 8.63 5.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.717 1.607 . . . . 0.0 114.056 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -76.91 128.82 35.26 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.092 1.357 . . . . 0.0 111.848 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.5 mt -105.26 141.58 36.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.574 1.95 . . . . 0.0 110.437 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -96.94 143.68 27.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.526 2.33 . . . . 0.0 108.474 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.2 t -132.56 115.89 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.184 0.994 . . . . 0.0 109.782 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.98 173.26 16.5 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 125.912 1.72 . . . . 0.0 113.226 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m120 64.95 20.47 12.12 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.956 1.702 . . . . 0.0 113.093 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.9 mt -61.6 140.75 95.05 Favored Pre-proline 0 CA--C 1.549 0.936 0 O-C-N 121.198 -0.939 . . . . 0.0 112.319 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.41 164.4 35.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.369 3.38 . . . . 0.0 111.898 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.88 5.8 4.19 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.837 3.024 . . . . 0.0 113.691 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.3 p30 -128.15 13.9 6.71 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.969 1.708 . . . . 0.0 114.042 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.8 tp -80.12 143.63 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.123 0.969 . . . . 0.0 110.423 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.3 p -132.8 167.25 20.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.126 1.77 . . . . 0.0 109.677 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.67 -28.47 68.63 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.641 0.376 . . . . 0.0 111.82 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -70.43 -45.56 65.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.346 1.058 . . . . 0.0 110.975 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -65.2 -38.66 91.16 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.719 -0.613 . . . . 0.0 111.695 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.6 ttt -69.44 -38.2 77.73 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.646 0.657 . . . . 0.0 111.98 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -63.66 -37.22 86.5 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.435 -0.791 . . . . 0.0 111.992 170.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.3 -43.1 64.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.087 0.955 . . . . 0.0 111.872 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.6 mt -57.02 -28.85 62.86 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.058 1.343 . . . . 0.0 113.343 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -105.45 8.17 33.4 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.311 1.444 . . . . 0.0 112.693 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.09 -25.74 67.92 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -169.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -64.41 -21.54 66.67 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.696 0.798 . . . . 0.0 112.724 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -102.96 6.33 38.85 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.096 1.758 . . . . 0.0 112.097 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.13 173.7 46.26 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.174 1.369 . . . . 0.0 112.587 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -67.18 136.04 54.43 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.497 -1.001 . . . . 0.0 111.317 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.08 157.24 37.22 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.927 0.891 . . . . 0.0 112.071 173.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.06 -12.07 62.37 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.048 1.308 . . . . 0.0 113.753 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -152.77 137.09 16.61 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.901 1.68 . . . . 0.0 109.28 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.0 127.81 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.06 1.744 . . . . 0.0 108.853 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -143.96 140.48 29.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.836 1.254 . . . . 0.0 111.454 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.7 mt -139.85 129.4 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.859 1.664 . . . . 0.0 108.276 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -122.23 112.95 18.79 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.841 0.857 . . . . 0.0 112.56 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -70.5 -35.19 73.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 113.613 -173.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.23 -23.66 61.27 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.805 0.842 . . . . 0.0 113.044 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -103.3 -26.48 12.93 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.23 35.68 14.34 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 124.876 1.227 . . . . 0.0 114.115 175.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -140.64 153.16 45.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.21 1.404 . . . . 0.0 112.366 -172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.06 158.14 22.99 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.359 1.456 . . . . 0.0 113.092 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -138.67 137.84 37.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.83 2.052 . . . . 0.0 109.012 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.3 tt -151.81 130.39 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.535 0.734 . . . . 0.0 110.971 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -119.15 113.56 21.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.948 0.899 . . . . 0.0 110.409 -170.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.0 mt -90.73 166.07 13.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.641 0.777 . . . . 0.0 111.124 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -78.56 -17.95 55.36 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.0 p -144.04 157.32 44.4 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.773 1.229 . . . . 0.0 111.616 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -59.6 -40.33 87.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.789 0.835 . . . . 0.0 111.429 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.7 m -58.88 -47.53 84.62 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.011 1.325 . . . . 0.0 111.212 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.3 -42.9 99.08 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.265 0.626 . . . . 0.0 111.179 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.03 -36.27 83.84 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.03 -46.5 71.03 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.888 0.875 . . . . 0.0 111.697 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.95 -47.96 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.633 -0.667 . . . . 0.0 110.102 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.76 -44.35 93.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.423 0.689 . . . . 0.0 112.104 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -54.57 -52.58 61.66 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.258 0.935 . . . . 0.0 111.507 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.29 -34.3 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.382 0.537 . . . . 0.0 111.961 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -81.03 -36.05 31.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.5 -21.78 17.5 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -170.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.31 127.24 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.02 0.827 . . . . 0.0 111.276 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 71.2 11.75 6.82 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.28 2.232 . . . . 0.0 113.786 -173.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.9 ttp -74.33 137.34 75.02 Favored Pre-proline 0 N--CA 1.475 0.796 0 O-C-N 120.549 -1.344 . . . . 0.0 110.893 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.67 141.07 24.37 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.256 2.637 . . . . 0.0 111.191 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.6 tp -137.04 104.25 5.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.512 1.525 . . . . 0.0 110.059 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 59.03 22.56 10.6 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.594 1.558 . . . . 0.0 114.256 172.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.37 -9.97 49.9 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.994 1.759 . . . . 0.0 114.788 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -94.27 166.44 12.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.796 1.298 . . . . 0.0 111.254 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -96.62 176.18 6.11 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.089 0.956 . . . . 0.0 110.401 169.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.8 mt -135.7 116.66 14.22 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.608 1.163 . . . . 0.0 109.723 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -95.77 111.09 23.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.734 0.814 . . . . 0.0 108.955 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.81 130.51 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.127 0.971 . . . . 0.0 109.54 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -150.99 163.76 37.98 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.401 1.48 . . . . 0.0 111.077 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -72.67 137.76 46.23 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.535 -0.728 . . . . 0.0 110.83 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.75 4.78 53.13 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.979 1.312 . . . . 0.0 113.084 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 75.9 m -139.51 17.79 2.55 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.988 2.115 . . . . 0.0 112.556 -173.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -165.04 137.4 4.39 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.744 2.418 . . . . 0.0 109.489 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.1 t -151.5 82.82 1.3 Allowed 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.138 -0.976 . . . . 0.0 110.57 -172.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 58.91 22.9 10.8 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.813 1.645 . . . . 0.0 113.334 -175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 m -76.6 30.66 0.13 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.543 1.937 . . . . 0.0 114.103 -169.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.55 69.97 8.33 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.469 1.908 . . . . 0.0 111.137 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 m -76.91 75.81 3.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.316 1.447 . . . . 0.0 109.869 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 25.9 t -163.95 145.85 9.1 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.911 1.685 . . . . 0.0 111.065 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -121.36 78.92 0.33 Allowed Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.254 1.407 . . . . 0.0 112.279 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.31 171.22 17.39 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.6 2.867 . . . . 0.0 111.413 174.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 t -148.22 136.66 21.43 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.215 1.006 . . . . 0.0 111.352 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.1 t -166.74 163.24 16.55 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.144 1.778 . . . . 0.0 110.733 -175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.126 1.346 . . . . 0.0 113.008 -178.357 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 p -73.54 161.33 30.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.54 1.136 . . . . 0.0 112.359 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.1 m -79.87 -27.92 40.03 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.702 -1.249 . . . . 0.0 112.778 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.36 41.72 77.04 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.013 0.816 . . . . 0.0 113.689 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.8 p -62.73 152.01 36.87 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.694 1.198 . . . . 0.0 113.492 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 t -108.89 161.08 15.46 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.83 1.252 . . . . 0.0 112.533 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.43 159.66 35.71 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.121 1.82 . . . . 0.0 113.016 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.87 179.59 45.69 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.969 1.271 . . . . 0.0 113.662 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.02 153.91 22.98 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.049 1.74 . . . . 0.0 110.497 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -98.13 126.12 43.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.967 0.907 . . . . 0.0 110.697 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.5 p -147.45 155.11 41.61 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.158 1.783 . . . . 0.0 110.988 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -82.37 39.0 0.57 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.542 1.937 . . . . 0.0 112.657 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.9 p -128.16 -176.4 3.79 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.241 1.816 . . . . 0.0 111.659 -170.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -150.47 156.32 41.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.228 1.411 . . . . 0.0 111.106 -173.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -136.97 43.24 2.39 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.418 1.487 . . . . 0.0 111.095 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.0 p -82.41 0.54 41.61 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.914 -1.116 . . . . 0.0 113.729 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -80.97 123.33 28.24 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.367 1.467 . . . . 0.0 111.015 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -115.07 140.78 48.78 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.829 1.652 . . . . 0.0 110.795 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -95.92 140.17 31.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.257 2.223 . . . . 0.0 108.669 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.52 108.38 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.301 1.04 . . . . 0.0 109.31 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.06 171.63 19.93 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.337 1.446 . . . . 0.0 112.873 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.0 m120 62.09 31.15 17.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.007 1.323 . . . . 0.0 111.923 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.9 mt -66.67 143.32 98.06 Favored Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 121.457 -0.777 . . . . 0.0 111.395 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.35 162.06 40.44 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.193 2.595 . . . . 0.0 111.158 170.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.99 -7.61 18.37 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.249 2.633 . . . . 0.0 112.413 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -96.14 6.95 47.68 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.559 1.944 . . . . 0.0 113.332 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -81.97 146.56 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.211 -0.931 . . . . 0.0 111.029 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.7 p -134.0 166.34 22.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.073 1.749 . . . . 0.0 109.351 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -61.58 -25.54 67.39 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.13 -40.8 59.47 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.164 0.986 . . . . 0.0 111.67 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -64.38 -41.97 96.41 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.494 0.588 . . . . 0.0 110.637 171.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.3 ttt -68.43 -36.55 79.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.534 0.734 . . . . 0.0 112.394 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -62.51 -41.55 98.92 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.716 0.689 . . . . 0.0 111.567 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -71.43 -39.75 70.85 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.976 0.807 . . . . 0.0 112.919 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -57.65 -22.59 46.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.148 1.379 . . . . 0.0 113.581 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -114.57 11.45 17.04 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.752 1.621 . . . . 0.0 112.616 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.4 -23.38 67.27 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -63.33 -23.33 67.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.177 1.391 . . . . 0.0 112.989 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -106.56 9.83 31.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.048 1.739 . . . . 0.0 112.598 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.44 -175.45 50.99 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.026 1.298 . . . . 0.0 113.121 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -73.77 128.48 35.63 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.094 -0.651 . . . . 0.0 110.944 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.05 143.34 47.52 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.239 1.015 . . . . 0.0 111.562 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.22 -11.9 82.94 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.973 0.797 . . . . 0.0 113.936 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -158.71 138.03 11.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.095 1.758 . . . . 0.0 109.389 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.56 127.39 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.873 1.669 . . . . 0.0 108.534 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -144.79 143.84 30.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.843 1.257 . . . . 0.0 112.018 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.1 mt -140.77 132.79 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.144 1.777 . . . . 0.0 108.687 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -125.59 104.95 8.67 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.936 0.895 . . . . 0.0 112.066 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.08 -23.97 60.6 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -172.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -72.92 -14.22 61.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.24 1.016 . . . . 0.0 113.339 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -117.22 -19.87 9.46 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.958 1.303 . . . . 0.0 114.005 173.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.2 26.45 40.3 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 124.826 1.203 . . . . 0.0 114.213 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -130.87 145.98 52.16 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.013 1.325 . . . . 0.0 112.196 -172.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.05 162.38 24.24 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.691 1.615 . . . . 0.0 112.576 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -143.19 136.47 28.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.485 1.914 . . . . 0.0 108.632 -170.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.2 tt -149.23 143.36 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.455 0.702 . . . . 0.0 111.099 -175.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.2 112.68 17.97 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.976 1.31 . . . . 0.0 110.135 -172.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.0 mt -89.67 175.76 7.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.389 0.54 . . . . 0.0 111.726 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.23 -26.43 58.91 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.3 p -144.54 159.27 43.06 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.684 1.193 . . . . 0.0 111.95 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -60.59 -33.64 73.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.804 0.842 . . . . 0.0 112.357 170.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.8 m -67.2 -45.88 75.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.461 1.504 . . . . 0.0 111.024 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.7 mt -61.19 -39.88 91.83 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.182 0.593 . . . . 0.0 111.131 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.84 -35.69 77.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -60.93 -51.56 68.75 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.398 0.999 . . . . 0.0 110.882 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.33 -49.09 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.3 0.64 . . . . 0.0 110.565 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.46 86.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.517 0.727 . . . . 0.0 111.819 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.44 -45.29 91.98 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.272 -0.892 . . . . 0.0 111.748 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.12 -33.27 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.837 0.855 . . . . 0.0 112.31 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -86.12 -24.66 26.14 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.9 mt -107.03 -16.95 14.31 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -170.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.81 134.2 52.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.204 1.365 . . . . 0.0 112.074 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.2 t30 65.57 14.31 9.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.901 2.08 . . . . 0.0 113.845 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.1 ttp -72.77 135.84 80.63 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 120.56 -1.337 . . . . 0.0 110.559 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.71 131.8 13.86 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.488 2.792 . . . . 0.0 110.869 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.9 tp -143.47 115.44 8.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.151 1.38 . . . . 0.0 109.55 174.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 53.55 35.51 21.06 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.789 1.236 . . . . 0.0 112.951 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.7 1.84 89.94 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.556 1.55 . . . . 0.0 115.204 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -105.91 149.5 26.51 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.762 1.625 . . . . 0.0 110.854 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -104.44 110.85 23.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.029 0.932 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 82.1 mt -72.23 125.69 27.94 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.874 0.87 . . . . 0.0 112.513 -169.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.17 105.97 18.2 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.979 0.912 . . . . 0.0 109.04 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.7 t -114.66 131.39 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.023 0.929 . . . . 0.0 110.123 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -153.37 169.27 23.52 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.569 1.548 . . . . 0.0 111.218 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -70.62 138.88 51.15 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.519 -0.738 . . . . 0.0 111.572 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.05 98.03 11.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.96 0.904 . . . . 0.0 108.835 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 34.2 t -161.46 150.25 15.94 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.224 1.409 . . . . 0.0 110.748 -171.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -150.52 110.76 4.16 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.213 1.405 . . . . 0.0 110.884 175.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.3 t -90.53 129.7 36.65 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.403 0.681 . . . . 0.0 109.631 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.82 -46.43 75.18 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.993 -0.442 . . . . 0.0 112.058 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 89.7 p 54.86 11.87 0.53 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 127.74 2.416 . . . . 0.0 115.24 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.8 tp -76.75 147.08 37.53 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.058 1.743 . . . . 0.0 111.955 -171.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 30.0 p -75.47 -15.56 60.4 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.653 1.581 . . . . 0.0 114.34 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 75.0 m -87.11 123.49 32.23 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.384 1.073 . . . . 0.0 110.763 172.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 166.11 -158.14 30.92 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.613 1.102 . . . . 0.0 113.107 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -80.0 36.35 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 124.745 3.63 . . . . 0.0 112.843 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.6 t -165.02 167.31 18.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.965 1.706 . . . . 0.0 111.019 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.9 p -164.76 131.05 2.88 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.361 1.464 . . . . 0.0 111.277 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.248 0 CA-C-O 117.417 -1.768 . . . . 0.0 112.891 178.53 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.7 t 68.78 28.15 5.57 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.415 1.486 . . . . 0.0 113.754 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 m -138.77 148.76 44.24 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.363 1.465 . . . . 0.0 111.38 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.09 75.51 1.23 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.557 1.075 . . . . 0.0 111.893 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m -80.84 -8.26 59.66 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.0 m -146.03 150.55 36.2 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.436 1.894 . . . . 0.0 110.447 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.98 -177.26 37.38 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.325 0.964 . . . . 0.0 114.232 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.47 -167.61 37.1 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.12 1.343 . . . . 0.0 113.18 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -87.91 148.5 24.57 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.261 1.024 . . . . 0.0 111.85 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? 54.49 45.09 27.75 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.16 1.384 . . . . 0.0 113.401 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.8 p -61.99 159.72 13.73 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.068 1.747 . . . . 0.0 112.275 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -79.89 5.77 12.93 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.086 1.354 . . . . 0.0 114.427 -171.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.1 p -65.61 145.76 55.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.046 1.738 . . . . 0.0 111.121 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -101.35 73.46 1.49 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.254 1.022 . . . . 0.0 111.584 -168.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -68.41 -28.3 66.97 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m -132.04 29.45 4.38 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.345 1.058 . . . . 0.0 113.361 -168.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -89.78 125.65 35.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.867 1.267 . . . . 0.0 112.057 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.31 146.45 35.7 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.859 2.063 . . . . 0.0 110.988 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -97.62 143.12 28.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.985 2.514 . . . . 0.0 108.658 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.1 t -135.38 112.99 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.148 0.979 . . . . 0.0 109.861 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -111.29 174.41 16.75 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 125.748 1.642 . . . . 0.0 113.498 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 m120 64.93 20.92 12.24 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.988 1.715 . . . . 0.0 113.161 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.17 142.7 95.6 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 121.206 -0.934 . . . . 0.0 112.21 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.77 163.71 38.04 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.207 3.271 . . . . 0.0 111.9 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.39 5.84 2.57 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 123.715 2.943 . . . . 0.0 113.557 171.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -124.15 12.13 8.89 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.168 1.787 . . . . 0.0 113.486 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.1 tp -82.06 145.28 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 120.911 -1.118 . . . . 0.0 110.828 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 31.5 p -133.2 168.27 18.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.198 1.799 . . . . 0.0 109.623 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.11 -31.61 70.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.818 0.447 . . . . 0.0 111.824 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.08 -40.41 65.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.092 0.957 . . . . 0.0 111.709 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -66.2 -38.43 87.94 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.568 0.622 . . . . 0.0 111.31 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 6.0 ttt -68.74 -36.1 77.95 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.612 -0.68 . . . . 0.0 112.201 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -64.52 -40.23 95.23 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.692 0.797 . . . . 0.0 111.688 169.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -68.81 -41.85 78.06 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.305 1.042 . . . . 0.0 112.699 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.13 -24.36 62.93 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.435 1.494 . . . . 0.0 113.596 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -112.42 11.47 19.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.503 1.521 . . . . 0.0 112.654 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.44 -21.66 66.68 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -171.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -62.69 -24.57 67.72 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.253 1.021 . . . . 0.0 112.517 172.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -104.11 14.02 31.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.528 1.931 . . . . 0.0 112.307 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.53 -173.64 54.83 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.386 0.993 . . . . 0.0 112.176 -173.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -71.54 147.25 47.88 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.66 -0.906 . . . . 0.0 111.88 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.95 147.13 37.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.495 0.718 . . . . 0.0 111.577 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.27 -17.39 66.92 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.062 1.315 . . . . 0.0 113.553 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -157.94 147.76 20.09 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.318 1.447 . . . . 0.0 110.645 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -142.31 129.07 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 126.992 2.117 . . . . 0.0 109.643 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -140.99 138.64 33.88 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.03 1.332 . . . . 0.0 111.387 171.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 61.6 mt -138.84 124.58 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.59 1.556 . . . . 0.0 108.211 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -121.36 102.19 8.12 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.075 0.94 . . . . 0.0 112.379 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.33 -18.77 61.74 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -77.53 -14.54 59.64 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.282 1.033 . . . . 0.0 112.96 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -116.78 -27.14 6.72 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.83 1.252 . . . . 0.0 113.498 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.4 27.19 23.39 Favored Glycine 0 N--CA 1.476 1.342 0 C-N-CA 124.896 1.236 . . . . 0.0 114.078 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -137.04 154.37 50.39 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.354 1.462 . . . . 0.0 111.822 -173.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.79 170.13 25.34 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.501 1.524 . . . . 0.0 113.038 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -143.83 148.72 35.93 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.312 1.845 . . . . 0.0 109.874 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 tt -153.87 137.75 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.786 0.834 . . . . 0.0 110.317 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -115.59 125.37 52.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.791 0.836 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -96.01 170.03 9.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.998 0.519 . . . . 0.0 111.438 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -72.74 -26.6 61.62 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.4 p -142.64 155.9 45.0 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.137 1.375 . . . . 0.0 110.931 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -69.38 -27.46 65.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.911 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.8 m -62.32 -47.49 84.04 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.955 1.302 . . . . 0.0 110.54 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.55 -39.01 93.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.946 -0.55 . . . . 0.0 111.427 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.99 89.43 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -64.59 -50.38 67.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.315 0.961 . . . . 0.0 111.226 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.06 -49.42 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 122.891 0.476 . . . . 0.0 110.25 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.28 -46.1 89.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.497 0.719 . . . . 0.0 111.979 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.53 -43.4 93.47 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.182 -0.949 . . . . 0.0 111.802 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.35 -32.93 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.932 0.893 . . . . 0.0 112.388 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -88.8 -24.5 22.58 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.1 mt -102.92 -18.12 15.19 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.43 131.21 45.85 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.944 1.247 . . . . 0.0 111.739 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.0 t30 65.07 17.26 10.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.517 1.927 . . . . 0.0 113.834 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.5 ttp -72.83 134.76 81.14 Favored Pre-proline 0 CA--C 1.544 0.718 0 O-C-N 120.609 -1.307 . . . . 0.0 110.223 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.52 138.79 19.85 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.159 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.0 tp -138.07 105.85 5.63 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.504 1.522 . . . . 0.0 109.821 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 55.57 27.53 10.54 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.491 1.516 . . . . 0.0 113.798 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.49 -8.46 69.0 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.729 1.633 . . . . 0.0 114.812 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -89.08 155.92 19.16 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.868 1.334 . . . . 0.0 110.653 170.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.53 172.16 9.97 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.643 0.777 . . . . 0.0 109.814 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.0 mt -132.57 117.41 17.92 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 110.364 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -92.87 113.68 26.02 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.833 0.853 . . . . 0.0 109.188 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.9 t -123.55 126.02 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.882 0.873 . . . . 0.0 110.141 -174.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -149.44 168.74 22.59 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.52 1.528 . . . . 0.0 111.661 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -78.54 136.98 37.68 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.352 0.661 . . . . 0.0 111.671 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.57 26.89 2.16 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.351 1.46 . . . . 0.0 112.553 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 17.6 t -74.13 -31.56 62.8 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.065 1.346 . . . . 0.0 113.313 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -80.64 162.7 24.09 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.362 1.065 . . . . 0.0 112.481 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 81.7 p -153.47 158.82 41.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.549 1.14 . . . . 0.0 112.483 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.0 125.34 29.21 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.177 0.991 . . . . 0.0 111.748 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.5 t -168.24 171.95 8.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.172 1.789 . . . . 0.0 110.799 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.5 mt -75.25 150.29 38.62 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.209 1.004 . . . . 0.0 111.352 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.0 t -71.09 154.72 41.53 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.519 1.128 . . . . 0.0 111.824 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 98.6 p -165.66 176.14 8.29 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.93 1.692 . . . . 0.0 111.857 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.5 -152.76 19.82 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 124.791 1.186 . . . . 0.0 112.426 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.99 150.95 61.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.429 2.752 . . . . 0.0 111.611 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.6 m -105.79 132.33 52.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.535 1.134 . . . . 0.0 111.347 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.3 t -163.28 153.32 15.66 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.228 1.411 . . . . 0.0 111.038 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.28 0 C-N-CA 125.053 1.311 . . . . 0.0 113.583 177.907 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m -149.4 155.85 41.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.296 1.438 . . . . 0.0 111.425 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.1 p -92.08 152.32 20.0 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.594 1.158 . . . . 0.0 112.895 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.17 156.94 15.57 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.407 1.479 . . . . 0.0 112.714 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.3 m -75.59 143.47 42.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.204 1.002 . . . . 0.0 112.567 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 p -84.37 138.76 32.68 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.304 1.041 . . . . 0.0 112.36 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -95.46 -14.97 45.57 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 124.346 0.974 . . . . 0.0 115.101 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.42 -156.03 53.2 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.665 1.232 . . . . 0.0 113.0 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 61.25 46.35 7.98 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.449 1.5 . . . . 0.0 112.435 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -145.64 142.33 28.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.022 1.329 . . . . 0.0 111.959 -173.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 m -138.86 57.9 1.66 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.974 1.71 . . . . 0.0 109.649 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -144.89 130.72 19.15 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.667 1.587 . . . . 0.0 109.868 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.0 m -68.05 -44.44 76.4 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.816 1.246 . . . . 0.0 112.718 -170.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -152.88 153.97 34.13 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.376 1.87 . . . . 0.0 109.527 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -73.87 74.86 1.63 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.372 1.082 . . . . 0.0 111.216 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 m -86.17 39.82 0.84 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.157 1.783 . . . . 0.0 112.315 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -99.13 132.36 44.49 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.315 1.846 . . . . 0.0 111.739 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -117.78 143.94 45.79 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.67 1.588 . . . . 0.0 111.352 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -102.6 139.41 38.23 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.178 2.591 . . . . 0.0 108.441 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.76 116.71 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.306 1.043 . . . . 0.0 108.978 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.89 167.81 13.19 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.31 1.433 . . . . 0.0 114.053 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.66 31.51 9.77 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.504 1.522 . . . . 0.0 111.836 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.5 mt -66.21 143.64 98.42 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.969 0.908 . . . . 0.0 112.432 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -69.6 159.44 53.51 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.166 2.578 . . . . 0.0 111.271 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.44 -9.12 23.74 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.414 2.742 . . . . 0.0 113.275 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -94.41 5.33 52.12 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.709 1.604 . . . . 0.0 113.461 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.3 tp -86.78 137.59 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 121.051 -1.03 . . . . 0.0 111.65 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.0 p -133.74 176.98 8.07 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.593 1.557 . . . . 0.0 108.786 168.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.31 -21.74 62.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.44 0.696 . . . . 0.0 112.548 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -73.68 -47.82 36.89 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.125 0.875 . . . . 0.0 111.249 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -63.04 -42.56 99.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.144 0.578 . . . . 0.0 110.874 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.5 ttt -66.12 -33.86 76.75 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -69.35 -36.27 76.71 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.14 0.882 . . . . 0.0 112.336 170.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -44.14 67.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.117 0.967 . . . . 0.0 111.344 178.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.4 mt -56.33 -28.14 57.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.68 1.592 . . . . 0.0 113.343 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.84 10.54 26.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.406 1.483 . . . . 0.0 112.93 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.81 -23.03 66.61 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -170.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -62.88 -23.3 67.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.445 1.098 . . . . 0.0 112.375 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.64 12.97 30.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.589 1.956 . . . . 0.0 112.2 -175.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.08 -171.06 54.98 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.76 1.171 . . . . 0.0 112.488 -176.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -71.45 142.07 50.24 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.746 -0.855 . . . . 0.0 111.723 172.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.14 148.23 32.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.779 0.831 . . . . 0.0 111.302 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.51 -11.39 71.71 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.918 1.247 . . . . 0.0 113.962 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -158.83 137.94 11.37 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.454 1.902 . . . . 0.0 108.607 173.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.7 t -140.05 128.65 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.311 1.444 . . . . 0.0 109.055 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -143.03 139.42 30.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.92 1.288 . . . . 0.0 111.796 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.2 mt -140.45 128.23 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.375 1.87 . . . . 0.0 107.702 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -125.46 112.54 16.38 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.659 0.742 . . . . 0.0 112.864 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -75.92 -20.13 58.25 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -171.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.86 -21.21 51.74 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.87 0.868 . . . . 0.0 112.515 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -104.31 -32.58 9.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.816 1.247 . . . . 0.0 113.143 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.28 29.01 26.19 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 124.641 1.115 . . . . 0.0 113.857 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -140.92 156.47 46.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.671 1.588 . . . . 0.0 111.767 -171.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.95 166.52 27.03 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.085 1.326 . . . . 0.0 113.507 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -142.48 147.6 36.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.475 1.91 . . . . 0.0 109.806 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.9 tt -154.3 132.21 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.912 0.885 . . . . 0.0 110.738 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 -107.81 125.66 51.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.765 0.826 . . . . 0.0 110.074 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.6 mt -97.87 164.56 12.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.465 0.706 . . . . 0.0 109.684 173.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -82.58 -11.58 58.32 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 65.9 p -148.47 146.72 28.51 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.172 1.389 . . . . 0.0 111.741 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.57 -33.09 69.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.466 1.106 . . . . 0.0 113.592 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 m -68.24 -46.86 69.34 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.756 1.222 . . . . 0.0 110.573 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.38 -37.02 85.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.76 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.21 93.46 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.046 0.839 . . . . 0.0 112.718 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.3 -50.88 68.35 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.169 0.988 . . . . 0.0 111.381 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.28 -46.91 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.855 -0.528 . . . . 0.0 110.379 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.68 90.83 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.63 0.772 . . . . 0.0 112.015 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -48.86 78.17 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.258 0.936 . . . . 0.0 111.219 174.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.76 -36.6 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.593 0.757 . . . . 0.0 112.225 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.31 -29.47 34.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.6 mt -106.26 -22.89 12.71 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -169.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.06 130.41 43.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.417 1.008 . . . . 0.0 110.781 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.0 t30 73.86 8.93 4.83 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.38 2.272 . . . . 0.0 114.074 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.3 ttp -76.15 137.35 68.73 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.462 -1.399 . . . . 0.0 111.528 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.67 135.29 15.96 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.449 2.766 . . . . 0.0 111.319 175.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.6 tp -145.89 120.21 9.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.442 1.497 . . . . 0.0 109.848 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 58.3 23.59 10.59 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.813 1.245 . . . . 0.0 113.619 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.42 -2.85 85.22 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.583 1.563 . . . . 0.0 114.593 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -93.61 148.4 22.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.491 1.517 . . . . 0.0 110.936 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -98.56 109.38 22.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.552 1.541 . . . . 0.0 107.182 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.75 147.46 47.3 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.664 0.786 . . . . 0.0 111.693 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 130.88 53.62 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.246 1.418 . . . . 0.0 109.054 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.7 t -134.02 129.23 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.857 0.863 . . . . 0.0 110.855 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -140.18 170.22 16.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.112 1.765 . . . . 0.0 110.387 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -77.61 134.54 38.19 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.502 -0.749 . . . . 0.0 110.373 168.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -90.05 114.59 26.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.294 1.037 . . . . 0.0 109.432 172.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 22.7 p -161.85 152.19 17.23 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.175 0.99 . . . . 0.0 112.981 -169.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -144.12 154.81 43.57 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.15 1.78 . . . . 0.0 111.455 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -163.5 171.01 16.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.91 1.284 . . . . 0.0 111.992 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -156.81 170.03 23.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.864 1.665 . . . . 0.0 111.255 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.8 t -156.25 144.51 19.84 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.014 1.325 . . . . 0.0 110.586 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.5 mp -90.33 91.9 8.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.052 0.941 . . . . 0.0 109.238 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.0 m -61.72 142.31 57.32 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.634 1.574 . . . . 0.0 110.323 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 28.5 t -147.25 134.13 20.17 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.368 1.067 . . . . 0.0 111.315 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -118.73 83.59 0.35 Allowed Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.618 1.58 . . . . 0.0 111.447 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.95 156.87 55.79 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.492 2.795 . . . . 0.0 111.392 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.3 t -78.71 138.65 38.37 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.447 0.699 . . . . 0.0 111.729 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 73.9 p -162.28 159.7 25.9 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.978 1.311 . . . . 0.0 112.31 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.19 0 C-N-CA 125.049 1.309 . . . . 0.0 112.966 -179.343 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.47 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.4 m -151.13 146.49 26.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.037 1.335 . . . . 0.0 110.647 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -163.37 166.85 22.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.012 1.325 . . . . 0.0 111.486 -177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.97 -158.89 27.88 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.97 1.747 . . . . 0.0 112.815 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 p -74.73 160.75 30.36 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.42 1.088 . . . . 0.0 112.627 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 t -110.03 126.59 54.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.256 1.022 . . . . 0.0 110.73 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.83 116.62 1.43 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.262 1.411 . . . . 0.0 111.794 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -97.9 -142.47 13.38 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.308 1.433 . . . . 0.0 112.33 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -113.87 134.41 54.82 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.266 1.426 . . . . 0.0 109.889 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -155.5 117.75 4.15 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.547 1.139 . . . . 0.0 111.428 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 p -91.7 -59.96 1.99 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.028 1.731 . . . . 0.0 110.615 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -81.31 101.46 9.79 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.389 1.076 . . . . 0.0 110.935 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.7 t -96.48 19.93 11.41 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.143 1.777 . . . . 0.0 112.313 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -84.69 13.4 5.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.893 1.677 . . . . 0.0 113.422 -170.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -122.4 109.29 14.21 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.048 1.339 . . . . 0.0 109.849 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m -81.84 33.63 0.38 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.346 1.858 . . . . 0.0 113.251 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 -86.97 129.44 34.88 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.372 1.469 . . . . 0.0 111.513 -176.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.9 mt -116.54 135.46 53.8 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.25 1.82 . . . . 0.0 110.544 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -89.4 142.48 27.62 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.347 2.259 . . . . 0.0 108.608 171.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.1 103.29 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.06 168.53 15.79 Favored Glycine 0 N--CA 1.464 0.565 0 C-N-CA 125.315 1.436 . . . . 0.0 112.986 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 60.09 32.45 20.99 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.897 1.279 . . . . 0.0 111.969 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.4 mt -63.25 143.37 97.72 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 121.269 -0.894 . . . . 0.0 111.347 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -66.93 158.0 58.81 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.801 2.334 . . . . 0.0 110.655 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.13 -7.32 20.4 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.699 2.933 . . . . 0.0 113.163 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -104.15 5.55 35.09 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.986 1.714 . . . . 0.0 113.264 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -75.18 146.67 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.274 -0.891 . . . . 0.0 111.247 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.5 p -131.73 165.55 23.5 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.961 1.704 . . . . 0.0 109.875 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.16 -32.85 66.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.245 0.618 . . . . 0.0 111.419 172.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -70.09 -36.79 75.15 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.242 1.017 . . . . 0.0 112.294 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -72.1 -36.7 69.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.78 0.718 . . . . 0.0 111.91 173.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.6 ttm -66.52 -38.62 87.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.24 0.927 . . . . 0.0 111.989 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -61.68 -40.44 94.98 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.09 0.956 . . . . 0.0 111.45 170.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -73.35 -41.19 63.76 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.1 mt -56.48 -24.98 49.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.118 1.367 . . . . 0.0 113.389 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -112.38 11.04 19.92 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.536 1.534 . . . . 0.0 112.802 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.97 -22.42 65.92 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -171.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.13 -25.36 67.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.978 0.911 . . . . 0.0 112.343 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.01 11.27 37.53 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.49 1.916 . . . . 0.0 112.672 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.87 -171.03 55.04 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.633 1.111 . . . . 0.0 112.974 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -71.76 134.61 46.31 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.989 -0.712 . . . . 0.0 111.561 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.14 148.86 35.75 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.438 1.095 . . . . 0.0 111.37 174.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.99 -15.34 75.19 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.166 0.888 . . . . 0.0 113.393 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -155.39 145.25 21.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.433 1.093 . . . . 0.0 111.547 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.0 127.9 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.651 1.98 . . . . 0.0 110.057 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -142.3 142.5 32.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.735 1.614 . . . . 0.0 112.006 171.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 68.9 mt -138.15 125.91 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.909 1.683 . . . . 0.0 107.995 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -119.59 102.62 8.76 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.36 1.064 . . . . 0.0 111.776 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -74.11 -24.22 59.43 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.96 -23.11 63.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.307 1.043 . . . . 0.0 113.053 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -109.45 -26.47 9.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.416 1.086 . . . . 0.0 113.488 174.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.69 29.23 13.95 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 124.957 1.265 . . . . 0.0 114.274 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.68 148.47 45.74 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.229 1.412 . . . . 0.0 111.788 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.71 168.9 23.74 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.696 1.617 . . . . 0.0 112.939 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -146.1 140.71 26.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.131 1.772 . . . . 0.0 109.449 -170.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.9 tt -148.7 146.75 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.115 0.966 . . . . 0.0 110.559 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.66 117.3 22.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.487 1.115 . . . . 0.0 109.407 -178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.72 163.56 13.71 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.104 0.562 . . . . 0.0 110.516 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.65 -21.55 59.37 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.5 p -141.69 151.97 43.47 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.383 1.073 . . . . 0.0 112.354 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -57.22 -38.63 74.04 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.733 1.213 . . . . 0.0 112.869 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -63.29 -50.44 70.07 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.814 1.246 . . . . 0.0 110.85 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.85 -38.77 92.08 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.64 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.17 -39.88 94.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.65 -47.87 76.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.206 0.912 . . . . 0.0 111.759 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.5 mt -59.31 -48.49 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.092 0.557 . . . . 0.0 110.262 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.3 94.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.146 0.579 . . . . 0.0 112.322 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -46.29 88.54 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.961 -1.087 . . . . 0.0 111.131 174.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.19 -38.82 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.211 0.605 . . . . 0.0 112.002 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -82.33 -23.58 35.02 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.2 mt -108.63 -22.16 12.38 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.53 133.0 48.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.924 1.238 . . . . 0.0 111.142 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.5 t30 68.64 11.28 8.29 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.565 1.946 . . . . 0.0 113.732 -175.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.1 ttp -75.72 137.61 70.23 Favored Pre-proline 0 CA--C 1.544 0.719 0 O-C-N 120.611 -1.305 . . . . 0.0 110.933 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.46 134.23 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.365 2.71 . . . . 0.0 111.038 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.2 tp -140.14 113.61 8.56 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.28 1.432 . . . . 0.0 109.96 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.88 24.18 7.26 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.163 1.385 . . . . 0.0 113.344 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.27 -5.55 74.94 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.887 1.708 . . . . 0.0 114.771 -176.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -88.66 146.75 24.9 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.242 1.417 . . . . 0.0 110.451 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -92.56 119.56 32.14 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 69.2 mt -78.15 134.64 37.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.398 0.544 . . . . 0.0 111.669 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -99.17 125.25 44.7 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.823 1.249 . . . . 0.0 108.465 169.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.4 t -135.2 126.25 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.3 0.955 . . . . 0.0 110.362 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -146.13 168.98 19.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.159 1.783 . . . . 0.0 110.848 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -77.12 140.07 40.14 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.607 -0.683 . . . . 0.0 111.053 169.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.11 118.95 38.09 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.877 1.271 . . . . 0.0 111.347 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 71.4 m -142.03 167.98 20.83 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.699 1.599 . . . . 0.0 111.621 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -130.25 158.1 40.68 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.282 1.833 . . . . 0.0 111.331 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t -121.57 120.55 35.16 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.269 1.028 . . . . 0.0 110.566 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.73 -36.53 28.49 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t 56.21 28.29 12.96 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.171 1.388 . . . . 0.0 113.025 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.1 tt -60.81 -42.32 97.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.68 1.592 . . . . 0.0 112.748 -169.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.2 t -164.12 151.93 12.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.101 1.76 . . . . 0.0 110.491 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.7 t -168.0 152.35 6.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.684 1.993 . . . . 0.0 110.13 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -174.67 -179.71 45.44 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 123.922 0.772 . . . . 0.0 114.787 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -83.39 -2.17 10.47 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.432 3.422 . . . . 0.0 114.251 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.3 t -70.14 136.55 50.24 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.434 1.015 . . . . 0.0 112.222 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.4 m -68.41 124.09 22.57 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.337 1.055 . . . . 0.0 112.89 -175.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.272 1.415 . . . . 0.0 113.222 177.696 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.3 m -149.84 162.54 40.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.984 1.314 . . . . 0.0 111.508 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 t -155.22 134.94 12.72 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.534 1.134 . . . . 0.0 110.927 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.32 -161.05 30.32 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.167 1.365 . . . . 0.0 113.246 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 t -103.5 136.89 42.39 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.759 1.224 . . . . 0.0 110.572 173.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.9 p -82.72 151.11 26.34 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.409 1.084 . . . . 0.0 113.21 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.95 174.46 45.85 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.662 1.125 . . . . 0.0 113.951 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.9 -177.63 54.31 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.769 1.176 . . . . 0.0 113.399 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -119.01 131.06 55.97 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.173 1.389 . . . . 0.0 110.144 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.21 172.2 9.64 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.712 1.205 . . . . 0.0 113.205 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.43 -179.09 6.43 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.454 1.502 . . . . 0.0 111.143 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -69.07 150.23 47.84 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.127 1.371 . . . . 0.0 111.999 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -162.62 140.45 8.32 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.033 1.333 . . . . 0.0 111.55 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -166.17 136.25 3.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.279 2.232 . . . . 0.0 108.284 175.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -80.93 144.39 31.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.917 0.887 . . . . 0.0 111.064 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.2 p -92.14 6.04 48.05 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.134 0.973 . . . . 0.0 113.293 170.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -77.45 122.37 25.11 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.746 1.618 . . . . 0.0 110.321 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -103.45 135.47 45.0 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.771 1.628 . . . . 0.0 110.027 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -90.57 137.63 32.2 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.103 2.161 . . . . 0.0 108.549 169.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.1 110.07 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.513 1.125 . . . . 0.0 109.388 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.75 170.8 14.13 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.58 1.562 . . . . 0.0 114.151 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 69.74 20.05 7.0 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.415 1.886 . . . . 0.0 113.006 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -61.72 143.48 93.93 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.823 0.849 . . . . 0.0 112.321 -171.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.03 165.08 33.53 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.405 3.403 . . . . 0.0 111.535 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.18 -3.61 14.09 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.111 2.541 . . . . 0.0 113.162 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -106.92 5.52 28.37 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.231 1.813 . . . . 0.0 113.739 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 tp -82.25 144.97 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.057 -1.027 . . . . 0.0 110.862 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.4 p -132.81 168.82 17.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.225 1.81 . . . . 0.0 109.037 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.56 -26.92 67.28 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -76.21 -40.06 53.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.948 0.899 . . . . 0.0 111.658 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -64.62 -37.17 86.66 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.963 -0.46 . . . . 0.0 111.193 171.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.3 tpt -66.11 -44.56 83.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.648 0.779 . . . . 0.0 111.416 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -59.58 -33.57 71.62 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.97 0.908 . . . . 0.0 112.097 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -74.62 -45.53 44.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.75 0.82 . . . . 0.0 112.579 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.95 -31.08 64.62 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.981 1.312 . . . . 0.0 113.097 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -106.92 10.85 30.43 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.211 1.404 . . . . 0.0 113.12 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -63.47 -28.81 70.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -16.26 63.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.582 0.753 . . . . 0.0 112.618 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -100.83 9.82 41.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.545 1.938 . . . . 0.0 112.458 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.73 -177.46 54.36 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.749 1.166 . . . . 0.0 112.962 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -71.32 134.91 47.09 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.708 -0.878 . . . . 0.0 111.111 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.63 148.82 34.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.609 1.164 . . . . 0.0 112.194 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.89 -10.23 79.26 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.865 1.221 . . . . 0.0 113.923 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -158.92 137.64 11.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.379 1.872 . . . . 0.0 108.983 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.14 130.05 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.602 1.561 . . . . 0.0 108.808 174.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -144.29 139.24 28.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.592 1.157 . . . . 0.0 111.295 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 86.9 mt -138.8 126.66 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.455 1.502 . . . . 0.0 108.518 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -120.11 104.43 10.11 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.522 1.129 . . . . 0.0 111.846 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -73.76 -26.4 60.64 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -171.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.86 -22.03 62.35 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.957 0.903 . . . . 0.0 113.086 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -107.42 -29.12 9.43 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.475 1.11 . . . . 0.0 113.465 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.05 28.44 17.96 Favored Glycine 0 N--CA 1.477 1.374 0 C-N-CA 124.891 1.234 . . . . 0.0 114.152 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -137.6 155.79 48.8 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.339 1.455 . . . . 0.0 111.788 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.16 176.74 30.32 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.111 1.339 . . . . 0.0 113.576 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -144.37 153.71 42.24 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.306 1.842 . . . . 0.0 110.779 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 tt -155.23 132.36 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.54 1.136 . . . . 0.0 110.607 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -113.52 121.93 45.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.904 0.881 . . . . 0.0 110.961 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.39 165.64 12.46 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.236 0.614 . . . . 0.0 111.305 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.61 -23.72 60.98 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -172.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.6 p -145.11 146.47 31.83 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.118 1.367 . . . . 0.0 111.513 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -55.88 -43.42 77.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.059 1.344 . . . . 0.0 112.246 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.4 m -59.2 -45.87 89.93 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.924 1.289 . . . . 0.0 112.081 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.76 -35.89 82.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 119.158 -0.448 . . . . 0.0 112.088 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.06 -33.44 74.57 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -64.55 -49.55 70.76 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.21 0.914 . . . . 0.0 110.22 172.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.8 mt -60.94 -48.47 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.604 0.762 . . . . 0.0 110.399 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.22 91.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.238 0.615 . . . . 0.0 111.819 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -57.19 -49.61 75.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.29 0.95 . . . . 0.0 111.332 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.71 -36.17 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.438 0.695 . . . . 0.0 112.095 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -81.65 -25.14 35.84 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.5 mt -109.61 -23.99 11.18 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -170.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.42 121.98 16.95 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.843 1.202 . . . . 0.0 110.839 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 74.59 15.52 3.32 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 128.142 2.577 . . . . 0.0 114.01 -173.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.0 ttp -76.44 137.12 67.74 Favored Pre-proline 0 N--CA 1.475 0.782 0 O-C-N 120.958 -1.089 . . . . 0.0 111.295 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.64 141.38 22.03 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.467 2.778 . . . . 0.0 111.647 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 34.4 tp -144.93 118.13 8.93 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.533 1.533 . . . . 0.0 110.303 173.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 58.7 24.77 12.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.321 1.448 . . . . 0.0 113.825 174.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.82 -5.59 83.36 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 125.472 1.511 . . . . 0.0 114.38 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -94.41 171.93 8.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.578 1.551 . . . . 0.0 110.726 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -99.43 -176.12 3.2 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 109.656 169.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.4 mt -141.68 120.03 12.31 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.302 1.441 . . . . 0.0 108.982 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.49 116.29 32.45 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.93 122.83 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.819 0.848 . . . . 0.0 111.335 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -141.88 161.66 37.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.772 2.029 . . . . 0.0 110.565 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -73.0 130.74 41.01 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.634 -0.666 . . . . 0.0 109.671 168.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.07 73.76 3.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.561 1.144 . . . . 0.0 110.699 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 76.5 m -78.91 50.76 1.04 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.184 1.794 . . . . 0.0 112.433 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -58.25 144.08 42.24 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.594 1.158 . . . . 0.0 112.967 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.5 t -154.87 153.27 30.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.254 1.421 . . . . 0.0 110.576 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -117.22 12.63 14.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.349 1.46 . . . . 0.0 113.498 -172.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.1 p -145.25 140.8 28.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.845 1.258 . . . . 0.0 112.172 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.32 145.94 29.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.372 1.069 . . . . 0.0 111.049 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.3 p 71.13 -4.88 1.67 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.661 2.784 . . . . 0.0 115.163 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.5 m -70.72 101.45 2.08 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.557 1.143 . . . . 0.0 111.662 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -93.64 -90.56 1.6 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.072 1.32 . . . . 0.0 111.392 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -76.49 -13.04 18.55 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.632 2.888 . . . . 0.0 112.835 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.7 p -83.52 150.97 25.64 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.911 1.684 . . . . 0.0 113.005 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.9 p -85.3 -15.99 41.56 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 C-N-CA 126.053 1.787 . . . . 0.0 112.848 177.769 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.4 p -166.99 163.99 16.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.259 1.424 . . . . 0.0 111.524 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -81.51 46.34 0.95 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.138 1.375 . . . . 0.0 112.889 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.1 71.64 1.7 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.706 1.622 . . . . 0.0 112.406 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.7 m -143.73 163.4 33.41 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.919 1.688 . . . . 0.0 111.669 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.6 m -161.04 162.34 31.67 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.762 1.625 . . . . 0.0 111.259 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.5 -34.52 0.12 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.112 0.863 . . . . 0.0 114.506 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.0 175.17 43.06 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.85 1.214 . . . . 0.0 113.293 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.12 5.93 20.87 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.785 1.234 . . . . 0.0 113.736 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -149.95 162.25 40.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.233 1.813 . . . . 0.0 112.337 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.9 p -140.82 158.35 44.08 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.905 1.682 . . . . 0.0 110.935 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -83.89 148.18 27.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.103 0.961 . . . . 0.0 111.935 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.4 m -73.98 128.45 35.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.51 1.124 . . . . 0.0 109.383 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -69.45 125.12 25.72 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.637 0.375 . . . . 0.0 110.044 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.28 133.35 55.6 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -173.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.6 m -118.68 25.18 10.42 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.998 1.719 . . . . 0.0 111.835 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -98.14 141.11 31.47 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.986 1.714 . . . . 0.0 112.561 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.44 141.92 50.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.82 2.048 . . . . 0.0 110.147 -172.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -100.66 140.38 35.02 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.193 2.197 . . . . 0.0 108.797 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.13 114.57 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.667 1.187 . . . . 0.0 108.951 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.33 164.57 12.28 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 125.488 1.518 . . . . 0.0 114.433 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.7 t30 70.57 20.35 5.85 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.593 1.957 . . . . 0.0 112.928 -177.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.9 mt -57.73 148.65 56.59 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.75 1.22 . . . . 0.0 113.082 -172.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 162.32 40.7 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.133 2.556 . . . . 0.0 111.444 172.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.94 -6.77 17.01 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.721 2.947 . . . . 0.0 112.174 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -99.76 8.29 44.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.676 1.991 . . . . 0.0 113.272 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.5 tp -81.86 145.46 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.01 -1.056 . . . . 0.0 110.909 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.2 p -134.3 167.66 20.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.236 1.814 . . . . 0.0 109.48 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -56.73 -34.51 67.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.106 0.563 . . . . 0.0 111.625 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.82 -26.93 49.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.478 1.111 . . . . 0.0 113.027 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -77.06 -39.02 51.38 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.933 0.788 . . . . 0.0 110.855 169.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.2 ttt -70.46 -37.48 74.3 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.32 -0.863 . . . . 0.0 112.195 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -62.64 -38.03 88.68 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.897 0.879 . . . . 0.0 111.507 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -73.34 -39.98 64.8 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.009 1.324 . . . . 0.0 113.092 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.6 mt -57.39 -27.39 62.28 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.958 1.303 . . . . 0.0 113.205 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -108.02 8.4 28.28 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.627 1.571 . . . . 0.0 112.753 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.9 -20.49 65.92 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -59.39 -22.73 61.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.636 1.174 . . . . 0.0 112.315 169.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -109.64 10.1 24.97 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.258 2.223 . . . . 0.0 112.321 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.45 -178.8 53.32 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.029 0.823 . . . . 0.0 112.448 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -71.04 144.57 50.34 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.699 -0.883 . . . . 0.0 111.664 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.64 152.27 30.1 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.166 0.986 . . . . 0.0 111.822 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.35 -8.22 71.58 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.82 1.2 . . . . 0.0 113.83 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -158.61 136.05 10.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.58 1.952 . . . . 0.0 108.582 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.73 128.65 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.493 1.517 . . . . 0.0 109.059 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -143.83 141.78 30.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.172 1.389 . . . . 0.0 111.579 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.3 mt -140.47 132.98 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.702 1.601 . . . . 0.0 108.67 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -129.1 109.02 10.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.93 0.892 . . . . 0.0 112.129 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -33.93 69.7 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.494 1.118 . . . . 0.0 112.798 -171.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.63 -26.22 68.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.367 1.067 . . . . 0.0 113.229 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -97.72 -32.58 11.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.176 0.99 . . . . 0.0 113.031 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.27 29.19 12.84 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 125.101 1.334 . . . . 0.0 114.055 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.95 158.84 43.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.266 1.426 . . . . 0.0 111.852 -171.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.46 168.78 26.63 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.275 1.417 . . . . 0.0 113.483 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.27 148.24 50.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.72 2.008 . . . . 0.0 109.828 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.9 tt -153.82 140.88 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.412 1.085 . . . . 0.0 110.583 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -123.94 124.89 43.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.863 0.865 . . . . 0.0 110.947 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.4 168.09 10.43 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.389 0.676 . . . . 0.0 110.935 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -72.85 -24.94 60.95 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.9 p -143.61 157.65 44.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.619 1.168 . . . . 0.0 111.881 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -58.73 -35.77 73.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 112.528 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -62.8 -49.46 74.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.054 1.342 . . . . 0.0 110.64 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.49 -42.86 99.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.217 0.607 . . . . 0.0 111.215 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.25 99.26 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -62.91 -49.78 73.44 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.087 0.858 . . . . 0.0 111.79 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.71 -48.95 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.104 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.01 91.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.333 0.653 . . . . 0.0 112.288 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -47.52 84.67 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.447 -0.783 . . . . 0.0 111.007 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.69 -36.49 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -84.79 -28.68 26.0 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -174.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.4 mt -101.18 -19.22 15.81 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -66.86 137.81 56.86 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.188 0.904 . . . . 0.0 110.661 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.5 t30 69.28 16.29 8.43 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.653 1.581 . . . . 0.0 113.636 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.0 ttp -89.83 134.02 32.86 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 120.866 -1.146 . . . . 0.0 111.148 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.28 141.42 18.22 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.299 2.666 . . . . 0.0 111.307 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.4 tp -144.92 114.59 7.24 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.827 1.651 . . . . 0.0 110.098 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 57.67 24.5 10.64 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.288 1.435 . . . . 0.0 113.738 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.73 -1.92 69.23 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.547 1.546 . . . . 0.0 114.836 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -102.9 145.86 29.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.285 1.434 . . . . 0.0 111.192 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -75.31 167.64 21.52 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.656 -0.653 . . . . 0.0 110.187 167.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.7 mt -133.96 135.8 43.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.5 1.12 . . . . 0.0 110.996 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.67 122.08 46.67 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.685 1.994 . . . . 0.0 109.096 175.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -131.94 125.63 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.773 0.829 . . . . 0.0 110.119 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.53 156.92 37.52 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.431 1.492 . . . . 0.0 111.706 -172.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -69.0 132.03 46.02 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.579 -0.701 . . . . 0.0 111.816 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -86.31 83.62 7.65 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.616 0.766 . . . . 0.0 110.818 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 24.5 p -164.21 152.81 13.14 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.127 1.371 . . . . 0.0 112.718 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -100.21 156.07 17.41 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.135 1.374 . . . . 0.0 110.829 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 p -73.49 123.36 23.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.053 0.941 . . . . 0.0 111.752 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.45 -13.39 60.11 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.004 0.922 . . . . 0.0 113.459 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 78.9 p -161.44 159.77 28.52 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.952 2.501 . . . . 0.0 109.221 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 pp -128.25 168.16 15.87 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.369 1.067 . . . . 0.0 112.718 -171.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.0 t -65.51 133.01 50.33 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.244 1.018 . . . . 0.0 110.858 -176.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.4 m -172.38 167.55 5.66 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.799 2.04 . . . . 0.0 110.801 -170.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 119.24 74.7 0.45 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.299 1.428 . . . . 0.0 112.097 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.1 -11.75 29.44 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.524 2.816 . . . . 0.0 113.793 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.5 t -80.34 -5.37 56.27 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.782 0.833 . . . . 0.0 113.201 173.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.2 m -95.63 124.74 39.8 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.75 -1.219 . . . . 0.0 111.314 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.915 -179.272 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 m -68.84 155.49 40.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.379 1.072 . . . . 0.0 113.092 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.5 t -159.86 171.92 18.56 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.182 1.393 . . . . 0.0 111.428 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.45 -178.26 35.3 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.464 1.507 . . . . 0.0 113.515 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -136.71 27.16 3.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.98 1.312 . . . . 0.0 112.689 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 t -155.01 177.49 11.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.29 1.436 . . . . 0.0 112.054 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.13 62.44 0.67 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.687 1.613 . . . . 0.0 112.327 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.98 171.09 40.16 Favored Glycine 0 N--CA 1.473 1.123 0 C-N-CA 125.28 1.419 . . . . 0.0 113.752 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -77.7 -18.57 56.48 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.171 0.989 . . . . 0.0 113.275 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.64 154.41 47.93 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.06 1.744 . . . . 0.0 111.011 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.69 -14.11 62.33 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.143 1.777 . . . . 0.0 113.451 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -135.14 145.56 47.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.759 1.224 . . . . 0.0 112.022 -169.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.5 p -145.29 173.02 12.33 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.704 2.002 . . . . 0.0 110.863 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -124.32 107.51 11.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.511 1.125 . . . . 0.0 110.167 -173.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.64 54.8 3.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.632 1.173 . . . . 0.0 111.091 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m -75.13 40.18 0.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.059 2.144 . . . . 0.0 114.283 -173.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -99.22 124.13 44.05 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.703 1.601 . . . . 0.0 111.851 -170.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.6 mt -111.75 149.82 31.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.709 2.004 . . . . 0.0 110.999 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -114.58 137.86 51.36 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.203 2.601 . . . . 0.0 108.472 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -131.29 113.37 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.167 0.987 . . . . 0.0 109.947 -173.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -113.02 169.64 13.03 Favored Glycine 0 N--CA 1.467 0.756 0 C-N-CA 126.042 1.782 . . . . 0.0 113.738 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 69.01 15.87 8.78 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.098 1.759 . . . . 0.0 112.582 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 28.8 mt -56.58 139.04 76.1 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.089 0.955 . . . . 0.0 112.048 -174.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 83' ' ' LEU . 12.8 Cg_exo -68.15 160.92 46.69 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.748 2.298 . . . . 0.0 111.223 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.04 -2.79 12.09 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.815 3.01 . . . . 0.0 112.967 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -103.61 0.82 31.28 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.082 1.753 . . . . 0.0 113.792 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -76.41 146.32 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 119.453 1.024 . . . . 0.0 111.275 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 p -130.58 165.42 22.8 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.706 1.602 . . . . 0.0 110.409 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -62.85 -25.78 68.44 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.226 0.61 . . . . 0.0 111.822 172.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -72.64 -44.39 61.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.183 0.993 . . . . 0.0 111.474 172.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -66.09 -39.18 89.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.55 0.614 . . . . 0.0 111.696 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -69.21 -33.57 73.54 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.773 0.715 . . . . 0.0 112.471 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -67.61 -39.4 84.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.581 0.628 . . . . 0.0 111.643 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -72.92 -38.08 66.98 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.29 -0.881 . . . . 0.0 113.074 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.44 -25.06 49.34 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.358 1.463 . . . . 0.0 113.256 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -110.75 10.51 22.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.644 1.578 . . . . 0.0 112.673 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.21 -24.87 67.48 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -64.63 -19.33 65.63 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.334 1.054 . . . . 0.0 113.015 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.93 10.5 30.5 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.807 2.043 . . . . 0.0 112.141 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.44 -173.42 55.23 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.865 1.221 . . . . 0.0 113.021 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -71.73 145.07 49.02 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.836 -0.802 . . . . 0.0 112.274 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -89.19 150.39 22.69 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.415 1.086 . . . . 0.0 111.528 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.0 -11.05 70.76 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.823 1.202 . . . . 0.0 113.871 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -153.94 137.11 15.62 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.124 1.77 . . . . 0.0 109.073 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.46 129.36 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.906 1.682 . . . . 0.0 108.858 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -145.09 144.08 30.75 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.895 1.278 . . . . 0.0 111.87 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.2 mt -140.86 132.47 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.168 1.787 . . . . 0.0 108.459 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -126.43 111.82 14.89 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.887 0.875 . . . . 0.0 112.386 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -70.75 -31.95 68.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.424 1.09 . . . . 0.0 113.307 -171.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -73.63 -13.24 60.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.07 0.948 . . . . 0.0 113.51 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -112.75 -26.48 8.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.743 1.217 . . . . 0.0 113.311 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.0 29.84 24.73 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.613 1.102 . . . . 0.0 113.963 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -140.12 157.29 45.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.327 1.451 . . . . 0.0 112.202 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.41 169.19 25.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.755 1.645 . . . . 0.0 113.209 174.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -137.89 147.63 44.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.673 1.989 . . . . 0.0 109.425 -177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.0 tt -153.77 139.23 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.897 0.879 . . . . 0.0 110.601 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -128.92 118.68 23.06 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.622 0.769 . . . . 0.0 110.307 -172.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.67 -176.16 3.98 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.215 1.006 . . . . 0.0 111.893 -171.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -86.02 -25.84 25.72 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 49.7 p -149.42 144.4 26.33 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.138 1.375 . . . . 0.0 111.851 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -59.46 -35.91 74.97 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.248 1.019 . . . . 0.0 113.057 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.9 m -60.21 -47.69 84.87 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.773 1.229 . . . . 0.0 111.181 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.6 mt -65.65 -35.99 82.38 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.958 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.68 -36.76 81.28 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.08 0.854 . . . . 0.0 112.875 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.39 -49.48 71.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.128 0.971 . . . . 0.0 110.891 172.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.81 -48.74 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.082 0.553 . . . . 0.0 110.353 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.98 -46.02 85.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.626 0.77 . . . . 0.0 111.91 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -58.25 -48.69 79.62 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.319 -0.863 . . . . 0.0 111.345 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.15 -36.49 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.464 0.705 . . . . 0.0 112.16 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -80.6 -30.45 36.82 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.3 mt -102.72 -21.78 14.04 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -171.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.18 129.14 38.94 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.672 1.123 . . . . 0.0 111.456 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 67.98 14.25 9.32 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.73 2.412 . . . . 0.0 113.697 -173.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.2 ttp -73.83 135.91 77.31 Favored Pre-proline 0 N--CA 1.474 0.757 0 O-C-N 120.507 -1.371 . . . . 0.0 110.719 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.24 140.6 19.81 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.3 2.666 . . . . 0.0 111.325 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.3 tp -145.12 117.19 8.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.086 1.355 . . . . 0.0 110.106 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 69.9 mmt-85 57.11 27.38 13.34 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.929 1.291 . . . . 0.0 113.922 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.42 -6.23 83.82 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 125.521 1.534 . . . . 0.0 114.484 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -90.78 169.3 11.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.934 1.694 . . . . 0.0 110.333 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -100.98 -172.67 2.21 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.612 -0.68 . . . . 0.0 109.244 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.46 116.67 10.03 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.34 1.056 . . . . 0.0 109.079 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -91.58 118.07 30.28 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.44 123.94 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.647 0.779 . . . . 0.0 109.959 -173.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -154.78 163.98 39.47 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.087 1.355 . . . . 0.0 111.239 -173.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -71.36 144.1 49.99 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.769 -0.582 . . . . 0.0 111.043 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.51 42.97 0.53 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.939 1.296 . . . . 0.0 112.94 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 28.2 p -64.86 -21.64 66.84 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -80.62 -10.45 59.73 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.379 1.072 . . . . 0.0 113.128 172.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.4 m -114.28 60.78 0.67 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.26 1.824 . . . . 0.0 110.278 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.33 161.0 41.17 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.715 2.006 . . . . 0.0 110.744 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 20.1 t -74.76 121.16 21.32 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.539 -0.725 . . . . 0.0 111.605 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -158.76 117.72 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.557 1.543 . . . . 0.0 109.22 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.6 m -147.2 147.37 30.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.291 1.837 . . . . 0.0 109.038 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.9 t -145.44 127.4 15.49 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.226 1.01 . . . . 0.0 110.743 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -92.71 -174.74 41.41 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.091 1.329 . . . . 0.0 113.516 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.19 139.92 43.46 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.702 2.935 . . . . 0.0 110.616 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 t -73.32 -28.96 62.36 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.2 t 67.89 4.92 4.22 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.523 1.929 . . . . 0.0 115.224 171.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.159 0 C-N-CA 125.271 1.415 . . . . 0.0 113.059 179.271 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.508 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.8 m -146.84 154.81 41.77 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.137 1.375 . . . . 0.0 110.952 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 t -159.58 158.29 31.42 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.526 1.13 . . . . 0.0 111.75 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.78 139.98 7.8 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.601 1.572 . . . . 0.0 112.468 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 p -91.57 140.03 30.13 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.751 1.221 . . . . 0.0 112.062 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -68.14 130.46 42.99 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.992 -1.068 . . . . 0.0 112.194 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.04 170.57 49.65 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.439 1.019 . . . . 0.0 113.822 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.94 -173.18 48.66 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.879 1.228 . . . . 0.0 113.769 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -108.84 153.57 23.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.265 1.426 . . . . 0.0 111.704 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -68.85 145.81 53.39 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.608 -0.683 . . . . 0.0 112.066 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.9 p -140.65 172.71 12.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.97 2.108 . . . . 0.0 110.1 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -58.78 134.01 56.48 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.207 0.603 . . . . 0.0 111.529 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.3 m -138.92 148.65 43.85 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.084 1.754 . . . . 0.0 109.394 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -142.3 143.19 32.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.872 1.269 . . . . 0.0 110.621 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.54 142.22 53.68 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.429 0.692 . . . . 0.0 112.559 -174.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m -86.47 41.38 0.94 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.298 1.439 . . . . 0.0 112.706 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 -84.15 133.41 34.61 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.434 1.494 . . . . 0.0 113.006 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.6 mt -113.81 134.52 54.73 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.034 1.733 . . . . 0.0 110.257 170.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -92.09 137.89 31.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.17 2.188 . . . . 0.0 107.748 169.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.6 t -130.47 110.92 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.072 0.949 . . . . 0.0 109.435 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.53 174.56 18.11 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.825 1.678 . . . . 0.0 113.501 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.8 m120 65.48 20.07 11.65 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.863 1.665 . . . . 0.0 112.808 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.19 140.12 97.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 O-C-N 121.05 -1.031 . . . . 0.0 112.103 -171.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.11 165.73 31.48 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.294 3.33 . . . . 0.0 111.837 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.51 -2.89 13.03 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.173 2.582 . . . . 0.0 113.179 172.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -108.19 12.55 26.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.028 1.731 . . . . 0.0 113.419 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.3 tp -91.32 140.08 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.254 1.022 . . . . 0.0 110.599 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.8 p -133.76 174.06 10.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.389 1.476 . . . . 0.0 108.695 168.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.33 -22.62 63.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.043 0.537 . . . . 0.0 112.421 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.71 -45.14 38.39 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.307 -0.871 . . . . 0.0 111.41 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -63.27 -43.8 96.93 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.058 0.543 . . . . 0.0 111.088 172.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.9 ttt -65.35 -37.31 86.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.997 0.519 . . . . 0.0 112.337 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.6 mtp-105 -66.46 -38.18 86.78 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.509 -0.744 . . . . 0.0 112.066 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -72.03 -40.32 68.49 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.411 -0.806 . . . . 0.0 112.557 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.9 mt -59.34 -29.58 67.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.986 1.714 . . . . 0.0 113.027 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -105.88 8.44 32.65 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.22 1.408 . . . . 0.0 112.656 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.03 -27.04 68.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.246 0.93 . . . . 0.0 113.214 -173.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -72.55 -5.54 37.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.775 1.23 . . . . 0.0 113.657 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -111.86 8.81 20.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.433 1.893 . . . . 0.0 111.83 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.11 -177.6 53.72 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.802 1.192 . . . . 0.0 112.253 -172.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -71.16 144.18 50.28 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.637 -0.919 . . . . 0.0 111.998 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.26 156.3 33.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.878 0.871 . . . . 0.0 111.857 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.96 -10.29 58.84 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.939 1.256 . . . . 0.0 113.87 175.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.65 135.83 5.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.699 2.0 . . . . 0.0 108.611 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.1 t -143.56 128.77 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.644 1.578 . . . . 0.0 109.43 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -145.1 142.31 29.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.382 1.473 . . . . 0.0 111.765 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.9 mt -138.51 127.18 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.559 1.544 . . . . 0.0 108.575 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -115.57 103.25 10.54 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.446 1.098 . . . . 0.0 111.831 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -69.79 -20.34 63.47 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -87.18 -15.17 39.12 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -117.6 -19.25 9.47 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.613 1.165 . . . . 0.0 113.985 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.25 29.79 21.42 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 124.665 1.126 . . . . 0.0 114.312 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -132.51 149.07 52.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.942 1.297 . . . . 0.0 111.832 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.68 169.5 25.17 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.875 1.702 . . . . 0.0 112.754 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -141.83 142.52 33.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.173 1.789 . . . . 0.0 109.566 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.6 tt -152.18 143.19 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.726 0.81 . . . . 0.0 110.686 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -121.3 124.32 44.32 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.922 0.889 . . . . 0.0 110.706 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.0 mt -97.31 171.2 8.57 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.582 0.753 . . . . 0.0 111.132 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -74.73 -26.46 59.82 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.3 p -144.7 159.29 43.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.686 1.194 . . . . 0.0 111.983 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -60.24 -31.35 70.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.844 0.857 . . . . 0.0 112.755 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -68.47 -46.79 68.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.019 1.328 . . . . 0.0 110.486 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.6 mt -62.39 -42.73 99.65 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.249 0.62 . . . . 0.0 111.125 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.59 -36.94 85.87 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.89 -47.93 73.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.508 1.123 . . . . 0.0 111.905 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.7 mt -62.35 -47.83 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.418 -0.802 . . . . 0.0 110.18 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.41 -42.49 98.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.277 0.631 . . . . 0.0 112.409 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -54.01 -51.87 62.59 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.421 1.009 . . . . 0.0 111.287 170.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.36 -34.91 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.151 0.432 . . . . 0.0 111.785 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -85.57 -23.98 27.4 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.0 mt -106.67 -22.17 12.82 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.24 128.84 37.92 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.476 1.034 . . . . 0.0 110.992 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.6 t30 70.48 12.75 7.45 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.27 2.228 . . . . 0.0 114.106 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.5 ttp -75.67 136.95 70.52 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.565 -1.334 . . . . 0.0 110.91 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.99 139.91 19.73 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.452 2.768 . . . . 0.0 111.169 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.8 tp -145.72 121.57 10.61 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.506 1.522 . . . . 0.0 109.893 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 59.17 23.09 11.35 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.902 1.281 . . . . 0.0 113.699 172.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.1 2.15 74.85 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.394 1.473 . . . . 0.0 114.728 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -111.73 156.98 21.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.233 1.813 . . . . 0.0 111.629 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.99 173.07 10.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.163 0.985 . . . . 0.0 111.137 169.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.2 mt -134.24 119.01 18.22 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.544 1.138 . . . . 0.0 109.148 169.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -92.67 122.51 35.15 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.85 128.32 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.194 0.906 . . . . 0.0 109.689 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -148.1 165.27 31.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.581 1.552 . . . . 0.0 110.986 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.19 137.87 41.58 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.633 -0.667 . . . . 0.0 110.566 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -86.24 111.33 20.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.234 0.614 . . . . 0.0 110.786 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 73.5 m -109.48 136.34 49.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.063 1.345 . . . . 0.0 111.474 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -74.8 -23.24 58.46 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.2 m -153.03 162.23 41.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.115 1.766 . . . . 0.0 111.142 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.89 163.98 26.31 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.935 0.894 . . . . 0.0 112.258 171.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.4 t -157.23 169.83 23.87 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.899 1.279 . . . . 0.0 111.483 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.9 mt -130.26 168.63 16.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.083 1.753 . . . . 0.0 111.428 -172.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.0 t -156.49 154.68 30.74 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.785 1.634 . . . . 0.0 110.91 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.4 t -75.47 157.99 33.24 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.822 0.849 . . . . 0.0 112.072 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.72 -77.33 0.2 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.867 1.222 . . . . 0.0 112.22 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.94 115.52 4.35 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.532 2.821 . . . . 0.0 110.251 176.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 79.5 p -170.43 169.87 7.27 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.86 1.664 . . . . 0.0 111.58 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 73.2 m -77.35 141.92 39.62 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.98 -1.075 . . . . 0.0 111.943 174.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.192 0 CA-C-O 118.268 -1.296 . . . . 0.0 112.871 -179.642 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.322 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.6 p -75.07 163.55 27.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.691 1.197 . . . . 0.0 113.355 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.5 t -74.05 -17.7 60.93 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 120.851 -1.156 . . . . 0.0 113.689 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.19 157.66 29.97 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.755 1.645 . . . . 0.0 113.437 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.9 m -94.87 -3.44 48.79 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -173.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.9 p -90.97 152.32 20.74 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.474 1.51 . . . . 0.0 113.23 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.98 -175.91 39.84 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.064 1.316 . . . . 0.0 113.613 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.78 36.62 18.7 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.061 0.839 . . . . 0.0 113.723 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -110.51 150.16 29.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.536 1.534 . . . . 0.0 111.981 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.58 157.2 38.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.514 1.126 . . . . 0.0 112.97 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -76.38 -10.19 59.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.011 1.725 . . . . 0.0 113.743 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -153.94 149.45 27.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.349 1.859 . . . . 0.0 110.204 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.6 p -147.96 133.08 18.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.172 1.389 . . . . 0.0 110.545 -174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -91.08 45.06 1.22 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.477 1.111 . . . . 0.0 112.877 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -75.3 37.82 0.13 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.51 1.524 . . . . 0.0 112.713 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 m -78.79 36.33 0.27 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.89 2.076 . . . . 0.0 112.589 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.13 129.18 55.18 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.074 1.75 . . . . 0.0 110.744 -174.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.3 mt -108.15 130.61 55.11 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.585 1.554 . . . . 0.0 110.294 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -89.83 134.5 34.16 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.645 1.978 . . . . 0.0 107.949 169.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.9 t -129.16 121.88 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.996 0.918 . . . . 0.0 109.792 -174.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.43 172.66 14.56 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 125.921 1.724 . . . . 0.0 113.686 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 m120 65.32 17.08 10.86 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.169 1.788 . . . . 0.0 113.371 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 32.2 mt -58.19 143.48 78.92 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.409 1.084 . . . . 0.0 112.474 -171.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -70.32 158.06 57.37 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.199 2.6 . . . . 0.0 110.852 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.5 -9.67 25.54 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.316 2.677 . . . . 0.0 112.87 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.79 4.42 52.87 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.793 2.037 . . . . 0.0 113.409 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 tp -81.74 145.28 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 120.785 -1.197 . . . . 0.0 111.181 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.8 p -135.27 167.63 20.66 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.52 1.928 . . . . 0.0 109.139 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -57.7 -35.42 70.6 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.962 0.505 . . . . 0.0 111.887 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -80.23 -30.97 38.59 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.518 1.127 . . . . 0.0 113.076 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.08 -39.2 66.06 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.024 0.93 . . . . 0.0 111.309 172.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 4.3 tpt -61.86 -42.27 98.85 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.709 0.804 . . . . 0.0 111.074 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.0 ttp85 -63.26 -27.85 69.63 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.424 -0.798 . . . . 0.0 112.191 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -47.67 37.7 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.157 1.383 . . . . 0.0 112.494 171.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.7 mt -55.62 -34.27 64.74 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.01 1.324 . . . . 0.0 112.634 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -102.52 9.93 39.2 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.05 1.34 . . . . 0.0 113.267 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.63 -24.89 67.15 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -61.92 -25.21 67.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.555 1.142 . . . . 0.0 112.388 173.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -102.32 12.69 36.24 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.209 1.804 . . . . 0.0 112.478 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.55 -145.68 20.4 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.756 1.17 . . . . 0.0 111.93 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -103.54 131.14 50.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.599 1.159 . . . . 0.0 111.085 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.5 146.49 51.85 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.172 0.989 . . . . 0.0 111.844 176.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.81 -18.14 70.97 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.287 0.946 . . . . 0.0 113.454 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -158.68 146.38 17.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.569 1.548 . . . . 0.0 110.321 172.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.9 t -143.18 128.46 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.083 1.753 . . . . 0.0 109.542 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -140.65 142.35 34.97 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.401 1.481 . . . . 0.0 111.444 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.5 mt -142.12 128.97 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.004 1.721 . . . . 0.0 108.222 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -123.27 102.13 7.76 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.046 0.938 . . . . 0.0 111.985 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -73.6 -16.35 61.24 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.94 -20.53 60.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.305 1.042 . . . . 0.0 112.808 175.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -116.75 -23.22 8.22 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.832 1.253 . . . . 0.0 113.756 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.71 28.73 23.23 Favored Glycine 0 N--CA 1.477 1.371 0 C-N-CA 124.673 1.13 . . . . 0.0 114.25 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -136.78 155.16 50.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.389 1.476 . . . . 0.0 112.023 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.96 168.97 25.84 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.676 1.607 . . . . 0.0 113.055 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -140.56 140.2 35.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.703 2.001 . . . . 0.0 108.735 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.5 tt -150.6 132.27 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.685 -0.634 . . . . 0.0 111.487 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 123.1 47.63 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.749 1.22 . . . . 0.0 110.172 -177.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -99.73 157.12 16.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.246 0.618 . . . . 0.0 110.181 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.34 -18.47 63.08 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -169.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.9 p -151.01 151.54 32.21 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.667 1.587 . . . . 0.0 111.435 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 36.9 ptt-85 -55.27 -35.66 65.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.756 1.222 . . . . 0.0 114.24 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 m -60.92 -45.92 92.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.058 1.343 . . . . 0.0 111.265 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.09 -44.0 97.61 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.773 0.829 . . . . 0.0 110.915 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.85 79.41 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.297 0.639 . . . . 0.0 112.63 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.53 -48.32 67.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.861 0.865 . . . . 0.0 111.909 172.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.34 -46.56 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.522 -0.736 . . . . 0.0 110.279 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.99 99.54 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.759 0.824 . . . . 0.0 112.053 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -56.09 -50.65 70.43 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.566 1.076 . . . . 0.0 111.489 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.8 -35.15 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.793 0.724 . . . . 0.0 112.338 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -87.2 -33.44 19.35 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.0 mt -98.91 -22.68 15.66 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -171.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -70.2 122.71 20.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.0 0.818 . . . . 0.0 110.773 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 70.61 14.92 7.18 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 127.543 2.337 . . . . 0.0 114.262 -171.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.4 ttp -72.79 138.1 79.95 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 120.518 -1.364 . . . . 0.0 110.939 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.11 139.58 21.66 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.44 2.76 . . . . 0.0 111.402 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.8 tp -144.88 116.22 8.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.343 1.457 . . . . 0.0 109.969 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 59.03 18.88 6.69 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.211 1.404 . . . . 0.0 113.916 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.57 -6.73 80.26 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.665 1.602 . . . . 0.0 114.508 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -85.38 153.99 22.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.758 1.279 . . . . 0.0 110.557 170.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -86.11 163.41 17.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 167.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.0 mt -122.1 137.52 54.79 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.305 1.042 . . . . 0.0 110.046 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.4 135.67 46.36 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.382 1.073 . . . . 0.0 109.529 170.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.37 132.93 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.965 0.906 . . . . 0.0 110.955 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -147.73 165.61 30.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.163 1.385 . . . . 0.0 111.573 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -73.54 136.85 44.08 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.545 -0.722 . . . . 0.0 110.946 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.5 126.11 30.39 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.693 0.797 . . . . 0.0 110.572 174.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 37.5 t -160.3 140.26 11.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.365 1.466 . . . . 0.0 110.971 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -146.99 136.03 22.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.741 1.616 . . . . 0.0 111.393 -173.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 33.5 t -165.19 135.21 3.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.668 1.187 . . . . 0.0 111.266 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.69 53.37 1.88 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.981 1.313 . . . . 0.0 111.44 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.3 t -82.3 111.15 18.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.067 0.947 . . . . 0.0 111.227 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.61 149.73 25.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.571 1.148 . . . . 0.0 110.747 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.5 t -80.26 -173.84 4.23 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.828 1.251 . . . . 0.0 111.334 174.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.9 t -149.14 177.13 9.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.466 1.506 . . . . 0.0 111.878 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -71.18 162.74 54.17 Favored Glycine 0 CA--C 1.543 1.833 0 C-N-CA 124.5 1.048 . . . . 0.0 114.133 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.73 8.71 4.1 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.663 3.575 . . . . 0.0 113.886 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.8 p -69.34 153.47 43.56 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.006 1.323 . . . . 0.0 113.268 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.6 p -78.7 148.16 33.2 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.865 -1.147 . . . . 0.0 113.472 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 C-N-CA 125.213 1.387 . . . . 0.0 112.821 -179.3 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.6 m -146.61 141.34 26.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.978 1.311 . . . . 0.0 110.998 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m 69.01 -5.64 1.01 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.736 2.015 . . . . 0.0 115.747 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.23 169.36 30.52 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.893 1.711 . . . . 0.0 113.377 175.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.6 t -163.82 172.96 13.35 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.697 1.599 . . . . 0.0 111.074 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.3 p -84.61 151.83 24.24 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.805 1.242 . . . . 0.0 112.711 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.04 117.25 4.42 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.975 0.798 . . . . 0.0 112.065 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.64 163.88 31.28 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.932 1.254 . . . . 0.0 112.43 172.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -143.93 140.23 29.58 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.022 1.329 . . . . 0.0 110.782 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -93.06 33.85 1.15 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.353 1.461 . . . . 0.0 113.831 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.9 p -65.77 -15.96 63.34 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.313 1.845 . . . . 0.0 114.228 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -154.45 171.81 18.76 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.317 1.847 . . . . 0.0 110.649 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.5 m -55.01 128.07 31.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.344 1.458 . . . . 0.0 110.537 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -60.07 131.59 51.31 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.44 1.096 . . . . 0.0 110.797 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -70.17 -59.03 3.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.103 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.5 p 49.61 29.13 2.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.693 1.597 . . . . 0.0 114.832 174.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -86.11 135.01 33.77 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.233 1.413 . . . . 0.0 111.406 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.83 127.4 51.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.809 1.643 . . . . 0.0 110.206 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -89.65 135.7 33.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.731 2.013 . . . . 0.0 108.13 171.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.63 113.22 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.048 0.939 . . . . 0.0 109.46 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.16 174.41 21.33 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.606 1.574 . . . . 0.0 113.271 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 m120 66.48 16.61 10.46 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.028 1.731 . . . . 0.0 113.761 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.5 mt -60.8 140.52 93.25 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 121.156 -0.965 . . . . 0.0 113.033 -170.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -68.67 159.28 54.31 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.08 3.187 . . . . 0.0 111.745 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.95 -1.47 11.25 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.572 2.848 . . . . 0.0 114.031 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -116.84 12.49 14.79 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.682 1.593 . . . . 0.0 113.0 -174.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 tp -82.24 137.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.42 1.088 . . . . 0.0 110.734 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.5 p -128.86 176.18 8.05 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.261 1.424 . . . . 0.0 110.009 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -54.22 -32.82 56.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.913 0.885 . . . . 0.0 112.202 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -73.34 -34.01 65.43 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.784 0.834 . . . . 0.0 112.479 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -71.48 -44.13 65.3 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.654 0.661 . . . . 0.0 110.56 170.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.9 ttt -65.28 -33.26 75.57 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -63.98 -45.15 90.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.068 0.947 . . . . 0.0 111.318 169.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -70.84 -38.51 73.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.634 0.774 . . . . 0.0 112.825 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.8 mt -59.62 -24.21 63.63 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.551 1.54 . . . . 0.0 113.328 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -113.2 10.25 18.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.577 1.551 . . . . 0.0 112.539 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -21.33 65.42 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.63 -20.52 60.97 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.038 1.335 . . . . 0.0 112.593 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -112.47 11.59 19.87 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.257 2.223 . . . . 0.0 111.855 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.5 -169.99 52.98 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.479 1.037 . . . . 0.0 113.211 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -71.63 129.6 39.11 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.014 -0.698 . . . . 0.0 111.293 174.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.9 149.73 43.2 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.058 0.943 . . . . 0.0 111.439 172.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.23 -12.89 75.26 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.717 1.151 . . . . 0.0 113.78 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -156.12 138.08 14.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.88 1.672 . . . . 0.0 109.316 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -141.69 127.68 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.437 1.495 . . . . 0.0 108.801 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -145.2 139.15 27.0 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.562 1.145 . . . . 0.0 111.936 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.7 mt -139.86 137.8 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.485 1.914 . . . . 0.0 107.978 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -143.51 129.17 19.23 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 122.63 1.205 . . . . 0.0 113.897 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -74.21 -11.49 60.3 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.313 1.445 . . . . 0.0 113.463 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.17 -32.09 61.89 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.45 1.5 . . . . 0.0 113.031 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -123.73 -20.67 5.4 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.39 42.35 7.47 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 119.26 0.936 . . . . 0.0 113.252 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -137.78 154.75 49.54 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.734 1.614 . . . . 0.0 111.151 -177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.64 162.08 25.12 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.099 1.333 . . . . 0.0 113.647 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -137.27 139.71 41.13 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.921 2.088 . . . . 0.0 109.167 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.93 139.99 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.124 0.97 . . . . 0.0 110.313 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -125.88 116.17 21.11 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.95 0.9 . . . . 0.0 110.292 -172.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.5 mt -92.83 167.86 11.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.1 0.56 . . . . 0.0 111.242 -174.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -76.31 -19.53 58.16 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.2 p -143.8 155.11 44.03 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.643 1.177 . . . . 0.0 111.649 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 37.4 ptt-85 -60.11 -36.01 76.51 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.716 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.1 m -62.19 -50.62 71.08 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.351 1.46 . . . . 0.0 110.698 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.32 -37.6 87.6 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.692 -0.67 . . . . 0.0 111.758 176.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.02 89.55 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.106 0.866 . . . . 0.0 113.129 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -65.6 -49.57 68.29 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.678 0.791 . . . . 0.0 111.531 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.71 -48.45 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.967 -0.458 . . . . 0.0 110.125 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.56 86.29 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.596 0.758 . . . . 0.0 112.204 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -60.17 -42.42 94.96 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.247 -0.908 . . . . 0.0 112.15 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.17 -35.21 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.828 0.74 . . . . 0.0 112.049 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.69 -30.78 32.48 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.8 mt -104.73 -19.52 13.91 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -169.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.71 128.33 36.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.207 0.912 . . . . 0.0 111.664 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.1 t30 70.83 17.87 6.3 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.034 2.534 . . . . 0.0 113.348 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.6 ttp -76.49 138.17 67.33 Favored Pre-proline 0 N--CA 1.475 0.805 0 O-C-N 120.796 -1.19 . . . . 0.0 111.343 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.65 143.6 21.49 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.444 2.763 . . . . 0.0 111.708 175.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.2 tp -146.73 115.51 6.84 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.413 1.485 . . . . 0.0 110.247 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 57.08 25.68 11.11 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.513 1.525 . . . . 0.0 114.164 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.16 -1.96 78.07 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.225 1.393 . . . . 0.0 114.607 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -100.41 166.85 10.74 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.581 1.552 . . . . 0.0 111.191 169.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -92.66 175.21 6.9 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.481 1.112 . . . . 0.0 109.904 171.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.6 mt -136.9 110.25 7.89 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.745 1.218 . . . . 0.0 108.89 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.06 122.39 37.68 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.71 125.49 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.87 0.868 . . . . 0.0 110.846 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -139.67 166.71 23.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.885 1.674 . . . . 0.0 111.164 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -77.71 134.46 38.1 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.602 -0.687 . . . . 0.0 111.482 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.72 80.4 5.32 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.173 0.989 . . . . 0.0 110.645 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 10.5 t -163.38 160.01 23.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.18 1.792 . . . . 0.0 110.686 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -61.12 -23.85 65.82 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 37.1 m 61.48 29.54 18.44 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.198 1.399 . . . . 0.0 113.626 170.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.21 146.26 35.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.45 1.5 . . . . 0.0 111.809 -173.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.4 p -169.5 166.63 10.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.361 1.864 . . . . 0.0 110.608 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -66.1 144.03 56.94 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.619 -0.676 . . . . 0.0 112.178 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 20.6 p -87.94 149.61 23.96 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.139 1.376 . . . . 0.0 110.48 172.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 18.4 p -67.8 142.76 56.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.233 0.613 . . . . 0.0 111.551 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.27 145.93 48.21 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-O 118.796 -1.002 . . . . 0.0 112.223 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.4 139.22 48.82 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.23 2.62 . . . . 0.0 110.907 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.7 t -123.63 33.48 5.32 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.053 1.341 . . . . 0.0 111.174 -173.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.1 t -149.34 134.84 18.5 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.975 1.71 . . . . 0.0 110.276 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.193 1.378 . . . . 0.0 113.256 -173.801 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 t 63.53 35.63 11.72 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.066 1.347 . . . . 0.0 113.431 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 t -149.4 140.15 22.69 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.676 -1.265 . . . . 0.0 111.923 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.89 -101.54 2.38 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 125.91 1.719 . . . . 0.0 111.475 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.5 m 67.31 25.45 8.77 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.394 1.477 . . . . 0.0 113.913 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 t -155.28 152.5 29.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.396 1.479 . . . . 0.0 111.465 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 164.5 -159.14 32.04 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.031 1.3 . . . . 0.0 113.552 -176.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.83 -179.33 42.81 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.951 1.263 . . . . 0.0 113.887 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -165.11 146.09 7.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.579 1.951 . . . . 0.0 109.285 -175.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.57 136.77 36.62 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.09 0.956 . . . . 0.0 110.794 173.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.2 m -60.65 -29.74 69.45 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.557 1.543 . . . . 0.0 112.489 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -134.72 129.85 35.34 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.731 1.612 . . . . 0.0 109.372 176.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.6 t -165.68 171.67 12.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.664 1.586 . . . . 0.0 110.82 -174.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -140.94 77.69 1.61 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.837 1.655 . . . . 0.0 109.169 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.5 mtm-85 -68.82 142.49 54.85 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.839 0.828 . . . . 0.0 112.629 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.5 m -98.06 28.51 3.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.619 1.568 . . . . 0.0 112.181 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -97.56 131.55 44.05 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.719 1.208 . . . . 0.0 112.026 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.9 mt -102.98 152.45 21.31 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.64 1.976 . . . . 0.0 110.586 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.428 ' CD2' ' HD3' ' A' ' 144' ' ' ARG . 12.1 t80 -124.48 126.28 45.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.778 2.431 . . . . 0.0 108.076 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.31 111.6 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.567 1.147 . . . . 0.0 109.478 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.57 167.23 25.75 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.79 1.186 . . . . 0.0 112.619 173.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 64.97 26.49 12.72 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.61 1.564 . . . . 0.0 113.217 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.53 144.01 95.91 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 121.074 -1.016 . . . . 0.0 111.345 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.38 161.8 44.71 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.79 2.993 . . . . 0.0 111.85 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.03 6.08 1.9 Allowed 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 124.157 3.238 . . . . 0.0 114.347 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -140.43 19.0 2.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.462 1.505 . . . . 0.0 114.335 -172.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -73.07 150.72 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.065 0.946 . . . . 0.0 110.151 169.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 p -126.83 163.54 23.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.081 1.352 . . . . 0.0 110.619 170.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -58.16 -32.96 68.71 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.14 0.576 . . . . 0.0 111.44 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -68.26 -42.44 79.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 111.673 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.11 -40.73 94.92 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.884 -0.51 . . . . 0.0 111.802 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.9 ttt -66.51 -38.6 87.59 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.656 0.662 . . . . 0.0 111.629 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -62.95 -38.73 92.25 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.52 1.128 . . . . 0.0 111.707 173.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.91 -45.45 61.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.96 1.304 . . . . 0.0 111.32 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.59 -29.09 58.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.007 1.323 . . . . 0.0 113.524 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -107.07 10.03 30.34 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.371 1.468 . . . . 0.0 112.792 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.06 -23.42 67.17 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -58.5 -26.72 63.77 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.976 1.31 . . . . 0.0 112.863 171.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -101.47 10.7 40.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.964 1.706 . . . . 0.0 112.729 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.18 -167.84 43.97 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.777 1.18 . . . . 0.0 112.625 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -79.06 123.73 27.62 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.952 -0.734 . . . . 0.0 110.265 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.82 143.64 54.52 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.8 0.84 . . . . 0.0 111.581 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.18 -9.32 76.88 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.792 1.187 . . . . 0.0 114.117 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -155.44 134.39 12.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.296 1.838 . . . . 0.0 108.48 173.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.5 t -140.54 125.77 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.196 1.398 . . . . 0.0 109.112 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -140.74 140.35 34.81 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.628 1.571 . . . . 0.0 111.238 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 62.0 mt -140.21 130.57 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.838 1.655 . . . . 0.0 108.211 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -120.34 108.16 13.81 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.798 0.839 . . . . 0.0 112.079 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.73 -17.86 61.06 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -171.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -78.98 -19.42 51.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.115 0.966 . . . . 0.0 112.758 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -108.28 -29.28 8.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.744 1.218 . . . . 0.0 113.615 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.79 28.18 27.11 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 124.608 1.099 . . . . 0.0 114.182 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -133.86 156.95 47.16 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.519 1.527 . . . . 0.0 111.893 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.75 165.8 27.53 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.865 1.221 . . . . 0.0 113.615 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.33 146.58 46.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.555 1.942 . . . . 0.0 109.78 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.6 tt -153.26 127.39 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.583 0.753 . . . . 0.0 111.43 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -114.0 121.15 43.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.155 0.982 . . . . 0.0 111.176 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.0 mt -97.42 167.15 11.17 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.74 0.816 . . . . 0.0 110.73 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -70.37 -24.07 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.7 p -145.52 160.7 41.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.466 1.506 . . . . 0.0 111.138 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -62.49 -31.76 72.56 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 119.01 -0.519 . . . . 0.0 111.985 173.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.0 m -61.24 -47.19 87.2 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.91 1.284 . . . . 0.0 110.564 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.06 -45.78 93.36 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.298 0.639 . . . . 0.0 111.076 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.46 -36.15 83.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -68.49 -44.26 75.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.064 1.345 . . . . 0.0 111.428 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.53 -52.0 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.432 -0.793 . . . . 0.0 109.883 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.15 90.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.625 0.77 . . . . 0.0 112.389 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -52.94 -50.05 64.8 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.032 0.933 . . . . 0.0 111.679 172.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.4 t -74.68 -36.23 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.389 0.54 . . . . 0.0 111.852 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -77.29 -21.32 53.73 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.5 mt -110.83 0.11 17.12 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.521 1.128 . . . . 0.0 113.758 -174.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.67 125.9 26.72 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.14 -0.975 . . . . 0.0 112.218 -176.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 57.51 22.4 8.05 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.479 1.912 . . . . 0.0 113.5 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 51.0 ttp -63.81 133.55 95.6 Favored Pre-proline 0 N--CA 1.472 0.652 0 O-C-N 120.777 -1.202 . . . . 0.0 111.09 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -73.54 127.33 11.65 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.003 2.469 . . . . 0.0 110.432 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 45.6 tp -135.51 107.46 7.11 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.813 1.645 . . . . 0.0 108.117 170.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 57.81 29.18 17.07 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.769 1.228 . . . . 0.0 113.202 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.74 -5.61 62.12 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.249 1.88 . . . . 0.0 115.066 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -101.23 142.19 33.02 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.151 1.38 . . . . 0.0 111.025 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -102.14 117.4 34.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.88 0.872 . . . . 0.0 109.736 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.42 119.15 23.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.665 1.186 . . . . 0.0 112.28 -169.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -97.29 106.63 18.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.3 0.64 . . . . 0.0 110.312 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.44 129.24 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.512 1.125 . . . . 0.0 110.595 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.428 ' HD3' ' CD2' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -134.11 170.4 15.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.518 1.927 . . . . 0.0 110.819 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -90.57 140.42 29.77 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.522 0.729 . . . . 0.0 110.952 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -94.07 64.58 3.33 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.004 1.322 . . . . 0.0 111.791 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 29.9 p -158.51 173.78 16.09 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.68 1.592 . . . . 0.0 112.634 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -153.77 138.38 16.91 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.678 1.591 . . . . 0.0 111.731 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.5 t -168.68 -172.81 1.72 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.216 1.806 . . . . 0.0 110.372 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.71 115.98 11.12 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.795 1.638 . . . . 0.0 110.045 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.8 t -104.25 37.88 1.99 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.168 1.387 . . . . 0.0 111.319 -176.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.6 mt -134.63 167.31 21.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.732 2.013 . . . . 0.0 111.252 -171.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.5 t -156.5 160.39 39.48 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.052 1.741 . . . . 0.0 110.321 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 27.4 p -80.81 140.0 35.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.528 1.131 . . . . 0.0 112.63 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.25 -54.72 27.99 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 118.108 -1.385 . . . . 0.0 114.051 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -83.1 62.68 7.66 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.754 2.969 . . . . 0.0 110.824 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 62.8 p -81.78 151.24 27.52 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.594 1.158 . . . . 0.0 113.075 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 75.6 m -146.34 143.79 29.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.331 1.452 . . . . 0.0 111.161 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 C-N-CA 125.0 1.286 . . . . 0.0 113.146 178.781 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.8 t -85.99 131.33 34.3 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.625 -0.926 . . . . 0.0 111.279 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 p -82.41 98.63 8.97 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.253 1.021 . . . . 0.0 111.295 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.19 -134.58 7.02 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.381 1.467 . . . . 0.0 112.882 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.5 p -159.68 -179.5 7.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.609 1.563 . . . . 0.0 111.62 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.2 t -151.35 152.13 32.72 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.89 1.276 . . . . 0.0 110.978 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.29 13.12 77.45 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.3 0.953 . . . . 0.0 114.316 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.94 -148.77 19.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.406 1.479 . . . . 0.0 113.002 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -155.2 144.98 21.44 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.544 1.537 . . . . 0.0 109.806 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -83.23 -12.72 56.54 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -169.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.6 p -90.37 173.96 7.83 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.003 1.721 . . . . 0.0 111.578 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -57.38 131.21 49.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.038 0.935 . . . . 0.0 111.321 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 100.0 m -130.15 139.81 50.84 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.792 1.637 . . . . 0.0 109.824 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -69.15 150.56 47.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.988 1.315 . . . . 0.0 113.178 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -99.93 23.96 9.12 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.728 1.211 . . . . 0.0 113.952 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.5 p -78.38 8.26 5.33 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -77.03 121.38 23.45 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.497 1.119 . . . . 0.0 110.599 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.4 mt -105.1 134.32 48.4 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.705 1.602 . . . . 0.0 110.354 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -91.94 135.31 34.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.049 2.14 . . . . 0.0 108.086 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.3 t -131.48 106.22 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.353 1.061 . . . . 0.0 108.884 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.01 163.08 15.19 Favored Glycine 0 N--CA 1.464 0.546 0 C-N-CA 124.991 1.281 . . . . 0.0 113.724 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 t30 68.7 27.56 5.87 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.85 1.66 . . . . 0.0 112.745 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.74 145.57 95.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 O-C-N 121.187 -0.946 . . . . 0.0 111.854 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.1 165.86 31.03 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.209 3.273 . . . . 0.0 111.777 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.19 -5.98 17.77 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.091 2.528 . . . . 0.0 113.4 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -106.87 0.48 23.96 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.124 1.37 . . . . 0.0 114.181 -172.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 tp -74.25 143.2 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.268 -0.895 . . . . 0.0 111.129 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 65.7 p -128.23 166.51 18.41 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.035 1.734 . . . . 0.0 110.074 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.96 -31.98 69.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.033 0.533 . . . . 0.0 111.536 171.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -70.76 -42.09 70.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.213 1.005 . . . . 0.0 111.924 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -66.28 -41.86 89.22 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.78 0.718 . . . . 0.0 111.302 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.8 tpt -65.11 -37.92 89.03 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.891 -0.505 . . . . 0.0 111.629 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -63.11 -48.4 78.71 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.404 -0.81 . . . . 0.0 110.273 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -60.49 -38.89 85.73 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.196 0.998 . . . . 0.0 113.296 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.6 mt -63.99 -29.78 70.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.38 1.472 . . . . 0.0 113.988 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.434 ' CZ ' HD13 ' A' ' 131' ' ' LEU . 47.8 m-85 -109.89 -4.0 16.26 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.69 1.196 . . . . 0.0 113.51 -176.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.38 -27.52 67.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.927 1.691 . . . . 0.0 115.16 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -55.78 -24.43 35.62 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.961 1.304 . . . . 0.0 112.707 171.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -107.02 14.54 26.27 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.937 2.095 . . . . 0.0 112.029 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.02 172.66 44.97 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.137 1.827 . . . . 0.0 112.78 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.57 132.91 46.21 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.873 -0.78 . . . . 0.0 110.931 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.1 145.44 51.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.885 0.874 . . . . 0.0 112.163 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.05 -11.59 75.93 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.631 1.11 . . . . 0.0 113.905 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -157.69 135.92 11.01 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.712 2.005 . . . . 0.0 108.371 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.34 128.84 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.265 1.426 . . . . 0.0 108.609 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -140.87 139.88 34.5 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.147 1.379 . . . . 0.0 110.904 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.8 mt -139.1 120.6 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.371 1.469 . . . . 0.0 108.312 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -115.97 98.18 6.5 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.234 1.014 . . . . 0.0 112.12 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.07 -15.86 62.02 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.92 -23.61 60.72 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.278 1.031 . . . . 0.0 112.697 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -117.06 -25.27 7.23 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.59 27.7 18.97 Favored Glycine 0 N--CA 1.477 1.428 0 C-N-CA 124.569 1.081 . . . . 0.0 114.171 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.91 150.54 52.15 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.373 1.469 . . . . 0.0 111.46 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.64 167.4 25.32 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.56 1.552 . . . . 0.0 113.08 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -139.52 142.62 37.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.468 1.907 . . . . 0.0 109.402 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 tt -151.65 130.65 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.382 0.673 . . . . 0.0 111.454 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.49 122.38 45.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.611 1.164 . . . . 0.0 110.441 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -97.59 168.41 10.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.005 0.522 . . . . 0.0 111.085 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -67.58 -32.4 73.12 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -171.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.9 p -140.44 159.32 42.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.827 1.251 . . . . 0.0 112.102 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -60.88 -31.95 71.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.818 0.847 . . . . 0.0 113.001 173.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m -68.71 -47.93 65.14 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.161 1.384 . . . . 0.0 110.658 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.8 mt -58.88 -42.34 89.23 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.614 0.766 . . . . 0.0 111.261 173.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.67 -35.39 78.76 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.79 -47.25 75.76 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.742 1.155 . . . . 0.0 111.361 172.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.7 mt -59.43 -48.73 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.19 0.596 . . . . 0.0 110.316 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.98 93.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.203 0.601 . . . . 0.0 112.033 176.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -57.54 -49.0 77.76 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.412 1.005 . . . . 0.0 111.182 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.86 -35.87 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.192 0.597 . . . . 0.0 111.963 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -83.48 -24.32 31.82 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.434 HD13 ' CZ ' ' A' ' 96' ' ' PHE . 55.3 mt -111.23 -18.48 12.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -171.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.67 128.39 35.77 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.897 1.226 . . . . 0.0 111.975 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 59.5 27.47 16.63 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.897 2.079 . . . . 0.0 113.364 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.8 ttp -74.72 137.43 73.73 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.535 -0.728 . . . . 0.0 109.664 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.31 136.3 15.81 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.315 2.677 . . . . 0.0 111.058 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -145.12 123.49 12.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.971 1.708 . . . . 0.0 109.0 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 58.83 22.87 10.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.775 1.23 . . . . 0.0 113.716 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.15 3.1 85.29 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.317 1.436 . . . . 0.0 114.474 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -106.17 148.91 27.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.17 1.788 . . . . 0.0 110.879 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -84.22 168.47 15.7 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.339 168.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.01 127.87 37.13 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.29 1.036 . . . . 0.0 110.701 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.63 111.34 23.52 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.84 0.856 . . . . 0.0 108.902 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.94 124.21 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.767 0.827 . . . . 0.0 109.822 -173.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.9 ptt85 -149.63 173.6 13.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.311 1.444 . . . . 0.0 111.247 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -75.2 144.97 42.41 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.616 -0.678 . . . . 0.0 111.85 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.02 17.99 3.84 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.221 1.408 . . . . 0.0 113.095 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 89.3 m -53.5 128.64 29.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.919 1.687 . . . . 0.0 112.99 -177.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -76.34 160.95 29.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.14 0.976 . . . . 0.0 112.025 171.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.3 t -149.25 119.09 7.07 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.44 0.696 . . . . 0.0 110.373 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.34 113.65 1.85 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.836 1.654 . . . . 0.0 109.747 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.1 t -169.03 163.26 11.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.113 1.765 . . . . 0.0 110.266 -177.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.16 134.56 54.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.166 1.386 . . . . 0.0 110.109 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.8 m -70.51 -28.49 65.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.863 1.265 . . . . 0.0 112.115 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 21.1 t -77.65 120.6 22.81 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.699 0.8 . . . . 0.0 110.876 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 164.2 90.11 0.08 OUTLIER Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.402 -1.221 . . . . 0.0 111.999 -177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.11 156.06 38.02 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.562 2.841 . . . . 0.0 111.904 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.9 t -80.84 146.89 30.66 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.871 0.868 . . . . 0.0 111.677 173.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.4 p -73.51 145.47 45.59 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.003 -1.061 . . . . 0.0 112.843 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 125.154 1.359 . . . . 0.0 112.899 -179.469 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.0 t -81.76 167.24 19.3 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.541 -0.976 . . . . 0.0 111.929 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.3 t -169.15 -165.18 0.51 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.183 1.793 . . . . 0.0 110.55 -173.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.88 -105.69 1.33 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.283 1.42 . . . . 0.0 111.969 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -64.62 -15.75 61.66 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.694 1.198 . . . . 0.0 113.39 172.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.8 m -123.98 59.7 1.14 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.675 1.59 . . . . 0.0 110.903 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.07 55.09 3.92 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.719 1.628 . . . . 0.0 113.246 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.59 -177.86 45.47 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.739 1.638 . . . . 0.0 113.518 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -79.38 135.76 36.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.383 1.073 . . . . 0.0 111.061 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 160.73 26.97 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.3 p -128.2 157.8 39.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.882 1.673 . . . . 0.0 110.834 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -82.03 155.08 25.33 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.078 0.951 . . . . 0.0 111.636 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.4 p -141.59 144.69 34.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.639 1.576 . . . . 0.0 110.504 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -104.85 29.34 6.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.202 1.401 . . . . 0.0 112.123 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.4 ttm105 -142.71 125.8 16.35 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.571 1.548 . . . . 0.0 111.04 -172.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.4 m -93.28 28.27 2.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.519 1.527 . . . . 0.0 113.409 -173.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -85.88 122.19 29.59 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.05 1.34 . . . . 0.0 111.443 -176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.6 mt -105.15 135.85 45.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.329 1.852 . . . . 0.0 110.066 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -90.87 138.53 31.52 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.144 1.777 . . . . 0.0 108.723 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.93 106.06 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.24 1.016 . . . . 0.0 108.788 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.79 168.74 20.63 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 125.454 1.502 . . . . 0.0 112.83 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.1 m120 61.48 35.36 17.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.828 1.251 . . . . 0.0 112.045 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.7 mt -66.26 145.78 99.0 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 121.3 -0.875 . . . . 0.0 111.442 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -70.11 158.08 57.65 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.946 2.431 . . . . 0.0 111.338 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.24 -2.32 11.48 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.93 3.087 . . . . 0.0 113.333 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -112.99 14.13 19.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.556 1.943 . . . . 0.0 112.604 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.25 150.21 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 O-C-N 121.012 -1.055 . . . . 0.0 110.753 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.0 p -136.2 170.06 16.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.832 1.653 . . . . 0.0 109.683 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.27 -35.41 71.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.57 0.348 . . . . 0.0 111.464 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.44 -41.26 66.35 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.975 0.91 . . . . 0.0 111.806 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.29 -46.79 82.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.233 0.613 . . . . 0.0 111.261 173.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.2 ttt -64.42 -35.51 81.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.116 0.566 . . . . 0.0 112.264 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -64.91 -45.11 87.29 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.415 0.686 . . . . 0.0 110.97 171.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -64.35 -42.98 95.95 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.197 -0.94 . . . . 0.0 111.946 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.1 mt -57.65 -24.61 57.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.476 1.51 . . . . 0.0 113.964 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -115.14 -1.85 12.9 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.681 1.192 . . . . 0.0 113.572 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.27 -28.79 69.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.728 1.611 . . . . 0.0 115.164 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -61.11 -22.03 64.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.523 1.129 . . . . 0.0 112.91 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -103.49 24.99 10.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.912 2.085 . . . . 0.0 111.67 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.24 -176.82 45.52 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.934 1.73 . . . . 0.0 112.664 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.66 144.38 56.97 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.95 -0.735 . . . . 0.0 111.949 175.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.14 118.01 16.6 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.16 -15.15 75.27 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.807 1.194 . . . . 0.0 113.566 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -161.17 145.25 13.33 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.672 1.989 . . . . 0.0 108.677 168.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.8 t -144.35 130.73 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.32 1.448 . . . . 0.0 110.365 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -140.52 136.69 33.15 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.405 1.482 . . . . 0.0 110.844 171.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 63.7 mt -139.29 137.03 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.249 1.82 . . . . 0.0 107.84 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -139.55 125.29 19.51 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.135 0.969 . . . . 0.0 113.087 170.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.15 -18.68 62.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.441 1.096 . . . . 0.0 112.779 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.36 -38.72 63.57 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.337 1.855 . . . . 0.0 113.081 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -120.77 -15.32 8.4 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.67 41.16 5.77 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.787 1.184 . . . . 0.0 113.811 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -136.86 159.26 42.39 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.114 1.366 . . . . 0.0 112.223 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.96 167.37 29.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.496 1.046 . . . . 0.0 114.191 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -139.11 147.06 41.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.705 2.002 . . . . 0.0 109.571 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.2 tt -147.88 132.28 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.202 1.001 . . . . 0.0 110.646 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -101.63 128.42 47.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.965 0.906 . . . . 0.0 109.131 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 124' ' ' ALA . 12.5 mt -98.68 165.99 11.54 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.361 0.528 . . . . 0.0 110.278 170.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -76.5 -18.05 58.95 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -169.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.2 p -144.4 154.3 42.83 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.828 1.251 . . . . 0.0 111.5 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -62.87 -33.15 74.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.61 0.764 . . . . 0.0 112.891 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.1 m -64.48 -47.66 78.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.691 1.196 . . . . 0.0 110.793 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -66.71 -35.89 81.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.338 0.655 . . . . 0.0 111.394 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.45 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -64.8 -39.77 94.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 173.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.94 -47.76 76.51 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.489 1.041 . . . . 0.0 111.214 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 93.9 mt -59.54 -50.41 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.202 0.601 . . . . 0.0 110.272 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.64 -45.68 88.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.093 0.557 . . . . 0.0 111.806 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.38 -46.22 86.79 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.391 -0.818 . . . . 0.0 111.69 176.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.1 t -67.56 -35.77 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.516 0.598 . . . . 0.0 111.89 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -80.81 -24.35 38.58 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 48.9 mt -109.09 -16.71 14.05 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.02 133.71 49.47 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.05 1.295 . . . . 0.0 112.615 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 59.4 t30 65.71 15.83 10.22 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.939 2.496 . . . . 0.0 113.757 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.8 ttp -71.43 136.13 83.92 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 120.834 -1.166 . . . . 0.0 110.563 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.93 129.77 11.8 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.363 2.709 . . . . 0.0 110.607 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.9 tp -139.32 113.29 8.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.036 1.335 . . . . 0.0 109.557 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 58.81 23.62 11.45 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.906 1.282 . . . . 0.0 113.478 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.26 -3.37 76.09 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.847 1.689 . . . . 0.0 114.671 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -92.14 147.68 22.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.413 1.485 . . . . 0.0 110.7 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -102.67 110.46 22.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.749 0.82 . . . . 0.0 109.348 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 80.4 mt -73.56 121.21 20.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.699 0.8 . . . . 0.0 111.661 -172.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -92.07 112.7 24.73 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.919 0.888 . . . . 0.0 108.8 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.66 120.47 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.186 0.994 . . . . 0.0 110.131 -172.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -155.08 156.09 35.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.773 1.229 . . . . 0.0 111.473 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -67.85 133.03 48.47 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.672 -0.643 . . . . 0.0 111.435 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -85.33 121.74 28.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.121 0.968 . . . . 0.0 110.399 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 27.5 p -158.91 170.51 21.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.061 1.344 . . . . 0.0 112.596 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -158.23 -168.16 2.4 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.932 1.693 . . . . 0.0 112.234 -175.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 80.6 p -151.17 156.42 40.91 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.779 1.232 . . . . 0.0 111.573 174.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.19 134.44 16.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.73 1.212 . . . . 0.0 111.138 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.1 t -104.27 1.28 30.28 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.57 1.148 . . . . 0.0 112.865 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.7 mt -53.48 112.63 0.94 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.873 1.669 . . . . 0.0 111.424 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.3 p 50.17 27.38 2.56 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.872 2.469 . . . . 0.0 114.258 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.5 t -112.23 87.57 2.6 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.687 1.195 . . . . 0.0 111.241 -173.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -141.84 95.36 0.19 Allowed Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.268 -1.296 . . . . 0.0 112.331 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -82.14 -8.61 11.87 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.807 3.005 . . . . 0.0 113.438 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.3 m -61.68 145.23 52.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.038 1.335 . . . . 0.0 113.143 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.4 m -62.68 123.05 17.39 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.155 0.982 . . . . 0.0 112.948 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.246 0 C-N-CA 125.377 1.465 . . . . 0.0 113.092 179.381 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.3 m -145.59 154.27 41.96 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.507 1.523 . . . . 0.0 111.168 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.4 t -162.22 165.5 26.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.288 1.435 . . . . 0.0 110.952 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.55 -128.6 8.77 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.309 0.956 . . . . 0.0 111.72 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 p -157.61 136.8 11.78 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.798 1.239 . . . . 0.0 111.438 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.6 m -79.41 136.21 36.9 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.292 -0.88 . . . . 0.0 112.695 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.74 155.88 34.07 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.44 1.019 . . . . 0.0 112.593 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -93.2 -139.1 9.15 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.019 1.295 . . . . 0.0 112.166 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -72.95 1.9 7.92 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.594 1.557 . . . . 0.0 113.54 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -146.0 158.01 43.87 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.249 1.82 . . . . 0.0 112.152 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.2 m -112.73 97.23 6.43 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.628 1.571 . . . . 0.0 109.728 -175.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -138.06 60.22 1.63 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.606 1.562 . . . . 0.0 109.621 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.4 p -78.93 115.9 18.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.476 1.51 . . . . 0.0 109.884 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -165.75 168.01 16.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.582 1.553 . . . . 0.0 111.157 -173.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -139.16 45.29 1.98 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.767 1.627 . . . . 0.0 111.94 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 t -92.59 -0.8 57.27 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.337 1.855 . . . . 0.0 113.58 -174.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -76.73 125.74 29.78 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.762 -1.211 . . . . 0.0 110.973 -175.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.2 mt -114.02 139.28 49.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.238 2.215 . . . . 0.0 110.26 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -100.74 142.56 32.04 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.238 2.215 . . . . 0.0 108.567 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.43 114.89 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.218 1.007 . . . . 0.0 110.001 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.88 173.73 17.03 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 126.021 1.772 . . . . 0.0 113.057 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.2 m120 66.64 11.79 8.38 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.462 1.905 . . . . 0.0 114.024 -175.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.5 mt -53.98 144.24 38.51 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.342 1.057 . . . . 0.0 113.41 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.03 165.29 33.04 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.257 3.305 . . . . 0.0 112.032 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.61 -8.14 20.19 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.389 2.726 . . . . 0.0 113.833 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -121.65 23.25 10.3 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.794 1.638 . . . . 0.0 113.561 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 tp -81.81 143.13 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.806 0.843 . . . . 0.0 110.53 173.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.0 p -136.52 167.65 20.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.557 1.943 . . . . 0.0 109.892 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -62.53 -28.54 69.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.32 0.648 . . . . 0.0 112.318 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -72.15 -47.62 49.59 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.993 -1.067 . . . . 0.0 112.496 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -57.82 -41.13 81.57 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.136 0.575 . . . . 0.0 111.86 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -70.07 -34.73 73.55 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.594 -0.691 . . . . 0.0 112.451 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -68.37 -37.05 80.06 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.518 -0.739 . . . . 0.0 111.906 169.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -68.97 -41.82 77.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.11 0.964 . . . . 0.0 112.449 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.3 mt -58.06 -26.52 62.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.101 1.36 . . . . 0.0 113.46 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -109.23 10.45 25.77 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.545 1.538 . . . . 0.0 112.526 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.78 -22.22 66.03 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -61.43 -21.7 64.35 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.602 1.161 . . . . 0.0 112.419 171.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.07 13.12 24.77 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.123 2.169 . . . . 0.0 112.131 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.37 -168.94 53.38 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.827 1.203 . . . . 0.0 112.916 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -76.57 124.75 28.09 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.55 0.74 . . . . 0.0 110.973 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.14 149.43 48.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.205 1.002 . . . . 0.0 111.681 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.07 -13.94 65.38 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.538 1.066 . . . . 0.0 113.914 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -154.79 136.21 14.16 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.853 1.661 . . . . 0.0 108.919 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 t -143.2 128.72 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.708 1.603 . . . . 0.0 109.066 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -145.35 144.32 30.64 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.062 1.345 . . . . 0.0 111.82 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.2 mt -137.68 128.1 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.352 1.461 . . . . 0.0 108.542 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -115.84 92.62 3.96 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.387 1.075 . . . . 0.0 110.542 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -74.54 -12.3 60.43 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.43 -23.24 62.7 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.073 1.349 . . . . 0.0 112.877 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -117.03 -22.37 8.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.729 1.212 . . . . 0.0 114.168 175.484 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.46 36.26 7.05 Favored Glycine 0 N--CA 1.475 1.288 0 C-N-CA 125.09 1.329 . . . . 0.0 114.276 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.13 152.08 44.44 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.113 1.365 . . . . 0.0 112.037 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.58 163.01 24.71 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.389 1.471 . . . . 0.0 113.375 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -142.3 140.66 32.26 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.642 1.977 . . . . 0.0 109.156 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.9 tt -154.32 148.12 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.829 0.852 . . . . 0.0 110.73 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -138.87 125.78 21.07 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.776 0.83 . . . . 0.0 110.58 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.28 176.85 5.05 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.24 1.016 . . . . 0.0 111.733 -170.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -76.9 -25.29 52.83 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.6 p -144.66 154.11 42.44 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.348 1.059 . . . . 0.0 112.147 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -58.49 -34.61 71.11 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.659 0.784 . . . . 0.0 112.884 172.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.1 m -62.22 -50.19 72.77 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.251 1.42 . . . . 0.0 110.445 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.11 -36.88 85.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.993 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.77 -37.24 85.79 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.115 0.87 . . . . 0.0 113.282 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -67.95 -45.27 74.72 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.771 0.828 . . . . 0.0 111.808 173.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.76 -48.0 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.57 -0.706 . . . . 0.0 110.243 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.88 91.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.929 0.891 . . . . 0.0 112.017 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -53.69 -53.77 47.33 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.016 0.826 . . . . 0.0 111.479 171.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.8 t -67.88 -33.03 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.582 0.628 . . . . 0.0 112.182 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.71 -36.03 44.03 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.06 -20.84 14.61 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.185 1.179 . . . . 0.0 114.185 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -67.07 134.01 51.0 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.114 0.87 . . . . 0.0 110.908 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . 0.3 0.4 OUTLIER 58.49 17.81 5.19 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.607 2.363 . . . . 0.0 115.246 -170.654 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.3 ttp -75.88 137.59 69.65 Favored Pre-proline 0 CA--C 1.545 0.771 0 O-C-N 120.873 -1.142 . . . . 0.0 110.947 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.73 140.8 21.21 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.467 2.778 . . . . 0.0 111.427 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 32.6 tp -146.56 119.3 8.61 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.459 1.504 . . . . 0.0 110.287 174.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? 58.98 23.9 12.04 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.065 1.346 . . . . 0.0 113.894 171.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.1 1.24 72.92 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.533 1.539 . . . . 0.0 114.734 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -107.66 165.15 11.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.669 1.988 . . . . 0.0 110.768 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -90.45 176.29 6.76 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.6 -0.688 . . . . 0.0 109.99 168.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.4 mt -133.85 116.11 15.27 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.6 1.16 . . . . 0.0 109.196 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -92.13 119.87 32.2 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.0 t -124.72 129.99 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.563 0.745 . . . . 0.0 109.926 -176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -146.98 164.4 33.11 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.304 1.442 . . . . 0.0 111.13 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -70.97 130.58 41.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 168.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.87 71.12 8.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.88 1.272 . . . . 0.0 110.759 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 6.1 t -155.44 169.58 23.93 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.34 1.456 . . . . 0.0 112.016 -170.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.77 176.92 11.75 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.56 2.344 . . . . 0.0 110.935 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.4 t -148.34 143.17 26.7 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.977 -1.077 . . . . 0.0 112.428 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.85 45.54 0.82 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.945 1.698 . . . . 0.0 112.811 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 67.8 m -77.91 105.46 9.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.269 1.028 . . . . 0.0 111.102 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.52 142.64 33.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.112 0.965 . . . . 0.0 110.101 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 56.7 m -145.57 131.97 19.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.998 1.719 . . . . 0.0 108.783 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.0 t -162.06 148.52 13.55 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.923 1.289 . . . . 0.0 111.004 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -163.63 79.9 0.13 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.468 -1.185 . . . . 0.0 112.702 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.81 -8.55 14.54 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.911 3.074 . . . . 0.0 113.461 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.6 m -61.2 138.9 58.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.051 1.34 . . . . 0.0 113.126 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.3 p -73.19 126.49 30.18 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.121 -0.987 . . . . 0.0 112.403 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.255 0 C-N-CA 125.211 1.386 . . . . 0.0 112.988 178.94 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.465 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.6 m -142.65 123.34 14.18 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.668 1.187 . . . . 0.0 110.926 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -168.07 152.13 6.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.531 1.532 . . . . 0.0 110.899 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.97 175.35 53.07 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.322 0.963 . . . . 0.0 112.451 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.9 p -76.76 152.54 35.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.97 0.908 . . . . 0.0 112.465 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.4 t -96.37 3.41 52.92 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.963 -1.085 . . . . 0.0 113.86 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.51 -156.57 43.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.698 1.142 . . . . 0.0 112.69 -175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.9 -150.78 32.91 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.434 1.016 . . . . 0.0 112.973 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -72.88 152.41 41.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.167 0.987 . . . . 0.0 111.902 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.69 158.13 25.43 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.7 p -104.72 170.64 7.77 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.747 1.619 . . . . 0.0 111.337 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -143.26 140.44 30.65 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.275 1.43 . . . . 0.0 110.564 -170.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -89.31 152.56 21.47 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.853 0.861 . . . . 0.0 111.417 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -95.65 -11.11 27.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.034 1.334 . . . . 0.0 112.414 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -140.44 141.84 35.44 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.182 1.393 . . . . 0.0 111.696 -171.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.8 p -98.29 20.09 13.15 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.17 1.788 . . . . 0.0 113.189 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -76.52 128.5 34.87 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.597 1.159 . . . . 0.0 111.311 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.02 140.28 49.42 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.181 1.792 . . . . 0.0 110.468 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -95.9 140.72 30.26 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.536 2.334 . . . . 0.0 108.814 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.2 110.46 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.94 0.896 . . . . 0.0 109.401 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.34 172.35 21.22 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.447 1.498 . . . . 0.0 113.321 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 m120 65.25 19.09 11.63 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.669 1.588 . . . . 0.0 113.128 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.1 mt -58.79 143.46 82.68 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.252 1.021 . . . . 0.0 111.857 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.7 158.57 56.57 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.696 2.93 . . . . 0.0 111.255 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.83 0.36 7.82 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.422 2.748 . . . . 0.0 113.568 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -114.64 4.75 15.18 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.943 1.697 . . . . 0.0 113.639 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.5 tp -74.03 142.41 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.28 -0.887 . . . . 0.0 111.247 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.7 p -123.72 165.59 17.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.971 1.708 . . . . 0.0 110.051 175.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.72 -27.78 68.16 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.699 0.399 . . . . 0.0 111.918 172.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.08 -40.27 62.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.168 0.987 . . . . 0.0 111.76 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -67.54 -37.81 83.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.637 0.653 . . . . 0.0 111.466 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.2 tpt -66.38 -40.98 90.03 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.641 -0.662 . . . . 0.0 111.657 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -60.56 -38.15 83.59 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.657 -0.652 . . . . 0.0 111.101 172.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -72.02 -40.3 68.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.05 0.94 . . . . 0.0 113.333 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 38.0 mt -56.02 -29.52 60.5 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.792 1.237 . . . . 0.0 112.766 173.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -109.05 12.88 24.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.446 1.498 . . . . 0.0 113.152 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -20.18 61.6 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.804 -1.185 . . . . 0.0 114.006 -174.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -64.53 -17.89 64.33 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.556 -0.715 . . . . 0.0 112.269 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -102.71 8.4 39.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.829 2.052 . . . . 0.0 112.178 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.08 -109.03 3.77 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.09 157.54 46.47 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.628 1.171 . . . . 0.0 112.413 170.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.97 151.11 26.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.742 0.817 . . . . 0.0 110.228 168.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.81 -14.31 61.27 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.697 1.142 . . . . 0.0 113.299 173.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -153.42 144.92 23.24 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.003 1.321 . . . . 0.0 110.622 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.29 128.8 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.549 1.94 . . . . 0.0 109.205 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -140.62 138.55 34.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.12 1.368 . . . . 0.0 111.514 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.4 mt -141.97 126.34 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.83 1.652 . . . . 0.0 107.816 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -118.18 106.81 13.22 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.932 0.872 . . . . 0.0 112.541 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -65.06 -27.18 68.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.989 1.316 . . . . 0.0 114.088 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.45 -9.08 59.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.851 1.261 . . . . 0.0 112.881 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -114.79 -32.7 5.72 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.132 1.373 . . . . 0.0 112.874 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.72 26.86 28.42 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.705 1.145 . . . . 0.0 113.753 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.65 155.18 48.51 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.717 1.607 . . . . 0.0 111.505 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.1 167.48 26.83 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.926 1.251 . . . . 0.0 113.677 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -139.18 148.14 42.75 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.729 2.011 . . . . 0.0 109.76 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.8 tt -154.76 138.93 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.955 0.902 . . . . 0.0 110.609 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -121.93 113.21 19.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.208 1.003 . . . . 0.0 109.87 -171.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.9 mt -88.48 167.05 13.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.135 0.574 . . . . 0.0 111.825 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -75.73 -17.32 59.96 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.7 p -145.44 159.92 42.36 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.369 1.467 . . . . 0.0 110.566 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -64.93 -34.35 78.2 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 171.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.8 m -55.71 -45.39 77.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.59 1.156 . . . . 0.0 111.119 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.2 -42.7 96.51 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.492 173.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.39 98.93 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.35 -51.25 70.16 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.353 1.433 . . . . 0.0 112.721 170.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.29 -45.9 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.905 -0.497 . . . . 0.0 110.293 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.81 94.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.362 0.665 . . . . 0.0 112.021 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.43 -45.1 94.86 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.397 -0.814 . . . . 0.0 111.564 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.76 -36.95 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.623 0.647 . . . . 0.0 112.006 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.08 -35.88 36.33 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.6 mt -96.78 -19.74 18.7 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -171.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -59.36 120.84 10.06 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.496 0.718 . . . . 0.0 111.762 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 64.32 21.59 12.55 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.964 2.106 . . . . 0.0 113.486 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.7 ttp -72.34 136.62 81.34 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 120.811 -1.181 . . . . 0.0 110.574 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.66 140.63 21.25 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.457 2.772 . . . . 0.0 111.628 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -148.44 116.43 6.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.619 1.568 . . . . 0.0 109.938 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 53.49 38.98 29.35 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.91 1.284 . . . . 0.0 113.288 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.88 77.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.379 1.466 . . . . 0.0 114.686 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -101.03 160.74 14.12 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.996 1.718 . . . . 0.0 110.45 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -93.89 173.14 7.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.985 0.914 . . . . 0.0 109.42 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 89.7 mt -133.0 110.35 10.19 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.214 1.005 . . . . 0.0 109.577 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 106.26 18.24 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.5 132.04 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 122.83 0.452 . . . . 0.0 111.602 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -139.22 169.1 18.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.547 1.939 . . . . 0.0 110.812 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -84.64 130.15 34.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.649 0.779 . . . . 0.0 111.077 169.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -97.97 53.63 1.1 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.75 1.62 . . . . 0.0 111.669 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 85.6 m -83.32 140.5 32.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.442 1.097 . . . . 0.0 112.075 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.27 5.49 51.59 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -174.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.9 m -138.32 168.33 19.97 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.122 1.769 . . . . 0.0 111.872 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -145.48 163.99 32.96 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.459 1.504 . . . . 0.0 112.086 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 74.1 m -145.26 158.63 43.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.839 1.656 . . . . 0.0 111.45 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 93.7 mt -104.85 124.05 48.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.798 1.239 . . . . 0.0 110.745 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 12.0 m -85.38 -19.19 31.77 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.111 1.364 . . . . 0.0 112.606 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 42.4 p -128.37 139.86 52.16 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.478 1.511 . . . . 0.0 112.086 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -170.02 86.49 0.09 OUTLIER Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.391 -1.227 . . . . 0.0 112.712 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.99 152.83 32.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.842 3.028 . . . . 0.0 111.587 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.7 m -149.68 130.9 14.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.034 1.334 . . . . 0.0 110.752 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 52.0 p 67.49 -0.71 1.79 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 127.601 2.36 . . . . 0.0 116.244 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 C-N-CA 125.624 1.583 . . . . 0.0 113.062 179.848 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -95.32 124.89 39.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.588 1.555 . . . . 0.0 111.253 -171.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.5 mt -109.03 134.82 51.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.241 1.817 . . . . 0.0 110.328 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -89.56 137.85 31.97 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 127.092 2.157 . . . . 0.0 107.717 169.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.41 111.07 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.841 0.856 . . . . 0.0 109.153 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.8 172.26 15.72 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.626 1.584 . . . . 0.0 113.097 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.6 m120 61.74 30.63 18.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.005 1.322 . . . . 0.0 111.807 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.54 140.66 96.63 Favored Pre-proline 0 CA--C 1.546 0.82 0 O-C-N 121.459 -0.776 . . . . 0.0 111.21 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.2 161.59 39.64 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.225 2.617 . . . . 0.0 111.165 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.87 -7.2 18.2 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.396 2.731 . . . . 0.0 112.676 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -102.87 11.47 37.43 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.797 2.039 . . . . 0.0 112.701 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.04 147.23 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 120.863 -1.148 . . . . 0.0 110.894 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.5 p -133.19 167.16 20.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.045 1.738 . . . . 0.0 109.671 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.55 -32.74 67.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.106 0.562 . . . . 0.0 111.488 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.52 -38.05 59.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.146 0.978 . . . . 0.0 112.473 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -63.95 -42.85 97.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.872 0.76 . . . . 0.0 110.659 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.8 ttt -68.99 -37.32 78.68 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.321 0.649 . . . . 0.0 112.127 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -62.68 -42.83 99.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.721 0.808 . . . . 0.0 111.225 171.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.92 -42.55 85.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.116 0.967 . . . . 0.0 113.212 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.6 mt -56.74 -25.02 53.79 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.74 1.216 . . . . 0.0 113.315 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -110.44 5.7 21.59 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.229 1.412 . . . . 0.0 113.464 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -67.33 -21.5 65.65 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.127 -0.983 . . . . 0.0 113.371 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -22.9 67.11 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.11 1.364 . . . . 0.0 112.388 172.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -105.67 7.26 32.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.568 1.947 . . . . 0.0 112.465 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.31 177.26 51.78 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.207 1.384 . . . . 0.0 113.069 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -71.37 130.08 40.44 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.805 -0.821 . . . . 0.0 111.347 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.21 153.4 42.49 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.351 1.06 . . . . 0.0 112.211 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.24 -17.29 67.18 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.816 1.198 . . . . 0.0 113.537 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -154.48 146.03 23.18 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.736 1.214 . . . . 0.0 110.809 170.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.2 t -145.22 126.47 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 126.456 1.902 . . . . 0.0 109.247 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -141.8 144.1 33.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.05 1.34 . . . . 0.0 112.316 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.3 mt -140.67 133.83 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 126.142 1.777 . . . . 0.0 108.483 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -124.88 107.49 10.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.954 0.902 . . . . 0.0 112.043 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -72.14 -27.24 62.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -171.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.67 -11.68 60.49 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.897 0.879 . . . . 0.0 113.27 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -114.8 -31.34 6.16 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.942 1.297 . . . . 0.0 113.204 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.5 29.34 19.42 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.744 1.164 . . . . 0.0 113.985 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -138.74 155.38 48.26 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.317 1.447 . . . . 0.0 112.022 -173.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.06 170.82 25.19 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.198 1.38 . . . . 0.0 113.49 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -144.78 144.03 30.96 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.197 1.799 . . . . 0.0 109.412 -173.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.1 tt -153.83 134.99 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.522 0.729 . . . . 0.0 110.6 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -125.79 117.99 24.58 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.898 0.879 . . . . 0.0 110.04 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.92 178.65 5.59 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.765 0.826 . . . . 0.0 111.965 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -80.85 -27.32 36.49 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.1 p -144.19 158.07 43.94 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.366 1.066 . . . . 0.0 111.792 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -57.44 -37.82 73.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.935 0.894 . . . . 0.0 112.404 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.0 m -62.06 -47.42 84.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.189 1.396 . . . . 0.0 110.794 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.03 -42.98 99.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.11 0.564 . . . . 0.0 111.305 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.53 -35.94 80.05 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.59 -47.74 71.77 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.2 1.0 . . . . 0.0 111.347 173.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.47 -47.63 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.715 -0.615 . . . . 0.0 110.14 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.06 -45.52 86.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.71 0.804 . . . . 0.0 112.249 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -55.58 -50.6 69.65 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.206 -0.934 . . . . 0.0 111.697 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.1 t -65.47 -34.01 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.762 0.71 . . . . 0.0 112.29 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -82.75 -32.69 27.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 61.0 mt -105.48 -20.42 13.48 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.275 1.584 . . . . 0.0 115.275 -168.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -70.5 128.61 36.73 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.514 1.052 . . . . 0.0 111.421 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 58.0 t30 69.02 13.73 8.79 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.394 2.278 . . . . 0.0 114.186 -171.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.5 ttp -72.48 138.65 80.85 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 120.569 -1.332 . . . . 0.0 110.894 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -74.37 134.31 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.448 2.766 . . . . 0.0 111.153 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 45.1 tp -143.22 115.99 8.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.49 1.516 . . . . 0.0 110.172 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 57.57 21.74 7.45 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.241 1.416 . . . . 0.0 113.471 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.28 -3.02 68.94 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.925 1.726 . . . . 0.0 115.083 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -97.08 156.15 16.5 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.723 1.609 . . . . 0.0 110.959 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -105.58 117.09 33.14 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.265 -0.897 . . . . 0.0 109.366 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.3 mt -72.71 136.01 45.48 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.96 0.904 . . . . 0.0 112.226 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.0 tpp180 -99.77 124.29 44.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.619 1.168 . . . . 0.0 108.767 169.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.74 128.06 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.985 0.914 . . . . 0.0 109.75 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -150.7 160.16 44.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.863 1.265 . . . . 0.0 111.192 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -68.69 132.61 47.14 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.721 -0.612 . . . . 0.0 110.356 170.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.183 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -83.27 129.01 34.98 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.335 1.454 . . . . 0.0 110.468 -176.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.4 mt -113.98 134.38 54.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.146 1.778 . . . . 0.0 110.056 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -89.26 137.4 32.36 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.141 2.176 . . . . 0.0 108.529 170.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -130.06 109.93 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.126 0.97 . . . . 0.0 109.415 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.1 173.8 20.11 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.21 1.862 . . . . 0.0 113.328 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.1 m120 64.0 19.59 11.82 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.951 1.701 . . . . 0.0 113.276 -173.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.67 140.63 92.78 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.067 -1.021 . . . . 0.0 112.778 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -69.44 157.35 61.34 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.856 3.037 . . . . 0.0 110.991 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.66 -5.47 17.12 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.26 2.64 . . . . 0.0 113.164 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -104.38 9.74 35.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.338 1.855 . . . . 0.0 113.321 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.2 tp -82.04 144.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.091 -1.006 . . . . 0.0 111.016 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.9 p -135.12 166.57 22.76 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.492 1.917 . . . . 0.0 109.303 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -60.73 -27.34 67.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.859 0.464 . . . . 0.0 112.012 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -72.9 -40.0 65.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.983 0.913 . . . . 0.0 111.773 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -65.42 -42.3 92.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.409 0.55 . . . . 0.0 111.004 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.3 ttt -69.12 -36.76 77.86 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.621 0.768 . . . . 0.0 112.221 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -61.62 -46.61 89.07 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.742 0.817 . . . . 0.0 110.79 169.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -66.38 -39.8 89.31 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.0 mt -59.62 -22.85 62.42 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.074 1.35 . . . . 0.0 113.694 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -116.09 7.83 14.33 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.437 1.495 . . . . 0.0 112.569 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -68.72 -22.0 64.37 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -169.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -67.13 -22.28 65.8 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.286 -0.883 . . . . 0.0 112.207 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -93.92 10.8 31.88 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.414 1.886 . . . . 0.0 112.589 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.48 -175.94 53.55 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.334 1.445 . . . . 0.0 113.189 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -72.1 128.92 37.2 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.992 -0.71 . . . . 0.0 111.186 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.35 147.08 48.37 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.959 0.904 . . . . 0.0 111.673 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.05 -1.28 82.25 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.831 1.205 . . . . 0.0 113.819 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -162.76 128.63 3.34 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.496 1.918 . . . . 0.0 108.18 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.71 123.32 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.745 1.218 . . . . 0.0 108.917 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -141.22 137.79 32.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.976 1.311 . . . . 0.0 110.927 176.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.7 mt -137.76 126.77 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.42 1.488 . . . . 0.0 108.359 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -118.32 108.42 15.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.281 1.033 . . . . 0.0 112.02 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -71.62 -30.6 65.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.019 0.928 . . . . 0.0 113.285 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.78 -20.22 61.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.049 0.94 . . . . 0.0 113.454 -176.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -112.83 -24.47 9.55 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.54 38.15 7.76 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 124.76 1.172 . . . . 0.0 114.154 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -140.62 152.99 45.87 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.16 1.384 . . . . 0.0 112.122 -173.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.37 161.48 24.97 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.029 1.3 . . . . 0.0 113.553 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.45 138.11 34.43 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.486 1.914 . . . . 0.0 109.476 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.4 tt -147.81 135.13 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 110.713 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -118.71 123.52 45.08 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.543 0.737 . . . . 0.0 110.749 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.64 170.33 9.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.711 0.804 . . . . 0.0 110.887 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.43 -22.27 51.74 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.8 p -146.26 144.05 29.6 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.747 1.219 . . . . 0.0 111.951 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.416 ' HD2' ' H ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -60.43 -32.53 71.45 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 m -63.92 -48.15 77.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.578 1.151 . . . . 0.0 110.756 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.18 -35.77 82.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.844 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.17 86.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.033 0.833 . . . . 0.0 112.736 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.09 -47.39 71.36 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.176 0.898 . . . . 0.0 111.812 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.9 mt -60.08 -50.12 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.778 -0.576 . . . . 0.0 110.044 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.02 -43.55 91.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.626 0.77 . . . . 0.0 111.87 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -57.24 -47.91 80.16 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.076 0.853 . . . . 0.0 111.586 174.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 78.6 t -71.09 -34.94 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 118.802 0.728 . . . . 0.0 112.176 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -82.79 -28.86 30.0 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 55.5 mt -99.31 -16.25 18.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.165 0.986 . . . . 0.0 113.374 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.96 116.6 2.84 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.022 1.729 . . . . 0.0 111.885 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.0 m120 64.32 19.47 11.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.138 2.175 . . . . 0.0 114.286 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.9 ttp -70.5 137.12 86.04 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 120.703 -1.248 . . . . 0.0 110.858 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.27 139.28 23.42 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.356 2.704 . . . . 0.0 111.437 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.9 tp -142.08 115.2 8.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.684 1.594 . . . . 0.0 109.801 173.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 57.18 25.22 10.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.931 1.292 . . . . 0.0 113.768 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.54 -3.67 83.64 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.542 1.544 . . . . 0.0 114.706 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -95.66 161.39 14.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.551 1.54 . . . . 0.0 111.047 172.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -88.24 176.05 7.41 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.79 169.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.0 mt -134.51 115.07 13.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.525 1.13 . . . . 0.0 109.704 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -91.97 115.91 28.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.629 0.771 . . . . 0.0 109.064 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.4 t -119.6 123.31 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.904 0.882 . . . . 0.0 110.503 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -139.94 164.61 29.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.029 1.732 . . . . 0.0 111.387 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -79.04 126.84 31.23 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.532 -0.73 . . . . 0.0 111.051 169.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 125.74 1.616 . . . . 0.0 110.603 176.068 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.7 p . . . . . 0 CA--C 1.548 0.892 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -95.11 128.27 41.81 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.829 1.652 . . . . 0.0 111.257 -169.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -111.18 137.98 48.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.381 1.872 . . . . 0.0 110.474 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -92.47 136.3 33.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.371 2.268 . . . . 0.0 108.596 169.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.8 t -128.71 116.06 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.469 1.108 . . . . 0.0 109.024 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.88 165.51 14.03 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 125.013 1.292 . . . . 0.0 114.561 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 64.76 33.1 10.59 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.691 1.596 . . . . 0.0 111.658 -174.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 mt -66.19 143.29 98.28 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 121.143 -0.973 . . . . 0.0 112.144 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.27 163.81 37.34 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.167 3.245 . . . . 0.0 111.506 174.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.0 -7.68 19.39 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.243 2.629 . . . . 0.0 113.195 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -94.87 7.75 44.96 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.725 1.61 . . . . 0.0 113.528 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 tp -97.43 135.95 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.644 1.178 . . . . 0.0 111.398 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.8 p -131.23 179.6 5.92 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.594 1.558 . . . . 0.0 109.235 169.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -57.31 -25.37 59.21 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.712 0.805 . . . . 0.0 112.549 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.45 -47.79 38.77 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.979 -1.076 . . . . 0.0 111.808 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -63.72 -41.54 98.05 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.078 0.551 . . . . 0.0 111.115 174.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.9 ttt -67.78 -33.14 74.24 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -67.56 -40.05 84.92 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.877 0.762 . . . . 0.0 111.447 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.8 -42.42 81.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.9 0.88 . . . . 0.0 112.683 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.7 mt -57.4 -28.18 63.01 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.404 1.482 . . . . 0.0 113.526 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -110.49 9.18 23.27 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.339 1.456 . . . . 0.0 112.677 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.29 -25.12 67.91 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -62.57 -22.82 66.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.955 1.302 . . . . 0.0 112.987 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -102.88 9.88 38.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.324 1.85 . . . . 0.0 112.644 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.78 -179.05 53.52 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.233 0.921 . . . . 0.0 112.612 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.52 141.28 50.13 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.79 -0.829 . . . . 0.0 112.175 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.41 150.42 27.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.483 1.113 . . . . 0.0 112.133 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.06 -9.42 73.69 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.205 1.384 . . . . 0.0 113.886 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -155.91 137.41 14.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.577 1.951 . . . . 0.0 108.409 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.2 t -143.87 127.24 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.448 1.499 . . . . 0.0 109.174 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -144.9 142.56 29.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.312 1.445 . . . . 0.0 112.201 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 57.4 mt -141.02 131.84 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.455 1.902 . . . . 0.0 108.838 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -125.28 113.17 17.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.094 0.957 . . . . 0.0 111.86 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -72.79 -36.19 67.56 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -170.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.39 -24.6 62.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.741 0.817 . . . . 0.0 113.043 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -100.19 -27.87 13.3 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.237 1.015 . . . . 0.0 113.346 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.81 29.78 19.91 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.798 1.19 . . . . 0.0 114.304 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -137.8 156.59 47.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.245 1.418 . . . . 0.0 112.267 -172.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.28 168.79 26.54 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.215 1.388 . . . . 0.0 113.417 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -142.52 149.68 39.45 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.034 1.733 . . . . 0.0 110.402 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.6 tt -155.31 141.92 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.233 1.013 . . . . 0.0 110.492 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -123.7 123.93 41.61 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.944 0.793 . . . . 0.0 111.308 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.4 mt -95.44 167.43 11.32 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.998 0.919 . . . . 0.0 110.639 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.29 -13.25 61.09 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.2 p -147.32 157.72 43.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.288 1.435 . . . . 0.0 111.684 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -60.12 -32.27 70.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.758 0.823 . . . . 0.0 113.1 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 m -63.97 -48.49 76.25 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.394 1.478 . . . . 0.0 110.506 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.66 -41.45 99.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.136 0.574 . . . . 0.0 111.202 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.63 87.26 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.48 -50.29 70.23 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.306 0.957 . . . . 0.0 111.969 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 83.4 mt -61.31 -47.92 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.752 -0.593 . . . . 0.0 110.289 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.14 95.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.703 0.801 . . . . 0.0 111.998 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.26 -44.57 92.41 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.213 -0.929 . . . . 0.0 112.042 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.2 t -66.72 -36.89 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.268 0.627 . . . . 0.0 111.918 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -85.23 -28.55 25.32 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.5 mt -103.69 -18.84 14.54 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.64 140.83 58.91 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.4 1.0 . . . . 0.0 111.127 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . 0.298 12.0 p30 55.15 18.99 2.62 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.327 2.251 . . . . 0.0 114.966 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.2 ttp -76.29 139.5 68.32 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.092 1.357 . . . . 0.0 111.109 173.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.83 138.88 19.19 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.546 2.831 . . . . 0.0 111.371 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -149.11 122.63 9.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.698 1.599 . . . . 0.0 109.726 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 56.51 32.19 20.33 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.758 1.223 . . . . 0.0 113.235 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.36 4.46 89.96 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.122 1.344 . . . . 0.0 114.637 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.45 156.92 20.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.492 1.917 . . . . 0.0 110.633 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -90.08 167.83 12.45 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.764 -0.585 . . . . 0.0 109.893 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.9 mt -129.77 140.32 51.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.69 1.196 . . . . 0.0 110.857 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -102.93 130.59 50.04 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.868 1.267 . . . . 0.0 108.312 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.39 120.42 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.136 0.88 . . . . 0.0 110.347 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -140.02 167.76 21.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.427 1.891 . . . . 0.0 110.554 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -75.94 134.44 40.22 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.575 -0.703 . . . . 0.0 111.127 169.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.886 0 C-N-CA 124.552 1.141 . . . . 0.0 113.054 172.765 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.64 134.73 34.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.705 1.202 . . . . 0.0 110.483 172.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.1 mt -111.54 133.98 53.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.147 1.379 . . . . 0.0 110.056 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -85.57 144.76 27.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.225 2.21 . . . . 0.0 108.004 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.53 110.02 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.192 0.997 . . . . 0.0 109.185 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.65 169.94 13.69 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.501 1.524 . . . . 0.0 113.249 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 65.47 29.04 11.43 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.381 1.473 . . . . 0.0 111.819 -173.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.8 mt -65.6 144.08 98.81 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.848 -1.157 . . . . 0.0 111.928 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.4 159.39 50.55 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.224 2.616 . . . . 0.0 111.292 174.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.08 -0.47 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.484 2.789 . . . . 0.0 113.299 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -114.38 7.35 16.31 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.732 1.613 . . . . 0.0 113.083 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.9 tp -73.28 145.54 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.789 0.836 . . . . 0.0 111.126 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.8 p -127.7 163.03 25.18 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.654 1.582 . . . . 0.0 110.079 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.98 -28.09 67.39 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.323 0.649 . . . . 0.0 111.687 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.24 -41.94 69.49 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.122 0.969 . . . . 0.0 111.507 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -66.07 -37.56 86.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.84 -0.537 . . . . 0.0 111.494 172.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.9 ttt -68.07 -38.98 83.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.536 0.734 . . . . 0.0 112.064 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -62.39 -37.55 86.17 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.107 0.963 . . . . 0.0 111.939 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -71.52 -42.74 67.59 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.412 -0.805 . . . . 0.0 112.453 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.6 mt -57.94 -27.86 63.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.862 1.265 . . . . 0.0 113.082 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -108.82 11.94 25.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.371 1.469 . . . . 0.0 112.769 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.73 -22.31 66.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.093 -1.004 . . . . 0.0 113.684 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -61.1 -22.79 64.98 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.895 1.278 . . . . 0.0 112.616 171.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -108.39 12.14 26.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.784 2.033 . . . . 0.0 112.375 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.18 -172.36 55.18 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.465 1.031 . . . . 0.0 112.94 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -71.47 133.73 46.06 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.989 0.916 . . . . 0.0 111.026 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.11 150.68 31.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.592 1.157 . . . . 0.0 112.02 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.45 -11.84 74.14 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.614 1.102 . . . . 0.0 114.138 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -159.87 138.77 10.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.065 1.746 . . . . 0.0 109.28 174.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.0 t -139.09 130.92 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.934 1.693 . . . . 0.0 109.222 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -141.59 141.03 33.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.21 1.404 . . . . 0.0 111.443 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.3 mt -140.6 129.34 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.011 1.724 . . . . 0.0 107.929 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -118.15 108.7 15.5 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.721 0.772 . . . . 0.0 112.324 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -72.26 -19.65 61.66 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -81.2 -13.75 58.25 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.192 0.997 . . . . 0.0 112.992 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -117.07 -25.66 7.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.916 1.286 . . . . 0.0 113.987 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.43 27.73 35.18 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 124.482 1.039 . . . . 0.0 114.257 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -134.5 149.96 50.75 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.419 1.488 . . . . 0.0 111.616 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.67 166.87 25.23 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.38 1.467 . . . . 0.0 113.134 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -146.19 143.28 29.17 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.342 1.857 . . . . 0.0 109.745 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.1 tt -150.95 133.39 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.078 0.951 . . . . 0.0 110.974 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -112.88 122.12 46.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.172 0.989 . . . . 0.0 110.541 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.27 163.48 12.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.688 0.795 . . . . 0.0 111.063 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.6 -23.77 53.45 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -171.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.5 p -148.71 143.6 26.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.402 1.481 . . . . 0.0 111.642 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -58.95 -32.92 70.06 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.7 m -59.43 -48.59 81.06 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.987 1.315 . . . . 0.0 111.032 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.07 -37.9 89.11 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.388 0.675 . . . . 0.0 111.817 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.51 -33.62 73.1 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.2 -46.78 72.88 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.831 0.852 . . . . 0.0 111.545 171.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.75 -47.46 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.72 -0.613 . . . . 0.0 110.061 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.96 -45.18 91.15 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.899 0.88 . . . . 0.0 112.218 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -55.47 -50.55 69.58 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.076 -1.015 . . . . 0.0 111.66 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.62 -34.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.695 0.68 . . . . 0.0 112.287 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -82.37 -32.89 29.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.8 mt -105.91 -19.57 13.7 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -168.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -71.97 127.46 32.63 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.696 1.135 . . . . 0.0 111.235 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 71.49 12.37 6.53 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.843 2.457 . . . . 0.0 113.736 -169.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.6 ttp -72.63 134.35 81.91 Favored Pre-proline 0 N--CA 1.473 0.691 0 O-C-N 120.574 -1.329 . . . . 0.0 110.767 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.61 132.29 15.8 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.065 2.51 . . . . 0.0 110.801 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 tp -137.29 104.76 5.49 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.514 1.126 . . . . 0.0 110.235 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.5 mtp-105 58.93 26.42 14.93 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.043 1.337 . . . . 0.0 113.691 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.94 -12.53 60.74 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.112 1.815 . . . . 0.0 114.576 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -82.09 163.86 21.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.578 1.189 . . . . 0.0 111.512 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -128.98 105.52 8.26 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.816 1.247 . . . . 0.0 108.878 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.81 125.13 25.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.008 1.323 . . . . 0.0 112.749 -168.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -93.06 118.02 30.72 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.264 1.025 . . . . 0.0 109.313 173.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.32 126.23 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.068 0.947 . . . . 0.0 109.943 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -143.33 159.73 41.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.753 1.621 . . . . 0.0 110.475 -173.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -81.31 124.62 29.5 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.504 -0.747 . . . . 0.0 110.792 170.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.823 0 C-N-CA 124.149 0.98 . . . . 0.0 111.231 174.899 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -76.91 128.82 35.26 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.092 1.357 . . . . 0.0 111.848 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.5 mt -105.26 141.58 36.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.574 1.95 . . . . 0.0 110.437 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -96.94 143.68 27.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.526 2.33 . . . . 0.0 108.474 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.2 t -132.56 115.89 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.184 0.994 . . . . 0.0 109.782 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.98 173.26 16.5 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 125.912 1.72 . . . . 0.0 113.226 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m120 64.95 20.47 12.12 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.956 1.702 . . . . 0.0 113.093 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.9 mt -61.6 140.75 95.05 Favored Pre-proline 0 CA--C 1.549 0.936 0 O-C-N 121.198 -0.939 . . . . 0.0 112.319 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.41 164.4 35.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.369 3.38 . . . . 0.0 111.898 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.88 5.8 4.19 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.837 3.024 . . . . 0.0 113.691 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.3 p30 -128.15 13.9 6.71 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.969 1.708 . . . . 0.0 114.042 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.8 tp -80.12 143.63 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.123 0.969 . . . . 0.0 110.423 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.3 p -132.8 167.25 20.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.126 1.77 . . . . 0.0 109.677 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.67 -28.47 68.63 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.641 0.376 . . . . 0.0 111.82 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -70.43 -45.56 65.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.346 1.058 . . . . 0.0 110.975 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -65.2 -38.66 91.16 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.719 -0.613 . . . . 0.0 111.695 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.6 ttt -69.44 -38.2 77.73 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.646 0.657 . . . . 0.0 111.98 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -63.66 -37.22 86.5 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.435 -0.791 . . . . 0.0 111.992 170.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.3 -43.1 64.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.087 0.955 . . . . 0.0 111.872 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.6 mt -57.02 -28.85 62.86 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.058 1.343 . . . . 0.0 113.343 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -105.45 8.17 33.4 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.311 1.444 . . . . 0.0 112.693 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.09 -25.74 67.92 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -169.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -64.41 -21.54 66.67 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.696 0.798 . . . . 0.0 112.724 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -102.96 6.33 38.85 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.096 1.758 . . . . 0.0 112.097 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.13 173.7 46.26 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.174 1.369 . . . . 0.0 112.587 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -67.18 136.04 54.43 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.497 -1.001 . . . . 0.0 111.317 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.08 157.24 37.22 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.927 0.891 . . . . 0.0 112.071 173.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.06 -12.07 62.37 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.048 1.308 . . . . 0.0 113.753 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -152.77 137.09 16.61 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.901 1.68 . . . . 0.0 109.28 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.0 127.81 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.06 1.744 . . . . 0.0 108.853 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -143.96 140.48 29.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.836 1.254 . . . . 0.0 111.454 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.7 mt -139.85 129.4 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.859 1.664 . . . . 0.0 108.276 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -122.23 112.95 18.79 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.841 0.857 . . . . 0.0 112.56 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -70.5 -35.19 73.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 113.613 -173.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.23 -23.66 61.27 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.805 0.842 . . . . 0.0 113.044 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -103.3 -26.48 12.93 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.23 35.68 14.34 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 124.876 1.227 . . . . 0.0 114.115 175.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -140.64 153.16 45.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.21 1.404 . . . . 0.0 112.366 -172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.06 158.14 22.99 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.359 1.456 . . . . 0.0 113.092 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -138.67 137.84 37.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.83 2.052 . . . . 0.0 109.012 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.3 tt -151.81 130.39 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.535 0.734 . . . . 0.0 110.971 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -119.15 113.56 21.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.948 0.899 . . . . 0.0 110.409 -170.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.0 mt -90.73 166.07 13.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.641 0.777 . . . . 0.0 111.124 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -78.56 -17.95 55.36 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.0 p -144.04 157.32 44.4 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.773 1.229 . . . . 0.0 111.616 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -59.6 -40.33 87.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.789 0.835 . . . . 0.0 111.429 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.7 m -58.88 -47.53 84.62 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.011 1.325 . . . . 0.0 111.212 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.3 -42.9 99.08 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.265 0.626 . . . . 0.0 111.179 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.03 -36.27 83.84 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.03 -46.5 71.03 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.888 0.875 . . . . 0.0 111.697 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.95 -47.96 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.633 -0.667 . . . . 0.0 110.102 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.76 -44.35 93.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.423 0.689 . . . . 0.0 112.104 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -54.57 -52.58 61.66 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.258 0.935 . . . . 0.0 111.507 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.29 -34.3 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.382 0.537 . . . . 0.0 111.961 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -81.03 -36.05 31.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.5 -21.78 17.5 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -170.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.31 127.24 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.02 0.827 . . . . 0.0 111.276 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 71.2 11.75 6.82 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.28 2.232 . . . . 0.0 113.786 -173.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.9 ttp -74.33 137.34 75.02 Favored Pre-proline 0 N--CA 1.475 0.796 0 O-C-N 120.549 -1.344 . . . . 0.0 110.893 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.67 141.07 24.37 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.256 2.637 . . . . 0.0 111.191 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.6 tp -137.04 104.25 5.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.512 1.525 . . . . 0.0 110.059 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 59.03 22.56 10.6 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.594 1.558 . . . . 0.0 114.256 172.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.37 -9.97 49.9 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.994 1.759 . . . . 0.0 114.788 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -94.27 166.44 12.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.796 1.298 . . . . 0.0 111.254 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -96.62 176.18 6.11 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.089 0.956 . . . . 0.0 110.401 169.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.8 mt -135.7 116.66 14.22 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.608 1.163 . . . . 0.0 109.723 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -95.77 111.09 23.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.734 0.814 . . . . 0.0 108.955 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.81 130.51 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.127 0.971 . . . . 0.0 109.54 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -150.99 163.76 37.98 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.401 1.48 . . . . 0.0 111.077 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -72.67 137.76 46.23 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.535 -0.728 . . . . 0.0 110.83 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.829 0 C-N-CA 124.979 1.312 . . . . 0.0 113.084 177.001 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -80.97 123.33 28.24 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.367 1.467 . . . . 0.0 111.015 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -115.07 140.78 48.78 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.829 1.652 . . . . 0.0 110.795 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -95.92 140.17 31.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.257 2.223 . . . . 0.0 108.669 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.52 108.38 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.301 1.04 . . . . 0.0 109.31 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.06 171.63 19.93 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.337 1.446 . . . . 0.0 112.873 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.0 m120 62.09 31.15 17.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.007 1.323 . . . . 0.0 111.923 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.9 mt -66.67 143.32 98.06 Favored Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 121.457 -0.777 . . . . 0.0 111.395 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.35 162.06 40.44 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.193 2.595 . . . . 0.0 111.158 170.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.99 -7.61 18.37 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.249 2.633 . . . . 0.0 112.413 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -96.14 6.95 47.68 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.559 1.944 . . . . 0.0 113.332 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -81.97 146.56 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.211 -0.931 . . . . 0.0 111.029 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.7 p -134.0 166.34 22.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.073 1.749 . . . . 0.0 109.351 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -61.58 -25.54 67.39 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.13 -40.8 59.47 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.164 0.986 . . . . 0.0 111.67 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -64.38 -41.97 96.41 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.494 0.588 . . . . 0.0 110.637 171.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.3 ttt -68.43 -36.55 79.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.534 0.734 . . . . 0.0 112.394 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -62.51 -41.55 98.92 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.716 0.689 . . . . 0.0 111.567 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -71.43 -39.75 70.85 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.976 0.807 . . . . 0.0 112.919 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -57.65 -22.59 46.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.148 1.379 . . . . 0.0 113.581 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -114.57 11.45 17.04 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.752 1.621 . . . . 0.0 112.616 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.4 -23.38 67.27 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -63.33 -23.33 67.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.177 1.391 . . . . 0.0 112.989 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -106.56 9.83 31.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.048 1.739 . . . . 0.0 112.598 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.44 -175.45 50.99 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.026 1.298 . . . . 0.0 113.121 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -73.77 128.48 35.63 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.094 -0.651 . . . . 0.0 110.944 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.05 143.34 47.52 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.239 1.015 . . . . 0.0 111.562 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.22 -11.9 82.94 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.973 0.797 . . . . 0.0 113.936 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -158.71 138.03 11.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.095 1.758 . . . . 0.0 109.389 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.56 127.39 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.873 1.669 . . . . 0.0 108.534 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -144.79 143.84 30.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.843 1.257 . . . . 0.0 112.018 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.1 mt -140.77 132.79 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.144 1.777 . . . . 0.0 108.687 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -125.59 104.95 8.67 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.936 0.895 . . . . 0.0 112.066 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.08 -23.97 60.6 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -172.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -72.92 -14.22 61.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.24 1.016 . . . . 0.0 113.339 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -117.22 -19.87 9.46 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.958 1.303 . . . . 0.0 114.005 173.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.2 26.45 40.3 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 124.826 1.203 . . . . 0.0 114.213 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -130.87 145.98 52.16 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.013 1.325 . . . . 0.0 112.196 -172.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.05 162.38 24.24 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.691 1.615 . . . . 0.0 112.576 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -143.19 136.47 28.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.485 1.914 . . . . 0.0 108.632 -170.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.2 tt -149.23 143.36 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.455 0.702 . . . . 0.0 111.099 -175.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.2 112.68 17.97 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.976 1.31 . . . . 0.0 110.135 -172.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.0 mt -89.67 175.76 7.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.389 0.54 . . . . 0.0 111.726 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.23 -26.43 58.91 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.3 p -144.54 159.27 43.06 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.684 1.193 . . . . 0.0 111.95 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -60.59 -33.64 73.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.804 0.842 . . . . 0.0 112.357 170.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.8 m -67.2 -45.88 75.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.461 1.504 . . . . 0.0 111.024 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.7 mt -61.19 -39.88 91.83 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.182 0.593 . . . . 0.0 111.131 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.84 -35.69 77.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -60.93 -51.56 68.75 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.398 0.999 . . . . 0.0 110.882 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.33 -49.09 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.3 0.64 . . . . 0.0 110.565 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.46 86.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.517 0.727 . . . . 0.0 111.819 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.44 -45.29 91.98 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.272 -0.892 . . . . 0.0 111.748 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.12 -33.27 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.837 0.855 . . . . 0.0 112.31 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -86.12 -24.66 26.14 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.9 mt -107.03 -16.95 14.31 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -170.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.81 134.2 52.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.204 1.365 . . . . 0.0 112.074 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.2 t30 65.57 14.31 9.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.901 2.08 . . . . 0.0 113.845 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.1 ttp -72.77 135.84 80.63 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 120.56 -1.337 . . . . 0.0 110.559 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.71 131.8 13.86 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.488 2.792 . . . . 0.0 110.869 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.9 tp -143.47 115.44 8.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.151 1.38 . . . . 0.0 109.55 174.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 53.55 35.51 21.06 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.789 1.236 . . . . 0.0 112.951 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.7 1.84 89.94 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.556 1.55 . . . . 0.0 115.204 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -105.91 149.5 26.51 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.762 1.625 . . . . 0.0 110.854 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -104.44 110.85 23.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.029 0.932 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 82.1 mt -72.23 125.69 27.94 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.874 0.87 . . . . 0.0 112.513 -169.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.17 105.97 18.2 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.979 0.912 . . . . 0.0 109.04 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.7 t -114.66 131.39 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.023 0.929 . . . . 0.0 110.123 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -153.37 169.27 23.52 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.569 1.548 . . . . 0.0 111.218 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -70.62 138.88 51.15 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.519 -0.738 . . . . 0.0 111.572 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.542 0 C-N-CA 123.96 0.904 . . . . 0.0 108.835 171.424 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -89.78 125.65 35.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.867 1.267 . . . . 0.0 112.057 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.31 146.45 35.7 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.859 2.063 . . . . 0.0 110.988 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -97.62 143.12 28.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.985 2.514 . . . . 0.0 108.658 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.1 t -135.38 112.99 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.148 0.979 . . . . 0.0 109.861 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -111.29 174.41 16.75 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 125.748 1.642 . . . . 0.0 113.498 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 m120 64.93 20.92 12.24 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.988 1.715 . . . . 0.0 113.161 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.17 142.7 95.6 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 121.206 -0.934 . . . . 0.0 112.21 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.77 163.71 38.04 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.207 3.271 . . . . 0.0 111.9 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.39 5.84 2.57 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 123.715 2.943 . . . . 0.0 113.557 171.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -124.15 12.13 8.89 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.168 1.787 . . . . 0.0 113.486 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.1 tp -82.06 145.28 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 120.911 -1.118 . . . . 0.0 110.828 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 31.5 p -133.2 168.27 18.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.198 1.799 . . . . 0.0 109.623 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.11 -31.61 70.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.818 0.447 . . . . 0.0 111.824 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.08 -40.41 65.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.092 0.957 . . . . 0.0 111.709 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -66.2 -38.43 87.94 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.568 0.622 . . . . 0.0 111.31 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 6.0 ttt -68.74 -36.1 77.95 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.612 -0.68 . . . . 0.0 112.201 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -64.52 -40.23 95.23 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.692 0.797 . . . . 0.0 111.688 169.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -68.81 -41.85 78.06 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.305 1.042 . . . . 0.0 112.699 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.13 -24.36 62.93 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.435 1.494 . . . . 0.0 113.596 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -112.42 11.47 19.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.503 1.521 . . . . 0.0 112.654 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.44 -21.66 66.68 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -171.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -62.69 -24.57 67.72 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.253 1.021 . . . . 0.0 112.517 172.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -104.11 14.02 31.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.528 1.931 . . . . 0.0 112.307 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.53 -173.64 54.83 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.386 0.993 . . . . 0.0 112.176 -173.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -71.54 147.25 47.88 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.66 -0.906 . . . . 0.0 111.88 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.95 147.13 37.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.495 0.718 . . . . 0.0 111.577 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.27 -17.39 66.92 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.062 1.315 . . . . 0.0 113.553 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -157.94 147.76 20.09 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.318 1.447 . . . . 0.0 110.645 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -142.31 129.07 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 126.992 2.117 . . . . 0.0 109.643 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -140.99 138.64 33.88 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.03 1.332 . . . . 0.0 111.387 171.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 61.6 mt -138.84 124.58 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.59 1.556 . . . . 0.0 108.211 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -121.36 102.19 8.12 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.075 0.94 . . . . 0.0 112.379 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.33 -18.77 61.74 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -77.53 -14.54 59.64 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.282 1.033 . . . . 0.0 112.96 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -116.78 -27.14 6.72 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.83 1.252 . . . . 0.0 113.498 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.4 27.19 23.39 Favored Glycine 0 N--CA 1.476 1.342 0 C-N-CA 124.896 1.236 . . . . 0.0 114.078 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -137.04 154.37 50.39 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.354 1.462 . . . . 0.0 111.822 -173.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.79 170.13 25.34 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.501 1.524 . . . . 0.0 113.038 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -143.83 148.72 35.93 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.312 1.845 . . . . 0.0 109.874 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 tt -153.87 137.75 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.786 0.834 . . . . 0.0 110.317 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -115.59 125.37 52.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.791 0.836 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -96.01 170.03 9.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.998 0.519 . . . . 0.0 111.438 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -72.74 -26.6 61.62 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.4 p -142.64 155.9 45.0 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.137 1.375 . . . . 0.0 110.931 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -69.38 -27.46 65.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.911 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.8 m -62.32 -47.49 84.04 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.955 1.302 . . . . 0.0 110.54 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.55 -39.01 93.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.946 -0.55 . . . . 0.0 111.427 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.99 89.43 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -64.59 -50.38 67.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.315 0.961 . . . . 0.0 111.226 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.06 -49.42 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 122.891 0.476 . . . . 0.0 110.25 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.28 -46.1 89.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.497 0.719 . . . . 0.0 111.979 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.53 -43.4 93.47 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.182 -0.949 . . . . 0.0 111.802 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.35 -32.93 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.932 0.893 . . . . 0.0 112.388 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -88.8 -24.5 22.58 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.1 mt -102.92 -18.12 15.19 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.43 131.21 45.85 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.944 1.247 . . . . 0.0 111.739 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.0 t30 65.07 17.26 10.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.517 1.927 . . . . 0.0 113.834 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.5 ttp -72.83 134.76 81.14 Favored Pre-proline 0 CA--C 1.544 0.718 0 O-C-N 120.609 -1.307 . . . . 0.0 110.223 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.52 138.79 19.85 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.159 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.0 tp -138.07 105.85 5.63 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.504 1.522 . . . . 0.0 109.821 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 55.57 27.53 10.54 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.491 1.516 . . . . 0.0 113.798 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.49 -8.46 69.0 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.729 1.633 . . . . 0.0 114.812 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -89.08 155.92 19.16 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.868 1.334 . . . . 0.0 110.653 170.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.53 172.16 9.97 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.643 0.777 . . . . 0.0 109.814 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.0 mt -132.57 117.41 17.92 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 110.364 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -92.87 113.68 26.02 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.833 0.853 . . . . 0.0 109.188 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.9 t -123.55 126.02 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.882 0.873 . . . . 0.0 110.141 -174.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -149.44 168.74 22.59 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.52 1.528 . . . . 0.0 111.661 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -78.54 136.98 37.68 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.352 0.661 . . . . 0.0 111.671 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 125.351 1.46 . . . . 0.0 112.553 172.736 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 m . . . . . 0 CA--C 1.548 0.882 0 CA-C-O 121.728 0.775 . . . . 0.0 112.315 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -99.13 132.36 44.49 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.315 1.846 . . . . 0.0 111.739 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -117.78 143.94 45.79 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.67 1.588 . . . . 0.0 111.352 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -102.6 139.41 38.23 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.178 2.591 . . . . 0.0 108.441 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.76 116.71 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.306 1.043 . . . . 0.0 108.978 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.89 167.81 13.19 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.31 1.433 . . . . 0.0 114.053 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.66 31.51 9.77 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.504 1.522 . . . . 0.0 111.836 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.5 mt -66.21 143.64 98.42 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.969 0.908 . . . . 0.0 112.432 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -69.6 159.44 53.51 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.166 2.578 . . . . 0.0 111.271 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.44 -9.12 23.74 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.414 2.742 . . . . 0.0 113.275 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -94.41 5.33 52.12 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.709 1.604 . . . . 0.0 113.461 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.3 tp -86.78 137.59 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 121.051 -1.03 . . . . 0.0 111.65 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.0 p -133.74 176.98 8.07 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.593 1.557 . . . . 0.0 108.786 168.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.31 -21.74 62.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.44 0.696 . . . . 0.0 112.548 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -73.68 -47.82 36.89 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.125 0.875 . . . . 0.0 111.249 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -63.04 -42.56 99.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.144 0.578 . . . . 0.0 110.874 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.5 ttt -66.12 -33.86 76.75 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -69.35 -36.27 76.71 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.14 0.882 . . . . 0.0 112.336 170.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -44.14 67.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.117 0.967 . . . . 0.0 111.344 178.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.4 mt -56.33 -28.14 57.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.68 1.592 . . . . 0.0 113.343 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.84 10.54 26.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.406 1.483 . . . . 0.0 112.93 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.81 -23.03 66.61 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -170.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -62.88 -23.3 67.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.445 1.098 . . . . 0.0 112.375 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.64 12.97 30.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.589 1.956 . . . . 0.0 112.2 -175.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.08 -171.06 54.98 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.76 1.171 . . . . 0.0 112.488 -176.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -71.45 142.07 50.24 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.746 -0.855 . . . . 0.0 111.723 172.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.14 148.23 32.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.779 0.831 . . . . 0.0 111.302 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.51 -11.39 71.71 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.918 1.247 . . . . 0.0 113.962 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -158.83 137.94 11.37 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.454 1.902 . . . . 0.0 108.607 173.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.7 t -140.05 128.65 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.311 1.444 . . . . 0.0 109.055 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -143.03 139.42 30.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.92 1.288 . . . . 0.0 111.796 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.2 mt -140.45 128.23 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.375 1.87 . . . . 0.0 107.702 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -125.46 112.54 16.38 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.659 0.742 . . . . 0.0 112.864 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -75.92 -20.13 58.25 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -171.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.86 -21.21 51.74 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.87 0.868 . . . . 0.0 112.515 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -104.31 -32.58 9.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.816 1.247 . . . . 0.0 113.143 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.28 29.01 26.19 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 124.641 1.115 . . . . 0.0 113.857 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -140.92 156.47 46.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.671 1.588 . . . . 0.0 111.767 -171.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.95 166.52 27.03 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.085 1.326 . . . . 0.0 113.507 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -142.48 147.6 36.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.475 1.91 . . . . 0.0 109.806 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.9 tt -154.3 132.21 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.912 0.885 . . . . 0.0 110.738 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 -107.81 125.66 51.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.765 0.826 . . . . 0.0 110.074 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.6 mt -97.87 164.56 12.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.465 0.706 . . . . 0.0 109.684 173.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -82.58 -11.58 58.32 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 65.9 p -148.47 146.72 28.51 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.172 1.389 . . . . 0.0 111.741 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.57 -33.09 69.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.466 1.106 . . . . 0.0 113.592 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 m -68.24 -46.86 69.34 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.756 1.222 . . . . 0.0 110.573 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.38 -37.02 85.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.76 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.21 93.46 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.046 0.839 . . . . 0.0 112.718 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.3 -50.88 68.35 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.169 0.988 . . . . 0.0 111.381 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.28 -46.91 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.855 -0.528 . . . . 0.0 110.379 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.68 90.83 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.63 0.772 . . . . 0.0 112.015 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -48.86 78.17 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.258 0.936 . . . . 0.0 111.219 174.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.76 -36.6 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.593 0.757 . . . . 0.0 112.225 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.31 -29.47 34.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.6 mt -106.26 -22.89 12.71 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -169.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.06 130.41 43.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.417 1.008 . . . . 0.0 110.781 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.0 t30 73.86 8.93 4.83 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.38 2.272 . . . . 0.0 114.074 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.3 ttp -76.15 137.35 68.73 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.462 -1.399 . . . . 0.0 111.528 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.67 135.29 15.96 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.449 2.766 . . . . 0.0 111.319 175.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.6 tp -145.89 120.21 9.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.442 1.497 . . . . 0.0 109.848 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 58.3 23.59 10.59 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.813 1.245 . . . . 0.0 113.619 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.42 -2.85 85.22 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.583 1.563 . . . . 0.0 114.593 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -93.61 148.4 22.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.491 1.517 . . . . 0.0 110.936 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -98.56 109.38 22.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.552 1.541 . . . . 0.0 107.182 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.75 147.46 47.3 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.664 0.786 . . . . 0.0 111.693 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 130.88 53.62 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.246 1.418 . . . . 0.0 109.054 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.7 t -134.02 129.23 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.857 0.863 . . . . 0.0 110.855 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -140.18 170.22 16.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.112 1.765 . . . . 0.0 110.387 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -77.61 134.54 38.19 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.502 -0.749 . . . . 0.0 110.373 168.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.584 0 C-N-CA 124.294 1.037 . . . . 0.0 109.432 172.471 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 -86.97 129.44 34.88 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.372 1.469 . . . . 0.0 111.513 -176.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.9 mt -116.54 135.46 53.8 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.25 1.82 . . . . 0.0 110.544 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -89.4 142.48 27.62 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.347 2.259 . . . . 0.0 108.608 171.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.1 103.29 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.06 168.53 15.79 Favored Glycine 0 N--CA 1.464 0.565 0 C-N-CA 125.315 1.436 . . . . 0.0 112.986 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 60.09 32.45 20.99 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.897 1.279 . . . . 0.0 111.969 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.4 mt -63.25 143.37 97.72 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 121.269 -0.894 . . . . 0.0 111.347 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -66.93 158.0 58.81 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.801 2.334 . . . . 0.0 110.655 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.13 -7.32 20.4 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.699 2.933 . . . . 0.0 113.163 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -104.15 5.55 35.09 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.986 1.714 . . . . 0.0 113.264 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -75.18 146.67 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.274 -0.891 . . . . 0.0 111.247 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.5 p -131.73 165.55 23.5 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.961 1.704 . . . . 0.0 109.875 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.16 -32.85 66.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.245 0.618 . . . . 0.0 111.419 172.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -70.09 -36.79 75.15 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.242 1.017 . . . . 0.0 112.294 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -72.1 -36.7 69.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.78 0.718 . . . . 0.0 111.91 173.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.6 ttm -66.52 -38.62 87.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.24 0.927 . . . . 0.0 111.989 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -61.68 -40.44 94.98 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.09 0.956 . . . . 0.0 111.45 170.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -73.35 -41.19 63.76 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.1 mt -56.48 -24.98 49.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.118 1.367 . . . . 0.0 113.389 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -112.38 11.04 19.92 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.536 1.534 . . . . 0.0 112.802 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.97 -22.42 65.92 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -171.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.13 -25.36 67.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.978 0.911 . . . . 0.0 112.343 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.01 11.27 37.53 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.49 1.916 . . . . 0.0 112.672 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.87 -171.03 55.04 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.633 1.111 . . . . 0.0 112.974 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -71.76 134.61 46.31 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.989 -0.712 . . . . 0.0 111.561 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.14 148.86 35.75 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.438 1.095 . . . . 0.0 111.37 174.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.99 -15.34 75.19 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.166 0.888 . . . . 0.0 113.393 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -155.39 145.25 21.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.433 1.093 . . . . 0.0 111.547 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.0 127.9 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.651 1.98 . . . . 0.0 110.057 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -142.3 142.5 32.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.735 1.614 . . . . 0.0 112.006 171.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 68.9 mt -138.15 125.91 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.909 1.683 . . . . 0.0 107.995 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -119.59 102.62 8.76 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.36 1.064 . . . . 0.0 111.776 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -74.11 -24.22 59.43 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.96 -23.11 63.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.307 1.043 . . . . 0.0 113.053 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -109.45 -26.47 9.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.416 1.086 . . . . 0.0 113.488 174.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.69 29.23 13.95 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 124.957 1.265 . . . . 0.0 114.274 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.68 148.47 45.74 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.229 1.412 . . . . 0.0 111.788 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.71 168.9 23.74 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.696 1.617 . . . . 0.0 112.939 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -146.1 140.71 26.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.131 1.772 . . . . 0.0 109.449 -170.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.9 tt -148.7 146.75 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.115 0.966 . . . . 0.0 110.559 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.66 117.3 22.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.487 1.115 . . . . 0.0 109.407 -178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.72 163.56 13.71 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.104 0.562 . . . . 0.0 110.516 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.65 -21.55 59.37 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.5 p -141.69 151.97 43.47 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.383 1.073 . . . . 0.0 112.354 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -57.22 -38.63 74.04 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.733 1.213 . . . . 0.0 112.869 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -63.29 -50.44 70.07 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.814 1.246 . . . . 0.0 110.85 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.85 -38.77 92.08 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.64 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.17 -39.88 94.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.65 -47.87 76.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.206 0.912 . . . . 0.0 111.759 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.5 mt -59.31 -48.49 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.092 0.557 . . . . 0.0 110.262 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.3 94.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.146 0.579 . . . . 0.0 112.322 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -46.29 88.54 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.961 -1.087 . . . . 0.0 111.131 174.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.19 -38.82 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.211 0.605 . . . . 0.0 112.002 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -82.33 -23.58 35.02 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.2 mt -108.63 -22.16 12.38 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.53 133.0 48.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.924 1.238 . . . . 0.0 111.142 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.5 t30 68.64 11.28 8.29 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.565 1.946 . . . . 0.0 113.732 -175.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.1 ttp -75.72 137.61 70.23 Favored Pre-proline 0 CA--C 1.544 0.719 0 O-C-N 120.611 -1.305 . . . . 0.0 110.933 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.46 134.23 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.365 2.71 . . . . 0.0 111.038 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.2 tp -140.14 113.61 8.56 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.28 1.432 . . . . 0.0 109.96 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.88 24.18 7.26 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.163 1.385 . . . . 0.0 113.344 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.27 -5.55 74.94 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.887 1.708 . . . . 0.0 114.771 -176.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -88.66 146.75 24.9 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.242 1.417 . . . . 0.0 110.451 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -92.56 119.56 32.14 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 69.2 mt -78.15 134.64 37.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.398 0.544 . . . . 0.0 111.669 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -99.17 125.25 44.7 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.823 1.249 . . . . 0.0 108.465 169.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.4 t -135.2 126.25 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.3 0.955 . . . . 0.0 110.362 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -146.13 168.98 19.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.159 1.783 . . . . 0.0 110.848 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -77.12 140.07 40.14 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.607 -0.683 . . . . 0.0 111.053 169.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.497 0 C-N-CA 124.877 1.271 . . . . 0.0 111.347 178.168 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.2 p . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -77.45 122.37 25.11 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.746 1.618 . . . . 0.0 110.321 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -103.45 135.47 45.0 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.771 1.628 . . . . 0.0 110.027 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -90.57 137.63 32.2 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.103 2.161 . . . . 0.0 108.549 169.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.1 110.07 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.513 1.125 . . . . 0.0 109.388 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.75 170.8 14.13 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.58 1.562 . . . . 0.0 114.151 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 69.74 20.05 7.0 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.415 1.886 . . . . 0.0 113.006 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -61.72 143.48 93.93 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.823 0.849 . . . . 0.0 112.321 -171.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.03 165.08 33.53 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.405 3.403 . . . . 0.0 111.535 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.18 -3.61 14.09 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.111 2.541 . . . . 0.0 113.162 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -106.92 5.52 28.37 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.231 1.813 . . . . 0.0 113.739 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 tp -82.25 144.97 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.057 -1.027 . . . . 0.0 110.862 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.4 p -132.81 168.82 17.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.225 1.81 . . . . 0.0 109.037 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.56 -26.92 67.28 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -76.21 -40.06 53.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.948 0.899 . . . . 0.0 111.658 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -64.62 -37.17 86.66 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.963 -0.46 . . . . 0.0 111.193 171.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.3 tpt -66.11 -44.56 83.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.648 0.779 . . . . 0.0 111.416 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -59.58 -33.57 71.62 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.97 0.908 . . . . 0.0 112.097 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -74.62 -45.53 44.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.75 0.82 . . . . 0.0 112.579 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.95 -31.08 64.62 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.981 1.312 . . . . 0.0 113.097 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -106.92 10.85 30.43 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.211 1.404 . . . . 0.0 113.12 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -63.47 -28.81 70.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -16.26 63.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.582 0.753 . . . . 0.0 112.618 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -100.83 9.82 41.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.545 1.938 . . . . 0.0 112.458 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.73 -177.46 54.36 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.749 1.166 . . . . 0.0 112.962 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -71.32 134.91 47.09 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.708 -0.878 . . . . 0.0 111.111 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.63 148.82 34.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.609 1.164 . . . . 0.0 112.194 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.89 -10.23 79.26 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.865 1.221 . . . . 0.0 113.923 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -158.92 137.64 11.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.379 1.872 . . . . 0.0 108.983 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.14 130.05 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.602 1.561 . . . . 0.0 108.808 174.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -144.29 139.24 28.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.592 1.157 . . . . 0.0 111.295 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 86.9 mt -138.8 126.66 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.455 1.502 . . . . 0.0 108.518 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -120.11 104.43 10.11 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.522 1.129 . . . . 0.0 111.846 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -73.76 -26.4 60.64 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -171.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.86 -22.03 62.35 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.957 0.903 . . . . 0.0 113.086 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -107.42 -29.12 9.43 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.475 1.11 . . . . 0.0 113.465 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.05 28.44 17.96 Favored Glycine 0 N--CA 1.477 1.374 0 C-N-CA 124.891 1.234 . . . . 0.0 114.152 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -137.6 155.79 48.8 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.339 1.455 . . . . 0.0 111.788 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.16 176.74 30.32 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.111 1.339 . . . . 0.0 113.576 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -144.37 153.71 42.24 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.306 1.842 . . . . 0.0 110.779 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 tt -155.23 132.36 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.54 1.136 . . . . 0.0 110.607 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -113.52 121.93 45.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.904 0.881 . . . . 0.0 110.961 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.39 165.64 12.46 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.236 0.614 . . . . 0.0 111.305 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.61 -23.72 60.98 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -172.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.6 p -145.11 146.47 31.83 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.118 1.367 . . . . 0.0 111.513 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -55.88 -43.42 77.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.059 1.344 . . . . 0.0 112.246 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.4 m -59.2 -45.87 89.93 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.924 1.289 . . . . 0.0 112.081 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.76 -35.89 82.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 119.158 -0.448 . . . . 0.0 112.088 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.06 -33.44 74.57 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -64.55 -49.55 70.76 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.21 0.914 . . . . 0.0 110.22 172.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.8 mt -60.94 -48.47 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.604 0.762 . . . . 0.0 110.399 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.22 91.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.238 0.615 . . . . 0.0 111.819 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -57.19 -49.61 75.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.29 0.95 . . . . 0.0 111.332 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.71 -36.17 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.438 0.695 . . . . 0.0 112.095 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -81.65 -25.14 35.84 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.5 mt -109.61 -23.99 11.18 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -170.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.42 121.98 16.95 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.843 1.202 . . . . 0.0 110.839 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 74.59 15.52 3.32 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 128.142 2.577 . . . . 0.0 114.01 -173.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.0 ttp -76.44 137.12 67.74 Favored Pre-proline 0 N--CA 1.475 0.782 0 O-C-N 120.958 -1.089 . . . . 0.0 111.295 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.64 141.38 22.03 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.467 2.778 . . . . 0.0 111.647 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 34.4 tp -144.93 118.13 8.93 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.533 1.533 . . . . 0.0 110.303 173.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 58.7 24.77 12.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.321 1.448 . . . . 0.0 113.825 174.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.82 -5.59 83.36 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 125.472 1.511 . . . . 0.0 114.38 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -94.41 171.93 8.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.578 1.551 . . . . 0.0 110.726 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -99.43 -176.12 3.2 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 109.656 169.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.4 mt -141.68 120.03 12.31 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.302 1.441 . . . . 0.0 108.982 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.49 116.29 32.45 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.93 122.83 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.819 0.848 . . . . 0.0 111.335 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -141.88 161.66 37.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.772 2.029 . . . . 0.0 110.565 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -73.0 130.74 41.01 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.634 -0.666 . . . . 0.0 109.671 168.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.726 0 C-N-CA 124.561 1.144 . . . . 0.0 110.699 176.602 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.6 m . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 121.248 0.546 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -98.14 141.11 31.47 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.986 1.714 . . . . 0.0 112.561 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.44 141.92 50.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.82 2.048 . . . . 0.0 110.147 -172.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -100.66 140.38 35.02 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.193 2.197 . . . . 0.0 108.797 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.13 114.57 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.667 1.187 . . . . 0.0 108.951 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.33 164.57 12.28 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 125.488 1.518 . . . . 0.0 114.433 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.7 t30 70.57 20.35 5.85 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.593 1.957 . . . . 0.0 112.928 -177.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.9 mt -57.73 148.65 56.59 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.75 1.22 . . . . 0.0 113.082 -172.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 162.32 40.7 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.133 2.556 . . . . 0.0 111.444 172.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.94 -6.77 17.01 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.721 2.947 . . . . 0.0 112.174 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -99.76 8.29 44.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.676 1.991 . . . . 0.0 113.272 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.5 tp -81.86 145.46 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.01 -1.056 . . . . 0.0 110.909 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.2 p -134.3 167.66 20.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.236 1.814 . . . . 0.0 109.48 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -56.73 -34.51 67.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.106 0.563 . . . . 0.0 111.625 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.82 -26.93 49.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.478 1.111 . . . . 0.0 113.027 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -77.06 -39.02 51.38 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.933 0.788 . . . . 0.0 110.855 169.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.2 ttt -70.46 -37.48 74.3 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.32 -0.863 . . . . 0.0 112.195 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -62.64 -38.03 88.68 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.897 0.879 . . . . 0.0 111.507 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -73.34 -39.98 64.8 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.009 1.324 . . . . 0.0 113.092 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.6 mt -57.39 -27.39 62.28 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.958 1.303 . . . . 0.0 113.205 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -108.02 8.4 28.28 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.627 1.571 . . . . 0.0 112.753 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.9 -20.49 65.92 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -59.39 -22.73 61.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.636 1.174 . . . . 0.0 112.315 169.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -109.64 10.1 24.97 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.258 2.223 . . . . 0.0 112.321 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.45 -178.8 53.32 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.029 0.823 . . . . 0.0 112.448 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -71.04 144.57 50.34 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.699 -0.883 . . . . 0.0 111.664 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.64 152.27 30.1 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.166 0.986 . . . . 0.0 111.822 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.35 -8.22 71.58 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.82 1.2 . . . . 0.0 113.83 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -158.61 136.05 10.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.58 1.952 . . . . 0.0 108.582 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.73 128.65 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.493 1.517 . . . . 0.0 109.059 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -143.83 141.78 30.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.172 1.389 . . . . 0.0 111.579 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.3 mt -140.47 132.98 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.702 1.601 . . . . 0.0 108.67 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -129.1 109.02 10.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.93 0.892 . . . . 0.0 112.129 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -33.93 69.7 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.494 1.118 . . . . 0.0 112.798 -171.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.63 -26.22 68.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.367 1.067 . . . . 0.0 113.229 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -97.72 -32.58 11.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.176 0.99 . . . . 0.0 113.031 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.27 29.19 12.84 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 125.101 1.334 . . . . 0.0 114.055 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.95 158.84 43.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.266 1.426 . . . . 0.0 111.852 -171.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.46 168.78 26.63 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.275 1.417 . . . . 0.0 113.483 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.27 148.24 50.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.72 2.008 . . . . 0.0 109.828 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.9 tt -153.82 140.88 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.412 1.085 . . . . 0.0 110.583 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -123.94 124.89 43.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.863 0.865 . . . . 0.0 110.947 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.4 168.09 10.43 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.389 0.676 . . . . 0.0 110.935 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -72.85 -24.94 60.95 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.9 p -143.61 157.65 44.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.619 1.168 . . . . 0.0 111.881 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -58.73 -35.77 73.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 112.528 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -62.8 -49.46 74.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.054 1.342 . . . . 0.0 110.64 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.49 -42.86 99.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.217 0.607 . . . . 0.0 111.215 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.25 99.26 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -62.91 -49.78 73.44 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.087 0.858 . . . . 0.0 111.79 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.71 -48.95 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.104 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.01 91.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.333 0.653 . . . . 0.0 112.288 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -47.52 84.67 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.447 -0.783 . . . . 0.0 111.007 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.69 -36.49 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -84.79 -28.68 26.0 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -174.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.4 mt -101.18 -19.22 15.81 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -66.86 137.81 56.86 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.188 0.904 . . . . 0.0 110.661 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.5 t30 69.28 16.29 8.43 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.653 1.581 . . . . 0.0 113.636 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.0 ttp -89.83 134.02 32.86 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 120.866 -1.146 . . . . 0.0 111.148 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.28 141.42 18.22 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.299 2.666 . . . . 0.0 111.307 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.4 tp -144.92 114.59 7.24 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.827 1.651 . . . . 0.0 110.098 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 57.67 24.5 10.64 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.288 1.435 . . . . 0.0 113.738 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.73 -1.92 69.23 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.547 1.546 . . . . 0.0 114.836 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -102.9 145.86 29.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.285 1.434 . . . . 0.0 111.192 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -75.31 167.64 21.52 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.656 -0.653 . . . . 0.0 110.187 167.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.7 mt -133.96 135.8 43.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.5 1.12 . . . . 0.0 110.996 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.67 122.08 46.67 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.685 1.994 . . . . 0.0 109.096 175.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -131.94 125.63 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.773 0.829 . . . . 0.0 110.119 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.53 156.92 37.52 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.431 1.492 . . . . 0.0 111.706 -172.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -69.0 132.03 46.02 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.579 -0.701 . . . . 0.0 111.816 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.645 0 C-N-CA 123.616 0.766 . . . . 0.0 110.818 178.503 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -99.22 124.13 44.05 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.703 1.601 . . . . 0.0 111.851 -170.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.6 mt -111.75 149.82 31.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.709 2.004 . . . . 0.0 110.999 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -114.58 137.86 51.36 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.203 2.601 . . . . 0.0 108.472 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -131.29 113.37 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.167 0.987 . . . . 0.0 109.947 -173.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -113.02 169.64 13.03 Favored Glycine 0 N--CA 1.467 0.756 0 C-N-CA 126.042 1.782 . . . . 0.0 113.738 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 69.01 15.87 8.78 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.098 1.759 . . . . 0.0 112.582 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 28.8 mt -56.58 139.04 76.1 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.089 0.955 . . . . 0.0 112.048 -174.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 83' ' ' LEU . 12.8 Cg_exo -68.15 160.92 46.69 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.748 2.298 . . . . 0.0 111.223 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.04 -2.79 12.09 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.815 3.01 . . . . 0.0 112.967 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -103.61 0.82 31.28 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.082 1.753 . . . . 0.0 113.792 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -76.41 146.32 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 119.453 1.024 . . . . 0.0 111.275 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 p -130.58 165.42 22.8 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.706 1.602 . . . . 0.0 110.409 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -62.85 -25.78 68.44 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.226 0.61 . . . . 0.0 111.822 172.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -72.64 -44.39 61.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.183 0.993 . . . . 0.0 111.474 172.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -66.09 -39.18 89.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.55 0.614 . . . . 0.0 111.696 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -69.21 -33.57 73.54 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.773 0.715 . . . . 0.0 112.471 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -67.61 -39.4 84.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.581 0.628 . . . . 0.0 111.643 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -72.92 -38.08 66.98 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.29 -0.881 . . . . 0.0 113.074 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.44 -25.06 49.34 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.358 1.463 . . . . 0.0 113.256 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -110.75 10.51 22.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.644 1.578 . . . . 0.0 112.673 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.21 -24.87 67.48 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -64.63 -19.33 65.63 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.334 1.054 . . . . 0.0 113.015 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.93 10.5 30.5 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.807 2.043 . . . . 0.0 112.141 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.44 -173.42 55.23 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.865 1.221 . . . . 0.0 113.021 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -71.73 145.07 49.02 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.836 -0.802 . . . . 0.0 112.274 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -89.19 150.39 22.69 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.415 1.086 . . . . 0.0 111.528 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.0 -11.05 70.76 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.823 1.202 . . . . 0.0 113.871 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -153.94 137.11 15.62 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.124 1.77 . . . . 0.0 109.073 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.46 129.36 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.906 1.682 . . . . 0.0 108.858 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -145.09 144.08 30.75 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.895 1.278 . . . . 0.0 111.87 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.2 mt -140.86 132.47 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.168 1.787 . . . . 0.0 108.459 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -126.43 111.82 14.89 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.887 0.875 . . . . 0.0 112.386 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -70.75 -31.95 68.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.424 1.09 . . . . 0.0 113.307 -171.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -73.63 -13.24 60.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.07 0.948 . . . . 0.0 113.51 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -112.75 -26.48 8.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.743 1.217 . . . . 0.0 113.311 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.0 29.84 24.73 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.613 1.102 . . . . 0.0 113.963 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -140.12 157.29 45.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.327 1.451 . . . . 0.0 112.202 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.41 169.19 25.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.755 1.645 . . . . 0.0 113.209 174.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -137.89 147.63 44.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.673 1.989 . . . . 0.0 109.425 -177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.0 tt -153.77 139.23 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.897 0.879 . . . . 0.0 110.601 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -128.92 118.68 23.06 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.622 0.769 . . . . 0.0 110.307 -172.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.67 -176.16 3.98 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.215 1.006 . . . . 0.0 111.893 -171.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -86.02 -25.84 25.72 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 49.7 p -149.42 144.4 26.33 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.138 1.375 . . . . 0.0 111.851 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -59.46 -35.91 74.97 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.248 1.019 . . . . 0.0 113.057 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.9 m -60.21 -47.69 84.87 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.773 1.229 . . . . 0.0 111.181 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.6 mt -65.65 -35.99 82.38 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.958 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.68 -36.76 81.28 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.08 0.854 . . . . 0.0 112.875 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.39 -49.48 71.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.128 0.971 . . . . 0.0 110.891 172.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.81 -48.74 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.082 0.553 . . . . 0.0 110.353 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.98 -46.02 85.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.626 0.77 . . . . 0.0 111.91 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -58.25 -48.69 79.62 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.319 -0.863 . . . . 0.0 111.345 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.15 -36.49 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.464 0.705 . . . . 0.0 112.16 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -80.6 -30.45 36.82 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.3 mt -102.72 -21.78 14.04 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -171.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.18 129.14 38.94 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.672 1.123 . . . . 0.0 111.456 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 67.98 14.25 9.32 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.73 2.412 . . . . 0.0 113.697 -173.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.2 ttp -73.83 135.91 77.31 Favored Pre-proline 0 N--CA 1.474 0.757 0 O-C-N 120.507 -1.371 . . . . 0.0 110.719 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.24 140.6 19.81 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.3 2.666 . . . . 0.0 111.325 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.3 tp -145.12 117.19 8.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.086 1.355 . . . . 0.0 110.106 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 69.9 mmt-85 57.11 27.38 13.34 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.929 1.291 . . . . 0.0 113.922 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.42 -6.23 83.82 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 125.521 1.534 . . . . 0.0 114.484 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -90.78 169.3 11.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.934 1.694 . . . . 0.0 110.333 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -100.98 -172.67 2.21 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.612 -0.68 . . . . 0.0 109.244 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.46 116.67 10.03 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.34 1.056 . . . . 0.0 109.079 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -91.58 118.07 30.28 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.44 123.94 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.647 0.779 . . . . 0.0 109.959 -173.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -154.78 163.98 39.47 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.087 1.355 . . . . 0.0 111.239 -173.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -71.36 144.1 49.99 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.769 -0.582 . . . . 0.0 111.043 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.957 0 C-N-CA 124.939 1.296 . . . . 0.0 112.94 -177.083 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 -84.15 133.41 34.61 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.434 1.494 . . . . 0.0 113.006 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.6 mt -113.81 134.52 54.73 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.034 1.733 . . . . 0.0 110.257 170.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -92.09 137.89 31.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.17 2.188 . . . . 0.0 107.748 169.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.6 t -130.47 110.92 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.072 0.949 . . . . 0.0 109.435 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.53 174.56 18.11 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.825 1.678 . . . . 0.0 113.501 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.8 m120 65.48 20.07 11.65 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.863 1.665 . . . . 0.0 112.808 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.19 140.12 97.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 O-C-N 121.05 -1.031 . . . . 0.0 112.103 -171.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.11 165.73 31.48 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.294 3.33 . . . . 0.0 111.837 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.51 -2.89 13.03 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.173 2.582 . . . . 0.0 113.179 172.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -108.19 12.55 26.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.028 1.731 . . . . 0.0 113.419 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.3 tp -91.32 140.08 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.254 1.022 . . . . 0.0 110.599 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.8 p -133.76 174.06 10.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.389 1.476 . . . . 0.0 108.695 168.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.33 -22.62 63.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.043 0.537 . . . . 0.0 112.421 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.71 -45.14 38.39 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.307 -0.871 . . . . 0.0 111.41 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -63.27 -43.8 96.93 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.058 0.543 . . . . 0.0 111.088 172.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.9 ttt -65.35 -37.31 86.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.997 0.519 . . . . 0.0 112.337 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.6 mtp-105 -66.46 -38.18 86.78 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.509 -0.744 . . . . 0.0 112.066 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -72.03 -40.32 68.49 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.411 -0.806 . . . . 0.0 112.557 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.9 mt -59.34 -29.58 67.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.986 1.714 . . . . 0.0 113.027 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -105.88 8.44 32.65 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.22 1.408 . . . . 0.0 112.656 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.03 -27.04 68.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.246 0.93 . . . . 0.0 113.214 -173.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -72.55 -5.54 37.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.775 1.23 . . . . 0.0 113.657 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -111.86 8.81 20.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.433 1.893 . . . . 0.0 111.83 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.11 -177.6 53.72 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.802 1.192 . . . . 0.0 112.253 -172.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -71.16 144.18 50.28 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.637 -0.919 . . . . 0.0 111.998 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.26 156.3 33.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.878 0.871 . . . . 0.0 111.857 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.96 -10.29 58.84 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.939 1.256 . . . . 0.0 113.87 175.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.65 135.83 5.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.699 2.0 . . . . 0.0 108.611 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.1 t -143.56 128.77 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.644 1.578 . . . . 0.0 109.43 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -145.1 142.31 29.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.382 1.473 . . . . 0.0 111.765 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.9 mt -138.51 127.18 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.559 1.544 . . . . 0.0 108.575 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -115.57 103.25 10.54 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.446 1.098 . . . . 0.0 111.831 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -69.79 -20.34 63.47 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -87.18 -15.17 39.12 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -117.6 -19.25 9.47 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.613 1.165 . . . . 0.0 113.985 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.25 29.79 21.42 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 124.665 1.126 . . . . 0.0 114.312 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -132.51 149.07 52.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.942 1.297 . . . . 0.0 111.832 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.68 169.5 25.17 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.875 1.702 . . . . 0.0 112.754 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -141.83 142.52 33.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.173 1.789 . . . . 0.0 109.566 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.6 tt -152.18 143.19 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.726 0.81 . . . . 0.0 110.686 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -121.3 124.32 44.32 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.922 0.889 . . . . 0.0 110.706 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.0 mt -97.31 171.2 8.57 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.582 0.753 . . . . 0.0 111.132 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -74.73 -26.46 59.82 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.3 p -144.7 159.29 43.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.686 1.194 . . . . 0.0 111.983 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -60.24 -31.35 70.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.844 0.857 . . . . 0.0 112.755 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -68.47 -46.79 68.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.019 1.328 . . . . 0.0 110.486 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.6 mt -62.39 -42.73 99.65 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.249 0.62 . . . . 0.0 111.125 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.59 -36.94 85.87 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.89 -47.93 73.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.508 1.123 . . . . 0.0 111.905 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.7 mt -62.35 -47.83 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.418 -0.802 . . . . 0.0 110.18 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.41 -42.49 98.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.277 0.631 . . . . 0.0 112.409 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -54.01 -51.87 62.59 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.421 1.009 . . . . 0.0 111.287 170.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.36 -34.91 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.151 0.432 . . . . 0.0 111.785 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -85.57 -23.98 27.4 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.0 mt -106.67 -22.17 12.82 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.24 128.84 37.92 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.476 1.034 . . . . 0.0 110.992 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.6 t30 70.48 12.75 7.45 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.27 2.228 . . . . 0.0 114.106 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.5 ttp -75.67 136.95 70.52 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.565 -1.334 . . . . 0.0 110.91 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.99 139.91 19.73 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.452 2.768 . . . . 0.0 111.169 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.8 tp -145.72 121.57 10.61 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.506 1.522 . . . . 0.0 109.893 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 59.17 23.09 11.35 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.902 1.281 . . . . 0.0 113.699 172.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.1 2.15 74.85 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.394 1.473 . . . . 0.0 114.728 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -111.73 156.98 21.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.233 1.813 . . . . 0.0 111.629 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.99 173.07 10.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.163 0.985 . . . . 0.0 111.137 169.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.2 mt -134.24 119.01 18.22 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.544 1.138 . . . . 0.0 109.148 169.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -92.67 122.51 35.15 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.85 128.32 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.194 0.906 . . . . 0.0 109.689 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -148.1 165.27 31.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.581 1.552 . . . . 0.0 110.986 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.19 137.87 41.58 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.633 -0.667 . . . . 0.0 110.566 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 123.234 0.614 . . . . 0.0 110.786 178.722 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.13 129.18 55.18 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.074 1.75 . . . . 0.0 110.744 -174.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.3 mt -108.15 130.61 55.11 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.585 1.554 . . . . 0.0 110.294 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -89.83 134.5 34.16 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.645 1.978 . . . . 0.0 107.949 169.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.9 t -129.16 121.88 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.996 0.918 . . . . 0.0 109.792 -174.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.43 172.66 14.56 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 125.921 1.724 . . . . 0.0 113.686 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 m120 65.32 17.08 10.86 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.169 1.788 . . . . 0.0 113.371 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 32.2 mt -58.19 143.48 78.92 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.409 1.084 . . . . 0.0 112.474 -171.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -70.32 158.06 57.37 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.199 2.6 . . . . 0.0 110.852 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.5 -9.67 25.54 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.316 2.677 . . . . 0.0 112.87 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.79 4.42 52.87 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.793 2.037 . . . . 0.0 113.409 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 tp -81.74 145.28 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 120.785 -1.197 . . . . 0.0 111.181 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.8 p -135.27 167.63 20.66 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.52 1.928 . . . . 0.0 109.139 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -57.7 -35.42 70.6 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.962 0.505 . . . . 0.0 111.887 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -80.23 -30.97 38.59 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.518 1.127 . . . . 0.0 113.076 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.08 -39.2 66.06 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.024 0.93 . . . . 0.0 111.309 172.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 4.3 tpt -61.86 -42.27 98.85 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.709 0.804 . . . . 0.0 111.074 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.0 ttp85 -63.26 -27.85 69.63 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.424 -0.798 . . . . 0.0 112.191 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -47.67 37.7 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.157 1.383 . . . . 0.0 112.494 171.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.7 mt -55.62 -34.27 64.74 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.01 1.324 . . . . 0.0 112.634 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -102.52 9.93 39.2 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.05 1.34 . . . . 0.0 113.267 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.63 -24.89 67.15 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -61.92 -25.21 67.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.555 1.142 . . . . 0.0 112.388 173.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -102.32 12.69 36.24 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.209 1.804 . . . . 0.0 112.478 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.55 -145.68 20.4 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.756 1.17 . . . . 0.0 111.93 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -103.54 131.14 50.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.599 1.159 . . . . 0.0 111.085 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.5 146.49 51.85 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.172 0.989 . . . . 0.0 111.844 176.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.81 -18.14 70.97 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.287 0.946 . . . . 0.0 113.454 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -158.68 146.38 17.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.569 1.548 . . . . 0.0 110.321 172.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.9 t -143.18 128.46 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.083 1.753 . . . . 0.0 109.542 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -140.65 142.35 34.97 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.401 1.481 . . . . 0.0 111.444 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.5 mt -142.12 128.97 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.004 1.721 . . . . 0.0 108.222 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -123.27 102.13 7.76 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.046 0.938 . . . . 0.0 111.985 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -73.6 -16.35 61.24 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.94 -20.53 60.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.305 1.042 . . . . 0.0 112.808 175.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -116.75 -23.22 8.22 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.832 1.253 . . . . 0.0 113.756 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.71 28.73 23.23 Favored Glycine 0 N--CA 1.477 1.371 0 C-N-CA 124.673 1.13 . . . . 0.0 114.25 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -136.78 155.16 50.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.389 1.476 . . . . 0.0 112.023 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.96 168.97 25.84 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.676 1.607 . . . . 0.0 113.055 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -140.56 140.2 35.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.703 2.001 . . . . 0.0 108.735 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.5 tt -150.6 132.27 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.685 -0.634 . . . . 0.0 111.487 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 123.1 47.63 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.749 1.22 . . . . 0.0 110.172 -177.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -99.73 157.12 16.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.246 0.618 . . . . 0.0 110.181 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.34 -18.47 63.08 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -169.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.9 p -151.01 151.54 32.21 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.667 1.587 . . . . 0.0 111.435 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 36.9 ptt-85 -55.27 -35.66 65.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.756 1.222 . . . . 0.0 114.24 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 m -60.92 -45.92 92.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.058 1.343 . . . . 0.0 111.265 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.09 -44.0 97.61 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.773 0.829 . . . . 0.0 110.915 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.85 79.41 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.297 0.639 . . . . 0.0 112.63 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.53 -48.32 67.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.861 0.865 . . . . 0.0 111.909 172.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.34 -46.56 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.522 -0.736 . . . . 0.0 110.279 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.99 99.54 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.759 0.824 . . . . 0.0 112.053 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -56.09 -50.65 70.43 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.566 1.076 . . . . 0.0 111.489 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.8 -35.15 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.793 0.724 . . . . 0.0 112.338 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -87.2 -33.44 19.35 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.0 mt -98.91 -22.68 15.66 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -171.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -70.2 122.71 20.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.0 0.818 . . . . 0.0 110.773 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 70.61 14.92 7.18 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 127.543 2.337 . . . . 0.0 114.262 -171.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.4 ttp -72.79 138.1 79.95 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 120.518 -1.364 . . . . 0.0 110.939 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.11 139.58 21.66 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.44 2.76 . . . . 0.0 111.402 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.8 tp -144.88 116.22 8.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.343 1.457 . . . . 0.0 109.969 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 59.03 18.88 6.69 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.211 1.404 . . . . 0.0 113.916 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.57 -6.73 80.26 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.665 1.602 . . . . 0.0 114.508 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -85.38 153.99 22.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.758 1.279 . . . . 0.0 110.557 170.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -86.11 163.41 17.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 167.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.0 mt -122.1 137.52 54.79 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.305 1.042 . . . . 0.0 110.046 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.4 135.67 46.36 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.382 1.073 . . . . 0.0 109.529 170.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.37 132.93 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.965 0.906 . . . . 0.0 110.955 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -147.73 165.61 30.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.163 1.385 . . . . 0.0 111.573 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -73.54 136.85 44.08 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.545 -0.722 . . . . 0.0 110.946 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 123.693 0.797 . . . . 0.0 110.572 174.712 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -86.11 135.01 33.77 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.233 1.413 . . . . 0.0 111.406 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.83 127.4 51.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.809 1.643 . . . . 0.0 110.206 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -89.65 135.7 33.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.731 2.013 . . . . 0.0 108.13 171.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.63 113.22 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.048 0.939 . . . . 0.0 109.46 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.16 174.41 21.33 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.606 1.574 . . . . 0.0 113.271 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 m120 66.48 16.61 10.46 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.028 1.731 . . . . 0.0 113.761 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.5 mt -60.8 140.52 93.25 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 121.156 -0.965 . . . . 0.0 113.033 -170.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -68.67 159.28 54.31 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.08 3.187 . . . . 0.0 111.745 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.95 -1.47 11.25 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.572 2.848 . . . . 0.0 114.031 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -116.84 12.49 14.79 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.682 1.593 . . . . 0.0 113.0 -174.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 tp -82.24 137.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.42 1.088 . . . . 0.0 110.734 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.5 p -128.86 176.18 8.05 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.261 1.424 . . . . 0.0 110.009 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -54.22 -32.82 56.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.913 0.885 . . . . 0.0 112.202 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -73.34 -34.01 65.43 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.784 0.834 . . . . 0.0 112.479 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -71.48 -44.13 65.3 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.654 0.661 . . . . 0.0 110.56 170.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.9 ttt -65.28 -33.26 75.57 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -63.98 -45.15 90.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.068 0.947 . . . . 0.0 111.318 169.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -70.84 -38.51 73.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.634 0.774 . . . . 0.0 112.825 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.8 mt -59.62 -24.21 63.63 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.551 1.54 . . . . 0.0 113.328 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -113.2 10.25 18.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.577 1.551 . . . . 0.0 112.539 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -21.33 65.42 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.63 -20.52 60.97 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.038 1.335 . . . . 0.0 112.593 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -112.47 11.59 19.87 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.257 2.223 . . . . 0.0 111.855 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.5 -169.99 52.98 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.479 1.037 . . . . 0.0 113.211 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -71.63 129.6 39.11 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.014 -0.698 . . . . 0.0 111.293 174.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.9 149.73 43.2 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.058 0.943 . . . . 0.0 111.439 172.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.23 -12.89 75.26 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.717 1.151 . . . . 0.0 113.78 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -156.12 138.08 14.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.88 1.672 . . . . 0.0 109.316 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -141.69 127.68 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.437 1.495 . . . . 0.0 108.801 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -145.2 139.15 27.0 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.562 1.145 . . . . 0.0 111.936 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.7 mt -139.86 137.8 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.485 1.914 . . . . 0.0 107.978 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -143.51 129.17 19.23 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 122.63 1.205 . . . . 0.0 113.897 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -74.21 -11.49 60.3 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.313 1.445 . . . . 0.0 113.463 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.17 -32.09 61.89 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.45 1.5 . . . . 0.0 113.031 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -123.73 -20.67 5.4 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.39 42.35 7.47 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 119.26 0.936 . . . . 0.0 113.252 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -137.78 154.75 49.54 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.734 1.614 . . . . 0.0 111.151 -177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.64 162.08 25.12 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.099 1.333 . . . . 0.0 113.647 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -137.27 139.71 41.13 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.921 2.088 . . . . 0.0 109.167 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.93 139.99 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.124 0.97 . . . . 0.0 110.313 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -125.88 116.17 21.11 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.95 0.9 . . . . 0.0 110.292 -172.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.5 mt -92.83 167.86 11.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.1 0.56 . . . . 0.0 111.242 -174.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -76.31 -19.53 58.16 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.2 p -143.8 155.11 44.03 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.643 1.177 . . . . 0.0 111.649 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 37.4 ptt-85 -60.11 -36.01 76.51 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.716 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.1 m -62.19 -50.62 71.08 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.351 1.46 . . . . 0.0 110.698 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.32 -37.6 87.6 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.692 -0.67 . . . . 0.0 111.758 176.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.02 89.55 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.106 0.866 . . . . 0.0 113.129 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -65.6 -49.57 68.29 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.678 0.791 . . . . 0.0 111.531 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.71 -48.45 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.967 -0.458 . . . . 0.0 110.125 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.56 86.29 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.596 0.758 . . . . 0.0 112.204 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -60.17 -42.42 94.96 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.247 -0.908 . . . . 0.0 112.15 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.17 -35.21 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.828 0.74 . . . . 0.0 112.049 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.69 -30.78 32.48 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.8 mt -104.73 -19.52 13.91 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -169.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.71 128.33 36.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.207 0.912 . . . . 0.0 111.664 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.1 t30 70.83 17.87 6.3 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.034 2.534 . . . . 0.0 113.348 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.6 ttp -76.49 138.17 67.33 Favored Pre-proline 0 N--CA 1.475 0.805 0 O-C-N 120.796 -1.19 . . . . 0.0 111.343 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.65 143.6 21.49 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.444 2.763 . . . . 0.0 111.708 175.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.2 tp -146.73 115.51 6.84 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.413 1.485 . . . . 0.0 110.247 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 57.08 25.68 11.11 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.513 1.525 . . . . 0.0 114.164 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.16 -1.96 78.07 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.225 1.393 . . . . 0.0 114.607 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -100.41 166.85 10.74 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.581 1.552 . . . . 0.0 111.191 169.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -92.66 175.21 6.9 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.481 1.112 . . . . 0.0 109.904 171.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.6 mt -136.9 110.25 7.89 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.745 1.218 . . . . 0.0 108.89 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.06 122.39 37.68 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.71 125.49 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.87 0.868 . . . . 0.0 110.846 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -139.67 166.71 23.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.885 1.674 . . . . 0.0 111.164 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -77.71 134.46 38.1 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.602 -0.687 . . . . 0.0 111.482 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.648 0 C-N-CA 124.173 0.989 . . . . 0.0 110.645 174.337 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.5 m . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -97.56 131.55 44.05 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.719 1.208 . . . . 0.0 112.026 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.9 mt -102.98 152.45 21.31 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.64 1.976 . . . . 0.0 110.586 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.428 ' CD2' ' HD3' ' A' ' 144' ' ' ARG . 12.1 t80 -124.48 126.28 45.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.778 2.431 . . . . 0.0 108.076 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.31 111.6 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.567 1.147 . . . . 0.0 109.478 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.57 167.23 25.75 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.79 1.186 . . . . 0.0 112.619 173.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 64.97 26.49 12.72 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.61 1.564 . . . . 0.0 113.217 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.53 144.01 95.91 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 121.074 -1.016 . . . . 0.0 111.345 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.38 161.8 44.71 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.79 2.993 . . . . 0.0 111.85 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.03 6.08 1.9 Allowed 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 124.157 3.238 . . . . 0.0 114.347 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -140.43 19.0 2.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.462 1.505 . . . . 0.0 114.335 -172.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -73.07 150.72 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.065 0.946 . . . . 0.0 110.151 169.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 p -126.83 163.54 23.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.081 1.352 . . . . 0.0 110.619 170.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -58.16 -32.96 68.71 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.14 0.576 . . . . 0.0 111.44 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -68.26 -42.44 79.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 111.673 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.11 -40.73 94.92 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.884 -0.51 . . . . 0.0 111.802 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.9 ttt -66.51 -38.6 87.59 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.656 0.662 . . . . 0.0 111.629 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -62.95 -38.73 92.25 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.52 1.128 . . . . 0.0 111.707 173.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.91 -45.45 61.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.96 1.304 . . . . 0.0 111.32 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.59 -29.09 58.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.007 1.323 . . . . 0.0 113.524 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -107.07 10.03 30.34 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.371 1.468 . . . . 0.0 112.792 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.06 -23.42 67.17 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -58.5 -26.72 63.77 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.976 1.31 . . . . 0.0 112.863 171.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -101.47 10.7 40.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.964 1.706 . . . . 0.0 112.729 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.18 -167.84 43.97 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.777 1.18 . . . . 0.0 112.625 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -79.06 123.73 27.62 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.952 -0.734 . . . . 0.0 110.265 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.82 143.64 54.52 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.8 0.84 . . . . 0.0 111.581 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.18 -9.32 76.88 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.792 1.187 . . . . 0.0 114.117 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -155.44 134.39 12.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.296 1.838 . . . . 0.0 108.48 173.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.5 t -140.54 125.77 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.196 1.398 . . . . 0.0 109.112 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -140.74 140.35 34.81 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.628 1.571 . . . . 0.0 111.238 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 62.0 mt -140.21 130.57 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.838 1.655 . . . . 0.0 108.211 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -120.34 108.16 13.81 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.798 0.839 . . . . 0.0 112.079 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.73 -17.86 61.06 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -171.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -78.98 -19.42 51.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.115 0.966 . . . . 0.0 112.758 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -108.28 -29.28 8.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.744 1.218 . . . . 0.0 113.615 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.79 28.18 27.11 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 124.608 1.099 . . . . 0.0 114.182 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -133.86 156.95 47.16 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.519 1.527 . . . . 0.0 111.893 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.75 165.8 27.53 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.865 1.221 . . . . 0.0 113.615 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.33 146.58 46.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.555 1.942 . . . . 0.0 109.78 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.6 tt -153.26 127.39 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.583 0.753 . . . . 0.0 111.43 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -114.0 121.15 43.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.155 0.982 . . . . 0.0 111.176 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.0 mt -97.42 167.15 11.17 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.74 0.816 . . . . 0.0 110.73 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -70.37 -24.07 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.7 p -145.52 160.7 41.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.466 1.506 . . . . 0.0 111.138 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -62.49 -31.76 72.56 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 119.01 -0.519 . . . . 0.0 111.985 173.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.0 m -61.24 -47.19 87.2 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.91 1.284 . . . . 0.0 110.564 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.06 -45.78 93.36 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.298 0.639 . . . . 0.0 111.076 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.46 -36.15 83.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -68.49 -44.26 75.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.064 1.345 . . . . 0.0 111.428 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.53 -52.0 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.432 -0.793 . . . . 0.0 109.883 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.15 90.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.625 0.77 . . . . 0.0 112.389 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -52.94 -50.05 64.8 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.032 0.933 . . . . 0.0 111.679 172.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.4 t -74.68 -36.23 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.389 0.54 . . . . 0.0 111.852 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -77.29 -21.32 53.73 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.5 mt -110.83 0.11 17.12 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.521 1.128 . . . . 0.0 113.758 -174.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.67 125.9 26.72 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.14 -0.975 . . . . 0.0 112.218 -176.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 57.51 22.4 8.05 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.479 1.912 . . . . 0.0 113.5 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 51.0 ttp -63.81 133.55 95.6 Favored Pre-proline 0 N--CA 1.472 0.652 0 O-C-N 120.777 -1.202 . . . . 0.0 111.09 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -73.54 127.33 11.65 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.003 2.469 . . . . 0.0 110.432 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 45.6 tp -135.51 107.46 7.11 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.813 1.645 . . . . 0.0 108.117 170.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 57.81 29.18 17.07 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.769 1.228 . . . . 0.0 113.202 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.74 -5.61 62.12 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.249 1.88 . . . . 0.0 115.066 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -101.23 142.19 33.02 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.151 1.38 . . . . 0.0 111.025 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -102.14 117.4 34.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.88 0.872 . . . . 0.0 109.736 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.42 119.15 23.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.665 1.186 . . . . 0.0 112.28 -169.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -97.29 106.63 18.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.3 0.64 . . . . 0.0 110.312 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.44 129.24 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.512 1.125 . . . . 0.0 110.595 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.428 ' HD3' ' CD2' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -134.11 170.4 15.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.518 1.927 . . . . 0.0 110.819 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -90.57 140.42 29.77 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.522 0.729 . . . . 0.0 110.952 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.791 0 C-N-CA 125.004 1.322 . . . . 0.0 111.791 -179.819 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.5 p . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -77.03 121.38 23.45 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.497 1.119 . . . . 0.0 110.599 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.4 mt -105.1 134.32 48.4 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.705 1.602 . . . . 0.0 110.354 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -91.94 135.31 34.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.049 2.14 . . . . 0.0 108.086 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.3 t -131.48 106.22 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.353 1.061 . . . . 0.0 108.884 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.01 163.08 15.19 Favored Glycine 0 N--CA 1.464 0.546 0 C-N-CA 124.991 1.281 . . . . 0.0 113.724 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 t30 68.7 27.56 5.87 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.85 1.66 . . . . 0.0 112.745 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.74 145.57 95.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 O-C-N 121.187 -0.946 . . . . 0.0 111.854 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.1 165.86 31.03 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.209 3.273 . . . . 0.0 111.777 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.19 -5.98 17.77 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.091 2.528 . . . . 0.0 113.4 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -106.87 0.48 23.96 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.124 1.37 . . . . 0.0 114.181 -172.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 tp -74.25 143.2 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.268 -0.895 . . . . 0.0 111.129 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 65.7 p -128.23 166.51 18.41 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.035 1.734 . . . . 0.0 110.074 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.96 -31.98 69.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.033 0.533 . . . . 0.0 111.536 171.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -70.76 -42.09 70.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.213 1.005 . . . . 0.0 111.924 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -66.28 -41.86 89.22 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.78 0.718 . . . . 0.0 111.302 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.8 tpt -65.11 -37.92 89.03 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.891 -0.505 . . . . 0.0 111.629 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -63.11 -48.4 78.71 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.404 -0.81 . . . . 0.0 110.273 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -60.49 -38.89 85.73 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.196 0.998 . . . . 0.0 113.296 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.6 mt -63.99 -29.78 70.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.38 1.472 . . . . 0.0 113.988 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.434 ' CZ ' HD13 ' A' ' 131' ' ' LEU . 47.8 m-85 -109.89 -4.0 16.26 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.69 1.196 . . . . 0.0 113.51 -176.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.38 -27.52 67.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.927 1.691 . . . . 0.0 115.16 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -55.78 -24.43 35.62 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.961 1.304 . . . . 0.0 112.707 171.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -107.02 14.54 26.27 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.937 2.095 . . . . 0.0 112.029 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.02 172.66 44.97 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.137 1.827 . . . . 0.0 112.78 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.57 132.91 46.21 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.873 -0.78 . . . . 0.0 110.931 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.1 145.44 51.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.885 0.874 . . . . 0.0 112.163 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.05 -11.59 75.93 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.631 1.11 . . . . 0.0 113.905 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -157.69 135.92 11.01 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.712 2.005 . . . . 0.0 108.371 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.34 128.84 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.265 1.426 . . . . 0.0 108.609 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -140.87 139.88 34.5 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.147 1.379 . . . . 0.0 110.904 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.8 mt -139.1 120.6 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.371 1.469 . . . . 0.0 108.312 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -115.97 98.18 6.5 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.234 1.014 . . . . 0.0 112.12 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.07 -15.86 62.02 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.92 -23.61 60.72 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.278 1.031 . . . . 0.0 112.697 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -117.06 -25.27 7.23 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.59 27.7 18.97 Favored Glycine 0 N--CA 1.477 1.428 0 C-N-CA 124.569 1.081 . . . . 0.0 114.171 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.91 150.54 52.15 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.373 1.469 . . . . 0.0 111.46 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.64 167.4 25.32 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.56 1.552 . . . . 0.0 113.08 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -139.52 142.62 37.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.468 1.907 . . . . 0.0 109.402 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 tt -151.65 130.65 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.382 0.673 . . . . 0.0 111.454 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.49 122.38 45.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.611 1.164 . . . . 0.0 110.441 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -97.59 168.41 10.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.005 0.522 . . . . 0.0 111.085 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -67.58 -32.4 73.12 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -171.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.9 p -140.44 159.32 42.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.827 1.251 . . . . 0.0 112.102 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -60.88 -31.95 71.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.818 0.847 . . . . 0.0 113.001 173.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m -68.71 -47.93 65.14 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.161 1.384 . . . . 0.0 110.658 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.8 mt -58.88 -42.34 89.23 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.614 0.766 . . . . 0.0 111.261 173.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.67 -35.39 78.76 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.79 -47.25 75.76 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.742 1.155 . . . . 0.0 111.361 172.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.7 mt -59.43 -48.73 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.19 0.596 . . . . 0.0 110.316 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.98 93.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.203 0.601 . . . . 0.0 112.033 176.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -57.54 -49.0 77.76 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.412 1.005 . . . . 0.0 111.182 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.86 -35.87 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.192 0.597 . . . . 0.0 111.963 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -83.48 -24.32 31.82 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.434 HD13 ' CZ ' ' A' ' 96' ' ' PHE . 55.3 mt -111.23 -18.48 12.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -171.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.67 128.39 35.77 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.897 1.226 . . . . 0.0 111.975 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 59.5 27.47 16.63 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.897 2.079 . . . . 0.0 113.364 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.8 ttp -74.72 137.43 73.73 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.535 -0.728 . . . . 0.0 109.664 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.31 136.3 15.81 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.315 2.677 . . . . 0.0 111.058 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -145.12 123.49 12.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.971 1.708 . . . . 0.0 109.0 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 58.83 22.87 10.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.775 1.23 . . . . 0.0 113.716 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.15 3.1 85.29 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.317 1.436 . . . . 0.0 114.474 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -106.17 148.91 27.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.17 1.788 . . . . 0.0 110.879 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -84.22 168.47 15.7 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.339 168.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.01 127.87 37.13 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.29 1.036 . . . . 0.0 110.701 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.63 111.34 23.52 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.84 0.856 . . . . 0.0 108.902 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.94 124.21 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.767 0.827 . . . . 0.0 109.822 -173.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.9 ptt85 -149.63 173.6 13.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.311 1.444 . . . . 0.0 111.247 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -75.2 144.97 42.41 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.616 -0.678 . . . . 0.0 111.85 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.979 0 C-N-CA 125.221 1.408 . . . . 0.0 113.095 178.772 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.4 m . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -85.88 122.19 29.59 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.05 1.34 . . . . 0.0 111.443 -176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.6 mt -105.15 135.85 45.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.329 1.852 . . . . 0.0 110.066 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -90.87 138.53 31.52 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.144 1.777 . . . . 0.0 108.723 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.93 106.06 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.24 1.016 . . . . 0.0 108.788 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.79 168.74 20.63 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 125.454 1.502 . . . . 0.0 112.83 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.1 m120 61.48 35.36 17.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.828 1.251 . . . . 0.0 112.045 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.7 mt -66.26 145.78 99.0 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 121.3 -0.875 . . . . 0.0 111.442 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -70.11 158.08 57.65 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.946 2.431 . . . . 0.0 111.338 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.24 -2.32 11.48 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.93 3.087 . . . . 0.0 113.333 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -112.99 14.13 19.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.556 1.943 . . . . 0.0 112.604 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.25 150.21 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 O-C-N 121.012 -1.055 . . . . 0.0 110.753 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.0 p -136.2 170.06 16.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.832 1.653 . . . . 0.0 109.683 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.27 -35.41 71.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.57 0.348 . . . . 0.0 111.464 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.44 -41.26 66.35 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.975 0.91 . . . . 0.0 111.806 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.29 -46.79 82.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.233 0.613 . . . . 0.0 111.261 173.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.2 ttt -64.42 -35.51 81.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.116 0.566 . . . . 0.0 112.264 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -64.91 -45.11 87.29 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.415 0.686 . . . . 0.0 110.97 171.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -64.35 -42.98 95.95 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.197 -0.94 . . . . 0.0 111.946 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.1 mt -57.65 -24.61 57.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.476 1.51 . . . . 0.0 113.964 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -115.14 -1.85 12.9 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.681 1.192 . . . . 0.0 113.572 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.27 -28.79 69.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.728 1.611 . . . . 0.0 115.164 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -61.11 -22.03 64.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.523 1.129 . . . . 0.0 112.91 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -103.49 24.99 10.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.912 2.085 . . . . 0.0 111.67 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.24 -176.82 45.52 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.934 1.73 . . . . 0.0 112.664 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.66 144.38 56.97 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.95 -0.735 . . . . 0.0 111.949 175.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.14 118.01 16.6 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.16 -15.15 75.27 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.807 1.194 . . . . 0.0 113.566 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -161.17 145.25 13.33 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.672 1.989 . . . . 0.0 108.677 168.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.8 t -144.35 130.73 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.32 1.448 . . . . 0.0 110.365 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -140.52 136.69 33.15 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.405 1.482 . . . . 0.0 110.844 171.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 63.7 mt -139.29 137.03 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.249 1.82 . . . . 0.0 107.84 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -139.55 125.29 19.51 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.135 0.969 . . . . 0.0 113.087 170.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.15 -18.68 62.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.441 1.096 . . . . 0.0 112.779 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.36 -38.72 63.57 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.337 1.855 . . . . 0.0 113.081 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -120.77 -15.32 8.4 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.67 41.16 5.77 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.787 1.184 . . . . 0.0 113.811 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -136.86 159.26 42.39 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.114 1.366 . . . . 0.0 112.223 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.96 167.37 29.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.496 1.046 . . . . 0.0 114.191 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -139.11 147.06 41.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.705 2.002 . . . . 0.0 109.571 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.2 tt -147.88 132.28 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.202 1.001 . . . . 0.0 110.646 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -101.63 128.42 47.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.965 0.906 . . . . 0.0 109.131 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 124' ' ' ALA . 12.5 mt -98.68 165.99 11.54 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.361 0.528 . . . . 0.0 110.278 170.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -76.5 -18.05 58.95 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -169.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.2 p -144.4 154.3 42.83 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.828 1.251 . . . . 0.0 111.5 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -62.87 -33.15 74.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.61 0.764 . . . . 0.0 112.891 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.1 m -64.48 -47.66 78.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.691 1.196 . . . . 0.0 110.793 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -66.71 -35.89 81.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.338 0.655 . . . . 0.0 111.394 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.45 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -64.8 -39.77 94.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 173.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.94 -47.76 76.51 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.489 1.041 . . . . 0.0 111.214 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 93.9 mt -59.54 -50.41 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.202 0.601 . . . . 0.0 110.272 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.64 -45.68 88.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.093 0.557 . . . . 0.0 111.806 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.38 -46.22 86.79 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.391 -0.818 . . . . 0.0 111.69 176.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.1 t -67.56 -35.77 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.516 0.598 . . . . 0.0 111.89 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -80.81 -24.35 38.58 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 48.9 mt -109.09 -16.71 14.05 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.02 133.71 49.47 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.05 1.295 . . . . 0.0 112.615 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 59.4 t30 65.71 15.83 10.22 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.939 2.496 . . . . 0.0 113.757 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.8 ttp -71.43 136.13 83.92 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 120.834 -1.166 . . . . 0.0 110.563 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.93 129.77 11.8 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.363 2.709 . . . . 0.0 110.607 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.9 tp -139.32 113.29 8.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.036 1.335 . . . . 0.0 109.557 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 58.81 23.62 11.45 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.906 1.282 . . . . 0.0 113.478 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.26 -3.37 76.09 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.847 1.689 . . . . 0.0 114.671 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -92.14 147.68 22.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.413 1.485 . . . . 0.0 110.7 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -102.67 110.46 22.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.749 0.82 . . . . 0.0 109.348 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 80.4 mt -73.56 121.21 20.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.699 0.8 . . . . 0.0 111.661 -172.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -92.07 112.7 24.73 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.919 0.888 . . . . 0.0 108.8 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.66 120.47 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.186 0.994 . . . . 0.0 110.131 -172.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -155.08 156.09 35.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.773 1.229 . . . . 0.0 111.473 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -67.85 133.03 48.47 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.672 -0.643 . . . . 0.0 111.435 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 124.121 0.968 . . . . 0.0 110.399 179.227 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -76.73 125.74 29.78 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.762 -1.211 . . . . 0.0 110.973 -175.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.2 mt -114.02 139.28 49.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.238 2.215 . . . . 0.0 110.26 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -100.74 142.56 32.04 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.238 2.215 . . . . 0.0 108.567 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.43 114.89 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.218 1.007 . . . . 0.0 110.001 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.88 173.73 17.03 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 126.021 1.772 . . . . 0.0 113.057 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.2 m120 66.64 11.79 8.38 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.462 1.905 . . . . 0.0 114.024 -175.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.5 mt -53.98 144.24 38.51 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.342 1.057 . . . . 0.0 113.41 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.03 165.29 33.04 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.257 3.305 . . . . 0.0 112.032 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.61 -8.14 20.19 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.389 2.726 . . . . 0.0 113.833 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -121.65 23.25 10.3 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.794 1.638 . . . . 0.0 113.561 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 tp -81.81 143.13 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.806 0.843 . . . . 0.0 110.53 173.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.0 p -136.52 167.65 20.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.557 1.943 . . . . 0.0 109.892 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -62.53 -28.54 69.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.32 0.648 . . . . 0.0 112.318 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -72.15 -47.62 49.59 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.993 -1.067 . . . . 0.0 112.496 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -57.82 -41.13 81.57 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.136 0.575 . . . . 0.0 111.86 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -70.07 -34.73 73.55 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.594 -0.691 . . . . 0.0 112.451 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -68.37 -37.05 80.06 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.518 -0.739 . . . . 0.0 111.906 169.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -68.97 -41.82 77.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.11 0.964 . . . . 0.0 112.449 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.3 mt -58.06 -26.52 62.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.101 1.36 . . . . 0.0 113.46 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -109.23 10.45 25.77 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.545 1.538 . . . . 0.0 112.526 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.78 -22.22 66.03 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -61.43 -21.7 64.35 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.602 1.161 . . . . 0.0 112.419 171.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.07 13.12 24.77 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.123 2.169 . . . . 0.0 112.131 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.37 -168.94 53.38 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.827 1.203 . . . . 0.0 112.916 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -76.57 124.75 28.09 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.55 0.74 . . . . 0.0 110.973 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.14 149.43 48.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.205 1.002 . . . . 0.0 111.681 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.07 -13.94 65.38 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.538 1.066 . . . . 0.0 113.914 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -154.79 136.21 14.16 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.853 1.661 . . . . 0.0 108.919 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 t -143.2 128.72 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.708 1.603 . . . . 0.0 109.066 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -145.35 144.32 30.64 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.062 1.345 . . . . 0.0 111.82 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.2 mt -137.68 128.1 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.352 1.461 . . . . 0.0 108.542 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -115.84 92.62 3.96 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.387 1.075 . . . . 0.0 110.542 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -74.54 -12.3 60.43 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.43 -23.24 62.7 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.073 1.349 . . . . 0.0 112.877 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -117.03 -22.37 8.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.729 1.212 . . . . 0.0 114.168 175.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.46 36.26 7.05 Favored Glycine 0 N--CA 1.475 1.288 0 C-N-CA 125.09 1.329 . . . . 0.0 114.276 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.13 152.08 44.44 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.113 1.365 . . . . 0.0 112.037 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.58 163.01 24.71 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.389 1.471 . . . . 0.0 113.375 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -142.3 140.66 32.26 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.642 1.977 . . . . 0.0 109.156 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.9 tt -154.32 148.12 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.829 0.852 . . . . 0.0 110.73 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -138.87 125.78 21.07 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.776 0.83 . . . . 0.0 110.58 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.28 176.85 5.05 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.24 1.016 . . . . 0.0 111.733 -170.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -76.9 -25.29 52.83 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.6 p -144.66 154.11 42.44 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.348 1.059 . . . . 0.0 112.147 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -58.49 -34.61 71.11 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.659 0.784 . . . . 0.0 112.884 172.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.1 m -62.22 -50.19 72.77 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.251 1.42 . . . . 0.0 110.445 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.11 -36.88 85.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.993 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.77 -37.24 85.79 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.115 0.87 . . . . 0.0 113.282 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -67.95 -45.27 74.72 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.771 0.828 . . . . 0.0 111.808 173.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.76 -48.0 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.57 -0.706 . . . . 0.0 110.243 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.88 91.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.929 0.891 . . . . 0.0 112.017 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -53.69 -53.77 47.33 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.016 0.826 . . . . 0.0 111.479 171.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.8 t -67.88 -33.03 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.582 0.628 . . . . 0.0 112.182 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.71 -36.03 44.03 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.06 -20.84 14.61 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.185 1.179 . . . . 0.0 114.185 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -67.07 134.01 51.0 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.114 0.87 . . . . 0.0 110.908 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . 0.3 0.4 OUTLIER 58.49 17.81 5.19 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.607 2.363 . . . . 0.0 115.246 -170.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.3 ttp -75.88 137.59 69.65 Favored Pre-proline 0 CA--C 1.545 0.771 0 O-C-N 120.873 -1.142 . . . . 0.0 110.947 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.73 140.8 21.21 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.467 2.778 . . . . 0.0 111.427 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 32.6 tp -146.56 119.3 8.61 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.459 1.504 . . . . 0.0 110.287 174.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? 58.98 23.9 12.04 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.065 1.346 . . . . 0.0 113.894 171.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.1 1.24 72.92 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.533 1.539 . . . . 0.0 114.734 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -107.66 165.15 11.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.669 1.988 . . . . 0.0 110.768 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -90.45 176.29 6.76 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.6 -0.688 . . . . 0.0 109.99 168.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.4 mt -133.85 116.11 15.27 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.6 1.16 . . . . 0.0 109.196 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -92.13 119.87 32.2 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.0 t -124.72 129.99 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.563 0.745 . . . . 0.0 109.926 -176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -146.98 164.4 33.11 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.304 1.442 . . . . 0.0 111.13 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -70.97 130.58 41.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 168.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 124.88 1.272 . . . . 0.0 110.759 -176.631 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -76.52 128.5 34.87 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.597 1.159 . . . . 0.0 111.311 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.02 140.28 49.42 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.181 1.792 . . . . 0.0 110.468 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -95.9 140.72 30.26 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.536 2.334 . . . . 0.0 108.814 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.2 110.46 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.94 0.896 . . . . 0.0 109.401 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.34 172.35 21.22 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.447 1.498 . . . . 0.0 113.321 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 m120 65.25 19.09 11.63 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.669 1.588 . . . . 0.0 113.128 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.1 mt -58.79 143.46 82.68 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.252 1.021 . . . . 0.0 111.857 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.7 158.57 56.57 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.696 2.93 . . . . 0.0 111.255 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.83 0.36 7.82 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.422 2.748 . . . . 0.0 113.568 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -114.64 4.75 15.18 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.943 1.697 . . . . 0.0 113.639 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.5 tp -74.03 142.41 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.28 -0.887 . . . . 0.0 111.247 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.7 p -123.72 165.59 17.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.971 1.708 . . . . 0.0 110.051 175.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.72 -27.78 68.16 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.699 0.399 . . . . 0.0 111.918 172.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.08 -40.27 62.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.168 0.987 . . . . 0.0 111.76 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -67.54 -37.81 83.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.637 0.653 . . . . 0.0 111.466 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.2 tpt -66.38 -40.98 90.03 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.641 -0.662 . . . . 0.0 111.657 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -60.56 -38.15 83.59 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.657 -0.652 . . . . 0.0 111.101 172.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -72.02 -40.3 68.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.05 0.94 . . . . 0.0 113.333 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 38.0 mt -56.02 -29.52 60.5 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.792 1.237 . . . . 0.0 112.766 173.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -109.05 12.88 24.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.446 1.498 . . . . 0.0 113.152 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -20.18 61.6 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.804 -1.185 . . . . 0.0 114.006 -174.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -64.53 -17.89 64.33 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.556 -0.715 . . . . 0.0 112.269 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -102.71 8.4 39.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.829 2.052 . . . . 0.0 112.178 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.08 -109.03 3.77 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.09 157.54 46.47 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.628 1.171 . . . . 0.0 112.413 170.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.97 151.11 26.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.742 0.817 . . . . 0.0 110.228 168.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.81 -14.31 61.27 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.697 1.142 . . . . 0.0 113.299 173.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -153.42 144.92 23.24 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.003 1.321 . . . . 0.0 110.622 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.29 128.8 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.549 1.94 . . . . 0.0 109.205 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -140.62 138.55 34.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.12 1.368 . . . . 0.0 111.514 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.4 mt -141.97 126.34 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.83 1.652 . . . . 0.0 107.816 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -118.18 106.81 13.22 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.932 0.872 . . . . 0.0 112.541 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -65.06 -27.18 68.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.989 1.316 . . . . 0.0 114.088 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.45 -9.08 59.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.851 1.261 . . . . 0.0 112.881 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -114.79 -32.7 5.72 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.132 1.373 . . . . 0.0 112.874 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.72 26.86 28.42 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.705 1.145 . . . . 0.0 113.753 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.65 155.18 48.51 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.717 1.607 . . . . 0.0 111.505 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.1 167.48 26.83 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.926 1.251 . . . . 0.0 113.677 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -139.18 148.14 42.75 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.729 2.011 . . . . 0.0 109.76 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.8 tt -154.76 138.93 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.955 0.902 . . . . 0.0 110.609 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -121.93 113.21 19.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.208 1.003 . . . . 0.0 109.87 -171.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.9 mt -88.48 167.05 13.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.135 0.574 . . . . 0.0 111.825 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -75.73 -17.32 59.96 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.7 p -145.44 159.92 42.36 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.369 1.467 . . . . 0.0 110.566 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -64.93 -34.35 78.2 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 171.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.8 m -55.71 -45.39 77.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.59 1.156 . . . . 0.0 111.119 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.2 -42.7 96.51 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.492 173.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.39 98.93 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.35 -51.25 70.16 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.353 1.433 . . . . 0.0 112.721 170.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.29 -45.9 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.905 -0.497 . . . . 0.0 110.293 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.81 94.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.362 0.665 . . . . 0.0 112.021 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.43 -45.1 94.86 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.397 -0.814 . . . . 0.0 111.564 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.76 -36.95 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.623 0.647 . . . . 0.0 112.006 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.08 -35.88 36.33 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.6 mt -96.78 -19.74 18.7 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -171.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -59.36 120.84 10.06 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.496 0.718 . . . . 0.0 111.762 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 64.32 21.59 12.55 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.964 2.106 . . . . 0.0 113.486 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.7 ttp -72.34 136.62 81.34 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 120.811 -1.181 . . . . 0.0 110.574 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.66 140.63 21.25 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.457 2.772 . . . . 0.0 111.628 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -148.44 116.43 6.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.619 1.568 . . . . 0.0 109.938 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 53.49 38.98 29.35 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.91 1.284 . . . . 0.0 113.288 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.88 77.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.379 1.466 . . . . 0.0 114.686 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -101.03 160.74 14.12 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.996 1.718 . . . . 0.0 110.45 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -93.89 173.14 7.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.985 0.914 . . . . 0.0 109.42 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 89.7 mt -133.0 110.35 10.19 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.214 1.005 . . . . 0.0 109.577 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 106.26 18.24 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.5 132.04 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 122.83 0.452 . . . . 0.0 111.602 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -139.22 169.1 18.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.547 1.939 . . . . 0.0 110.812 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -84.64 130.15 34.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.649 0.779 . . . . 0.0 111.077 169.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 125.75 1.62 . . . . 0.0 111.669 178.025 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.506 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.2 t -87.02 -162.23 0.77 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.864 0.866 . . . . 0.0 111.546 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -149.87 153.1 36.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.659 1.584 . . . . 0.0 111.612 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.62 -138.21 17.91 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.619 1.104 . . . . 0.0 112.237 -174.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.3 t -157.98 152.94 25.34 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.812 1.245 . . . . 0.0 111.454 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.0 p -81.29 -3.87 53.86 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 113.462 173.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 123.24 -19.76 7.62 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 126.401 1.953 . . . . 0.0 113.986 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.54 -135.31 35.99 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-N 118.257 1.029 . . . . 0.0 113.572 172.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -158.59 143.59 16.22 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.159 1.783 . . . . 0.0 109.675 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.76 142.08 30.07 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.072 0.949 . . . . 0.0 112.266 176.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.9 p -139.2 160.7 39.19 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.945 1.698 . . . . 0.0 111.449 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -68.42 -13.51 62.35 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.872 1.269 . . . . 0.0 114.188 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.2 m -140.07 134.85 31.93 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.205 2.202 . . . . 0.0 107.28 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -77.5 153.27 33.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.045 0.538 . . . . 0.0 111.267 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.38 50.23 1.07 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.701 1.2 . . . . 0.0 111.459 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.2 m -78.54 34.6 0.22 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.188 2.595 . . . . 0.0 113.102 -174.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -95.32 124.89 39.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.588 1.555 . . . . 0.0 111.253 -171.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.5 mt -109.03 134.82 51.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.241 1.817 . . . . 0.0 110.328 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -89.56 137.85 31.97 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 127.092 2.157 . . . . 0.0 107.717 169.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.1 t -128.41 111.07 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.841 0.856 . . . . 0.0 109.153 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.8 172.26 15.72 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 125.626 1.584 . . . . 0.0 113.097 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.6 m120 61.74 30.63 18.47 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.005 1.322 . . . . 0.0 111.807 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.54 140.66 96.63 Favored Pre-proline 0 CA--C 1.546 0.82 0 O-C-N 121.459 -0.776 . . . . 0.0 111.21 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.2 161.59 39.64 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.225 2.617 . . . . 0.0 111.165 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.87 -7.2 18.2 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.396 2.731 . . . . 0.0 112.676 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -102.87 11.47 37.43 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.797 2.039 . . . . 0.0 112.701 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.04 147.23 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 120.863 -1.148 . . . . 0.0 110.894 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.5 p -133.19 167.16 20.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.045 1.738 . . . . 0.0 109.671 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.55 -32.74 67.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.106 0.562 . . . . 0.0 111.488 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.52 -38.05 59.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.146 0.978 . . . . 0.0 112.473 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -63.95 -42.85 97.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.872 0.76 . . . . 0.0 110.659 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.8 ttt -68.99 -37.32 78.68 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.321 0.649 . . . . 0.0 112.127 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -62.68 -42.83 99.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.721 0.808 . . . . 0.0 111.225 171.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.92 -42.55 85.19 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.116 0.967 . . . . 0.0 113.212 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.6 mt -56.74 -25.02 53.79 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.74 1.216 . . . . 0.0 113.315 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -110.44 5.7 21.59 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.229 1.412 . . . . 0.0 113.464 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -67.33 -21.5 65.65 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.127 -0.983 . . . . 0.0 113.371 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -22.9 67.11 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.11 1.364 . . . . 0.0 112.388 172.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -105.67 7.26 32.57 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.568 1.947 . . . . 0.0 112.465 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.31 177.26 51.78 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.207 1.384 . . . . 0.0 113.069 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -71.37 130.08 40.44 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.805 -0.821 . . . . 0.0 111.347 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.21 153.4 42.49 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.351 1.06 . . . . 0.0 112.211 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.24 -17.29 67.18 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.816 1.198 . . . . 0.0 113.537 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -154.48 146.03 23.18 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.736 1.214 . . . . 0.0 110.809 170.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.2 t -145.22 126.47 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 126.456 1.902 . . . . 0.0 109.247 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -141.8 144.1 33.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.05 1.34 . . . . 0.0 112.316 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.3 mt -140.67 133.83 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 126.142 1.777 . . . . 0.0 108.483 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -124.88 107.49 10.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.954 0.902 . . . . 0.0 112.043 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -72.14 -27.24 62.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -171.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.67 -11.68 60.49 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.897 0.879 . . . . 0.0 113.27 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -114.8 -31.34 6.16 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.942 1.297 . . . . 0.0 113.204 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.5 29.34 19.42 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.744 1.164 . . . . 0.0 113.985 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -138.74 155.38 48.26 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.317 1.447 . . . . 0.0 112.022 -173.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.06 170.82 25.19 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.198 1.38 . . . . 0.0 113.49 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -144.78 144.03 30.96 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.197 1.799 . . . . 0.0 109.412 -173.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.1 tt -153.83 134.99 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.522 0.729 . . . . 0.0 110.6 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -125.79 117.99 24.58 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.898 0.879 . . . . 0.0 110.04 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.92 178.65 5.59 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.765 0.826 . . . . 0.0 111.965 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -80.85 -27.32 36.49 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.1 p -144.19 158.07 43.94 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.366 1.066 . . . . 0.0 111.792 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -57.44 -37.82 73.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.935 0.894 . . . . 0.0 112.404 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.0 m -62.06 -47.42 84.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.189 1.396 . . . . 0.0 110.794 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.03 -42.98 99.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.11 0.564 . . . . 0.0 111.305 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.53 -35.94 80.05 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -66.59 -47.74 71.77 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.2 1.0 . . . . 0.0 111.347 173.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.47 -47.63 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.715 -0.615 . . . . 0.0 110.14 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.06 -45.52 86.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.71 0.804 . . . . 0.0 112.249 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -55.58 -50.6 69.65 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.206 -0.934 . . . . 0.0 111.697 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.1 t -65.47 -34.01 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 118.762 0.71 . . . . 0.0 112.29 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -82.75 -32.69 27.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 61.0 mt -105.48 -20.42 13.48 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.275 1.584 . . . . 0.0 115.275 -168.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -70.5 128.61 36.73 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.514 1.052 . . . . 0.0 111.421 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 58.0 t30 69.02 13.73 8.79 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.394 2.278 . . . . 0.0 114.186 -171.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.5 ttp -72.48 138.65 80.85 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 120.569 -1.332 . . . . 0.0 110.894 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -74.37 134.31 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.448 2.766 . . . . 0.0 111.153 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 45.1 tp -143.22 115.99 8.73 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.49 1.516 . . . . 0.0 110.172 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 57.57 21.74 7.45 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.241 1.416 . . . . 0.0 113.471 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.28 -3.02 68.94 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.925 1.726 . . . . 0.0 115.083 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -97.08 156.15 16.5 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.723 1.609 . . . . 0.0 110.959 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -105.58 117.09 33.14 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.265 -0.897 . . . . 0.0 109.366 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.3 mt -72.71 136.01 45.48 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.96 0.904 . . . . 0.0 112.226 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.0 tpp180 -99.77 124.29 44.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.619 1.168 . . . . 0.0 108.767 169.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.74 128.06 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.985 0.914 . . . . 0.0 109.75 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -150.7 160.16 44.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.863 1.265 . . . . 0.0 111.192 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -68.69 132.61 47.14 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.721 -0.612 . . . . 0.0 110.356 170.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.62 -21.42 61.84 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 72.7 m -134.1 135.64 43.35 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.117 2.167 . . . . 0.0 108.651 171.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -155.97 -48.4 0.08 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.4 t -82.78 131.33 35.2 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.454 0.702 . . . . 0.0 110.455 171.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.58 154.0 34.85 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.04 0.936 . . . . 0.0 112.621 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.7 t -77.79 175.88 9.56 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.56 0.744 . . . . 0.0 112.456 173.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.42 168.36 16.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.557 1.143 . . . . 0.0 112.943 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.1 t -156.54 156.89 34.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.531 1.532 . . . . 0.0 110.848 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 28.9 p -100.81 101.26 12.06 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.335 1.454 . . . . 0.0 111.175 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -172.3 86.94 0.08 OUTLIER Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.312 -1.271 . . . . 0.0 113.322 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.54 163.38 37.68 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.645 2.897 . . . . 0.0 111.17 175.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.1 m -137.79 136.1 36.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.755 1.222 . . . . 0.0 111.436 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.9 m -104.59 162.4 13.3 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.019 1.327 . . . . 0.0 112.476 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-O 118.047 -1.418 . . . . 0.0 113.256 -179.829 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.594 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t 73.58 5.2 4.9 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.211 1.804 . . . . 0.0 114.39 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.5 p -74.86 140.81 44.12 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.086 -1.634 . . . . 0.0 112.133 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.75 28.02 65.93 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.54 -0.725 . . . . 0.0 114.324 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -77.2 54.17 1.06 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.349 1.46 . . . . 0.0 112.58 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.5 m -83.78 86.18 7.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.495 1.518 . . . . 0.0 111.418 -177.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.65 22.76 7.26 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.375 1.464 . . . . 0.0 115.283 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.9 41.99 9.23 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.494 1.147 . . . . 0.0 112.806 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -66.95 123.64 20.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.725 1.21 . . . . 0.0 111.798 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -87.97 71.87 9.35 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.493 1.117 . . . . 0.0 111.592 -175.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.5 p -69.44 159.98 32.23 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.488 1.515 . . . . 0.0 111.792 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -54.76 -36.47 64.87 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.406 1.483 . . . . 0.0 113.426 -174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.1 p -139.36 151.53 46.42 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 127.277 2.231 . . . . 0.0 108.737 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -146.7 150.84 36.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.38 1.872 . . . . 0.0 107.864 -169.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 -143.18 129.72 20.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.987 0.899 . . . . 0.0 111.976 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.0 p -79.46 25.84 0.31 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 128.379 2.672 . . . . 0.0 113.413 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -83.27 129.01 34.98 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.335 1.454 . . . . 0.0 110.468 -176.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.4 mt -113.98 134.38 54.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.146 1.778 . . . . 0.0 110.056 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -89.26 137.4 32.36 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.141 2.176 . . . . 0.0 108.529 170.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -130.06 109.93 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.126 0.97 . . . . 0.0 109.415 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.1 173.8 20.11 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.21 1.862 . . . . 0.0 113.328 176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.1 m120 64.0 19.59 11.82 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.951 1.701 . . . . 0.0 113.276 -173.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.67 140.63 92.78 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.067 -1.021 . . . . 0.0 112.778 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -69.44 157.35 61.34 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.856 3.037 . . . . 0.0 110.991 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.66 -5.47 17.12 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.26 2.64 . . . . 0.0 113.164 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -104.38 9.74 35.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.338 1.855 . . . . 0.0 113.321 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.2 tp -82.04 144.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.091 -1.006 . . . . 0.0 111.016 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 47.9 p -135.12 166.57 22.76 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.492 1.917 . . . . 0.0 109.303 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -60.73 -27.34 67.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.859 0.464 . . . . 0.0 112.012 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -72.9 -40.0 65.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.983 0.913 . . . . 0.0 111.773 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -65.42 -42.3 92.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.409 0.55 . . . . 0.0 111.004 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.3 ttt -69.12 -36.76 77.86 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.621 0.768 . . . . 0.0 112.221 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -61.62 -46.61 89.07 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.742 0.817 . . . . 0.0 110.79 169.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -66.38 -39.8 89.31 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.0 mt -59.62 -22.85 62.42 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.074 1.35 . . . . 0.0 113.694 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -116.09 7.83 14.33 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.437 1.495 . . . . 0.0 112.569 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -68.72 -22.0 64.37 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -169.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -67.13 -22.28 65.8 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.286 -0.883 . . . . 0.0 112.207 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -93.92 10.8 31.88 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.414 1.886 . . . . 0.0 112.589 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.48 -175.94 53.55 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.334 1.445 . . . . 0.0 113.189 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -72.1 128.92 37.2 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.992 -0.71 . . . . 0.0 111.186 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.35 147.08 48.37 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.959 0.904 . . . . 0.0 111.673 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.05 -1.28 82.25 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.831 1.205 . . . . 0.0 113.819 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -162.76 128.63 3.34 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.496 1.918 . . . . 0.0 108.18 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.3 t -143.71 123.32 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.745 1.218 . . . . 0.0 108.917 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -141.22 137.79 32.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.976 1.311 . . . . 0.0 110.927 176.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.7 mt -137.76 126.77 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.42 1.488 . . . . 0.0 108.359 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -118.32 108.42 15.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.281 1.033 . . . . 0.0 112.02 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -71.62 -30.6 65.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.019 0.928 . . . . 0.0 113.285 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.78 -20.22 61.89 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.049 0.94 . . . . 0.0 113.454 -176.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -112.83 -24.47 9.55 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.54 38.15 7.76 Favored Glycine 0 N--CA 1.475 1.272 0 C-N-CA 124.76 1.172 . . . . 0.0 114.154 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -140.62 152.99 45.87 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.16 1.384 . . . . 0.0 112.122 -173.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.37 161.48 24.97 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.029 1.3 . . . . 0.0 113.553 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.45 138.11 34.43 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.486 1.914 . . . . 0.0 109.476 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.4 tt -147.81 135.13 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 110.713 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -118.71 123.52 45.08 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.543 0.737 . . . . 0.0 110.749 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -93.64 170.33 9.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.711 0.804 . . . . 0.0 110.887 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -77.43 -22.27 51.74 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.8 p -146.26 144.05 29.6 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.747 1.219 . . . . 0.0 111.951 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.416 ' HD2' ' H ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -60.43 -32.53 71.45 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 m -63.92 -48.15 77.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.578 1.151 . . . . 0.0 110.756 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.18 -35.77 82.13 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.844 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.17 86.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.033 0.833 . . . . 0.0 112.736 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.09 -47.39 71.36 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.176 0.898 . . . . 0.0 111.812 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.9 mt -60.08 -50.12 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.778 -0.576 . . . . 0.0 110.044 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.02 -43.55 91.59 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.626 0.77 . . . . 0.0 111.87 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -57.24 -47.91 80.16 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.076 0.853 . . . . 0.0 111.586 174.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 78.6 t -71.09 -34.94 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 118.802 0.728 . . . . 0.0 112.176 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -82.79 -28.86 30.0 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 55.5 mt -99.31 -16.25 18.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.165 0.986 . . . . 0.0 113.374 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -54.96 116.6 2.84 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.022 1.729 . . . . 0.0 111.885 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.0 m120 64.32 19.47 11.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.138 2.175 . . . . 0.0 114.286 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.9 ttp -70.5 137.12 86.04 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 120.703 -1.248 . . . . 0.0 110.858 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.27 139.28 23.42 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.356 2.704 . . . . 0.0 111.437 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.9 tp -142.08 115.2 8.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.684 1.594 . . . . 0.0 109.801 173.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 57.18 25.22 10.71 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.931 1.292 . . . . 0.0 113.768 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.54 -3.67 83.64 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.542 1.544 . . . . 0.0 114.706 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -95.66 161.39 14.06 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.551 1.54 . . . . 0.0 111.047 172.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -88.24 176.05 7.41 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.511 -0.743 . . . . 0.0 110.79 169.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.0 mt -134.51 115.07 13.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.525 1.13 . . . . 0.0 109.704 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -91.97 115.91 28.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.629 0.771 . . . . 0.0 109.064 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.4 t -119.6 123.31 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.904 0.882 . . . . 0.0 110.503 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -139.94 164.61 29.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.029 1.732 . . . . 0.0 111.387 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -79.04 126.84 31.23 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.532 -0.73 . . . . 0.0 111.051 169.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.99 66.03 4.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.74 1.616 . . . . 0.0 110.603 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 27.5 t -144.43 132.03 21.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.718 1.207 . . . . 0.0 111.474 -173.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -164.26 159.93 20.55 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.509 2.323 . . . . 0.0 110.428 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.0 t -152.86 118.32 5.27 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.182 0.993 . . . . 0.0 110.601 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.0 131.96 36.48 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.8 0.84 . . . . 0.0 110.569 174.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 60.4 p -158.69 144.0 16.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.64 1.176 . . . . 0.0 111.198 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 30.4 tp -105.41 66.4 0.74 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.656 1.183 . . . . 0.0 110.058 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.4 p -77.19 77.12 3.73 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.751 1.62 . . . . 0.0 110.865 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.1 t -70.78 -10.61 59.86 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.295 1.038 . . . . 0.0 113.626 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.28 168.34 44.68 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.815 1.674 . . . . 0.0 114.334 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.47 169.11 22.53 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.251 3.301 . . . . 0.0 111.45 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 61.1 p -155.52 142.12 18.77 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.497 1.119 . . . . 0.0 111.852 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.9 t -164.33 152.21 12.33 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.364 1.466 . . . . 0.0 110.904 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.199 0 C-N-CA 125.203 1.382 . . . . 0.0 113.769 -176.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.478 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.4 m -84.44 161.7 20.22 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.241 1.016 . . . . 0.0 113.16 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.1 m -139.55 149.8 44.31 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.932 1.693 . . . . 0.0 110.531 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.34 -35.19 48.78 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -169.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 t -169.98 155.5 5.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.855 1.262 . . . . 0.0 112.125 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 72.7 p -86.32 -5.33 59.2 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.266 1.426 . . . . 0.0 113.181 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.47 0.72 62.69 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.665 1.603 . . . . 0.0 113.23 -169.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.78 16.72 67.34 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.724 1.154 . . . . 0.0 114.931 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -139.99 144.85 37.19 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.198 1.399 . . . . 0.0 110.869 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.83 147.51 45.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.251 1.02 . . . . 0.0 113.372 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.6 p -116.38 -39.5 3.36 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.21 1.804 . . . . 0.0 112.254 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -149.99 152.28 34.66 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.017 2.127 . . . . 0.0 110.561 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.7 m -136.87 120.34 17.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.238 1.415 . . . . 0.0 108.997 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -125.01 47.13 2.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.296 1.439 . . . . 0.0 109.532 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -96.56 76.98 2.9 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.747 1.219 . . . . 0.0 109.079 175.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.7 p -72.25 36.2 0.07 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.888 2.875 . . . . 0.0 113.511 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -95.11 128.27 41.81 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.829 1.652 . . . . 0.0 111.257 -169.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -111.18 137.98 48.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.381 1.872 . . . . 0.0 110.474 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -92.47 136.3 33.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.371 2.268 . . . . 0.0 108.596 169.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.8 t -128.71 116.06 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.469 1.108 . . . . 0.0 109.024 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.88 165.51 14.03 Favored Glycine 0 N--CA 1.466 0.673 0 C-N-CA 125.013 1.292 . . . . 0.0 114.561 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 64.76 33.1 10.59 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.691 1.596 . . . . 0.0 111.658 -174.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 mt -66.19 143.29 98.28 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 121.143 -0.973 . . . . 0.0 112.144 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.27 163.81 37.34 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.167 3.245 . . . . 0.0 111.506 174.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.0 -7.68 19.39 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.243 2.629 . . . . 0.0 113.195 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -94.87 7.75 44.96 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.725 1.61 . . . . 0.0 113.528 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 tp -97.43 135.95 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.644 1.178 . . . . 0.0 111.398 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.8 p -131.23 179.6 5.92 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.594 1.558 . . . . 0.0 109.235 169.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -57.31 -25.37 59.21 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.712 0.805 . . . . 0.0 112.549 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.45 -47.79 38.77 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.979 -1.076 . . . . 0.0 111.808 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 mp0 -63.72 -41.54 98.05 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.078 0.551 . . . . 0.0 111.115 174.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.9 ttt -67.78 -33.14 74.24 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -67.56 -40.05 84.92 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.877 0.762 . . . . 0.0 111.447 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.8 -42.42 81.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.9 0.88 . . . . 0.0 112.683 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.7 mt -57.4 -28.18 63.01 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.404 1.482 . . . . 0.0 113.526 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -110.49 9.18 23.27 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.339 1.456 . . . . 0.0 112.677 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.29 -25.12 67.91 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -62.57 -22.82 66.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.955 1.302 . . . . 0.0 112.987 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -102.88 9.88 38.63 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.324 1.85 . . . . 0.0 112.644 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.78 -179.05 53.52 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.233 0.921 . . . . 0.0 112.612 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.52 141.28 50.13 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.79 -0.829 . . . . 0.0 112.175 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.41 150.42 27.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.483 1.113 . . . . 0.0 112.133 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.06 -9.42 73.69 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.205 1.384 . . . . 0.0 113.886 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -155.91 137.41 14.07 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.577 1.951 . . . . 0.0 108.409 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.2 t -143.87 127.24 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.448 1.499 . . . . 0.0 109.174 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -144.9 142.56 29.98 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.312 1.445 . . . . 0.0 112.201 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 57.4 mt -141.02 131.84 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.455 1.902 . . . . 0.0 108.838 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -125.28 113.17 17.26 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.094 0.957 . . . . 0.0 111.86 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -72.79 -36.19 67.56 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -170.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -71.39 -24.6 62.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.741 0.817 . . . . 0.0 113.043 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -100.19 -27.87 13.3 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.237 1.015 . . . . 0.0 113.346 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.81 29.78 19.91 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.798 1.19 . . . . 0.0 114.304 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -137.8 156.59 47.79 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.245 1.418 . . . . 0.0 112.267 -172.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.28 168.79 26.54 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.215 1.388 . . . . 0.0 113.417 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -142.52 149.68 39.45 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.034 1.733 . . . . 0.0 110.402 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.6 tt -155.31 141.92 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.233 1.013 . . . . 0.0 110.492 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -123.7 123.93 41.61 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.944 0.793 . . . . 0.0 111.308 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.4 mt -95.44 167.43 11.32 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.998 0.919 . . . . 0.0 110.639 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.29 -13.25 61.09 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.2 p -147.32 157.72 43.69 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.288 1.435 . . . . 0.0 111.684 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -60.12 -32.27 70.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.758 0.823 . . . . 0.0 113.1 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 m -63.97 -48.49 76.25 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.394 1.478 . . . . 0.0 110.506 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.66 -41.45 99.07 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.136 0.574 . . . . 0.0 111.202 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.63 87.26 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.48 -50.29 70.23 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.306 0.957 . . . . 0.0 111.969 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 83.4 mt -61.31 -47.92 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.752 -0.593 . . . . 0.0 110.289 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.14 95.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.703 0.801 . . . . 0.0 111.998 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.26 -44.57 92.41 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.213 -0.929 . . . . 0.0 112.042 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 51.2 t -66.72 -36.89 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.268 0.627 . . . . 0.0 111.918 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -85.23 -28.55 25.32 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 51.5 mt -103.69 -18.84 14.54 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.64 140.83 58.91 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.4 1.0 . . . . 0.0 111.127 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . 0.298 12.0 p30 55.15 18.99 2.62 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.327 2.251 . . . . 0.0 114.966 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.2 ttp -76.29 139.5 68.32 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.092 1.357 . . . . 0.0 111.109 173.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.83 138.88 19.19 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.546 2.831 . . . . 0.0 111.371 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -149.11 122.63 9.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.698 1.599 . . . . 0.0 109.726 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 56.51 32.19 20.33 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.758 1.223 . . . . 0.0 113.235 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.36 4.46 89.96 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.122 1.344 . . . . 0.0 114.637 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.45 156.92 20.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.492 1.917 . . . . 0.0 110.633 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -90.08 167.83 12.45 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.764 -0.585 . . . . 0.0 109.893 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.9 mt -129.77 140.32 51.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.69 1.196 . . . . 0.0 110.857 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -102.93 130.59 50.04 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.868 1.267 . . . . 0.0 108.312 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.39 120.42 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.136 0.88 . . . . 0.0 110.347 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -140.02 167.76 21.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.427 1.891 . . . . 0.0 110.554 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -75.94 134.44 40.22 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.575 -0.703 . . . . 0.0 111.127 169.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.61 -7.52 57.38 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.552 1.141 . . . . 0.0 113.054 172.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 46.7 t -73.78 143.09 46.17 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.395 1.478 . . . . 0.0 112.008 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -81.18 -165.55 0.95 Allowed 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.863 1.665 . . . . 0.0 113.069 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 30.1 t -156.38 -47.09 0.07 Allowed 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.79 -1.194 . . . . 0.0 112.277 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.67 162.82 33.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.667 1.587 . . . . 0.0 111.669 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.9 m -73.78 -14.14 61.06 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -170.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -117.31 132.65 56.56 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.696 1.598 . . . . 0.0 110.185 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.0 t -85.62 -19.56 30.82 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.78 1.232 . . . . 0.0 113.248 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.3 t -163.89 163.67 23.62 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.755 1.622 . . . . 0.0 110.945 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 144.05 175.3 17.05 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.747 1.641 . . . . 0.0 113.445 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.35 127.6 12.8 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.659 2.906 . . . . 0.0 110.996 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.6 m -167.53 153.06 7.33 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.927 2.091 . . . . 0.0 110.724 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.9 m 68.29 7.91 6.24 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 169.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.337 0 C-N-CA 125.893 1.711 . . . . 0.0 113.458 177.758 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 112.006 -0.437 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.6 p -85.64 -13.55 48.31 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.0 p -92.7 142.41 27.39 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.505 1.522 . . . . 0.0 112.078 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.8 -169.74 47.05 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.284 0.945 . . . . 0.0 113.459 -177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.7 t -166.67 -159.7 0.37 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.028 1.731 . . . . 0.0 110.709 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.2 t -143.2 146.88 34.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.666 1.586 . . . . 0.0 111.356 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.93 163.06 18.23 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.464 1.507 . . . . 0.0 113.153 -172.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.17 72.7 2.76 Favored Glycine 0 N--CA 1.471 1.006 0 C-N-CA 124.988 1.28 . . . . 0.0 113.311 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 55.95 11.81 0.79 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 128.554 2.742 . . . . 0.0 116.566 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -68.53 123.69 21.52 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.588 -1.32 . . . . 0.0 112.096 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.7 p -146.75 160.43 42.25 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.717 2.007 . . . . 0.0 110.633 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -84.62 -17.5 38.45 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.6 t -170.42 159.97 7.29 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.156 2.182 . . . . 0.0 109.973 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -90.63 99.65 12.64 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.966 0.906 . . . . 0.0 109.618 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -78.83 56.19 1.86 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.002 1.321 . . . . 0.0 111.76 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.0 m -77.53 58.85 1.82 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.877 2.071 . . . . 0.0 113.397 -174.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.64 134.73 34.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.705 1.202 . . . . 0.0 110.483 172.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.1 mt -111.54 133.98 53.43 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.147 1.379 . . . . 0.0 110.056 171.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -85.57 144.76 27.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.225 2.21 . . . . 0.0 108.004 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.53 110.02 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.192 0.997 . . . . 0.0 109.185 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.65 169.94 13.69 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.501 1.524 . . . . 0.0 113.249 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 65.47 29.04 11.43 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.381 1.473 . . . . 0.0 111.819 -173.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.8 mt -65.6 144.08 98.81 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.848 -1.157 . . . . 0.0 111.928 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.4 159.39 50.55 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.224 2.616 . . . . 0.0 111.292 174.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.08 -0.47 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.484 2.789 . . . . 0.0 113.299 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -114.38 7.35 16.31 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.732 1.613 . . . . 0.0 113.083 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.9 tp -73.28 145.54 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.789 0.836 . . . . 0.0 111.126 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.8 p -127.7 163.03 25.18 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.654 1.582 . . . . 0.0 110.079 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.98 -28.09 67.39 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.323 0.649 . . . . 0.0 111.687 172.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.24 -41.94 69.49 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.122 0.969 . . . . 0.0 111.507 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -66.07 -37.56 86.13 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.84 -0.537 . . . . 0.0 111.494 172.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.9 ttt -68.07 -38.98 83.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.536 0.734 . . . . 0.0 112.064 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -62.39 -37.55 86.17 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.107 0.963 . . . . 0.0 111.939 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -71.52 -42.74 67.59 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.412 -0.805 . . . . 0.0 112.453 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.6 mt -57.94 -27.86 63.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.862 1.265 . . . . 0.0 113.082 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -108.82 11.94 25.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.371 1.469 . . . . 0.0 112.769 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.73 -22.31 66.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.093 -1.004 . . . . 0.0 113.684 -173.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -61.1 -22.79 64.98 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.895 1.278 . . . . 0.0 112.616 171.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -108.39 12.14 26.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.784 2.033 . . . . 0.0 112.375 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.18 -172.36 55.18 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.465 1.031 . . . . 0.0 112.94 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -71.47 133.73 46.06 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.989 0.916 . . . . 0.0 111.026 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.11 150.68 31.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.592 1.157 . . . . 0.0 112.02 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.45 -11.84 74.14 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.614 1.102 . . . . 0.0 114.138 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -159.87 138.77 10.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.065 1.746 . . . . 0.0 109.28 174.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.0 t -139.09 130.92 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.934 1.693 . . . . 0.0 109.222 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -141.59 141.03 33.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.21 1.404 . . . . 0.0 111.443 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.3 mt -140.6 129.34 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 126.011 1.724 . . . . 0.0 107.929 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -118.15 108.7 15.5 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.721 0.772 . . . . 0.0 112.324 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -72.26 -19.65 61.66 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -81.2 -13.75 58.25 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.192 0.997 . . . . 0.0 112.992 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -117.07 -25.66 7.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.916 1.286 . . . . 0.0 113.987 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.43 27.73 35.18 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 124.482 1.039 . . . . 0.0 114.257 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -134.5 149.96 50.75 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.419 1.488 . . . . 0.0 111.616 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.67 166.87 25.23 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.38 1.467 . . . . 0.0 113.134 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -146.19 143.28 29.17 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.342 1.857 . . . . 0.0 109.745 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.1 tt -150.95 133.39 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.078 0.951 . . . . 0.0 110.974 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -112.88 122.12 46.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.172 0.989 . . . . 0.0 110.541 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.27 163.48 12.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.688 0.795 . . . . 0.0 111.063 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.6 -23.77 53.45 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -171.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.5 p -148.71 143.6 26.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.402 1.481 . . . . 0.0 111.642 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -58.95 -32.92 70.06 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.7 m -59.43 -48.59 81.06 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.987 1.315 . . . . 0.0 111.032 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.1 mt -64.07 -37.9 89.11 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.388 0.675 . . . . 0.0 111.817 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.51 -33.62 73.1 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -67.2 -46.78 72.88 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.831 0.852 . . . . 0.0 111.545 171.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.75 -47.46 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.72 -0.613 . . . . 0.0 110.061 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.96 -45.18 91.15 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.899 0.88 . . . . 0.0 112.218 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -55.47 -50.55 69.58 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.076 -1.015 . . . . 0.0 111.66 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.62 -34.17 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 118.695 0.68 . . . . 0.0 112.287 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -82.37 -32.89 29.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 52.8 mt -105.91 -19.57 13.7 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -168.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -71.97 127.46 32.63 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.696 1.135 . . . . 0.0 111.235 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 71.49 12.37 6.53 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.843 2.457 . . . . 0.0 113.736 -169.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.6 ttp -72.63 134.35 81.91 Favored Pre-proline 0 N--CA 1.473 0.691 0 O-C-N 120.574 -1.329 . . . . 0.0 110.767 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.61 132.29 15.8 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.065 2.51 . . . . 0.0 110.801 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 tp -137.29 104.76 5.49 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.514 1.126 . . . . 0.0 110.235 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.5 mtp-105 58.93 26.42 14.93 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.043 1.337 . . . . 0.0 113.691 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.94 -12.53 60.74 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.112 1.815 . . . . 0.0 114.576 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -82.09 163.86 21.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.578 1.189 . . . . 0.0 111.512 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -128.98 105.52 8.26 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.816 1.247 . . . . 0.0 108.878 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.1 mt -67.81 125.13 25.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.008 1.323 . . . . 0.0 112.749 -168.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -93.06 118.02 30.72 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.264 1.025 . . . . 0.0 109.313 173.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.32 126.23 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.068 0.947 . . . . 0.0 109.943 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -143.33 159.73 41.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.753 1.621 . . . . 0.0 110.475 -173.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -81.31 124.62 29.5 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.504 -0.747 . . . . 0.0 110.792 170.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.86 74.13 8.86 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.149 0.98 . . . . 0.0 111.231 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 86.7 m -86.17 34.77 0.63 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.075 1.75 . . . . 0.0 113.29 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -62.27 138.15 58.38 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 121.141 -0.974 . . . . 0.0 113.339 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 70.9 m -153.16 165.54 35.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.587 1.955 . . . . 0.0 110.518 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -139.8 98.85 3.56 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.586 1.154 . . . . 0.0 110.779 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.8 t -168.35 170.37 9.99 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.575 1.95 . . . . 0.0 110.555 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -155.93 32.74 0.35 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.576 1.55 . . . . 0.0 113.298 -172.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.7 p -59.4 141.04 55.55 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.091 1.356 . . . . 0.0 111.567 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 77.3 p -167.68 171.05 10.48 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.385 1.474 . . . . 0.0 111.805 -171.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 93.59 90.24 1.6 Allowed Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.969 1.271 . . . . 0.0 112.089 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.26 119.73 5.94 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.218 2.612 . . . . 0.0 110.662 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.1 t 66.31 8.53 5.71 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.653 1.581 . . . . 0.0 114.158 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.2 t -159.77 117.33 2.65 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.4 -1.438 . . . . 0.0 111.111 -173.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 C-N-CA 125.471 1.51 . . . . 0.0 112.754 178.776 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.8 m -92.47 124.56 36.6 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.931 0.866 . . . . 0.0 111.293 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.2 p -166.89 167.51 14.8 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.829 1.652 . . . . 0.0 111.143 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.07 47.29 13.62 Favored Glycine 0 N--CA 1.472 1.064 0 O-C-N 121.598 -0.688 . . . . 0.0 112.794 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 m -64.25 -15.7 60.6 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.9 m -101.86 6.42 41.48 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.867 1.267 . . . . 0.0 113.468 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.87 -37.1 1.98 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.465 1.983 . . . . 0.0 113.475 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.37 -152.77 51.2 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.578 1.085 . . . . 0.0 113.815 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -78.72 170.37 16.77 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.883 1.273 . . . . 0.0 111.788 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -60.83 142.32 56.24 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.176 -0.953 . . . . 0.0 112.647 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.0 p -143.35 171.33 14.26 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.025 2.13 . . . . 0.0 111.076 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -63.33 153.58 34.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.988 1.315 . . . . 0.0 112.814 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.7 t -88.11 161.57 17.23 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.852 1.261 . . . . 0.0 111.576 175.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 pt20 -93.0 21.49 5.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.473 1.509 . . . . 0.0 113.085 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.3 ttm-85 -62.86 -18.15 62.5 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.632 -1.292 . . . . 0.0 114.353 -173.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 m -78.95 8.63 5.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.717 1.607 . . . . 0.0 114.056 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -76.91 128.82 35.26 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.092 1.357 . . . . 0.0 111.848 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.5 mt -105.26 141.58 36.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.574 1.95 . . . . 0.0 110.437 174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -96.94 143.68 27.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.526 2.33 . . . . 0.0 108.474 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.2 t -132.56 115.89 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.184 0.994 . . . . 0.0 109.782 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.98 173.26 16.5 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 125.912 1.72 . . . . 0.0 113.226 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m120 64.95 20.47 12.12 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.956 1.702 . . . . 0.0 113.093 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.9 mt -61.6 140.75 95.05 Favored Pre-proline 0 CA--C 1.549 0.936 0 O-C-N 121.198 -0.939 . . . . 0.0 112.319 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.41 164.4 35.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.369 3.38 . . . . 0.0 111.898 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.88 5.8 4.19 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.837 3.024 . . . . 0.0 113.691 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.3 p30 -128.15 13.9 6.71 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.969 1.708 . . . . 0.0 114.042 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.8 tp -80.12 143.63 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.123 0.969 . . . . 0.0 110.423 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.3 p -132.8 167.25 20.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.126 1.77 . . . . 0.0 109.677 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.67 -28.47 68.63 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.641 0.376 . . . . 0.0 111.82 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -70.43 -45.56 65.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.346 1.058 . . . . 0.0 110.975 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -65.2 -38.66 91.16 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.719 -0.613 . . . . 0.0 111.695 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.6 ttt -69.44 -38.2 77.73 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 118.646 0.657 . . . . 0.0 111.98 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -63.66 -37.22 86.5 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.435 -0.791 . . . . 0.0 111.992 170.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.3 -43.1 64.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.087 0.955 . . . . 0.0 111.872 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.6 mt -57.02 -28.85 62.86 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.058 1.343 . . . . 0.0 113.343 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -105.45 8.17 33.4 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.311 1.444 . . . . 0.0 112.693 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.09 -25.74 67.92 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -169.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -64.41 -21.54 66.67 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.696 0.798 . . . . 0.0 112.724 174.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -102.96 6.33 38.85 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.096 1.758 . . . . 0.0 112.097 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.13 173.7 46.26 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.174 1.369 . . . . 0.0 112.587 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -67.18 136.04 54.43 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.497 -1.001 . . . . 0.0 111.317 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.08 157.24 37.22 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.927 0.891 . . . . 0.0 112.071 173.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.06 -12.07 62.37 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.048 1.308 . . . . 0.0 113.753 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -152.77 137.09 16.61 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.901 1.68 . . . . 0.0 109.28 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.0 127.81 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.06 1.744 . . . . 0.0 108.853 176.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -143.96 140.48 29.68 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.836 1.254 . . . . 0.0 111.454 173.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.7 mt -139.85 129.4 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.859 1.664 . . . . 0.0 108.276 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -122.23 112.95 18.79 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.841 0.857 . . . . 0.0 112.56 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -70.5 -35.19 73.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 113.613 -173.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.23 -23.66 61.27 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.805 0.842 . . . . 0.0 113.044 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -103.3 -26.48 12.93 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.23 35.68 14.34 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 124.876 1.227 . . . . 0.0 114.115 175.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -140.64 153.16 45.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.21 1.404 . . . . 0.0 112.366 -172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.06 158.14 22.99 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.359 1.456 . . . . 0.0 113.092 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -138.67 137.84 37.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.83 2.052 . . . . 0.0 109.012 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.3 tt -151.81 130.39 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.535 0.734 . . . . 0.0 110.971 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -119.15 113.56 21.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.948 0.899 . . . . 0.0 110.409 -170.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.0 mt -90.73 166.07 13.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.641 0.777 . . . . 0.0 111.124 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -78.56 -17.95 55.36 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.0 p -144.04 157.32 44.4 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.773 1.229 . . . . 0.0 111.616 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 -59.6 -40.33 87.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.789 0.835 . . . . 0.0 111.429 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.7 m -58.88 -47.53 84.62 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.011 1.325 . . . . 0.0 111.212 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.3 -42.9 99.08 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.265 0.626 . . . . 0.0 111.179 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.03 -36.27 83.84 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.03 -46.5 71.03 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.888 0.875 . . . . 0.0 111.697 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.95 -47.96 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.633 -0.667 . . . . 0.0 110.102 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.76 -44.35 93.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.423 0.689 . . . . 0.0 112.104 175.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -54.57 -52.58 61.66 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.258 0.935 . . . . 0.0 111.507 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.29 -34.3 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.382 0.537 . . . . 0.0 111.961 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -81.03 -36.05 31.08 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.7 mt -96.5 -21.78 17.5 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -170.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -68.31 127.24 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.02 0.827 . . . . 0.0 111.276 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 71.2 11.75 6.82 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 127.28 2.232 . . . . 0.0 113.786 -173.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 62.9 ttp -74.33 137.34 75.02 Favored Pre-proline 0 N--CA 1.475 0.796 0 O-C-N 120.549 -1.344 . . . . 0.0 110.893 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.67 141.07 24.37 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.256 2.637 . . . . 0.0 111.191 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.6 tp -137.04 104.25 5.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.512 1.525 . . . . 0.0 110.059 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 61.0 mtp85 59.03 22.56 10.6 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.594 1.558 . . . . 0.0 114.256 172.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.37 -9.97 49.9 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.994 1.759 . . . . 0.0 114.788 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -94.27 166.44 12.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.796 1.298 . . . . 0.0 111.254 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -96.62 176.18 6.11 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.089 0.956 . . . . 0.0 110.401 169.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.8 mt -135.7 116.66 14.22 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.608 1.163 . . . . 0.0 109.723 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -95.77 111.09 23.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.734 0.814 . . . . 0.0 108.955 175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.81 130.51 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.127 0.971 . . . . 0.0 109.54 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -150.99 163.76 37.98 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.401 1.48 . . . . 0.0 111.077 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -72.67 137.76 46.23 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.535 -0.728 . . . . 0.0 110.83 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.75 4.78 53.13 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.979 1.312 . . . . 0.0 113.084 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 75.9 m -139.51 17.79 2.55 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.988 2.115 . . . . 0.0 112.556 -173.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -165.04 137.4 4.39 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.744 2.418 . . . . 0.0 109.489 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.1 t -151.5 82.82 1.3 Allowed 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.138 -0.976 . . . . 0.0 110.57 -172.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 58.91 22.9 10.8 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.813 1.645 . . . . 0.0 113.334 -175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 m -76.6 30.66 0.13 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.543 1.937 . . . . 0.0 114.103 -169.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.55 69.97 8.33 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.469 1.908 . . . . 0.0 111.137 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.1 m -76.91 75.81 3.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.316 1.447 . . . . 0.0 109.869 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 25.9 t -163.95 145.85 9.1 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.911 1.685 . . . . 0.0 111.065 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -121.36 78.92 0.33 Allowed Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.254 1.407 . . . . 0.0 112.279 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.31 171.22 17.39 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.6 2.867 . . . . 0.0 111.413 174.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 t -148.22 136.66 21.43 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.215 1.006 . . . . 0.0 111.352 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.1 t -166.74 163.24 16.55 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.144 1.778 . . . . 0.0 110.733 -175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.126 1.346 . . . . 0.0 113.008 -178.357 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 p -73.54 161.33 30.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.54 1.136 . . . . 0.0 112.359 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.1 m -79.87 -27.92 40.03 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.702 -1.249 . . . . 0.0 112.778 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.36 41.72 77.04 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.013 0.816 . . . . 0.0 113.689 172.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.8 p -62.73 152.01 36.87 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.694 1.198 . . . . 0.0 113.492 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 t -108.89 161.08 15.46 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.83 1.252 . . . . 0.0 112.533 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.43 159.66 35.71 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.121 1.82 . . . . 0.0 113.016 -175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.87 179.59 45.69 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.969 1.271 . . . . 0.0 113.662 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -160.02 153.91 22.98 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.049 1.74 . . . . 0.0 110.497 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -98.13 126.12 43.44 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.967 0.907 . . . . 0.0 110.697 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.5 p -147.45 155.11 41.61 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.158 1.783 . . . . 0.0 110.988 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -82.37 39.0 0.57 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.542 1.937 . . . . 0.0 112.657 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.9 p -128.16 -176.4 3.79 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.241 1.816 . . . . 0.0 111.659 -170.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -150.47 156.32 41.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.228 1.411 . . . . 0.0 111.106 -173.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -136.97 43.24 2.39 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.418 1.487 . . . . 0.0 111.095 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 93.0 p -82.41 0.54 41.61 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.914 -1.116 . . . . 0.0 113.729 175.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -80.97 123.33 28.24 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.367 1.467 . . . . 0.0 111.015 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -115.07 140.78 48.78 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.829 1.652 . . . . 0.0 110.795 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -95.92 140.17 31.06 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.257 2.223 . . . . 0.0 108.669 170.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.52 108.38 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.301 1.04 . . . . 0.0 109.31 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.06 171.63 19.93 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.337 1.446 . . . . 0.0 112.873 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.0 m120 62.09 31.15 17.92 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.007 1.323 . . . . 0.0 111.923 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.9 mt -66.67 143.32 98.06 Favored Pre-proline 0 CA--C 1.547 0.841 0 O-C-N 121.457 -0.777 . . . . 0.0 111.395 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.35 162.06 40.44 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.193 2.595 . . . . 0.0 111.158 170.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.99 -7.61 18.37 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.249 2.633 . . . . 0.0 112.413 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -96.14 6.95 47.68 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.559 1.944 . . . . 0.0 113.332 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -81.97 146.56 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.211 -0.931 . . . . 0.0 111.029 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.7 p -134.0 166.34 22.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.073 1.749 . . . . 0.0 109.351 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -61.58 -25.54 67.39 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.13 -40.8 59.47 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.164 0.986 . . . . 0.0 111.67 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -64.38 -41.97 96.41 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.494 0.588 . . . . 0.0 110.637 171.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.3 ttt -68.43 -36.55 79.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.534 0.734 . . . . 0.0 112.394 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -62.51 -41.55 98.92 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.716 0.689 . . . . 0.0 111.567 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -71.43 -39.75 70.85 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.976 0.807 . . . . 0.0 112.919 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -57.65 -22.59 46.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.148 1.379 . . . . 0.0 113.581 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -114.57 11.45 17.04 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.752 1.621 . . . . 0.0 112.616 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.4 -23.38 67.27 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -63.33 -23.33 67.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.177 1.391 . . . . 0.0 112.989 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -106.56 9.83 31.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.048 1.739 . . . . 0.0 112.598 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.44 -175.45 50.99 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.026 1.298 . . . . 0.0 113.121 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -73.77 128.48 35.63 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.094 -0.651 . . . . 0.0 110.944 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.05 143.34 47.52 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.239 1.015 . . . . 0.0 111.562 174.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.22 -11.9 82.94 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.973 0.797 . . . . 0.0 113.936 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -158.71 138.03 11.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.095 1.758 . . . . 0.0 109.389 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.56 127.39 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 125.873 1.669 . . . . 0.0 108.534 177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -144.79 143.84 30.86 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.843 1.257 . . . . 0.0 112.018 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.1 mt -140.77 132.79 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.144 1.777 . . . . 0.0 108.687 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -125.59 104.95 8.67 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.936 0.895 . . . . 0.0 112.066 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.08 -23.97 60.6 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -172.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -72.92 -14.22 61.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.24 1.016 . . . . 0.0 113.339 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -117.22 -19.87 9.46 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.958 1.303 . . . . 0.0 114.005 173.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.2 26.45 40.3 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 124.826 1.203 . . . . 0.0 114.213 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -130.87 145.98 52.16 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.013 1.325 . . . . 0.0 112.196 -172.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.05 162.38 24.24 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.691 1.615 . . . . 0.0 112.576 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -143.19 136.47 28.18 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.485 1.914 . . . . 0.0 108.632 -170.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.2 tt -149.23 143.36 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.455 0.702 . . . . 0.0 111.099 -175.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.2 112.68 17.97 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.976 1.31 . . . . 0.0 110.135 -172.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.0 mt -89.67 175.76 7.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.389 0.54 . . . . 0.0 111.726 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.23 -26.43 58.91 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.3 p -144.54 159.27 43.06 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.684 1.193 . . . . 0.0 111.95 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -60.59 -33.64 73.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.804 0.842 . . . . 0.0 112.357 170.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.8 m -67.2 -45.88 75.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.461 1.504 . . . . 0.0 111.024 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.7 mt -61.19 -39.88 91.83 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.182 0.593 . . . . 0.0 111.131 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.84 -35.69 77.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -60.93 -51.56 68.75 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.398 0.999 . . . . 0.0 110.882 169.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.33 -49.09 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.3 0.64 . . . . 0.0 110.565 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.46 86.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.517 0.727 . . . . 0.0 111.819 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.44 -45.29 91.98 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.272 -0.892 . . . . 0.0 111.748 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.3 t -65.12 -33.27 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.837 0.855 . . . . 0.0 112.31 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -86.12 -24.66 26.14 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.9 mt -107.03 -16.95 14.31 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -170.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.81 134.2 52.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.204 1.365 . . . . 0.0 112.074 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.2 t30 65.57 14.31 9.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.901 2.08 . . . . 0.0 113.845 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.1 ttp -72.77 135.84 80.63 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 120.56 -1.337 . . . . 0.0 110.559 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.71 131.8 13.86 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.488 2.792 . . . . 0.0 110.869 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.9 tp -143.47 115.44 8.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.151 1.38 . . . . 0.0 109.55 174.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 53.55 35.51 21.06 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.789 1.236 . . . . 0.0 112.951 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.7 1.84 89.94 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.556 1.55 . . . . 0.0 115.204 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -105.91 149.5 26.51 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.762 1.625 . . . . 0.0 110.854 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -104.44 110.85 23.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.029 0.932 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 82.1 mt -72.23 125.69 27.94 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.874 0.87 . . . . 0.0 112.513 -169.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.17 105.97 18.2 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.979 0.912 . . . . 0.0 109.04 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.7 t -114.66 131.39 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.023 0.929 . . . . 0.0 110.123 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -153.37 169.27 23.52 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.569 1.548 . . . . 0.0 111.218 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -70.62 138.88 51.15 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.519 -0.738 . . . . 0.0 111.572 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.05 98.03 11.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.96 0.904 . . . . 0.0 108.835 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 34.2 t -161.46 150.25 15.94 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.224 1.409 . . . . 0.0 110.748 -171.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -150.52 110.76 4.16 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.213 1.405 . . . . 0.0 110.884 175.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.3 t -90.53 129.7 36.65 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.403 0.681 . . . . 0.0 109.631 170.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.82 -46.43 75.18 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.993 -0.442 . . . . 0.0 112.058 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 89.7 p 54.86 11.87 0.53 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 127.74 2.416 . . . . 0.0 115.24 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.8 tp -76.75 147.08 37.53 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.058 1.743 . . . . 0.0 111.955 -171.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 30.0 p -75.47 -15.56 60.4 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.653 1.581 . . . . 0.0 114.34 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 75.0 m -87.11 123.49 32.23 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.384 1.073 . . . . 0.0 110.763 172.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 166.11 -158.14 30.92 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.613 1.102 . . . . 0.0 113.107 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -80.0 36.35 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 124.745 3.63 . . . . 0.0 112.843 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.6 t -165.02 167.31 18.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.965 1.706 . . . . 0.0 111.019 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.9 p -164.76 131.05 2.88 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.361 1.464 . . . . 0.0 111.277 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.248 0 CA-C-O 117.417 -1.768 . . . . 0.0 112.891 178.53 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.7 t 68.78 28.15 5.57 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.415 1.486 . . . . 0.0 113.754 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 m -138.77 148.76 44.24 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.363 1.465 . . . . 0.0 111.38 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.09 75.51 1.23 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.557 1.075 . . . . 0.0 111.893 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m -80.84 -8.26 59.66 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.0 m -146.03 150.55 36.2 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.436 1.894 . . . . 0.0 110.447 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -164.98 -177.26 37.38 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.325 0.964 . . . . 0.0 114.232 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.47 -167.61 37.1 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.12 1.343 . . . . 0.0 113.18 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -87.91 148.5 24.57 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.261 1.024 . . . . 0.0 111.85 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? 54.49 45.09 27.75 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.16 1.384 . . . . 0.0 113.401 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.8 p -61.99 159.72 13.73 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.068 1.747 . . . . 0.0 112.275 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -79.89 5.77 12.93 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.086 1.354 . . . . 0.0 114.427 -171.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.1 p -65.61 145.76 55.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.046 1.738 . . . . 0.0 111.121 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -101.35 73.46 1.49 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.254 1.022 . . . . 0.0 111.584 -168.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -68.41 -28.3 66.97 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m -132.04 29.45 4.38 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.345 1.058 . . . . 0.0 113.361 -168.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -89.78 125.65 35.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.867 1.267 . . . . 0.0 112.057 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.31 146.45 35.7 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.859 2.063 . . . . 0.0 110.988 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -97.62 143.12 28.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.985 2.514 . . . . 0.0 108.658 172.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.1 t -135.38 112.99 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.148 0.979 . . . . 0.0 109.861 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -111.29 174.41 16.75 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 125.748 1.642 . . . . 0.0 113.498 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 m120 64.93 20.92 12.24 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.988 1.715 . . . . 0.0 113.161 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.17 142.7 95.6 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 121.206 -0.934 . . . . 0.0 112.21 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.77 163.71 38.04 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.207 3.271 . . . . 0.0 111.9 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.39 5.84 2.57 Favored 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 123.715 2.943 . . . . 0.0 113.557 171.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -124.15 12.13 8.89 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.168 1.787 . . . . 0.0 113.486 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.1 tp -82.06 145.28 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 120.911 -1.118 . . . . 0.0 110.828 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 31.5 p -133.2 168.27 18.85 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.198 1.799 . . . . 0.0 109.623 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.11 -31.61 70.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.818 0.447 . . . . 0.0 111.824 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -73.08 -40.41 65.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.092 0.957 . . . . 0.0 111.709 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -66.2 -38.43 87.94 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.568 0.622 . . . . 0.0 111.31 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 6.0 ttt -68.74 -36.1 77.95 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.612 -0.68 . . . . 0.0 112.201 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -64.52 -40.23 95.23 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.692 0.797 . . . . 0.0 111.688 169.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -68.81 -41.85 78.06 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.305 1.042 . . . . 0.0 112.699 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.5 mt -59.13 -24.36 62.93 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.435 1.494 . . . . 0.0 113.596 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -112.42 11.47 19.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.503 1.521 . . . . 0.0 112.654 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.44 -21.66 66.68 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -171.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -62.69 -24.57 67.72 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.253 1.021 . . . . 0.0 112.517 172.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -104.11 14.02 31.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.528 1.931 . . . . 0.0 112.307 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.53 -173.64 54.83 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.386 0.993 . . . . 0.0 112.176 -173.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -71.54 147.25 47.88 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.66 -0.906 . . . . 0.0 111.88 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.95 147.13 37.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.495 0.718 . . . . 0.0 111.577 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.27 -17.39 66.92 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.062 1.315 . . . . 0.0 113.553 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -157.94 147.76 20.09 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.318 1.447 . . . . 0.0 110.645 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.3 t -142.31 129.07 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 126.992 2.117 . . . . 0.0 109.643 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -140.99 138.64 33.88 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.03 1.332 . . . . 0.0 111.387 171.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 61.6 mt -138.84 124.58 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.59 1.556 . . . . 0.0 108.211 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -121.36 102.19 8.12 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.075 0.94 . . . . 0.0 112.379 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -72.33 -18.77 61.74 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -77.53 -14.54 59.64 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.282 1.033 . . . . 0.0 112.96 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -116.78 -27.14 6.72 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.83 1.252 . . . . 0.0 113.498 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.4 27.19 23.39 Favored Glycine 0 N--CA 1.476 1.342 0 C-N-CA 124.896 1.236 . . . . 0.0 114.078 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -137.04 154.37 50.39 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.354 1.462 . . . . 0.0 111.822 -173.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.79 170.13 25.34 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.501 1.524 . . . . 0.0 113.038 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -143.83 148.72 35.93 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.312 1.845 . . . . 0.0 109.874 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 tt -153.87 137.75 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.786 0.834 . . . . 0.0 110.317 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -115.59 125.37 52.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.791 0.836 . . . . 0.0 109.849 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -96.01 170.03 9.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.998 0.519 . . . . 0.0 111.438 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -72.74 -26.6 61.62 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -171.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.4 p -142.64 155.9 45.0 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.137 1.375 . . . . 0.0 110.931 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.9 ttp85 -69.38 -27.46 65.34 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.911 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.8 m -62.32 -47.49 84.04 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.955 1.302 . . . . 0.0 110.54 172.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.55 -39.01 93.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.946 -0.55 . . . . 0.0 111.427 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.99 89.43 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -64.59 -50.38 67.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.315 0.961 . . . . 0.0 111.226 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.2 mt -59.06 -49.42 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 122.891 0.476 . . . . 0.0 110.25 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.28 -46.1 89.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.497 0.719 . . . . 0.0 111.979 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.53 -43.4 93.47 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.182 -0.949 . . . . 0.0 111.802 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.35 -32.93 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.932 0.893 . . . . 0.0 112.388 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -88.8 -24.5 22.58 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.1 mt -102.92 -18.12 15.19 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.43 131.21 45.85 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.944 1.247 . . . . 0.0 111.739 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.0 t30 65.07 17.26 10.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.517 1.927 . . . . 0.0 113.834 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.5 ttp -72.83 134.76 81.14 Favored Pre-proline 0 CA--C 1.544 0.718 0 O-C-N 120.609 -1.307 . . . . 0.0 110.223 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.52 138.79 19.85 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.159 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.0 tp -138.07 105.85 5.63 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.504 1.522 . . . . 0.0 109.821 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 55.57 27.53 10.54 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.491 1.516 . . . . 0.0 113.798 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 95.49 -8.46 69.0 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.729 1.633 . . . . 0.0 114.812 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -89.08 155.92 19.16 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.868 1.334 . . . . 0.0 110.653 170.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -87.53 172.16 9.97 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.643 0.777 . . . . 0.0 109.814 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.0 mt -132.57 117.41 17.92 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 110.364 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -92.87 113.68 26.02 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.833 0.853 . . . . 0.0 109.188 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.9 t -123.55 126.02 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.882 0.873 . . . . 0.0 110.141 -174.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -149.44 168.74 22.59 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.52 1.528 . . . . 0.0 111.661 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -78.54 136.98 37.68 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.352 0.661 . . . . 0.0 111.671 172.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.57 26.89 2.16 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.351 1.46 . . . . 0.0 112.553 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 17.6 t -74.13 -31.56 62.8 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.065 1.346 . . . . 0.0 113.313 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -80.64 162.7 24.09 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.362 1.065 . . . . 0.0 112.481 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 81.7 p -153.47 158.82 41.93 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.549 1.14 . . . . 0.0 112.483 -176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.0 125.34 29.21 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.177 0.991 . . . . 0.0 111.748 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.5 t -168.24 171.95 8.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.172 1.789 . . . . 0.0 110.799 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.5 mt -75.25 150.29 38.62 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.209 1.004 . . . . 0.0 111.352 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.0 t -71.09 154.72 41.53 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.519 1.128 . . . . 0.0 111.824 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 98.6 p -165.66 176.14 8.29 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.93 1.692 . . . . 0.0 111.857 -172.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.5 -152.76 19.82 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 124.791 1.186 . . . . 0.0 112.426 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.99 150.95 61.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.429 2.752 . . . . 0.0 111.611 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.6 m -105.79 132.33 52.04 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.535 1.134 . . . . 0.0 111.347 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.3 t -163.28 153.32 15.66 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.228 1.411 . . . . 0.0 111.038 -176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.28 0 C-N-CA 125.053 1.311 . . . . 0.0 113.583 177.907 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m -149.4 155.85 41.1 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.296 1.438 . . . . 0.0 111.425 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.1 p -92.08 152.32 20.0 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.594 1.158 . . . . 0.0 112.895 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.17 156.94 15.57 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.407 1.479 . . . . 0.0 112.714 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.3 m -75.59 143.47 42.32 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.204 1.002 . . . . 0.0 112.567 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 p -84.37 138.76 32.68 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.304 1.041 . . . . 0.0 112.36 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -95.46 -14.97 45.57 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 124.346 0.974 . . . . 0.0 115.101 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.42 -156.03 53.2 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 118.665 1.232 . . . . 0.0 113.0 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 61.25 46.35 7.98 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.449 1.5 . . . . 0.0 112.435 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -145.64 142.33 28.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.022 1.329 . . . . 0.0 111.959 -173.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 m -138.86 57.9 1.66 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.974 1.71 . . . . 0.0 109.649 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -144.89 130.72 19.15 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.667 1.587 . . . . 0.0 109.868 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.0 m -68.05 -44.44 76.4 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.816 1.246 . . . . 0.0 112.718 -170.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -152.88 153.97 34.13 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.376 1.87 . . . . 0.0 109.527 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -73.87 74.86 1.63 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.372 1.082 . . . . 0.0 111.216 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 m -86.17 39.82 0.84 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.157 1.783 . . . . 0.0 112.315 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -99.13 132.36 44.49 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.315 1.846 . . . . 0.0 111.739 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -117.78 143.94 45.79 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.67 1.588 . . . . 0.0 111.352 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -102.6 139.41 38.23 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.178 2.591 . . . . 0.0 108.441 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.76 116.71 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.306 1.043 . . . . 0.0 108.978 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.89 167.81 13.19 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.31 1.433 . . . . 0.0 114.053 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.66 31.51 9.77 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.504 1.522 . . . . 0.0 111.836 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.5 mt -66.21 143.64 98.42 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.969 0.908 . . . . 0.0 112.432 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -69.6 159.44 53.51 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.166 2.578 . . . . 0.0 111.271 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.44 -9.12 23.74 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.414 2.742 . . . . 0.0 113.275 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -94.41 5.33 52.12 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.709 1.604 . . . . 0.0 113.461 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.3 tp -86.78 137.59 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 121.051 -1.03 . . . . 0.0 111.65 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.0 p -133.74 176.98 8.07 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.593 1.557 . . . . 0.0 108.786 168.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.31 -21.74 62.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.44 0.696 . . . . 0.0 112.548 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -73.68 -47.82 36.89 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.125 0.875 . . . . 0.0 111.249 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -63.04 -42.56 99.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.144 0.578 . . . . 0.0 110.874 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.5 ttt -66.12 -33.86 76.75 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -69.35 -36.27 76.71 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.14 0.882 . . . . 0.0 112.336 170.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -44.14 67.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.117 0.967 . . . . 0.0 111.344 178.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.4 mt -56.33 -28.14 57.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.68 1.592 . . . . 0.0 113.343 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -108.84 10.54 26.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.406 1.483 . . . . 0.0 112.93 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.81 -23.03 66.61 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -170.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -62.88 -23.3 67.27 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.445 1.098 . . . . 0.0 112.375 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.64 12.97 30.54 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.589 1.956 . . . . 0.0 112.2 -175.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.08 -171.06 54.98 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.76 1.171 . . . . 0.0 112.488 -176.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -71.45 142.07 50.24 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.746 -0.855 . . . . 0.0 111.723 172.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.14 148.23 32.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.779 0.831 . . . . 0.0 111.302 175.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.51 -11.39 71.71 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.918 1.247 . . . . 0.0 113.962 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -158.83 137.94 11.37 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.454 1.902 . . . . 0.0 108.607 173.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.7 t -140.05 128.65 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.311 1.444 . . . . 0.0 109.055 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -143.03 139.42 30.54 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.92 1.288 . . . . 0.0 111.796 174.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.2 mt -140.45 128.23 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.375 1.87 . . . . 0.0 107.702 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -125.46 112.54 16.38 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.659 0.742 . . . . 0.0 112.864 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -75.92 -20.13 58.25 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -171.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.86 -21.21 51.74 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.87 0.868 . . . . 0.0 112.515 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -104.31 -32.58 9.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.816 1.247 . . . . 0.0 113.143 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.28 29.01 26.19 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 124.641 1.115 . . . . 0.0 113.857 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -140.92 156.47 46.08 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.671 1.588 . . . . 0.0 111.767 -171.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.95 166.52 27.03 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.085 1.326 . . . . 0.0 113.507 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -142.48 147.6 36.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.475 1.91 . . . . 0.0 109.806 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.9 tt -154.3 132.21 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.912 0.885 . . . . 0.0 110.738 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 -107.81 125.66 51.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.765 0.826 . . . . 0.0 110.074 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.6 mt -97.87 164.56 12.32 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.465 0.706 . . . . 0.0 109.684 173.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -82.58 -11.58 58.32 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -169.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 65.9 p -148.47 146.72 28.51 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.172 1.389 . . . . 0.0 111.741 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -58.57 -33.09 69.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.466 1.106 . . . . 0.0 113.592 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 m -68.24 -46.86 69.34 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.756 1.222 . . . . 0.0 110.573 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.38 -37.02 85.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.76 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.21 93.46 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.046 0.839 . . . . 0.0 112.718 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.3 -50.88 68.35 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.169 0.988 . . . . 0.0 111.381 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.7 mt -60.28 -46.91 94.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.855 -0.528 . . . . 0.0 110.379 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.68 90.83 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.63 0.772 . . . . 0.0 112.015 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -48.86 78.17 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.258 0.936 . . . . 0.0 111.219 174.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.76 -36.6 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.593 0.757 . . . . 0.0 112.225 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.31 -29.47 34.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 63.6 mt -106.26 -22.89 12.71 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -169.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.06 130.41 43.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.417 1.008 . . . . 0.0 110.781 173.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.0 t30 73.86 8.93 4.83 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.38 2.272 . . . . 0.0 114.074 -175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.3 ttp -76.15 137.35 68.73 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 120.462 -1.399 . . . . 0.0 111.528 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.67 135.29 15.96 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.449 2.766 . . . . 0.0 111.319 175.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.6 tp -145.89 120.21 9.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.442 1.497 . . . . 0.0 109.848 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 58.3 23.59 10.59 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.813 1.245 . . . . 0.0 113.619 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.42 -2.85 85.22 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.583 1.563 . . . . 0.0 114.593 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -93.61 148.4 22.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.491 1.517 . . . . 0.0 110.936 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -98.56 109.38 22.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.552 1.541 . . . . 0.0 107.182 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.75 147.46 47.3 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.664 0.786 . . . . 0.0 111.693 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.14 130.88 53.62 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.246 1.418 . . . . 0.0 109.054 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.7 t -134.02 129.23 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.857 0.863 . . . . 0.0 110.855 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -140.18 170.22 16.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.112 1.765 . . . . 0.0 110.387 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -77.61 134.54 38.19 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.502 -0.749 . . . . 0.0 110.373 168.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -90.05 114.59 26.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.294 1.037 . . . . 0.0 109.432 172.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 22.7 p -161.85 152.19 17.23 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.175 0.99 . . . . 0.0 112.981 -169.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -144.12 154.81 43.57 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.15 1.78 . . . . 0.0 111.455 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.1 p -163.5 171.01 16.49 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.91 1.284 . . . . 0.0 111.992 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -156.81 170.03 23.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.864 1.665 . . . . 0.0 111.255 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.8 t -156.25 144.51 19.84 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.014 1.325 . . . . 0.0 110.586 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.5 mp -90.33 91.9 8.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.052 0.941 . . . . 0.0 109.238 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.0 m -61.72 142.31 57.32 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.634 1.574 . . . . 0.0 110.323 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 28.5 t -147.25 134.13 20.17 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.368 1.067 . . . . 0.0 111.315 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -118.73 83.59 0.35 Allowed Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.618 1.58 . . . . 0.0 111.447 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.95 156.87 55.79 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.492 2.795 . . . . 0.0 111.392 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.3 t -78.71 138.65 38.37 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.447 0.699 . . . . 0.0 111.729 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 73.9 p -162.28 159.7 25.9 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.978 1.311 . . . . 0.0 112.31 -174.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.19 0 C-N-CA 125.049 1.309 . . . . 0.0 112.966 -179.343 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.47 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.4 m -151.13 146.49 26.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.037 1.335 . . . . 0.0 110.647 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -163.37 166.85 22.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.012 1.325 . . . . 0.0 111.486 -177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.97 -158.89 27.88 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.97 1.747 . . . . 0.0 112.815 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 p -74.73 160.75 30.36 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.42 1.088 . . . . 0.0 112.627 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 t -110.03 126.59 54.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.256 1.022 . . . . 0.0 110.73 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.83 116.62 1.43 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.262 1.411 . . . . 0.0 111.794 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -97.9 -142.47 13.38 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.308 1.433 . . . . 0.0 112.33 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -113.87 134.41 54.82 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.266 1.426 . . . . 0.0 109.889 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -155.5 117.75 4.15 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.547 1.139 . . . . 0.0 111.428 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 p -91.7 -59.96 1.99 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.028 1.731 . . . . 0.0 110.615 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -81.31 101.46 9.79 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.389 1.076 . . . . 0.0 110.935 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.7 t -96.48 19.93 11.41 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.143 1.777 . . . . 0.0 112.313 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -84.69 13.4 5.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.893 1.677 . . . . 0.0 113.422 -170.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -122.4 109.29 14.21 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.048 1.339 . . . . 0.0 109.849 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m -81.84 33.63 0.38 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.346 1.858 . . . . 0.0 113.251 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 74.4 mtp85 -86.97 129.44 34.88 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.372 1.469 . . . . 0.0 111.513 -176.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.9 mt -116.54 135.46 53.8 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.25 1.82 . . . . 0.0 110.544 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -89.4 142.48 27.62 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.347 2.259 . . . . 0.0 108.608 171.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.1 103.29 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.06 168.53 15.79 Favored Glycine 0 N--CA 1.464 0.565 0 C-N-CA 125.315 1.436 . . . . 0.0 112.986 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 60.09 32.45 20.99 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.897 1.279 . . . . 0.0 111.969 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.4 mt -63.25 143.37 97.72 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 121.269 -0.894 . . . . 0.0 111.347 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -66.93 158.0 58.81 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.801 2.334 . . . . 0.0 110.655 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.13 -7.32 20.4 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.699 2.933 . . . . 0.0 113.163 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -104.15 5.55 35.09 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.986 1.714 . . . . 0.0 113.264 -175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -75.18 146.67 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.274 -0.891 . . . . 0.0 111.247 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.5 p -131.73 165.55 23.5 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.961 1.704 . . . . 0.0 109.875 175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.16 -32.85 66.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.245 0.618 . . . . 0.0 111.419 172.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -70.09 -36.79 75.15 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.242 1.017 . . . . 0.0 112.294 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -72.1 -36.7 69.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.78 0.718 . . . . 0.0 111.91 173.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.6 ttm -66.52 -38.62 87.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.24 0.927 . . . . 0.0 111.989 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -61.68 -40.44 94.98 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.09 0.956 . . . . 0.0 111.45 170.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -73.35 -41.19 63.76 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.1 mt -56.48 -24.98 49.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.118 1.367 . . . . 0.0 113.389 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -112.38 11.04 19.92 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.536 1.534 . . . . 0.0 112.802 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.97 -22.42 65.92 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -171.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.13 -25.36 67.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.978 0.911 . . . . 0.0 112.343 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -103.01 11.27 37.53 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.49 1.916 . . . . 0.0 112.672 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.87 -171.03 55.04 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.633 1.111 . . . . 0.0 112.974 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -71.76 134.61 46.31 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.989 -0.712 . . . . 0.0 111.561 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.14 148.86 35.75 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.438 1.095 . . . . 0.0 111.37 174.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.99 -15.34 75.19 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.166 0.888 . . . . 0.0 113.393 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -155.39 145.25 21.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.433 1.093 . . . . 0.0 111.547 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.0 127.9 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.651 1.98 . . . . 0.0 110.057 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -142.3 142.5 32.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.735 1.614 . . . . 0.0 112.006 171.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 68.9 mt -138.15 125.91 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.909 1.683 . . . . 0.0 107.995 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -119.59 102.62 8.76 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.36 1.064 . . . . 0.0 111.776 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -74.11 -24.22 59.43 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.96 -23.11 63.13 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.307 1.043 . . . . 0.0 113.053 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -109.45 -26.47 9.96 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.416 1.086 . . . . 0.0 113.488 174.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.69 29.23 13.95 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 124.957 1.265 . . . . 0.0 114.274 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -137.68 148.47 45.74 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.229 1.412 . . . . 0.0 111.788 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -135.71 168.9 23.74 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.696 1.617 . . . . 0.0 112.939 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -146.1 140.71 26.92 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.131 1.772 . . . . 0.0 109.449 -170.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.9 tt -148.7 146.75 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.115 0.966 . . . . 0.0 110.559 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.66 117.3 22.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.487 1.115 . . . . 0.0 109.407 -178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -92.72 163.56 13.71 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.104 0.562 . . . . 0.0 110.516 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.65 -21.55 59.37 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.5 p -141.69 151.97 43.47 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.383 1.073 . . . . 0.0 112.354 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -57.22 -38.63 74.04 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.733 1.213 . . . . 0.0 112.869 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -63.29 -50.44 70.07 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.814 1.246 . . . . 0.0 110.85 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.85 -38.77 92.08 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.64 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.17 -39.88 94.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.65 -47.87 76.89 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.206 0.912 . . . . 0.0 111.759 174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.5 mt -59.31 -48.49 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.092 0.557 . . . . 0.0 110.262 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.91 -43.3 94.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.146 0.579 . . . . 0.0 112.322 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -46.29 88.54 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 120.961 -1.087 . . . . 0.0 111.131 174.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.19 -38.82 83.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.211 0.605 . . . . 0.0 112.002 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -82.33 -23.58 35.02 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.2 mt -108.63 -22.16 12.38 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.53 133.0 48.67 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.924 1.238 . . . . 0.0 111.142 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.5 t30 68.64 11.28 8.29 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.565 1.946 . . . . 0.0 113.732 -175.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.1 ttp -75.72 137.61 70.23 Favored Pre-proline 0 CA--C 1.544 0.719 0 O-C-N 120.611 -1.305 . . . . 0.0 110.933 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.46 134.23 15.25 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.365 2.71 . . . . 0.0 111.038 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.2 tp -140.14 113.61 8.56 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.28 1.432 . . . . 0.0 109.96 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.88 24.18 7.26 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.163 1.385 . . . . 0.0 113.344 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.27 -5.55 74.94 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.887 1.708 . . . . 0.0 114.771 -176.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -88.66 146.75 24.9 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.242 1.417 . . . . 0.0 110.451 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -92.56 119.56 32.14 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 69.2 mt -78.15 134.64 37.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.398 0.544 . . . . 0.0 111.669 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -99.17 125.25 44.7 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.823 1.249 . . . . 0.0 108.465 169.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.4 t -135.2 126.25 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.3 0.955 . . . . 0.0 110.362 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -146.13 168.98 19.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.159 1.783 . . . . 0.0 110.848 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -77.12 140.07 40.14 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.607 -0.683 . . . . 0.0 111.053 169.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.11 118.95 38.09 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.877 1.271 . . . . 0.0 111.347 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 71.4 m -142.03 167.98 20.83 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.699 1.599 . . . . 0.0 111.621 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -130.25 158.1 40.68 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.282 1.833 . . . . 0.0 111.331 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.8 t -121.57 120.55 35.16 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.269 1.028 . . . . 0.0 110.566 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.73 -36.53 28.49 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t 56.21 28.29 12.96 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.171 1.388 . . . . 0.0 113.025 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.1 tt -60.81 -42.32 97.44 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.68 1.592 . . . . 0.0 112.748 -169.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.2 t -164.12 151.93 12.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.101 1.76 . . . . 0.0 110.491 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.7 t -168.0 152.35 6.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.684 1.993 . . . . 0.0 110.13 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -174.67 -179.71 45.44 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 123.922 0.772 . . . . 0.0 114.787 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -83.39 -2.17 10.47 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.432 3.422 . . . . 0.0 114.251 -175.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.3 t -70.14 136.55 50.24 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.434 1.015 . . . . 0.0 112.222 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.4 m -68.41 124.09 22.57 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.337 1.055 . . . . 0.0 112.89 -175.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.272 1.415 . . . . 0.0 113.222 177.696 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.3 m -149.84 162.54 40.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.984 1.314 . . . . 0.0 111.508 -171.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 t -155.22 134.94 12.72 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.534 1.134 . . . . 0.0 110.927 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.32 -161.05 30.32 Favored Glycine 0 N--CA 1.471 1.033 0 C-N-CA 125.167 1.365 . . . . 0.0 113.246 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.5 t -103.5 136.89 42.39 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.759 1.224 . . . . 0.0 110.572 173.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.9 p -82.72 151.11 26.34 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.409 1.084 . . . . 0.0 113.21 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -172.95 174.46 45.85 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.662 1.125 . . . . 0.0 113.951 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.9 -177.63 54.31 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.769 1.176 . . . . 0.0 113.399 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -119.01 131.06 55.97 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.173 1.389 . . . . 0.0 110.144 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.21 172.2 9.64 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.712 1.205 . . . . 0.0 113.205 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.43 -179.09 6.43 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.454 1.502 . . . . 0.0 111.143 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -69.07 150.23 47.84 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.127 1.371 . . . . 0.0 111.999 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -162.62 140.45 8.32 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.033 1.333 . . . . 0.0 111.55 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -166.17 136.25 3.36 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.279 2.232 . . . . 0.0 108.284 175.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -80.93 144.39 31.94 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.917 0.887 . . . . 0.0 111.064 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.2 p -92.14 6.04 48.05 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.134 0.973 . . . . 0.0 113.293 170.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -77.45 122.37 25.11 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.746 1.618 . . . . 0.0 110.321 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.2 mt -103.45 135.47 45.0 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.771 1.628 . . . . 0.0 110.027 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -90.57 137.63 32.2 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.103 2.161 . . . . 0.0 108.549 169.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.1 110.07 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.513 1.125 . . . . 0.0 109.388 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -110.75 170.8 14.13 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.58 1.562 . . . . 0.0 114.151 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 69.74 20.05 7.0 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.415 1.886 . . . . 0.0 113.006 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -61.72 143.48 93.93 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.823 0.849 . . . . 0.0 112.321 -171.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.03 165.08 33.53 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.405 3.403 . . . . 0.0 111.535 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.18 -3.61 14.09 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.111 2.541 . . . . 0.0 113.162 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -106.92 5.52 28.37 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.231 1.813 . . . . 0.0 113.739 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 tp -82.25 144.97 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.057 -1.027 . . . . 0.0 110.862 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.4 p -132.81 168.82 17.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.225 1.81 . . . . 0.0 109.037 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.56 -26.92 67.28 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -76.21 -40.06 53.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.948 0.899 . . . . 0.0 111.658 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -64.62 -37.17 86.66 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.963 -0.46 . . . . 0.0 111.193 171.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.3 tpt -66.11 -44.56 83.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.648 0.779 . . . . 0.0 111.416 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -59.58 -33.57 71.62 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.97 0.908 . . . . 0.0 112.097 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -74.62 -45.53 44.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.75 0.82 . . . . 0.0 112.579 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.95 -31.08 64.62 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.981 1.312 . . . . 0.0 113.097 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -106.92 10.85 30.43 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.211 1.404 . . . . 0.0 113.12 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -63.47 -28.81 70.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -16.26 63.1 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.582 0.753 . . . . 0.0 112.618 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -100.83 9.82 41.88 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.545 1.938 . . . . 0.0 112.458 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.73 -177.46 54.36 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.749 1.166 . . . . 0.0 112.962 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -71.32 134.91 47.09 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.708 -0.878 . . . . 0.0 111.111 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.63 148.82 34.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.609 1.164 . . . . 0.0 112.194 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.89 -10.23 79.26 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.865 1.221 . . . . 0.0 113.923 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -158.92 137.64 11.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.379 1.872 . . . . 0.0 108.983 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.14 130.05 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.602 1.561 . . . . 0.0 108.808 174.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -144.29 139.24 28.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.592 1.157 . . . . 0.0 111.295 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 86.9 mt -138.8 126.66 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.455 1.502 . . . . 0.0 108.518 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -120.11 104.43 10.11 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.522 1.129 . . . . 0.0 111.846 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -73.76 -26.4 60.64 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -171.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.86 -22.03 62.35 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.957 0.903 . . . . 0.0 113.086 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -107.42 -29.12 9.43 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.475 1.11 . . . . 0.0 113.465 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.05 28.44 17.96 Favored Glycine 0 N--CA 1.477 1.374 0 C-N-CA 124.891 1.234 . . . . 0.0 114.152 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -137.6 155.79 48.8 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.339 1.455 . . . . 0.0 111.788 -173.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.16 176.74 30.32 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.111 1.339 . . . . 0.0 113.576 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -144.37 153.71 42.24 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.306 1.842 . . . . 0.0 110.779 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.3 tt -155.23 132.36 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.54 1.136 . . . . 0.0 110.607 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -113.52 121.93 45.73 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.904 0.881 . . . . 0.0 110.961 -176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.1 mt -94.39 165.64 12.46 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.236 0.614 . . . . 0.0 111.305 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.61 -23.72 60.98 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -172.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.6 p -145.11 146.47 31.83 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.118 1.367 . . . . 0.0 111.513 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -55.88 -43.42 77.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.059 1.344 . . . . 0.0 112.246 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.4 m -59.2 -45.87 89.93 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.924 1.289 . . . . 0.0 112.081 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.5 mt -63.76 -35.89 82.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 119.158 -0.448 . . . . 0.0 112.088 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.06 -33.44 74.57 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -64.55 -49.55 70.76 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.21 0.914 . . . . 0.0 110.22 172.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.8 mt -60.94 -48.47 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.604 0.762 . . . . 0.0 110.399 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.22 91.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.238 0.615 . . . . 0.0 111.819 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -57.19 -49.61 75.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.29 0.95 . . . . 0.0 111.332 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.71 -36.17 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.438 0.695 . . . . 0.0 112.095 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -81.65 -25.14 35.84 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 54.5 mt -109.61 -23.99 11.18 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -170.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.42 121.98 16.95 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.843 1.202 . . . . 0.0 110.839 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 74.59 15.52 3.32 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 128.142 2.577 . . . . 0.0 114.01 -173.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.0 ttp -76.44 137.12 67.74 Favored Pre-proline 0 N--CA 1.475 0.782 0 O-C-N 120.958 -1.089 . . . . 0.0 111.295 174.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.64 141.38 22.03 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.467 2.778 . . . . 0.0 111.647 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 34.4 tp -144.93 118.13 8.93 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.533 1.533 . . . . 0.0 110.303 173.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 58.7 24.77 12.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.321 1.448 . . . . 0.0 113.825 174.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.82 -5.59 83.36 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 125.472 1.511 . . . . 0.0 114.38 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -94.41 171.93 8.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.578 1.551 . . . . 0.0 110.726 169.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -99.43 -176.12 3.2 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 109.656 169.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.4 mt -141.68 120.03 12.31 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.302 1.441 . . . . 0.0 108.982 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.49 116.29 32.45 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.7 t -126.93 122.83 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.819 0.848 . . . . 0.0 111.335 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -141.88 161.66 37.43 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.772 2.029 . . . . 0.0 110.565 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -73.0 130.74 41.01 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.634 -0.666 . . . . 0.0 109.671 168.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.07 73.76 3.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.561 1.144 . . . . 0.0 110.699 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 76.5 m -78.91 50.76 1.04 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.184 1.794 . . . . 0.0 112.433 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -58.25 144.08 42.24 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.594 1.158 . . . . 0.0 112.967 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 25.5 t -154.87 153.27 30.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.254 1.421 . . . . 0.0 110.576 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -117.22 12.63 14.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.349 1.46 . . . . 0.0 113.498 -172.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.1 p -145.25 140.8 28.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.845 1.258 . . . . 0.0 112.172 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.32 145.94 29.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.372 1.069 . . . . 0.0 111.049 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.3 p 71.13 -4.88 1.67 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.661 2.784 . . . . 0.0 115.163 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.5 m -70.72 101.45 2.08 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.557 1.143 . . . . 0.0 111.662 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -93.64 -90.56 1.6 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.072 1.32 . . . . 0.0 111.392 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -76.49 -13.04 18.55 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.632 2.888 . . . . 0.0 112.835 174.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.7 p -83.52 150.97 25.64 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.911 1.684 . . . . 0.0 113.005 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.9 p -85.3 -15.99 41.56 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 C-N-CA 126.053 1.787 . . . . 0.0 112.848 177.769 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.4 p -166.99 163.99 16.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.259 1.424 . . . . 0.0 111.524 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -81.51 46.34 0.95 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.138 1.375 . . . . 0.0 112.889 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.1 71.64 1.7 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.706 1.622 . . . . 0.0 112.406 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.7 m -143.73 163.4 33.41 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.919 1.688 . . . . 0.0 111.669 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.6 m -161.04 162.34 31.67 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.762 1.625 . . . . 0.0 111.259 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.5 -34.52 0.12 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.112 0.863 . . . . 0.0 114.506 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.0 175.17 43.06 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.85 1.214 . . . . 0.0 113.293 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.12 5.93 20.87 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.785 1.234 . . . . 0.0 113.736 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -149.95 162.25 40.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.233 1.813 . . . . 0.0 112.337 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.9 p -140.82 158.35 44.08 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.905 1.682 . . . . 0.0 110.935 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -83.89 148.18 27.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.103 0.961 . . . . 0.0 111.935 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.4 m -73.98 128.45 35.54 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.51 1.124 . . . . 0.0 109.383 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -69.45 125.12 25.72 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.637 0.375 . . . . 0.0 110.044 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.28 133.35 55.6 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -173.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.6 m -118.68 25.18 10.42 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.998 1.719 . . . . 0.0 111.835 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -98.14 141.11 31.47 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.986 1.714 . . . . 0.0 112.561 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.44 141.92 50.92 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.82 2.048 . . . . 0.0 110.147 -172.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -100.66 140.38 35.02 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.193 2.197 . . . . 0.0 108.797 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.13 114.57 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.667 1.187 . . . . 0.0 108.951 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.33 164.57 12.28 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 125.488 1.518 . . . . 0.0 114.433 -175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.7 t30 70.57 20.35 5.85 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.593 1.957 . . . . 0.0 112.928 -177.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.9 mt -57.73 148.65 56.59 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.75 1.22 . . . . 0.0 113.082 -172.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 162.32 40.7 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.133 2.556 . . . . 0.0 111.444 172.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.94 -6.77 17.01 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.721 2.947 . . . . 0.0 112.174 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -99.76 8.29 44.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.676 1.991 . . . . 0.0 113.272 -177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.5 tp -81.86 145.46 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.01 -1.056 . . . . 0.0 110.909 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.2 p -134.3 167.66 20.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.236 1.814 . . . . 0.0 109.48 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -56.73 -34.51 67.58 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.106 0.563 . . . . 0.0 111.625 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.82 -26.93 49.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.478 1.111 . . . . 0.0 113.027 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -77.06 -39.02 51.38 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.933 0.788 . . . . 0.0 110.855 169.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.2 ttt -70.46 -37.48 74.3 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.32 -0.863 . . . . 0.0 112.195 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -62.64 -38.03 88.68 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.897 0.879 . . . . 0.0 111.507 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -73.34 -39.98 64.8 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.009 1.324 . . . . 0.0 113.092 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.6 mt -57.39 -27.39 62.28 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.958 1.303 . . . . 0.0 113.205 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -108.02 8.4 28.28 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.627 1.571 . . . . 0.0 112.753 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.9 -20.49 65.92 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -59.39 -22.73 61.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.636 1.174 . . . . 0.0 112.315 169.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -109.64 10.1 24.97 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.258 2.223 . . . . 0.0 112.321 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.45 -178.8 53.32 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.029 0.823 . . . . 0.0 112.448 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -71.04 144.57 50.34 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.699 -0.883 . . . . 0.0 111.664 174.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.64 152.27 30.1 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.166 0.986 . . . . 0.0 111.822 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.35 -8.22 71.58 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.82 1.2 . . . . 0.0 113.83 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -158.61 136.05 10.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.58 1.952 . . . . 0.0 108.582 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.73 128.65 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.493 1.517 . . . . 0.0 109.059 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -143.83 141.78 30.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.172 1.389 . . . . 0.0 111.579 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.3 mt -140.47 132.98 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.702 1.601 . . . . 0.0 108.67 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -129.1 109.02 10.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.93 0.892 . . . . 0.0 112.129 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -33.93 69.7 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.494 1.118 . . . . 0.0 112.798 -171.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.63 -26.22 68.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.367 1.067 . . . . 0.0 113.229 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -97.72 -32.58 11.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.176 0.99 . . . . 0.0 113.031 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.27 29.19 12.84 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 125.101 1.334 . . . . 0.0 114.055 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.95 158.84 43.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.266 1.426 . . . . 0.0 111.852 -171.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.46 168.78 26.63 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.275 1.417 . . . . 0.0 113.483 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.27 148.24 50.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.72 2.008 . . . . 0.0 109.828 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.9 tt -153.82 140.88 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.412 1.085 . . . . 0.0 110.583 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -123.94 124.89 43.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.863 0.865 . . . . 0.0 110.947 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.4 168.09 10.43 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.389 0.676 . . . . 0.0 110.935 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -72.85 -24.94 60.95 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -169.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.9 p -143.61 157.65 44.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.619 1.168 . . . . 0.0 111.881 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -58.73 -35.77 73.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 112.528 173.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.2 m -62.8 -49.46 74.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.054 1.342 . . . . 0.0 110.64 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.49 -42.86 99.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.217 0.607 . . . . 0.0 111.215 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.25 99.26 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -62.91 -49.78 73.44 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.087 0.858 . . . . 0.0 111.79 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.71 -48.95 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.104 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.01 -44.01 91.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.333 0.653 . . . . 0.0 112.288 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.89 -47.52 84.67 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.447 -0.783 . . . . 0.0 111.007 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.69 -36.49 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -84.79 -28.68 26.0 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -174.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 53.4 mt -101.18 -19.22 15.81 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -66.86 137.81 56.86 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.188 0.904 . . . . 0.0 110.661 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.5 t30 69.28 16.29 8.43 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.653 1.581 . . . . 0.0 113.636 -177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 60.0 ttp -89.83 134.02 32.86 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 120.866 -1.146 . . . . 0.0 111.148 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.28 141.42 18.22 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.299 2.666 . . . . 0.0 111.307 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.4 tp -144.92 114.59 7.24 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.827 1.651 . . . . 0.0 110.098 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 57.67 24.5 10.64 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.288 1.435 . . . . 0.0 113.738 176.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.73 -1.92 69.23 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.547 1.546 . . . . 0.0 114.836 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -102.9 145.86 29.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.285 1.434 . . . . 0.0 111.192 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -75.31 167.64 21.52 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.656 -0.653 . . . . 0.0 110.187 167.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.7 mt -133.96 135.8 43.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.5 1.12 . . . . 0.0 110.996 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.67 122.08 46.67 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.685 1.994 . . . . 0.0 109.096 175.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -131.94 125.63 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.773 0.829 . . . . 0.0 110.119 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.53 156.92 37.52 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.431 1.492 . . . . 0.0 111.706 -172.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -69.0 132.03 46.02 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.579 -0.701 . . . . 0.0 111.816 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -86.31 83.62 7.65 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.616 0.766 . . . . 0.0 110.818 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 24.5 p -164.21 152.81 13.14 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.127 1.371 . . . . 0.0 112.718 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -100.21 156.07 17.41 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.135 1.374 . . . . 0.0 110.829 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 p -73.49 123.36 23.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.053 0.941 . . . . 0.0 111.752 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.45 -13.39 60.11 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.004 0.922 . . . . 0.0 113.459 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 78.9 p -161.44 159.77 28.52 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.952 2.501 . . . . 0.0 109.221 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 pp -128.25 168.16 15.87 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.369 1.067 . . . . 0.0 112.718 -171.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.0 t -65.51 133.01 50.33 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.244 1.018 . . . . 0.0 110.858 -176.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.4 m -172.38 167.55 5.66 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.799 2.04 . . . . 0.0 110.801 -170.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 119.24 74.7 0.45 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.299 1.428 . . . . 0.0 112.097 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.1 -11.75 29.44 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.524 2.816 . . . . 0.0 113.793 -176.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.5 t -80.34 -5.37 56.27 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.782 0.833 . . . . 0.0 113.201 173.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.2 m -95.63 124.74 39.8 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.75 -1.219 . . . . 0.0 111.314 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.915 -179.272 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.516 0 N-CA-C 111.819 -0.512 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 m -68.84 155.49 40.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.379 1.072 . . . . 0.0 113.092 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.5 t -159.86 171.92 18.56 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.182 1.393 . . . . 0.0 111.428 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.45 -178.26 35.3 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.464 1.507 . . . . 0.0 113.515 -175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -136.71 27.16 3.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.98 1.312 . . . . 0.0 112.689 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 t -155.01 177.49 11.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.29 1.436 . . . . 0.0 112.054 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.13 62.44 0.67 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.687 1.613 . . . . 0.0 112.327 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.98 171.09 40.16 Favored Glycine 0 N--CA 1.473 1.123 0 C-N-CA 125.28 1.419 . . . . 0.0 113.752 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -77.7 -18.57 56.48 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.171 0.989 . . . . 0.0 113.275 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.64 154.41 47.93 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.06 1.744 . . . . 0.0 111.011 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.69 -14.11 62.33 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.143 1.777 . . . . 0.0 113.451 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -135.14 145.56 47.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.759 1.224 . . . . 0.0 112.022 -169.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.5 p -145.29 173.02 12.33 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.704 2.002 . . . . 0.0 110.863 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -124.32 107.51 11.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.511 1.125 . . . . 0.0 110.167 -173.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.64 54.8 3.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.632 1.173 . . . . 0.0 111.091 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m -75.13 40.18 0.15 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.059 2.144 . . . . 0.0 114.283 -173.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -99.22 124.13 44.05 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.703 1.601 . . . . 0.0 111.851 -170.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.6 mt -111.75 149.82 31.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.709 2.004 . . . . 0.0 110.999 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -114.58 137.86 51.36 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.203 2.601 . . . . 0.0 108.472 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -131.29 113.37 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.167 0.987 . . . . 0.0 109.947 -173.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -113.02 169.64 13.03 Favored Glycine 0 N--CA 1.467 0.756 0 C-N-CA 126.042 1.782 . . . . 0.0 113.738 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 69.01 15.87 8.78 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.098 1.759 . . . . 0.0 112.582 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 28.8 mt -56.58 139.04 76.1 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.089 0.955 . . . . 0.0 112.048 -174.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 83' ' ' LEU . 12.8 Cg_exo -68.15 160.92 46.69 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.748 2.298 . . . . 0.0 111.223 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.04 -2.79 12.09 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.815 3.01 . . . . 0.0 112.967 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -103.61 0.82 31.28 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.082 1.753 . . . . 0.0 113.792 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.6 tp -76.41 146.32 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 119.453 1.024 . . . . 0.0 111.275 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 p -130.58 165.42 22.8 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.706 1.602 . . . . 0.0 110.409 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -62.85 -25.78 68.44 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.226 0.61 . . . . 0.0 111.822 172.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -72.64 -44.39 61.97 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.183 0.993 . . . . 0.0 111.474 172.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -66.09 -39.18 89.8 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.55 0.614 . . . . 0.0 111.696 176.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -69.21 -33.57 73.54 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.773 0.715 . . . . 0.0 112.471 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -67.61 -39.4 84.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.581 0.628 . . . . 0.0 111.643 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -72.92 -38.08 66.98 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.29 -0.881 . . . . 0.0 113.074 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.44 -25.06 49.34 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.358 1.463 . . . . 0.0 113.256 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -110.75 10.51 22.66 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.644 1.578 . . . . 0.0 112.673 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.21 -24.87 67.48 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -64.63 -19.33 65.63 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.334 1.054 . . . . 0.0 113.015 172.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.93 10.5 30.5 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.807 2.043 . . . . 0.0 112.141 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.44 -173.42 55.23 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.865 1.221 . . . . 0.0 113.021 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -71.73 145.07 49.02 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.836 -0.802 . . . . 0.0 112.274 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -89.19 150.39 22.69 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.415 1.086 . . . . 0.0 111.528 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.0 -11.05 70.76 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.823 1.202 . . . . 0.0 113.871 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -153.94 137.11 15.62 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.124 1.77 . . . . 0.0 109.073 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.46 129.36 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.906 1.682 . . . . 0.0 108.858 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -145.09 144.08 30.75 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.895 1.278 . . . . 0.0 111.87 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.2 mt -140.86 132.47 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.168 1.787 . . . . 0.0 108.459 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -126.43 111.82 14.89 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.887 0.875 . . . . 0.0 112.386 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -70.75 -31.95 68.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.424 1.09 . . . . 0.0 113.307 -171.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -73.63 -13.24 60.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.07 0.948 . . . . 0.0 113.51 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -112.75 -26.48 8.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.743 1.217 . . . . 0.0 113.311 173.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.0 29.84 24.73 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.613 1.102 . . . . 0.0 113.963 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -140.12 157.29 45.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.327 1.451 . . . . 0.0 112.202 -172.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.41 169.19 25.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.755 1.645 . . . . 0.0 113.209 174.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -137.89 147.63 44.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.673 1.989 . . . . 0.0 109.425 -177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.0 tt -153.77 139.23 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.897 0.879 . . . . 0.0 110.601 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -128.92 118.68 23.06 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.622 0.769 . . . . 0.0 110.307 -172.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.67 -176.16 3.98 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.215 1.006 . . . . 0.0 111.893 -171.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -86.02 -25.84 25.72 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 49.7 p -149.42 144.4 26.33 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.138 1.375 . . . . 0.0 111.851 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -59.46 -35.91 74.97 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.248 1.019 . . . . 0.0 113.057 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.9 m -60.21 -47.69 84.87 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.773 1.229 . . . . 0.0 111.181 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.6 mt -65.65 -35.99 82.38 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.958 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.68 -36.76 81.28 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.08 0.854 . . . . 0.0 112.875 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.39 -49.48 71.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.128 0.971 . . . . 0.0 110.891 172.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.81 -48.74 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.082 0.553 . . . . 0.0 110.353 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.98 -46.02 85.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.626 0.77 . . . . 0.0 111.91 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -58.25 -48.69 79.62 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.319 -0.863 . . . . 0.0 111.345 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.15 -36.49 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.464 0.705 . . . . 0.0 112.16 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -80.6 -30.45 36.82 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.3 mt -102.72 -21.78 14.04 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -171.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.18 129.14 38.94 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.672 1.123 . . . . 0.0 111.456 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 67.98 14.25 9.32 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.73 2.412 . . . . 0.0 113.697 -173.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 64.2 ttp -73.83 135.91 77.31 Favored Pre-proline 0 N--CA 1.474 0.757 0 O-C-N 120.507 -1.371 . . . . 0.0 110.719 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.24 140.6 19.81 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.3 2.666 . . . . 0.0 111.325 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.3 tp -145.12 117.19 8.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.086 1.355 . . . . 0.0 110.106 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 69.9 mmt-85 57.11 27.38 13.34 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.929 1.291 . . . . 0.0 113.922 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.42 -6.23 83.82 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 125.521 1.534 . . . . 0.0 114.484 -177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -90.78 169.3 11.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.934 1.694 . . . . 0.0 110.333 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -100.98 -172.67 2.21 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.612 -0.68 . . . . 0.0 109.244 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.46 116.67 10.03 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.34 1.056 . . . . 0.0 109.079 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -91.58 118.07 30.28 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.44 123.94 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.647 0.779 . . . . 0.0 109.959 -173.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -154.78 163.98 39.47 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.087 1.355 . . . . 0.0 111.239 -173.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -71.36 144.1 49.99 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.769 -0.582 . . . . 0.0 111.043 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.51 42.97 0.53 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.939 1.296 . . . . 0.0 112.94 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 28.2 p -64.86 -21.64 66.84 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -80.62 -10.45 59.73 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.379 1.072 . . . . 0.0 113.128 172.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 20.4 m -114.28 60.78 0.67 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.26 1.824 . . . . 0.0 110.278 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.33 161.0 41.17 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.715 2.006 . . . . 0.0 110.744 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 20.1 t -74.76 121.16 21.32 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.539 -0.725 . . . . 0.0 111.605 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -158.76 117.72 3.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.557 1.543 . . . . 0.0 109.22 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.6 m -147.2 147.37 30.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.291 1.837 . . . . 0.0 109.038 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 19.9 t -145.44 127.4 15.49 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.226 1.01 . . . . 0.0 110.743 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -92.71 -174.74 41.41 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.091 1.329 . . . . 0.0 113.516 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.19 139.92 43.46 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.702 2.935 . . . . 0.0 110.616 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 t -73.32 -28.96 62.36 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -176.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.2 t 67.89 4.92 4.22 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.523 1.929 . . . . 0.0 115.224 171.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.159 0 C-N-CA 125.271 1.415 . . . . 0.0 113.059 179.271 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.508 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.8 m -146.84 154.81 41.77 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.137 1.375 . . . . 0.0 110.952 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 t -159.58 158.29 31.42 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.526 1.13 . . . . 0.0 111.75 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.78 139.98 7.8 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.601 1.572 . . . . 0.0 112.468 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.9 p -91.57 140.03 30.13 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.751 1.221 . . . . 0.0 112.062 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -68.14 130.46 42.99 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.992 -1.068 . . . . 0.0 112.194 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.04 170.57 49.65 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.439 1.019 . . . . 0.0 113.822 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.94 -173.18 48.66 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.879 1.228 . . . . 0.0 113.769 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -108.84 153.57 23.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.265 1.426 . . . . 0.0 111.704 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -68.85 145.81 53.39 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.608 -0.683 . . . . 0.0 112.066 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.9 p -140.65 172.71 12.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.97 2.108 . . . . 0.0 110.1 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -58.78 134.01 56.48 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.207 0.603 . . . . 0.0 111.529 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.3 m -138.92 148.65 43.85 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.084 1.754 . . . . 0.0 109.394 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -142.3 143.19 32.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.872 1.269 . . . . 0.0 110.621 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.54 142.22 53.68 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.429 0.692 . . . . 0.0 112.559 -174.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m -86.47 41.38 0.94 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.298 1.439 . . . . 0.0 112.706 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.0 mmm-85 -84.15 133.41 34.61 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.434 1.494 . . . . 0.0 113.006 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.6 mt -113.81 134.52 54.73 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.034 1.733 . . . . 0.0 110.257 170.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -92.09 137.89 31.99 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.17 2.188 . . . . 0.0 107.748 169.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.6 t -130.47 110.92 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.072 0.949 . . . . 0.0 109.435 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.53 174.56 18.11 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.825 1.678 . . . . 0.0 113.501 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.8 m120 65.48 20.07 11.65 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.863 1.665 . . . . 0.0 112.808 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.19 140.12 97.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 O-C-N 121.05 -1.031 . . . . 0.0 112.103 -171.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.11 165.73 31.48 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.294 3.33 . . . . 0.0 111.837 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.51 -2.89 13.03 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.173 2.582 . . . . 0.0 113.179 172.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -108.19 12.55 26.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.028 1.731 . . . . 0.0 113.419 -174.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.3 tp -91.32 140.08 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.254 1.022 . . . . 0.0 110.599 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.8 p -133.76 174.06 10.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.389 1.476 . . . . 0.0 108.695 168.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.33 -22.62 63.43 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.043 0.537 . . . . 0.0 112.421 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.71 -45.14 38.39 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.307 -0.871 . . . . 0.0 111.41 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -63.27 -43.8 96.93 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.058 0.543 . . . . 0.0 111.088 172.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 8.9 ttt -65.35 -37.31 86.68 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.997 0.519 . . . . 0.0 112.337 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.6 mtp-105 -66.46 -38.18 86.78 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.509 -0.744 . . . . 0.0 112.066 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -72.03 -40.32 68.49 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.411 -0.806 . . . . 0.0 112.557 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.9 mt -59.34 -29.58 67.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.986 1.714 . . . . 0.0 113.027 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -105.88 8.44 32.65 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.22 1.408 . . . . 0.0 112.656 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.03 -27.04 68.6 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.246 0.93 . . . . 0.0 113.214 -173.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -72.55 -5.54 37.8 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.775 1.23 . . . . 0.0 113.657 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -111.86 8.81 20.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.433 1.893 . . . . 0.0 111.83 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.11 -177.6 53.72 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.802 1.192 . . . . 0.0 112.253 -172.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -71.16 144.18 50.28 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.637 -0.919 . . . . 0.0 111.998 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.26 156.3 33.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.878 0.871 . . . . 0.0 111.857 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.96 -10.29 58.84 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.939 1.256 . . . . 0.0 113.87 175.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.65 135.83 5.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.699 2.0 . . . . 0.0 108.611 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.1 t -143.56 128.77 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.644 1.578 . . . . 0.0 109.43 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -145.1 142.31 29.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.382 1.473 . . . . 0.0 111.765 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 65.9 mt -138.51 127.18 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.559 1.544 . . . . 0.0 108.575 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -115.57 103.25 10.54 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.446 1.098 . . . . 0.0 111.831 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -69.79 -20.34 63.47 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -87.18 -15.17 39.12 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -173.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -117.6 -19.25 9.47 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.613 1.165 . . . . 0.0 113.985 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.25 29.79 21.42 Favored Glycine 0 N--CA 1.476 1.337 0 C-N-CA 124.665 1.126 . . . . 0.0 114.312 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -132.51 149.07 52.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.942 1.297 . . . . 0.0 111.832 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.68 169.5 25.17 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.875 1.702 . . . . 0.0 112.754 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -141.83 142.52 33.16 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.173 1.789 . . . . 0.0 109.566 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.6 tt -152.18 143.19 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.726 0.81 . . . . 0.0 110.686 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -121.3 124.32 44.32 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.922 0.889 . . . . 0.0 110.706 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.0 mt -97.31 171.2 8.57 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.582 0.753 . . . . 0.0 111.132 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -74.73 -26.46 59.82 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.3 p -144.7 159.29 43.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.686 1.194 . . . . 0.0 111.983 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -60.24 -31.35 70.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.844 0.857 . . . . 0.0 112.755 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -68.47 -46.79 68.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.019 1.328 . . . . 0.0 110.486 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.6 mt -62.39 -42.73 99.65 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.249 0.62 . . . . 0.0 111.125 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.59 -36.94 85.87 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -65.89 -47.93 73.17 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.508 1.123 . . . . 0.0 111.905 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.7 mt -62.35 -47.83 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.418 -0.802 . . . . 0.0 110.18 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.41 -42.49 98.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.277 0.631 . . . . 0.0 112.409 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -54.01 -51.87 62.59 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.421 1.009 . . . . 0.0 111.287 170.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.36 -34.91 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.151 0.432 . . . . 0.0 111.785 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -85.57 -23.98 27.4 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.0 mt -106.67 -22.17 12.82 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -67.24 128.84 37.92 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.476 1.034 . . . . 0.0 110.992 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.6 t30 70.48 12.75 7.45 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.27 2.228 . . . . 0.0 114.106 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.5 ttp -75.67 136.95 70.52 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 120.565 -1.334 . . . . 0.0 110.91 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.99 139.91 19.73 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.452 2.768 . . . . 0.0 111.169 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.8 tp -145.72 121.57 10.61 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.506 1.522 . . . . 0.0 109.893 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 59.17 23.09 11.35 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.902 1.281 . . . . 0.0 113.699 172.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.1 2.15 74.85 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.394 1.473 . . . . 0.0 114.728 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -111.73 156.98 21.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.233 1.813 . . . . 0.0 111.629 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.99 173.07 10.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.163 0.985 . . . . 0.0 111.137 169.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.2 mt -134.24 119.01 18.22 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.544 1.138 . . . . 0.0 109.148 169.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -92.67 122.51 35.15 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.85 128.32 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.194 0.906 . . . . 0.0 109.689 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -148.1 165.27 31.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.581 1.552 . . . . 0.0 110.986 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.19 137.87 41.58 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.633 -0.667 . . . . 0.0 110.566 169.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -86.24 111.33 20.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.234 0.614 . . . . 0.0 110.786 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 73.5 m -109.48 136.34 49.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.063 1.345 . . . . 0.0 111.474 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -74.8 -23.24 58.46 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.2 m -153.03 162.23 41.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.115 1.766 . . . . 0.0 111.142 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.89 163.98 26.31 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.935 0.894 . . . . 0.0 112.258 171.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.4 t -157.23 169.83 23.87 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.899 1.279 . . . . 0.0 111.483 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.9 mt -130.26 168.63 16.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.083 1.753 . . . . 0.0 111.428 -172.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 15.0 t -156.49 154.68 30.74 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.785 1.634 . . . . 0.0 110.91 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.4 t -75.47 157.99 33.24 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.822 0.849 . . . . 0.0 112.072 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 155.72 -77.33 0.2 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.867 1.222 . . . . 0.0 112.22 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.94 115.52 4.35 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.532 2.821 . . . . 0.0 110.251 176.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 79.5 p -170.43 169.87 7.27 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.86 1.664 . . . . 0.0 111.58 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 73.2 m -77.35 141.92 39.62 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.98 -1.075 . . . . 0.0 111.943 174.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.192 0 CA-C-O 118.268 -1.296 . . . . 0.0 112.871 -179.642 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.322 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.6 p -75.07 163.55 27.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.691 1.197 . . . . 0.0 113.355 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.5 t -74.05 -17.7 60.93 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 120.851 -1.156 . . . . 0.0 113.689 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.19 157.66 29.97 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.755 1.645 . . . . 0.0 113.437 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.9 m -94.87 -3.44 48.79 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -173.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.9 p -90.97 152.32 20.74 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.474 1.51 . . . . 0.0 113.23 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.98 -175.91 39.84 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.064 1.316 . . . . 0.0 113.613 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.78 36.62 18.7 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.061 0.839 . . . . 0.0 113.723 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -110.51 150.16 29.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.536 1.534 . . . . 0.0 111.981 -175.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.58 157.2 38.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.514 1.126 . . . . 0.0 112.97 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -76.38 -10.19 59.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.011 1.725 . . . . 0.0 113.743 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -153.94 149.45 27.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.349 1.859 . . . . 0.0 110.204 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.6 p -147.96 133.08 18.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.172 1.389 . . . . 0.0 110.545 -174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -91.08 45.06 1.22 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.477 1.111 . . . . 0.0 112.877 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -75.3 37.82 0.13 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.51 1.524 . . . . 0.0 112.713 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 m -78.79 36.33 0.27 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.89 2.076 . . . . 0.0 112.589 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.13 129.18 55.18 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.074 1.75 . . . . 0.0 110.744 -174.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.3 mt -108.15 130.61 55.11 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.585 1.554 . . . . 0.0 110.294 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -89.83 134.5 34.16 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.645 1.978 . . . . 0.0 107.949 169.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.9 t -129.16 121.88 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.996 0.918 . . . . 0.0 109.792 -174.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.43 172.66 14.56 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 125.921 1.724 . . . . 0.0 113.686 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 m120 65.32 17.08 10.86 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 126.169 1.788 . . . . 0.0 113.371 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 32.2 mt -58.19 143.48 78.92 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.409 1.084 . . . . 0.0 112.474 -171.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -70.32 158.06 57.37 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.199 2.6 . . . . 0.0 110.852 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.5 -9.67 25.54 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.316 2.677 . . . . 0.0 112.87 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.79 4.42 52.87 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.793 2.037 . . . . 0.0 113.409 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.0 tp -81.74 145.28 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 120.785 -1.197 . . . . 0.0 111.181 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.8 p -135.27 167.63 20.66 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.52 1.928 . . . . 0.0 109.139 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -57.7 -35.42 70.6 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.962 0.505 . . . . 0.0 111.887 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -80.23 -30.97 38.59 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.518 1.127 . . . . 0.0 113.076 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.08 -39.2 66.06 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.024 0.93 . . . . 0.0 111.309 172.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 4.3 tpt -61.86 -42.27 98.85 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.709 0.804 . . . . 0.0 111.074 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.0 ttp85 -63.26 -27.85 69.63 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.424 -0.798 . . . . 0.0 112.191 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -47.67 37.7 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.157 1.383 . . . . 0.0 112.494 171.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.7 mt -55.62 -34.27 64.74 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.01 1.324 . . . . 0.0 112.634 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -102.52 9.93 39.2 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.05 1.34 . . . . 0.0 113.267 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.63 -24.89 67.15 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.612 0.968 . . . . 0.0 113.612 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -61.92 -25.21 67.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.555 1.142 . . . . 0.0 112.388 173.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -102.32 12.69 36.24 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.209 1.804 . . . . 0.0 112.478 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.55 -145.68 20.4 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.756 1.17 . . . . 0.0 111.93 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -103.54 131.14 50.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.599 1.159 . . . . 0.0 111.085 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.5 146.49 51.85 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.172 0.989 . . . . 0.0 111.844 176.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -80.81 -18.14 70.97 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.287 0.946 . . . . 0.0 113.454 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -158.68 146.38 17.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.569 1.548 . . . . 0.0 110.321 172.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.9 t -143.18 128.46 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.083 1.753 . . . . 0.0 109.542 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -140.65 142.35 34.97 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.401 1.481 . . . . 0.0 111.444 175.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.5 mt -142.12 128.97 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 126.004 1.721 . . . . 0.0 108.222 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -123.27 102.13 7.76 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.046 0.938 . . . . 0.0 111.985 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -73.6 -16.35 61.24 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.94 -20.53 60.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.305 1.042 . . . . 0.0 112.808 175.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -116.75 -23.22 8.22 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.832 1.253 . . . . 0.0 113.756 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.71 28.73 23.23 Favored Glycine 0 N--CA 1.477 1.371 0 C-N-CA 124.673 1.13 . . . . 0.0 114.25 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -136.78 155.16 50.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.389 1.476 . . . . 0.0 112.023 -173.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.96 168.97 25.84 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.676 1.607 . . . . 0.0 113.055 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -140.56 140.2 35.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.703 2.001 . . . . 0.0 108.735 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.5 tt -150.6 132.27 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 121.685 -0.634 . . . . 0.0 111.487 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 123.1 47.63 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.749 1.22 . . . . 0.0 110.172 -177.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -99.73 157.12 16.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.246 0.618 . . . . 0.0 110.181 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.34 -18.47 63.08 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -169.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.9 p -151.01 151.54 32.21 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.667 1.587 . . . . 0.0 111.435 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 36.9 ptt-85 -55.27 -35.66 65.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.756 1.222 . . . . 0.0 114.24 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 m -60.92 -45.92 92.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.058 1.343 . . . . 0.0 111.265 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.9 mt -62.09 -44.0 97.61 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.773 0.829 . . . . 0.0 110.915 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.85 79.41 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.297 0.639 . . . . 0.0 112.63 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.53 -48.32 67.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.861 0.865 . . . . 0.0 111.909 172.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.4 mt -61.34 -46.56 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 121.522 -0.736 . . . . 0.0 110.279 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.99 99.54 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.759 0.824 . . . . 0.0 112.053 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -56.09 -50.65 70.43 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.566 1.076 . . . . 0.0 111.489 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.8 -35.15 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 118.793 0.724 . . . . 0.0 112.338 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -87.2 -33.44 19.35 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 57.0 mt -98.91 -22.68 15.66 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -171.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -70.2 122.71 20.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.0 0.818 . . . . 0.0 110.773 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 70.61 14.92 7.18 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 127.543 2.337 . . . . 0.0 114.262 -171.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.4 ttp -72.79 138.1 79.95 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 120.518 -1.364 . . . . 0.0 110.939 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.11 139.58 21.66 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.44 2.76 . . . . 0.0 111.402 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.8 tp -144.88 116.22 8.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.343 1.457 . . . . 0.0 109.969 174.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 59.03 18.88 6.69 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.211 1.404 . . . . 0.0 113.916 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.57 -6.73 80.26 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.665 1.602 . . . . 0.0 114.508 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -85.38 153.99 22.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.758 1.279 . . . . 0.0 110.557 170.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -86.11 163.41 17.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 167.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.0 mt -122.1 137.52 54.79 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.305 1.042 . . . . 0.0 110.046 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.4 135.67 46.36 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.382 1.073 . . . . 0.0 109.529 170.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.37 132.93 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.965 0.906 . . . . 0.0 110.955 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -147.73 165.61 30.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.163 1.385 . . . . 0.0 111.573 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -73.54 136.85 44.08 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.545 -0.722 . . . . 0.0 110.946 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.5 126.11 30.39 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.693 0.797 . . . . 0.0 110.572 174.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 37.5 t -160.3 140.26 11.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.365 1.466 . . . . 0.0 110.971 -175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -146.99 136.03 22.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.741 1.616 . . . . 0.0 111.393 -173.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 33.5 t -165.19 135.21 3.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.668 1.187 . . . . 0.0 111.266 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.69 53.37 1.88 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.981 1.313 . . . . 0.0 111.44 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.3 t -82.3 111.15 18.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.067 0.947 . . . . 0.0 111.227 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.61 149.73 25.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.571 1.148 . . . . 0.0 110.747 175.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.5 t -80.26 -173.84 4.23 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.828 1.251 . . . . 0.0 111.334 174.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.9 t -149.14 177.13 9.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.466 1.506 . . . . 0.0 111.878 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -71.18 162.74 54.17 Favored Glycine 0 CA--C 1.543 1.833 0 C-N-CA 124.5 1.048 . . . . 0.0 114.133 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.73 8.71 4.1 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.663 3.575 . . . . 0.0 113.886 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.8 p -69.34 153.47 43.56 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.006 1.323 . . . . 0.0 113.268 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.6 p -78.7 148.16 33.2 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.865 -1.147 . . . . 0.0 113.472 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 C-N-CA 125.213 1.387 . . . . 0.0 112.821 -179.3 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.6 m -146.61 141.34 26.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.978 1.311 . . . . 0.0 110.998 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.3 m 69.01 -5.64 1.01 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.736 2.015 . . . . 0.0 115.747 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.23 169.36 30.52 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.893 1.711 . . . . 0.0 113.377 175.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.6 t -163.82 172.96 13.35 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.697 1.599 . . . . 0.0 111.074 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.3 p -84.61 151.83 24.24 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.805 1.242 . . . . 0.0 112.711 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.04 117.25 4.42 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.975 0.798 . . . . 0.0 112.065 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.64 163.88 31.28 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.932 1.254 . . . . 0.0 112.43 172.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -143.93 140.23 29.58 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.022 1.329 . . . . 0.0 110.782 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -93.06 33.85 1.15 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.353 1.461 . . . . 0.0 113.831 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.9 p -65.77 -15.96 63.34 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.313 1.845 . . . . 0.0 114.228 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -154.45 171.81 18.76 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.317 1.847 . . . . 0.0 110.649 171.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.5 m -55.01 128.07 31.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.344 1.458 . . . . 0.0 110.537 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -60.07 131.59 51.31 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.44 1.096 . . . . 0.0 110.797 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -70.17 -59.03 3.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.103 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.5 p 49.61 29.13 2.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.693 1.597 . . . . 0.0 114.832 174.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -86.11 135.01 33.77 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.233 1.413 . . . . 0.0 111.406 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -120.83 127.4 51.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.809 1.643 . . . . 0.0 110.206 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -89.65 135.7 33.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.731 2.013 . . . . 0.0 108.13 171.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.63 113.22 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.048 0.939 . . . . 0.0 109.46 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.16 174.41 21.33 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.606 1.574 . . . . 0.0 113.271 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 m120 66.48 16.61 10.46 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.028 1.731 . . . . 0.0 113.761 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.5 mt -60.8 140.52 93.25 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 121.156 -0.965 . . . . 0.0 113.033 -170.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -68.67 159.28 54.31 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.08 3.187 . . . . 0.0 111.745 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.95 -1.47 11.25 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.572 2.848 . . . . 0.0 114.031 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -116.84 12.49 14.79 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.682 1.593 . . . . 0.0 113.0 -174.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 tp -82.24 137.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.42 1.088 . . . . 0.0 110.734 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.5 p -128.86 176.18 8.05 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.261 1.424 . . . . 0.0 110.009 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -54.22 -32.82 56.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.913 0.885 . . . . 0.0 112.202 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -73.34 -34.01 65.43 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.784 0.834 . . . . 0.0 112.479 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -71.48 -44.13 65.3 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.654 0.661 . . . . 0.0 110.56 170.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.9 ttt -65.28 -33.26 75.57 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -63.98 -45.15 90.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.068 0.947 . . . . 0.0 111.318 169.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -70.84 -38.51 73.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.634 0.774 . . . . 0.0 112.825 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.8 mt -59.62 -24.21 63.63 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.551 1.54 . . . . 0.0 113.328 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -113.2 10.25 18.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.577 1.551 . . . . 0.0 112.539 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -21.33 65.42 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.63 -20.52 60.97 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.038 1.335 . . . . 0.0 112.593 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -112.47 11.59 19.87 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.257 2.223 . . . . 0.0 111.855 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.5 -169.99 52.98 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.479 1.037 . . . . 0.0 113.211 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -71.63 129.6 39.11 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.014 -0.698 . . . . 0.0 111.293 174.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.9 149.73 43.2 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.058 0.943 . . . . 0.0 111.439 172.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.23 -12.89 75.26 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.717 1.151 . . . . 0.0 113.78 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -156.12 138.08 14.47 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.88 1.672 . . . . 0.0 109.316 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.8 t -141.69 127.68 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.437 1.495 . . . . 0.0 108.801 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -145.2 139.15 27.0 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.562 1.145 . . . . 0.0 111.936 176.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 70.7 mt -139.86 137.8 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.485 1.914 . . . . 0.0 107.978 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -143.51 129.17 19.23 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 122.63 1.205 . . . . 0.0 113.897 169.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -74.21 -11.49 60.3 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.313 1.445 . . . . 0.0 113.463 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -55.17 -32.09 61.89 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.45 1.5 . . . . 0.0 113.031 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -123.73 -20.67 5.4 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.39 42.35 7.47 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 119.26 0.936 . . . . 0.0 113.252 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -137.78 154.75 49.54 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.734 1.614 . . . . 0.0 111.151 -177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.64 162.08 25.12 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.099 1.333 . . . . 0.0 113.647 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -137.27 139.71 41.13 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.921 2.088 . . . . 0.0 109.167 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.93 139.99 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.124 0.97 . . . . 0.0 110.313 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -125.88 116.17 21.11 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.95 0.9 . . . . 0.0 110.292 -172.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.5 mt -92.83 167.86 11.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.1 0.56 . . . . 0.0 111.242 -174.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -76.31 -19.53 58.16 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.2 p -143.8 155.11 44.03 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.643 1.177 . . . . 0.0 111.649 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 37.4 ptt-85 -60.11 -36.01 76.51 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.716 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.1 m -62.19 -50.62 71.08 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.351 1.46 . . . . 0.0 110.698 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -65.32 -37.6 87.6 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.692 -0.67 . . . . 0.0 111.758 176.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.02 89.55 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.106 0.866 . . . . 0.0 113.129 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -65.6 -49.57 68.29 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.678 0.791 . . . . 0.0 111.531 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.71 -48.45 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.967 -0.458 . . . . 0.0 110.125 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.44 -46.56 86.29 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.596 0.758 . . . . 0.0 112.204 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -60.17 -42.42 94.96 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.247 -0.908 . . . . 0.0 112.15 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.17 -35.21 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.828 0.74 . . . . 0.0 112.049 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.69 -30.78 32.48 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 60.8 mt -104.73 -19.52 13.91 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -169.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -67.71 128.33 36.06 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.207 0.912 . . . . 0.0 111.664 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.1 t30 70.83 17.87 6.3 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 128.034 2.534 . . . . 0.0 113.348 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 61.6 ttp -76.49 138.17 67.33 Favored Pre-proline 0 N--CA 1.475 0.805 0 O-C-N 120.796 -1.19 . . . . 0.0 111.343 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.65 143.6 21.49 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.444 2.763 . . . . 0.0 111.708 175.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.2 tp -146.73 115.51 6.84 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.413 1.485 . . . . 0.0 110.247 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 57.08 25.68 11.11 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.513 1.525 . . . . 0.0 114.164 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.16 -1.96 78.07 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.225 1.393 . . . . 0.0 114.607 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -100.41 166.85 10.74 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.581 1.552 . . . . 0.0 111.191 169.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -92.66 175.21 6.9 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.481 1.112 . . . . 0.0 109.904 171.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.6 mt -136.9 110.25 7.89 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.745 1.218 . . . . 0.0 108.89 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.06 122.39 37.68 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.71 125.49 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.87 0.868 . . . . 0.0 110.846 -175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -139.67 166.71 23.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.885 1.674 . . . . 0.0 111.164 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -77.71 134.46 38.1 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.602 -0.687 . . . . 0.0 111.482 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.72 80.4 5.32 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.173 0.989 . . . . 0.0 110.645 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 10.5 t -163.38 160.01 23.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.18 1.792 . . . . 0.0 110.686 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -61.12 -23.85 65.82 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 37.1 m 61.48 29.54 18.44 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.198 1.399 . . . . 0.0 113.626 170.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.21 146.26 35.01 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.45 1.5 . . . . 0.0 111.809 -173.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.4 p -169.5 166.63 10.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.361 1.864 . . . . 0.0 110.608 -173.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -66.1 144.03 56.94 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.619 -0.676 . . . . 0.0 112.178 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 20.6 p -87.94 149.61 23.96 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.139 1.376 . . . . 0.0 110.48 172.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 18.4 p -67.8 142.76 56.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.233 0.613 . . . . 0.0 111.551 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.27 145.93 48.21 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-O 118.796 -1.002 . . . . 0.0 112.223 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.4 139.22 48.82 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.23 2.62 . . . . 0.0 110.907 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.7 t -123.63 33.48 5.32 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.053 1.341 . . . . 0.0 111.174 -173.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.1 t -149.34 134.84 18.5 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.975 1.71 . . . . 0.0 110.276 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.193 1.378 . . . . 0.0 113.256 -173.801 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 t 63.53 35.63 11.72 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.066 1.347 . . . . 0.0 113.431 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 t -149.4 140.15 22.69 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.676 -1.265 . . . . 0.0 111.923 -175.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.89 -101.54 2.38 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 125.91 1.719 . . . . 0.0 111.475 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.5 m 67.31 25.45 8.77 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.394 1.477 . . . . 0.0 113.913 171.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 t -155.28 152.5 29.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.396 1.479 . . . . 0.0 111.465 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 164.5 -159.14 32.04 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.031 1.3 . . . . 0.0 113.552 -176.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.83 -179.33 42.81 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.951 1.263 . . . . 0.0 113.887 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -165.11 146.09 7.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.579 1.951 . . . . 0.0 109.285 -175.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.57 136.77 36.62 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.09 0.956 . . . . 0.0 110.794 173.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.2 m -60.65 -29.74 69.45 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.557 1.543 . . . . 0.0 112.489 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -134.72 129.85 35.34 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.731 1.612 . . . . 0.0 109.372 176.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.6 t -165.68 171.67 12.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.664 1.586 . . . . 0.0 110.82 -174.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -140.94 77.69 1.61 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.837 1.655 . . . . 0.0 109.169 -176.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 64.5 mtm-85 -68.82 142.49 54.85 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.839 0.828 . . . . 0.0 112.629 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.5 m -98.06 28.51 3.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.619 1.568 . . . . 0.0 112.181 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -97.56 131.55 44.05 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.719 1.208 . . . . 0.0 112.026 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.9 mt -102.98 152.45 21.31 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.64 1.976 . . . . 0.0 110.586 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.428 ' CD2' ' HD3' ' A' ' 144' ' ' ARG . 12.1 t80 -124.48 126.28 45.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.778 2.431 . . . . 0.0 108.076 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.31 111.6 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.567 1.147 . . . . 0.0 109.478 -169.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.57 167.23 25.75 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.79 1.186 . . . . 0.0 112.619 173.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 64.97 26.49 12.72 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.61 1.564 . . . . 0.0 113.217 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.53 144.01 95.91 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 121.074 -1.016 . . . . 0.0 111.345 176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.38 161.8 44.71 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.79 2.993 . . . . 0.0 111.85 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.03 6.08 1.9 Allowed 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 124.157 3.238 . . . . 0.0 114.347 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -140.43 19.0 2.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.462 1.505 . . . . 0.0 114.335 -172.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.4 tp -73.07 150.72 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.065 0.946 . . . . 0.0 110.151 169.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.1 p -126.83 163.54 23.37 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.081 1.352 . . . . 0.0 110.619 170.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -58.16 -32.96 68.71 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.14 0.576 . . . . 0.0 111.44 170.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -68.26 -42.44 79.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 111.673 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -65.11 -40.73 94.92 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.884 -0.51 . . . . 0.0 111.802 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.9 ttt -66.51 -38.6 87.59 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.656 0.662 . . . . 0.0 111.629 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -62.95 -38.73 92.25 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.52 1.128 . . . . 0.0 111.707 173.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.91 -45.45 61.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.96 1.304 . . . . 0.0 111.32 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.59 -29.09 58.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.007 1.323 . . . . 0.0 113.524 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -107.07 10.03 30.34 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.371 1.468 . . . . 0.0 112.792 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.06 -23.42 67.17 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -58.5 -26.72 63.77 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.976 1.31 . . . . 0.0 112.863 171.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -101.47 10.7 40.15 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.964 1.706 . . . . 0.0 112.729 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.18 -167.84 43.97 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.777 1.18 . . . . 0.0 112.625 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -79.06 123.73 27.62 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.952 -0.734 . . . . 0.0 110.265 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.82 143.64 54.52 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.8 0.84 . . . . 0.0 111.581 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -86.18 -9.32 76.88 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.792 1.187 . . . . 0.0 114.117 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -155.44 134.39 12.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.296 1.838 . . . . 0.0 108.48 173.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.5 t -140.54 125.77 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.196 1.398 . . . . 0.0 109.112 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -140.74 140.35 34.81 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.628 1.571 . . . . 0.0 111.238 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 62.0 mt -140.21 130.57 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.838 1.655 . . . . 0.0 108.211 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -120.34 108.16 13.81 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.798 0.839 . . . . 0.0 112.079 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -73.73 -17.86 61.06 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -171.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -78.98 -19.42 51.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.115 0.966 . . . . 0.0 112.758 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -108.28 -29.28 8.97 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.744 1.218 . . . . 0.0 113.615 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.79 28.18 27.11 Favored Glycine 0 N--CA 1.475 1.295 0 C-N-CA 124.608 1.099 . . . . 0.0 114.182 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -133.86 156.95 47.16 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.519 1.527 . . . . 0.0 111.893 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.75 165.8 27.53 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.865 1.221 . . . . 0.0 113.615 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -136.33 146.58 46.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.555 1.942 . . . . 0.0 109.78 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.6 tt -153.26 127.39 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.583 0.753 . . . . 0.0 111.43 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -114.0 121.15 43.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.155 0.982 . . . . 0.0 111.176 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.0 mt -97.42 167.15 11.17 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.74 0.816 . . . . 0.0 110.73 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -70.37 -24.07 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.7 p -145.52 160.7 41.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.466 1.506 . . . . 0.0 111.138 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -62.49 -31.76 72.56 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 119.01 -0.519 . . . . 0.0 111.985 173.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.0 m -61.24 -47.19 87.2 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.91 1.284 . . . . 0.0 110.564 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.0 mt -61.06 -45.78 93.36 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.298 0.639 . . . . 0.0 111.076 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.46 -36.15 83.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -68.49 -44.26 75.12 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.064 1.345 . . . . 0.0 111.428 175.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -62.53 -52.0 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.432 -0.793 . . . . 0.0 109.883 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.15 90.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.625 0.77 . . . . 0.0 112.389 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -52.94 -50.05 64.8 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.032 0.933 . . . . 0.0 111.679 172.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.4 t -74.68 -36.23 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.389 0.54 . . . . 0.0 111.852 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -77.29 -21.32 53.73 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 66.5 mt -110.83 0.11 17.12 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.521 1.128 . . . . 0.0 113.758 -174.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.67 125.9 26.72 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.14 -0.975 . . . . 0.0 112.218 -176.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 57.51 22.4 8.05 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.479 1.912 . . . . 0.0 113.5 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 51.0 ttp -63.81 133.55 95.6 Favored Pre-proline 0 N--CA 1.472 0.652 0 O-C-N 120.777 -1.202 . . . . 0.0 111.09 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -73.54 127.33 11.65 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.003 2.469 . . . . 0.0 110.432 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 45.6 tp -135.51 107.46 7.11 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.813 1.645 . . . . 0.0 108.117 170.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 57.81 29.18 17.07 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.769 1.228 . . . . 0.0 113.202 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.74 -5.61 62.12 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.249 1.88 . . . . 0.0 115.066 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -101.23 142.19 33.02 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.151 1.38 . . . . 0.0 111.025 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -102.14 117.4 34.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.88 0.872 . . . . 0.0 109.736 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.42 119.15 23.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.665 1.186 . . . . 0.0 112.28 -169.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -97.29 106.63 18.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.3 0.64 . . . . 0.0 110.312 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.44 129.24 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.512 1.125 . . . . 0.0 110.595 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.428 ' HD3' ' CD2' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -134.11 170.4 15.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.518 1.927 . . . . 0.0 110.819 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -90.57 140.42 29.77 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.522 0.729 . . . . 0.0 110.952 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -94.07 64.58 3.33 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.004 1.322 . . . . 0.0 111.791 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 29.9 p -158.51 173.78 16.09 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.68 1.592 . . . . 0.0 112.634 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -153.77 138.38 16.91 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.678 1.591 . . . . 0.0 111.731 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 8.5 t -168.68 -172.81 1.72 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.216 1.806 . . . . 0.0 110.372 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.71 115.98 11.12 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.795 1.638 . . . . 0.0 110.045 175.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.8 t -104.25 37.88 1.99 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.168 1.387 . . . . 0.0 111.319 -176.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.6 mt -134.63 167.31 21.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.732 2.013 . . . . 0.0 111.252 -171.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.5 t -156.5 160.39 39.48 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.052 1.741 . . . . 0.0 110.321 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 27.4 p -80.81 140.0 35.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.528 1.131 . . . . 0.0 112.63 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.25 -54.72 27.99 Favored Glycine 0 CA--C 1.539 1.581 0 CA-C-O 118.108 -1.385 . . . . 0.0 114.051 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -83.1 62.68 7.66 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.754 2.969 . . . . 0.0 110.824 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 62.8 p -81.78 151.24 27.52 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.594 1.158 . . . . 0.0 113.075 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 75.6 m -146.34 143.79 29.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.331 1.452 . . . . 0.0 111.161 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 C-N-CA 125.0 1.286 . . . . 0.0 113.146 178.781 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.8 t -85.99 131.33 34.3 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.625 -0.926 . . . . 0.0 111.279 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 p -82.41 98.63 8.97 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.253 1.021 . . . . 0.0 111.295 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.19 -134.58 7.02 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.381 1.467 . . . . 0.0 112.882 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.5 p -159.68 -179.5 7.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.609 1.563 . . . . 0.0 111.62 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.2 t -151.35 152.13 32.72 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.89 1.276 . . . . 0.0 110.978 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.29 13.12 77.45 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.3 0.953 . . . . 0.0 114.316 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.94 -148.77 19.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.406 1.479 . . . . 0.0 113.002 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -155.2 144.98 21.44 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.544 1.537 . . . . 0.0 109.806 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -83.23 -12.72 56.54 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -169.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.6 p -90.37 173.96 7.83 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.003 1.721 . . . . 0.0 111.578 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -57.38 131.21 49.4 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.038 0.935 . . . . 0.0 111.321 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 100.0 m -130.15 139.81 50.84 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.792 1.637 . . . . 0.0 109.824 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -69.15 150.56 47.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.988 1.315 . . . . 0.0 113.178 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -99.93 23.96 9.12 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.728 1.211 . . . . 0.0 113.952 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.5 p -78.38 8.26 5.33 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -77.03 121.38 23.45 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.497 1.119 . . . . 0.0 110.599 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 97.4 mt -105.1 134.32 48.4 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.705 1.602 . . . . 0.0 110.354 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -91.94 135.31 34.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.049 2.14 . . . . 0.0 108.086 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.3 t -131.48 106.22 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.353 1.061 . . . . 0.0 108.884 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.01 163.08 15.19 Favored Glycine 0 N--CA 1.464 0.546 0 C-N-CA 124.991 1.281 . . . . 0.0 113.724 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 t30 68.7 27.56 5.87 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.85 1.66 . . . . 0.0 112.745 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.4 mt -62.74 145.57 95.55 Favored Pre-proline 0 CA--C 1.549 0.937 0 O-C-N 121.187 -0.946 . . . . 0.0 111.854 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.1 165.86 31.03 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.209 3.273 . . . . 0.0 111.777 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.19 -5.98 17.77 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.091 2.528 . . . . 0.0 113.4 175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -106.87 0.48 23.96 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.124 1.37 . . . . 0.0 114.181 -172.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 tp -74.25 143.2 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.268 -0.895 . . . . 0.0 111.129 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 65.7 p -128.23 166.51 18.41 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.035 1.734 . . . . 0.0 110.074 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -58.96 -31.98 69.23 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.033 0.533 . . . . 0.0 111.536 171.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -70.76 -42.09 70.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.213 1.005 . . . . 0.0 111.924 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -66.28 -41.86 89.22 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.78 0.718 . . . . 0.0 111.302 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.8 tpt -65.11 -37.92 89.03 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.891 -0.505 . . . . 0.0 111.629 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -63.11 -48.4 78.71 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.404 -0.81 . . . . 0.0 110.273 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -60.49 -38.89 85.73 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.196 0.998 . . . . 0.0 113.296 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.6 mt -63.99 -29.78 70.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.38 1.472 . . . . 0.0 113.988 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.434 ' CZ ' HD13 ' A' ' 131' ' ' LEU . 47.8 m-85 -109.89 -4.0 16.26 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.69 1.196 . . . . 0.0 113.51 -176.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.38 -27.52 67.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.927 1.691 . . . . 0.0 115.16 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -55.78 -24.43 35.62 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.961 1.304 . . . . 0.0 112.707 171.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -107.02 14.54 26.27 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.937 2.095 . . . . 0.0 112.029 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.02 172.66 44.97 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.137 1.827 . . . . 0.0 112.78 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.57 132.91 46.21 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.873 -0.78 . . . . 0.0 110.931 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.1 145.44 51.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.885 0.874 . . . . 0.0 112.163 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -85.05 -11.59 75.93 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.631 1.11 . . . . 0.0 113.905 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -157.69 135.92 11.01 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.712 2.005 . . . . 0.0 108.371 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.34 128.84 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.265 1.426 . . . . 0.0 108.609 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -140.87 139.88 34.5 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.147 1.379 . . . . 0.0 110.904 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.8 mt -139.1 120.6 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.371 1.469 . . . . 0.0 108.312 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -115.97 98.18 6.5 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.234 1.014 . . . . 0.0 112.12 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.07 -15.86 62.02 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -174.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.92 -23.61 60.72 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.278 1.031 . . . . 0.0 112.697 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -117.06 -25.27 7.23 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.59 27.7 18.97 Favored Glycine 0 N--CA 1.477 1.428 0 C-N-CA 124.569 1.081 . . . . 0.0 114.171 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.91 150.54 52.15 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.373 1.469 . . . . 0.0 111.46 -174.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.64 167.4 25.32 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.56 1.552 . . . . 0.0 113.08 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -139.52 142.62 37.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.468 1.907 . . . . 0.0 109.402 -175.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 tt -151.65 130.65 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.382 0.673 . . . . 0.0 111.454 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.49 122.38 45.88 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.611 1.164 . . . . 0.0 110.441 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 mt -97.59 168.41 10.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.005 0.522 . . . . 0.0 111.085 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -67.58 -32.4 73.12 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -171.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.9 p -140.44 159.32 42.45 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.827 1.251 . . . . 0.0 112.102 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -60.88 -31.95 71.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.818 0.847 . . . . 0.0 113.001 173.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m -68.71 -47.93 65.14 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.161 1.384 . . . . 0.0 110.658 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.8 mt -58.88 -42.34 89.23 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.614 0.766 . . . . 0.0 111.261 173.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.67 -35.39 78.76 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -65.79 -47.25 75.76 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.742 1.155 . . . . 0.0 111.361 172.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.7 mt -59.43 -48.73 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.19 0.596 . . . . 0.0 110.316 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.55 -44.98 93.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.203 0.601 . . . . 0.0 112.033 176.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -57.54 -49.0 77.76 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.412 1.005 . . . . 0.0 111.182 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.86 -35.87 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.192 0.597 . . . . 0.0 111.963 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -83.48 -24.32 31.82 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.434 HD13 ' CZ ' ' A' ' 96' ' ' PHE . 55.3 mt -111.23 -18.48 12.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -171.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.67 128.39 35.77 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.897 1.226 . . . . 0.0 111.975 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 59.5 27.47 16.63 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.897 2.079 . . . . 0.0 113.364 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 47.8 ttp -74.72 137.43 73.73 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.535 -0.728 . . . . 0.0 109.664 169.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.31 136.3 15.81 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.315 2.677 . . . . 0.0 111.058 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -145.12 123.49 12.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.971 1.708 . . . . 0.0 109.0 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 58.83 22.87 10.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.775 1.23 . . . . 0.0 113.716 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.15 3.1 85.29 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.317 1.436 . . . . 0.0 114.474 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -106.17 148.91 27.33 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.17 1.788 . . . . 0.0 110.879 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -84.22 168.47 15.7 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.538 -0.726 . . . . 0.0 109.339 168.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.01 127.87 37.13 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.29 1.036 . . . . 0.0 110.701 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.63 111.34 23.52 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.84 0.856 . . . . 0.0 108.902 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.94 124.21 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.767 0.827 . . . . 0.0 109.822 -173.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.9 ptt85 -149.63 173.6 13.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.311 1.444 . . . . 0.0 111.247 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -75.2 144.97 42.41 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.616 -0.678 . . . . 0.0 111.85 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.02 17.99 3.84 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.221 1.408 . . . . 0.0 113.095 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 89.3 m -53.5 128.64 29.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.919 1.687 . . . . 0.0 112.99 -177.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -76.34 160.95 29.12 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.14 0.976 . . . . 0.0 112.025 171.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.3 t -149.25 119.09 7.07 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.44 0.696 . . . . 0.0 110.373 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.34 113.65 1.85 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.836 1.654 . . . . 0.0 109.747 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.1 t -169.03 163.26 11.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.113 1.765 . . . . 0.0 110.266 -177.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.16 134.56 54.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.166 1.386 . . . . 0.0 110.109 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.8 m -70.51 -28.49 65.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.863 1.265 . . . . 0.0 112.115 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 21.1 t -77.65 120.6 22.81 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.699 0.8 . . . . 0.0 110.876 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 164.2 90.11 0.08 OUTLIER Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.402 -1.221 . . . . 0.0 111.999 -177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.11 156.06 38.02 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.562 2.841 . . . . 0.0 111.904 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.9 t -80.84 146.89 30.66 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.871 0.868 . . . . 0.0 111.677 173.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.4 p -73.51 145.47 45.59 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.003 -1.061 . . . . 0.0 112.843 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 125.154 1.359 . . . . 0.0 112.899 -179.469 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.0 t -81.76 167.24 19.3 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.541 -0.976 . . . . 0.0 111.929 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.3 t -169.15 -165.18 0.51 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.183 1.793 . . . . 0.0 110.55 -173.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.88 -105.69 1.33 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.283 1.42 . . . . 0.0 111.969 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -64.62 -15.75 61.66 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.694 1.198 . . . . 0.0 113.39 172.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.8 m -123.98 59.7 1.14 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.675 1.59 . . . . 0.0 110.903 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.07 55.09 3.92 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.719 1.628 . . . . 0.0 113.246 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.59 -177.86 45.47 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.739 1.638 . . . . 0.0 113.518 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -79.38 135.76 36.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.383 1.073 . . . . 0.0 111.061 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.49 160.73 26.97 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.3 p -128.2 157.8 39.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.882 1.673 . . . . 0.0 110.834 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -82.03 155.08 25.33 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.078 0.951 . . . . 0.0 111.636 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.4 p -141.59 144.69 34.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.639 1.576 . . . . 0.0 110.504 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -104.85 29.34 6.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.202 1.401 . . . . 0.0 112.123 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.4 ttm105 -142.71 125.8 16.35 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.571 1.548 . . . . 0.0 111.04 -172.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.4 m -93.28 28.27 2.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.519 1.527 . . . . 0.0 113.409 -173.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -85.88 122.19 29.59 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.05 1.34 . . . . 0.0 111.443 -176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.6 mt -105.15 135.85 45.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.329 1.852 . . . . 0.0 110.066 175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -90.87 138.53 31.52 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.144 1.777 . . . . 0.0 108.723 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.93 106.06 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.24 1.016 . . . . 0.0 108.788 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.79 168.74 20.63 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 125.454 1.502 . . . . 0.0 112.83 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.1 m120 61.48 35.36 17.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.828 1.251 . . . . 0.0 112.045 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.7 mt -66.26 145.78 99.0 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 121.3 -0.875 . . . . 0.0 111.442 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -70.11 158.08 57.65 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.946 2.431 . . . . 0.0 111.338 173.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.24 -2.32 11.48 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.93 3.087 . . . . 0.0 113.333 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -112.99 14.13 19.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.556 1.943 . . . . 0.0 112.604 -175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.25 150.21 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 O-C-N 121.012 -1.055 . . . . 0.0 110.753 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.0 p -136.2 170.06 16.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.832 1.653 . . . . 0.0 109.683 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -58.27 -35.41 71.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.57 0.348 . . . . 0.0 111.464 170.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.44 -41.26 66.35 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.975 0.91 . . . . 0.0 111.806 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.29 -46.79 82.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.233 0.613 . . . . 0.0 111.261 173.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.2 ttt -64.42 -35.51 81.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.116 0.566 . . . . 0.0 112.264 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -64.91 -45.11 87.29 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.415 0.686 . . . . 0.0 110.97 171.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -64.35 -42.98 95.95 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.197 -0.94 . . . . 0.0 111.946 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.1 mt -57.65 -24.61 57.47 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.476 1.51 . . . . 0.0 113.964 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -115.14 -1.85 12.9 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.681 1.192 . . . . 0.0 113.572 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -61.27 -28.79 69.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.728 1.611 . . . . 0.0 115.164 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -61.11 -22.03 64.27 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.523 1.129 . . . . 0.0 112.91 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -103.49 24.99 10.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.912 2.085 . . . . 0.0 111.67 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.24 -176.82 45.52 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.934 1.73 . . . . 0.0 112.664 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.66 144.38 56.97 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.95 -0.735 . . . . 0.0 111.949 175.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.14 118.01 16.6 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.16 -15.15 75.27 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.807 1.194 . . . . 0.0 113.566 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -161.17 145.25 13.33 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.672 1.989 . . . . 0.0 108.677 168.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.8 t -144.35 130.73 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.32 1.448 . . . . 0.0 110.365 -178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -140.52 136.69 33.15 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.405 1.482 . . . . 0.0 110.844 171.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 63.7 mt -139.29 137.03 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.249 1.82 . . . . 0.0 107.84 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -139.55 125.29 19.51 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.135 0.969 . . . . 0.0 113.087 170.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.15 -18.68 62.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.441 1.096 . . . . 0.0 112.779 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.36 -38.72 63.57 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.337 1.855 . . . . 0.0 113.081 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -120.77 -15.32 8.4 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.67 41.16 5.77 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.787 1.184 . . . . 0.0 113.811 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -136.86 159.26 42.39 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.114 1.366 . . . . 0.0 112.223 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.96 167.37 29.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.496 1.046 . . . . 0.0 114.191 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -139.11 147.06 41.45 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.705 2.002 . . . . 0.0 109.571 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.2 tt -147.88 132.28 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.202 1.001 . . . . 0.0 110.646 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.7 ttp85 -101.63 128.42 47.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.965 0.906 . . . . 0.0 109.131 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 124' ' ' ALA . 12.5 mt -98.68 165.99 11.54 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.361 0.528 . . . . 0.0 110.278 170.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -76.5 -18.05 58.95 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -169.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.2 p -144.4 154.3 42.83 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.828 1.251 . . . . 0.0 111.5 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -62.87 -33.15 74.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.61 0.764 . . . . 0.0 112.891 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.1 m -64.48 -47.66 78.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.691 1.196 . . . . 0.0 110.793 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.6 mt -66.71 -35.89 81.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.338 0.655 . . . . 0.0 111.394 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.45 ' HA ' HD12 ' A' ' 118' ' ' LEU . . . -64.8 -39.77 94.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 173.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.94 -47.76 76.51 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.489 1.041 . . . . 0.0 111.214 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 93.9 mt -59.54 -50.41 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.202 0.601 . . . . 0.0 110.272 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.64 -45.68 88.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.093 0.557 . . . . 0.0 111.806 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.38 -46.22 86.79 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.391 -0.818 . . . . 0.0 111.69 176.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 75.1 t -67.56 -35.77 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.516 0.598 . . . . 0.0 111.89 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -80.81 -24.35 38.58 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 48.9 mt -109.09 -16.71 14.05 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.02 133.71 49.47 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.05 1.295 . . . . 0.0 112.615 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 59.4 t30 65.71 15.83 10.22 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.939 2.496 . . . . 0.0 113.757 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.8 ttp -71.43 136.13 83.92 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 120.834 -1.166 . . . . 0.0 110.563 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.93 129.77 11.8 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.363 2.709 . . . . 0.0 110.607 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.9 tp -139.32 113.29 8.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.036 1.335 . . . . 0.0 109.557 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 58.81 23.62 11.45 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.906 1.282 . . . . 0.0 113.478 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.26 -3.37 76.09 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.847 1.689 . . . . 0.0 114.671 -175.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -92.14 147.68 22.75 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.413 1.485 . . . . 0.0 110.7 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -102.67 110.46 22.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.749 0.82 . . . . 0.0 109.348 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 80.4 mt -73.56 121.21 20.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.699 0.8 . . . . 0.0 111.661 -172.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -92.07 112.7 24.73 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.919 0.888 . . . . 0.0 108.8 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.66 120.47 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.186 0.994 . . . . 0.0 110.131 -172.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -155.08 156.09 35.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.773 1.229 . . . . 0.0 111.473 -171.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -67.85 133.03 48.47 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.672 -0.643 . . . . 0.0 111.435 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -85.33 121.74 28.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.121 0.968 . . . . 0.0 110.399 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 27.5 p -158.91 170.51 21.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.061 1.344 . . . . 0.0 112.596 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -158.23 -168.16 2.4 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.932 1.693 . . . . 0.0 112.234 -175.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 80.6 p -151.17 156.42 40.91 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.779 1.232 . . . . 0.0 111.573 174.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.19 134.44 16.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.73 1.212 . . . . 0.0 111.138 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.1 t -104.27 1.28 30.28 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.57 1.148 . . . . 0.0 112.865 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 96.7 mt -53.48 112.63 0.94 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.873 1.669 . . . . 0.0 111.424 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.3 p 50.17 27.38 2.56 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.872 2.469 . . . . 0.0 114.258 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.5 t -112.23 87.57 2.6 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.687 1.195 . . . . 0.0 111.241 -173.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -141.84 95.36 0.19 Allowed Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.268 -1.296 . . . . 0.0 112.331 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -82.14 -8.61 11.87 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.807 3.005 . . . . 0.0 113.438 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.3 m -61.68 145.23 52.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.038 1.335 . . . . 0.0 113.143 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.4 m -62.68 123.05 17.39 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.155 0.982 . . . . 0.0 112.948 -177.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.246 0 C-N-CA 125.377 1.465 . . . . 0.0 113.092 179.381 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.3 m -145.59 154.27 41.96 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.507 1.523 . . . . 0.0 111.168 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.4 t -162.22 165.5 26.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.288 1.435 . . . . 0.0 110.952 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.55 -128.6 8.77 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.309 0.956 . . . . 0.0 111.72 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 p -157.61 136.8 11.78 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.798 1.239 . . . . 0.0 111.438 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.6 m -79.41 136.21 36.9 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.292 -0.88 . . . . 0.0 112.695 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.74 155.88 34.07 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.44 1.019 . . . . 0.0 112.593 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -93.2 -139.1 9.15 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.019 1.295 . . . . 0.0 112.166 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.0 mp0 -72.95 1.9 7.92 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.594 1.557 . . . . 0.0 113.54 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -146.0 158.01 43.87 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.249 1.82 . . . . 0.0 112.152 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.2 m -112.73 97.23 6.43 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.628 1.571 . . . . 0.0 109.728 -175.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -138.06 60.22 1.63 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.606 1.562 . . . . 0.0 109.621 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.4 p -78.93 115.9 18.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.476 1.51 . . . . 0.0 109.884 177.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -165.75 168.01 16.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.582 1.553 . . . . 0.0 111.157 -173.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -139.16 45.29 1.98 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.767 1.627 . . . . 0.0 111.94 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 t -92.59 -0.8 57.27 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.337 1.855 . . . . 0.0 113.58 -174.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -76.73 125.74 29.78 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.762 -1.211 . . . . 0.0 110.973 -175.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.2 mt -114.02 139.28 49.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.238 2.215 . . . . 0.0 110.26 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -100.74 142.56 32.04 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.238 2.215 . . . . 0.0 108.567 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.43 114.89 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.218 1.007 . . . . 0.0 110.001 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.88 173.73 17.03 Favored Glycine 0 N--CA 1.468 0.783 0 C-N-CA 126.021 1.772 . . . . 0.0 113.057 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.2 m120 66.64 11.79 8.38 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.462 1.905 . . . . 0.0 114.024 -175.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.5 mt -53.98 144.24 38.51 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.342 1.057 . . . . 0.0 113.41 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.03 165.29 33.04 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.257 3.305 . . . . 0.0 112.032 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.61 -8.14 20.19 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.389 2.726 . . . . 0.0 113.833 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -121.65 23.25 10.3 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.794 1.638 . . . . 0.0 113.561 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 tp -81.81 143.13 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.806 0.843 . . . . 0.0 110.53 173.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 70.0 p -136.52 167.65 20.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.557 1.943 . . . . 0.0 109.892 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -62.53 -28.54 69.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.32 0.648 . . . . 0.0 112.318 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -72.15 -47.62 49.59 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.993 -1.067 . . . . 0.0 112.496 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -57.82 -41.13 81.57 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.136 0.575 . . . . 0.0 111.86 172.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 11.1 ttt -70.07 -34.73 73.55 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.594 -0.691 . . . . 0.0 112.451 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -68.37 -37.05 80.06 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.518 -0.739 . . . . 0.0 111.906 169.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -68.97 -41.82 77.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.11 0.964 . . . . 0.0 112.449 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.3 mt -58.06 -26.52 62.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.101 1.36 . . . . 0.0 113.46 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -109.23 10.45 25.77 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.545 1.538 . . . . 0.0 112.526 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -66.78 -22.22 66.03 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -61.43 -21.7 64.35 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.602 1.161 . . . . 0.0 112.419 171.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.07 13.12 24.77 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.123 2.169 . . . . 0.0 112.131 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.37 -168.94 53.38 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.827 1.203 . . . . 0.0 112.916 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -76.57 124.75 28.09 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.55 0.74 . . . . 0.0 110.973 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.14 149.43 48.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.205 1.002 . . . . 0.0 111.681 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.07 -13.94 65.38 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.538 1.066 . . . . 0.0 113.914 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -154.79 136.21 14.16 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.853 1.661 . . . . 0.0 108.919 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 t -143.2 128.72 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.708 1.603 . . . . 0.0 109.066 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -145.35 144.32 30.64 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.062 1.345 . . . . 0.0 111.82 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.2 mt -137.68 128.1 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.352 1.461 . . . . 0.0 108.542 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -115.84 92.62 3.96 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.387 1.075 . . . . 0.0 110.542 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -74.54 -12.3 60.43 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.43 -23.24 62.7 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.073 1.349 . . . . 0.0 112.877 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -117.03 -22.37 8.46 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.729 1.212 . . . . 0.0 114.168 175.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.46 36.26 7.05 Favored Glycine 0 N--CA 1.475 1.288 0 C-N-CA 125.09 1.329 . . . . 0.0 114.276 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -141.13 152.08 44.44 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.113 1.365 . . . . 0.0 112.037 -173.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.58 163.01 24.71 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.389 1.471 . . . . 0.0 113.375 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -142.3 140.66 32.26 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.642 1.977 . . . . 0.0 109.156 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 16.9 tt -154.32 148.12 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.829 0.852 . . . . 0.0 110.73 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -138.87 125.78 21.07 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.776 0.83 . . . . 0.0 110.58 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.28 176.85 5.05 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.24 1.016 . . . . 0.0 111.733 -170.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -76.9 -25.29 52.83 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -172.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.6 p -144.66 154.11 42.44 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.348 1.059 . . . . 0.0 112.147 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -58.49 -34.61 71.11 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.659 0.784 . . . . 0.0 112.884 172.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.1 m -62.22 -50.19 72.77 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.251 1.42 . . . . 0.0 110.445 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.11 -36.88 85.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.993 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.77 -37.24 85.79 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.115 0.87 . . . . 0.0 113.282 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -67.95 -45.27 74.72 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.771 0.828 . . . . 0.0 111.808 173.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.76 -48.0 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.57 -0.706 . . . . 0.0 110.243 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.88 91.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.929 0.891 . . . . 0.0 112.017 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -53.69 -53.77 47.33 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.016 0.826 . . . . 0.0 111.479 171.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.8 t -67.88 -33.03 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.582 0.628 . . . . 0.0 112.182 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.71 -36.03 44.03 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.06 -20.84 14.61 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.185 1.179 . . . . 0.0 114.185 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -67.07 134.01 51.0 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.114 0.87 . . . . 0.0 110.908 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . 0.3 0.4 OUTLIER 58.49 17.81 5.19 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.607 2.363 . . . . 0.0 115.246 -170.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 63.3 ttp -75.88 137.59 69.65 Favored Pre-proline 0 CA--C 1.545 0.771 0 O-C-N 120.873 -1.142 . . . . 0.0 110.947 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.73 140.8 21.21 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.467 2.778 . . . . 0.0 111.427 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 32.6 tp -146.56 119.3 8.61 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.459 1.504 . . . . 0.0 110.287 174.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? 58.98 23.9 12.04 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.065 1.346 . . . . 0.0 113.894 171.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.1 1.24 72.92 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.533 1.539 . . . . 0.0 114.734 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -107.66 165.15 11.64 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.669 1.988 . . . . 0.0 110.768 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -90.45 176.29 6.76 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.6 -0.688 . . . . 0.0 109.99 168.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.4 mt -133.85 116.11 15.27 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.6 1.16 . . . . 0.0 109.196 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -92.13 119.87 32.2 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 173.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 53.0 t -124.72 129.99 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.563 0.745 . . . . 0.0 109.926 -176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -146.98 164.4 33.11 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.304 1.442 . . . . 0.0 111.13 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -70.97 130.58 41.97 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 168.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.87 71.12 8.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.88 1.272 . . . . 0.0 110.759 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 6.1 t -155.44 169.58 23.93 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.34 1.456 . . . . 0.0 112.016 -170.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.77 176.92 11.75 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.56 2.344 . . . . 0.0 110.935 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.4 t -148.34 143.17 26.7 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.977 -1.077 . . . . 0.0 112.428 -175.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.85 45.54 0.82 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.945 1.698 . . . . 0.0 112.811 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 67.8 m -77.91 105.46 9.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.269 1.028 . . . . 0.0 111.102 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.52 142.64 33.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.112 0.965 . . . . 0.0 110.101 173.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 56.7 m -145.57 131.97 19.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.998 1.719 . . . . 0.0 108.783 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.0 t -162.06 148.52 13.55 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.923 1.289 . . . . 0.0 111.004 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -163.63 79.9 0.13 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.468 -1.185 . . . . 0.0 112.702 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.81 -8.55 14.54 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.911 3.074 . . . . 0.0 113.461 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.6 m -61.2 138.9 58.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.051 1.34 . . . . 0.0 113.126 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.3 p -73.19 126.49 30.18 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.121 -0.987 . . . . 0.0 112.403 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.255 0 C-N-CA 125.211 1.386 . . . . 0.0 112.988 178.94 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.465 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.6 m -142.65 123.34 14.18 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.668 1.187 . . . . 0.0 110.926 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -168.07 152.13 6.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.531 1.532 . . . . 0.0 110.899 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.97 175.35 53.07 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.322 0.963 . . . . 0.0 112.451 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.9 p -76.76 152.54 35.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.97 0.908 . . . . 0.0 112.465 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.4 t -96.37 3.41 52.92 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.963 -1.085 . . . . 0.0 113.86 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.51 -156.57 43.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.698 1.142 . . . . 0.0 112.69 -175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.9 -150.78 32.91 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.434 1.016 . . . . 0.0 112.973 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -72.88 152.41 41.49 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.167 0.987 . . . . 0.0 111.902 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.69 158.13 25.43 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.7 p -104.72 170.64 7.77 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.747 1.619 . . . . 0.0 111.337 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -143.26 140.44 30.65 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.275 1.43 . . . . 0.0 110.564 -170.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -89.31 152.56 21.47 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.853 0.861 . . . . 0.0 111.417 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -95.65 -11.11 27.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.034 1.334 . . . . 0.0 112.414 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -140.44 141.84 35.44 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.182 1.393 . . . . 0.0 111.696 -171.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.8 p -98.29 20.09 13.15 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.17 1.788 . . . . 0.0 113.189 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -76.52 128.5 34.87 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.597 1.159 . . . . 0.0 111.311 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.02 140.28 49.42 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.181 1.792 . . . . 0.0 110.468 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -95.9 140.72 30.26 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.536 2.334 . . . . 0.0 108.814 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.2 110.46 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.94 0.896 . . . . 0.0 109.401 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.34 172.35 21.22 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.447 1.498 . . . . 0.0 113.321 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.0 m120 65.25 19.09 11.63 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.669 1.588 . . . . 0.0 113.128 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.1 mt -58.79 143.46 82.68 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.252 1.021 . . . . 0.0 111.857 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.7 158.57 56.57 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.696 2.93 . . . . 0.0 111.255 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.83 0.36 7.82 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.422 2.748 . . . . 0.0 113.568 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -114.64 4.75 15.18 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.943 1.697 . . . . 0.0 113.639 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.5 tp -74.03 142.41 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.28 -0.887 . . . . 0.0 111.247 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.7 p -123.72 165.59 17.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.971 1.708 . . . . 0.0 110.051 175.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.72 -27.78 68.16 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.699 0.399 . . . . 0.0 111.918 172.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.08 -40.27 62.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.168 0.987 . . . . 0.0 111.76 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -67.54 -37.81 83.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.637 0.653 . . . . 0.0 111.466 172.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.2 tpt -66.38 -40.98 90.03 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.641 -0.662 . . . . 0.0 111.657 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -60.56 -38.15 83.59 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.657 -0.652 . . . . 0.0 111.101 172.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -72.02 -40.3 68.56 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.05 0.94 . . . . 0.0 113.333 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 38.0 mt -56.02 -29.52 60.5 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.792 1.237 . . . . 0.0 112.766 173.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -109.05 12.88 24.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.446 1.498 . . . . 0.0 113.152 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.22 -20.18 61.6 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.804 -1.185 . . . . 0.0 114.006 -174.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -64.53 -17.89 64.33 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.556 -0.715 . . . . 0.0 112.269 173.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -102.71 8.4 39.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.829 2.052 . . . . 0.0 112.178 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.08 -109.03 3.77 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.09 157.54 46.47 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.628 1.171 . . . . 0.0 112.413 170.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.97 151.11 26.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.742 0.817 . . . . 0.0 110.228 168.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -88.81 -14.31 61.27 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.697 1.142 . . . . 0.0 113.299 173.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -153.42 144.92 23.24 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.003 1.321 . . . . 0.0 110.622 170.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.29 128.8 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.549 1.94 . . . . 0.0 109.205 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -140.62 138.55 34.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.12 1.368 . . . . 0.0 111.514 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.4 mt -141.97 126.34 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.83 1.652 . . . . 0.0 107.816 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -118.18 106.81 13.22 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.932 0.872 . . . . 0.0 112.541 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -65.06 -27.18 68.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.989 1.316 . . . . 0.0 114.088 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.45 -9.08 59.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.851 1.261 . . . . 0.0 112.881 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -114.79 -32.7 5.72 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.132 1.373 . . . . 0.0 112.874 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.72 26.86 28.42 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.705 1.145 . . . . 0.0 113.753 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -138.65 155.18 48.51 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.717 1.607 . . . . 0.0 111.505 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.1 167.48 26.83 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.926 1.251 . . . . 0.0 113.677 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -139.18 148.14 42.75 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.729 2.011 . . . . 0.0 109.76 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.8 tt -154.76 138.93 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.955 0.902 . . . . 0.0 110.609 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -121.93 113.21 19.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.208 1.003 . . . . 0.0 109.87 -171.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.9 mt -88.48 167.05 13.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.135 0.574 . . . . 0.0 111.825 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -75.73 -17.32 59.96 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.7 p -145.44 159.92 42.36 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.369 1.467 . . . . 0.0 110.566 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -64.93 -34.35 78.2 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 171.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.8 m -55.71 -45.39 77.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.59 1.156 . . . . 0.0 111.119 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.2 -42.7 96.51 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.05 -0.5 . . . . 0.0 111.492 173.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.39 98.93 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.35 -51.25 70.16 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 120.353 1.433 . . . . 0.0 112.721 170.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.29 -45.9 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 O-C-N 121.905 -0.497 . . . . 0.0 110.293 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.81 94.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.362 0.665 . . . . 0.0 112.021 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.43 -45.1 94.86 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.397 -0.814 . . . . 0.0 111.564 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.76 -36.95 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 118.623 0.647 . . . . 0.0 112.006 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.08 -35.88 36.33 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 50.6 mt -96.78 -19.74 18.7 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -171.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -59.36 120.84 10.06 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.496 0.718 . . . . 0.0 111.762 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 64.32 21.59 12.55 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.964 2.106 . . . . 0.0 113.486 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 58.7 ttp -72.34 136.62 81.34 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 120.811 -1.181 . . . . 0.0 110.574 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.66 140.63 21.25 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.457 2.772 . . . . 0.0 111.628 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -148.44 116.43 6.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.619 1.568 . . . . 0.0 109.938 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 53.49 38.98 29.35 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.91 1.284 . . . . 0.0 113.288 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.88 77.62 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.379 1.466 . . . . 0.0 114.686 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -101.03 160.74 14.12 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.996 1.718 . . . . 0.0 110.45 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -93.89 173.14 7.82 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.985 0.914 . . . . 0.0 109.42 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 89.7 mt -133.0 110.35 10.19 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.214 1.005 . . . . 0.0 109.577 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 106.26 18.24 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -176.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.5 132.04 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 122.83 0.452 . . . . 0.0 111.602 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -139.22 169.1 18.39 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.547 1.939 . . . . 0.0 110.812 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -84.64 130.15 34.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.649 0.779 . . . . 0.0 111.077 169.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -97.97 53.63 1.1 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.75 1.62 . . . . 0.0 111.669 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . . . . . . . . . 85.6 m -83.32 140.5 32.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.442 1.097 . . . . 0.0 112.075 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.27 5.49 51.59 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -174.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 69.9 m -138.32 168.33 19.97 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.122 1.769 . . . . 0.0 111.872 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -145.48 163.99 32.96 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.459 1.504 . . . . 0.0 112.086 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 74.1 m -145.26 158.63 43.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.839 1.656 . . . . 0.0 111.45 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 93.7 mt -104.85 124.05 48.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.798 1.239 . . . . 0.0 110.745 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 12.0 m -85.38 -19.19 31.77 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.111 1.364 . . . . 0.0 112.606 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 42.4 p -128.37 139.86 52.16 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.478 1.511 . . . . 0.0 112.086 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -170.02 86.49 0.09 OUTLIER Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.391 -1.227 . . . . 0.0 112.712 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.99 152.83 32.09 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.842 3.028 . . . . 0.0 111.587 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.7 m -149.68 130.9 14.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.034 1.334 . . . . 0.0 110.752 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 52.0 p 67.49 -0.71 1.79 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 127.601 2.36 . . . . 0.0 116.244 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 C-N-CA 125.624 1.583 . . . . 0.0 113.062 179.848 . . . . . . . . 0 0 . 1 stop_ save_